data_2kwx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kwx _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo . . . . . 0 N--CA 1.489 1.259 0 N-CA-C 110.904 -0.46 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 18.6 tp -64.81 -51.52 61.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.972 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.23 -51.57 65.69 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.142 0.496 . . . . 0.0 109.928 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 49.2 t -56.91 -42.86 79.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.651 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.93 -45.49 78.73 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.73 -46.04 81.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.113 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.3 t -56.05 -50.66 70.34 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.332 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.422 HD13 HG23 ' A' ' 32' ' ' ILE . 55.3 mt -56.59 -37.82 54.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.611 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 87.5 mt -65.37 -41.88 92.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.055 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.13 -52.32 37.59 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.643 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.5 -44.6 93.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 52.4 tp -63.9 -32.06 73.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.485 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -68.62 -51.66 39.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.817 0.341 . . . . 0.0 111.043 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 28.8 tp -63.04 -51.22 67.59 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.29 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.8 mm -61.58 -44.33 98.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.983 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 47.5 tp -61.54 -38.91 89.15 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.302 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 39.9 t-105 -63.5 -55.72 21.79 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.87 0.367 . . . . 0.0 111.405 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 74.8 mt -59.47 -54.18 38.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.802 -177.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 44.9 tp -61.25 -44.66 96.89 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.961 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -51.98 -44.87 64.23 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.472 ' NH2' ' CB ' ' D' ' 54' ' ' PHE . 65.8 ttt180 -61.2 -50.89 71.29 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.255 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.5 mt -81.73 -131.3 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.78 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 39.5 t80 62.47 101.31 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.592 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 41.73 38.83 1.03 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.605 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 66.9 mttm 53.39 49.42 19.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.158 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.9 t -49.49 -27.37 4.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.632 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.452 ' CD1' ' O ' ' A' ' 45' ' ' ARG . 3.6 mp -47.5 -45.33 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.9 0.381 . . . . 0.0 110.093 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.519 ' CE2' ' OE1' ' A' ' 56' ' ' GLU . 86.8 t80 -71.15 -29.04 64.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.175 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.527 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 79.5 mtp180 -69.02 -45.53 70.27 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.027 0.441 . . . . 0.0 110.33 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -70.69 -37.11 73.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.651 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -67.91 -39.91 83.49 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 120.629 -0.429 . . . . 0.0 111.661 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.519 ' OE1' ' CE2' ' A' ' 52' ' ' TYR . 21.9 pt-20 -76.41 -40.1 51.72 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.145 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.527 ' ND1' ' O ' ' A' ' 53' ' ' ARG . 32.6 m170 -64.77 -45.84 84.65 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.757 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.815 0 N-CA-C 110.774 -0.931 . . . . 0.0 110.774 179.917 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.718 0.294 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -51.63 -32.87 46.43 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.492 2.128 . . . . 0.0 111.27 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 19.2 tp -61.5 -47.31 86.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.904 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.93 -46.15 91.82 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 91.9 t -60.56 -33.39 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.39 -35.65 81.12 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.77 -44.07 74.43 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.386 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 4.8 t -67.02 -51.32 56.34 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 120.081 -0.648 . . . . 0.0 111.563 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 19.9 tt -62.72 -40.96 90.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.738 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 17.4 tt -71.68 -28.44 31.01 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.14 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.247 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.15 -52.22 28.85 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 6.4 pt -64.27 -42.94 96.99 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.217 0 C-N-CA 120.234 -0.587 . . . . 0.0 109.902 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 11.5 tp -59.75 -39.44 84.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.67 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . 0.545 ' NE2' ' NE2' ' C' ' 37' ' ' HIS . 28.9 t60 -68.0 -54.46 18.27 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -178.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 38.5 tp -62.12 -51.54 67.48 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 120.999 0.428 . . . . 0.0 111.761 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.478 ' CD1' ' N ' ' B' ' 39' ' ' ILE . 1.2 mp -62.18 -43.36 97.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.229 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 37.0 tp -59.46 -38.49 80.9 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.98 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 6.8 t-105 -63.85 -63.23 1.22 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.998 0.428 . . . . 0.0 111.611 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.548 ' CG2' ' N ' ' B' ' 43' ' ' LEU . 8.6 tt -53.25 -50.89 44.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 119.944 -0.703 . . . . 0.0 110.74 -177.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.548 ' N ' ' CG2' ' B' ' 42' ' ' ILE . 0.5 OUTLIER -57.65 -50.23 73.86 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.46 -178.128 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -50.27 -37.27 35.17 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 63.9 ttt-85 -68.95 -50.99 44.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.084 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.438 ' O ' ' O ' ' B' ' 43' ' ' LEU . 0.3 OUTLIER -96.79 128.47 43.77 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.614 -179.398 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -162.53 -54.29 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.422 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -170.92 -60.31 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.303 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -147.87 18.46 1.13 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.316 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 47.3 t -54.34 -49.84 68.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.729 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 49.9 mt -53.84 -50.05 54.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.986 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.479 ' CE2' ' OE2' ' B' ' 56' ' ' GLU . 79.2 t80 -74.18 -30.6 62.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.748 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 20.1 mmt85 -69.15 -47.75 64.15 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.705 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -72.6 -39.77 67.04 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.872 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -64.08 -41.39 97.34 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 120.751 -0.379 . . . . 0.0 111.462 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . 0.479 ' OE2' ' CE2' ' B' ' 52' ' ' TYR . 10.9 pt-20 -76.92 -38.07 54.13 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 120.404 -0.519 . . . . 0.0 110.738 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -59.58 -49.27 78.4 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.35 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.21 -29.48 74.43 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 9.6 tp -87.29 58.12 4.83 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.802 0.334 . . . . 0.0 110.296 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 62.8 mttp . . . . . 0 N--CA 1.466 0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.399 -179.904 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -157.71 72.29 4.24 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.778 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -51.04 -35.69 51.62 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.485 2.123 . . . . 0.0 111.221 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 15.3 tp -58.16 -53.07 62.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.958 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.25 -46.09 91.0 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.044 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 89.9 t -60.25 -33.46 53.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.07 -38.39 90.9 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.95 -51.32 62.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.106 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 31' ' ' SER . . . . . 0.419 ' H ' ' HG ' ' C' ' 31' ' ' SER . 2.8 p -62.01 -52.27 64.67 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.595 -0.442 . . . . 0.0 112.022 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 10.1 tp -59.37 -37.71 70.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.489 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 29.6 mt -63.14 -40.86 90.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.73 -52.1 45.71 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.65 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 50.2 mm -56.7 -48.24 81.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.551 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 7.4 tp -62.73 -34.3 76.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.834 0.35 . . . . 0.0 110.816 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . 0.545 ' NE2' ' NE2' ' B' ' 37' ' ' HIS . 1.5 t60 -65.12 -50.16 67.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.431 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 11.0 mp -66.56 -44.86 81.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.411 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 30.6 mm -63.34 -47.14 93.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.268 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 34.8 mt -65.9 -40.46 91.55 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.666 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 32.7 t-105 -61.27 -54.47 43.69 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.021 0.439 . . . . 0.0 111.607 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . 0.409 HD13 HG23 ' C' ' 42' ' ' ILE . 82.8 mt -65.43 -55.0 22.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.113 -177.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . 0.426 ' C ' ' CD1' ' C' ' 43' ' ' LEU . 2.9 tm? -59.83 -52.37 65.76 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.141 -178.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . 0.499 ' OD1' ' CE1' ' C' ' 54' ' ' PHE . 66.4 t0 -52.86 -41.77 64.6 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.107 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 55.1 ttt-85 -59.94 -53.55 56.58 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.224 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . 0.403 ' O ' ' CB ' ' C' ' 47' ' ' PHE . 4.1 mt -84.08 -140.42 0.07 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.091 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . 0.529 ' O ' ' N ' ' C' ' 49' ' ' LYS . 7.2 t80 78.63 -164.22 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.168 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . 0.406 ' O ' ' C ' ' C' ' 49' ' ' LYS . 85.9 t80 -57.03 81.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.406 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' C' ' 47' ' ' PHE . 15.9 ptpt 33.27 53.34 0.41 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.122 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 42.9 t -57.88 -46.32 85.06 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.302 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 3.5 mp -43.46 -42.48 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.944 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -71.11 -31.2 67.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.455 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -70.13 -46.73 64.16 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.512 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . 0.499 ' CE1' ' OD1' ' C' ' 44' ' ' ASP . 32.2 m-85 -66.14 -43.49 86.93 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.29 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -61.67 -39.9 93.03 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.693 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 . . . . . 0 CA--C 1.535 0.373 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.894 179.724 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo . . . . . 0 N--CA 1.483 0.907 0 N-CA-C 110.496 -0.617 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 pp -67.86 -37.53 81.94 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.7 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.4 -40.38 59.16 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.741 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 90.4 t -57.58 -45.21 86.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.67 -32.79 70.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.265 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.61 -35.41 78.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.992 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 5.1 t -68.38 -50.84 50.2 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.519 -0.473 . . . . 0.0 111.081 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 63.9 mt -64.72 -40.33 88.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.407 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 6.8 tt -68.95 -35.68 70.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.893 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.72 -52.64 14.48 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.673 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 10.3 tp -63.15 -40.83 90.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.934 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 52.4 tp -63.4 -37.46 87.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.755 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -63.07 -50.74 69.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.465 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 37.3 tp -57.04 -48.3 78.87 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.554 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . 0.424 HD11 HG22 ' D' ' 39' ' ' ILE . 97.1 mt -60.05 -41.26 85.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.67 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 37.9 mt -62.32 -39.41 92.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.186 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 31.5 t-105 -63.33 -54.4 37.62 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.798 0.332 . . . . 0.0 111.23 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 61.5 mt -61.77 -53.19 51.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 120.65 -0.42 . . . . 0.0 112.11 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' D' ' 46' ' ' LEU . 37.0 tp -61.51 -48.38 81.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.12 -178.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . 0.443 ' O ' ' CB ' ' D' ' 50' ' ' SER . 32.3 t70 -54.36 -45.69 72.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.209 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -60.1 -50.23 74.54 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.513 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' D' ' 43' ' ' LEU . 2.8 pp -122.73 125.62 45.9 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.056 0.455 . . . . 0.0 110.583 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -174.19 -45.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.539 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . 0.527 ' O ' ' NH1' ' D' ' 53' ' ' ARG . 77.8 t80 -172.92 67.96 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.293 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 67.2 mttm 55.94 39.48 30.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.278 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 50' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 6.6 t -64.15 -52.78 57.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.921 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 62.1 mt -49.0 -34.34 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.856 0.36 . . . . 0.0 110.264 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -72.53 -29.85 63.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.01 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 53' ' ' ARG . . . . . 0.527 ' NH1' ' O ' ' D' ' 48' ' ' PHE . 95.3 mtm-85 -72.09 -48.2 45.74 Favored 'General case' 0 CA--C 1.522 -0.122 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.616 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . 0.472 ' CB ' ' NH2' ' A' ' 45' ' ' ARG . 87.4 m-85 -68.04 -42.09 81.08 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.792 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -65.64 -40.94 93.06 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.279 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -77.18 -21.87 53.33 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.61 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -74.28 -48.71 26.82 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.318 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.41 -31.47 78.98 Favored Glycine 0 N--CA 1.46 0.265 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 59' ' ' LEU . . . . . 0.402 ' C ' ' CD1' ' D' ' 59' ' ' LEU . 0.2 OUTLIER -65.1 -62.69 1.4 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.831 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 97.3 mttt . . . . . 0 C--N 1.333 -0.131 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.573 179.675 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo . . . . . 0 N--CA 1.487 1.104 0 N-CA-C 110.905 -0.46 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 pp -70.53 -30.21 66.9 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.704 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.09 -40.41 73.59 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 120.586 -0.446 . . . . 0.0 109.815 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.7 t -58.54 -45.84 90.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.45 -32.26 71.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.755 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.24 -47.31 77.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.553 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.5 p -65.28 -35.05 79.82 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.409 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.5 mm -66.07 -50.51 68.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.607 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.4 tt -68.87 -28.61 40.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.795 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.99 -48.86 30.69 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.497 -0.858 . . . . 0.0 111.121 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.0 mm -64.51 -44.49 96.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.808 0.337 . . . . 0.0 110.162 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.2 tp -63.63 -39.21 93.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.034 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -63.32 -46.1 88.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.268 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.48 ' CD1' ' HD1' ' D' ' 37' ' ' HIS . 16.6 tp -65.66 -47.55 75.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.843 0.354 . . . . 0.0 111.535 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 29.2 mm -61.66 -50.1 81.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.408 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -65.77 -33.02 74.9 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.23 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 21.0 t-105 -64.3 -52.62 57.64 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.811 0.339 . . . . 0.0 111.406 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.3 mt -67.75 -50.38 60.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.82 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.7 tp -61.94 -44.89 95.83 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.03 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.439 ' O ' ' CB ' ' A' ' 50' ' ' SER . 28.4 t70 -58.99 -44.58 91.63 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.811 -0.355 . . . . 0.0 110.119 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 61.8 ttt85 -60.39 -45.04 95.0 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.612 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.5 pp -135.74 129.9 33.32 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.919 0.39 . . . . 0.0 110.996 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -173.83 -33.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.366 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.471 ' CD2' ' O ' ' A' ' 48' ' ' PHE . 52.9 t80 -172.52 45.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.164 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt 73.28 40.69 0.52 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.235 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.462 ' O ' ' N ' ' A' ' 53' ' ' ARG . 9.8 t -62.12 -46.24 89.89 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.004 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 91.2 mt -44.13 -38.97 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.025 0.44 . . . . 0.0 110.26 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -74.99 -28.26 60.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.217 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.53 ' O ' ' CD2' ' A' ' 57' ' ' HIS . 87.1 mtt180 -68.76 -49.48 58.33 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 121.007 0.432 . . . . 0.0 110.344 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -71.35 -39.97 70.96 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.876 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -64.76 -40.35 95.15 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.795 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -76.86 -41.17 45.0 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.971 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.53 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 9.2 m-70 -59.73 -48.43 81.73 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.665 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.807 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.99 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.672 0.272 . . . . 0.0 110.683 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -49.95 -36.75 44.93 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.447 2.098 . . . . 0.0 111.242 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 18.2 tp -57.5 -50.72 72.16 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.939 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.21 -51.24 70.4 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.401 ' O ' ' OG ' ' B' ' 31' ' ' SER . 93.1 t -54.6 -38.82 43.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.86 -40.25 79.71 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.72 -40.14 94.83 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.232 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' B' ' 28' ' ' VAL . 31.9 p -67.22 -55.76 12.7 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.587 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 18.5 tt -59.7 -41.13 84.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.904 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 16.3 tt -70.05 -29.76 41.28 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.213 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.76 -51.05 37.76 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.0 mp -61.03 -43.66 96.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 12.3 tp -60.91 -38.24 85.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.684 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -66.94 -52.72 39.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.706 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 42.0 tp -62.45 -50.54 71.06 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.602 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 14.7 mm -61.36 -42.19 92.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.423 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 6.4 tt -61.91 -38.82 89.82 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.075 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 49.9 t-105 -63.65 -55.49 23.12 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 60.2 mt -63.65 -53.47 44.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.767 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.88 -47.34 83.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.128 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . 0.434 ' O ' ' OG ' ' B' ' 50' ' ' SER . 64.9 t0 -59.72 -45.98 90.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.928 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -58.71 -52.33 66.17 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.058 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.11 129.82 56.77 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 120.996 0.427 . . . . 0.0 110.277 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -175.04 -55.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.296 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -169.31 71.74 0.08 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.306 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 49.5 mttp 60.14 30.19 19.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.469 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' B' ' 44' ' ' ASP . 11.0 t -56.31 -50.84 70.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.857 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 59.2 mt -51.9 -44.37 37.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.889 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.494 ' CE2' ' OE1' ' B' ' 56' ' ' GLU . 78.2 t80 -71.99 -32.2 66.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.474 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . 0.529 ' O ' ' CG ' ' B' ' 57' ' ' HIS . 78.7 mtp180 -67.67 -45.99 73.66 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.724 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -71.89 -38.94 69.91 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.792 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -64.18 -41.22 97.19 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.49 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . 0.494 ' OE1' ' CE2' ' B' ' 52' ' ' TYR . 21.1 pt-20 -76.78 -39.02 52.96 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.692 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' HIS . . . . . 0.529 ' CG ' ' O ' ' B' ' 53' ' ' ARG . 6.4 m-70 -58.63 -48.21 81.76 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.657 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.31 -28.5 73.64 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 11.0 mp -104.64 66.68 0.79 Allowed 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 97.6 mttt . . . . . 0 N--CA 1.466 0.336 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.362 -179.791 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 49.14 68.66 3.3 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.674 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -51.65 -31.57 41.28 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.496 2.131 . . . . 0.0 111.186 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' C' ' 29' ' ' ALA . 3.0 pp -60.69 -28.24 68.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.781 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -46.94 -38.9 11.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.259 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 68.2 t -59.78 -40.96 84.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' C' ' 26' ' ' LEU . . . -62.33 -34.42 76.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.392 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.18 -49.5 69.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.927 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 31' ' ' SER . . . . . 0.407 ' H ' ' HG ' ' C' ' 31' ' ' SER . 4.4 p -64.6 -50.79 65.81 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 3.2 tp -60.17 -37.94 75.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.559 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 51.1 mt -67.73 -38.0 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.654 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.5 -51.81 34.46 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.804 -0.713 . . . . 0.0 111.967 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 9.6 pt -64.45 -37.9 81.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.467 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 13.0 tp -65.7 -40.73 92.59 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -63.86 -52.61 59.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.587 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 50.9 tp -63.63 -47.8 79.87 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.652 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 84.4 mt -59.92 -45.35 95.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.143 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.5 -38.82 92.34 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.906 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 25.7 t-105 -59.46 -57.21 13.99 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.334 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 54.1 mt -63.75 -54.53 30.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -177.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' C' ' 46' ' ' LEU . 0.8 OUTLIER -58.45 -48.98 78.96 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.75 0.309 . . . . 0.0 111.191 -178.443 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . 0.502 ' O ' ' CB ' ' C' ' 50' ' ' SER . 38.7 t70 -57.49 -48.67 78.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.986 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 34.2 ttt-85 -56.79 -52.8 63.65 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.229 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' C' ' 43' ' ' LEU . 2.6 pp -113.68 129.94 56.49 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.132 0.491 . . . . 0.0 110.977 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -173.81 -39.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.329 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -169.51 -67.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.368 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -150.44 25.63 0.78 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.096 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 50' ' ' SER . . . . . 0.502 ' CB ' ' O ' ' C' ' 44' ' ' ASP . 6.6 t -50.23 -53.65 26.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.559 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 66.3 mt -50.68 -49.41 25.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.212 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -73.6 -31.11 63.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.687 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -70.42 -49.4 49.24 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.428 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -67.36 -41.47 85.05 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.351 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -62.61 -38.68 91.13 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 120.484 -0.487 . . . . 0.0 110.809 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 . . . . . 0 CA--C 1.536 0.433 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.916 179.657 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . 0.425 ' O ' ' N ' ' D' ' 29' ' ' ALA . 76.0 Cg_exo . . . . . 0 N--CA 1.489 1.211 0 N-CA-C 110.819 -0.493 . . . . 0.0 110.819 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 25.9 tp -56.48 -48.47 77.07 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.2 -51.2 71.0 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.21 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 89.3 t -60.28 -29.16 43.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.57 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' D' ' 25' ' ' PRO . . . -66.88 -37.05 83.68 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.32 -38.41 74.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.561 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 1.4 m -68.98 -47.57 65.25 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.7 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 10.0 tp -69.11 -41.22 81.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.632 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 9.9 tt -67.06 -39.95 84.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.498 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.65 -51.03 32.73 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.879 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . 0.405 ' CG2' ' N ' ' D' ' 36' ' ' LEU . 0.2 OUTLIER -59.93 -43.59 92.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.409 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . 0.405 ' N ' ' CG2' ' D' ' 35' ' ' ILE . 49.7 tp -60.41 -39.6 87.96 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.89 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . 0.48 ' HD1' ' CD1' ' A' ' 38' ' ' LEU . 53.7 t60 -61.35 -48.4 81.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.29 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 57.4 tp -55.47 -52.79 62.46 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.837 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 1.4 mp -61.88 -33.23 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.443 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 6.1 tp -65.49 -42.97 91.56 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.717 0.294 . . . . 0.0 110.576 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 21.9 t-105 -66.13 -58.75 4.74 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 120.883 0.373 . . . . 0.0 111.54 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . 0.519 ' CG2' ' N ' ' D' ' 43' ' ' LEU . 9.1 tt -60.47 -47.39 92.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.466 -177.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . 0.519 ' N ' ' CG2' ' D' ' 42' ' ' ILE . 23.0 tp -63.43 -44.86 93.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.564 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . 0.516 ' OD1' ' CE1' ' D' ' 54' ' ' PHE . 40.8 t0 -56.44 -37.69 70.59 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 12.4 ttm180 -69.42 -53.53 18.86 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.895 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.08 113.5 22.39 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.987 0.422 . . . . 0.0 110.149 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -174.8 83.9 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.074 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 54.97 71.61 0.53 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.525 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 98.5 mttt 51.2 48.89 22.18 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.289 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 2.6 t -68.79 -52.85 25.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.127 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 9.4 mt -47.74 -37.54 5.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.087 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -73.87 -31.27 63.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.133 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -71.08 -47.2 59.67 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.877 0.37 . . . . 0.0 110.772 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . 0.516 ' CE1' ' OD1' ' D' ' 44' ' ' ASP . 64.9 m-85 -71.74 -37.35 70.59 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.763 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -67.84 -41.16 83.41 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.615 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -76.71 -36.96 56.86 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.72 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 62.7 t-80 -63.49 -48.31 78.15 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.299 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.04 -27.91 73.55 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 5.9 tp -92.96 39.07 1.03 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.871 0.367 . . . . 0.0 110.326 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 3.1 tmtm? . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.386 -179.666 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo . . . . . 0 N--CA 1.493 1.445 0 CA-C-O 120.931 0.305 . . . . 0.0 111.661 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 pp -62.64 -29.8 70.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.06 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.48 -34.48 25.14 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.152 0.501 . . . . 0.0 109.982 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.2 t -59.13 -48.81 85.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 CA-C-O 121.539 0.685 . . . . 0.0 109.274 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.22 -30.69 71.27 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.567 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.68 -47.36 81.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.213 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.9 t -62.22 -48.07 81.6 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.866 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.2 mp -62.12 -33.51 58.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.293 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 38.4 mt -70.49 -38.92 75.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 121.123 -0.231 . . . . 0.0 110.759 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.15 -53.48 18.08 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.393 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.404 ' CG2' ' N ' ' A' ' 36' ' ' LEU . 19.2 tt -60.24 -41.1 85.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.728 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.404 ' N ' ' CG2' ' A' ' 35' ' ' ILE . 40.5 tp -66.42 -30.87 71.33 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.35 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -68.55 -48.97 62.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.472 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.5 mp -63.86 -50.36 69.15 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.978 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 86.1 mt -62.13 -48.1 90.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.378 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.7 tp -61.08 -42.1 97.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.701 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.7 t-105 -62.46 -56.26 19.85 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 120.865 0.364 . . . . 0.0 111.518 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.03 -55.24 24.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.871 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.2 tp -61.24 -48.15 82.78 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.289 -0.564 . . . . 0.0 111.36 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -53.58 -39.15 64.6 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 42.1 ttt-85 -63.49 -51.17 66.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.442 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 48' ' ' PHE . 7.1 mt -83.18 -77.05 0.26 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.023 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.416 ' CD2' ' N ' ' A' ' 48' ' ' PHE . 88.4 t80 46.69 -88.25 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.415 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.534 ' N ' ' O ' ' A' ' 46' ' ' LEU . 62.5 t80 -164.39 87.33 0.48 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.099 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm 59.14 27.47 16.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.13 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.8 t -59.78 -44.47 93.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.657 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.3 mp -52.19 -36.38 20.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.01 0.433 . . . . 0.0 110.068 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.495 ' CD2' ' OE2' ' A' ' 56' ' ' GLU . 81.4 t80 -74.01 -27.78 61.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.221 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 48' ' ' PHE . 68.2 mtt85 -69.97 -49.33 52.76 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.96 0.409 . . . . 0.0 110.559 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -72.03 -39.17 69.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.945 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -66.79 -39.69 87.86 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.711 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.495 ' OE2' ' CD2' ' A' ' 52' ' ' TYR . 10.1 pt-20 -76.17 -40.36 52.66 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.658 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.529 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 6.4 m-70 -60.68 -47.43 86.29 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.54 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.948 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.935 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 120.635 0.255 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -50.4 -29.33 23.56 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.511 2.141 . . . . 0.0 111.606 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 14.3 tp -61.64 -52.29 64.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.189 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.98 -46.34 88.36 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.609 0.719 . . . . 0.0 109.384 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.445 ' O ' ' OG ' ' B' ' 31' ' ' SER . 72.5 t -56.69 -47.11 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.1 -44.38 52.07 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.69 -50.35 72.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.796 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' B' ' 28' ' ' VAL . 60.7 p -57.45 -48.81 78.19 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 120.309 -0.557 . . . . 0.0 111.447 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 34.1 mm -59.67 -35.64 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.114 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . 0.41 HD13 HG23 ' B' ' 33' ' ' ILE . 86.3 mt -70.24 -34.43 58.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.572 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.85 -52.94 21.86 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.497 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 7.9 pt -64.7 -39.97 87.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.1 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 37.3 tp -62.23 -40.03 94.8 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.47 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 22.3 t-160 -66.85 -53.68 30.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.732 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 34.8 tp -61.99 -53.21 58.74 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.737 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 56.7 mt -60.48 -44.22 95.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.794 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 32.5 tp -56.72 -43.26 80.42 Favored 'General case' 0 C--O 1.222 -0.364 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 21.7 t-105 -60.44 -54.19 48.58 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.161 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 5.2 mm -54.02 -58.34 3.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-O 121.237 0.541 . . . . 0.0 111.921 -177.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.449 ' CD1' ' C ' ' B' ' 43' ' ' LEU . 0.3 OUTLIER -62.4 -35.8 80.33 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.78 -178.488 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . 0.434 ' O ' ' OG ' ' B' ' 50' ' ' SER . 22.8 t70 -58.1 -44.84 87.87 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -65.77 -45.01 84.09 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.444 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.541 ' C ' ' H ' ' B' ' 48' ' ' PHE . 0.3 OUTLIER -113.74 -120.49 0.3 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.098 179.485 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 37.3 t80 68.06 -35.29 0.27 Allowed 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.15 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . 0.541 ' H ' ' C ' ' B' ' 46' ' ' LEU . 31.0 t80 -169.06 42.97 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.678 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt 45.05 40.38 4.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.57 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' SER . . . . . 0.461 ' O ' ' N ' ' B' ' 53' ' ' ARG . 1.4 p -61.8 -24.02 66.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.857 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 9.4 mt -41.55 -41.05 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.878 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -74.25 -29.69 61.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.379 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . 0.461 ' N ' ' O ' ' B' ' 50' ' ' SER . 99.2 mtt180 -71.53 -47.61 54.11 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.935 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . 0.596 ' CE1' ' NH2' ' C' ' 45' ' ' ARG . 66.6 m-85 -72.81 -39.7 66.43 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.939 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -67.87 -39.26 83.76 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.644 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -76.93 -38.83 52.62 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.614 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -62.02 -47.29 85.42 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.259 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.12 -27.48 72.95 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 35.2 tp -79.85 -73.76 0.33 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.711 0.291 . . . . 0.0 110.541 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 68.5 mttm . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.601 -179.995 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 17.9 m . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -177.54 56.53 0.11 Allowed Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.493 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.77 -30.42 68.91 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.104 1.869 . . . . 0.0 110.698 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 19.2 tp -68.8 -48.26 64.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.068 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.61 -46.91 87.58 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.234 0.54 . . . . 0.0 109.615 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 82.1 t -59.39 -34.34 54.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.247 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.91 -34.85 78.88 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.47 -42.71 78.35 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.231 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 6.6 t -68.45 -48.48 64.45 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.189 -0.604 . . . . 0.0 111.802 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 14.6 tt -66.03 -40.84 88.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.64 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 tt -69.22 -36.4 72.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.703 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.09 -51.45 38.97 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 120.497 -0.858 . . . . 0.0 110.973 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 34.7 mm -60.6 -41.21 87.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 13.4 tp -60.45 -45.02 95.18 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.361 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . 0.476 ' C ' ' ND1' ' C' ' 37' ' ' HIS . 9.1 t-80 -60.82 -52.29 65.71 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.84 0.352 . . . . 0.0 111.379 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 55.4 tp -56.6 -48.62 77.04 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.05 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 56.1 mt -63.79 -34.47 68.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.006 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.52 -48.64 74.37 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 15.3 t-105 -62.81 -56.96 12.74 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 73.6 mt -59.48 -51.91 67.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.872 -177.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' C' ' 46' ' ' LEU . 2.8 tm? -58.87 -50.77 72.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.504 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -56.88 -35.16 68.62 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.025 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . 0.596 ' NH2' ' CE1' ' B' ' 54' ' ' PHE . 50.8 ttp180 -69.95 -57.68 4.74 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.831 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' C' ' 43' ' ' LEU . 1.1 pp -108.17 -164.34 0.95 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.66 0.267 . . . . 0.0 111.058 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 12.2 t80 74.42 -11.12 1.05 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.919 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' C' ' 49' ' ' LYS . 32.2 t80 -164.09 158.0 18.84 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.468 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . 0.541 ' N ' ' CD1' ' C' ' 48' ' ' PHE . 36.5 tttm -72.52 42.38 0.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.285 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 50' ' ' SER . . . . . 0.498 ' H ' ' C ' ' C' ' 48' ' ' PHE . 6.7 t -66.47 -47.5 72.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.0 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 71.5 mt -43.95 -42.17 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.941 -0.303 . . . . 0.0 111.306 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -72.47 -29.82 64.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.302 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -71.3 -49.66 40.51 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.535 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . 0.404 ' CB ' ' NH2' ' D' ' 45' ' ' ARG . 45.7 m-85 -65.68 -44.24 86.83 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.38 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -63.06 -36.47 83.69 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.527 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 . . . . . 0 CA--C 1.536 0.406 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.63 179.655 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo . . . . . 0 N--CA 1.495 1.567 0 CA-C-O 121.095 0.373 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 16.9 tp -61.53 -51.72 67.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.652 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.63 -44.99 93.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.44 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 88.9 t -59.48 -38.44 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.88 -35.32 76.33 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.93 -51.12 59.15 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.08 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 6.1 p -61.18 -50.52 72.82 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.786 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 3.3 tp -62.11 -37.65 78.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.596 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 29.4 mt -62.72 -41.31 91.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 120.399 -0.521 . . . . 0.0 109.673 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.97 -46.15 83.31 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.06 -0.59 . . . . 0.0 111.957 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.61 -47.48 93.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.918 0.389 . . . . 0.0 110.523 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 21.6 tp -64.18 -32.17 73.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.055 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -64.87 -49.94 68.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.005 0.431 . . . . 0.0 110.523 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 46.9 tp -63.12 -46.55 86.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.1 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.42 -47.62 91.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.122 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -62.54 -37.88 87.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.241 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 40.4 t-105 -62.27 -57.29 11.94 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.524 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 62.0 mt -61.45 -53.57 46.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.954 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 55.9 tp -58.76 -47.22 85.43 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.946 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -54.33 -45.26 72.62 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . 0.404 ' NH2' ' CB ' ' C' ' 54' ' ' PHE . 77.0 ttt180 -59.18 -53.13 61.84 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.402 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.91 113.3 25.92 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 120.904 0.383 . . . . 0.0 110.185 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -173.67 91.89 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.42 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 54.29 59.19 4.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.416 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? 53.69 54.61 9.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.49 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 5.6 t -68.11 -52.01 39.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.134 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 58.0 mt -48.5 -35.13 5.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.627 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -70.81 -29.93 66.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.085 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -69.63 -42.62 74.08 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.963 0.411 . . . . 0.0 110.464 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -72.09 -39.37 69.0 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.802 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -66.09 -40.74 91.04 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.511 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 56' ' ' GLU . . . . . 0.44 ' CD ' ' N ' ' D' ' 57' ' ' HIS . 2.9 pp20? -76.39 -37.13 57.6 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.501 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 57' ' ' HIS . . . . . 0.44 ' N ' ' CD ' ' D' ' 56' ' ' GLU . 86.3 t60 -60.69 -51.69 68.28 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.275 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.07 -26.66 73.42 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 14.7 tp -152.86 88.0 1.31 Allowed 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 64.5 mttp . . . . . 0 N--CA 1.458 -0.042 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.497 -179.617 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo . . . . . 0 N--CA 1.492 1.397 0 N-CA-C 111.226 -0.336 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.2 tp -63.65 -53.22 54.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.032 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.2 -41.93 85.06 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 95.8 t -63.41 -32.35 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.241 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.48 -36.21 83.2 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.43 -50.12 55.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.955 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.8 p -61.15 -50.09 74.57 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.683 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.0 tp -63.98 -34.19 66.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.072 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.43 HD12 HG21 ' A' ' 33' ' ' ILE . 25.1 mt -68.44 -43.04 84.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.553 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.28 -51.45 37.96 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.013 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.402 ' CG2' ' N ' ' A' ' 36' ' ' LEU . 9.7 tt -62.27 -40.09 86.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.017 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.402 ' N ' ' CG2' ' A' ' 35' ' ' ILE . 48.5 tp -64.57 -36.02 82.88 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.304 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -67.33 -50.9 58.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.803 0.335 . . . . 0.0 110.964 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 26.9 tp -61.74 -52.65 63.4 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.713 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 60.9 mt -62.73 -48.4 88.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.097 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 43.3 tp -54.78 -43.29 72.68 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 17.8 t-105 -60.67 -54.37 46.12 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.304 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.436 ' CG2' ' N ' ' A' ' 43' ' ' LEU . 1.0 OUTLIER -54.27 -48.9 66.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.002 -177.601 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.436 ' N ' ' CG2' ' A' ' 42' ' ' ILE . 20.6 tp -64.4 -41.9 96.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.386 -178.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.438 ' O ' ' OG ' ' A' ' 50' ' ' SER . 31.6 t70 -59.45 -36.24 75.57 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -71.18 -51.45 24.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.823 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.6 pp -123.67 125.34 44.61 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.109 0.48 . . . . 0.0 110.707 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -173.95 -43.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.251 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -172.48 67.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.263 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 68.2 mttm 55.43 38.55 30.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.411 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 44' ' ' ASP . 34.8 t -63.35 -48.07 79.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.806 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 80.0 mt -48.69 -39.1 10.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.926 0.393 . . . . 0.0 109.989 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.517 ' CE2' ' OE2' ' A' ' 56' ' ' GLU . 93.3 t80 -70.98 -29.56 65.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.314 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.515 ' O ' ' CD2' ' A' ' 57' ' ' HIS . 90.2 mtt-85 -69.12 -44.17 72.93 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.125 0.488 . . . . 0.0 110.388 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.505 ' CB ' HH21 ' B' ' 45' ' ' ARG . 58.2 m-85 -70.94 -40.68 71.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.804 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -65.75 -39.27 90.91 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.744 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.517 ' OE2' ' CE2' ' A' ' 52' ' ' TYR . 12.5 pt-20 -76.47 -40.43 50.42 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.902 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.515 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 6.9 m-70 -60.98 -52.26 65.75 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.487 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.606 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.543 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 . . . . . 0 CA--C 1.528 0.102 0 CA-C-O 120.475 0.179 . . . . 0.0 110.682 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -50.7 -33.04 38.47 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.407 2.072 . . . . 0.0 111.309 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 17.7 tp -61.13 -51.2 70.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.064 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.75 -42.42 97.38 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 91.6 t -61.67 -34.91 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.37 -40.41 94.2 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.94 -50.98 68.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.07 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' SER . . . . . 0.404 ' H ' ' HG ' ' B' ' 31' ' ' SER . 4.3 p -60.17 -53.11 61.64 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 8.8 tp -60.16 -38.48 77.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.993 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 69.2 mt -64.41 -40.3 88.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.029 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.8 -52.31 49.31 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 48.4 mm -56.36 -43.38 77.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.971 0.415 . . . . 0.0 110.034 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 11.4 tp -62.12 -36.1 80.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.654 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . 0.607 ' NE2' ' NE2' ' C' ' 37' ' ' HIS . 18.8 t60 -67.96 -54.43 18.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.942 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 40.2 tp -62.68 -49.94 73.11 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.63 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 15.8 mm -62.29 -44.03 98.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.513 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 43.8 tp -59.17 -39.9 83.95 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.534 -0.466 . . . . 0.0 109.877 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 21.8 t-105 -63.47 -56.28 17.38 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.413 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 94.6 mt -55.41 -51.57 55.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.141 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 mt -60.21 -44.82 94.83 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.216 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . 0.428 ' O ' ' OG ' ' B' ' 50' ' ' SER . 65.9 t0 -58.71 -37.82 76.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.805 0.336 . . . . 0.0 110.657 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.505 HH21 ' CB ' ' A' ' 54' ' ' PHE . 61.8 ttt85 -68.93 -48.34 63.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.067 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.46 111.8 19.12 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 120.974 0.416 . . . . 0.0 110.371 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -175.46 87.79 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.185 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 48.8 t80 58.43 60.41 2.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.462 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp 54.76 47.88 21.43 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.522 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' B' ' 44' ' ' ASP . 6.5 t -62.93 -49.82 73.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.859 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 10.9 mt -48.55 -40.82 11.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.704 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -71.34 -28.69 64.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.53 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -69.38 -43.51 73.37 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.606 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -73.47 -44.58 57.7 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.938 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -62.93 -40.08 96.53 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.513 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -77.49 -37.32 51.42 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.549 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -58.63 -48.19 81.87 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.348 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.32 -33.07 84.99 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -81.89 -72.36 0.44 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 63.4 tttm . . . . . 0 C--N 1.331 -0.209 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.379 -179.896 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 29.6 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -159.96 71.3 3.14 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.856 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -51.26 -30.96 35.19 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.446 2.097 . . . . 0.0 111.273 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 12.0 tp -61.02 -52.04 66.68 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.906 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.27 -46.59 89.31 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.019 178.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . 0.435 ' O ' ' OG ' ' C' ' 31' ' ' SER . 76.5 t -57.15 -47.27 84.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.79 -42.2 57.85 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.13 -49.58 77.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.919 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 31' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' C' ' 28' ' ' VAL . 1.1 p -57.8 -50.94 71.59 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.283 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 22.1 mm -61.79 -29.57 46.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.65 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 2.3 mm -68.18 -41.35 83.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.35 -52.64 25.61 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.574 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 48.1 mm -60.88 -43.98 96.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.887 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 12.5 tp -63.93 -40.67 96.98 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . 0.607 ' NE2' ' NE2' ' B' ' 37' ' ' HIS . 57.1 t60 -60.95 -48.66 80.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.88 0.371 . . . . 0.0 111.173 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 29.6 tp -65.05 -50.8 64.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.106 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 4.3 mm -60.21 -47.52 91.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.389 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . 0.407 ' O ' ' CB ' ' C' ' 44' ' ' ASP . 3.1 mm? -64.58 -36.95 85.9 Favored 'General case' 0 C--O 1.22 -0.476 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.036 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . 0.458 ' CZ3' ' CZ2' ' D' ' 41' ' ' TRP . 14.2 t-105 -60.47 -53.95 51.41 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.141 0.495 . . . . 0.0 111.257 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 90.4 mt -66.85 -56.41 14.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.052 -177.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.43 -48.19 77.52 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.642 -178.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . 0.407 ' CB ' ' O ' ' C' ' 40' ' ' LEU . 28.9 t70 -53.8 -45.7 70.84 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 60.3 ttt85 -58.22 -52.19 66.61 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.069 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 9.8 mt -72.28 -76.87 0.1 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.511 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . 0.492 ' CG ' ' N ' ' C' ' 48' ' ' PHE . 37.4 t80 52.4 -177.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.176 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . 0.492 ' N ' ' CG ' ' C' ' 47' ' ' PHE . 39.0 m-85 -56.24 -41.36 75.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.954 0.407 . . . . 0.0 110.34 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -171.91 48.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.102 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 5.1 t -69.95 -45.88 66.5 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.65 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 64.5 mt -44.48 -55.68 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -74.96 -34.91 62.1 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -71.24 -49.99 37.59 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.819 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -66.04 -43.85 86.32 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.232 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -63.22 -36.64 84.33 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.702 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 . . . . . 0 CA--C 1.536 0.438 0 C-N-CA 120.384 -0.527 . . . . 0.0 110.879 179.401 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo . . . . . 0 N--CA 1.49 1.308 0 N-CA-C 110.8 -0.5 . . . . 0.0 110.8 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 14.1 tp -60.29 -51.96 67.3 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.509 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.46 -47.9 82.5 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 94.4 t -58.47 -33.73 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.197 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.43 -35.77 81.99 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.41 -39.09 81.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.392 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.96 -53.44 26.14 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.28 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 16.8 tt -62.65 -40.12 87.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.67 -178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 9.2 tt -70.05 -30.7 44.94 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 C-N-CA 120.179 -0.608 . . . . 0.0 110.282 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.68 -53.3 16.67 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 2.1 mp -60.87 -43.92 96.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 11.9 tp -62.31 -34.55 76.82 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.447 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 21.5 t-160 -66.09 -49.99 65.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.655 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 50.2 tp -60.33 -50.94 71.64 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.045 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 4.9 mm -60.26 -43.44 93.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 33.6 mt -61.56 -40.88 96.31 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.272 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . 0.458 ' CZ2' ' CZ3' ' C' ' 41' ' ' TRP . 40.4 t-105 -62.52 -53.96 47.0 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.64 0.257 . . . . 0.0 111.451 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 66.1 mt -63.49 -54.25 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -177.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' D' ' 46' ' ' LEU . 54.5 tp -61.57 -45.39 94.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.406 -178.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . 0.439 ' O ' ' CB ' ' D' ' 50' ' ' SER . 11.6 t70 -64.04 -32.39 73.93 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.466 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 56.2 ttt-85 -69.07 -56.31 8.12 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.262 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' D' ' 43' ' ' LEU . 0.1 OUTLIER -105.76 -167.39 1.31 Allowed 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.588 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 9.9 t80 72.86 124.96 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.78 0.324 . . . . 0.0 110.291 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . 0.436 ' CD2' ' O ' ' D' ' 48' ' ' PHE . 40.7 t80 59.74 20.01 8.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.424 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt 47.53 66.92 0.9 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.401 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 50' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 45.4 t -67.75 -46.57 71.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.005 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 55.8 mt -45.88 -40.27 3.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.84 0.352 . . . . 0.0 110.401 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -72.42 -32.91 66.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.051 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -72.01 -50.18 30.79 Favored 'General case' 0 C--N 1.335 -0.038 0 CA-C-O 120.911 0.386 . . . . 0.0 110.74 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -64.49 -42.4 95.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.25 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -63.69 -40.38 96.65 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.08 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -75.86 -20.8 57.82 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.452 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -74.13 -50.32 19.95 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.525 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.14 -27.72 73.55 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 6.4 tp -80.69 43.0 0.65 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.818 0.342 . . . . 0.0 110.421 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.579 -179.979 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo . . . . . 0 N--CA 1.491 1.335 0 N-CA-C 110.636 -0.563 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.5 tp -69.39 -44.55 71.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.982 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.2 -55.91 18.36 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.314 0.578 . . . . 0.0 110.015 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.2 t -55.09 -43.61 70.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.109 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.61 -45.44 70.07 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.45 -48.11 77.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.873 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.79 -43.57 69.4 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 120.438 -0.505 . . . . 0.0 109.891 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.44 HG23 HD11 ' A' ' 32' ' ' ILE . 57.6 mt -62.5 -39.72 85.52 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.052 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 93.6 mt -66.58 -41.97 89.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.466 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.89 -51.57 33.93 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.047 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.434 ' CG2' ' N ' ' A' ' 36' ' ' LEU . 14.9 tt -62.65 -43.56 98.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.34 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.434 ' N ' ' CG2' ' A' ' 35' ' ' ILE . 9.9 tp -63.96 -33.57 76.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.301 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -66.73 -53.54 32.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.829 0.347 . . . . 0.0 111.217 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.2 tp -59.85 -48.43 81.73 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.975 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.4 mm -61.47 -41.83 91.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.795 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.2 mt -59.98 -45.28 93.24 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.288 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 15.4 t-105 -61.52 -57.7 11.07 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.608 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 94.6 mt -56.88 -56.31 15.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -177.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 47' ' ' PHE . 24.1 tp -61.45 -51.29 69.33 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.208 -178.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -47.36 -40.54 17.62 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.445 ' NH2' ' CB ' ' D' ' 54' ' ' PHE . 61.4 ttt180 -64.37 -52.43 58.32 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.143 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.48 33.62 1.98 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.884 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.457 ' N ' ' O ' ' A' ' 43' ' ' LEU . 66.1 t80 -85.26 84.92 7.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.772 0.32 . . . . 0.0 110.571 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.5 t80 56.55 60.86 2.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.45 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 51.29 27.35 3.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.491 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.9 t -49.68 -30.42 9.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.565 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.1 mt -50.01 -41.26 17.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.954 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -73.55 -28.36 61.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.142 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.521 ' O ' ' CD2' ' A' ' 57' ' ' HIS . 0.8 OUTLIER -69.98 -48.77 56.91 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.309 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.467 ' CB ' ' NH2' ' B' ' 45' ' ' ARG . 53.6 m-85 -71.23 -37.24 72.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.95 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -68.31 -39.13 82.1 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.734 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -77.38 -40.94 42.06 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.102 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.521 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 21.5 m-70 -64.07 -47.37 80.39 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.751 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.854 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.916 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.682 0.277 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.04 -31.34 53.4 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.437 2.092 . . . . 0.0 111.278 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 16.5 tp -60.2 -51.2 70.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.903 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.27 -45.45 93.27 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 89.1 t -60.04 -36.55 68.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.094 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.5 -35.75 78.57 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.91 -45.15 75.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.325 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 8.0 p -66.01 -52.64 47.5 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.524 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 20.4 tt -61.45 -42.32 93.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 13.9 tt -69.38 -29.64 42.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 C-N-CA 119.794 -0.763 . . . . 0.0 110.232 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.98 -51.68 38.02 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 46.6 mm -61.26 -38.12 79.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 120.603 -0.439 . . . . 0.0 109.888 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 10.2 tp -62.55 -41.77 99.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.694 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -66.84 -51.71 52.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.888 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 39.9 tp -60.99 -49.44 77.45 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.284 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 26.7 mt -61.86 -42.08 93.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.465 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 56.3 tp -60.92 -41.25 95.79 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.271 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 41.3 t-105 -63.82 -57.77 8.85 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.785 0.326 . . . . 0.0 111.789 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 68.7 mt -59.19 -53.44 47.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.364 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.428 ' CD1' ' C ' ' B' ' 43' ' ' LEU . 3.1 tm? -55.94 -50.87 69.58 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.746 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -53.15 -45.43 68.43 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.945 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.467 ' NH2' ' CB ' ' A' ' 54' ' ' PHE . 65.8 ttt180 -61.43 -56.68 17.57 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.349 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.419 ' O ' ' O ' ' B' ' 43' ' ' LEU . 0.1 OUTLIER -108.61 130.99 55.31 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.05 0.452 . . . . 0.0 110.315 179.62 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.525 ' O ' ' CD2' ' B' ' 48' ' ' PHE . 63.7 t80 -174.04 -64.51 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.124 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . 0.525 ' CD2' ' O ' ' B' ' 47' ' ' PHE . 8.4 m-85 -161.25 83.65 0.64 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.813 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 64.8 mttp 53.86 27.89 7.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.535 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 8.0 t -57.67 -51.99 67.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.726 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 89.0 mt -52.92 -41.81 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.765 0.317 . . . . 0.0 110.685 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.506 ' CD2' ' OE2' ' B' ' 56' ' ' GLU . 81.7 t80 -72.46 -30.97 65.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.634 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -72.0 -46.14 58.3 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.971 0.415 . . . . 0.0 110.817 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -71.45 -38.05 71.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.99 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -70.77 -38.08 73.4 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.717 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . 0.506 ' OE2' ' CD2' ' B' ' 52' ' ' TYR . 10.4 pt-20 -76.16 -38.46 56.63 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.691 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -66.76 -45.64 77.89 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.279 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.32 -27.6 69.57 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 5.4 tp -70.14 -67.87 0.46 Allowed 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.786 0.327 . . . . 0.0 110.481 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.552 -179.939 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 54.9 68.62 2.47 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.739 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.22 -35.68 53.57 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.486 2.124 . . . . 0.0 111.466 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . 0.446 ' CD1' ' OG ' ' D' ' 31' ' ' SER . 14.2 tp -60.12 -51.11 71.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.859 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.53 -43.63 75.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.747 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 90.2 t -60.99 -32.03 51.42 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.45 -38.3 90.54 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.96 -51.89 59.3 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.058 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 5.3 t -60.57 -51.45 69.37 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.52 -0.472 . . . . 0.0 112.146 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 9.9 tp -61.84 -30.93 49.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.39 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 12.1 mt -67.0 -41.53 87.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 120.627 -0.429 . . . . 0.0 109.997 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.48 -51.22 32.72 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.933 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . 0.454 ' CG2' ' N ' ' C' ' 36' ' ' LEU . 0.2 OUTLIER -59.92 -45.61 94.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-O 121.378 0.608 . . . . 0.0 109.663 -179.678 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . 0.454 ' N ' ' CG2' ' C' ' 35' ' ' ILE . 53.6 tp -60.34 -40.47 90.8 Favored 'General case' 0 C--O 1.215 -0.746 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.129 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -59.27 -52.41 65.79 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.158 0.504 . . . . 0.0 111.017 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 16.7 tp -56.38 -50.14 72.41 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.407 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 1.2 mp -65.49 -31.65 54.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.853 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.38 -47.96 77.28 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.719 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 15.9 t-105 -63.84 -56.41 15.6 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 120.804 -0.359 . . . . 0.0 111.511 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 96.2 mt -56.84 -55.41 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.416 -0.514 . . . . 0.0 112.003 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . 0.431 ' C ' ' CD1' ' C' ' 43' ' ' LEU . 3.0 tm? -61.73 -50.9 70.57 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.939 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . 0.513 ' OD2' ' NH1' ' D' ' 45' ' ' ARG . 25.3 t70 -47.14 -43.32 20.69 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.047 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 60.9 ttt-85 -64.15 -52.26 59.91 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.576 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.15 114.94 26.69 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.595 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -174.22 102.36 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.416 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . 0.402 ' O ' ' CD2' ' C' ' 48' ' ' PHE . 51.6 t80 44.37 49.87 8.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.581 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? 57.16 40.27 28.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.306 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 4.6 t -62.39 -34.55 76.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.318 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 60.6 mt -47.34 -41.01 6.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.21 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 52' ' ' TYR . . . . . 0.478 ' CZ ' ' OE1' ' C' ' 56' ' ' GLU . 89.2 t80 -72.37 -29.41 63.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.519 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 73.1 mtm180 -71.38 -48.0 52.76 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.648 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -68.4 -41.84 79.91 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.397 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -64.44 -36.92 85.72 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.824 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . 0.478 ' OE1' ' CZ ' ' C' ' 52' ' ' TYR . 64.8 tt0 . . . . . 0 CA--C 1.536 0.405 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.784 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo . . . . . 0 N--CA 1.493 1.462 0 N-CA-C 110.725 -0.529 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 16.6 tp -63.3 -50.39 70.25 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.0 -47.3 85.71 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 71.7 t -60.11 -32.41 50.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.324 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.96 -32.9 74.45 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.05 -44.45 69.14 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.726 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 31' ' ' SER . . . . . 0.446 ' OG ' ' CD1' ' C' ' 26' ' ' LEU . 2.3 m -68.17 -45.01 74.64 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.733 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 11.5 tt -68.16 -41.47 84.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.553 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 13.0 tt -70.02 -34.67 60.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.485 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.07 -51.64 22.36 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.674 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 3.5 tp -64.02 -37.48 79.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.76 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 50.3 tp -64.07 -38.33 90.67 Favored 'General case' 0 CA--C 1.521 -0.136 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -65.95 -43.39 88.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.075 0.464 . . . . 0.0 109.86 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 mt -59.87 -51.36 70.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.778 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 74.3 mt -63.26 -40.48 89.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.209 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 7.6 tt -63.16 -45.22 92.85 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.981 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 31.8 t-105 -65.71 -52.0 54.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.89 0.376 . . . . 0.0 111.928 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 74.6 mt -63.29 -53.46 45.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.874 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 26.6 tp -61.87 -45.78 92.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.817 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . 0.464 ' O ' ' CB ' ' D' ' 50' ' ' SER . 27.5 t70 -55.66 -43.19 76.06 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.611 -0.436 . . . . 0.0 109.925 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . 0.513 ' NH1' ' OD2' ' C' ' 44' ' ' ASP . 67.5 ttt180 -61.97 -51.38 68.31 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.596 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.1 124.69 43.07 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 120.95 0.405 . . . . 0.0 110.207 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -174.61 -43.8 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.513 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . 0.428 ' CD2' ' O ' ' D' ' 48' ' ' PHE . 72.4 t80 -165.81 63.93 0.11 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.307 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? 54.52 40.19 31.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.182 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 50' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 7.4 t -62.15 -51.06 69.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.086 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 78.0 mt -48.51 -35.71 6.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.183 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 52' ' ' TYR . . . . . 0.501 ' CE2' ' OE2' ' D' ' 56' ' ' GLU . 90.6 t80 -71.44 -30.13 65.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.101 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -70.35 -43.18 70.75 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.974 0.416 . . . . 0.0 110.452 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . 0.445 ' CB ' ' NH2' ' A' ' 45' ' ' ARG . 72.9 m-85 -71.6 -39.89 70.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.727 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -66.11 -40.95 91.11 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.477 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 56' ' ' GLU . . . . . 0.501 ' OE2' ' CE2' ' D' ' 52' ' ' TYR . 12.7 pt-20 -74.41 -38.33 63.12 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.454 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 -61.1 -46.15 91.81 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.119 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.46 -26.95 71.12 Favored Glycine 0 N--CA 1.462 0.406 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.16 75.18 1.28 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 53.2 tttp . . . . . 0 C--N 1.332 -0.158 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.48 -179.709 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo . . . . . 0 N--CA 1.494 1.548 0 N-CA-C 111.306 -0.305 . . . . 0.0 111.306 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.2 tp -62.88 -48.28 79.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.97 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.55 -45.34 92.09 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 97.4 t -63.01 -28.32 44.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.379 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.6 -36.43 78.68 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.35 -45.51 65.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.281 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.8 p -68.63 -44.58 73.89 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.243 -0.583 . . . . 0.0 111.754 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.3 tp -68.48 -40.44 82.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.6 -178.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.1 tt -71.27 -33.56 51.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.607 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.45 -51.64 20.5 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.35 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.4 tp -63.31 -38.32 81.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.553 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.1 tp -65.9 -32.79 74.5 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.888 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 -67.81 -52.07 41.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.833 0.349 . . . . 0.0 110.602 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 30.4 tp -61.14 -52.17 65.97 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.426 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 74.1 mt -61.72 -42.25 93.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.979 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 34.8 tp -60.91 -41.93 97.06 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.343 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.4 t-105 -63.9 -59.53 4.4 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 120.973 0.416 . . . . 0.0 111.553 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 96.3 mt -56.59 -54.41 29.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.606 -177.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.475 ' O ' ' O ' ' A' ' 46' ' ' LEU . 0.7 OUTLIER -60.24 -45.47 93.11 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.691 -179.037 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -51.02 -41.38 59.77 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -65.04 -50.48 66.05 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.134 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.475 ' O ' ' O ' ' A' ' 43' ' ' LEU . 0.7 OUTLIER -92.63 131.29 37.85 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.074 -179.434 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.436 ' CD2' ' N ' ' A' ' 48' ' ' PHE . 73.6 t80 -163.55 -94.97 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.858 0.361 . . . . 0.0 110.564 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.436 ' N ' ' CD2' ' A' ' 47' ' ' PHE . 57.6 t80 -132.6 57.8 1.78 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.821 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.2 tttt 71.14 25.67 3.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.721 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.9 t -59.21 -43.19 92.29 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.571 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 56.9 mt -45.04 -41.65 2.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.604 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -74.11 -27.94 61.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.023 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.532 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 90.9 mtt-85 -71.2 -48.57 50.77 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.598 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -71.5 -41.18 69.59 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.052 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -67.53 -38.69 84.59 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.731 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.542 ' OE2' ' CD2' ' A' ' 57' ' ' HIS . 1.8 pp20? -76.65 -42.31 42.44 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.067 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.542 ' CD2' ' OE2' ' A' ' 56' ' ' GLU . 24.9 m80 -61.11 -45.66 93.77 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.552 -0.459 . . . . 0.0 109.907 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.982 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 -179.915 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.731 0.301 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -50.74 -36.68 52.25 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.618 2.212 . . . . 0.0 111.537 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 15.0 tp -60.6 -52.38 65.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.798 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.53 -42.99 93.53 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 93.8 t -62.51 -33.89 61.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.74 -34.49 78.0 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.28 -47.01 63.16 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.397 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 6.3 p -65.21 -48.13 74.44 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.234 -0.586 . . . . 0.0 111.524 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.412 ' CG2' ' N ' ' B' ' 33' ' ' ILE . 10.4 tp -65.55 -44.32 93.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -178.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . 0.412 ' N ' ' CG2' ' B' ' 32' ' ' ILE . 15.1 tt -66.67 -33.49 63.79 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.066 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.248 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.48 -45.3 86.52 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 91.2 mt -61.57 -44.54 98.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 14.1 tp -61.06 -36.1 78.7 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.312 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . 0.585 ' NE2' ' CE1' ' C' ' 37' ' ' HIS . 7.5 t-80 -67.34 -50.33 60.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.782 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 22.7 tp -63.66 -52.43 60.78 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.778 -178.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.431 ' N ' ' CD1' ' B' ' 39' ' ' ILE . 1.4 mp -61.15 -43.03 95.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.071 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 43.0 tp -61.21 -37.5 83.25 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.311 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 32.5 t-105 -63.3 -56.69 14.34 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.662 0.268 . . . . 0.0 111.291 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 68.2 mt -60.92 -53.46 48.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 C-N-CA 120.231 -0.588 . . . . 0.0 111.714 -178.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.33 -45.02 84.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.94 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -58.97 -45.5 90.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.833 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 57.8 ttt85 -59.74 -52.75 64.14 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 120.181 -0.607 . . . . 0.0 111.059 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.23 112.13 24.11 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.953 0.406 . . . . 0.0 110.166 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -165.78 79.23 0.28 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.252 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 34.0 t80 62.11 55.28 2.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.745 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 74.7 tttt 60.24 50.15 6.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.818 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 5.8 t -70.71 -44.42 66.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.602 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 64.5 mt -44.38 -35.87 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.656 0.265 . . . . 0.0 111.228 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -70.34 -28.19 64.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.482 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 78.3 mtt85 -68.64 -42.39 78.07 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.378 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -72.73 -42.23 64.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.783 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -63.93 -39.88 95.18 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.632 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -76.72 -38.36 54.44 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.697 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -59.56 -44.82 93.17 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.656 -0.418 . . . . 0.0 109.926 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.98 -24.03 53.22 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' B' ' 60' ' ' LYS . 1.6 tt -131.0 52.01 2.09 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 -178.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' B' ' 59' ' ' LEU . 16.2 ptpt . . . . . 0 N--CA 1.474 0.751 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.524 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 37.3 t . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 46.15 75.3 0.67 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.709 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -51.55 -33.48 48.15 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.483 2.122 . . . . 0.0 111.432 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.15 -47.88 82.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.739 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.44 -39.18 60.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.726 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 80.7 t -59.78 -44.29 93.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.01 -33.51 72.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.405 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.14 -44.01 80.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.209 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 8.0 p -67.51 -47.54 69.67 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 18.6 tt -66.52 -38.19 81.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.979 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 70.0 mt -68.13 -42.22 84.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.005 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.7 -50.04 45.24 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 121.062 -0.59 . . . . 0.0 111.677 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.71 -43.53 98.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.89 0.376 . . . . 0.0 110.257 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 56.8 tp -63.55 -37.98 89.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.248 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . 0.585 ' CE1' ' NE2' ' B' ' 37' ' ' HIS . 12.3 t-80 -66.09 -48.4 71.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.808 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 41.3 tp -67.07 -55.23 15.2 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.84 0.352 . . . . 0.0 111.697 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . 0.427 ' N ' ' CD1' ' C' ' 39' ' ' ILE . 1.3 mp -59.35 -45.46 93.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.487 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 44.7 tp -62.03 -41.89 98.59 Favored 'General case' 0 C--O 1.218 -0.564 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.983 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 16.0 t-105 -57.16 -59.53 4.96 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 120.812 0.339 . . . . 0.0 111.488 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 34.8 mt -62.88 -57.1 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.344 -0.542 . . . . 0.0 112.315 -177.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.17 -51.84 67.72 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.519 -177.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -53.29 -41.89 66.05 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 18.5 tpt85 -58.39 -52.35 65.97 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.729 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' C' ' 48' ' ' PHE . 1.9 mt -82.25 -72.7 0.43 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.0 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 82.2 t80 57.76 -77.91 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.314 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . 0.537 ' N ' ' O ' ' C' ' 46' ' ' LEU . 84.7 t80 -158.84 -40.19 0.06 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.065 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -173.59 31.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.089 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 50' ' ' SER . . . . . 0.465 ' OG ' ' CD1' ' C' ' 54' ' ' PHE . 35.8 t -63.73 -39.78 95.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.139 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 40.3 mt -46.6 -50.86 5.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.613 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -73.6 -32.18 63.97 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -72.03 -49.76 34.12 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.644 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . 0.465 ' CD1' ' OG ' ' C' ' 50' ' ' SER . 10.8 m-85 -66.44 -42.17 88.06 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.29 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -64.56 -37.67 88.35 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.903 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 . . . . . 0 CA--C 1.536 0.434 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.465 179.399 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo . . . . . 0 N--CA 1.488 1.173 0 N-CA-C 110.405 -0.652 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 16.8 tp -65.18 -45.28 85.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.321 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.75 -61.09 2.65 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 87.0 t -50.44 -43.36 22.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.734 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.57 -45.3 69.89 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.015 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.83 -40.87 98.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.984 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 2.5 t -61.44 -52.04 66.22 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.613 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 14.8 tt -64.93 -30.93 51.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.623 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 39.3 mt -66.35 -44.24 90.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.927 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.49 -50.53 43.02 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.982 -0.628 . . . . 0.0 111.975 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . 0.402 ' CG2' ' N ' ' D' ' 36' ' ' LEU . 4.5 tt -58.22 -43.15 85.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.001 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . 0.402 ' N ' ' CG2' ' D' ' 35' ' ' ILE . 7.4 tp -69.22 -27.64 65.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.503 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -67.78 -56.04 10.73 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.187 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 3.5 pp -68.87 -34.69 75.87 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.854 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . 0.438 HG21 HD13 ' D' ' 39' ' ' ILE . 52.9 mt -62.77 -45.12 99.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 120.311 -0.556 . . . . 0.0 109.778 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 36.8 mt -64.01 -41.55 97.42 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.471 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 9.2 t-105 -59.96 -58.0 10.43 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.332 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 79.0 mt -59.92 -53.5 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.406 -177.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 28.8 tp -59.96 -44.14 94.61 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.82 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . 0.436 ' O ' ' CB ' ' D' ' 50' ' ' SER . 26.6 t70 -55.95 -46.15 78.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.126 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 56.3 ttt85 -60.49 -50.67 72.65 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.868 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 pp -125.4 127.93 47.34 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.145 0.498 . . . . 0.0 110.796 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -174.77 -42.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.092 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -171.66 63.46 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.234 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 55.7 mttm 58.23 37.81 26.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.226 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 50' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 10.8 t -59.29 -50.29 74.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.835 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 68.1 mt -50.56 -41.44 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.607 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -72.2 -31.38 65.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.084 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -70.96 -47.04 61.21 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.001 0.429 . . . . 0.0 110.601 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -69.71 -36.32 75.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.676 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -68.92 -40.74 78.89 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.5 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -75.78 -33.44 60.18 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.481 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -66.43 -47.34 73.5 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.694 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.23 -36.37 93.32 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 110.641 -0.983 . . . . 0.0 110.641 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 mp -74.9 -67.43 0.64 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt . . . . . 0 N--CA 1.462 0.14 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.397 179.753 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo . . . . . 0 N--CA 1.492 1.424 0 N-CA-C 111.025 -0.413 . . . . 0.0 111.025 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.5 tp -64.23 -48.72 74.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.041 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.32 -50.23 66.44 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.296 0.57 . . . . 0.0 109.739 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.41 ' O ' ' OG ' ' A' ' 31' ' ' SER . 82.3 t -57.95 -44.67 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.94 -36.52 67.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.514 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.04 -51.29 67.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.536 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.439 ' HG ' ' H ' ' A' ' 32' ' ' ILE . 12.3 p -56.53 -50.07 72.92 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.912 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.439 ' H ' ' HG ' ' A' ' 31' ' ' SER . 46.6 mm -61.18 -32.16 52.12 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.99 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.2 mm -69.75 -40.13 78.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.223 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.43 -53.13 26.65 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.311 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 40.9 mm -62.12 -44.03 98.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 C-N-CA 120.461 -0.495 . . . . 0.0 110.306 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 47.4 tp -57.84 -47.92 81.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.568 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.534 ' HD1' ' C ' ' A' ' 37' ' ' HIS . 5.0 t-80 -60.16 -47.91 83.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.085 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 42.7 tp -55.66 -51.91 65.63 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.182 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.5 tt -64.17 -32.85 59.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.456 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.14 -47.96 80.53 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.419 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 14.2 t-105 -63.44 -55.27 25.55 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 120.614 0.245 . . . . 0.0 111.551 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 88.8 mt -58.91 -52.74 56.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.34 -0.544 . . . . 0.0 112.124 -177.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.6 tp -62.43 -44.08 97.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.391 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.429 ' O ' ' OG ' ' A' ' 50' ' ' SER . 25.8 t70 -57.01 -43.37 81.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.764 0.316 . . . . 0.0 110.171 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 57.0 ttt-85 -63.95 -48.67 75.58 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.471 -0.491 . . . . 0.0 110.725 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.6 pp -127.71 127.33 43.5 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.031 0.443 . . . . 0.0 110.8 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -174.03 -39.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.233 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.523 ' O ' ' NH1' ' A' ' 53' ' ' ARG . 63.8 t80 -172.08 61.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.213 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm 60.13 37.66 20.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.162 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 44' ' ' ASP . 15.0 t -61.7 -47.7 84.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.752 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.2 mt -49.44 -37.2 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.493 ' CE2' ' OE2' ' A' ' 56' ' ' GLU . 92.5 t80 -72.69 -30.16 63.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.241 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.523 ' NH1' ' O ' ' A' ' 48' ' ' PHE . 93.9 mtm-85 -71.77 -46.78 57.25 Favored 'General case' 0 N--CA 1.461 0.102 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.54 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -70.47 -37.8 74.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.863 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -69.76 -38.85 76.92 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.696 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.493 ' OE2' ' CE2' ' A' ' 52' ' ' TYR . 12.2 pt-20 -76.57 -38.85 54.29 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.91 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.523 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 6.8 m-70 -66.45 -42.63 87.33 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.738 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.909 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -179.924 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 . . . . . 0 CA--C 1.537 0.466 0 CA-C-O 119.905 -0.093 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -48.56 -36.7 32.39 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.873 1.715 . . . . 0.0 111.723 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 17.6 tp -61.14 -51.22 70.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.222 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.37 -45.52 84.35 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 84.4 t -59.48 -32.82 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.557 -0.747 . . . . 0.0 108.999 178.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.39 -37.43 85.73 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.05 -49.99 65.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.831 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 4.8 t -60.07 -50.56 73.24 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 20.4 tt -63.65 -35.04 71.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.36 -178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 45.7 mt -69.05 -37.85 77.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.392 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.77 -56.2 8.62 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.506 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.3 pp -56.44 -40.07 65.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.387 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 54.7 tp -65.34 -34.41 78.26 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.388 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -66.45 -53.54 34.28 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.449 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 29.7 tp -66.32 -50.16 64.58 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.649 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 74.2 mt -59.74 -44.88 94.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.663 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 49.7 tp -64.04 -37.61 88.06 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.032 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . 0.45 ' CZ3' ' CZ2' ' C' ' 41' ' ' TRP . 23.1 t-105 -59.66 -52.32 66.01 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.543 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.6 mt -71.9 -56.83 8.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 120.079 -0.649 . . . . 0.0 111.674 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -50.67 -46.61 58.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.865 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -67.94 -40.92 83.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.761 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 53.5 ttt85 -51.75 -51.83 53.24 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.813 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.72 -82.8 0.25 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.494 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.449 ' O ' ' CD1' ' B' ' 48' ' ' PHE . 60.5 t80 57.51 -87.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.501 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . 0.449 ' CD1' ' O ' ' B' ' 47' ' ' PHE . 34.1 m-85 -153.44 86.38 1.21 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.037 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 65.9 mttm 51.76 34.51 13.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.362 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 7.9 t -58.98 -47.07 86.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.405 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 53.4 mt -49.83 -50.8 17.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.909 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -71.41 -32.66 68.67 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.693 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -71.52 -43.74 65.92 Favored 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.017 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -71.41 -39.49 71.09 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.756 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . 0.413 ' CD1' ' C ' ' B' ' 55' ' ' PHE . 24.3 t80 -70.2 -39.11 75.38 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.816 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -76.66 -35.91 57.68 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 120.424 -0.511 . . . . 0.0 110.729 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -67.3 -49.19 65.17 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.511 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.94 -28.6 68.9 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 7.8 tp -72.51 -68.92 0.44 Allowed 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.742 0.306 . . . . 0.0 110.527 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 55.4 tttp . . . . . 0 N--CA 1.467 0.375 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.405 179.814 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 13.7 m . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -158.43 72.75 3.86 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.83 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -50.91 -30.52 30.61 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.538 2.158 . . . . 0.0 111.269 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 16.6 tp -55.48 -51.68 66.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.045 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.69 -47.62 85.44 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 99.3 t -59.58 -29.98 43.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.82 -35.61 80.45 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.15 -42.38 76.03 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.337 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 3.9 p -69.9 -46.22 65.91 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.72 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 10.1 tt -67.66 -40.18 83.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.524 -178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 8.0 tt -69.33 -35.17 66.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.502 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.77 -53.24 20.76 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.272 -0.966 . . . . 0.0 110.953 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 96.8 mt -57.86 -42.87 83.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.306 -0.558 . . . . 0.0 109.977 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 15.0 tp -61.83 -39.45 91.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.101 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -61.52 -50.66 71.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.887 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 10.4 mp -60.52 -48.6 81.08 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.403 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 71.8 mt -59.95 -44.72 95.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.133 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.5 mt -62.44 -39.39 93.17 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.336 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . 0.45 ' CZ2' ' CZ3' ' B' ' 41' ' ' TRP . 24.3 t-105 -60.52 -57.67 11.76 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 120.89 0.376 . . . . 0.0 111.248 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 72.0 mt -60.64 -56.36 18.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.129 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.42 -50.99 71.24 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.773 -178.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -51.23 -42.59 61.09 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -59.07 -53.31 59.83 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.511 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' C' ' 48' ' ' PHE . 3.4 mt -79.71 -72.45 0.4 Allowed 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.949 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 75.3 t80 50.0 -88.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.272 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . 0.503 ' N ' ' O ' ' C' ' 46' ' ' LEU . 55.5 t80 -161.13 89.96 0.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.3 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 74.1 tttt 54.92 22.33 4.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.065 0.459 . . . . 0.0 110.027 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 11.3 t -61.1 -38.68 87.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.078 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 67.4 mt -48.68 -53.91 5.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.755 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -75.09 -33.6 61.65 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 20.0 mmt85 -69.93 -48.83 56.92 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.837 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -69.93 -39.95 75.81 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.302 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -62.13 -41.33 98.16 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.818 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 . . . . . 0 CA--C 1.535 0.388 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.892 179.506 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo . . . . . 0 N--CA 1.49 1.303 0 N-CA-C 110.693 -0.541 . . . . 0.0 110.693 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 16.4 tp -62.89 -50.55 70.45 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.78 -46.16 88.15 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 92.0 t -59.77 -37.25 70.55 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.343 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.37 -37.07 82.03 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.45 -50.11 66.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.773 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 4.0 t -60.78 -51.47 69.19 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 7.3 tp -62.26 -35.71 70.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.582 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 26.5 mt -63.23 -44.58 99.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.736 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.49 -45.5 94.67 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.755 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 88.3 mt -62.39 -43.5 98.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.784 0.326 . . . . 0.0 110.525 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 18.1 tp -65.18 -33.2 75.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.326 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -68.13 -50.65 53.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.897 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 55.9 tp -61.28 -47.93 83.74 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.802 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 95.8 mt -61.91 -43.82 98.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.856 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 20.0 mt -59.62 -49.4 77.9 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.452 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 11.9 t-105 -58.41 -58.86 6.66 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.929 0.395 . . . . 0.0 111.705 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 73.1 mt -57.89 -60.4 2.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 27.6 tp -57.18 -46.56 82.7 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.447 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -50.98 -45.98 61.16 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.633 -0.427 . . . . 0.0 109.926 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . 0.413 ' O ' ' CG1' ' D' ' 51' ' ' ILE . 70.0 ttt180 -64.56 -56.85 11.35 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 119.914 -0.715 . . . . 0.0 111.394 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.36 114.82 27.45 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.021 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 47' ' ' PHE . . . . . 0.569 ' O ' ' N ' ' D' ' 49' ' ' LYS . 77.0 t80 -172.92 90.22 0.09 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.073 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 57.94 -73.49 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.45 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . 0.569 ' N ' ' O ' ' D' ' 47' ' ' PHE . 10.7 ttpp -165.58 37.46 0.06 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.884 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 50' ' ' SER . . . . . 0.532 ' O ' ' N ' ' D' ' 53' ' ' ARG . 13.0 t -62.77 -45.06 94.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.082 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 51' ' ' ILE . . . . . 0.413 ' CG1' ' O ' ' D' ' 45' ' ' ARG . 23.6 mt -41.25 -30.35 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.869 0.366 . . . . 0.0 110.487 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 52' ' ' TYR . . . . . 0.518 ' CE2' ' OE1' ' D' ' 56' ' ' GLU . 85.7 t80 -74.12 -33.84 63.72 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.34 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 53' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' D' ' 50' ' ' SER . 6.9 ptm180 -69.64 -40.14 76.68 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.351 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -72.71 -41.92 64.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.884 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -65.74 -40.18 91.86 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.459 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 56' ' ' GLU . . . . . 0.518 ' OE1' ' CE2' ' D' ' 52' ' ' TYR . 10.8 pt-20 -75.85 -38.81 57.61 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.796 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -61.51 -43.99 97.87 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 120.876 -0.329 . . . . 0.0 110.34 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.84 -27.82 71.75 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 7.9 tp -84.09 -75.75 0.33 Allowed 'General case' 0 C--O 1.231 0.087 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.615 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt . . . . . 0 N--CA 1.467 0.422 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.539 179.799 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo . . . . . 0 N--CA 1.492 1.43 0 N-CA-C 111.217 -0.34 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 22.0 tp -61.54 -50.49 72.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.969 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.74 -46.75 88.26 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.271 0.558 . . . . 0.0 109.551 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 92.4 t -59.03 -41.44 83.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.51 -31.36 71.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.757 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.95 -43.52 71.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.649 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.7 t -66.18 -43.32 87.22 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.914 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 38.4 mm -67.24 -42.42 87.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.684 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.2 tt -71.15 -33.38 50.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.721 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.13 -52.0 15.65 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.315 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.2 tt -63.16 -39.57 85.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.695 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 47.1 tp -66.63 -32.39 73.69 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.086 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -68.34 -49.6 59.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.675 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.6 tp -63.31 -51.93 64.02 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.222 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 81.1 mt -61.79 -42.92 96.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.947 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.5 tt -63.56 -37.75 88.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.624 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 41.6 t-105 -65.11 -54.66 26.47 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.034 0.445 . . . . 0.0 111.305 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.553 ' CG2' ' N ' ' A' ' 43' ' ' LEU . 5.9 tt -63.74 -51.26 72.2 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.646 -177.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.553 ' N ' ' CG2' ' A' ' 42' ' ' ILE . 29.6 tp -63.21 -48.85 76.55 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.008 -177.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' A' ' 44' ' ' ASP . 60.2 t0 -51.59 -38.9 56.63 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.417 ' NH2' ' CB ' ' D' ' 54' ' ' PHE . 64.3 ttt180 -64.76 -52.24 58.02 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.522 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 48' ' ' PHE . 5.3 mt -86.31 -76.67 0.34 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 119.934 -0.706 . . . . 0.0 110.817 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 69.5 t80 51.4 -86.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.892 0.377 . . . . 0.0 110.373 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.515 ' N ' ' O ' ' A' ' 46' ' ' LEU . 38.5 t80 -158.31 90.58 1.04 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.142 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm 52.11 17.01 0.62 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.116 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.9 t -51.7 -41.87 61.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.612 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 35.7 mt -48.18 -41.63 10.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.055 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -71.41 -30.14 65.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.295 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.51 ' O ' ' CG ' ' A' ' 57' ' ' HIS . 1.8 mpt_? -66.8 -45.03 79.67 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.074 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -70.96 -38.62 72.81 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.479 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -63.55 -40.48 97.11 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.646 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -77.0 -40.19 47.55 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.789 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.51 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 56.0 m170 -57.4 -50.47 72.89 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.202 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.632 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 179.478 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 5.9 t0 . . . . . 0 CA--C 1.532 0.252 0 CA-C-O 121.035 0.445 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -48.13 -27.89 9.97 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.031 1.82 . . . . 0.0 111.092 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 pp -72.79 -31.2 64.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.894 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.9 -39.71 66.02 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.972 0.415 . . . . 0.0 109.999 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 94.2 t -60.23 -43.64 93.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.97 -35.57 69.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.391 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.13 -49.81 66.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.878 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' SER . . . . . 0.493 ' HG ' ' H ' ' B' ' 32' ' ' ILE . 22.2 p -59.16 -51.19 71.07 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.493 ' H ' ' HG ' ' B' ' 31' ' ' SER . 19.1 tt -65.39 -33.75 65.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.295 -179.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 28.9 mt -67.34 -37.36 78.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.766 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.85 -51.38 24.73 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 83.3 mt -58.14 -49.29 82.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.412 0.625 . . . . 0.0 109.734 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 12.1 tp -58.53 -39.89 81.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.318 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -61.41 -48.35 81.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.58 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 10.1 mp -63.57 -51.05 67.04 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.832 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 mp -61.38 -46.05 97.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.076 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -63.16 -37.12 85.95 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.058 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 15.4 t-105 -60.85 -57.5 12.39 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.154 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.413 HD13 HG23 ' B' ' 42' ' ' ILE . 68.8 mt -61.88 -55.38 24.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.8 -177.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.4 -50.61 71.12 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.044 -178.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -55.74 -39.64 71.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.245 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -59.73 -53.46 57.77 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.678 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' B' ' 48' ' ' PHE . 0.9 OUTLIER -80.93 -72.81 0.4 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.52 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.432 ' CD2' ' N ' ' B' ' 48' ' ' PHE . 84.7 t80 47.24 -88.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.569 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . 0.517 ' N ' ' O ' ' B' ' 46' ' ' LEU . 80.7 t80 -154.36 84.5 1.12 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.325 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 62.4 mttp 48.73 27.36 1.51 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.439 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 16.0 p -63.49 -34.76 78.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.689 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 21.2 mt -49.88 -46.6 22.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.662 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.515 ' CD2' ' OE1' ' B' ' 56' ' ' GLU . 64.5 t80 -72.45 -27.88 62.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.553 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -70.8 -45.27 64.94 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.631 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -72.89 -41.57 64.5 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.561 -0.455 . . . . 0.0 110.75 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -66.01 -39.69 90.47 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.545 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . 0.515 ' OE1' ' CD2' ' B' ' 52' ' ' TYR . 9.6 pt-20 -75.6 -39.28 58.19 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.571 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -61.22 -41.79 97.47 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.621 -0.431 . . . . 0.0 110.092 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.31 -32.4 76.81 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 25.0 tp -63.25 -52.56 61.61 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.074 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt . . . . . 0 C--N 1.332 -0.157 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.569 179.982 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 36.8 p . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 46.22 74.75 0.75 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.73 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.62 -29.27 32.09 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.605 2.204 . . . . 0.0 111.378 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.18 -35.46 81.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.786 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.22 -49.44 33.08 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.123 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 61.3 t -55.53 -36.45 41.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.3 -33.94 76.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.546 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.76 -40.1 79.91 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.853 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 3.3 t -69.14 -54.0 17.2 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.488 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 17.5 tt -60.98 -40.87 86.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.53 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 13.6 tt -70.98 -31.21 44.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.609 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.08 -51.95 30.76 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.242 -0.98 . . . . 0.0 111.084 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.59 -34.71 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 C-N-CA 120.173 -0.611 . . . . 0.0 109.943 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 46.0 tp -64.89 -39.68 93.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.359 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -68.29 -49.67 58.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.513 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 34.9 tp -61.01 -51.87 67.41 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.226 0.536 . . . . 0.0 111.253 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 1.2 mp -60.58 -43.29 94.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.262 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 18.6 mt -61.04 -40.5 93.85 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.935 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 18.0 t-105 -59.43 -58.11 10.03 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.366 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 56.1 mt -62.33 -54.94 27.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' C' ' 46' ' ' LEU . 0.7 OUTLIER -59.94 -49.28 78.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.472 -178.183 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . 0.484 ' O ' ' CB ' ' C' ' 50' ' ' SER . 61.2 t0 -57.81 -42.4 84.18 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.655 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . 0.507 ' NH1' ' CD1' ' C' ' 51' ' ' ILE . 3.2 tpt85 -61.04 -52.74 63.69 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.204 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' C' ' 43' ' ' LEU . 0.1 OUTLIER -118.31 137.37 53.12 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.039 0.447 . . . . 0.0 110.661 179.538 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -172.59 -38.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.107 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -172.67 -46.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.312 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 45.0 tttt -173.89 39.67 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.846 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 50' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' C' ' 44' ' ' ASP . 47.9 t -65.31 -51.61 59.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.807 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 51' ' ' ILE . . . . . 0.507 ' CD1' ' NH1' ' C' ' 45' ' ' ARG . 96.0 mt -43.39 -40.89 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.677 0.275 . . . . 0.0 111.215 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -73.62 -28.52 61.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.6 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 56.8 ttm-85 -69.71 -49.35 54.18 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.052 0.453 . . . . 0.0 110.246 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -69.08 -42.6 75.97 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.702 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -63.22 -37.02 85.61 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.792 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 . . . . . 0 CA--C 1.536 0.423 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.739 179.418 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo . . . . . 0 N--CA 1.492 1.413 0 N-CA-C 110.647 -0.559 . . . . 0.0 110.647 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 17.8 tp -59.11 -49.83 76.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.231 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.03 -53.81 54.04 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 83.5 t -52.43 -43.88 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.463 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.8 -42.55 68.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.227 0.537 . . . . 0.0 109.924 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.61 -42.54 98.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.792 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 6.3 t -61.68 -52.64 63.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.841 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 13.6 tt -64.01 -31.08 51.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.574 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 33.2 mt -67.21 -40.88 85.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.488 -0.485 . . . . 0.0 109.725 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.39 -52.05 33.49 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 120.991 -0.623 . . . . 0.0 111.64 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 4.3 mm -60.23 -43.85 94.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.109 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 47.0 tp -62.23 -38.61 89.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.346 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -63.96 -51.23 65.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.849 0.356 . . . . 0.0 110.908 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 50.5 tp -58.12 -45.56 87.07 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.513 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 97.4 mt -62.36 -40.16 86.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.628 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.84 -44.03 97.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.18 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 28.2 t-105 -63.83 -56.36 16.0 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.736 0.303 . . . . 0.0 111.782 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 74.3 mt -58.71 -53.43 47.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.244 -0.435 . . . . 0.0 112.017 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 36.9 tp -61.55 -46.73 88.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.733 0.301 . . . . 0.0 111.089 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -52.99 -46.8 68.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.295 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -63.19 -50.69 69.34 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.89 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.17 123.99 46.86 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.974 0.416 . . . . 0.0 110.33 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -172.27 -47.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.246 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -172.08 71.12 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.275 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt 54.29 33.37 18.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.289 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 9.7 t -57.77 -50.09 74.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.745 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 55.5 mt -52.56 -44.23 44.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.598 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -71.91 -30.59 65.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.27 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -71.22 -44.15 65.94 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.892 0.377 . . . . 0.0 110.747 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . 0.417 ' CB ' ' NH2' ' A' ' 45' ' ' ARG . 50.9 m-85 -71.92 -38.29 69.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.88 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -69.18 -40.1 78.3 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.652 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -76.62 -36.6 57.37 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.616 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -65.47 -47.51 75.83 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.667 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.54 -28.99 72.23 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 10.6 mp -103.85 65.48 0.82 Allowed 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 86.6 tttt . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.652 -179.817 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo . . . . . 0 N--CA 1.493 1.457 0 N-CA-C 111.163 -0.36 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.3 tp -63.71 -50.56 68.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.218 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.18 -44.71 94.64 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.329 0.585 . . . . 0.0 109.917 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.9 t -58.79 -45.89 91.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.259 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.98 -31.38 69.84 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.606 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.09 -50.43 64.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.446 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.3 t -58.02 -42.43 85.28 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.402 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.1 mp -65.95 -37.98 81.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.184 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.4 tt -69.03 -36.44 73.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.637 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.43 -52.34 17.27 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.159 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.83 -43.44 91.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.145 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 57.2 tp -64.7 -34.69 78.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.359 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -65.39 -50.33 65.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.844 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.5 mp -62.84 -47.25 84.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.976 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.9 mt -61.62 -44.84 99.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.1 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 35.0 tp -62.86 -43.33 99.09 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.7 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.9 t-105 -62.32 -58.46 7.62 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 120.82 0.343 . . . . 0.0 111.847 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 73.7 mt -59.54 -54.31 36.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.743 -177.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.5 tp -58.34 -50.8 72.34 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.801 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -52.11 -38.85 58.73 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.07 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.416 HH21 ' CB ' ' D' ' 54' ' ' PHE . 54.0 ttt85 -64.65 -54.35 33.23 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.596 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 48' ' ' PHE . 0.1 OUTLIER -91.91 -84.83 0.26 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.862 -179.525 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.421 ' CD2' ' N ' ' A' ' 48' ' ' PHE . 82.2 t80 56.54 -80.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.539 ' N ' ' O ' ' A' ' 46' ' ' LEU . 65.2 t80 -165.64 98.04 0.67 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.375 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt 47.93 33.32 3.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.485 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.413 ' O ' ' N ' ' A' ' 53' ' ' ARG . 5.4 t -63.9 -44.15 93.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.89 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.3 mm -41.93 -43.52 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.488 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.507 ' CE2' ' OE1' ' A' ' 56' ' ' GLU . 90.8 t80 -73.23 -31.22 64.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.352 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.531 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 23.4 mmt180 -70.79 -48.44 54.21 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-O 120.975 0.417 . . . . 0.0 110.541 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -70.05 -35.99 74.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.621 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -68.13 -41.02 82.31 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 120.886 -0.325 . . . . 0.0 111.613 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.507 ' OE1' ' CE2' ' A' ' 52' ' ' TYR . 21.4 pt-20 -76.4 -41.92 46.11 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.119 -0.633 . . . . 0.0 111.02 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.531 ' ND1' ' O ' ' A' ' 53' ' ' ARG . 15.8 m80 -61.95 -51.83 66.5 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.324 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.667 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 179.695 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.61 0.243 . . . . 0.0 110.804 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -50.56 -35.02 44.89 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.502 2.135 . . . . 0.0 111.495 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 17.8 tp -59.15 -51.49 69.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.975 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.49 -44.52 93.05 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 88.5 t -61.03 -32.64 53.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.15 -34.14 77.39 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.03 -46.53 64.86 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.318 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 3.9 m -66.04 -47.3 74.84 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 119.981 -0.688 . . . . 0.0 111.561 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.406 ' CG2' ' N ' ' B' ' 33' ' ' ILE . 21.1 tt -64.48 -45.19 96.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.738 -178.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . 0.406 ' N ' ' CG2' ' B' ' 32' ' ' ILE . 16.4 tt -64.86 -34.78 72.62 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.087 0 C-N-CA 119.409 -0.916 . . . . 0.0 109.937 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.49 -46.06 93.36 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 94.3 mt -59.52 -43.3 90.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 37.4 tp -60.01 -40.17 88.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.578 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -66.08 -51.56 56.91 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 31.8 tp -61.95 -51.86 66.39 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 120.865 0.365 . . . . 0.0 111.717 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.413 ' N ' ' CD1' ' B' ' 39' ' ' ILE . 1.3 mp -61.45 -40.52 86.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.021 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 62.9 tp -62.56 -37.32 85.69 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.501 -0.48 . . . . 0.0 109.983 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 39.3 t-105 -64.32 -56.04 17.2 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.637 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 54.6 mt -63.23 -50.84 77.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.424 -0.511 . . . . 0.0 111.769 -177.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' B' ' 46' ' ' LEU . 0.9 OUTLIER -61.15 -49.3 77.78 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.442 -178.734 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . 0.434 ' O ' ' OG ' ' B' ' 50' ' ' SER . 20.8 t70 -61.5 -37.44 83.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.693 0.282 . . . . 0.0 110.952 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 50.0 ttt-85 -65.84 -51.02 62.44 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.703 -0.399 . . . . 0.0 112.066 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' B' ' 43' ' ' LEU . 0.6 OUTLIER -123.31 -159.39 0.84 Allowed 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 120.882 0.372 . . . . 0.0 111.58 -179.086 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.464 ' O ' ' CD2' ' B' ' 47' ' ' PHE . 31.1 t80 50.06 19.43 0.48 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.203 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -168.77 -1.67 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.38 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt 44.61 40.24 3.91 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.606 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' B' ' 44' ' ' ASP . 2.3 p -62.96 -33.28 75.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.753 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 78.0 mt -47.33 -46.09 9.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.82 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -72.16 -30.0 64.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.439 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . 0.529 ' O ' ' ND1' ' B' ' 57' ' ' HIS . 95.5 mtt-85 -71.54 -45.6 61.89 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.727 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -71.54 -38.34 71.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.911 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -70.03 -39.35 75.81 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.608 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . 0.528 ' OE2' ' CD2' ' B' ' 57' ' ' HIS . 1.2 pp20? -75.75 -39.76 56.62 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.748 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' HIS . . . . . 0.529 ' ND1' ' O ' ' B' ' 53' ' ' ARG . 26.6 m80 -65.16 -45.38 85.17 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.29 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.72 -27.79 73.01 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 9.4 tp -86.17 58.25 4.95 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.897 0.38 . . . . 0.0 110.349 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? . . . . . 0 N--CA 1.466 0.352 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.417 -179.886 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 25.9 t . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 53.46 70.61 1.7 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.676 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -51.74 -38.75 67.36 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.573 2.182 . . . . 0.0 111.565 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 26.0 tp -57.16 -48.61 78.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.018 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.44 -48.98 77.26 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.389 0.614 . . . . 0.0 109.497 178.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 85.4 t -58.95 -31.67 45.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.34 -33.87 76.69 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.15 -43.71 73.78 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.305 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 4.4 p -69.58 -45.92 67.55 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 119.972 -0.691 . . . . 0.0 111.616 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 13.5 tt -67.87 -39.72 82.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.563 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 7.6 tt -70.01 -35.91 66.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.784 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.67 -51.42 25.42 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 120.413 -0.898 . . . . 0.0 111.202 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 94.0 mt -61.21 -46.3 96.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.551 -0.46 . . . . 0.0 109.846 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 15.4 tp -58.14 -42.87 86.8 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.894 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -59.72 -51.78 68.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.757 0.313 . . . . 0.0 111.484 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 35.9 tp -57.47 -52.6 64.71 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.751 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . 0.401 ' N ' ' CD1' ' C' ' 39' ' ' ILE . 1.3 mp -61.02 -41.04 87.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.836 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.66 -43.06 94.1 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 12.9 t-105 -61.45 -58.5 7.91 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.466 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . 0.411 HD13 HG22 ' C' ' 42' ' ' ILE . 96.2 mt -55.76 -56.91 9.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.92 -177.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' C' ' 47' ' ' PHE . 0.6 OUTLIER -59.7 -45.55 91.77 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.881 -178.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -48.55 -46.38 38.8 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 54.9 ttt-85 -64.54 -48.16 76.11 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.94 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . 0.496 ' O ' ' N ' ' C' ' 48' ' ' PHE . 8.2 mt -82.68 4.4 25.11 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.126 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . 0.518 ' O ' ' N ' ' C' ' 49' ' ' LYS . 48.3 t80 -45.34 91.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.86 0.362 . . . . 0.0 110.78 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . 0.496 ' N ' ' O ' ' C' ' 46' ' ' LEU . 88.1 t80 55.47 -81.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.615 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' C' ' 47' ' ' PHE . 76.6 tttt -161.01 39.05 0.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.101 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 50' ' ' SER . . . . . 0.432 ' OG ' ' CE2' ' C' ' 54' ' ' PHE . 4.8 t -70.83 -26.14 63.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.465 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 53.0 mt -42.05 -48.02 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.211 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -73.25 -28.73 62.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.398 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 20.0 mmt85 -71.78 -49.3 40.08 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.662 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . 0.432 ' CE2' ' OG ' ' C' ' 50' ' ' SER . 38.0 m-85 -69.46 -39.2 77.87 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.44 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -66.8 -38.04 85.72 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 120.561 -0.455 . . . . 0.0 111.026 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 . . . . . 0 CA--C 1.534 0.336 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.852 179.63 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo . . . . . 0 N--CA 1.491 1.378 0 N-CA-C 110.815 -0.494 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 17.7 tp -63.21 -50.95 68.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.612 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.75 -47.28 78.77 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.811 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 96.5 t -56.76 -41.74 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.38 -38.94 85.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.471 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.69 -50.55 73.45 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.739 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 6.2 t -62.97 -39.76 95.66 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.365 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 5.2 mm -62.42 -48.24 89.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.444 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 18.5 tt -66.84 -31.1 51.97 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.282 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.92 -48.96 57.88 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.222 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 97.2 mt -63.79 -44.49 98.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.065 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 33.9 tp -63.45 -30.68 71.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.012 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -68.68 -51.28 43.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.754 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 43.3 tp -59.5 -48.07 83.06 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.51 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 96.8 mt -61.06 -43.86 97.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.786 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 22.1 mt -61.34 -41.04 96.39 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.351 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 46.7 t-105 -61.61 -54.66 39.96 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.767 0.318 . . . . 0.0 111.556 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 64.1 mt -62.9 -55.78 21.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 120.293 -0.563 . . . . 0.0 112.182 -177.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 43.1 tp -59.06 -50.25 74.79 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.173 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . 0.459 ' O ' ' CB ' ' D' ' 50' ' ' SER . 31.6 t70 -52.72 -44.83 66.64 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.106 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -58.35 -54.84 42.5 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.395 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.13 106.91 15.65 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 120.956 0.408 . . . . 0.0 110.121 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -174.6 94.47 0.08 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.306 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 35.7 t80 59.3 49.53 8.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.536 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? 54.72 52.56 11.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.596 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 50' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 11.5 t -62.82 -49.48 74.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.994 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 53.0 mt -45.18 -43.91 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.926 0.393 . . . . 0.0 110.584 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -71.48 -28.09 63.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.65 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 53' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' D' ' 50' ' ' SER . 12.0 ttm180 -70.09 -49.67 48.61 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.035 0.445 . . . . 0.0 110.175 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . 0.416 ' CB ' HH21 ' A' ' 45' ' ' ARG . 55.1 m-85 -65.42 -43.02 91.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.303 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -63.23 -38.36 90.88 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.919 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -76.06 -22.51 55.58 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.615 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -75.07 -54.34 7.32 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.167 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -73.9 -26.12 69.9 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 12.6 tp -146.41 86.91 1.7 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 63.7 mttp . . . . . 0 C--N 1.334 -0.096 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.592 -179.725 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo . . . . . 0 N--CA 1.492 1.428 0 CA-C-O 120.975 0.323 . . . . 0.0 111.297 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.2 tp -62.55 -49.61 74.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.944 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.75 -46.25 88.91 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.0 t -60.05 -40.41 83.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.15 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.73 -30.89 71.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.716 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.61 -51.06 46.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.53 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.1 p -61.76 -36.68 81.72 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.574 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.7 mm -68.4 -41.75 83.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.594 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.4 tt -70.64 -34.19 56.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.371 -0.531 . . . . 0.0 110.744 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.64 -52.15 13.47 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.697 -0.764 . . . . 0.0 111.389 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.476 ' CG2' ' N ' ' A' ' 36' ' ' LEU . 15.3 tt -63.17 -44.52 99.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.784 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.476 ' N ' ' CG2' ' A' ' 35' ' ' ILE . 48.9 tp -59.93 -41.88 92.73 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.811 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 20.9 t-160 -60.07 -49.92 75.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.745 0.307 . . . . 0.0 111.093 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 37.2 tp -59.3 -51.81 68.33 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.925 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.3 mp -61.6 -46.06 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.049 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.7 -39.93 86.23 Favored 'General case' 0 C--O 1.218 -0.59 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 13.5 t-105 -62.64 -57.11 12.22 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.483 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 97.2 mt -56.43 -54.59 26.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.703 -177.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 47' ' ' PHE . 34.5 tp -61.64 -42.5 98.98 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.359 -0.537 . . . . 0.0 110.978 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -51.59 -44.93 62.98 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -63.2 -54.8 31.9 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.246 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 48' ' ' PHE . 5.5 mt -77.15 -77.19 0.15 Allowed 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.777 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.416 ' CD2' ' N ' ' A' ' 48' ' ' PHE . 93.3 t80 53.88 -83.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.788 0.328 . . . . 0.0 110.434 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.533 ' N ' ' O ' ' A' ' 46' ' ' LEU . 81.2 t80 -167.65 86.72 0.24 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.259 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm 59.8 30.44 20.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.339 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.5 t -68.46 -29.18 67.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.621 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.9 mm -44.21 -43.18 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-O 120.989 0.423 . . . . 0.0 110.283 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -74.6 -28.44 60.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.349 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.507 ' O ' ' CG ' ' A' ' 57' ' ' HIS . 98.9 mtt180 -68.28 -49.82 57.89 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.015 0.436 . . . . 0.0 110.46 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -72.39 -40.35 67.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.93 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -63.73 -40.75 97.5 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.617 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -77.16 -41.79 40.32 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.973 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.507 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 6.2 m-70 -56.9 -50.42 72.59 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.277 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.587 0 N-CA-C 110.756 -0.937 . . . . 0.0 110.756 179.426 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.748 0.309 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.412 ' O ' ' N ' ' B' ' 29' ' ' ALA . 53.9 Cg_exo -51.0 -33.66 43.37 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.668 2.245 . . . . 0.0 111.52 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 19.2 tp -59.7 -50.93 71.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.269 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.52 -42.9 99.5 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 82.3 t -63.47 -31.08 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' B' ' 25' ' ' PRO . . . -64.83 -34.9 79.46 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.15 -47.45 61.58 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.385 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 4.8 t -64.83 -48.35 74.67 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.534 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.409 ' CG2' ' N ' ' B' ' 33' ' ' ILE . 10.7 tp -65.41 -44.48 94.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.966 -178.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . 0.409 ' N ' ' CG2' ' B' ' 32' ' ' ILE . 15.6 tt -66.18 -32.85 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.975 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.64 -45.84 81.21 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 5.2 mm -60.08 -42.79 91.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 12.0 tp -61.71 -37.4 84.03 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.373 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . 0.458 ' NE2' ' NE2' ' C' ' 37' ' ' HIS . 1.5 t60 -65.66 -53.03 46.83 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 28.6 tp -64.79 -52.38 57.18 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.452 ' N ' ' CD1' ' B' ' 39' ' ' ILE . 1.3 mp -62.05 -47.97 90.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.883 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 41.6 tp -61.2 -35.94 78.53 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.253 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 41.2 t-105 -63.44 -57.16 11.16 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.384 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 73.2 mt -60.93 -53.01 55.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.768 -177.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 11.1 mt -60.12 -53.31 59.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.421 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . 0.411 ' O ' ' CB ' ' B' ' 50' ' ' SER . 66.2 t0 -57.41 -31.74 66.15 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.158 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -66.36 -50.67 62.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.282 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' B' ' 48' ' ' PHE . 0.1 OUTLIER -110.2 -88.98 0.49 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.821 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 33.9 t80 57.04 -79.37 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.888 0.375 . . . . 0.0 110.414 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . 0.533 ' N ' ' O ' ' B' ' 46' ' ' LEU . 47.7 t80 -138.75 58.53 1.65 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.536 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm 57.15 54.61 6.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.424 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' B' ' 44' ' ' ASP . 39.0 t -65.69 -45.74 81.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.133 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 59.2 mt -46.72 -28.6 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.044 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.49 ' CZ ' ' OE1' ' B' ' 56' ' ' GLU . 60.4 t80 -71.85 -36.94 70.31 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.72 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -70.77 -45.28 65.03 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.881 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . 0.438 ' CD1' ' NH1' ' C' ' 45' ' ' ARG . 61.4 m-85 -70.18 -35.9 74.29 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.923 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -71.17 -39.76 71.68 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.72 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . 0.49 ' OE1' ' CZ ' ' B' ' 52' ' ' TYR . 18.3 pt-20 -76.11 -39.25 55.61 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.871 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -67.48 -43.4 81.06 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.414 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.05 -28.57 72.31 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 10.8 mp -102.69 65.4 0.91 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.537 -179.816 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 15.7 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -158.48 72.66 3.83 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.812 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.2 -32.42 40.37 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.529 2.153 . . . . 0.0 111.461 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 14.2 tp -62.01 -52.04 65.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.1 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.41 -47.77 84.24 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.03 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 92.4 t -54.6 -50.26 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.54 -44.02 56.25 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.565 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.81 -50.35 70.76 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 3.0 t -57.6 -52.27 66.09 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.401 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 21.5 mm -58.88 -30.71 43.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.715 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 50.3 mt -69.03 -40.2 80.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.395 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.81 -52.12 26.26 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 120.657 -0.783 . . . . 0.0 111.81 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 mp -62.52 -44.47 99.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.776 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 54.7 tp -60.48 -39.15 86.63 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.707 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . 0.458 ' NE2' ' NE2' ' B' ' 37' ' ' HIS . 1.1 t60 -61.33 -51.07 70.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.922 0.391 . . . . 0.0 110.794 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.25 -51.93 66.32 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.837 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 26.3 mm -60.52 -41.52 88.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.179 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.56 -41.88 98.01 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 16.5 t-105 -63.11 -57.55 10.21 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 120.889 0.376 . . . . 0.0 111.414 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 82.3 mt -57.91 -55.6 20.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.877 -177.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.3 -48.78 80.33 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.63 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -49.08 -45.37 43.02 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . 0.438 ' NH1' ' CD1' ' B' ' 54' ' ' PHE . 62.4 ttp85 -61.47 -50.89 70.93 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.086 -0.646 . . . . 0.0 110.708 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' C' ' 48' ' ' PHE . 12.4 mt -76.44 -76.89 0.15 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.052 -0.659 . . . . 0.0 111.253 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 69.2 t80 58.32 -78.0 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.428 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . 0.528 ' N ' ' O ' ' C' ' 46' ' ' LEU . 38.7 t80 -169.57 -29.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.336 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . 0.415 ' NZ ' ' CD2' ' C' ' 52' ' ' TYR . 49.8 tttm -173.07 18.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.91 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.08 -32.34 69.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.697 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 35.1 mt -56.38 -54.17 31.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.438 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 52' ' ' TYR . . . . . 0.415 ' CD2' ' NZ ' ' C' ' 49' ' ' LYS . 70.5 t80 -76.87 -33.11 57.87 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 63.6 mmt-85 -66.76 -49.45 65.88 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.635 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -73.67 -39.75 64.21 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.901 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -61.03 -40.72 94.69 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.463 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? . . . . . 0 N--CA 1.463 0.201 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.319 179.417 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo . . . . . 0 N--CA 1.49 1.266 0 N-CA-C 110.394 -0.656 . . . . 0.0 110.394 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 16.2 tp -62.84 -50.33 71.35 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.04 178.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.46 -47.78 84.61 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.78 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 87.1 t -58.2 -50.57 77.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.581 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.33 -42.82 53.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.645 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.69 -49.86 75.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.568 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.28 -47.63 80.95 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.534 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 27.2 mm -62.21 -35.09 67.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.861 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 74.5 mt -67.23 -41.75 87.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.696 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.63 -51.34 31.26 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.008 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 14.1 tt -62.63 -39.96 86.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.091 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 52.8 tp -66.35 -34.47 78.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.852 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -65.88 -48.15 72.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.444 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 59.9 tp -63.14 -50.98 68.31 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.162 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 91.8 mt -59.46 -45.93 93.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.995 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 7.7 tp -62.7 -38.02 88.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.339 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 38.9 t-105 -62.23 -52.59 63.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.764 0.316 . . . . 0.0 111.551 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 64.8 mt -66.32 -53.49 35.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -177.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 54.2 tp -60.95 -46.12 91.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.697 0.284 . . . . 0.0 111.308 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . 0.489 ' O ' ' CB ' ' D' ' 50' ' ' SER . 28.1 t70 -59.8 -47.2 86.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.769 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -58.53 -50.19 74.66 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.101 -0.64 . . . . 0.0 111.071 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 2.5 pp -124.49 134.9 52.88 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.898 0.38 . . . . 0.0 110.655 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -168.43 -39.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.346 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -171.17 -36.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.401 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 177.28 26.81 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.899 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 50' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 10.3 t -50.22 -54.55 20.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.02 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 87.4 mt -48.93 -40.68 12.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.268 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -73.79 -30.8 62.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.307 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 43.4 mtm180 -67.31 -47.23 71.16 Favored 'General case' 0 CA--C 1.522 -0.097 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.318 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -71.97 -41.51 67.63 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.809 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -59.7 -43.74 93.96 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.368 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -78.21 -31.62 49.49 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.455 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -58.32 -52.16 66.77 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.874 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' D' ' 60' ' ' LYS . . . -69.82 -35.12 72.6 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.55 23.83 0.61 Allowed 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 60' ' ' LYS . . . . . 0.431 ' H ' ' C ' ' D' ' 58' ' ' GLY . 1.3 tmtp? . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.181 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo . . . . . 0 N--CA 1.493 1.496 0 CA-C-O 121.075 0.365 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.87 -54.52 33.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.875 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.97 -50.41 68.68 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.895 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 87.5 t -55.47 -47.13 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.14 -41.0 67.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.968 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.32 -48.7 80.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.665 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.4 t -59.43 -46.23 89.31 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.193 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 43.7 mm -60.63 -38.19 77.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.792 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.7 mm -69.74 -36.09 68.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.692 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.95 -52.03 26.03 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.611 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.1 pt -66.76 -37.74 80.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.626 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -67.83 -36.68 80.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.269 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.462 ' CE1' ' NE2' ' D' ' 37' ' ' HIS . 0.3 OUTLIER -68.09 -50.37 55.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.194 -179.463 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 38.2 tp -65.68 -51.53 58.66 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.332 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 89.5 mt -60.84 -51.65 70.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.333 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 41.2 tp -59.71 -40.29 87.46 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.478 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 27.1 t-105 -61.08 -55.55 31.32 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.706 0.288 . . . . 0.0 111.484 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 96.8 mt -57.93 -55.81 19.53 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 CA-C-O 121.242 0.544 . . . . 0.0 111.536 -178.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.445 ' C ' ' CD1' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -59.43 -37.71 78.8 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.567 -179.165 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -59.65 -41.47 90.6 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -63.01 -46.65 86.64 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.15 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.421 ' O ' ' O ' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -106.59 -112.65 0.28 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.991 179.654 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.421 ' O ' ' O ' ' A' ' 46' ' ' LEU . 32.6 t80 47.76 97.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.861 0.362 . . . . 0.0 110.248 -179.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.522 ' CD2' ' O ' ' A' ' 48' ' ' PHE . 49.0 t80 60.37 27.94 17.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.552 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.6 mttm 53.01 65.56 1.48 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.589 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.454 ' OG ' ' CE2' ' A' ' 54' ' ' PHE . 4.7 t -69.51 -28.83 66.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.02 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.0 mt -44.34 -43.23 2.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.916 0.389 . . . . 0.0 110.221 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -71.65 -28.03 63.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.038 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.427 ' CG ' ' CE1' ' A' ' 57' ' ' HIS . 43.9 ttm180 -71.1 -49.24 46.49 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 120.948 0.404 . . . . 0.0 110.315 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.454 ' CE2' ' OG ' ' A' ' 50' ' ' SER . 63.4 m-85 -65.4 -44.78 86.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.604 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -65.7 -35.0 79.49 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.265 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -76.89 -24.81 52.52 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.865 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.427 ' CE1' ' CG ' ' A' ' 53' ' ' ARG . 41.5 m170 -76.7 -47.14 22.87 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.389 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.444 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -179.842 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 . . . . . 0 C--O 1.232 0.171 0 CA-C-O 120.707 0.289 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.437 ' O ' ' N ' ' B' ' 29' ' ' ALA . 50.4 Cg_exo -51.96 -32.67 48.86 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.563 2.176 . . . . 0.0 111.206 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 20.6 tp -60.32 -47.13 87.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.737 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.94 -57.37 7.05 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 82.4 t -52.67 -34.81 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' B' ' 25' ' ' PRO . . . -64.27 -34.74 78.8 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.56 -48.66 59.55 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.511 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 42.2 t -63.69 -48.85 75.45 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.574 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 19.5 tt -65.66 -43.0 93.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.122 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 8.2 tt -67.17 -30.33 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.854 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.69 -51.21 37.19 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 179.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . 0.416 HD12 HG23 ' B' ' 35' ' ' ILE . 96.8 mt -58.12 -46.09 88.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.255 0.55 . . . . 0.0 109.98 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 11.2 tp -60.76 -38.15 84.25 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.894 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . 0.454 ' ND1' ' C ' ' B' ' 37' ' ' HIS . 0.4 OUTLIER -65.86 -53.95 33.1 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.811 0.338 . . . . 0.0 111.718 -178.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 27.4 tp -60.59 -54.74 41.72 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.691 -178.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 11.5 mm -60.61 -43.7 95.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.523 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 31.0 tp -54.87 -44.53 74.11 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -60.75 -54.64 42.78 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.218 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 47.9 mm -51.18 -53.66 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.325 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' B' ' 46' ' ' LEU . 1.0 OUTLIER -61.9 -38.97 90.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.136 -178.747 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -58.65 -47.58 83.96 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.219 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 53.4 ttt85 -69.92 -53.59 17.21 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.689 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' B' ' 43' ' ' LEU . 1.9 pp -108.49 147.32 31.87 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.027 0.441 . . . . 0.0 111.198 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -172.45 -48.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.074 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -172.2 -38.34 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.304 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.524 ' NZ ' ' CG ' ' B' ' 52' ' ' TYR . 42.9 tttm -172.88 21.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.259 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 13.2 t -59.01 -46.56 87.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.194 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 71.4 mt -45.53 -32.3 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.906 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.524 ' CG ' ' NZ ' ' B' ' 49' ' ' LYS . 26.3 t80 -72.17 -31.23 65.74 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.461 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . 0.481 ' N ' ' CD ' ' B' ' 53' ' ' ARG . 0.9 OUTLIER -71.57 -45.1 63.19 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.622 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -71.14 -38.15 72.24 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.045 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -70.91 -39.47 72.72 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.655 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -75.27 -39.08 60.1 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.916 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -67.57 -44.94 77.0 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.437 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.8 -28.02 67.6 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 7.9 tp -84.01 49.84 1.72 Allowed 'General case' 0 C--O 1.231 0.102 0 CA-C-O 120.823 0.344 . . . . 0.0 110.375 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 34.9 tptt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.516 -179.869 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 7.8 m . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 53.78 77.01 0.47 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.795 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -50.42 -35.12 43.95 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.544 2.163 . . . . 0.0 111.533 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 18.6 tp -60.97 -49.11 78.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.736 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.39 -45.59 92.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.113 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 91.5 t -58.46 -43.94 87.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.42 -38.48 71.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.338 0.59 . . . . 0.0 109.494 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.6 -46.83 84.01 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.172 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 2.2 p -63.08 -52.39 62.89 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.912 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 14.7 tt -59.95 -35.74 62.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.538 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 49.8 mt -68.13 -37.53 78.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.64 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.24 -52.95 20.09 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.869 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . 0.409 ' CG1' ' N ' ' C' ' 36' ' ' LEU . 6.5 pt -62.14 -41.51 91.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.396 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . 0.409 ' N ' ' CG1' ' C' ' 35' ' ' ILE . 10.5 tp -65.11 -40.79 95.0 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.341 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -62.15 -50.76 70.59 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 50.9 tp -67.7 -48.63 66.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.915 0.388 . . . . 0.0 111.624 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 92.3 mt -58.38 -50.53 78.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.311 -178.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -65.82 -37.16 85.48 Favored 'General case' 0 C--O 1.221 -0.441 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.027 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 21.9 t-105 -56.8 -53.52 56.92 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.276 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 60.3 mt -70.82 -56.54 10.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.524 -0.47 . . . . 0.0 112.251 -177.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.44 -50.85 66.68 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.825 -178.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . 0.484 ' O ' ' CB ' ' C' ' 50' ' ' SER . 36.4 t70 -58.05 -42.56 85.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.355 -0.384 . . . . 0.0 109.997 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -53.62 -51.96 61.4 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 119.889 -0.724 . . . . 0.0 110.573 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' C' ' 47' ' ' PHE . 5.7 mt -74.89 -74.21 0.21 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 120.016 -0.674 . . . . 0.0 111.035 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . 0.467 ' CG ' ' N ' ' C' ' 48' ' ' PHE . 21.4 t80 45.78 -171.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.283 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . 0.467 ' N ' ' CG ' ' C' ' 47' ' ' PHE . 26.2 m-85 -56.3 -54.63 43.13 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.243 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -153.21 36.82 0.48 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.248 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 50' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' C' ' 44' ' ' ASP . 1.4 t -50.21 -52.41 35.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.18 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 62.0 mt -50.46 -51.57 18.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.264 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -74.45 -31.56 62.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.876 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -69.93 -48.64 57.71 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.474 -0.491 . . . . 0.0 110.672 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -69.57 -42.11 74.94 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.54 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -63.06 -36.66 84.31 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.501 -0.479 . . . . 0.0 110.864 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 . . . . . 0 CA--C 1.536 0.428 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.801 179.466 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo . . . . . 0 N--CA 1.493 1.466 0 N-CA-C 111.108 -0.382 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 pp -59.6 -28.51 67.25 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.069 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.57 -34.18 24.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.702 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 84.6 t -59.41 -47.81 89.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.83 -35.43 74.72 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.474 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.56 -52.26 65.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.83 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 36.7 m -60.16 -44.7 94.8 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.042 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 5.6 mm -61.82 -34.64 63.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.768 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . 0.4 HD11 HG22 ' D' ' 33' ' ' ILE . 51.9 mt -69.36 -37.45 75.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.5 -52.41 26.15 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.858 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . 0.42 ' CG2' ' N ' ' D' ' 36' ' ' LEU . 19.1 tt -63.25 -42.5 96.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.111 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . 0.42 ' N ' ' CG2' ' D' ' 35' ' ' ILE . 59.5 tp -61.91 -39.15 90.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.79 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . 0.462 ' NE2' ' CE1' ' A' ' 37' ' ' HIS . 2.6 t60 -62.08 -49.23 76.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.387 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 39.1 tp -57.02 -47.32 81.17 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.439 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 95.3 mt -59.79 -43.15 91.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.614 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 57.9 mt -62.07 -39.88 93.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.303 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 17.8 t-105 -61.78 -55.15 33.15 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 120.642 0.258 . . . . 0.0 111.231 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 61.7 mt -61.65 -54.7 31.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.401 -0.519 . . . . 0.0 112.154 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 53.2 tp -59.85 -50.13 74.98 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.199 -178.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . 0.444 ' O ' ' OG ' ' D' ' 50' ' ' SER . 8.8 t0 -53.49 -44.3 68.91 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.186 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 30.2 ttm-85 -59.67 -52.41 65.63 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 120.061 -0.655 . . . . 0.0 110.376 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.39 106.22 15.49 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.01 0.433 . . . . 0.0 110.272 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -173.47 101.54 0.12 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.322 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 47.35 50.38 14.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.662 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . 0.539 ' CB ' ' HZ3' ' D' ' 49' ' ' LYS . 9.1 mtmp? 56.01 53.8 8.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.546 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 50' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' D' ' 44' ' ' ASP . 7.5 t -63.94 -51.21 65.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.296 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 20.0 mt -47.4 -33.13 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.324 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -73.87 -28.14 61.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.961 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 53' ' ' ARG . . . . . 0.414 ' N ' ' O ' ' D' ' 50' ' ' SER . 74.6 mtm180 -72.7 -47.34 48.02 Favored 'General case' 0 N--CA 1.461 0.093 0 CA-C-O 120.923 0.392 . . . . 0.0 110.748 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -72.06 -39.74 68.82 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.896 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -68.77 -40.03 79.93 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.663 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -75.34 -37.83 60.5 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.386 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -62.61 -48.75 78.05 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.22 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.02 -27.47 73.86 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 6.4 tp -92.65 60.16 3.43 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.772 0.32 . . . . 0.0 110.594 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 65.3 tttp . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.402 179.815 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.406 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 61.4 Cg_exo . . . . . 0 N--CA 1.492 1.389 0 CA-C-O 121.062 0.359 . . . . 0.0 111.335 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.3 tp -62.02 -50.39 72.23 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.784 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.17 -53.37 50.37 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.08 0.467 . . . . 0.0 110.068 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.9 t -56.86 -40.42 71.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.406 ' CB ' ' O ' ' A' ' 25' ' ' PRO . . . -57.78 -42.26 83.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.623 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.64 -42.7 93.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.735 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.0 t -60.34 -41.66 94.05 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.011 -0.675 . . . . 0.0 110.138 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.435 HD12 HG23 ' A' ' 32' ' ' ILE . 87.7 mt -63.02 -43.78 99.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.733 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.6 tt -70.23 -29.91 41.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.016 -178.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.09 -50.55 22.23 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.002 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.425 HG21 HD13 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -65.1 -41.28 91.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.409 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.6 tp -62.47 -36.68 83.23 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.95 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -67.4 -41.99 84.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.944 0.402 . . . . 0.0 110.317 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.84 -57.95 8.29 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.211 0.529 . . . . 0.0 111.441 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.2 mm -61.75 -45.78 97.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.828 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.407 ' O ' ' CB ' ' A' ' 44' ' ' ASP . 57.9 tp -60.26 -38.75 84.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.269 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 31.2 t-105 -63.89 -54.05 40.93 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 120.922 0.392 . . . . 0.0 111.486 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 97.1 mt -62.51 -55.32 24.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.141 -0.623 . . . . 0.0 111.813 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.0 tp -60.29 -46.76 88.73 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.072 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.407 ' CB ' ' O ' ' A' ' 40' ' ' LEU . 18.6 t70 -50.5 -47.25 57.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -59.98 -53.03 62.69 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.535 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 47' ' ' PHE . 15.5 mt -73.4 -78.54 0.09 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.034 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.484 ' O ' ' N ' ' A' ' 49' ' ' LYS . 13.3 t80 41.32 -164.5 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.405 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.408 ' N ' ' CG ' ' A' ' 47' ' ' PHE . 20.7 m-85 -64.53 68.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.358 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 47' ' ' PHE . 29.7 mtmm 46.29 47.0 13.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.619 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.428 ' O ' ' N ' ' A' ' 53' ' ' ARG . 90.3 p -69.06 -30.9 69.32 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.631 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.1 mt -44.14 -42.1 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.963 0.411 . . . . 0.0 110.052 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.407 ' CZ ' ' OE1' ' A' ' 56' ' ' GLU . 52.8 t80 -74.85 -28.92 60.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.136 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.522 ' O ' ' CD2' ' A' ' 57' ' ' HIS . 67.9 mtm180 -70.98 -48.25 54.32 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.468 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -71.2 -40.55 71.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.768 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -66.21 -39.57 89.73 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.755 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.407 ' OE1' ' CZ ' ' A' ' 52' ' ' TYR . 15.7 pt-20 -76.35 -41.1 49.4 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.828 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.522 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 10.2 m-70 -60.14 -47.93 83.84 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.53 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.822 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.871 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.744 0.307 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -51.18 -35.66 53.0 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.465 2.11 . . . . 0.0 111.354 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.436 ' CD1' ' OG ' ' C' ' 31' ' ' SER . 15.8 tp -59.38 -51.35 70.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.839 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.93 -43.48 86.31 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 92.0 t -61.93 -33.29 57.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.235 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.41 -35.38 80.71 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.26 -45.86 68.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.258 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 3.9 t -66.19 -52.07 51.66 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.331 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.408 ' CG2' ' N ' ' B' ' 33' ' ' ILE . 10.9 tp -60.77 -43.04 94.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -178.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . 0.408 ' N ' ' CG2' ' B' ' 32' ' ' ILE . 7.8 tt -69.89 -28.57 37.24 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.08 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.329 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.64 -50.61 41.59 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 mp -62.86 -42.14 95.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 11.0 tp -58.25 -46.96 85.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.889 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 15.2 t-160 -63.9 -52.03 61.8 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 40.9 tp -58.23 -47.09 84.63 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 120.549 -0.461 . . . . 0.0 111.136 -178.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 3.2 mm -63.79 -41.06 91.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.982 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.51 -42.6 96.73 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.904 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 46.0 t-105 -64.81 -57.22 9.47 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 75.5 mt -58.48 -53.75 42.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.597 -177.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 41.9 tp -59.73 -46.44 89.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.164 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -55.07 -47.28 75.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.648 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -62.75 -48.56 78.64 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.491 -0.483 . . . . 0.0 111.351 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.54 124.19 43.81 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.125 0.488 . . . . 0.0 110.43 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -172.98 -47.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.367 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -171.1 65.81 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.389 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm 55.25 35.44 24.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.566 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 11.2 t -60.0 -49.22 78.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.919 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 48.0 mt -47.36 -31.26 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.759 0.314 . . . . 0.0 110.882 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.527 ' CD2' ' OE1' ' B' ' 56' ' ' GLU . 76.2 t80 -70.84 -29.8 66.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.465 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -71.14 -44.01 66.44 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.41 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -71.21 -38.73 72.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.011 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -69.76 -39.28 76.81 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.737 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . 0.527 ' OE1' ' CD2' ' B' ' 52' ' ' TYR . 10.6 pt-20 -75.58 -38.51 59.09 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 120.254 -0.579 . . . . 0.0 110.644 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -65.03 -47.23 78.16 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.322 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.0 -28.64 73.78 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 32.9 tp -73.39 -68.72 0.48 Allowed 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.402 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.54 179.946 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -156.74 68.83 4.56 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.899 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -51.23 -30.34 32.63 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.514 2.142 . . . . 0.0 111.141 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 16.8 tp -59.09 -51.52 69.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.757 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.5 -46.97 87.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.033 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 61.3 t -58.82 -42.72 86.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.0 -37.9 72.33 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.47 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.38 -49.77 70.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.103 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 31' ' ' SER . . . . . 0.436 ' OG ' ' CD1' ' B' ' 26' ' ' LEU . 2.9 m -60.23 -50.79 72.26 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.96 -179.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 17.5 tt -63.71 -33.68 63.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.983 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 32.3 mt -67.24 -42.21 87.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.441 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.07 -49.51 46.69 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 121.019 -0.61 . . . . 0.0 111.666 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 5.1 mm -61.67 -45.37 98.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.128 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 11.6 tp -61.22 -41.65 97.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.169 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 32.7 t60 -61.51 -48.67 80.01 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.61 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 31.2 tp -63.19 -52.93 60.34 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -178.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 1.3 mp -60.46 -46.19 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.017 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -62.06 -40.62 96.39 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.821 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 6.7 t-105 -57.71 -58.41 8.46 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.245 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . 0.401 HD12 HG21 ' C' ' 42' ' ' ILE . 68.8 mt -62.13 -56.27 18.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -177.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . 0.434 ' CD1' ' C ' ' C' ' 43' ' ' LEU . 3.0 tm? -57.99 -52.82 63.92 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.177 -178.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -53.35 -41.24 65.59 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -57.61 -56.23 24.63 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.455 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' C' ' 48' ' ' PHE . 2.2 mt -80.73 -71.12 0.48 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.855 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . 0.46 ' CD2' ' N ' ' C' ' 48' ' ' PHE . 85.2 t80 49.26 -89.56 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.181 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . 0.51 ' N ' ' O ' ' C' ' 46' ' ' LEU . 68.7 t80 -153.49 85.52 1.19 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.236 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 56.9 mttp 52.09 29.26 6.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.935 0.398 . . . . 0.0 110.187 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 11.3 t -62.47 -39.54 93.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.121 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 54.6 mt -47.08 -48.91 8.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.306 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -71.69 -32.25 67.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.58 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -70.75 -48.07 56.34 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.481 -0.487 . . . . 0.0 110.619 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -66.03 -42.28 89.81 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.226 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -63.09 -39.29 94.26 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.459 -0.497 . . . . 0.0 110.854 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 . . . . . 0 CA--C 1.535 0.39 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.759 179.82 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo . . . . . 0 N--CA 1.485 0.983 0 N-CA-C 110.227 -0.721 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 pp -68.13 -35.4 78.05 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.088 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.07 -37.95 48.7 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.102 0.477 . . . . 0.0 109.879 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 71.4 t -59.24 -47.42 90.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 CA-C-O 121.428 0.632 . . . . 0.0 109.487 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.33 -39.49 76.0 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.286 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.47 -47.3 84.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.174 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 11.2 t -57.36 -50.21 73.7 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.871 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 61.0 mt -61.35 -31.71 51.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.55 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 55.2 mt -68.19 -40.46 82.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.348 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.99 -52.14 25.28 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.883 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . 0.422 ' CG2' ' N ' ' D' ' 36' ' ' LEU . 15.6 tt -61.95 -42.29 94.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.806 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . 0.422 ' N ' ' CG2' ' D' ' 35' ' ' ILE . 43.6 tp -63.71 -34.9 78.9 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.985 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -63.67 -50.93 67.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.964 0.411 . . . . 0.0 110.247 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 36.3 tp -58.35 -47.5 83.57 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.85 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 5.0 mm -61.69 -44.37 98.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.319 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.82 -39.26 91.17 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 23.7 t-105 -64.07 -56.6 13.83 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 120.875 0.369 . . . . 0.0 111.434 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . 0.403 HG23 HD12 ' D' ' 42' ' ' ILE . 82.1 mt -58.55 -53.2 50.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.777 -177.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 29.9 tp -61.1 -47.4 86.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.881 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -51.91 -44.16 63.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.265 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . 0.463 ' HE ' ' CD2' ' D' ' 46' ' ' LEU . 60.1 ttp180 -64.12 -53.45 49.29 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.77 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . 0.463 ' CD2' ' HE ' ' D' ' 45' ' ' ARG . 0.2 OUTLIER -113.53 110.31 20.05 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.046 0.451 . . . . 0.0 110.3 179.143 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -174.77 92.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.146 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 53.96 58.16 5.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.539 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? 53.73 52.93 12.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.95 0.405 . . . . 0.0 110.372 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 50' ' ' SER . . . . . 0.524 ' OG ' ' NH2' ' D' ' 53' ' ' ARG . 8.1 t -68.22 -51.76 41.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.227 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 4.7 mt -48.15 -35.01 5.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -72.37 -28.97 63.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.05 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 53' ' ' ARG . . . . . 0.524 ' NH2' ' OG ' ' D' ' 50' ' ' SER . 36.7 mtm105 -71.86 -46.49 57.76 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.96 0.41 . . . . 0.0 110.525 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -70.94 -36.85 72.79 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.788 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -70.06 -39.7 75.49 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.659 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -75.43 -37.73 60.23 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.614 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -65.94 -44.37 85.27 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.27 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.18 -26.74 70.67 Favored Glycine 0 N--CA 1.462 0.374 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.8 70.24 0.77 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.271 0.558 . . . . 0.0 109.728 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 16.3 ttpp . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.512 -179.721 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo . . . . . 0 N--CA 1.491 1.367 0 N-CA-C 110.957 -0.44 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.4 tp -65.21 -50.27 66.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.18 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.43 -50.67 64.54 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.34 0.59 . . . . 0.0 109.568 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.429 ' O ' ' OG ' ' A' ' 31' ' ' SER . 85.2 t -54.59 -46.68 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.44 -42.36 70.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.691 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.72 -47.63 76.54 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.17 0.51 . . . . 0.0 110.567 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 28' ' ' VAL . 80.8 p -62.39 -39.96 94.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.803 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 35.6 mm -61.97 -47.58 92.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.608 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.9 tt -68.96 -29.64 44.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.7 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.13 -50.21 47.61 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.171 -1.014 . . . . 0.0 110.578 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 28.1 mm -62.91 -44.24 99.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 51.4 tp -63.21 -31.13 72.2 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.433 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -69.5 -52.22 28.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.985 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 32.1 tp -61.76 -51.28 68.99 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.207 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.9 mm -61.86 -43.69 97.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.908 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 35.5 tp -61.2 -38.95 88.39 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.381 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 44.3 t-105 -63.78 -55.17 25.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.824 0.345 . . . . 0.0 111.647 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.7 mt -61.44 -51.65 70.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 120.454 -0.498 . . . . 0.0 111.78 -177.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.9 tp -60.96 -42.35 98.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.983 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -57.78 -45.29 86.19 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -60.03 -48.66 80.78 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.484 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.4 pp -130.91 132.87 45.39 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.026 0.441 . . . . 0.0 111.088 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -175.41 -38.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.161 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -167.24 60.03 0.08 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.251 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp 60.85 42.47 13.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.38 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.5 t -62.34 -49.91 73.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.696 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.4 HG22 HD13 ' A' ' 51' ' ' ILE . 94.1 mt -49.67 -41.96 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.205 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -72.26 -28.5 63.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.216 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.525 ' O ' ' CD2' ' A' ' 57' ' ' HIS . 12.1 mmm180 -69.71 -46.57 65.68 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.317 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -71.41 -40.23 70.61 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.075 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -67.37 -38.18 84.34 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.746 -179.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.52 ' OE2' ' CE1' ' A' ' 57' ' ' HIS . 0.7 OUTLIER -77.5 -38.03 49.91 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.876 -179.974 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.525 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 26.4 m-70 -63.87 -50.54 68.41 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.469 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.468 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 -179.825 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.665 0.269 . . . . 0.0 110.76 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -51.55 -31.4 39.61 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.57 2.18 . . . . 0.0 111.427 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 19.0 tp -58.76 -51.28 70.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.912 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.62 -46.12 91.46 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 91.8 t -59.74 -35.84 62.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.34 -35.63 79.71 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.6 -45.54 71.71 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.387 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 8.4 p -65.5 -51.86 56.94 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.423 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 20.0 tt -61.86 -43.05 96.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -178.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 8.3 tt -69.16 -30.3 45.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 C-N-CA 119.731 -0.788 . . . . 0.0 110.304 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.52 -50.55 42.7 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 mp -61.58 -41.59 90.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 19.8 tp -60.39 -40.97 92.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.747 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -67.71 -51.76 45.71 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 35.1 tp -61.68 -52.4 64.47 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.614 -178.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.6 mm -62.0 -41.76 92.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.392 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 46.0 tp -59.59 -41.66 90.78 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.249 -0.58 . . . . 0.0 109.944 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 9.9 t-105 -62.5 -59.37 5.05 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.724 0.297 . . . . 0.0 111.724 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 72.0 mt -58.53 -56.52 15.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.635 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.0 -49.78 70.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.641 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -52.24 -44.19 64.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.326 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -59.2 -53.01 63.1 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.641 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 2.8 mt -77.45 -141.03 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 119.871 -0.732 . . . . 0.0 110.594 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.424 ' O ' ' O ' ' B' ' 48' ' ' PHE . 47.8 t80 59.78 110.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.615 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . 0.545 ' CG ' ' N ' ' B' ' 49' ' ' LYS . 57.5 t80 48.35 -178.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.404 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.545 ' N ' ' CG ' ' B' ' 48' ' ' PHE . 0.1 OUTLIER -72.19 45.42 0.13 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.377 -179.878 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' SER . . . . . 0.446 ' H ' ' C ' ' B' ' 48' ' ' PHE . 11.1 t -62.56 -47.57 83.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.853 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 51.2 mt -48.22 -41.88 10.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.592 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.515 ' CE2' ' OE2' ' B' ' 56' ' ' GLU . 78.9 t80 -71.39 -29.72 65.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.446 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 69.6 mtm180 -68.14 -44.04 76.93 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.412 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -72.26 -39.47 68.37 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.762 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -64.45 -40.84 96.5 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.488 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . 0.515 ' OE2' ' CE2' ' B' ' 52' ' ' TYR . 13.2 pt-20 -76.48 -38.79 54.79 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.63 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -59.08 -47.06 86.63 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.174 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.35 -28.37 73.65 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 8.0 tp -88.87 49.06 1.72 Allowed 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.708 0.289 . . . . 0.0 110.468 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm . . . . . 0 N--CA 1.469 0.481 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.627 -179.986 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 25.1 t . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -159.18 70.78 3.46 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.871 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.0 -29.51 36.26 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.621 2.214 . . . . 0.0 111.281 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.59 -56.32 23.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.89 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.2 -46.79 82.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.57 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 74.6 t -58.21 -43.44 85.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.64 -39.93 78.08 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.528 178.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.77 -49.37 76.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.164 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 2.2 t -62.17 -53.79 50.26 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 16.5 tt -58.44 -35.8 55.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.663 -179.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 51.0 mt -67.46 -37.48 78.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.399 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.33 -51.22 28.11 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.93 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -62.82 -43.54 98.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 11.4 tp -63.22 -41.61 99.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.838 0.351 . . . . 0.0 110.237 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -61.61 -48.06 82.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.522 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 51.3 tp -65.0 -51.01 64.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.789 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 50.9 mt -59.3 -48.49 86.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.19 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -63.25 -37.65 88.08 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.671 -0.412 . . . . 0.0 109.981 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 25.5 t-105 -59.35 -59.37 5.56 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.346 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 48.4 mt -62.63 -54.97 26.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.514 -0.474 . . . . 0.0 112.047 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . 0.444 ' CD1' ' C ' ' C' ' 43' ' ' LEU . 3.2 tm? -57.9 -52.36 65.83 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.196 -178.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . 0.454 ' O ' ' CB ' ' C' ' 50' ' ' SER . 67.9 t0 -53.11 -41.94 65.49 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.02 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -58.49 -53.24 60.61 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.791 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' C' ' 48' ' ' PHE . 3.6 mt -84.53 -71.41 0.52 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.176 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 91.7 t80 56.75 -80.42 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.246 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . 0.527 ' N ' ' O ' ' C' ' 46' ' ' LEU . 86.4 t80 -172.91 -22.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.334 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . 0.464 ' NZ ' ' CD1' ' C' ' 52' ' ' TYR . 49.8 tttm -170.75 21.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.91 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 50' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' C' ' 44' ' ' ASP . 10.8 t -62.08 -48.47 80.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.282 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 12.8 mt -50.21 -53.99 9.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.3 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 52' ' ' TYR . . . . . 0.464 ' CD1' ' NZ ' ' C' ' 49' ' ' LYS . 27.7 t80 -70.57 -32.83 70.38 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.668 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 19.9 mmt85 -70.01 -43.41 71.4 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.586 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -66.29 -47.23 74.3 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.176 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -62.2 -36.55 82.27 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.925 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . 0.411 ' OE1' ' O ' ' C' ' 56' ' ' GLU . 3.0 tm-20 . . . . . 0 CA--C 1.536 0.428 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.535 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 N--CA 1.494 1.548 0 N-CA-C 111.091 -0.388 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 2.4 pp -65.95 -30.88 71.52 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.678 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.32 -49.7 42.83 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 95.4 t -50.81 -38.09 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 178.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.6 -40.06 95.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.639 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.94 -50.48 68.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.268 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 45.9 t -60.51 -51.89 67.53 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.904 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 20.1 tt -63.27 -31.41 52.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.629 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 19.4 mt -67.47 -41.8 86.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.017 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.01 -51.74 32.32 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.121 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 10.7 tp -64.49 -39.18 84.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.402 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 56.8 tp -64.58 -38.64 91.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.109 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 32.4 t60 -65.11 -48.66 72.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.368 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 50.3 tp -59.08 -47.01 86.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.562 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.36 -42.76 94.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.851 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 40.2 mt -61.58 -42.45 98.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.208 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 18.4 t-105 -62.07 -55.58 27.63 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.696 0.284 . . . . 0.0 111.508 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 72.5 mt -60.54 -54.93 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -177.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 40.0 tp -60.92 -44.43 97.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.61 0.243 . . . . 0.0 111.343 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . 0.435 ' O ' ' CB ' ' D' ' 50' ' ' SER . 22.6 t70 -58.08 -42.77 86.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.594 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -66.11 -56.61 10.6 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.066 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.67 130.8 54.34 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -171.76 -43.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.454 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -172.71 -48.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.426 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -172.46 28.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.339 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 50' ' ' SER . . . . . 0.435 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 7.8 t -57.92 -50.93 71.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.181 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 7.3 mt -49.39 -39.35 13.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.32 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 52' ' ' TYR . . . . . 0.465 ' CE2' ' OE2' ' D' ' 56' ' ' GLU . 82.5 t80 -73.98 -29.56 62.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.242 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 -68.15 -48.32 65.67 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.916 0.388 . . . . 0.0 110.482 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -72.34 -39.49 68.12 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.752 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -62.1 -41.96 98.74 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.348 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 56' ' ' GLU . . . . . 0.465 ' OE2' ' CE2' ' D' ' 52' ' ' TYR . 14.8 pt-20 -77.49 -37.11 51.88 Favored 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 120.219 -0.592 . . . . 0.0 110.434 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -56.18 -48.89 75.48 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.217 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.82 -27.08 74.16 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.439 -1.065 . . . . 0.0 110.439 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 59' ' ' LEU . . . . . 0.411 ' N ' ' CD2' ' D' ' 59' ' ' LEU . 3.0 mm? -99.29 52.69 0.95 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.025 0.441 . . . . 0.0 109.983 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 63.7 tttp . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.586 179.923 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo . . . . . 0 N--CA 1.491 1.347 0 N-CA-C 111.03 -0.412 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.9 tp -63.3 -49.01 75.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.936 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.84 -55.08 37.25 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.7 t -51.87 -47.66 40.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.811 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.93 -48.84 64.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.899 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.76 -48.63 66.65 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.18 -53.01 56.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.482 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 44.7 mm -53.62 -38.25 33.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.223 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 70.6 mt -69.47 -32.8 54.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.291 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.1 -53.04 15.66 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.855 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -33.97 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.108 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.6 tp -69.41 -35.97 76.27 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.338 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.561 ' CE1' ' CD2' ' B' ' 37' ' ' HIS . 47.9 t60 -70.01 -51.3 33.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.654 0.264 . . . . 0.0 111.054 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.6 tp -62.73 -50.38 71.32 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.934 0.397 . . . . 0.0 111.222 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 29.5 mm -63.32 -44.59 99.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.279 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 50.2 tp -60.66 -43.23 97.91 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.234 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 16.6 t-105 -61.91 -57.24 12.52 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.744 0.307 . . . . 0.0 111.74 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 76.5 mt -59.56 -55.46 23.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.531 -0.467 . . . . 0.0 112.22 -177.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.7 tp -59.73 -46.97 87.51 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.167 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -53.71 -41.78 67.34 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 45.2 ttt-85 -60.59 -51.53 69.04 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.252 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.81 107.42 18.61 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 120.776 -0.369 . . . . 0.0 110.203 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -174.11 100.32 0.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.217 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.508 ' CD2' ' O ' ' A' ' 48' ' ' PHE . 69.3 t80 45.45 52.07 9.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.39 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.0 mttp 55.32 52.94 10.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.618 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.5 t -62.65 -42.78 99.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.96 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.5 mp -47.74 -31.48 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.504 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -72.95 -28.51 62.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.097 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.542 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 77.9 mtp180 -68.42 -48.04 65.68 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.378 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -71.46 -39.28 71.04 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.795 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -64.36 -39.97 94.94 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.7 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.534 ' OE2' ' CD2' ' A' ' 57' ' ' HIS . 1.6 pp20? -77.01 -41.29 43.32 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.851 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.542 ' ND1' ' O ' ' A' ' 53' ' ' ARG . 23.9 m80 -57.87 -50.49 73.14 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 120.314 -0.554 . . . . 0.0 109.782 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.672 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 179.556 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.785 0.326 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -50.84 -30.6 30.42 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.646 2.231 . . . . 0.0 111.244 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 19.7 tp -60.85 -50.12 74.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.078 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.43 -43.1 79.08 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 83.7 t -61.37 -34.3 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.29 -34.63 78.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.305 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.13 -51.68 43.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.087 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 6.1 p -61.71 -50.42 72.53 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.783 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 3.8 tp -62.33 -40.93 89.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.989 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 34.1 mt -62.19 -44.3 98.91 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.922 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.04 -53.78 43.56 Favored Glycine 0 N--CA 1.462 0.376 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 96.8 mt -50.55 -39.13 17.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.94 -45.89 90.32 Favored 'General case' 0 C--O 1.219 -0.5 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.28 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . 0.561 ' CD2' ' CE1' ' A' ' 37' ' ' HIS . 1.4 t60 -60.35 -48.58 81.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.592 -178.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.471 ' CD1' ' HD1' ' A' ' 37' ' ' HIS . 9.6 mp -64.07 -47.86 78.45 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.741 -178.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 18.1 mm -62.52 -47.93 90.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.295 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 7.1 mp -63.66 -34.01 76.9 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 28.6 t-105 -64.66 -57.26 9.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 120.89 0.376 . . . . 0.0 111.262 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.409 HD13 HG23 ' B' ' 42' ' ' ILE . 77.7 mt -60.0 -51.73 69.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.773 -178.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 8.6 mt -63.4 -50.94 67.85 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.502 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . 0.478 ' O ' ' CB ' ' B' ' 50' ' ' SER . 36.3 t70 -53.4 -41.94 66.46 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.325 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -65.3 -45.45 84.32 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.946 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 2.5 pp -139.5 124.08 18.32 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.266 0.555 . . . . 0.0 111.507 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -173.79 -31.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.879 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . 0.415 ' CD2' ' O ' ' B' ' 48' ' ' PHE . 63.4 t80 -167.4 58.93 0.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.051 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 97.5 mttt 55.14 53.95 9.47 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.504 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' SER . . . . . 0.585 ' HG ' ' N ' ' B' ' 51' ' ' ILE . 3.0 p -68.39 -52.28 34.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.995 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . 0.585 ' N ' ' HG ' ' B' ' 50' ' ' SER . 80.6 mt -50.3 -46.73 25.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.974 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.518 ' CE2' ' OE2' ' B' ' 56' ' ' GLU . 86.5 t80 -71.25 -29.82 65.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.317 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 33.1 mmm-85 -70.76 -44.7 66.2 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.831 0.348 . . . . 0.0 110.541 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -71.64 -39.23 70.53 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.881 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -68.18 -38.97 82.6 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.684 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . 0.518 ' OE2' ' CE2' ' B' ' 52' ' ' TYR . 11.5 pt-20 -76.16 -38.54 56.55 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.569 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -62.88 -47.67 82.33 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.235 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.79 -27.58 72.24 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 9.9 tp -89.38 59.46 4.83 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-O 120.837 0.351 . . . . 0.0 110.275 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp . . . . . 0 N--CA 1.466 0.372 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.287 -179.984 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -35.83 100.54 0.2 Allowed Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.45 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.85 -34.79 37.75 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.044 1.83 . . . . 0.0 111.559 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . 0.401 ' C ' ' CD1' ' C' ' 26' ' ' LEU . 0.2 OUTLIER -58.48 -55.69 31.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.489 0.662 . . . . 0.0 109.477 179.428 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.49 -45.63 88.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.427 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 88.0 t -56.9 -40.19 70.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.9 -37.65 85.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.761 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.41 -51.24 64.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.542 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 10.4 p -63.44 -51.45 65.66 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 120.689 -0.404 . . . . 0.0 112.04 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 20.7 tt -59.85 -36.51 66.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.764 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 41.3 mt -68.5 -39.56 80.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.64 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.78 -52.81 31.19 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.734 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 6.8 pt -61.91 -42.59 95.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.295 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 8.7 tp -63.82 -34.34 77.69 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.313 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -66.75 -52.67 41.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.241 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 33.1 tp -61.9 -49.44 76.19 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.045 0.45 . . . . 0.0 111.121 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 30.3 mm -59.79 -43.89 92.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.73 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 25.7 mt -62.34 -40.28 95.84 Favored 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.919 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 25.0 t-105 -59.58 -52.31 66.1 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.308 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 65.9 mt -66.68 -56.59 13.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.266 -0.574 . . . . 0.0 112.411 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . 0.431 ' CD1' ' C ' ' C' ' 43' ' ' LEU . 2.9 tm? -58.28 -52.09 67.05 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.886 -178.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -52.93 -43.38 66.24 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.22 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 52.9 ttt-85 -58.84 -52.09 67.21 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.853 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' C' ' 48' ' ' PHE . 8.5 mt -79.59 -73.95 0.32 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 120.274 -0.571 . . . . 0.0 111.263 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 49.3 t80 62.03 -71.32 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.407 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' C' ' 46' ' ' LEU . 66.2 t80 -172.75 -32.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.261 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 46.6 tttp -172.96 26.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.917 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 39.6 t -63.73 -42.23 97.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.298 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 58.3 mt -48.98 -52.78 9.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.389 -179.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -74.86 -32.64 61.96 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -71.73 -49.58 37.94 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.673 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -67.66 -43.32 80.53 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.428 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -64.88 -35.87 82.54 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.829 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 . . . . . 0 CA--C 1.534 0.336 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.561 179.262 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo . . . . . 0 N--CA 1.488 1.176 0 N-CA-C 110.878 -0.47 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 pp -66.18 -42.71 88.52 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.832 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.31 -53.47 21.81 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.558 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 87.7 t -48.1 -36.98 6.49 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.06 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.58 -37.04 85.52 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.275 0.56 . . . . 0.0 109.818 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.94 -51.22 60.43 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.883 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 58.4 m -62.43 -50.44 71.48 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 3.3 tp -62.29 -35.84 71.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.73 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 37.7 mt -68.03 -38.21 79.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.07 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.38 -50.76 42.02 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.15 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . 0.424 ' CG2' ' N ' ' D' ' 36' ' ' LEU . 18.4 tt -66.05 -42.75 92.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.347 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . 0.424 ' N ' ' CG2' ' D' ' 35' ' ' ILE . 7.2 tp -60.62 -38.5 84.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.864 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -66.92 -45.43 77.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.604 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 31.6 tp -57.67 -54.3 48.46 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.195 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 13.6 pt -64.08 -37.31 79.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.816 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 17.9 mt -58.82 -42.55 89.48 Favored 'General case' 0 C--O 1.224 -0.263 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 33.5 t-105 -64.58 -51.44 62.72 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.101 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 mm -56.48 -56.72 12.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.531 -0.467 . . . . 0.0 111.771 -177.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 36.6 tp -62.03 -45.23 94.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.789 0.328 . . . . 0.0 110.8 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -50.76 -44.44 58.61 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.004 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -66.48 -54.57 22.52 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.564 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.72 105.62 15.74 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.279 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -172.99 95.79 0.12 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.313 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 52.2 51.69 15.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.742 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 18.0 mtpp 54.44 49.75 17.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.594 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 10.9 t -61.85 -46.36 89.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.992 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 38.2 mt -49.44 -39.11 13.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.656 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -72.72 -28.86 62.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.112 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 35.7 mtm105 -71.5 -47.49 55.08 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.984 0.421 . . . . 0.0 110.56 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -71.16 -35.16 71.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.739 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -70.64 -37.91 73.81 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.604 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -77.51 -37.89 50.11 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.644 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -66.16 -48.63 70.11 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.504 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.86 -27.34 72.0 Favored Glycine 0 N--CA 1.461 0.311 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.13 77.15 1.77 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 57.3 tttm . . . . . 0 C--N 1.333 -0.111 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.539 -179.695 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo . . . . . 0 N--CA 1.491 1.345 0 N-CA-C 111.115 -0.379 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.3 tp -65.56 -50.73 64.09 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.059 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.43 -50.23 70.61 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.392 0.615 . . . . 0.0 109.567 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.3 t -57.94 -45.27 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.6 -35.36 65.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.779 179.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.55 -50.05 68.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.413 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.6 m -58.52 -41.09 84.65 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.477 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 35.5 mm -64.52 -41.74 93.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.505 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.6 tt -68.43 -35.61 71.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.627 -178.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.26 -51.47 32.53 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 89.3 mt -60.7 -43.87 95.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.96 0.409 . . . . 0.0 110.067 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.2 tp -65.01 -31.07 72.13 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.364 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.447 ' ND1' ' C ' ' A' ' 37' ' ' HIS . 0.3 OUTLIER -68.55 -51.97 37.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.805 0.336 . . . . 0.0 110.903 -179.517 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 51.2 tp -62.58 -51.44 67.31 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.265 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 83.5 mt -61.98 -44.58 99.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.076 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 35.0 tp -60.32 -41.72 94.09 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.322 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.1 t-105 -62.59 -57.78 9.88 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 120.95 0.405 . . . . 0.0 111.516 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 95.3 mt -56.64 -54.72 25.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.925 -177.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 47' ' ' PHE . 29.0 tp -61.97 -44.01 97.64 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.025 -178.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -50.43 -45.95 56.13 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 57.7 ttt85 -61.71 -52.72 63.12 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.14 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 48' ' ' PHE . 5.6 mt -81.93 -77.38 0.22 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.806 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.464 ' N ' ' O ' ' A' ' 43' ' ' LEU . 92.6 t80 52.9 -83.69 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.8 0.333 . . . . 0.0 110.415 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.525 ' N ' ' O ' ' A' ' 46' ' ' LEU . 49.9 t80 -157.39 81.43 0.9 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.119 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.6 mttm 51.28 25.35 2.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.244 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.497 ' OG ' ' CE2' ' A' ' 54' ' ' PHE . 3.9 t -61.76 -29.66 70.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.587 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.9 mt -45.34 -37.0 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.988 0.423 . . . . 0.0 110.06 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -74.37 -27.58 60.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.001 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.537 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 95.7 mtt-85 -71.61 -48.63 46.84 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.542 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.497 ' CE2' ' OG ' ' A' ' 50' ' ' SER . 48.1 m-85 -71.33 -38.93 71.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.006 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -69.87 -38.87 76.55 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 120.829 -0.349 . . . . 0.0 111.724 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.523 ' OE2' ' CD2' ' A' ' 57' ' ' HIS . 0.8 OUTLIER -75.84 -38.42 58.05 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.785 -179.871 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.537 ' ND1' ' O ' ' A' ' 53' ' ' ARG . 27.8 m170 -66.39 -44.95 81.64 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.449 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.38 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 179.889 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.655 0.264 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -49.68 -28.96 18.36 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.365 2.043 . . . . 0.0 111.241 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 19.4 tp -60.85 -51.19 70.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.86 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.64 -51.68 57.7 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.362 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 14.7 t -56.97 -42.33 78.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.82 -43.91 77.41 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.43 -44.85 80.81 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.384 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -61.35 -48.99 78.77 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.299 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 74.7 mt -57.39 -48.73 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.743 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 15.5 tt -67.96 -27.16 36.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.695 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.7 -49.18 57.2 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.2 mp -67.78 -41.13 84.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 12.4 tp -55.87 -52.05 65.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.925 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -67.36 -40.65 85.82 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.308 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 48.1 tp -63.29 -57.86 9.02 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 120.652 -0.419 . . . . 0.0 112.097 -178.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 4.6 tt -66.56 -36.87 78.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.812 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 52.5 tp -63.98 -36.74 84.98 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.539 -0.465 . . . . 0.0 109.966 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -67.73 -56.67 8.37 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.805 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.538 ' CG2' ' N ' ' B' ' 43' ' ' LEU . 8.3 tt -62.38 -47.63 92.13 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.476 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.071 -177.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.538 ' N ' ' CG2' ' B' ' 42' ' ' ILE . 17.8 tp -63.92 -47.0 82.29 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.338 -177.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . 0.43 ' O ' ' OG ' ' B' ' 50' ' ' SER . 41.7 t0 -57.96 -38.28 75.72 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 70.2 ttt-85 -69.67 -45.79 67.56 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.082 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 2.7 pp -133.62 125.61 29.11 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.098 0.475 . . . . 0.0 110.904 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -173.74 -37.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.551 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -172.21 56.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.297 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp 60.62 43.23 12.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.43 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' B' ' 44' ' ' ASP . 13.4 t -63.73 -51.02 66.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.817 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 73.1 mt -46.53 -40.46 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.856 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.522 ' CE2' ' OE2' ' B' ' 56' ' ' GLU . 92.0 t80 -71.65 -30.2 65.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.55 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . 0.523 ' O ' ' CD2' ' B' ' 57' ' ' HIS . 93.5 mtt180 -70.63 -45.12 65.81 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.011 0.434 . . . . 0.0 110.655 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -71.66 -38.06 70.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.824 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -68.48 -39.1 81.49 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.529 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . 0.522 ' OE2' ' CE2' ' B' ' 52' ' ' TYR . 12.4 pt-20 -75.92 -39.4 56.31 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 120.296 -0.561 . . . . 0.0 110.683 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' HIS . . . . . 0.523 ' CD2' ' O ' ' B' ' 53' ' ' ARG . 9.9 m-70 -63.5 -45.5 90.41 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.552 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.45 -28.49 73.19 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 5.1 tp -89.66 33.2 0.84 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.872 0.367 . . . . 0.0 110.336 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . 0.716 ' HZ3' ' HZ2' ' C' ' 49' ' ' LYS . 25.3 pttm . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.597 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . 0.433 ' N ' ' OD1' ' C' ' 24' ' ' ASP . 6.8 p30 -170.65 72.55 0.57 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.787 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -51.54 -33.59 48.52 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 C-N-CA 122.152 1.901 . . . . 0.0 111.047 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 18.5 tp -64.81 -50.43 66.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.97 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.52 -48.06 83.41 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.507 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . 0.438 ' O ' ' OG ' ' C' ' 31' ' ' SER . 48.2 t -57.28 -42.58 80.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.12 -42.23 80.5 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.58 -49.86 75.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.553 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 31' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' C' ' 28' ' ' VAL . 2.5 p -56.85 -46.74 81.55 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.93 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 52.4 mt -61.36 -33.91 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.518 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 3.4 mm -67.37 -42.78 87.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.072 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.1 -51.63 32.47 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.942 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . 0.428 ' CG2' ' N ' ' C' ' 36' ' ' LEU . 14.8 tt -63.26 -41.62 93.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.762 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . 0.428 ' N ' ' CG2' ' C' ' 35' ' ' ILE . 56.0 tp -64.96 -38.43 90.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.273 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.3 t60 -63.96 -50.68 67.64 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 28.5 tp -61.57 -48.29 81.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.494 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 66.9 mt -61.41 -43.16 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.291 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 36.6 mt -64.23 -40.29 95.73 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.398 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 10.3 t-105 -61.98 -60.72 3.21 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.114 0.483 . . . . 0.0 111.431 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . 0.554 ' CG2' ' N ' ' C' ' 43' ' ' LEU . 9.0 tt -58.6 -50.82 77.69 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.579 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.691 -177.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . 0.554 ' N ' ' CG2' ' C' ' 42' ' ' ILE . 2.7 tm? -61.26 -53.6 54.71 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.792 -177.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . 0.407 ' O ' ' OD1' ' C' ' 44' ' ' ASP . 68.2 t0 -52.01 -34.43 42.78 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . 0.46 ' O ' ' CD1' ' C' ' 51' ' ' ILE . 39.0 ttt-85 -69.03 -51.07 42.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.012 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 20.2 mt -79.96 -126.29 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.935 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 5.4 t80 72.75 -155.26 0.08 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.084 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -71.57 65.4 0.47 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.549 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . 0.716 ' HZ2' ' HZ3' ' B' ' 60' ' ' LYS . 49.7 mttp 54.87 52.57 11.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.938 0.399 . . . . 0.0 110.092 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 38.7 t -62.14 -40.97 97.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.221 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 51' ' ' ILE . . . . . 0.46 ' CD1' ' O ' ' C' ' 45' ' ' ARG . 3.7 mp -46.87 -47.5 8.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.356 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -72.36 -29.79 64.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.549 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -69.99 -47.24 62.98 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.685 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -69.58 -41.18 76.17 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.346 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -62.52 -39.69 94.37 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.837 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 CA--C 1.537 0.457 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.199 179.602 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo . . . . . 0 N--CA 1.491 1.342 0 N-CA-C 110.83 -0.488 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 pp -57.13 -29.25 63.41 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.03 -41.6 47.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.776 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 79.0 t -57.31 -44.48 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.42 -29.88 70.21 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.681 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.88 -42.31 73.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.778 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 16.0 p -69.61 -46.42 66.32 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.675 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 9.5 tt -67.99 -40.16 82.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.554 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 13.0 tt -71.28 -32.38 46.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.43 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.82 -52.49 14.71 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 19.0 tt -63.12 -39.89 86.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.912 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 43.8 tp -63.9 -37.52 87.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.911 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . 0.484 ' HD1' ' C ' ' D' ' 37' ' ' HIS . 0.3 OUTLIER -64.05 -50.06 69.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.431 -179.918 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 32.0 tp -57.98 -47.64 82.38 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.698 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . 0.403 HD13 HG23 ' D' ' 39' ' ' ILE . 97.7 mt -60.78 -43.82 96.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.16 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.89 -40.86 96.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.181 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . 0.481 ' HE1' HH21 ' D' ' 45' ' ' ARG . 30.8 t-105 -62.09 -55.02 33.22 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.739 0.304 . . . . 0.0 111.287 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 79.2 mt -60.03 -55.98 20.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.913 -178.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 52.7 tp -58.34 -41.5 84.79 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.841 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . 0.426 ' O ' ' CB ' ' D' ' 50' ' ' SER . 4.2 t70 -58.54 -40.84 84.1 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . 0.481 HH21 ' HE1' ' D' ' 41' ' ' TRP . 14.8 ttm180 -62.78 -50.91 69.17 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.546 -0.461 . . . . 0.0 110.445 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.39 109.45 21.44 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.001 0.429 . . . . 0.0 109.908 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -173.18 86.53 0.06 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.374 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 53.71 55.64 8.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.419 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt 60.35 52.19 4.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.223 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 50' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 0.3 OUTLIER -58.79 -42.23 88.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.73 -179.59 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 51' ' ' ILE . . . . . 0.617 ' H ' ' CD1' ' D' ' 51' ' ' ILE . 0.0 OUTLIER -55.37 -43.52 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -70.59 -28.24 64.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.122 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -68.7 -44.61 73.59 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.42 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -72.16 -40.99 67.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.775 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -63.19 -41.04 99.12 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.449 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -76.94 -36.89 56.24 Favored 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.562 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -58.44 -49.81 75.98 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.406 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.47 -27.35 73.07 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -93.86 57.55 2.49 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 86.8 tttt . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.53 -179.96 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 90.3 p . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 4.3 p30 -163.18 74.39 1.93 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.805 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -50.51 -35.36 45.57 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.137 1.891 . . . . 0.0 110.904 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 18.6 tp -64.81 -51.52 61.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.972 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.23 -51.57 65.69 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.142 0.496 . . . . 0.0 109.928 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 49.2 t -56.91 -42.86 79.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.651 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.93 -45.49 78.73 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.73 -46.04 81.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.113 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.3 t -56.05 -50.66 70.34 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.332 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.422 HD13 HG23 ' A' ' 32' ' ' ILE . 55.3 mt -56.59 -37.82 54.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.611 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 87.5 mt -65.37 -41.88 92.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.055 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.13 -52.32 37.59 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.643 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.5 -44.6 93.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 52.4 tp -63.9 -32.06 73.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.485 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -68.62 -51.66 39.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.817 0.341 . . . . 0.0 111.043 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 28.8 tp -63.04 -51.22 67.59 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.29 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.8 mm -61.58 -44.33 98.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.983 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 47.5 tp -61.54 -38.91 89.15 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.302 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 39.9 t-105 -63.5 -55.72 21.79 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.87 0.367 . . . . 0.0 111.405 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 74.8 mt -59.47 -54.18 38.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.802 -177.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 44.9 tp -61.25 -44.66 96.89 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.961 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -51.98 -44.87 64.23 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.472 ' NH2' ' CB ' ' D' ' 54' ' ' PHE . 65.8 ttt180 -61.2 -50.89 71.29 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.255 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.5 mt -81.73 -131.3 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.78 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 39.5 t80 62.47 101.31 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.592 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 41.73 38.83 1.03 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.605 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 66.9 mttm 53.39 49.42 19.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.158 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.9 t -49.49 -27.37 4.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.632 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.452 ' CD1' ' O ' ' A' ' 45' ' ' ARG . 3.6 mp -47.5 -45.33 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.9 0.381 . . . . 0.0 110.093 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.519 ' CE2' ' OE1' ' A' ' 56' ' ' GLU . 86.8 t80 -71.15 -29.04 64.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.175 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.527 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 79.5 mtp180 -69.02 -45.53 70.27 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.027 0.441 . . . . 0.0 110.33 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -70.69 -37.11 73.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.651 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -67.91 -39.91 83.49 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 120.629 -0.429 . . . . 0.0 111.661 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.519 ' OE1' ' CE2' ' A' ' 52' ' ' TYR . 21.9 pt-20 -76.41 -40.1 51.72 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.145 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.527 ' ND1' ' O ' ' A' ' 53' ' ' ARG . 32.6 m170 -64.77 -45.84 84.65 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.757 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.9 -27.89 73.18 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.774 -0.931 . . . . 0.0 110.774 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.9 tp -85.86 50.28 1.94 Allowed 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.807 0.337 . . . . 0.0 110.425 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.558 -179.868 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -159.86 70.16 3.12 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.72 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -51.63 -32.87 46.43 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.492 2.128 . . . . 0.0 111.27 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 19.2 tp -61.5 -47.31 86.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.904 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.93 -46.15 91.82 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 91.9 t -60.56 -33.39 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.39 -35.65 81.12 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.77 -44.07 74.43 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.386 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 4.8 t -67.02 -51.32 56.34 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 120.081 -0.648 . . . . 0.0 111.563 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 19.9 tt -62.72 -40.96 90.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.738 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 17.4 tt -71.68 -28.44 31.01 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.14 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.247 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.15 -52.22 28.85 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 6.4 pt -64.27 -42.94 96.99 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.217 0 C-N-CA 120.234 -0.587 . . . . 0.0 109.902 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 11.5 tp -59.75 -39.44 84.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.67 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . 0.545 ' NE2' ' NE2' ' C' ' 37' ' ' HIS . 28.9 t60 -68.0 -54.46 18.27 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -178.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 38.5 tp -62.12 -51.54 67.48 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 120.999 0.428 . . . . 0.0 111.761 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.478 ' CD1' ' N ' ' B' ' 39' ' ' ILE . 1.2 mp -62.18 -43.36 97.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.229 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 37.0 tp -59.46 -38.49 80.9 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.98 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 6.8 t-105 -63.85 -63.23 1.22 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.998 0.428 . . . . 0.0 111.611 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.548 ' CG2' ' N ' ' B' ' 43' ' ' LEU . 8.6 tt -53.25 -50.89 44.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 119.944 -0.703 . . . . 0.0 110.74 -177.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.548 ' N ' ' CG2' ' B' ' 42' ' ' ILE . 0.5 OUTLIER -57.65 -50.23 73.86 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.46 -178.128 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -50.27 -37.27 35.17 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 63.9 ttt-85 -68.95 -50.99 44.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.084 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.438 ' O ' ' O ' ' B' ' 43' ' ' LEU . 0.3 OUTLIER -96.79 128.47 43.77 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.614 -179.398 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -162.53 -54.29 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.422 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -170.92 -60.31 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.303 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -147.87 18.46 1.13 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.316 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 47.3 t -54.34 -49.84 68.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.729 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 49.9 mt -53.84 -50.05 54.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.986 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.479 ' CE2' ' OE2' ' B' ' 56' ' ' GLU . 79.2 t80 -74.18 -30.6 62.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.748 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 20.1 mmt85 -69.15 -47.75 64.15 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.705 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -72.6 -39.77 67.04 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.872 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -64.08 -41.39 97.34 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 120.751 -0.379 . . . . 0.0 111.462 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . 0.479 ' OE2' ' CE2' ' B' ' 52' ' ' TYR . 10.9 pt-20 -76.92 -38.07 54.13 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 120.404 -0.519 . . . . 0.0 110.738 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -59.58 -49.27 78.4 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.35 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.21 -29.48 74.43 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 9.6 tp -87.29 58.12 4.83 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.802 0.334 . . . . 0.0 110.296 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 62.8 mttp . . . . . 0 N--CA 1.466 0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.399 -179.904 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -157.71 72.29 4.24 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.778 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -51.04 -35.69 51.62 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.485 2.123 . . . . 0.0 111.221 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 15.3 tp -58.16 -53.07 62.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.958 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.25 -46.09 91.0 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.044 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 89.9 t -60.25 -33.46 53.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.07 -38.39 90.9 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.95 -51.32 62.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.106 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 31' ' ' SER . . . . . 0.419 ' H ' ' HG ' ' C' ' 31' ' ' SER . 2.8 p -62.01 -52.27 64.67 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.595 -0.442 . . . . 0.0 112.022 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 10.1 tp -59.37 -37.71 70.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.489 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 29.6 mt -63.14 -40.86 90.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.73 -52.1 45.71 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.65 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 50.2 mm -56.7 -48.24 81.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.551 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 7.4 tp -62.73 -34.3 76.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.834 0.35 . . . . 0.0 110.816 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . 0.545 ' NE2' ' NE2' ' B' ' 37' ' ' HIS . 1.5 t60 -65.12 -50.16 67.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.431 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 11.0 mp -66.56 -44.86 81.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.411 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 30.6 mm -63.34 -47.14 93.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.268 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 34.8 mt -65.9 -40.46 91.55 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.666 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 32.7 t-105 -61.27 -54.47 43.69 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.021 0.439 . . . . 0.0 111.607 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . 0.409 HD13 HG23 ' C' ' 42' ' ' ILE . 82.8 mt -65.43 -55.0 22.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.113 -177.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . 0.426 ' C ' ' CD1' ' C' ' 43' ' ' LEU . 2.9 tm? -59.83 -52.37 65.76 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.141 -178.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . 0.499 ' OD1' ' CE1' ' C' ' 54' ' ' PHE . 66.4 t0 -52.86 -41.77 64.6 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.107 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 55.1 ttt-85 -59.94 -53.55 56.58 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.224 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . 0.403 ' O ' ' CB ' ' C' ' 47' ' ' PHE . 4.1 mt -84.08 -140.42 0.07 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.091 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . 0.529 ' O ' ' N ' ' C' ' 49' ' ' LYS . 7.2 t80 78.63 -164.22 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.168 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . 0.406 ' O ' ' C ' ' C' ' 49' ' ' LYS . 85.9 t80 -57.03 81.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.406 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' C' ' 47' ' ' PHE . 15.9 ptpt 33.27 53.34 0.41 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.122 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 42.9 t -57.88 -46.32 85.06 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.302 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 3.5 mp -43.46 -42.48 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.944 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -71.11 -31.2 67.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.455 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 53' ' ' ARG . . . . . 0.515 ' O ' ' CG ' ' C' ' 57' ' ' HIS . 76.0 mtp180 -70.13 -46.73 64.16 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.512 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . 0.499 ' CE1' ' OD1' ' C' ' 44' ' ' ASP . 32.2 m-85 -66.14 -43.49 86.93 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.29 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -61.67 -39.9 93.03 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.693 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -76.62 -22.82 53.64 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.894 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 57' ' ' HIS . . . . . 0.515 ' CG ' ' O ' ' C' ' 53' ' ' ARG . 5.8 m-70 -72.28 -46.14 57.11 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.909 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.2 -28.79 73.19 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 5.7 tp -93.21 31.26 1.5 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.78 0.324 . . . . 0.0 110.373 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt . . . . . 0 N--CA 1.469 0.479 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.496 -179.93 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 9.2 p . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . 0.461 ' O ' ' N ' ' D' ' 27' ' ' ALA . 19.2 p30 -166.06 63.11 0.82 Allowed Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.498 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -45.41 -27.3 3.18 Favored 'Trans proline' 0 C--N 1.3 -2.005 0 C-N-CA 121.518 1.478 . . . . 0.0 110.496 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 pp -67.86 -37.53 81.94 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.7 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 27' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' D' ' 24' ' ' ASP . . . -51.4 -40.38 59.16 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.741 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 90.4 t -57.58 -45.21 86.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.67 -32.79 70.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.265 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.61 -35.41 78.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.992 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 5.1 t -68.38 -50.84 50.2 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.519 -0.473 . . . . 0.0 111.081 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 63.9 mt -64.72 -40.33 88.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.407 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 6.8 tt -68.95 -35.68 70.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.893 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.72 -52.64 14.48 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.673 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 10.3 tp -63.15 -40.83 90.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.934 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 52.4 tp -63.4 -37.46 87.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.755 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -63.07 -50.74 69.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.465 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 37.3 tp -57.04 -48.3 78.87 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.554 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . 0.424 HD11 HG22 ' D' ' 39' ' ' ILE . 97.1 mt -60.05 -41.26 85.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.67 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 37.9 mt -62.32 -39.41 92.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.186 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 31.5 t-105 -63.33 -54.4 37.62 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.798 0.332 . . . . 0.0 111.23 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 61.5 mt -61.77 -53.19 51.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 120.65 -0.42 . . . . 0.0 112.11 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' D' ' 46' ' ' LEU . 37.0 tp -61.51 -48.38 81.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.12 -178.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . 0.443 ' O ' ' CB ' ' D' ' 50' ' ' SER . 32.3 t70 -54.36 -45.69 72.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.209 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -60.1 -50.23 74.54 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.513 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' D' ' 43' ' ' LEU . 2.8 pp -122.73 125.62 45.9 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.056 0.455 . . . . 0.0 110.583 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -174.19 -45.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.539 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . 0.527 ' O ' ' NH1' ' D' ' 53' ' ' ARG . 77.8 t80 -172.92 67.96 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.293 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 67.2 mttm 55.94 39.48 30.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.278 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 50' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 6.6 t -64.15 -52.78 57.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.921 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 62.1 mt -49.0 -34.34 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.856 0.36 . . . . 0.0 110.264 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -72.53 -29.85 63.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.01 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 53' ' ' ARG . . . . . 0.527 ' NH1' ' O ' ' D' ' 48' ' ' PHE . 95.3 mtm-85 -72.09 -48.2 45.74 Favored 'General case' 0 CA--C 1.522 -0.122 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.616 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . 0.472 ' CB ' ' NH2' ' A' ' 45' ' ' ARG . 87.4 m-85 -68.04 -42.09 81.08 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.792 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -65.64 -40.94 93.06 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.279 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -77.18 -21.87 53.33 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.61 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -74.28 -48.71 26.82 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.318 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.41 -31.47 78.98 Favored Glycine 0 N--CA 1.46 0.265 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 59' ' ' LEU . . . . . 0.402 ' C ' ' CD1' ' D' ' 59' ' ' LEU . 0.2 OUTLIER -65.1 -62.69 1.4 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.831 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 97.3 mttt . . . . . 0 C--N 1.333 -0.131 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.573 179.675 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -167.77 70.14 0.89 Allowed Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.605 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -49.62 -29.13 18.43 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 C-N-CA 121.783 1.655 . . . . 0.0 110.905 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 pp -70.53 -30.21 66.9 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.704 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.09 -40.41 73.59 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 120.586 -0.446 . . . . 0.0 109.815 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.7 t -58.54 -45.84 90.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.45 -32.26 71.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.755 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.24 -47.31 77.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.553 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.5 p -65.28 -35.05 79.82 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.409 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.5 mm -66.07 -50.51 68.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.607 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.4 tt -68.87 -28.61 40.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.795 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.99 -48.86 30.69 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.497 -0.858 . . . . 0.0 111.121 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.0 mm -64.51 -44.49 96.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.808 0.337 . . . . 0.0 110.162 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.2 tp -63.63 -39.21 93.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.034 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -63.32 -46.1 88.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.268 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.48 ' CD1' ' HD1' ' D' ' 37' ' ' HIS . 16.6 tp -65.66 -47.55 75.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.843 0.354 . . . . 0.0 111.535 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 29.2 mm -61.66 -50.1 81.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.408 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -65.77 -33.02 74.9 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.23 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 21.0 t-105 -64.3 -52.62 57.64 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.811 0.339 . . . . 0.0 111.406 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.3 mt -67.75 -50.38 60.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.82 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.7 tp -61.94 -44.89 95.83 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.03 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.439 ' O ' ' CB ' ' A' ' 50' ' ' SER . 28.4 t70 -58.99 -44.58 91.63 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.811 -0.355 . . . . 0.0 110.119 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 61.8 ttt85 -60.39 -45.04 95.0 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.612 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.5 pp -135.74 129.9 33.32 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.919 0.39 . . . . 0.0 110.996 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -173.83 -33.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.366 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.471 ' CD2' ' O ' ' A' ' 48' ' ' PHE . 52.9 t80 -172.52 45.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.164 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt 73.28 40.69 0.52 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.235 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.462 ' O ' ' N ' ' A' ' 53' ' ' ARG . 9.8 t -62.12 -46.24 89.89 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.004 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 91.2 mt -44.13 -38.97 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.025 0.44 . . . . 0.0 110.26 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -74.99 -28.26 60.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.217 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.53 ' O ' ' CD2' ' A' ' 57' ' ' HIS . 87.1 mtt180 -68.76 -49.48 58.33 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 121.007 0.432 . . . . 0.0 110.344 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -71.35 -39.97 70.96 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.876 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -64.76 -40.35 95.15 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.795 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -76.86 -41.17 45.0 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.971 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.53 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 9.2 m-70 -59.73 -48.43 81.73 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.665 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.01 -28.32 73.75 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.6 tp -88.43 50.45 1.97 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.762 0.315 . . . . 0.0 110.335 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.599 -179.948 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 12.3 m . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 51.29 69.02 2.78 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.683 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -49.95 -36.75 44.93 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.447 2.098 . . . . 0.0 111.242 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 18.2 tp -57.5 -50.72 72.16 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.939 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.21 -51.24 70.4 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.401 ' O ' ' OG ' ' B' ' 31' ' ' SER . 93.1 t -54.6 -38.82 43.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.86 -40.25 79.71 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.72 -40.14 94.83 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.232 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' B' ' 28' ' ' VAL . 31.9 p -67.22 -55.76 12.7 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.587 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 18.5 tt -59.7 -41.13 84.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.904 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 16.3 tt -70.05 -29.76 41.28 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.213 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.76 -51.05 37.76 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.0 mp -61.03 -43.66 96.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 12.3 tp -60.91 -38.24 85.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.684 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -66.94 -52.72 39.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.706 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 42.0 tp -62.45 -50.54 71.06 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.602 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 14.7 mm -61.36 -42.19 92.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.423 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 6.4 tt -61.91 -38.82 89.82 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.075 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 49.9 t-105 -63.65 -55.49 23.12 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 60.2 mt -63.65 -53.47 44.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.767 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.88 -47.34 83.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.128 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . 0.434 ' O ' ' OG ' ' B' ' 50' ' ' SER . 64.9 t0 -59.72 -45.98 90.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.928 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -58.71 -52.33 66.17 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.058 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.11 129.82 56.77 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 120.996 0.427 . . . . 0.0 110.277 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -175.04 -55.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.296 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -169.31 71.74 0.08 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.306 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 49.5 mttp 60.14 30.19 19.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.469 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' B' ' 44' ' ' ASP . 11.0 t -56.31 -50.84 70.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.857 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 59.2 mt -51.9 -44.37 37.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.889 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.494 ' CE2' ' OE1' ' B' ' 56' ' ' GLU . 78.2 t80 -71.99 -32.2 66.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.474 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . 0.529 ' O ' ' CG ' ' B' ' 57' ' ' HIS . 78.7 mtp180 -67.67 -45.99 73.66 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.724 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -71.89 -38.94 69.91 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.792 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -64.18 -41.22 97.19 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.49 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . 0.494 ' OE1' ' CE2' ' B' ' 52' ' ' TYR . 21.1 pt-20 -76.78 -39.02 52.96 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.692 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' HIS . . . . . 0.529 ' CG ' ' O ' ' B' ' 53' ' ' ARG . 6.4 m-70 -58.63 -48.21 81.76 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.657 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.31 -28.5 73.64 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 11.0 mp -104.64 66.68 0.79 Allowed 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 97.6 mttt . . . . . 0 N--CA 1.466 0.336 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.362 -179.791 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 49.14 68.66 3.3 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.674 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -51.65 -31.57 41.28 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.496 2.131 . . . . 0.0 111.186 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' C' ' 29' ' ' ALA . 3.0 pp -60.69 -28.24 68.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.781 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -46.94 -38.9 11.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.259 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 68.2 t -59.78 -40.96 84.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' C' ' 26' ' ' LEU . . . -62.33 -34.42 76.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.392 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.18 -49.5 69.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.927 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 31' ' ' SER . . . . . 0.407 ' H ' ' HG ' ' C' ' 31' ' ' SER . 4.4 p -64.6 -50.79 65.81 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 3.2 tp -60.17 -37.94 75.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.559 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 51.1 mt -67.73 -38.0 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.654 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.5 -51.81 34.46 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.804 -0.713 . . . . 0.0 111.967 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 9.6 pt -64.45 -37.9 81.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.467 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 13.0 tp -65.7 -40.73 92.59 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -63.86 -52.61 59.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.587 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 50.9 tp -63.63 -47.8 79.87 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.652 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 84.4 mt -59.92 -45.35 95.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.143 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.5 -38.82 92.34 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.906 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 25.7 t-105 -59.46 -57.21 13.99 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.334 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 54.1 mt -63.75 -54.53 30.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -177.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' C' ' 46' ' ' LEU . 0.8 OUTLIER -58.45 -48.98 78.96 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.75 0.309 . . . . 0.0 111.191 -178.443 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . 0.502 ' O ' ' CB ' ' C' ' 50' ' ' SER . 38.7 t70 -57.49 -48.67 78.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.986 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 34.2 ttt-85 -56.79 -52.8 63.65 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.229 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' C' ' 43' ' ' LEU . 2.6 pp -113.68 129.94 56.49 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.132 0.491 . . . . 0.0 110.977 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -173.81 -39.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.329 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -169.51 -67.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.368 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -150.44 25.63 0.78 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.096 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 50' ' ' SER . . . . . 0.502 ' CB ' ' O ' ' C' ' 44' ' ' ASP . 6.6 t -50.23 -53.65 26.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.559 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 66.3 mt -50.68 -49.41 25.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.212 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -73.6 -31.11 63.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.687 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 53' ' ' ARG . . . . . 0.528 ' O ' ' CD2' ' C' ' 57' ' ' HIS . 84.3 mtt-85 -70.42 -49.4 49.24 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.428 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -67.36 -41.47 85.05 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.351 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -62.61 -38.68 91.13 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 120.484 -0.487 . . . . 0.0 110.809 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -78.67 -22.48 46.71 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.916 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 57' ' ' HIS . . . . . 0.528 ' CD2' ' O ' ' C' ' 53' ' ' ARG . 55.2 m170 -73.26 -48.24 36.42 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.355 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.91 -27.69 70.66 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 10.9 mp -105.42 66.87 0.75 Allowed 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . 0.467 ' CB ' ' HZ1' ' C' ' 60' ' ' LYS . 3.1 ttmp? . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.453 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 26.5 p . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -162.23 83.7 1.64 Allowed Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.083 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . 0.425 ' O ' ' N ' ' D' ' 29' ' ' ALA . 76.0 Cg_exo -49.41 -37.86 42.11 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 121.863 1.709 . . . . 0.0 110.819 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 25.9 tp -56.48 -48.47 77.07 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.2 -51.2 71.0 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.21 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 89.3 t -60.28 -29.16 43.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.57 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' D' ' 25' ' ' PRO . . . -66.88 -37.05 83.68 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.32 -38.41 74.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.561 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 1.4 m -68.98 -47.57 65.25 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.7 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 10.0 tp -69.11 -41.22 81.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.632 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 9.9 tt -67.06 -39.95 84.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.498 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.65 -51.03 32.73 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.879 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . 0.405 ' CG2' ' N ' ' D' ' 36' ' ' LEU . 0.2 OUTLIER -59.93 -43.59 92.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.409 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . 0.405 ' N ' ' CG2' ' D' ' 35' ' ' ILE . 49.7 tp -60.41 -39.6 87.96 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.89 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . 0.48 ' HD1' ' CD1' ' A' ' 38' ' ' LEU . 53.7 t60 -61.35 -48.4 81.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.29 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 57.4 tp -55.47 -52.79 62.46 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.837 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 1.4 mp -61.88 -33.23 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.443 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 6.1 tp -65.49 -42.97 91.56 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.717 0.294 . . . . 0.0 110.576 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 21.9 t-105 -66.13 -58.75 4.74 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 120.883 0.373 . . . . 0.0 111.54 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . 0.519 ' CG2' ' N ' ' D' ' 43' ' ' LEU . 9.1 tt -60.47 -47.39 92.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.466 -177.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . 0.519 ' N ' ' CG2' ' D' ' 42' ' ' ILE . 23.0 tp -63.43 -44.86 93.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.564 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . 0.516 ' OD1' ' CE1' ' D' ' 54' ' ' PHE . 40.8 t0 -56.44 -37.69 70.59 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 12.4 ttm180 -69.42 -53.53 18.86 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.895 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.08 113.5 22.39 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.987 0.422 . . . . 0.0 110.149 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -174.8 83.9 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.074 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 54.97 71.61 0.53 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.525 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 98.5 mttt 51.2 48.89 22.18 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.289 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 2.6 t -68.79 -52.85 25.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.127 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 9.4 mt -47.74 -37.54 5.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.087 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -73.87 -31.27 63.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.133 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -71.08 -47.2 59.67 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.877 0.37 . . . . 0.0 110.772 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . 0.516 ' CE1' ' OD1' ' D' ' 44' ' ' ASP . 64.9 m-85 -71.74 -37.35 70.59 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.763 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -67.84 -41.16 83.41 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.615 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -76.71 -36.96 56.86 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.72 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 62.7 t-80 -63.49 -48.31 78.15 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.299 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.04 -27.91 73.55 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 5.9 tp -92.96 39.07 1.03 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.871 0.367 . . . . 0.0 110.326 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 3.1 tmtm? . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.386 -179.666 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.1 t . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 51.31 70.86 1.73 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.854 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.35 -34.05 48.52 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.603 2.202 . . . . 0.0 111.661 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 pp -62.64 -29.8 70.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.06 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.48 -34.48 25.14 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.152 0.501 . . . . 0.0 109.982 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.2 t -59.13 -48.81 85.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 CA-C-O 121.539 0.685 . . . . 0.0 109.274 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.22 -30.69 71.27 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.567 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.68 -47.36 81.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.213 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.9 t -62.22 -48.07 81.6 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.866 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.2 mp -62.12 -33.51 58.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.293 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 38.4 mt -70.49 -38.92 75.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 121.123 -0.231 . . . . 0.0 110.759 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.15 -53.48 18.08 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.393 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.404 ' CG2' ' N ' ' A' ' 36' ' ' LEU . 19.2 tt -60.24 -41.1 85.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.728 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.404 ' N ' ' CG2' ' A' ' 35' ' ' ILE . 40.5 tp -66.42 -30.87 71.33 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.35 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -68.55 -48.97 62.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.472 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.5 mp -63.86 -50.36 69.15 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.978 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 86.1 mt -62.13 -48.1 90.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.378 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.7 tp -61.08 -42.1 97.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.701 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.7 t-105 -62.46 -56.26 19.85 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 120.865 0.364 . . . . 0.0 111.518 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.03 -55.24 24.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.871 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.2 tp -61.24 -48.15 82.78 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.289 -0.564 . . . . 0.0 111.36 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -53.58 -39.15 64.6 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 42.1 ttt-85 -63.49 -51.17 66.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.442 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 48' ' ' PHE . 7.1 mt -83.18 -77.05 0.26 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.023 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.416 ' CD2' ' N ' ' A' ' 48' ' ' PHE . 88.4 t80 46.69 -88.25 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.415 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.534 ' N ' ' O ' ' A' ' 46' ' ' LEU . 62.5 t80 -164.39 87.33 0.48 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.099 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm 59.14 27.47 16.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.13 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.8 t -59.78 -44.47 93.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.657 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.3 mp -52.19 -36.38 20.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.01 0.433 . . . . 0.0 110.068 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.495 ' CD2' ' OE2' ' A' ' 56' ' ' GLU . 81.4 t80 -74.01 -27.78 61.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.221 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 48' ' ' PHE . 68.2 mtt85 -69.97 -49.33 52.76 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.96 0.409 . . . . 0.0 110.559 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -72.03 -39.17 69.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.945 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -66.79 -39.69 87.86 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.711 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.495 ' OE2' ' CD2' ' A' ' 52' ' ' TYR . 10.1 pt-20 -76.17 -40.36 52.66 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.658 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.529 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 6.4 m-70 -60.68 -47.43 86.29 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.54 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.68 -30.11 75.8 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.6 tp -87.8 27.63 1.13 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.95 0.375 . . . . 0.0 110.316 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.013 -179.771 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 94.8 p . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -160.83 79.4 2.31 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.709 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -50.4 -29.33 23.56 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.511 2.141 . . . . 0.0 111.606 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 14.3 tp -61.64 -52.29 64.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.189 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.98 -46.34 88.36 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.609 0.719 . . . . 0.0 109.384 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.445 ' O ' ' OG ' ' B' ' 31' ' ' SER . 72.5 t -56.69 -47.11 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.1 -44.38 52.07 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.69 -50.35 72.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.796 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' B' ' 28' ' ' VAL . 60.7 p -57.45 -48.81 78.19 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 120.309 -0.557 . . . . 0.0 111.447 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 34.1 mm -59.67 -35.64 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.114 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . 0.41 HD13 HG23 ' B' ' 33' ' ' ILE . 86.3 mt -70.24 -34.43 58.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.572 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.85 -52.94 21.86 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.497 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 7.9 pt -64.7 -39.97 87.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.1 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 37.3 tp -62.23 -40.03 94.8 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.47 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 22.3 t-160 -66.85 -53.68 30.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.732 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 34.8 tp -61.99 -53.21 58.74 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.737 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 56.7 mt -60.48 -44.22 95.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.794 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 32.5 tp -56.72 -43.26 80.42 Favored 'General case' 0 C--O 1.222 -0.364 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 21.7 t-105 -60.44 -54.19 48.58 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.161 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 5.2 mm -54.02 -58.34 3.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-O 121.237 0.541 . . . . 0.0 111.921 -177.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.449 ' CD1' ' C ' ' B' ' 43' ' ' LEU . 0.3 OUTLIER -62.4 -35.8 80.33 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.78 -178.488 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . 0.434 ' O ' ' OG ' ' B' ' 50' ' ' SER . 22.8 t70 -58.1 -44.84 87.87 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -65.77 -45.01 84.09 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.444 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.541 ' C ' ' H ' ' B' ' 48' ' ' PHE . 0.3 OUTLIER -113.74 -120.49 0.3 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.098 179.485 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 37.3 t80 68.06 -35.29 0.27 Allowed 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.15 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . 0.541 ' H ' ' C ' ' B' ' 46' ' ' LEU . 31.0 t80 -169.06 42.97 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.678 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt 45.05 40.38 4.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.57 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' SER . . . . . 0.461 ' O ' ' N ' ' B' ' 53' ' ' ARG . 1.4 p -61.8 -24.02 66.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.857 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 9.4 mt -41.55 -41.05 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.878 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -74.25 -29.69 61.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.379 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . 0.461 ' N ' ' O ' ' B' ' 50' ' ' SER . 99.2 mtt180 -71.53 -47.61 54.11 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.935 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . 0.596 ' CE1' ' NH2' ' C' ' 45' ' ' ARG . 66.6 m-85 -72.81 -39.7 66.43 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.939 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -67.87 -39.26 83.76 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.644 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -76.93 -38.83 52.62 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.614 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -62.02 -47.29 85.42 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.259 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.12 -27.48 72.95 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 35.2 tp -79.85 -73.76 0.33 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.711 0.291 . . . . 0.0 110.541 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 68.5 mttm . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.601 -179.995 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 17.9 m . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -177.54 56.53 0.11 Allowed Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.493 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.77 -30.42 68.91 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.104 1.869 . . . . 0.0 110.698 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 19.2 tp -68.8 -48.26 64.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.068 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.61 -46.91 87.58 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.234 0.54 . . . . 0.0 109.615 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 82.1 t -59.39 -34.34 54.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.247 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.91 -34.85 78.88 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.47 -42.71 78.35 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.231 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 6.6 t -68.45 -48.48 64.45 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.189 -0.604 . . . . 0.0 111.802 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 14.6 tt -66.03 -40.84 88.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.64 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 tt -69.22 -36.4 72.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.703 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.09 -51.45 38.97 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 120.497 -0.858 . . . . 0.0 110.973 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 34.7 mm -60.6 -41.21 87.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 13.4 tp -60.45 -45.02 95.18 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.361 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . 0.476 ' C ' ' ND1' ' C' ' 37' ' ' HIS . 9.1 t-80 -60.82 -52.29 65.71 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.84 0.352 . . . . 0.0 111.379 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 55.4 tp -56.6 -48.62 77.04 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.05 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 56.1 mt -63.79 -34.47 68.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.006 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.52 -48.64 74.37 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 15.3 t-105 -62.81 -56.96 12.74 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 73.6 mt -59.48 -51.91 67.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.872 -177.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' C' ' 46' ' ' LEU . 2.8 tm? -58.87 -50.77 72.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.504 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -56.88 -35.16 68.62 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.025 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . 0.596 ' NH2' ' CE1' ' B' ' 54' ' ' PHE . 50.8 ttp180 -69.95 -57.68 4.74 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.831 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' C' ' 43' ' ' LEU . 1.1 pp -108.17 -164.34 0.95 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.66 0.267 . . . . 0.0 111.058 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 12.2 t80 74.42 -11.12 1.05 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.919 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' C' ' 49' ' ' LYS . 32.2 t80 -164.09 158.0 18.84 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.468 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . 0.541 ' N ' ' CD1' ' C' ' 48' ' ' PHE . 36.5 tttm -72.52 42.38 0.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.285 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 50' ' ' SER . . . . . 0.498 ' H ' ' C ' ' C' ' 48' ' ' PHE . 6.7 t -66.47 -47.5 72.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.0 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 71.5 mt -43.95 -42.17 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.941 -0.303 . . . . 0.0 111.306 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -72.47 -29.82 64.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.302 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -71.3 -49.66 40.51 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.535 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . 0.404 ' CB ' ' NH2' ' D' ' 45' ' ' ARG . 45.7 m-85 -65.68 -44.24 86.83 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.38 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -63.06 -36.47 83.69 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.527 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -75.53 -24.77 56.79 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.63 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -73.34 -46.14 51.06 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 120.241 -0.584 . . . . 0.0 109.836 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.51 -27.2 73.94 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 8.8 tp -90.67 57.21 3.52 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-O 120.801 0.334 . . . . 0.0 110.49 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 86.9 tttt . . . . . 0 N--CA 1.467 0.393 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.447 -179.929 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 46.8 t . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 48.43 90.06 0.08 OUTLIER Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.62 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -47.61 -30.12 11.8 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.945 1.763 . . . . 0.0 111.263 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 16.9 tp -61.53 -51.72 67.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.652 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.63 -44.99 93.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.44 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 88.9 t -59.48 -38.44 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.88 -35.32 76.33 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.93 -51.12 59.15 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.08 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 6.1 p -61.18 -50.52 72.82 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.786 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 3.3 tp -62.11 -37.65 78.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.596 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 29.4 mt -62.72 -41.31 91.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 120.399 -0.521 . . . . 0.0 109.673 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.97 -46.15 83.31 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.06 -0.59 . . . . 0.0 111.957 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.61 -47.48 93.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.918 0.389 . . . . 0.0 110.523 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 21.6 tp -64.18 -32.17 73.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.055 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -64.87 -49.94 68.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.005 0.431 . . . . 0.0 110.523 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 46.9 tp -63.12 -46.55 86.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.1 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.42 -47.62 91.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.122 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -62.54 -37.88 87.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.241 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 40.4 t-105 -62.27 -57.29 11.94 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.524 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 62.0 mt -61.45 -53.57 46.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.954 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 55.9 tp -58.76 -47.22 85.43 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.946 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -54.33 -45.26 72.62 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . 0.404 ' NH2' ' CB ' ' C' ' 54' ' ' PHE . 77.0 ttt180 -59.18 -53.13 61.84 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.402 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.91 113.3 25.92 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 120.904 0.383 . . . . 0.0 110.185 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -173.67 91.89 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.42 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 54.29 59.19 4.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.416 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? 53.69 54.61 9.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.49 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 5.6 t -68.11 -52.01 39.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.134 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 58.0 mt -48.5 -35.13 5.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.627 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -70.81 -29.93 66.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.085 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -69.63 -42.62 74.08 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.963 0.411 . . . . 0.0 110.464 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -72.09 -39.37 69.0 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.802 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -66.09 -40.74 91.04 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.511 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 56' ' ' GLU . . . . . 0.44 ' CD ' ' N ' ' D' ' 57' ' ' HIS . 2.9 pp20? -76.39 -37.13 57.6 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.501 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 57' ' ' HIS . . . . . 0.44 ' N ' ' CD ' ' D' ' 56' ' ' GLU . 86.3 t60 -60.69 -51.69 68.28 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.275 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.07 -26.66 73.42 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 14.7 tp -152.86 88.0 1.31 Allowed 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 64.5 mttp . . . . . 0 N--CA 1.458 -0.042 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.497 -179.617 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.3 p . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 46.01 73.38 1.0 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.734 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.78 -34.68 55.62 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.474 2.116 . . . . 0.0 111.226 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.2 tp -63.65 -53.22 54.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.032 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.2 -41.93 85.06 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 95.8 t -63.41 -32.35 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.241 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.48 -36.21 83.2 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.43 -50.12 55.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.955 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.8 p -61.15 -50.09 74.57 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.683 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.0 tp -63.98 -34.19 66.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.072 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.43 HD12 HG21 ' A' ' 33' ' ' ILE . 25.1 mt -68.44 -43.04 84.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.553 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.28 -51.45 37.96 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.013 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.402 ' CG2' ' N ' ' A' ' 36' ' ' LEU . 9.7 tt -62.27 -40.09 86.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.017 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.402 ' N ' ' CG2' ' A' ' 35' ' ' ILE . 48.5 tp -64.57 -36.02 82.88 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.304 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -67.33 -50.9 58.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.803 0.335 . . . . 0.0 110.964 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 26.9 tp -61.74 -52.65 63.4 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.713 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 60.9 mt -62.73 -48.4 88.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.097 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 43.3 tp -54.78 -43.29 72.68 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 17.8 t-105 -60.67 -54.37 46.12 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.304 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.436 ' CG2' ' N ' ' A' ' 43' ' ' LEU . 1.0 OUTLIER -54.27 -48.9 66.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.002 -177.601 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.436 ' N ' ' CG2' ' A' ' 42' ' ' ILE . 20.6 tp -64.4 -41.9 96.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.386 -178.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.438 ' O ' ' OG ' ' A' ' 50' ' ' SER . 31.6 t70 -59.45 -36.24 75.57 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -71.18 -51.45 24.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.823 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.6 pp -123.67 125.34 44.61 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.109 0.48 . . . . 0.0 110.707 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -173.95 -43.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.251 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -172.48 67.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.263 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 68.2 mttm 55.43 38.55 30.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.411 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 44' ' ' ASP . 34.8 t -63.35 -48.07 79.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.806 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 80.0 mt -48.69 -39.1 10.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.926 0.393 . . . . 0.0 109.989 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.517 ' CE2' ' OE2' ' A' ' 56' ' ' GLU . 93.3 t80 -70.98 -29.56 65.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.314 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.515 ' O ' ' CD2' ' A' ' 57' ' ' HIS . 90.2 mtt-85 -69.12 -44.17 72.93 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.125 0.488 . . . . 0.0 110.388 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.505 ' CB ' HH21 ' B' ' 45' ' ' ARG . 58.2 m-85 -70.94 -40.68 71.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.804 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -65.75 -39.27 90.91 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.744 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.517 ' OE2' ' CE2' ' A' ' 52' ' ' TYR . 12.5 pt-20 -76.47 -40.43 50.42 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.902 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.515 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 6.9 m-70 -60.98 -52.26 65.75 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.487 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.27 -25.76 73.7 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.5 tp -148.1 87.78 1.62 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm . . . . . 0 C--N 1.333 -0.136 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.644 -179.739 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 70.7 m . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -160.04 80.87 2.41 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.682 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -50.7 -33.04 38.47 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.407 2.072 . . . . 0.0 111.309 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 17.7 tp -61.13 -51.2 70.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.064 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.75 -42.42 97.38 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 91.6 t -61.67 -34.91 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.37 -40.41 94.2 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.94 -50.98 68.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.07 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' SER . . . . . 0.404 ' H ' ' HG ' ' B' ' 31' ' ' SER . 4.3 p -60.17 -53.11 61.64 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 8.8 tp -60.16 -38.48 77.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.993 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 69.2 mt -64.41 -40.3 88.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.029 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.8 -52.31 49.31 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 48.4 mm -56.36 -43.38 77.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.971 0.415 . . . . 0.0 110.034 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 11.4 tp -62.12 -36.1 80.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.654 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . 0.607 ' NE2' ' NE2' ' C' ' 37' ' ' HIS . 18.8 t60 -67.96 -54.43 18.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.942 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 40.2 tp -62.68 -49.94 73.11 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.63 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 15.8 mm -62.29 -44.03 98.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.513 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 43.8 tp -59.17 -39.9 83.95 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.534 -0.466 . . . . 0.0 109.877 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 21.8 t-105 -63.47 -56.28 17.38 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.413 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 94.6 mt -55.41 -51.57 55.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.141 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 mt -60.21 -44.82 94.83 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.216 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . 0.428 ' O ' ' OG ' ' B' ' 50' ' ' SER . 65.9 t0 -58.71 -37.82 76.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.805 0.336 . . . . 0.0 110.657 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.505 HH21 ' CB ' ' A' ' 54' ' ' PHE . 61.8 ttt85 -68.93 -48.34 63.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.067 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.46 111.8 19.12 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 120.974 0.416 . . . . 0.0 110.371 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -175.46 87.79 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.185 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 48.8 t80 58.43 60.41 2.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.462 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp 54.76 47.88 21.43 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.522 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' B' ' 44' ' ' ASP . 6.5 t -62.93 -49.82 73.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.859 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 10.9 mt -48.55 -40.82 11.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.704 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -71.34 -28.69 64.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.53 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -69.38 -43.51 73.37 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.606 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -73.47 -44.58 57.7 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.938 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -62.93 -40.08 96.53 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.513 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -77.49 -37.32 51.42 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.549 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -58.63 -48.19 81.87 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.348 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.32 -33.07 84.99 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -81.89 -72.36 0.44 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 63.4 tttm . . . . . 0 C--N 1.331 -0.209 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.379 -179.896 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 29.6 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -159.96 71.3 3.14 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.856 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -51.26 -30.96 35.19 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.446 2.097 . . . . 0.0 111.273 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 12.0 tp -61.02 -52.04 66.68 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.906 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.27 -46.59 89.31 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.019 178.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . 0.435 ' O ' ' OG ' ' C' ' 31' ' ' SER . 76.5 t -57.15 -47.27 84.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.79 -42.2 57.85 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.13 -49.58 77.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.919 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 31' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' C' ' 28' ' ' VAL . 1.1 p -57.8 -50.94 71.59 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.283 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 22.1 mm -61.79 -29.57 46.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.65 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 2.3 mm -68.18 -41.35 83.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.35 -52.64 25.61 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.574 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 48.1 mm -60.88 -43.98 96.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.887 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 12.5 tp -63.93 -40.67 96.98 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . 0.607 ' NE2' ' NE2' ' B' ' 37' ' ' HIS . 57.1 t60 -60.95 -48.66 80.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.88 0.371 . . . . 0.0 111.173 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 29.6 tp -65.05 -50.8 64.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.106 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 4.3 mm -60.21 -47.52 91.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.389 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . 0.407 ' O ' ' CB ' ' C' ' 44' ' ' ASP . 3.1 mm? -64.58 -36.95 85.9 Favored 'General case' 0 C--O 1.22 -0.476 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.036 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . 0.458 ' CZ3' ' CZ2' ' D' ' 41' ' ' TRP . 14.2 t-105 -60.47 -53.95 51.41 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.141 0.495 . . . . 0.0 111.257 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 90.4 mt -66.85 -56.41 14.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.052 -177.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.43 -48.19 77.52 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.642 -178.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . 0.407 ' CB ' ' O ' ' C' ' 40' ' ' LEU . 28.9 t70 -53.8 -45.7 70.84 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 60.3 ttt85 -58.22 -52.19 66.61 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.069 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 9.8 mt -72.28 -76.87 0.1 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.511 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . 0.492 ' CG ' ' N ' ' C' ' 48' ' ' PHE . 37.4 t80 52.4 -177.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.176 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . 0.492 ' N ' ' CG ' ' C' ' 47' ' ' PHE . 39.0 m-85 -56.24 -41.36 75.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.954 0.407 . . . . 0.0 110.34 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -171.91 48.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.102 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 5.1 t -69.95 -45.88 66.5 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.65 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 64.5 mt -44.48 -55.68 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -74.96 -34.91 62.1 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 53' ' ' ARG . . . . . 0.526 ' O ' ' CD2' ' C' ' 57' ' ' HIS . 96.9 mtt180 -71.24 -49.99 37.59 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.819 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -66.04 -43.85 86.32 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.232 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -63.22 -36.64 84.33 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.702 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -77.58 -23.61 49.92 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 120.384 -0.527 . . . . 0.0 110.879 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 57' ' ' HIS . . . . . 0.526 ' CD2' ' O ' ' C' ' 53' ' ' ARG . 15.6 m-70 -73.5 -48.69 31.29 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.038 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.38 -31.21 79.66 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 18.0 tp -65.16 -58.54 5.75 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.758 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 65.9 tttm . . . . . 0 C--N 1.331 -0.196 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.518 179.906 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 89.0 p . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -157.19 58.54 1.56 Allowed Pre-proline 0 N--CA 1.465 0.288 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.634 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.56 -29.61 36.61 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.022 1.815 . . . . 0.0 110.8 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 14.1 tp -60.29 -51.96 67.3 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.509 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.46 -47.9 82.5 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 94.4 t -58.47 -33.73 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.197 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.43 -35.77 81.99 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.41 -39.09 81.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.392 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.96 -53.44 26.14 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.28 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 16.8 tt -62.65 -40.12 87.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.67 -178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 9.2 tt -70.05 -30.7 44.94 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 C-N-CA 120.179 -0.608 . . . . 0.0 110.282 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.68 -53.3 16.67 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 2.1 mp -60.87 -43.92 96.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 11.9 tp -62.31 -34.55 76.82 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.447 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 21.5 t-160 -66.09 -49.99 65.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.655 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 50.2 tp -60.33 -50.94 71.64 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.045 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 4.9 mm -60.26 -43.44 93.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 33.6 mt -61.56 -40.88 96.31 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.272 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . 0.458 ' CZ2' ' CZ3' ' C' ' 41' ' ' TRP . 40.4 t-105 -62.52 -53.96 47.0 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.64 0.257 . . . . 0.0 111.451 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 66.1 mt -63.49 -54.25 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -177.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' D' ' 46' ' ' LEU . 54.5 tp -61.57 -45.39 94.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.406 -178.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . 0.439 ' O ' ' CB ' ' D' ' 50' ' ' SER . 11.6 t70 -64.04 -32.39 73.93 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.466 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 56.2 ttt-85 -69.07 -56.31 8.12 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.262 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' D' ' 43' ' ' LEU . 0.1 OUTLIER -105.76 -167.39 1.31 Allowed 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.588 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 9.9 t80 72.86 124.96 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.78 0.324 . . . . 0.0 110.291 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . 0.436 ' CD2' ' O ' ' D' ' 48' ' ' PHE . 40.7 t80 59.74 20.01 8.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.424 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt 47.53 66.92 0.9 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.401 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 50' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 45.4 t -67.75 -46.57 71.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.005 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 55.8 mt -45.88 -40.27 3.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.84 0.352 . . . . 0.0 110.401 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -72.42 -32.91 66.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.051 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -72.01 -50.18 30.79 Favored 'General case' 0 C--N 1.335 -0.038 0 CA-C-O 120.911 0.386 . . . . 0.0 110.74 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -64.49 -42.4 95.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.25 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -63.69 -40.38 96.65 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.08 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -75.86 -20.8 57.82 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.452 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -74.13 -50.32 19.95 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.525 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.14 -27.72 73.55 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 6.4 tp -80.69 43.0 0.65 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.818 0.342 . . . . 0.0 110.421 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.579 -179.979 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.4 t . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 177.01 55.44 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.614 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.25 -30.34 73.98 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.041 1.827 . . . . 0.0 110.636 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.5 tp -69.39 -44.55 71.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.982 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.2 -55.91 18.36 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.314 0.578 . . . . 0.0 110.015 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.2 t -55.09 -43.61 70.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.109 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.61 -45.44 70.07 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.45 -48.11 77.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.873 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.79 -43.57 69.4 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 120.438 -0.505 . . . . 0.0 109.891 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.44 HG23 HD11 ' A' ' 32' ' ' ILE . 57.6 mt -62.5 -39.72 85.52 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.052 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 93.6 mt -66.58 -41.97 89.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.466 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.89 -51.57 33.93 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.047 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.434 ' CG2' ' N ' ' A' ' 36' ' ' LEU . 14.9 tt -62.65 -43.56 98.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.34 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.434 ' N ' ' CG2' ' A' ' 35' ' ' ILE . 9.9 tp -63.96 -33.57 76.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.301 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -66.73 -53.54 32.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.829 0.347 . . . . 0.0 111.217 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.2 tp -59.85 -48.43 81.73 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.975 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.4 mm -61.47 -41.83 91.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.795 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.2 mt -59.98 -45.28 93.24 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.288 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 15.4 t-105 -61.52 -57.7 11.07 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.608 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 94.6 mt -56.88 -56.31 15.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -177.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 47' ' ' PHE . 24.1 tp -61.45 -51.29 69.33 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.208 -178.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -47.36 -40.54 17.62 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.445 ' NH2' ' CB ' ' D' ' 54' ' ' PHE . 61.4 ttt180 -64.37 -52.43 58.32 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.143 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.48 33.62 1.98 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.884 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.457 ' N ' ' O ' ' A' ' 43' ' ' LEU . 66.1 t80 -85.26 84.92 7.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.772 0.32 . . . . 0.0 110.571 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.5 t80 56.55 60.86 2.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.45 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 51.29 27.35 3.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.491 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.9 t -49.68 -30.42 9.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.565 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.1 mt -50.01 -41.26 17.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.954 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -73.55 -28.36 61.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.142 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.521 ' O ' ' CD2' ' A' ' 57' ' ' HIS . 0.8 OUTLIER -69.98 -48.77 56.91 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.309 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.467 ' CB ' ' NH2' ' B' ' 45' ' ' ARG . 53.6 m-85 -71.23 -37.24 72.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.95 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -68.31 -39.13 82.1 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.734 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -77.38 -40.94 42.06 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.102 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.521 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 21.5 m-70 -64.07 -47.37 80.39 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.751 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.92 -27.67 70.67 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.9 tp -88.18 49.55 1.82 Allowed 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.804 0.335 . . . . 0.0 110.395 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.4 ttpp . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.565 -179.927 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 27.5 m . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -160.82 76.12 2.59 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.738 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.04 -31.34 53.4 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.437 2.092 . . . . 0.0 111.278 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 16.5 tp -60.2 -51.2 70.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.903 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.27 -45.45 93.27 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 89.1 t -60.04 -36.55 68.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.094 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.5 -35.75 78.57 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.91 -45.15 75.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.325 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 8.0 p -66.01 -52.64 47.5 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.524 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 20.4 tt -61.45 -42.32 93.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 13.9 tt -69.38 -29.64 42.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 C-N-CA 119.794 -0.763 . . . . 0.0 110.232 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.98 -51.68 38.02 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 46.6 mm -61.26 -38.12 79.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 120.603 -0.439 . . . . 0.0 109.888 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 10.2 tp -62.55 -41.77 99.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.694 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -66.84 -51.71 52.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.888 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 39.9 tp -60.99 -49.44 77.45 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.284 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 26.7 mt -61.86 -42.08 93.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.465 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 56.3 tp -60.92 -41.25 95.79 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.271 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 41.3 t-105 -63.82 -57.77 8.85 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.785 0.326 . . . . 0.0 111.789 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 68.7 mt -59.19 -53.44 47.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.364 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.428 ' CD1' ' C ' ' B' ' 43' ' ' LEU . 3.1 tm? -55.94 -50.87 69.58 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.746 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -53.15 -45.43 68.43 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.945 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.467 ' NH2' ' CB ' ' A' ' 54' ' ' PHE . 65.8 ttt180 -61.43 -56.68 17.57 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.349 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.419 ' O ' ' O ' ' B' ' 43' ' ' LEU . 0.1 OUTLIER -108.61 130.99 55.31 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.05 0.452 . . . . 0.0 110.315 179.62 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.525 ' O ' ' CD2' ' B' ' 48' ' ' PHE . 63.7 t80 -174.04 -64.51 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.124 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . 0.525 ' CD2' ' O ' ' B' ' 47' ' ' PHE . 8.4 m-85 -161.25 83.65 0.64 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.813 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 64.8 mttp 53.86 27.89 7.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.535 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 8.0 t -57.67 -51.99 67.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.726 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 89.0 mt -52.92 -41.81 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.765 0.317 . . . . 0.0 110.685 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.506 ' CD2' ' OE2' ' B' ' 56' ' ' GLU . 81.7 t80 -72.46 -30.97 65.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.634 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -72.0 -46.14 58.3 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.971 0.415 . . . . 0.0 110.817 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -71.45 -38.05 71.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.99 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -70.77 -38.08 73.4 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.717 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . 0.506 ' OE2' ' CD2' ' B' ' 52' ' ' TYR . 10.4 pt-20 -76.16 -38.46 56.63 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.691 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -66.76 -45.64 77.89 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.279 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.32 -27.6 69.57 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 5.4 tp -70.14 -67.87 0.46 Allowed 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.786 0.327 . . . . 0.0 110.481 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.552 -179.939 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 54.9 68.62 2.47 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.739 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.22 -35.68 53.57 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.486 2.124 . . . . 0.0 111.466 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . 0.446 ' CD1' ' OG ' ' D' ' 31' ' ' SER . 14.2 tp -60.12 -51.11 71.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.859 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.53 -43.63 75.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.747 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 90.2 t -60.99 -32.03 51.42 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.45 -38.3 90.54 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.96 -51.89 59.3 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.058 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 5.3 t -60.57 -51.45 69.37 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.52 -0.472 . . . . 0.0 112.146 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 9.9 tp -61.84 -30.93 49.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.39 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 12.1 mt -67.0 -41.53 87.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 120.627 -0.429 . . . . 0.0 109.997 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.48 -51.22 32.72 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.933 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . 0.454 ' CG2' ' N ' ' C' ' 36' ' ' LEU . 0.2 OUTLIER -59.92 -45.61 94.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-O 121.378 0.608 . . . . 0.0 109.663 -179.678 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . 0.454 ' N ' ' CG2' ' C' ' 35' ' ' ILE . 53.6 tp -60.34 -40.47 90.8 Favored 'General case' 0 C--O 1.215 -0.746 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.129 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -59.27 -52.41 65.79 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.158 0.504 . . . . 0.0 111.017 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 16.7 tp -56.38 -50.14 72.41 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.407 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 1.2 mp -65.49 -31.65 54.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.853 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.38 -47.96 77.28 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.719 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 15.9 t-105 -63.84 -56.41 15.6 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 120.804 -0.359 . . . . 0.0 111.511 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 96.2 mt -56.84 -55.41 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.416 -0.514 . . . . 0.0 112.003 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . 0.431 ' C ' ' CD1' ' C' ' 43' ' ' LEU . 3.0 tm? -61.73 -50.9 70.57 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.939 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . 0.513 ' OD2' ' NH1' ' D' ' 45' ' ' ARG . 25.3 t70 -47.14 -43.32 20.69 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.047 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 60.9 ttt-85 -64.15 -52.26 59.91 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.576 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.15 114.94 26.69 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.595 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -174.22 102.36 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.416 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . 0.402 ' O ' ' CD2' ' C' ' 48' ' ' PHE . 51.6 t80 44.37 49.87 8.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.581 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? 57.16 40.27 28.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.306 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 4.6 t -62.39 -34.55 76.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.318 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 60.6 mt -47.34 -41.01 6.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.21 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 52' ' ' TYR . . . . . 0.478 ' CZ ' ' OE1' ' C' ' 56' ' ' GLU . 89.2 t80 -72.37 -29.41 63.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.519 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 53' ' ' ARG . . . . . 0.524 ' O ' ' CG ' ' C' ' 57' ' ' HIS . 73.1 mtm180 -71.38 -48.0 52.76 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.648 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -68.4 -41.84 79.91 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.397 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -64.44 -36.92 85.72 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.824 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . 0.478 ' OE1' ' CZ ' ' C' ' 52' ' ' TYR . 64.8 tt0 -77.94 -24.02 48.36 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.784 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 57' ' ' HIS . . . . . 0.524 ' CG ' ' O ' ' C' ' 53' ' ' ARG . 60.7 m170 -73.18 -46.83 48.44 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 120.489 -0.485 . . . . 0.0 109.911 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.71 -28.13 72.47 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 9.6 tp -89.73 58.68 4.37 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.761 0.315 . . . . 0.0 110.376 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 61.3 mttp . . . . . 0 N--CA 1.468 0.456 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.413 -179.972 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 74.9 p . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' D' ' 24' ' ' ASP . 7.3 p30 -160.55 75.6 2.73 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.153 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.61 -30.48 85.84 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 121.164 1.243 . . . . 0.0 110.725 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 16.6 tp -63.3 -50.39 70.25 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.0 -47.3 85.71 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 71.7 t -60.11 -32.41 50.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.324 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.96 -32.9 74.45 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.05 -44.45 69.14 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.726 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 31' ' ' SER . . . . . 0.446 ' OG ' ' CD1' ' C' ' 26' ' ' LEU . 2.3 m -68.17 -45.01 74.64 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.733 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 11.5 tt -68.16 -41.47 84.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.553 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 13.0 tt -70.02 -34.67 60.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.485 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.07 -51.64 22.36 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.674 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 3.5 tp -64.02 -37.48 79.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.76 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 50.3 tp -64.07 -38.33 90.67 Favored 'General case' 0 CA--C 1.521 -0.136 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -65.95 -43.39 88.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.075 0.464 . . . . 0.0 109.86 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 mt -59.87 -51.36 70.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.778 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 74.3 mt -63.26 -40.48 89.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.209 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 7.6 tt -63.16 -45.22 92.85 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.981 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 31.8 t-105 -65.71 -52.0 54.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.89 0.376 . . . . 0.0 111.928 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 74.6 mt -63.29 -53.46 45.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.874 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 26.6 tp -61.87 -45.78 92.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.817 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . 0.464 ' O ' ' CB ' ' D' ' 50' ' ' SER . 27.5 t70 -55.66 -43.19 76.06 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.611 -0.436 . . . . 0.0 109.925 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . 0.513 ' NH1' ' OD2' ' C' ' 44' ' ' ASP . 67.5 ttt180 -61.97 -51.38 68.31 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.596 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.1 124.69 43.07 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 120.95 0.405 . . . . 0.0 110.207 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -174.61 -43.8 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.513 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . 0.428 ' CD2' ' O ' ' D' ' 48' ' ' PHE . 72.4 t80 -165.81 63.93 0.11 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.307 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? 54.52 40.19 31.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.182 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 50' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 7.4 t -62.15 -51.06 69.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.086 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 78.0 mt -48.51 -35.71 6.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.183 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 52' ' ' TYR . . . . . 0.501 ' CE2' ' OE2' ' D' ' 56' ' ' GLU . 90.6 t80 -71.44 -30.13 65.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.101 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -70.35 -43.18 70.75 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.974 0.416 . . . . 0.0 110.452 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . 0.445 ' CB ' ' NH2' ' A' ' 45' ' ' ARG . 72.9 m-85 -71.6 -39.89 70.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.727 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -66.11 -40.95 91.11 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.477 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 56' ' ' GLU . . . . . 0.501 ' OE2' ' CE2' ' D' ' 52' ' ' TYR . 12.7 pt-20 -74.41 -38.33 63.12 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.454 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 -61.1 -46.15 91.81 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.119 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.46 -26.95 71.12 Favored Glycine 0 N--CA 1.462 0.406 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.16 75.18 1.28 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 53.2 tttp . . . . . 0 C--N 1.332 -0.158 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.48 -179.709 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.3 p . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 0.5 OUTLIER 49.68 55.66 17.22 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.73 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 37.2 Cg_endo -65.37 -29.59 54.04 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.311 2.007 . . . . 0.0 111.306 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.2 tp -62.88 -48.28 79.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.97 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.55 -45.34 92.09 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 97.4 t -63.01 -28.32 44.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.379 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.6 -36.43 78.68 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.35 -45.51 65.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.281 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.8 p -68.63 -44.58 73.89 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.243 -0.583 . . . . 0.0 111.754 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.3 tp -68.48 -40.44 82.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.6 -178.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.1 tt -71.27 -33.56 51.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.607 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.45 -51.64 20.5 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.35 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.4 tp -63.31 -38.32 81.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.553 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.1 tp -65.9 -32.79 74.5 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.888 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 -67.81 -52.07 41.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.833 0.349 . . . . 0.0 110.602 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 30.4 tp -61.14 -52.17 65.97 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.426 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 74.1 mt -61.72 -42.25 93.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.979 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 34.8 tp -60.91 -41.93 97.06 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.343 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.4 t-105 -63.9 -59.53 4.4 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 120.973 0.416 . . . . 0.0 111.553 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 96.3 mt -56.59 -54.41 29.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.606 -177.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.475 ' O ' ' O ' ' A' ' 46' ' ' LEU . 0.7 OUTLIER -60.24 -45.47 93.11 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.691 -179.037 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -51.02 -41.38 59.77 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -65.04 -50.48 66.05 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.134 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.475 ' O ' ' O ' ' A' ' 43' ' ' LEU . 0.7 OUTLIER -92.63 131.29 37.85 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.074 -179.434 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.436 ' CD2' ' N ' ' A' ' 48' ' ' PHE . 73.6 t80 -163.55 -94.97 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.858 0.361 . . . . 0.0 110.564 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.436 ' N ' ' CD2' ' A' ' 47' ' ' PHE . 57.6 t80 -132.6 57.8 1.78 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.821 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.2 tttt 71.14 25.67 3.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.721 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.9 t -59.21 -43.19 92.29 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.571 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 56.9 mt -45.04 -41.65 2.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.604 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -74.11 -27.94 61.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.023 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.532 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 90.9 mtt-85 -71.2 -48.57 50.77 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.598 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -71.5 -41.18 69.59 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.052 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -67.53 -38.69 84.59 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.731 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.542 ' OE2' ' CD2' ' A' ' 57' ' ' HIS . 1.8 pp20? -76.65 -42.31 42.44 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.067 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.542 ' CD2' ' OE2' ' A' ' 56' ' ' GLU . 24.9 m80 -61.11 -45.66 93.77 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.552 -0.459 . . . . 0.0 109.907 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.69 -27.71 73.39 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.5 tp -92.24 56.3 2.77 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.871 0.335 . . . . 0.0 110.677 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt . . . . . 0 C--N 1.329 -0.3 0 C-N-CA 120.859 -0.337 . . . . 0.0 110.474 179.886 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 96.2 p . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -160.01 73.34 3.1 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.772 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -50.74 -36.68 52.25 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.618 2.212 . . . . 0.0 111.537 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 15.0 tp -60.6 -52.38 65.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.798 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.53 -42.99 93.53 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 93.8 t -62.51 -33.89 61.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.74 -34.49 78.0 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.28 -47.01 63.16 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.397 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 6.3 p -65.21 -48.13 74.44 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.234 -0.586 . . . . 0.0 111.524 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.412 ' CG2' ' N ' ' B' ' 33' ' ' ILE . 10.4 tp -65.55 -44.32 93.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -178.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . 0.412 ' N ' ' CG2' ' B' ' 32' ' ' ILE . 15.1 tt -66.67 -33.49 63.79 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.066 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.248 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.48 -45.3 86.52 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 91.2 mt -61.57 -44.54 98.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 14.1 tp -61.06 -36.1 78.7 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.312 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . 0.585 ' NE2' ' CE1' ' C' ' 37' ' ' HIS . 7.5 t-80 -67.34 -50.33 60.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.782 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 22.7 tp -63.66 -52.43 60.78 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.778 -178.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.431 ' CD1' ' N ' ' B' ' 39' ' ' ILE . 1.4 mp -61.15 -43.03 95.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.071 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 43.0 tp -61.21 -37.5 83.25 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.311 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 32.5 t-105 -63.3 -56.69 14.34 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.662 0.268 . . . . 0.0 111.291 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 68.2 mt -60.92 -53.46 48.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 C-N-CA 120.231 -0.588 . . . . 0.0 111.714 -178.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.33 -45.02 84.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.94 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -58.97 -45.5 90.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.833 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 57.8 ttt85 -59.74 -52.75 64.14 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 120.181 -0.607 . . . . 0.0 111.059 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.23 112.13 24.11 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.953 0.406 . . . . 0.0 110.166 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -165.78 79.23 0.28 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.252 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 34.0 t80 62.11 55.28 2.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.745 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 74.7 tttt 60.24 50.15 6.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.818 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 5.8 t -70.71 -44.42 66.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.602 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 64.5 mt -44.38 -35.87 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.656 0.265 . . . . 0.0 111.228 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -70.34 -28.19 64.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.482 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 78.3 mtt85 -68.64 -42.39 78.07 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.378 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -72.73 -42.23 64.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.783 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -63.93 -39.88 95.18 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.632 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -76.72 -38.36 54.44 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.697 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -59.56 -44.82 93.17 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.656 -0.418 . . . . 0.0 109.926 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.98 -24.03 53.22 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' B' ' 60' ' ' LYS . 1.6 tt -131.0 52.01 2.09 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 -178.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' B' ' 59' ' ' LEU . 16.2 ptpt . . . . . 0 N--CA 1.474 0.751 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.524 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 37.3 t . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 46.15 75.3 0.67 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.709 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -51.55 -33.48 48.15 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.483 2.122 . . . . 0.0 111.432 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.15 -47.88 82.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.739 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.44 -39.18 60.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.726 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 80.7 t -59.78 -44.29 93.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.01 -33.51 72.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.405 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.14 -44.01 80.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.209 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 8.0 p -67.51 -47.54 69.67 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 18.6 tt -66.52 -38.19 81.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.979 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 70.0 mt -68.13 -42.22 84.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.005 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.7 -50.04 45.24 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 121.062 -0.59 . . . . 0.0 111.677 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.71 -43.53 98.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.89 0.376 . . . . 0.0 110.257 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 56.8 tp -63.55 -37.98 89.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.248 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . 0.585 ' CE1' ' NE2' ' B' ' 37' ' ' HIS . 12.3 t-80 -66.09 -48.4 71.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.808 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 41.3 tp -67.07 -55.23 15.2 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.84 0.352 . . . . 0.0 111.697 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . 0.427 ' N ' ' CD1' ' C' ' 39' ' ' ILE . 1.3 mp -59.35 -45.46 93.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.487 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 44.7 tp -62.03 -41.89 98.59 Favored 'General case' 0 C--O 1.218 -0.564 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.983 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 16.0 t-105 -57.16 -59.53 4.96 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 120.812 0.339 . . . . 0.0 111.488 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 34.8 mt -62.88 -57.1 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.344 -0.542 . . . . 0.0 112.315 -177.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.17 -51.84 67.72 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.519 -177.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -53.29 -41.89 66.05 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 18.5 tpt85 -58.39 -52.35 65.97 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.729 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' C' ' 48' ' ' PHE . 1.9 mt -82.25 -72.7 0.43 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.0 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 82.2 t80 57.76 -77.91 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.314 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . 0.537 ' N ' ' O ' ' C' ' 46' ' ' LEU . 84.7 t80 -158.84 -40.19 0.06 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.065 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -173.59 31.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.089 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 50' ' ' SER . . . . . 0.465 ' OG ' ' CD1' ' C' ' 54' ' ' PHE . 35.8 t -63.73 -39.78 95.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.139 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 40.3 mt -46.6 -50.86 5.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.613 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -73.6 -32.18 63.97 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 53' ' ' ARG . . . . . 0.53 ' O ' ' CG ' ' C' ' 57' ' ' HIS . 99.5 mtt180 -72.03 -49.76 34.12 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.644 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . 0.465 ' CD1' ' OG ' ' C' ' 50' ' ' SER . 10.8 m-85 -66.44 -42.17 88.06 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.29 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -64.56 -37.67 88.35 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.903 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -77.29 -22.18 52.43 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.465 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 57' ' ' HIS . . . . . 0.53 ' CG ' ' O ' ' C' ' 53' ' ' ARG . 61.8 m170 -74.0 -47.25 38.45 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.059 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.43 -27.23 71.44 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 9.2 tp -92.18 60.23 3.68 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-O 120.811 0.339 . . . . 0.0 110.419 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm . . . . . 0 N--CA 1.467 0.396 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.366 -179.96 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 49.0 m . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' D' ' 24' ' ' ASP . 4.3 p30 -172.26 68.25 0.41 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.818 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -49.54 -30.41 21.38 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 C-N-CA 121.935 1.757 . . . . 0.0 110.405 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 16.8 tp -65.18 -45.28 85.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.321 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.75 -61.09 2.65 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 87.0 t -50.44 -43.36 22.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.734 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.57 -45.3 69.89 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.015 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.83 -40.87 98.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.984 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 2.5 t -61.44 -52.04 66.22 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.613 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 14.8 tt -64.93 -30.93 51.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.623 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 39.3 mt -66.35 -44.24 90.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.927 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.49 -50.53 43.02 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.982 -0.628 . . . . 0.0 111.975 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . 0.402 ' CG2' ' N ' ' D' ' 36' ' ' LEU . 4.5 tt -58.22 -43.15 85.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.001 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . 0.402 ' N ' ' CG2' ' D' ' 35' ' ' ILE . 7.4 tp -69.22 -27.64 65.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.503 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -67.78 -56.04 10.73 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.187 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 3.5 pp -68.87 -34.69 75.87 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.854 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . 0.438 HG21 HD13 ' D' ' 39' ' ' ILE . 52.9 mt -62.77 -45.12 99.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 120.311 -0.556 . . . . 0.0 109.778 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 36.8 mt -64.01 -41.55 97.42 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.471 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 9.2 t-105 -59.96 -58.0 10.43 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.332 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 79.0 mt -59.92 -53.5 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.406 -177.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 28.8 tp -59.96 -44.14 94.61 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.82 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . 0.436 ' O ' ' CB ' ' D' ' 50' ' ' SER . 26.6 t70 -55.95 -46.15 78.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.126 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 56.3 ttt85 -60.49 -50.67 72.65 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.868 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 pp -125.4 127.93 47.34 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.145 0.498 . . . . 0.0 110.796 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -174.77 -42.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.092 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -171.66 63.46 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.234 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 55.7 mttm 58.23 37.81 26.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.226 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 50' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 10.8 t -59.29 -50.29 74.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.835 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 68.1 mt -50.56 -41.44 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.607 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -72.2 -31.38 65.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.084 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -70.96 -47.04 61.21 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.001 0.429 . . . . 0.0 110.601 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -69.71 -36.32 75.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.676 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -68.92 -40.74 78.89 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.5 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -75.78 -33.44 60.18 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.481 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -66.43 -47.34 73.5 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.694 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.23 -36.37 93.32 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 110.641 -0.983 . . . . 0.0 110.641 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 mp -74.9 -67.43 0.64 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt . . . . . 0 N--CA 1.462 0.14 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.397 179.753 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.1 p . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 0.7 OUTLIER 46.71 54.0 14.32 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.724 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 34.7 Cg_endo -63.87 -28.04 67.3 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.466 2.11 . . . . 0.0 111.025 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.5 tp -64.23 -48.72 74.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.041 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.32 -50.23 66.44 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.296 0.57 . . . . 0.0 109.739 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.41 ' O ' ' OG ' ' A' ' 31' ' ' SER . 82.3 t -57.95 -44.67 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.94 -36.52 67.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.514 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.04 -51.29 67.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.536 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.439 ' HG ' ' H ' ' A' ' 32' ' ' ILE . 12.3 p -56.53 -50.07 72.92 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.912 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.439 ' H ' ' HG ' ' A' ' 31' ' ' SER . 46.6 mm -61.18 -32.16 52.12 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.99 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.2 mm -69.75 -40.13 78.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.223 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.43 -53.13 26.65 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.311 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 40.9 mm -62.12 -44.03 98.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 C-N-CA 120.461 -0.495 . . . . 0.0 110.306 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 47.4 tp -57.84 -47.92 81.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.568 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.534 ' C ' ' HD1' ' A' ' 37' ' ' HIS . 5.0 t-80 -60.16 -47.91 83.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.085 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 42.7 tp -55.66 -51.91 65.63 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.182 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.5 tt -64.17 -32.85 59.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.456 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.14 -47.96 80.53 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.419 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 14.2 t-105 -63.44 -55.27 25.55 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 120.614 0.245 . . . . 0.0 111.551 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 88.8 mt -58.91 -52.74 56.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.34 -0.544 . . . . 0.0 112.124 -177.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.6 tp -62.43 -44.08 97.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.391 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.429 ' O ' ' OG ' ' A' ' 50' ' ' SER . 25.8 t70 -57.01 -43.37 81.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.764 0.316 . . . . 0.0 110.171 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 57.0 ttt-85 -63.95 -48.67 75.58 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.471 -0.491 . . . . 0.0 110.725 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.6 pp -127.71 127.33 43.5 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.031 0.443 . . . . 0.0 110.8 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -174.03 -39.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.233 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.523 ' O ' ' NH1' ' A' ' 53' ' ' ARG . 63.8 t80 -172.08 61.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.213 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm 60.13 37.66 20.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.162 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 44' ' ' ASP . 15.0 t -61.7 -47.7 84.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.752 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.2 mt -49.44 -37.2 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.493 ' CE2' ' OE2' ' A' ' 56' ' ' GLU . 92.5 t80 -72.69 -30.16 63.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.241 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.523 ' NH1' ' O ' ' A' ' 48' ' ' PHE . 93.9 mtm-85 -71.77 -46.78 57.25 Favored 'General case' 0 N--CA 1.461 0.102 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.54 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -70.47 -37.8 74.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.863 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -69.76 -38.85 76.92 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.696 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 60' ' ' LYS . 12.2 pt-20 -76.57 -38.85 54.29 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.91 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.523 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 6.8 m-70 -66.45 -42.63 87.33 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.738 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.67 -27.34 61.31 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -157.87 63.72 0.46 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.966 0.412 . . . . 0.0 110.554 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 56' ' ' GLU . 4.2 tmtt? . . . . . 0 N--CA 1.469 0.476 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.183 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 31.5 t . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -37.32 101.85 0.23 Allowed Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.967 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -48.56 -36.7 32.39 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.873 1.715 . . . . 0.0 111.723 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 17.6 tp -61.14 -51.22 70.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.222 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.37 -45.52 84.35 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 84.4 t -59.48 -32.82 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.557 -0.747 . . . . 0.0 108.999 178.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.39 -37.43 85.73 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.05 -49.99 65.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.831 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 4.8 t -60.07 -50.56 73.24 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 20.4 tt -63.65 -35.04 71.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.36 -178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 45.7 mt -69.05 -37.85 77.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.392 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.77 -56.2 8.62 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.506 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.3 pp -56.44 -40.07 65.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.387 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 54.7 tp -65.34 -34.41 78.26 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.388 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -66.45 -53.54 34.28 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.449 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 29.7 tp -66.32 -50.16 64.58 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.649 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 74.2 mt -59.74 -44.88 94.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.663 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 49.7 tp -64.04 -37.61 88.06 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.032 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . 0.45 ' CZ3' ' CZ2' ' C' ' 41' ' ' TRP . 23.1 t-105 -59.66 -52.32 66.01 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.543 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.6 mt -71.9 -56.83 8.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 120.079 -0.649 . . . . 0.0 111.674 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -50.67 -46.61 58.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.865 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -67.94 -40.92 83.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.761 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 53.5 ttt85 -51.75 -51.83 53.24 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.813 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.72 -82.8 0.25 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.494 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.449 ' O ' ' CD1' ' B' ' 48' ' ' PHE . 60.5 t80 57.51 -87.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.501 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . 0.449 ' CD1' ' O ' ' B' ' 47' ' ' PHE . 34.1 m-85 -153.44 86.38 1.21 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.037 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 65.9 mttm 51.76 34.51 13.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.362 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 7.9 t -58.98 -47.07 86.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.405 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 53.4 mt -49.83 -50.8 17.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.909 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -71.41 -32.66 68.67 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.693 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -71.52 -43.74 65.92 Favored 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.017 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -71.41 -39.49 71.09 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.756 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . 0.413 ' CD1' ' C ' ' B' ' 55' ' ' PHE . 24.3 t80 -70.2 -39.11 75.38 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.816 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -76.66 -35.91 57.68 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 120.424 -0.511 . . . . 0.0 110.729 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -67.3 -49.19 65.17 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.511 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.94 -28.6 68.9 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 7.8 tp -72.51 -68.92 0.44 Allowed 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.742 0.306 . . . . 0.0 110.527 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 55.4 tttp . . . . . 0 N--CA 1.467 0.375 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.405 179.814 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 13.7 m . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -158.43 72.75 3.86 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.83 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -50.91 -30.52 30.61 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.538 2.158 . . . . 0.0 111.269 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 16.6 tp -55.48 -51.68 66.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.045 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.69 -47.62 85.44 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 99.3 t -59.58 -29.98 43.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.82 -35.61 80.45 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.15 -42.38 76.03 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.337 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 3.9 p -69.9 -46.22 65.91 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.72 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 10.1 tt -67.66 -40.18 83.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.524 -178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 8.0 tt -69.33 -35.17 66.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.502 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.77 -53.24 20.76 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.272 -0.966 . . . . 0.0 110.953 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 96.8 mt -57.86 -42.87 83.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.306 -0.558 . . . . 0.0 109.977 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 15.0 tp -61.83 -39.45 91.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.101 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -61.52 -50.66 71.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.887 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 10.4 mp -60.52 -48.6 81.08 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.403 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 71.8 mt -59.95 -44.72 95.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.133 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.5 mt -62.44 -39.39 93.17 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.336 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . 0.45 ' CZ2' ' CZ3' ' B' ' 41' ' ' TRP . 24.3 t-105 -60.52 -57.67 11.76 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 120.89 0.376 . . . . 0.0 111.248 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 72.0 mt -60.64 -56.36 18.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.129 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.42 -50.99 71.24 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.773 -178.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -51.23 -42.59 61.09 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -59.07 -53.31 59.83 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.511 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' C' ' 48' ' ' PHE . 3.4 mt -79.71 -72.45 0.4 Allowed 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.949 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 75.3 t80 50.0 -88.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.272 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . 0.503 ' N ' ' O ' ' C' ' 46' ' ' LEU . 55.5 t80 -161.13 89.96 0.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.3 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 74.1 tttt 54.92 22.33 4.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.065 0.459 . . . . 0.0 110.027 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 11.3 t -61.1 -38.68 87.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.078 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 67.4 mt -48.68 -53.91 5.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.755 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -75.09 -33.6 61.65 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 20.0 mmt85 -69.93 -48.83 56.92 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.837 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -69.93 -39.95 75.81 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.302 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -62.13 -41.33 98.16 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.818 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -80.05 -21.8 43.05 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.892 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -70.25 -47.69 60.2 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 120.438 -0.505 . . . . 0.0 109.64 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.86 -26.97 73.73 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . 0.44 ' N ' ' CD2' ' C' ' 59' ' ' LEU . 3.8 mm? -100.54 64.78 1.15 Allowed 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' C' ' 59' ' ' LEU . 50.0 pttt . . . . . 0 N--CA 1.474 0.768 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.665 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 177.45 75.11 0.11 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.073 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -49.14 -33.03 26.16 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.089 1.859 . . . . 0.0 110.693 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 16.4 tp -62.89 -50.55 70.45 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.78 -46.16 88.15 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 92.0 t -59.77 -37.25 70.55 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.343 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.37 -37.07 82.03 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.45 -50.11 66.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.773 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 4.0 t -60.78 -51.47 69.19 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 7.3 tp -62.26 -35.71 70.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.582 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 26.5 mt -63.23 -44.58 99.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.736 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.49 -45.5 94.67 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.755 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 88.3 mt -62.39 -43.5 98.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.784 0.326 . . . . 0.0 110.525 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 18.1 tp -65.18 -33.2 75.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.326 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -68.13 -50.65 53.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.897 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 55.9 tp -61.28 -47.93 83.74 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.802 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 95.8 mt -61.91 -43.82 98.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.856 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 20.0 mt -59.62 -49.4 77.9 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.452 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 11.9 t-105 -58.41 -58.86 6.66 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.929 0.395 . . . . 0.0 111.705 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 73.1 mt -57.89 -60.4 2.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 27.6 tp -57.18 -46.56 82.7 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.447 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -50.98 -45.98 61.16 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.633 -0.427 . . . . 0.0 109.926 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . 0.413 ' O ' ' CG1' ' D' ' 51' ' ' ILE . 70.0 ttt180 -64.56 -56.85 11.35 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 119.914 -0.715 . . . . 0.0 111.394 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.36 114.82 27.45 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.021 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 47' ' ' PHE . . . . . 0.569 ' O ' ' N ' ' D' ' 49' ' ' LYS . 77.0 t80 -172.92 90.22 0.09 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.073 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 57.94 -73.49 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.45 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . 0.569 ' N ' ' O ' ' D' ' 47' ' ' PHE . 10.7 ttpp -165.58 37.46 0.06 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.884 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 50' ' ' SER . . . . . 0.532 ' O ' ' N ' ' D' ' 53' ' ' ARG . 13.0 t -62.77 -45.06 94.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.082 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 51' ' ' ILE . . . . . 0.413 ' CG1' ' O ' ' D' ' 45' ' ' ARG . 23.6 mt -41.25 -30.35 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.869 0.366 . . . . 0.0 110.487 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 52' ' ' TYR . . . . . 0.518 ' CE2' ' OE1' ' D' ' 56' ' ' GLU . 85.7 t80 -74.12 -33.84 63.72 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.34 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 53' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' D' ' 50' ' ' SER . 6.9 ptm180 -69.64 -40.14 76.68 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.351 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -72.71 -41.92 64.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.884 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -65.74 -40.18 91.86 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.459 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 56' ' ' GLU . . . . . 0.518 ' OE1' ' CE2' ' D' ' 52' ' ' TYR . 10.8 pt-20 -75.85 -38.81 57.61 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.796 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -61.51 -43.99 97.87 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 120.876 -0.329 . . . . 0.0 110.34 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.84 -27.82 71.75 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 7.9 tp -84.09 -75.75 0.33 Allowed 'General case' 0 C--O 1.231 0.087 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.615 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt . . . . . 0 N--CA 1.467 0.422 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.539 179.799 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.4 m . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 51.54 72.28 1.26 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.755 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.33 -32.57 42.31 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.483 2.122 . . . . 0.0 111.217 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 22.0 tp -61.54 -50.49 72.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.969 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.74 -46.75 88.26 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.271 0.558 . . . . 0.0 109.551 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 92.4 t -59.03 -41.44 83.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.51 -31.36 71.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.757 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.95 -43.52 71.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.649 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.7 t -66.18 -43.32 87.22 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.914 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 38.4 mm -67.24 -42.42 87.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.684 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.2 tt -71.15 -33.38 50.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.721 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.13 -52.0 15.65 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.315 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.2 tt -63.16 -39.57 85.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.695 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 47.1 tp -66.63 -32.39 73.69 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.086 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -68.34 -49.6 59.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.675 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.6 tp -63.31 -51.93 64.02 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.222 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 81.1 mt -61.79 -42.92 96.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.947 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.5 tt -63.56 -37.75 88.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.624 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 41.6 t-105 -65.11 -54.66 26.47 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.034 0.445 . . . . 0.0 111.305 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.553 ' CG2' ' N ' ' A' ' 43' ' ' LEU . 5.9 tt -63.74 -51.26 72.2 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.646 -177.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.553 ' N ' ' CG2' ' A' ' 42' ' ' ILE . 29.6 tp -63.21 -48.85 76.55 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.008 -177.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' A' ' 44' ' ' ASP . 60.2 t0 -51.59 -38.9 56.63 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.417 ' NH2' ' CB ' ' D' ' 54' ' ' PHE . 64.3 ttt180 -64.76 -52.24 58.02 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.522 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 48' ' ' PHE . 5.3 mt -86.31 -76.67 0.34 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 119.934 -0.706 . . . . 0.0 110.817 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 69.5 t80 51.4 -86.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.892 0.377 . . . . 0.0 110.373 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.515 ' N ' ' O ' ' A' ' 46' ' ' LEU . 38.5 t80 -158.31 90.58 1.04 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.142 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm 52.11 17.01 0.62 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.116 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.9 t -51.7 -41.87 61.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.612 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 35.7 mt -48.18 -41.63 10.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.055 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -71.41 -30.14 65.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.295 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.51 ' O ' ' CG ' ' A' ' 57' ' ' HIS . 1.8 mpt_? -66.8 -45.03 79.67 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.074 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -70.96 -38.62 72.81 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.479 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -63.55 -40.48 97.11 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.646 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.403 ' O ' ' N ' ' A' ' 60' ' ' LYS . 22.5 pt-20 -77.0 -40.19 47.55 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.789 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.51 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 56.0 m170 -57.4 -50.47 72.89 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.202 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.1 -26.77 73.85 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.4 tp -156.12 89.18 1.13 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.328 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 56' ' ' GLU . 68.7 mttm . . . . . 0 CA--C 1.526 0.034 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.551 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -165.61 69.38 1.25 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.035 0.445 . . . . 0.0 110.663 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -48.13 -27.89 9.97 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.031 1.82 . . . . 0.0 111.092 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 pp -72.79 -31.2 64.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.894 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.9 -39.71 66.02 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.972 0.415 . . . . 0.0 109.999 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 94.2 t -60.23 -43.64 93.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.97 -35.57 69.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.391 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.13 -49.81 66.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.878 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' SER . . . . . 0.493 ' HG ' ' H ' ' B' ' 32' ' ' ILE . 22.2 p -59.16 -51.19 71.07 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.493 ' H ' ' HG ' ' B' ' 31' ' ' SER . 19.1 tt -65.39 -33.75 65.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.295 -179.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 28.9 mt -67.34 -37.36 78.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.766 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.85 -51.38 24.73 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 83.3 mt -58.14 -49.29 82.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.412 0.625 . . . . 0.0 109.734 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 12.1 tp -58.53 -39.89 81.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.318 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -61.41 -48.35 81.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.58 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 10.1 mp -63.57 -51.05 67.04 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.832 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 mp -61.38 -46.05 97.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.076 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -63.16 -37.12 85.95 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.058 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 15.4 t-105 -60.85 -57.5 12.39 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.154 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.413 HD13 HG23 ' B' ' 42' ' ' ILE . 68.8 mt -61.88 -55.38 24.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.8 -177.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.4 -50.61 71.12 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.044 -178.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -55.74 -39.64 71.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.245 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -59.73 -53.46 57.77 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.678 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' B' ' 48' ' ' PHE . 0.9 OUTLIER -80.93 -72.81 0.4 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.52 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.432 ' CD2' ' N ' ' B' ' 48' ' ' PHE . 84.7 t80 47.24 -88.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.569 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . 0.517 ' N ' ' O ' ' B' ' 46' ' ' LEU . 80.7 t80 -154.36 84.5 1.12 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.325 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 62.4 mttp 48.73 27.36 1.51 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.439 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 16.0 p -63.49 -34.76 78.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.689 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 21.2 mt -49.88 -46.6 22.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.662 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.515 ' CD2' ' OE1' ' B' ' 56' ' ' GLU . 64.5 t80 -72.45 -27.88 62.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.553 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -70.8 -45.27 64.94 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.631 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -72.89 -41.57 64.5 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.561 -0.455 . . . . 0.0 110.75 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -66.01 -39.69 90.47 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.545 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . 0.515 ' OE1' ' CD2' ' B' ' 52' ' ' TYR . 9.6 pt-20 -75.6 -39.28 58.19 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.571 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -61.22 -41.79 97.47 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.621 -0.431 . . . . 0.0 110.092 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.31 -32.4 76.81 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 25.0 tp -63.25 -52.56 61.61 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.074 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt . . . . . 0 C--N 1.332 -0.157 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.569 179.982 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 36.8 p . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 46.22 74.75 0.75 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.73 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.62 -29.27 32.09 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.605 2.204 . . . . 0.0 111.378 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.18 -35.46 81.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.786 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.22 -49.44 33.08 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.123 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 61.3 t -55.53 -36.45 41.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.3 -33.94 76.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.546 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.76 -40.1 79.91 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.853 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 3.3 t -69.14 -54.0 17.2 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.488 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 17.5 tt -60.98 -40.87 86.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.53 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 13.6 tt -70.98 -31.21 44.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.609 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.08 -51.95 30.76 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.242 -0.98 . . . . 0.0 111.084 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.59 -34.71 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 C-N-CA 120.173 -0.611 . . . . 0.0 109.943 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 46.0 tp -64.89 -39.68 93.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.359 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -68.29 -49.67 58.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.513 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 34.9 tp -61.01 -51.87 67.41 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.226 0.536 . . . . 0.0 111.253 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 1.2 mp -60.58 -43.29 94.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.262 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 18.6 mt -61.04 -40.5 93.85 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.935 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 18.0 t-105 -59.43 -58.11 10.03 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.366 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 56.1 mt -62.33 -54.94 27.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' C' ' 46' ' ' LEU . 0.7 OUTLIER -59.94 -49.28 78.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.472 -178.183 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . 0.484 ' O ' ' CB ' ' C' ' 50' ' ' SER . 61.2 t0 -57.81 -42.4 84.18 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.655 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . 0.507 ' NH1' ' CD1' ' C' ' 51' ' ' ILE . 3.2 tpt85 -61.04 -52.74 63.69 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.204 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' C' ' 43' ' ' LEU . 0.1 OUTLIER -118.31 137.37 53.12 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.039 0.447 . . . . 0.0 110.661 179.538 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -172.59 -38.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.107 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -172.67 -46.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.312 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 45.0 tttt -173.89 39.67 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.846 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 50' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' C' ' 44' ' ' ASP . 47.9 t -65.31 -51.61 59.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.807 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 51' ' ' ILE . . . . . 0.507 ' CD1' ' NH1' ' C' ' 45' ' ' ARG . 96.0 mt -43.39 -40.89 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.677 0.275 . . . . 0.0 111.215 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -73.62 -28.52 61.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.6 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 53' ' ' ARG . . . . . 0.463 ' O ' ' CD2' ' C' ' 57' ' ' HIS . 56.8 ttm-85 -69.71 -49.35 54.18 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.052 0.453 . . . . 0.0 110.246 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -69.08 -42.6 75.97 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.702 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -63.22 -37.02 85.61 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.792 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -78.66 -24.16 45.32 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.739 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 57' ' ' HIS . . . . . 0.463 ' CD2' ' O ' ' C' ' 53' ' ' ARG . 41.0 m170 -71.79 -49.29 40.08 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.848 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.41 -27.45 72.67 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 8.7 tp -94.44 53.24 1.66 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.706 0.288 . . . . 0.0 110.442 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 22.6 pttp . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.627 179.987 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 32.5 p . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -156.36 62.33 2.92 Favored Pre-proline 0 C--N 1.331 -0.227 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.517 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -50.02 -34.53 38.35 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 122.148 1.899 . . . . 0.0 110.647 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 17.8 tp -59.11 -49.83 76.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.231 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.03 -53.81 54.04 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 83.5 t -52.43 -43.88 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.463 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.8 -42.55 68.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.227 0.537 . . . . 0.0 109.924 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.61 -42.54 98.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.792 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 6.3 t -61.68 -52.64 63.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.841 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 13.6 tt -64.01 -31.08 51.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.574 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 33.2 mt -67.21 -40.88 85.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.488 -0.485 . . . . 0.0 109.725 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.39 -52.05 33.49 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 120.991 -0.623 . . . . 0.0 111.64 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 4.3 mm -60.23 -43.85 94.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.109 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 47.0 tp -62.23 -38.61 89.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.346 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -63.96 -51.23 65.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.849 0.356 . . . . 0.0 110.908 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 50.5 tp -58.12 -45.56 87.07 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.513 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 97.4 mt -62.36 -40.16 86.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.628 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.84 -44.03 97.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.18 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 28.2 t-105 -63.83 -56.36 16.0 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.736 0.303 . . . . 0.0 111.782 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 74.3 mt -58.71 -53.43 47.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.244 -0.435 . . . . 0.0 112.017 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 36.9 tp -61.55 -46.73 88.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.733 0.301 . . . . 0.0 111.089 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -52.99 -46.8 68.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.295 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -63.19 -50.69 69.34 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.89 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.17 123.99 46.86 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.974 0.416 . . . . 0.0 110.33 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -172.27 -47.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.246 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -172.08 71.12 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.275 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt 54.29 33.37 18.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.289 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 9.7 t -57.77 -50.09 74.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.745 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 55.5 mt -52.56 -44.23 44.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.598 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -71.91 -30.59 65.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.27 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -71.22 -44.15 65.94 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.892 0.377 . . . . 0.0 110.747 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . 0.417 ' CB ' ' NH2' ' A' ' 45' ' ' ARG . 50.9 m-85 -71.92 -38.29 69.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.88 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -69.18 -40.1 78.3 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.652 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -76.62 -36.6 57.37 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.616 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -65.47 -47.51 75.83 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.667 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.54 -28.99 72.23 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 10.6 mp -103.85 65.48 0.82 Allowed 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 86.6 tttt . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.652 -179.817 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 52.6 p . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.445 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 2.8 m-20 49.58 53.11 13.87 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.643 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 28.0 Cg_endo -62.14 -29.09 80.44 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.437 2.092 . . . . 0.0 111.163 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.3 tp -63.71 -50.56 68.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.218 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.18 -44.71 94.64 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.329 0.585 . . . . 0.0 109.917 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.9 t -58.79 -45.89 91.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.259 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.98 -31.38 69.84 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.606 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.09 -50.43 64.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.446 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.3 t -58.02 -42.43 85.28 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.402 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.1 mp -65.95 -37.98 81.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.184 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.4 tt -69.03 -36.44 73.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.637 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.43 -52.34 17.27 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.159 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.83 -43.44 91.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.145 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 57.2 tp -64.7 -34.69 78.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.359 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -65.39 -50.33 65.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.844 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.5 mp -62.84 -47.25 84.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.976 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.9 mt -61.62 -44.84 99.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.1 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 35.0 tp -62.86 -43.33 99.09 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.7 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.9 t-105 -62.32 -58.46 7.62 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 120.82 0.343 . . . . 0.0 111.847 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 73.7 mt -59.54 -54.31 36.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.743 -177.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.5 tp -58.34 -50.8 72.34 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.801 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -52.11 -38.85 58.73 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.07 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.416 HH21 ' CB ' ' D' ' 54' ' ' PHE . 54.0 ttt85 -64.65 -54.35 33.23 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.596 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 48' ' ' PHE . 0.1 OUTLIER -91.91 -84.83 0.26 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.862 -179.525 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.421 ' CD2' ' N ' ' A' ' 48' ' ' PHE . 82.2 t80 56.54 -80.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.539 ' N ' ' O ' ' A' ' 46' ' ' LEU . 65.2 t80 -165.64 98.04 0.67 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.375 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt 47.93 33.32 3.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.485 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.413 ' O ' ' N ' ' A' ' 53' ' ' ARG . 5.4 t -63.9 -44.15 93.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.89 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.3 mm -41.93 -43.52 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.488 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.507 ' CE2' ' OE1' ' A' ' 56' ' ' GLU . 90.8 t80 -73.23 -31.22 64.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.352 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.531 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 23.4 mmt180 -70.79 -48.44 54.21 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-O 120.975 0.417 . . . . 0.0 110.541 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -70.05 -35.99 74.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.621 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -68.13 -41.02 82.31 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 120.886 -0.325 . . . . 0.0 111.613 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.507 ' OE1' ' CE2' ' A' ' 52' ' ' TYR . 21.4 pt-20 -76.4 -41.92 46.11 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.119 -0.633 . . . . 0.0 111.02 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.531 ' ND1' ' O ' ' A' ' 53' ' ' ARG . 15.8 m80 -61.95 -51.83 66.5 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.324 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.14 -25.69 74.0 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.6 tp -150.23 88.67 1.53 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.082 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.286 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 45.6 t . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -160.89 79.47 2.28 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.804 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -50.56 -35.02 44.89 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.502 2.135 . . . . 0.0 111.495 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 17.8 tp -59.15 -51.49 69.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.975 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.49 -44.52 93.05 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 88.5 t -61.03 -32.64 53.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.15 -34.14 77.39 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.03 -46.53 64.86 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.318 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 3.9 m -66.04 -47.3 74.84 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 119.981 -0.688 . . . . 0.0 111.561 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.406 ' CG2' ' N ' ' B' ' 33' ' ' ILE . 21.1 tt -64.48 -45.19 96.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.738 -178.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . 0.406 ' N ' ' CG2' ' B' ' 32' ' ' ILE . 16.4 tt -64.86 -34.78 72.62 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.087 0 C-N-CA 119.409 -0.916 . . . . 0.0 109.937 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.49 -46.06 93.36 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 94.3 mt -59.52 -43.3 90.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 37.4 tp -60.01 -40.17 88.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.578 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -66.08 -51.56 56.91 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 31.8 tp -61.95 -51.86 66.39 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 120.865 0.365 . . . . 0.0 111.717 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.413 ' N ' ' CD1' ' B' ' 39' ' ' ILE . 1.3 mp -61.45 -40.52 86.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.021 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 62.9 tp -62.56 -37.32 85.69 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.501 -0.48 . . . . 0.0 109.983 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 39.3 t-105 -64.32 -56.04 17.2 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.637 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 54.6 mt -63.23 -50.84 77.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.424 -0.511 . . . . 0.0 111.769 -177.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' B' ' 46' ' ' LEU . 0.9 OUTLIER -61.15 -49.3 77.78 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.442 -178.734 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . 0.434 ' O ' ' OG ' ' B' ' 50' ' ' SER . 20.8 t70 -61.5 -37.44 83.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.693 0.282 . . . . 0.0 110.952 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 50.0 ttt-85 -65.84 -51.02 62.44 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.703 -0.399 . . . . 0.0 112.066 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' B' ' 43' ' ' LEU . 0.6 OUTLIER -123.31 -159.39 0.84 Allowed 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 120.882 0.372 . . . . 0.0 111.58 -179.086 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.464 ' O ' ' CD2' ' B' ' 47' ' ' PHE . 31.1 t80 50.06 19.43 0.48 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.203 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -168.77 -1.67 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.38 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt 44.61 40.24 3.91 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.606 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' B' ' 44' ' ' ASP . 2.3 p -62.96 -33.28 75.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.753 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 78.0 mt -47.33 -46.09 9.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.82 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -72.16 -30.0 64.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.439 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . 0.529 ' O ' ' ND1' ' B' ' 57' ' ' HIS . 95.5 mtt-85 -71.54 -45.6 61.89 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.727 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -71.54 -38.34 71.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.911 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -70.03 -39.35 75.81 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.608 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . 0.528 ' OE2' ' CD2' ' B' ' 57' ' ' HIS . 1.2 pp20? -75.75 -39.76 56.62 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.748 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' HIS . . . . . 0.529 ' ND1' ' O ' ' B' ' 53' ' ' ARG . 26.6 m80 -65.16 -45.38 85.17 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.29 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.72 -27.79 73.01 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 9.4 tp -86.17 58.25 4.95 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.897 0.38 . . . . 0.0 110.349 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? . . . . . 0 N--CA 1.466 0.352 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.417 -179.886 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 25.9 t . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 53.46 70.61 1.7 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.676 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -51.74 -38.75 67.36 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.573 2.182 . . . . 0.0 111.565 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 26.0 tp -57.16 -48.61 78.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.018 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.44 -48.98 77.26 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.389 0.614 . . . . 0.0 109.497 178.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 85.4 t -58.95 -31.67 45.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.34 -33.87 76.69 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.15 -43.71 73.78 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.305 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 4.4 p -69.58 -45.92 67.55 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 119.972 -0.691 . . . . 0.0 111.616 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 13.5 tt -67.87 -39.72 82.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.563 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 7.6 tt -70.01 -35.91 66.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.784 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.67 -51.42 25.42 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 120.413 -0.898 . . . . 0.0 111.202 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 94.0 mt -61.21 -46.3 96.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.551 -0.46 . . . . 0.0 109.846 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 15.4 tp -58.14 -42.87 86.8 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.894 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -59.72 -51.78 68.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.757 0.313 . . . . 0.0 111.484 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 35.9 tp -57.47 -52.6 64.71 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.751 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . 0.401 ' N ' ' CD1' ' C' ' 39' ' ' ILE . 1.3 mp -61.02 -41.04 87.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.836 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.66 -43.06 94.1 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 12.9 t-105 -61.45 -58.5 7.91 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.466 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . 0.411 HD13 HG22 ' C' ' 42' ' ' ILE . 96.2 mt -55.76 -56.91 9.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.92 -177.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' C' ' 47' ' ' PHE . 0.6 OUTLIER -59.7 -45.55 91.77 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.881 -178.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -48.55 -46.38 38.8 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 54.9 ttt-85 -64.54 -48.16 76.11 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.94 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . 0.496 ' O ' ' N ' ' C' ' 48' ' ' PHE . 8.2 mt -82.68 4.4 25.11 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.126 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . 0.518 ' O ' ' N ' ' C' ' 49' ' ' LYS . 48.3 t80 -45.34 91.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.86 0.362 . . . . 0.0 110.78 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . 0.496 ' N ' ' O ' ' C' ' 46' ' ' LEU . 88.1 t80 55.47 -81.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.615 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' C' ' 47' ' ' PHE . 76.6 tttt -161.01 39.05 0.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.101 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 50' ' ' SER . . . . . 0.432 ' OG ' ' CE2' ' C' ' 54' ' ' PHE . 4.8 t -70.83 -26.14 63.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.465 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 53.0 mt -42.05 -48.02 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.211 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -73.25 -28.73 62.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.398 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 53' ' ' ARG . . . . . 0.527 ' O ' ' CG ' ' C' ' 57' ' ' HIS . 20.0 mmt85 -71.78 -49.3 40.08 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.662 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . 0.432 ' CE2' ' OG ' ' C' ' 50' ' ' SER . 38.0 m-85 -69.46 -39.2 77.87 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.44 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -66.8 -38.04 85.72 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 120.561 -0.455 . . . . 0.0 111.026 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -79.43 -22.93 43.57 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.852 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 57' ' ' HIS . . . . . 0.527 ' CG ' ' O ' ' C' ' 53' ' ' ARG . 44.5 m170 -75.91 -45.49 35.02 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.229 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.48 -28.1 72.68 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 11.1 mp -100.41 64.92 1.18 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt . . . . . 0 N--CA 1.466 0.368 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.423 179.899 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 55.3 p . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -157.94 64.38 2.98 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.191 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -48.72 -31.8 20.17 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.058 1.839 . . . . 0.0 110.815 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 17.7 tp -63.21 -50.95 68.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.612 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.75 -47.28 78.77 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.811 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 96.5 t -56.76 -41.74 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.38 -38.94 85.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.471 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.69 -50.55 73.45 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.739 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 6.2 t -62.97 -39.76 95.66 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.365 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 5.2 mm -62.42 -48.24 89.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.444 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 18.5 tt -66.84 -31.1 51.97 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.282 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.92 -48.96 57.88 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.222 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 97.2 mt -63.79 -44.49 98.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.065 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 33.9 tp -63.45 -30.68 71.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.012 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -68.68 -51.28 43.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.754 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 43.3 tp -59.5 -48.07 83.06 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.51 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 96.8 mt -61.06 -43.86 97.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.786 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 22.1 mt -61.34 -41.04 96.39 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.351 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 46.7 t-105 -61.61 -54.66 39.96 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.767 0.318 . . . . 0.0 111.556 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 64.1 mt -62.9 -55.78 21.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 120.293 -0.563 . . . . 0.0 112.182 -177.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 43.1 tp -59.06 -50.25 74.79 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.173 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . 0.459 ' O ' ' CB ' ' D' ' 50' ' ' SER . 31.6 t70 -52.72 -44.83 66.64 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.106 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -58.35 -54.84 42.5 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.395 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.13 106.91 15.65 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 120.956 0.408 . . . . 0.0 110.121 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -174.6 94.47 0.08 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.306 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 35.7 t80 59.3 49.53 8.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.536 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? 54.72 52.56 11.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.596 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 50' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 11.5 t -62.82 -49.48 74.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.994 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 53.0 mt -45.18 -43.91 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.926 0.393 . . . . 0.0 110.584 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -71.48 -28.09 63.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.65 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 53' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' D' ' 50' ' ' SER . 12.0 ttm180 -70.09 -49.67 48.61 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.035 0.445 . . . . 0.0 110.175 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . 0.416 ' CB ' HH21 ' A' ' 45' ' ' ARG . 55.1 m-85 -65.42 -43.02 91.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.303 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -63.23 -38.36 90.88 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.919 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -76.06 -22.51 55.58 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.615 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -75.07 -54.34 7.32 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.167 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -73.9 -26.12 69.9 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 12.6 tp -146.41 86.91 1.7 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 63.7 mttp . . . . . 0 C--N 1.334 -0.096 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.592 -179.725 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -159.44 71.11 3.37 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.708 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -50.05 -33.44 34.81 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.432 2.088 . . . . 0.0 111.297 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.2 tp -62.55 -49.61 74.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.944 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.75 -46.25 88.91 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.0 t -60.05 -40.41 83.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.15 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.73 -30.89 71.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.716 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.61 -51.06 46.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.53 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.1 p -61.76 -36.68 81.72 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.574 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.7 mm -68.4 -41.75 83.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.594 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.4 tt -70.64 -34.19 56.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.371 -0.531 . . . . 0.0 110.744 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.64 -52.15 13.47 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.697 -0.764 . . . . 0.0 111.389 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.476 ' CG2' ' N ' ' A' ' 36' ' ' LEU . 15.3 tt -63.17 -44.52 99.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.784 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.476 ' N ' ' CG2' ' A' ' 35' ' ' ILE . 48.9 tp -59.93 -41.88 92.73 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.811 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 20.9 t-160 -60.07 -49.92 75.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.745 0.307 . . . . 0.0 111.093 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 37.2 tp -59.3 -51.81 68.33 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.925 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.3 mp -61.6 -46.06 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.049 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.7 -39.93 86.23 Favored 'General case' 0 C--O 1.218 -0.59 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 13.5 t-105 -62.64 -57.11 12.22 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.483 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 97.2 mt -56.43 -54.59 26.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.703 -177.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 47' ' ' PHE . 34.5 tp -61.64 -42.5 98.98 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.359 -0.537 . . . . 0.0 110.978 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -51.59 -44.93 62.98 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -63.2 -54.8 31.9 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.246 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 48' ' ' PHE . 5.5 mt -77.15 -77.19 0.15 Allowed 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.777 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.416 ' CD2' ' N ' ' A' ' 48' ' ' PHE . 93.3 t80 53.88 -83.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.788 0.328 . . . . 0.0 110.434 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.533 ' N ' ' O ' ' A' ' 46' ' ' LEU . 81.2 t80 -167.65 86.72 0.24 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.259 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm 59.8 30.44 20.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.339 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.5 t -68.46 -29.18 67.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.621 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.9 mm -44.21 -43.18 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-O 120.989 0.423 . . . . 0.0 110.283 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -74.6 -28.44 60.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.349 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.507 ' O ' ' CG ' ' A' ' 57' ' ' HIS . 98.9 mtt180 -68.28 -49.82 57.89 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.015 0.436 . . . . 0.0 110.46 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -72.39 -40.35 67.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.93 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -63.73 -40.75 97.5 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.617 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -77.16 -41.79 40.32 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.973 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.507 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 6.2 m-70 -56.9 -50.42 72.59 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.277 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.92 -27.01 71.33 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.756 -0.937 . . . . 0.0 110.756 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.8 tp -158.56 90.74 1.03 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.493 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.6 mttt . . . . . 0 C--N 1.338 0.089 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.477 -179.949 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 55.23 74.78 0.68 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.732 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.412 ' O ' ' N ' ' B' ' 29' ' ' ALA . 53.9 Cg_exo -51.0 -33.66 43.37 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.668 2.245 . . . . 0.0 111.52 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 19.2 tp -59.7 -50.93 71.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.269 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.52 -42.9 99.5 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 82.3 t -63.47 -31.08 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' B' ' 25' ' ' PRO . . . -64.83 -34.9 79.46 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.15 -47.45 61.58 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.385 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 4.8 t -64.83 -48.35 74.67 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.534 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.409 ' CG2' ' N ' ' B' ' 33' ' ' ILE . 10.7 tp -65.41 -44.48 94.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.966 -178.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . 0.409 ' N ' ' CG2' ' B' ' 32' ' ' ILE . 15.6 tt -66.18 -32.85 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.975 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.64 -45.84 81.21 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 5.2 mm -60.08 -42.79 91.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 12.0 tp -61.71 -37.4 84.03 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.373 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . 0.458 ' NE2' ' NE2' ' C' ' 37' ' ' HIS . 1.5 t60 -65.66 -53.03 46.83 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 28.6 tp -64.79 -52.38 57.18 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.452 ' CD1' ' N ' ' B' ' 39' ' ' ILE . 1.3 mp -62.05 -47.97 90.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.883 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 41.6 tp -61.2 -35.94 78.53 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.253 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 41.2 t-105 -63.44 -57.16 11.16 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.384 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 73.2 mt -60.93 -53.01 55.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.768 -177.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 11.1 mt -60.12 -53.31 59.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.421 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . 0.411 ' O ' ' CB ' ' B' ' 50' ' ' SER . 66.2 t0 -57.41 -31.74 66.15 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.158 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -66.36 -50.67 62.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.282 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' B' ' 48' ' ' PHE . 0.1 OUTLIER -110.2 -88.98 0.49 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.821 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 33.9 t80 57.04 -79.37 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.888 0.375 . . . . 0.0 110.414 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . 0.533 ' N ' ' O ' ' B' ' 46' ' ' LEU . 47.7 t80 -138.75 58.53 1.65 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.536 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm 57.15 54.61 6.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.424 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' B' ' 44' ' ' ASP . 39.0 t -65.69 -45.74 81.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.133 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 59.2 mt -46.72 -28.6 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.044 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.49 ' CZ ' ' OE1' ' B' ' 56' ' ' GLU . 60.4 t80 -71.85 -36.94 70.31 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.72 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -70.77 -45.28 65.03 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.881 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . 0.438 ' CD1' ' NH1' ' C' ' 45' ' ' ARG . 61.4 m-85 -70.18 -35.9 74.29 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.923 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -71.17 -39.76 71.68 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.72 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . 0.49 ' OE1' ' CZ ' ' B' ' 52' ' ' TYR . 18.3 pt-20 -76.11 -39.25 55.61 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.871 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -67.48 -43.4 81.06 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.414 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.05 -28.57 72.31 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 10.8 mp -102.69 65.4 0.91 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.537 -179.816 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 15.7 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -158.48 72.66 3.83 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.812 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.2 -32.42 40.37 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.529 2.153 . . . . 0.0 111.461 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 14.2 tp -62.01 -52.04 65.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.1 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.41 -47.77 84.24 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.03 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 92.4 t -54.6 -50.26 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.54 -44.02 56.25 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.565 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.81 -50.35 70.76 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 3.0 t -57.6 -52.27 66.09 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.401 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 21.5 mm -58.88 -30.71 43.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.715 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 50.3 mt -69.03 -40.2 80.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.395 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.81 -52.12 26.26 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 120.657 -0.783 . . . . 0.0 111.81 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 mp -62.52 -44.47 99.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.776 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 54.7 tp -60.48 -39.15 86.63 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.707 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . 0.458 ' NE2' ' NE2' ' B' ' 37' ' ' HIS . 1.1 t60 -61.33 -51.07 70.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.922 0.391 . . . . 0.0 110.794 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.25 -51.93 66.32 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.837 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 26.3 mm -60.52 -41.52 88.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.179 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.56 -41.88 98.01 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 16.5 t-105 -63.11 -57.55 10.21 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 120.889 0.376 . . . . 0.0 111.414 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 82.3 mt -57.91 -55.6 20.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.877 -177.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.3 -48.78 80.33 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.63 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -49.08 -45.37 43.02 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . 0.438 ' NH1' ' CD1' ' B' ' 54' ' ' PHE . 62.4 ttp85 -61.47 -50.89 70.93 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.086 -0.646 . . . . 0.0 110.708 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' C' ' 48' ' ' PHE . 12.4 mt -76.44 -76.89 0.15 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.052 -0.659 . . . . 0.0 111.253 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 69.2 t80 58.32 -78.0 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.428 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . 0.528 ' N ' ' O ' ' C' ' 46' ' ' LEU . 38.7 t80 -169.57 -29.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.336 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . 0.415 ' NZ ' ' CD2' ' C' ' 52' ' ' TYR . 49.8 tttm -173.07 18.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.91 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.08 -32.34 69.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.697 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 35.1 mt -56.38 -54.17 31.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.438 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 52' ' ' TYR . . . . . 0.415 ' CD2' ' NZ ' ' C' ' 49' ' ' LYS . 70.5 t80 -76.87 -33.11 57.87 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 53' ' ' ARG . . . . . 0.535 ' O ' ' CD2' ' C' ' 57' ' ' HIS . 63.6 mmt-85 -66.76 -49.45 65.88 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.635 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -73.67 -39.75 64.21 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.901 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -61.03 -40.72 94.69 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.463 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . 0.518 ' OE2' ' ND1' ' C' ' 57' ' ' HIS . 1.2 pp20? -78.65 -39.83 35.85 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.319 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 57' ' ' HIS . . . . . 0.535 ' CD2' ' O ' ' C' ' 53' ' ' ARG . 7.2 m-70 -52.05 -49.49 63.35 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.12 -27.4 73.72 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . 0.417 ' N ' ' CD2' ' C' ' 59' ' ' LEU . 3.7 mm? -103.96 64.15 0.78 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 62.7 tttm . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.519 -179.963 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' D' ' 24' ' ' ASP . 9.2 p30 -162.58 65.13 1.64 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.125 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -48.98 -31.1 19.47 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 121.916 1.744 . . . . 0.0 110.394 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 16.2 tp -62.84 -50.33 71.35 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.04 178.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.46 -47.78 84.61 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.78 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 87.1 t -58.2 -50.57 77.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.581 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.33 -42.82 53.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.645 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.69 -49.86 75.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.568 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.28 -47.63 80.95 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.534 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 27.2 mm -62.21 -35.09 67.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.861 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 74.5 mt -67.23 -41.75 87.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.696 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.63 -51.34 31.26 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.008 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 14.1 tt -62.63 -39.96 86.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.091 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 52.8 tp -66.35 -34.47 78.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.852 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -65.88 -48.15 72.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.444 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 59.9 tp -63.14 -50.98 68.31 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.162 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 91.8 mt -59.46 -45.93 93.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.995 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 7.7 tp -62.7 -38.02 88.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.339 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 38.9 t-105 -62.23 -52.59 63.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.764 0.316 . . . . 0.0 111.551 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 64.8 mt -66.32 -53.49 35.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -177.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 54.2 tp -60.95 -46.12 91.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.697 0.284 . . . . 0.0 111.308 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . 0.489 ' O ' ' CB ' ' D' ' 50' ' ' SER . 28.1 t70 -59.8 -47.2 86.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.769 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -58.53 -50.19 74.66 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.101 -0.64 . . . . 0.0 111.071 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 2.5 pp -124.49 134.9 52.88 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.898 0.38 . . . . 0.0 110.655 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -168.43 -39.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.346 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -171.17 -36.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.401 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 177.28 26.81 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.899 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 50' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 10.3 t -50.22 -54.55 20.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.02 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 87.4 mt -48.93 -40.68 12.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.268 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -73.79 -30.8 62.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.307 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 43.4 mtm180 -67.31 -47.23 71.16 Favored 'General case' 0 CA--C 1.522 -0.097 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.318 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -71.97 -41.51 67.63 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.809 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -59.7 -43.74 93.96 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.368 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -78.21 -31.62 49.49 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.455 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -58.32 -52.16 66.77 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.874 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' D' ' 60' ' ' LYS . . . -69.82 -35.12 72.6 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.55 23.83 0.61 Allowed 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 60' ' ' LYS . . . . . 0.431 ' H ' ' C ' ' D' ' 58' ' ' GLY . 1.3 tmtp? . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.181 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 82.0 p . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.416 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 1.7 m-20 53.76 54.06 11.56 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.605 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 27.2 Cg_endo -62.06 -28.96 80.72 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.4 2.067 . . . . 0.0 111.26 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.87 -54.52 33.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.875 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.97 -50.41 68.68 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.895 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 87.5 t -55.47 -47.13 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.14 -41.0 67.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.968 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.32 -48.7 80.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.665 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.4 t -59.43 -46.23 89.31 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.193 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 43.7 mm -60.63 -38.19 77.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.792 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.7 mm -69.74 -36.09 68.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.692 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.95 -52.03 26.03 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.611 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.1 pt -66.76 -37.74 80.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.626 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -67.83 -36.68 80.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.269 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.462 ' CE1' ' NE2' ' D' ' 37' ' ' HIS . 0.3 OUTLIER -68.09 -50.37 55.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.194 -179.463 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 38.2 tp -65.68 -51.53 58.66 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.332 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 89.5 mt -60.84 -51.65 70.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.333 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 41.2 tp -59.71 -40.29 87.46 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.478 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 27.1 t-105 -61.08 -55.55 31.32 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.706 0.288 . . . . 0.0 111.484 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 96.8 mt -57.93 -55.81 19.53 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 CA-C-O 121.242 0.544 . . . . 0.0 111.536 -178.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.445 ' C ' ' CD1' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -59.43 -37.71 78.8 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.567 -179.165 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -59.65 -41.47 90.6 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -63.01 -46.65 86.64 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.15 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.421 ' O ' ' O ' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -106.59 -112.65 0.28 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.991 179.654 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.421 ' O ' ' O ' ' A' ' 46' ' ' LEU . 32.6 t80 47.76 97.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.861 0.362 . . . . 0.0 110.248 -179.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.522 ' CD2' ' O ' ' A' ' 48' ' ' PHE . 49.0 t80 60.37 27.94 17.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.552 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.6 mttm 53.01 65.56 1.48 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.589 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.454 ' OG ' ' CE2' ' A' ' 54' ' ' PHE . 4.7 t -69.51 -28.83 66.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.02 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.0 mt -44.34 -43.23 2.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.916 0.389 . . . . 0.0 110.221 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -71.65 -28.03 63.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.038 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.427 ' CG ' ' CE1' ' A' ' 57' ' ' HIS . 43.9 ttm180 -71.1 -49.24 46.49 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 120.948 0.404 . . . . 0.0 110.315 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.454 ' CE2' ' OG ' ' A' ' 50' ' ' SER . 63.4 m-85 -65.4 -44.78 86.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.604 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -65.7 -35.0 79.49 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.265 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -76.89 -24.81 52.52 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.865 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.427 ' CE1' ' CG ' ' A' ' 53' ' ' ARG . 41.5 m170 -76.7 -47.14 22.87 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.389 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.43 -27.08 73.93 Favored Glycine 0 N--CA 1.463 0.444 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.07 82.18 1.38 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.241 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.8 mttp . . . . . 0 C--N 1.334 -0.078 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.639 -179.829 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 20.9 p . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -158.19 76.1 3.65 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.789 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.437 ' O ' ' N ' ' B' ' 29' ' ' ALA . 50.4 Cg_exo -51.96 -32.67 48.86 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.563 2.176 . . . . 0.0 111.206 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 20.6 tp -60.32 -47.13 87.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.737 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.94 -57.37 7.05 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 82.4 t -52.67 -34.81 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' B' ' 25' ' ' PRO . . . -64.27 -34.74 78.8 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.56 -48.66 59.55 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.511 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 42.2 t -63.69 -48.85 75.45 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.574 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 19.5 tt -65.66 -43.0 93.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.122 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 8.2 tt -67.17 -30.33 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.854 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.69 -51.21 37.19 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 179.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . 0.416 HD12 HG23 ' B' ' 35' ' ' ILE . 96.8 mt -58.12 -46.09 88.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.255 0.55 . . . . 0.0 109.98 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 11.2 tp -60.76 -38.15 84.25 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.894 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . 0.454 ' ND1' ' C ' ' B' ' 37' ' ' HIS . 0.4 OUTLIER -65.86 -53.95 33.1 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.811 0.338 . . . . 0.0 111.718 -178.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 27.4 tp -60.59 -54.74 41.72 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.691 -178.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 11.5 mm -60.61 -43.7 95.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.523 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 31.0 tp -54.87 -44.53 74.11 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -60.75 -54.64 42.78 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.218 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 47.9 mm -51.18 -53.66 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.325 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' B' ' 46' ' ' LEU . 1.0 OUTLIER -61.9 -38.97 90.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.136 -178.747 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -58.65 -47.58 83.96 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.219 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 53.4 ttt85 -69.92 -53.59 17.21 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.689 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' B' ' 43' ' ' LEU . 1.9 pp -108.49 147.32 31.87 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.027 0.441 . . . . 0.0 111.198 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -172.45 -48.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.074 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -172.2 -38.34 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.304 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.524 ' NZ ' ' CG ' ' B' ' 52' ' ' TYR . 42.9 tttm -172.88 21.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.259 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 13.2 t -59.01 -46.56 87.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.194 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 71.4 mt -45.53 -32.3 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.906 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.524 ' CG ' ' NZ ' ' B' ' 49' ' ' LYS . 26.3 t80 -72.17 -31.23 65.74 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.461 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . 0.481 ' N ' ' CD ' ' B' ' 53' ' ' ARG . 0.9 OUTLIER -71.57 -45.1 63.19 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.622 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -71.14 -38.15 72.24 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.045 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -70.91 -39.47 72.72 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.655 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -75.27 -39.08 60.1 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.916 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -67.57 -44.94 77.0 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.437 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.8 -28.02 67.6 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 7.9 tp -84.01 49.84 1.72 Allowed 'General case' 0 C--O 1.231 0.102 0 CA-C-O 120.823 0.344 . . . . 0.0 110.375 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 34.9 tptt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.516 -179.869 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 7.8 m . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 53.78 77.01 0.47 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.795 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -50.42 -35.12 43.95 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.544 2.163 . . . . 0.0 111.533 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 18.6 tp -60.97 -49.11 78.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.736 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.39 -45.59 92.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.113 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 91.5 t -58.46 -43.94 87.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.42 -38.48 71.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.338 0.59 . . . . 0.0 109.494 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.6 -46.83 84.01 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.172 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 2.2 p -63.08 -52.39 62.89 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.912 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 14.7 tt -59.95 -35.74 62.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.538 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 49.8 mt -68.13 -37.53 78.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.64 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.24 -52.95 20.09 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.869 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . 0.409 ' CG1' ' N ' ' C' ' 36' ' ' LEU . 6.5 pt -62.14 -41.51 91.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.396 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . 0.409 ' N ' ' CG1' ' C' ' 35' ' ' ILE . 10.5 tp -65.11 -40.79 95.0 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.341 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -62.15 -50.76 70.59 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 50.9 tp -67.7 -48.63 66.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.915 0.388 . . . . 0.0 111.624 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 92.3 mt -58.38 -50.53 78.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.311 -178.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -65.82 -37.16 85.48 Favored 'General case' 0 C--O 1.221 -0.441 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.027 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 21.9 t-105 -56.8 -53.52 56.92 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.276 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 60.3 mt -70.82 -56.54 10.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.524 -0.47 . . . . 0.0 112.251 -177.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.44 -50.85 66.68 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.825 -178.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . 0.484 ' O ' ' CB ' ' C' ' 50' ' ' SER . 36.4 t70 -58.05 -42.56 85.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.355 -0.384 . . . . 0.0 109.997 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -53.62 -51.96 61.4 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 119.889 -0.724 . . . . 0.0 110.573 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' C' ' 47' ' ' PHE . 5.7 mt -74.89 -74.21 0.21 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 120.016 -0.674 . . . . 0.0 111.035 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . 0.467 ' CG ' ' N ' ' C' ' 48' ' ' PHE . 21.4 t80 45.78 -171.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.283 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . 0.467 ' N ' ' CG ' ' C' ' 47' ' ' PHE . 26.2 m-85 -56.3 -54.63 43.13 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.243 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -153.21 36.82 0.48 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.248 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 50' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' C' ' 44' ' ' ASP . 1.4 t -50.21 -52.41 35.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.18 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 62.0 mt -50.46 -51.57 18.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.264 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -74.45 -31.56 62.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.876 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 53' ' ' ARG . . . . . 0.531 ' O ' ' CD2' ' C' ' 57' ' ' HIS . 85.3 mtt180 -69.93 -48.64 57.71 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.474 -0.491 . . . . 0.0 110.672 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -69.57 -42.11 74.94 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.54 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -63.06 -36.66 84.31 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.501 -0.479 . . . . 0.0 110.864 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -80.05 -24.07 40.97 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.801 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 57' ' ' HIS . . . . . 0.531 ' CD2' ' O ' ' C' ' 53' ' ' ARG . 54.8 m170 -72.41 -45.23 60.61 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.122 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.69 -28.36 73.54 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 10.9 mp -103.08 66.14 0.9 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 65.3 tttm . . . . . 0 N--CA 1.466 0.344 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.45 -179.928 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . 0.457 ' N ' ' HD3' ' D' ' 25' ' ' PRO . 1.0 OUTLIER -163.2 58.45 0.74 Allowed Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.648 179.517 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . 0.457 ' HD3' ' N ' ' D' ' 24' ' ' ASP . 4.6 Cg_exo -73.54 -50.95 0.17 Allowed 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.94 1.76 . . . . 0.0 111.108 179.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 pp -59.6 -28.51 67.25 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.069 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.57 -34.18 24.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.702 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 84.6 t -59.41 -47.81 89.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.83 -35.43 74.72 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.474 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.56 -52.26 65.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.83 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 36.7 m -60.16 -44.7 94.8 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.042 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 5.6 mm -61.82 -34.64 63.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.768 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . 0.4 HD11 HG22 ' D' ' 33' ' ' ILE . 51.9 mt -69.36 -37.45 75.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.5 -52.41 26.15 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.858 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . 0.42 ' CG2' ' N ' ' D' ' 36' ' ' LEU . 19.1 tt -63.25 -42.5 96.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.111 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . 0.42 ' N ' ' CG2' ' D' ' 35' ' ' ILE . 59.5 tp -61.91 -39.15 90.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.79 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . 0.462 ' NE2' ' CE1' ' A' ' 37' ' ' HIS . 2.6 t60 -62.08 -49.23 76.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.387 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 39.1 tp -57.02 -47.32 81.17 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.439 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 95.3 mt -59.79 -43.15 91.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.614 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 57.9 mt -62.07 -39.88 93.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.303 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 17.8 t-105 -61.78 -55.15 33.15 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 120.642 0.258 . . . . 0.0 111.231 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 61.7 mt -61.65 -54.7 31.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.401 -0.519 . . . . 0.0 112.154 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 53.2 tp -59.85 -50.13 74.98 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.199 -178.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . 0.444 ' O ' ' OG ' ' D' ' 50' ' ' SER . 8.8 t0 -53.49 -44.3 68.91 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.186 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 30.2 ttm-85 -59.67 -52.41 65.63 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 120.061 -0.655 . . . . 0.0 110.376 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.39 106.22 15.49 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.01 0.433 . . . . 0.0 110.272 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -173.47 101.54 0.12 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.322 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 47.35 50.38 14.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.662 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . 0.539 ' CB ' ' HZ3' ' D' ' 49' ' ' LYS . 9.1 mtmp? 56.01 53.8 8.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.546 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 50' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' D' ' 44' ' ' ASP . 7.5 t -63.94 -51.21 65.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.296 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 20.0 mt -47.4 -33.13 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.324 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -73.87 -28.14 61.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.961 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 53' ' ' ARG . . . . . 0.414 ' N ' ' O ' ' D' ' 50' ' ' SER . 74.6 mtm180 -72.7 -47.34 48.02 Favored 'General case' 0 N--CA 1.461 0.093 0 CA-C-O 120.923 0.392 . . . . 0.0 110.748 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -72.06 -39.74 68.82 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.896 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -68.77 -40.03 79.93 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.663 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -75.34 -37.83 60.5 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.386 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -62.61 -48.75 78.05 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.22 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.02 -27.47 73.86 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 6.4 tp -92.65 60.16 3.43 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.772 0.32 . . . . 0.0 110.594 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 65.3 tttp . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.402 179.815 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.3 p . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 55.3 76.17 0.53 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.842 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.406 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 61.4 Cg_exo -49.66 -29.33 19.24 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.475 2.117 . . . . 0.0 111.335 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.3 tp -62.02 -50.39 72.23 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.784 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.17 -53.37 50.37 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.08 0.467 . . . . 0.0 110.068 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.9 t -56.86 -40.42 71.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.406 ' CB ' ' O ' ' A' ' 25' ' ' PRO . . . -57.78 -42.26 83.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.623 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.64 -42.7 93.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.735 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.0 t -60.34 -41.66 94.05 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.011 -0.675 . . . . 0.0 110.138 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.435 HD12 HG23 ' A' ' 32' ' ' ILE . 87.7 mt -63.02 -43.78 99.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.733 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.6 tt -70.23 -29.91 41.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.016 -178.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.09 -50.55 22.23 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.002 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.425 HG21 HD13 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -65.1 -41.28 91.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.409 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.6 tp -62.47 -36.68 83.23 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.95 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -67.4 -41.99 84.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.944 0.402 . . . . 0.0 110.317 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.84 -57.95 8.29 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.211 0.529 . . . . 0.0 111.441 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.2 mm -61.75 -45.78 97.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.828 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.407 ' O ' ' CB ' ' A' ' 44' ' ' ASP . 57.9 tp -60.26 -38.75 84.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.269 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 31.2 t-105 -63.89 -54.05 40.93 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 120.922 0.392 . . . . 0.0 111.486 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 97.1 mt -62.51 -55.32 24.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.141 -0.623 . . . . 0.0 111.813 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.0 tp -60.29 -46.76 88.73 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.072 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.407 ' CB ' ' O ' ' A' ' 40' ' ' LEU . 18.6 t70 -50.5 -47.25 57.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -59.98 -53.03 62.69 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.535 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 47' ' ' PHE . 15.5 mt -73.4 -78.54 0.09 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.034 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.484 ' O ' ' N ' ' A' ' 49' ' ' LYS . 13.3 t80 41.32 -164.5 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.405 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.408 ' N ' ' CG ' ' A' ' 47' ' ' PHE . 20.7 m-85 -64.53 68.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.358 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 47' ' ' PHE . 29.7 mtmm 46.29 47.0 13.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.619 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.428 ' O ' ' N ' ' A' ' 53' ' ' ARG . 90.3 p -69.06 -30.9 69.32 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.631 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.1 mt -44.14 -42.1 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.963 0.411 . . . . 0.0 110.052 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.407 ' CZ ' ' OE1' ' A' ' 56' ' ' GLU . 52.8 t80 -74.85 -28.92 60.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.136 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.522 ' O ' ' CD2' ' A' ' 57' ' ' HIS . 67.9 mtm180 -70.98 -48.25 54.32 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.468 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -71.2 -40.55 71.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.768 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -66.21 -39.57 89.73 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.755 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.407 ' OE1' ' CZ ' ' A' ' 52' ' ' TYR . 15.7 pt-20 -76.35 -41.1 49.4 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.828 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.522 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 10.2 m-70 -60.14 -47.93 83.84 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.53 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.76 -27.82 73.57 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.9 tp -91.69 60.18 3.92 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.727 0.299 . . . . 0.0 110.637 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.5 ' HZ3' ' CB ' ' A' ' 60' ' ' LYS . 7.9 mtpm? . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.011 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 71.3 m . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -160.88 68.72 2.59 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.772 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -51.18 -35.66 53.0 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.465 2.11 . . . . 0.0 111.354 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.436 ' CD1' ' OG ' ' C' ' 31' ' ' SER . 15.8 tp -59.38 -51.35 70.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.839 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.93 -43.48 86.31 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 92.0 t -61.93 -33.29 57.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.235 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.41 -35.38 80.71 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.26 -45.86 68.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.258 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 3.9 t -66.19 -52.07 51.66 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.331 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.408 ' CG2' ' N ' ' B' ' 33' ' ' ILE . 10.9 tp -60.77 -43.04 94.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -178.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . 0.408 ' N ' ' CG2' ' B' ' 32' ' ' ILE . 7.8 tt -69.89 -28.57 37.24 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.08 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.329 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.64 -50.61 41.59 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 mp -62.86 -42.14 95.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 11.0 tp -58.25 -46.96 85.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.889 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 15.2 t-160 -63.9 -52.03 61.8 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 40.9 tp -58.23 -47.09 84.63 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 120.549 -0.461 . . . . 0.0 111.136 -178.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 3.2 mm -63.79 -41.06 91.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.982 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.51 -42.6 96.73 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.904 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 46.0 t-105 -64.81 -57.22 9.47 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 75.5 mt -58.48 -53.75 42.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.597 -177.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 41.9 tp -59.73 -46.44 89.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.164 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -55.07 -47.28 75.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.648 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -62.75 -48.56 78.64 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.491 -0.483 . . . . 0.0 111.351 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.54 124.19 43.81 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.125 0.488 . . . . 0.0 110.43 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -172.98 -47.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.367 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -171.1 65.81 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.389 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm 55.25 35.44 24.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.566 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 11.2 t -60.0 -49.22 78.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.919 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 48.0 mt -47.36 -31.26 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.759 0.314 . . . . 0.0 110.882 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.527 ' CD2' ' OE1' ' B' ' 56' ' ' GLU . 76.2 t80 -70.84 -29.8 66.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.465 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -71.14 -44.01 66.44 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.41 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -71.21 -38.73 72.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.011 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -69.76 -39.28 76.81 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.737 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . 0.527 ' OE1' ' CD2' ' B' ' 52' ' ' TYR . 10.6 pt-20 -75.58 -38.51 59.09 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 120.254 -0.579 . . . . 0.0 110.644 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -65.03 -47.23 78.16 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.322 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.0 -28.64 73.78 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 32.9 tp -73.39 -68.72 0.48 Allowed 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.402 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.54 179.946 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -156.74 68.83 4.56 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.899 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -51.23 -30.34 32.63 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.514 2.142 . . . . 0.0 111.141 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 16.8 tp -59.09 -51.52 69.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.757 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.5 -46.97 87.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.033 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 61.3 t -58.82 -42.72 86.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.0 -37.9 72.33 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.47 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.38 -49.77 70.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.103 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 31' ' ' SER . . . . . 0.436 ' OG ' ' CD1' ' B' ' 26' ' ' LEU . 2.9 m -60.23 -50.79 72.26 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.96 -179.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 17.5 tt -63.71 -33.68 63.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.983 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 32.3 mt -67.24 -42.21 87.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.441 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.07 -49.51 46.69 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 121.019 -0.61 . . . . 0.0 111.666 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 5.1 mm -61.67 -45.37 98.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.128 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 11.6 tp -61.22 -41.65 97.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.169 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 32.7 t60 -61.51 -48.67 80.01 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.61 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 31.2 tp -63.19 -52.93 60.34 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -178.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 1.3 mp -60.46 -46.19 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.017 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -62.06 -40.62 96.39 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.821 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 6.7 t-105 -57.71 -58.41 8.46 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.245 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . 0.401 HD12 HG21 ' C' ' 42' ' ' ILE . 68.8 mt -62.13 -56.27 18.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -177.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . 0.434 ' C ' ' CD1' ' C' ' 43' ' ' LEU . 3.0 tm? -57.99 -52.82 63.92 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.177 -178.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -53.35 -41.24 65.59 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -57.61 -56.23 24.63 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.455 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' C' ' 48' ' ' PHE . 2.2 mt -80.73 -71.12 0.48 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.855 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . 0.46 ' CD2' ' N ' ' C' ' 48' ' ' PHE . 85.2 t80 49.26 -89.56 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.181 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . 0.51 ' N ' ' O ' ' C' ' 46' ' ' LEU . 68.7 t80 -153.49 85.52 1.19 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.236 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 56.9 mttp 52.09 29.26 6.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.935 0.398 . . . . 0.0 110.187 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 11.3 t -62.47 -39.54 93.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.121 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 54.6 mt -47.08 -48.91 8.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.306 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -71.69 -32.25 67.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.58 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 53' ' ' ARG . . . . . 0.524 ' O ' ' CD2' ' C' ' 57' ' ' HIS . 77.3 mtp180 -70.75 -48.07 56.34 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.481 -0.487 . . . . 0.0 110.619 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -66.03 -42.28 89.81 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.226 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -63.09 -39.29 94.26 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.459 -0.497 . . . . 0.0 110.854 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -76.99 -22.03 53.78 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.759 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 57' ' ' HIS . . . . . 0.524 ' CD2' ' O ' ' C' ' 53' ' ' ARG . 11.9 m-70 -73.75 -49.24 26.51 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.091 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.85 -27.45 72.76 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 8.3 tp -91.86 48.66 1.46 Allowed 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.809 0.337 . . . . 0.0 110.375 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.531 -179.874 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 24.3 m . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' D' ' 27' ' ' ALA . 29.5 p30 -175.46 61.8 0.22 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.373 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -45.85 -27.36 3.95 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 C-N-CA 121.389 1.393 . . . . 0.0 110.227 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 pp -68.13 -35.4 78.05 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.088 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 27' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' D' ' 24' ' ' ASP . . . -51.07 -37.95 48.7 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.102 0.477 . . . . 0.0 109.879 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 71.4 t -59.24 -47.42 90.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 CA-C-O 121.428 0.632 . . . . 0.0 109.487 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.33 -39.49 76.0 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.286 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.47 -47.3 84.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.174 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 11.2 t -57.36 -50.21 73.7 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.871 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 61.0 mt -61.35 -31.71 51.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.55 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 55.2 mt -68.19 -40.46 82.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.348 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.99 -52.14 25.28 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.883 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . 0.422 ' CG2' ' N ' ' D' ' 36' ' ' LEU . 15.6 tt -61.95 -42.29 94.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.806 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . 0.422 ' N ' ' CG2' ' D' ' 35' ' ' ILE . 43.6 tp -63.71 -34.9 78.9 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.985 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -63.67 -50.93 67.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.964 0.411 . . . . 0.0 110.247 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 36.3 tp -58.35 -47.5 83.57 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.85 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 5.0 mm -61.69 -44.37 98.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.319 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.82 -39.26 91.17 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 23.7 t-105 -64.07 -56.6 13.83 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 120.875 0.369 . . . . 0.0 111.434 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . 0.403 HG23 HD12 ' D' ' 42' ' ' ILE . 82.1 mt -58.55 -53.2 50.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.777 -177.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 29.9 tp -61.1 -47.4 86.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.881 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -51.91 -44.16 63.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.265 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . 0.463 ' HE ' ' CD2' ' D' ' 46' ' ' LEU . 60.1 ttp180 -64.12 -53.45 49.29 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.77 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . 0.463 ' CD2' ' HE ' ' D' ' 45' ' ' ARG . 0.2 OUTLIER -113.53 110.31 20.05 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.046 0.451 . . . . 0.0 110.3 179.143 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -174.77 92.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.146 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 53.96 58.16 5.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.539 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? 53.73 52.93 12.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.95 0.405 . . . . 0.0 110.372 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 50' ' ' SER . . . . . 0.524 ' OG ' ' NH2' ' D' ' 53' ' ' ARG . 8.1 t -68.22 -51.76 41.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.227 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 4.7 mt -48.15 -35.01 5.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -72.37 -28.97 63.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.05 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 53' ' ' ARG . . . . . 0.524 ' NH2' ' OG ' ' D' ' 50' ' ' SER . 36.7 mtm105 -71.86 -46.49 57.76 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.96 0.41 . . . . 0.0 110.525 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -70.94 -36.85 72.79 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.788 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -70.06 -39.7 75.49 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.659 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -75.43 -37.73 60.23 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.614 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -65.94 -44.37 85.27 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.27 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.18 -26.74 70.67 Favored Glycine 0 N--CA 1.462 0.374 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.8 70.24 0.77 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.271 0.558 . . . . 0.0 109.728 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 16.3 ttpp . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.512 -179.721 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 56.7 m . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.515 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 6.1 p30 -174.83 75.55 0.32 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.798 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -52.16 -35.45 62.79 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.15 1.9 . . . . 0.0 110.957 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.4 tp -65.21 -50.27 66.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.18 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.43 -50.67 64.54 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.34 0.59 . . . . 0.0 109.568 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.429 ' O ' ' OG ' ' A' ' 31' ' ' SER . 85.2 t -54.59 -46.68 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.44 -42.36 70.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.691 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.72 -47.63 76.54 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.17 0.51 . . . . 0.0 110.567 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 28' ' ' VAL . 80.8 p -62.39 -39.96 94.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.803 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 35.6 mm -61.97 -47.58 92.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.608 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.9 tt -68.96 -29.64 44.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.7 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.13 -50.21 47.61 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.171 -1.014 . . . . 0.0 110.578 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 28.1 mm -62.91 -44.24 99.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 51.4 tp -63.21 -31.13 72.2 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.433 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -69.5 -52.22 28.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.985 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 32.1 tp -61.76 -51.28 68.99 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.207 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.9 mm -61.86 -43.69 97.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.908 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 35.5 tp -61.2 -38.95 88.39 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.381 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 44.3 t-105 -63.78 -55.17 25.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.824 0.345 . . . . 0.0 111.647 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.7 mt -61.44 -51.65 70.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 120.454 -0.498 . . . . 0.0 111.78 -177.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.9 tp -60.96 -42.35 98.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.983 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -57.78 -45.29 86.19 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -60.03 -48.66 80.78 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.484 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.4 pp -130.91 132.87 45.39 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.026 0.441 . . . . 0.0 111.088 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -175.41 -38.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.161 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -167.24 60.03 0.08 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.251 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp 60.85 42.47 13.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.38 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.5 t -62.34 -49.91 73.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.696 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.4 HG22 HD13 ' A' ' 51' ' ' ILE . 94.1 mt -49.67 -41.96 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.205 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -72.26 -28.5 63.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.216 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.525 ' O ' ' CD2' ' A' ' 57' ' ' HIS . 12.1 mmm180 -69.71 -46.57 65.68 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.317 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -71.41 -40.23 70.61 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.075 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -67.37 -38.18 84.34 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.746 -179.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.52 ' OE2' ' CE1' ' A' ' 57' ' ' HIS . 0.7 OUTLIER -77.5 -38.03 49.91 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.876 -179.974 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.525 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 26.4 m-70 -63.87 -50.54 68.41 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.469 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.75 -27.41 72.42 Favored Glycine 0 N--CA 1.463 0.468 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.81 71.82 0.77 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.122 0.487 . . . . 0.0 109.919 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 N--CA 1.466 0.346 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.594 179.992 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 44.8 t . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 56.94 70.02 1.52 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.76 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -51.55 -31.4 39.61 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.57 2.18 . . . . 0.0 111.427 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 19.0 tp -58.76 -51.28 70.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.912 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.62 -46.12 91.46 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 91.8 t -59.74 -35.84 62.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.34 -35.63 79.71 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.6 -45.54 71.71 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.387 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 8.4 p -65.5 -51.86 56.94 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.423 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 20.0 tt -61.86 -43.05 96.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -178.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 8.3 tt -69.16 -30.3 45.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 C-N-CA 119.731 -0.788 . . . . 0.0 110.304 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.52 -50.55 42.7 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 mp -61.58 -41.59 90.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 19.8 tp -60.39 -40.97 92.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.747 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -67.71 -51.76 45.71 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 35.1 tp -61.68 -52.4 64.47 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.614 -178.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.6 mm -62.0 -41.76 92.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.392 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 46.0 tp -59.59 -41.66 90.78 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.249 -0.58 . . . . 0.0 109.944 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 9.9 t-105 -62.5 -59.37 5.05 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.724 0.297 . . . . 0.0 111.724 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 72.0 mt -58.53 -56.52 15.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.635 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.0 -49.78 70.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.641 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -52.24 -44.19 64.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.326 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -59.2 -53.01 63.1 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.641 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 2.8 mt -77.45 -141.03 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 119.871 -0.732 . . . . 0.0 110.594 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.424 ' O ' ' O ' ' B' ' 48' ' ' PHE . 47.8 t80 59.78 110.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.615 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . 0.545 ' CG ' ' N ' ' B' ' 49' ' ' LYS . 57.5 t80 48.35 -178.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.404 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.545 ' N ' ' CG ' ' B' ' 48' ' ' PHE . 0.1 OUTLIER -72.19 45.42 0.13 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.377 -179.878 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' SER . . . . . 0.446 ' H ' ' C ' ' B' ' 48' ' ' PHE . 11.1 t -62.56 -47.57 83.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.853 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 51.2 mt -48.22 -41.88 10.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.592 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.515 ' CE2' ' OE2' ' B' ' 56' ' ' GLU . 78.9 t80 -71.39 -29.72 65.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.446 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 69.6 mtm180 -68.14 -44.04 76.93 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.412 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -72.26 -39.47 68.37 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.762 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -64.45 -40.84 96.5 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.488 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . 0.515 ' OE2' ' CE2' ' B' ' 52' ' ' TYR . 13.2 pt-20 -76.48 -38.79 54.79 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.63 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -59.08 -47.06 86.63 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.174 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.35 -28.37 73.65 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 8.0 tp -88.87 49.06 1.72 Allowed 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.708 0.289 . . . . 0.0 110.468 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm . . . . . 0 N--CA 1.469 0.481 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.627 -179.986 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 25.1 t . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -159.18 70.78 3.46 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.871 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.0 -29.51 36.26 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.621 2.214 . . . . 0.0 111.281 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.59 -56.32 23.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.89 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.2 -46.79 82.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.57 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 74.6 t -58.21 -43.44 85.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.64 -39.93 78.08 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.528 178.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.77 -49.37 76.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.164 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 2.2 t -62.17 -53.79 50.26 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 16.5 tt -58.44 -35.8 55.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.663 -179.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 51.0 mt -67.46 -37.48 78.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.399 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.33 -51.22 28.11 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.93 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -62.82 -43.54 98.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 11.4 tp -63.22 -41.61 99.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.838 0.351 . . . . 0.0 110.237 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -61.61 -48.06 82.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.522 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 51.3 tp -65.0 -51.01 64.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.789 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 50.9 mt -59.3 -48.49 86.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.19 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -63.25 -37.65 88.08 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.671 -0.412 . . . . 0.0 109.981 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 25.5 t-105 -59.35 -59.37 5.56 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.346 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 48.4 mt -62.63 -54.97 26.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.514 -0.474 . . . . 0.0 112.047 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . 0.444 ' C ' ' CD1' ' C' ' 43' ' ' LEU . 3.2 tm? -57.9 -52.36 65.83 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.196 -178.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . 0.454 ' O ' ' CB ' ' C' ' 50' ' ' SER . 67.9 t0 -53.11 -41.94 65.49 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.02 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -58.49 -53.24 60.61 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.791 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' C' ' 48' ' ' PHE . 3.6 mt -84.53 -71.41 0.52 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.176 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 91.7 t80 56.75 -80.42 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.246 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . 0.527 ' N ' ' O ' ' C' ' 46' ' ' LEU . 86.4 t80 -172.91 -22.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.334 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . 0.464 ' NZ ' ' CD1' ' C' ' 52' ' ' TYR . 49.8 tttm -170.75 21.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.91 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 50' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' C' ' 44' ' ' ASP . 10.8 t -62.08 -48.47 80.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.282 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 12.8 mt -50.21 -53.99 9.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.3 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 52' ' ' TYR . . . . . 0.464 ' CD1' ' NZ ' ' C' ' 49' ' ' LYS . 27.7 t80 -70.57 -32.83 70.38 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.668 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 19.9 mmt85 -70.01 -43.41 71.4 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.586 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -66.29 -47.23 74.3 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.176 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -62.2 -36.55 82.27 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.925 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . 0.411 ' O ' ' OE1' ' C' ' 56' ' ' GLU . 3.0 tm-20 -77.97 -21.9 50.25 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.535 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -73.42 -48.9 30.11 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 120.341 -0.544 . . . . 0.0 109.974 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.69 -27.11 73.09 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 8.6 tp -83.9 57.39 4.12 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.824 0.345 . . . . 0.0 110.311 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 18.7 tptm . . . . . 0 N--CA 1.466 0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.281 -179.867 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 18.4 p . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . 0.484 ' N ' ' HD3' ' D' ' 25' ' ' PRO . 0.7 OUTLIER -166.45 55.66 0.36 Allowed Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.811 179.606 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . 0.484 ' HD3' ' N ' ' D' ' 24' ' ' ASP . 6.1 Cg_exo -73.52 -41.19 1.24 Allowed 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 121.663 1.575 . . . . 0.0 111.091 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 2.4 pp -65.95 -30.88 71.52 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.678 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.32 -49.7 42.83 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 95.4 t -50.81 -38.09 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 178.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.6 -40.06 95.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.639 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.94 -50.48 68.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.268 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 45.9 t -60.51 -51.89 67.53 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.904 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 20.1 tt -63.27 -31.41 52.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.629 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 19.4 mt -67.47 -41.8 86.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.017 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.01 -51.74 32.32 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.121 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 10.7 tp -64.49 -39.18 84.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.402 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 56.8 tp -64.58 -38.64 91.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.109 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 32.4 t60 -65.11 -48.66 72.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.368 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 50.3 tp -59.08 -47.01 86.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.562 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.36 -42.76 94.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.851 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 40.2 mt -61.58 -42.45 98.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.208 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 18.4 t-105 -62.07 -55.58 27.63 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.696 0.284 . . . . 0.0 111.508 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 72.5 mt -60.54 -54.93 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -177.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 40.0 tp -60.92 -44.43 97.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.61 0.243 . . . . 0.0 111.343 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . 0.435 ' O ' ' CB ' ' D' ' 50' ' ' SER . 22.6 t70 -58.08 -42.77 86.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.594 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -66.11 -56.61 10.6 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.066 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.67 130.8 54.34 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -171.76 -43.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.454 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -172.71 -48.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.426 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -172.46 28.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.339 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 50' ' ' SER . . . . . 0.435 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 7.8 t -57.92 -50.93 71.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.181 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 7.3 mt -49.39 -39.35 13.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.32 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 52' ' ' TYR . . . . . 0.465 ' CE2' ' OE2' ' D' ' 56' ' ' GLU . 82.5 t80 -73.98 -29.56 62.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.242 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 -68.15 -48.32 65.67 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.916 0.388 . . . . 0.0 110.482 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -72.34 -39.49 68.12 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.752 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -62.1 -41.96 98.74 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.348 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 56' ' ' GLU . . . . . 0.465 ' OE2' ' CE2' ' D' ' 52' ' ' TYR . 14.8 pt-20 -77.49 -37.11 51.88 Favored 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 120.219 -0.592 . . . . 0.0 110.434 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -56.18 -48.89 75.48 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.217 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.82 -27.08 74.16 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.439 -1.065 . . . . 0.0 110.439 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 59' ' ' LEU . . . . . 0.411 ' N ' ' CD2' ' D' ' 59' ' ' LEU . 3.0 mm? -99.29 52.69 0.95 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.025 0.441 . . . . 0.0 109.983 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 63.7 tttp . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.586 179.923 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.2 m . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -163.29 74.85 1.9 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.782 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -51.29 -37.33 59.75 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.222 1.948 . . . . 0.0 111.03 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.9 tp -63.3 -49.01 75.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.936 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.84 -55.08 37.25 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.7 t -51.87 -47.66 40.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.811 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.93 -48.84 64.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.899 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.76 -48.63 66.65 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.18 -53.01 56.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.482 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 44.7 mm -53.62 -38.25 33.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.223 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 70.6 mt -69.47 -32.8 54.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.291 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.1 -53.04 15.66 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.855 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -33.97 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.108 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.6 tp -69.41 -35.97 76.27 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.338 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.561 ' CE1' ' CD2' ' B' ' 37' ' ' HIS . 47.9 t60 -70.01 -51.3 33.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.654 0.264 . . . . 0.0 111.054 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.6 tp -62.73 -50.38 71.32 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.934 0.397 . . . . 0.0 111.222 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 29.5 mm -63.32 -44.59 99.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.279 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 50.2 tp -60.66 -43.23 97.91 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.234 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 16.6 t-105 -61.91 -57.24 12.52 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.744 0.307 . . . . 0.0 111.74 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 76.5 mt -59.56 -55.46 23.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.531 -0.467 . . . . 0.0 112.22 -177.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.7 tp -59.73 -46.97 87.51 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.167 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -53.71 -41.78 67.34 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 45.2 ttt-85 -60.59 -51.53 69.04 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.252 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.81 107.42 18.61 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 120.776 -0.369 . . . . 0.0 110.203 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -174.11 100.32 0.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.217 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.508 ' CD2' ' O ' ' A' ' 48' ' ' PHE . 69.3 t80 45.45 52.07 9.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.39 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.0 mttp 55.32 52.94 10.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.618 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.5 t -62.65 -42.78 99.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.96 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.5 mp -47.74 -31.48 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.504 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -72.95 -28.51 62.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.097 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.542 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 77.9 mtp180 -68.42 -48.04 65.68 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.378 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -71.46 -39.28 71.04 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.795 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -64.36 -39.97 94.94 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.7 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.534 ' OE2' ' CD2' ' A' ' 57' ' ' HIS . 1.6 pp20? -77.01 -41.29 43.32 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.851 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.542 ' ND1' ' O ' ' A' ' 53' ' ' ARG . 23.9 m80 -57.87 -50.49 73.14 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 120.314 -0.554 . . . . 0.0 109.782 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.16 -26.83 72.96 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.0 tp -156.27 90.07 1.17 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.433 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.0 pttm . . . . . 0 N--CA 1.458 -0.055 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.657 -179.719 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 72.3 m . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -159.83 70.76 3.18 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.867 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -50.84 -30.6 30.42 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.646 2.231 . . . . 0.0 111.244 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 19.7 tp -60.85 -50.12 74.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.078 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.43 -43.1 79.08 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 83.7 t -61.37 -34.3 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.29 -34.63 78.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.305 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.13 -51.68 43.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.087 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 6.1 p -61.71 -50.42 72.53 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.783 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 3.8 tp -62.33 -40.93 89.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.989 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 34.1 mt -62.19 -44.3 98.91 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.922 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.04 -53.78 43.56 Favored Glycine 0 N--CA 1.462 0.376 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 96.8 mt -50.55 -39.13 17.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.94 -45.89 90.32 Favored 'General case' 0 C--O 1.219 -0.5 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.28 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . 0.561 ' CD2' ' CE1' ' A' ' 37' ' ' HIS . 1.4 t60 -60.35 -48.58 81.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.592 -178.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.471 ' CD1' ' HD1' ' A' ' 37' ' ' HIS . 9.6 mp -64.07 -47.86 78.45 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.741 -178.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 18.1 mm -62.52 -47.93 90.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.295 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 7.1 mp -63.66 -34.01 76.9 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 28.6 t-105 -64.66 -57.26 9.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 120.89 0.376 . . . . 0.0 111.262 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.409 HD13 HG23 ' B' ' 42' ' ' ILE . 77.7 mt -60.0 -51.73 69.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.773 -178.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 8.6 mt -63.4 -50.94 67.85 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.502 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . 0.478 ' O ' ' CB ' ' B' ' 50' ' ' SER . 36.3 t70 -53.4 -41.94 66.46 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.325 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -65.3 -45.45 84.32 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.946 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 2.5 pp -139.5 124.08 18.32 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.266 0.555 . . . . 0.0 111.507 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -173.79 -31.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.879 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . 0.415 ' CD2' ' O ' ' B' ' 48' ' ' PHE . 63.4 t80 -167.4 58.93 0.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.051 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 97.5 mttt 55.14 53.95 9.47 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.504 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' SER . . . . . 0.585 ' HG ' ' N ' ' B' ' 51' ' ' ILE . 3.0 p -68.39 -52.28 34.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.995 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . 0.585 ' N ' ' HG ' ' B' ' 50' ' ' SER . 80.6 mt -50.3 -46.73 25.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.974 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.518 ' CE2' ' OE2' ' B' ' 56' ' ' GLU . 86.5 t80 -71.25 -29.82 65.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.317 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 33.1 mmm-85 -70.76 -44.7 66.2 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.831 0.348 . . . . 0.0 110.541 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -71.64 -39.23 70.53 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.881 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -68.18 -38.97 82.6 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.684 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . 0.518 ' OE2' ' CE2' ' B' ' 52' ' ' TYR . 11.5 pt-20 -76.16 -38.54 56.55 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.569 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -62.88 -47.67 82.33 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.235 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.79 -27.58 72.24 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 9.9 tp -89.38 59.46 4.83 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-O 120.837 0.351 . . . . 0.0 110.275 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp . . . . . 0 N--CA 1.466 0.372 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.287 -179.984 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -35.83 100.54 0.2 Allowed Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.45 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.85 -34.79 37.75 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.044 1.83 . . . . 0.0 111.559 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . 0.401 ' C ' ' CD1' ' C' ' 26' ' ' LEU . 0.2 OUTLIER -58.48 -55.69 31.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.489 0.662 . . . . 0.0 109.477 179.428 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.49 -45.63 88.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.427 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 88.0 t -56.9 -40.19 70.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.9 -37.65 85.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.761 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.41 -51.24 64.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.542 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 10.4 p -63.44 -51.45 65.66 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 120.689 -0.404 . . . . 0.0 112.04 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 20.7 tt -59.85 -36.51 66.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.764 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 41.3 mt -68.5 -39.56 80.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.64 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.78 -52.81 31.19 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.734 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 6.8 pt -61.91 -42.59 95.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.295 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 8.7 tp -63.82 -34.34 77.69 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.313 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -66.75 -52.67 41.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.241 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 33.1 tp -61.9 -49.44 76.19 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.045 0.45 . . . . 0.0 111.121 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 30.3 mm -59.79 -43.89 92.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.73 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 25.7 mt -62.34 -40.28 95.84 Favored 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.919 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 25.0 t-105 -59.58 -52.31 66.1 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.308 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 65.9 mt -66.68 -56.59 13.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.266 -0.574 . . . . 0.0 112.411 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . 0.431 ' CD1' ' C ' ' C' ' 43' ' ' LEU . 2.9 tm? -58.28 -52.09 67.05 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.886 -178.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -52.93 -43.38 66.24 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.22 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 52.9 ttt-85 -58.84 -52.09 67.21 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.853 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' C' ' 48' ' ' PHE . 8.5 mt -79.59 -73.95 0.32 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 120.274 -0.571 . . . . 0.0 111.263 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 49.3 t80 62.03 -71.32 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.407 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' C' ' 46' ' ' LEU . 66.2 t80 -172.75 -32.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.261 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 46.6 tttp -172.96 26.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.917 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 39.6 t -63.73 -42.23 97.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.298 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 58.3 mt -48.98 -52.78 9.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.389 -179.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -74.86 -32.64 61.96 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 53' ' ' ARG . . . . . 0.527 ' O ' ' CD2' ' C' ' 57' ' ' HIS . 96.1 mtt180 -71.73 -49.58 37.94 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.673 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -67.66 -43.32 80.53 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.428 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -64.88 -35.87 82.54 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.829 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -77.56 -24.28 49.84 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.561 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 57' ' ' HIS . . . . . 0.527 ' CD2' ' O ' ' C' ' 53' ' ' ARG . 58.0 m170 -73.16 -45.51 56.16 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 120.541 -0.464 . . . . 0.0 109.77 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.1 -27.16 72.69 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 7.7 tp -84.12 57.73 4.36 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.837 0.351 . . . . 0.0 110.466 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 62.0 tttm . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.4 -179.952 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 15.2 p30 -162.34 76.39 2.09 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.021 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -51.45 -30.47 35.14 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.06 1.84 . . . . 0.0 110.878 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 pp -66.18 -42.71 88.52 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.832 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.31 -53.47 21.81 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.558 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 87.7 t -48.1 -36.98 6.49 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.06 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.58 -37.04 85.52 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.275 0.56 . . . . 0.0 109.818 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.94 -51.22 60.43 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.883 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 58.4 m -62.43 -50.44 71.48 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 3.3 tp -62.29 -35.84 71.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.73 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 37.7 mt -68.03 -38.21 79.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.07 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.38 -50.76 42.02 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.15 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . 0.424 ' CG2' ' N ' ' D' ' 36' ' ' LEU . 18.4 tt -66.05 -42.75 92.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.347 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . 0.424 ' N ' ' CG2' ' D' ' 35' ' ' ILE . 7.2 tp -60.62 -38.5 84.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.864 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -66.92 -45.43 77.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.604 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 31.6 tp -57.67 -54.3 48.46 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.195 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 13.6 pt -64.08 -37.31 79.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.816 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 17.9 mt -58.82 -42.55 89.48 Favored 'General case' 0 C--O 1.224 -0.263 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 33.5 t-105 -64.58 -51.44 62.72 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.101 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 mm -56.48 -56.72 12.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.531 -0.467 . . . . 0.0 111.771 -177.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 36.6 tp -62.03 -45.23 94.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.789 0.328 . . . . 0.0 110.8 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -50.76 -44.44 58.61 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.004 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -66.48 -54.57 22.52 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.564 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.72 105.62 15.74 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.279 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -172.99 95.79 0.12 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.313 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 52.2 51.69 15.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.742 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 18.0 mtpp 54.44 49.75 17.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.594 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 10.9 t -61.85 -46.36 89.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.992 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 38.2 mt -49.44 -39.11 13.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.656 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -72.72 -28.86 62.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.112 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 35.7 mtm105 -71.5 -47.49 55.08 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.984 0.421 . . . . 0.0 110.56 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -71.16 -35.16 71.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.739 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -70.64 -37.91 73.81 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.604 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -77.51 -37.89 50.11 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.644 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -66.16 -48.63 70.11 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.504 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.86 -27.34 72.0 Favored Glycine 0 N--CA 1.461 0.311 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.13 77.15 1.77 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 57.3 tttm . . . . . 0 C--N 1.333 -0.111 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.539 -179.695 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 38.23 69.48 1.49 Allowed Pre-proline 0 N--CA 1.463 0.203 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.964 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.04 -33.35 42.53 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.275 1.983 . . . . 0.0 111.115 179.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.3 tp -65.56 -50.73 64.09 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.059 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.43 -50.23 70.61 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.392 0.615 . . . . 0.0 109.567 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.3 t -57.94 -45.27 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.6 -35.36 65.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.779 179.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.55 -50.05 68.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.413 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.6 m -58.52 -41.09 84.65 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.477 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 35.5 mm -64.52 -41.74 93.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.505 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.6 tt -68.43 -35.61 71.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.627 -178.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.26 -51.47 32.53 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 89.3 mt -60.7 -43.87 95.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.96 0.409 . . . . 0.0 110.067 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.2 tp -65.01 -31.07 72.13 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.364 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.447 ' ND1' ' C ' ' A' ' 37' ' ' HIS . 0.3 OUTLIER -68.55 -51.97 37.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.805 0.336 . . . . 0.0 110.903 -179.517 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 51.2 tp -62.58 -51.44 67.31 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.265 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 83.5 mt -61.98 -44.58 99.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.076 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 35.0 tp -60.32 -41.72 94.09 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.322 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.1 t-105 -62.59 -57.78 9.88 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 120.95 0.405 . . . . 0.0 111.516 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 95.3 mt -56.64 -54.72 25.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.925 -177.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 47' ' ' PHE . 29.0 tp -61.97 -44.01 97.64 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.025 -178.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -50.43 -45.95 56.13 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 57.7 ttt85 -61.71 -52.72 63.12 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.14 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 48' ' ' PHE . 5.6 mt -81.93 -77.38 0.22 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.806 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.464 ' N ' ' O ' ' A' ' 43' ' ' LEU . 92.6 t80 52.9 -83.69 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.8 0.333 . . . . 0.0 110.415 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.525 ' N ' ' O ' ' A' ' 46' ' ' LEU . 49.9 t80 -157.39 81.43 0.9 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.119 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.6 mttm 51.28 25.35 2.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.244 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.497 ' OG ' ' CE2' ' A' ' 54' ' ' PHE . 3.9 t -61.76 -29.66 70.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.587 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.9 mt -45.34 -37.0 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.988 0.423 . . . . 0.0 110.06 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -74.37 -27.58 60.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.001 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.537 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 95.7 mtt-85 -71.61 -48.63 46.84 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.542 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.497 ' CE2' ' OG ' ' A' ' 50' ' ' SER . 48.1 m-85 -71.33 -38.93 71.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.006 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -69.87 -38.87 76.55 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 120.829 -0.349 . . . . 0.0 111.724 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.523 ' OE2' ' CD2' ' A' ' 57' ' ' HIS . 0.8 OUTLIER -75.84 -38.42 58.05 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.785 -179.871 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.537 ' ND1' ' O ' ' A' ' 53' ' ' ARG . 27.8 m170 -66.39 -44.95 81.64 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.449 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.68 -27.38 73.38 Favored Glycine 0 N--CA 1.462 0.38 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.49 78.91 1.8 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.933 0.397 . . . . 0.0 110.001 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? . . . . . 0 C--N 1.333 -0.127 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.654 -179.819 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 29.3 t . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 48.76 65.83 6.56 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -49.68 -28.96 18.36 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.365 2.043 . . . . 0.0 111.241 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 19.4 tp -60.85 -51.19 70.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.86 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.64 -51.68 57.7 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.362 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 14.7 t -56.97 -42.33 78.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.82 -43.91 77.41 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.43 -44.85 80.81 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.384 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -61.35 -48.99 78.77 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.299 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 74.7 mt -57.39 -48.73 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.743 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 15.5 tt -67.96 -27.16 36.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.695 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.7 -49.18 57.2 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.2 mp -67.78 -41.13 84.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 12.4 tp -55.87 -52.05 65.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.925 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -67.36 -40.65 85.82 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.308 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 48.1 tp -63.29 -57.86 9.02 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 120.652 -0.419 . . . . 0.0 112.097 -178.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 4.6 tt -66.56 -36.87 78.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.812 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 52.5 tp -63.98 -36.74 84.98 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.539 -0.465 . . . . 0.0 109.966 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -67.73 -56.67 8.37 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.805 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.538 ' CG2' ' N ' ' B' ' 43' ' ' LEU . 8.3 tt -62.38 -47.63 92.13 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.476 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.071 -177.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.538 ' N ' ' CG2' ' B' ' 42' ' ' ILE . 17.8 tp -63.92 -47.0 82.29 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.338 -177.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . 0.43 ' O ' ' OG ' ' B' ' 50' ' ' SER . 41.7 t0 -57.96 -38.28 75.72 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 70.2 ttt-85 -69.67 -45.79 67.56 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.082 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 2.7 pp -133.62 125.61 29.11 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.098 0.475 . . . . 0.0 110.904 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -173.74 -37.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.551 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -172.21 56.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.297 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp 60.62 43.23 12.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.43 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' B' ' 44' ' ' ASP . 13.4 t -63.73 -51.02 66.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.817 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 73.1 mt -46.53 -40.46 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.856 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.522 ' CE2' ' OE2' ' B' ' 56' ' ' GLU . 92.0 t80 -71.65 -30.2 65.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.55 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . 0.523 ' O ' ' CD2' ' B' ' 57' ' ' HIS . 93.5 mtt180 -70.63 -45.12 65.81 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.011 0.434 . . . . 0.0 110.655 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -71.66 -38.06 70.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.824 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -68.48 -39.1 81.49 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.529 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . 0.522 ' OE2' ' CE2' ' B' ' 52' ' ' TYR . 12.4 pt-20 -75.92 -39.4 56.31 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 120.296 -0.561 . . . . 0.0 110.683 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' HIS . . . . . 0.523 ' CD2' ' O ' ' B' ' 53' ' ' ARG . 9.9 m-70 -63.5 -45.5 90.41 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.552 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.45 -28.49 73.19 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 5.1 tp -89.66 33.2 0.84 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.872 0.367 . . . . 0.0 110.336 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . 0.716 ' HZ3' ' HZ2' ' C' ' 49' ' ' LYS . 25.3 pttm . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.597 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . 0.433 ' N ' ' OD1' ' C' ' 24' ' ' ASP . 6.8 p30 -170.65 72.55 0.57 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.787 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -51.54 -33.59 48.52 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 C-N-CA 122.152 1.901 . . . . 0.0 111.047 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 18.5 tp -64.81 -50.43 66.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.97 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.52 -48.06 83.41 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.507 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . 0.438 ' O ' ' OG ' ' C' ' 31' ' ' SER . 48.2 t -57.28 -42.58 80.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.12 -42.23 80.5 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.58 -49.86 75.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.553 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 31' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' C' ' 28' ' ' VAL . 2.5 p -56.85 -46.74 81.55 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.93 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 52.4 mt -61.36 -33.91 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.518 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 3.4 mm -67.37 -42.78 87.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.072 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.1 -51.63 32.47 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.942 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . 0.428 ' CG2' ' N ' ' C' ' 36' ' ' LEU . 14.8 tt -63.26 -41.62 93.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.762 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . 0.428 ' N ' ' CG2' ' C' ' 35' ' ' ILE . 56.0 tp -64.96 -38.43 90.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.273 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.3 t60 -63.96 -50.68 67.64 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 28.5 tp -61.57 -48.29 81.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.494 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 66.9 mt -61.41 -43.16 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.291 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 36.6 mt -64.23 -40.29 95.73 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.398 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 10.3 t-105 -61.98 -60.72 3.21 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.114 0.483 . . . . 0.0 111.431 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . 0.554 ' CG2' ' N ' ' C' ' 43' ' ' LEU . 9.0 tt -58.6 -50.82 77.69 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.579 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.691 -177.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . 0.554 ' N ' ' CG2' ' C' ' 42' ' ' ILE . 2.7 tm? -61.26 -53.6 54.71 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.792 -177.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . 0.407 ' O ' ' OD1' ' C' ' 44' ' ' ASP . 68.2 t0 -52.01 -34.43 42.78 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . 0.46 ' O ' ' CD1' ' C' ' 51' ' ' ILE . 39.0 ttt-85 -69.03 -51.07 42.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.012 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 20.2 mt -79.96 -126.29 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.935 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 5.4 t80 72.75 -155.26 0.08 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.084 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -71.57 65.4 0.47 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.549 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . 0.716 ' HZ2' ' HZ3' ' B' ' 60' ' ' LYS . 49.7 mttp 54.87 52.57 11.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.938 0.399 . . . . 0.0 110.092 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 38.7 t -62.14 -40.97 97.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.221 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 51' ' ' ILE . . . . . 0.46 ' CD1' ' O ' ' C' ' 45' ' ' ARG . 3.7 mp -46.87 -47.5 8.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.356 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -72.36 -29.79 64.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.549 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 53' ' ' ARG . . . . . 0.527 ' O ' ' CG ' ' C' ' 57' ' ' HIS . 91.8 mtt180 -69.99 -47.24 62.98 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.685 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -69.58 -41.18 76.17 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.346 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -62.52 -39.69 94.37 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.837 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -79.24 -23.11 43.93 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.199 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 57' ' ' HIS . . . . . 0.527 ' CG ' ' O ' ' C' ' 53' ' ' ARG . 49.6 m170 -72.67 -51.58 18.85 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.256 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.33 -27.65 73.41 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 7.8 tp -92.05 53.68 2.22 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.793 0.33 . . . . 0.0 110.305 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 64.8 tttm . . . . . 0 N--CA 1.466 0.351 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.354 -179.939 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 10.7 p . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -158.13 58.44 1.39 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.53 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -51.09 -30.38 31.54 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 121.671 1.58 . . . . 0.0 110.83 178.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 pp -57.13 -29.25 63.41 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.03 -41.6 47.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.776 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 79.0 t -57.31 -44.48 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.42 -29.88 70.21 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.681 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.88 -42.31 73.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.778 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 16.0 p -69.61 -46.42 66.32 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.675 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 9.5 tt -67.99 -40.16 82.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.554 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 13.0 tt -71.28 -32.38 46.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.43 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.82 -52.49 14.71 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 19.0 tt -63.12 -39.89 86.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.912 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 43.8 tp -63.9 -37.52 87.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.911 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . 0.484 ' HD1' ' C ' ' D' ' 37' ' ' HIS . 0.3 OUTLIER -64.05 -50.06 69.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.431 -179.918 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 32.0 tp -57.98 -47.64 82.38 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.698 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . 0.403 HD13 HG23 ' D' ' 39' ' ' ILE . 97.7 mt -60.78 -43.82 96.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.16 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.89 -40.86 96.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.181 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . 0.481 ' HE1' HH21 ' D' ' 45' ' ' ARG . 30.8 t-105 -62.09 -55.02 33.22 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.739 0.304 . . . . 0.0 111.287 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 79.2 mt -60.03 -55.98 20.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.913 -178.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 52.7 tp -58.34 -41.5 84.79 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.841 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . 0.426 ' O ' ' CB ' ' D' ' 50' ' ' SER . 4.2 t70 -58.54 -40.84 84.1 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . 0.481 HH21 ' HE1' ' D' ' 41' ' ' TRP . 14.8 ttm180 -62.78 -50.91 69.17 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.546 -0.461 . . . . 0.0 110.445 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.39 109.45 21.44 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.001 0.429 . . . . 0.0 109.908 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -173.18 86.53 0.06 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.374 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 53.71 55.64 8.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.419 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt 60.35 52.19 4.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.223 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 50' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 0.3 OUTLIER -58.79 -42.23 88.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.73 -179.59 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 51' ' ' ILE . . . . . 0.617 ' H ' ' CD1' ' D' ' 51' ' ' ILE . 0.0 OUTLIER -55.37 -43.52 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -70.59 -28.24 64.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.122 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -68.7 -44.61 73.59 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.42 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -72.16 -40.99 67.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.775 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -63.19 -41.04 99.12 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.449 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -76.94 -36.89 56.24 Favored 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.562 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -58.44 -49.81 75.98 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.406 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.47 -27.35 73.07 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -93.86 57.55 2.49 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 86.8 tttt . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.53 -179.96 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.42 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 56.5 Cg_exo . . . . . 0 N--CA 1.489 1.259 0 N-CA-C 110.904 -0.46 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 18.6 tp -64.81 -51.52 61.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.972 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.23 -51.57 65.69 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.142 0.496 . . . . 0.0 109.928 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 49.2 t -56.91 -42.86 79.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.651 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 25' ' ' PRO . . . -55.93 -45.49 78.73 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.73 -46.04 81.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.113 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.3 t -56.05 -50.66 70.34 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.332 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 55.3 mt -56.59 -37.82 54.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.611 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 87.5 mt -65.37 -41.88 92.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.055 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.13 -52.32 37.59 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.643 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.5 -44.6 93.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 52.4 tp -63.9 -32.06 73.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.485 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -68.62 -51.66 39.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.817 0.341 . . . . 0.0 111.043 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 28.8 tp -63.04 -51.22 67.59 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.29 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.8 mm -61.58 -44.33 98.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.983 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 47.5 tp -61.54 -38.91 89.15 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.302 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 39.9 t-105 -63.5 -55.72 21.79 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.87 0.367 . . . . 0.0 111.405 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 74.8 mt -59.47 -54.18 38.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.802 -177.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 44.9 tp -61.25 -44.66 96.89 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.961 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -51.98 -44.87 64.23 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.472 ' NH2' ' CB ' ' D' ' 54' ' ' PHE . 65.8 ttt180 -61.2 -50.89 71.29 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.255 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.5 mt -81.73 -131.3 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.78 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 39.5 t80 62.47 101.31 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.592 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 41.73 38.83 1.03 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.605 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 66.9 mttm 53.39 49.42 19.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.158 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.9 t -49.49 -27.37 4.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.632 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.452 ' CD1' ' O ' ' A' ' 45' ' ' ARG . 3.6 mp -47.5 -45.33 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.9 0.381 . . . . 0.0 110.093 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.519 ' CE2' ' OE1' ' A' ' 56' ' ' GLU . 86.8 t80 -71.15 -29.04 64.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.175 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.527 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 79.5 mtp180 -69.02 -45.53 70.27 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.027 0.441 . . . . 0.0 110.33 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -70.69 -37.11 73.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.651 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -67.91 -39.91 83.49 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 120.629 -0.429 . . . . 0.0 111.661 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.519 ' OE1' ' CE2' ' A' ' 52' ' ' TYR . 21.9 pt-20 -76.41 -40.1 51.72 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.145 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.527 ' ND1' ' O ' ' A' ' 53' ' ' ARG . 32.6 m170 -64.77 -45.84 84.65 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.757 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.815 0 N-CA-C 110.774 -0.931 . . . . 0.0 110.774 179.917 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.718 0.294 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -51.63 -32.87 46.43 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.492 2.128 . . . . 0.0 111.27 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.462 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 19.2 tp -61.5 -47.31 86.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.904 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.93 -46.15 91.82 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 91.9 t -60.56 -33.39 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -63.39 -35.65 81.12 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.77 -44.07 74.43 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.386 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 4.8 t -67.02 -51.32 56.34 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 120.081 -0.648 . . . . 0.0 111.563 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.464 HG23 ' N ' ' B' ' 33' ' ' ILE . 19.9 tt -62.72 -40.96 90.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.738 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.464 ' N ' HG23 ' B' ' 32' ' ' ILE . 17.4 tt -71.68 -28.44 31.01 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.14 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.247 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.15 -52.22 28.85 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 6.4 pt -64.27 -42.94 96.99 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.217 0 C-N-CA 120.234 -0.587 . . . . 0.0 109.902 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 11.5 tp -59.75 -39.44 84.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.67 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' HIS . . . . . 0.545 ' NE2' ' NE2' ' C' ' 37' ' ' HIS . 28.9 t60 -68.0 -54.46 18.27 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -178.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 38.5 tp -62.12 -51.54 67.48 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 120.999 0.428 . . . . 0.0 111.761 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.478 ' N ' ' CD1' ' B' ' 39' ' ' ILE . 1.2 mp -62.18 -43.36 97.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.229 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 37.0 tp -59.46 -38.49 80.9 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.98 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 6.8 t-105 -63.85 -63.23 1.22 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.998 0.428 . . . . 0.0 111.611 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.548 ' CG2' ' N ' ' B' ' 43' ' ' LEU . 8.6 tt -53.25 -50.89 44.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 119.944 -0.703 . . . . 0.0 110.74 -177.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.548 ' N ' ' CG2' ' B' ' 42' ' ' ILE . 0.5 OUTLIER -57.65 -50.23 73.86 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.46 -178.128 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -50.27 -37.27 35.17 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 63.9 ttt-85 -68.95 -50.99 44.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.084 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.438 ' O ' ' O ' ' B' ' 43' ' ' LEU . 0.3 OUTLIER -96.79 128.47 43.77 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.614 -179.398 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -162.53 -54.29 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.422 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -170.92 -60.31 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.303 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -147.87 18.46 1.13 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.316 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 47.3 t -54.34 -49.84 68.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.729 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 49.9 mt -53.84 -50.05 54.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.986 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.479 ' CE2' ' OE2' ' B' ' 56' ' ' GLU . 79.2 t80 -74.18 -30.6 62.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.748 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 20.1 mmt85 -69.15 -47.75 64.15 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.705 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 54' ' ' PHE . . . . . 0.409 ' HB3' HH22 ' C' ' 45' ' ' ARG . 47.9 m-85 -72.6 -39.77 67.04 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.872 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -64.08 -41.39 97.34 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 120.751 -0.379 . . . . 0.0 111.462 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 56' ' ' GLU . . . . . 0.479 ' OE2' ' CE2' ' B' ' 52' ' ' TYR . 10.9 pt-20 -76.92 -38.07 54.13 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 120.404 -0.519 . . . . 0.0 110.738 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -59.58 -49.27 78.4 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.35 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.21 -29.48 74.43 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 9.6 tp -87.29 58.12 4.83 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.802 0.334 . . . . 0.0 110.296 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 62.8 mttp . . . . . 0 N--CA 1.466 0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.399 -179.904 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -157.71 72.29 4.24 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.778 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -51.04 -35.69 51.62 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.485 2.123 . . . . 0.0 111.221 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 26' ' ' LEU . . . . . 0.414 ' O ' ' HB3' ' C' ' 29' ' ' ALA . 15.3 tp -58.16 -53.07 62.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.958 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.25 -46.09 91.0 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.044 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 89.9 t -60.25 -33.46 53.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 29' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' C' ' 26' ' ' LEU . . . -64.07 -38.39 90.9 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.95 -51.32 62.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.106 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 2.8 p -62.01 -52.27 64.67 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.595 -0.442 . . . . 0.0 112.022 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 10.1 tp -59.37 -37.71 70.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.489 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 29.6 mt -63.14 -40.86 90.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.73 -52.1 45.71 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.65 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 50.2 mm -56.7 -48.24 81.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.551 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 7.4 tp -62.73 -34.3 76.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.834 0.35 . . . . 0.0 110.816 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 37' ' ' HIS . . . . . 0.545 ' NE2' ' NE2' ' B' ' 37' ' ' HIS . 1.5 t60 -65.12 -50.16 67.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.431 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 11.0 mp -66.56 -44.86 81.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.411 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 30.6 mm -63.34 -47.14 93.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.268 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 34.8 mt -65.9 -40.46 91.55 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.666 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 32.7 t-105 -61.27 -54.47 43.69 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.021 0.439 . . . . 0.0 111.607 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 82.8 mt -65.43 -55.0 22.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.113 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.651 ' C ' HD13 ' C' ' 43' ' ' LEU . 2.9 tm? -59.83 -52.37 65.76 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.141 -178.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 44' ' ' ASP . . . . . 0.499 ' OD1' ' CE1' ' C' ' 54' ' ' PHE . 66.4 t0 -52.86 -41.77 64.6 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.107 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 45' ' ' ARG . . . . . 0.409 HH22 ' HB3' ' B' ' 54' ' ' PHE . 55.1 ttt-85 -59.94 -53.55 56.58 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.224 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 46' ' ' LEU . . . . . 0.403 ' O ' ' CB ' ' C' ' 47' ' ' PHE . 4.1 mt -84.08 -140.42 0.07 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.091 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 47' ' ' PHE . . . . . 0.529 ' O ' ' N ' ' C' ' 49' ' ' LYS . 7.2 t80 78.63 -164.22 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.168 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 48' ' ' PHE . . . . . 0.406 ' O ' ' C ' ' C' ' 49' ' ' LYS . 85.9 t80 -57.03 81.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.406 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 49' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' C' ' 47' ' ' PHE . 15.9 ptpt 33.27 53.34 0.41 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.122 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 42.9 t -57.88 -46.32 85.06 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.302 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 51' ' ' ILE . . . . . 0.553 ' H ' HD12 ' C' ' 51' ' ' ILE . 3.5 mp -43.46 -42.48 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.944 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -71.11 -31.2 67.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.455 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -70.13 -46.73 64.16 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.512 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 54' ' ' PHE . . . . . 0.499 ' CE1' ' OD1' ' C' ' 44' ' ' ASP . 32.2 m-85 -66.14 -43.49 86.93 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.29 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -61.67 -39.9 93.03 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.693 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 . . . . . 0 CA--C 1.535 0.373 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.894 179.724 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo . . . . . 0 N--CA 1.483 0.907 0 N-CA-C 110.496 -0.617 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 pp -67.86 -37.53 81.94 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.7 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 27' ' ' ALA . . . . . 0.451 ' O ' ' HB3' ' D' ' 30' ' ' ALA . . . -51.4 -40.38 59.16 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.741 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 90.4 t -57.58 -45.21 86.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.67 -32.79 70.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.265 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 30' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' D' ' 27' ' ' ALA . . . -67.61 -35.41 78.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.992 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 5.1 t -68.38 -50.84 50.2 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.519 -0.473 . . . . 0.0 111.081 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 63.9 mt -64.72 -40.33 88.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.407 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 33' ' ' ILE . . . . . 0.401 HG21 HD13 ' D' ' 33' ' ' ILE . 6.8 tt -68.95 -35.68 70.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.893 -178.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.72 -52.64 14.48 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.673 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 35' ' ' ILE . . . . . 0.47 HG23 ' N ' ' D' ' 36' ' ' LEU . 10.3 tp -63.15 -40.83 90.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.934 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.47 ' N ' HG23 ' D' ' 35' ' ' ILE . 52.4 tp -63.4 -37.46 87.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.755 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -63.07 -50.74 69.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.465 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 37.3 tp -57.04 -48.3 78.87 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.554 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.05 -41.26 85.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.67 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 37.9 mt -62.32 -39.41 92.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.186 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 31.5 t-105 -63.33 -54.4 37.62 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.798 0.332 . . . . 0.0 111.23 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 61.5 mt -61.77 -53.19 51.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 120.65 -0.42 . . . . 0.0 112.11 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' D' ' 46' ' ' LEU . 37.0 tp -61.51 -48.38 81.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.12 -178.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 44' ' ' ASP . . . . . 0.443 ' O ' ' CB ' ' D' ' 50' ' ' SER . 32.3 t70 -54.36 -45.69 72.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.209 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -60.1 -50.23 74.54 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.513 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 46' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' D' ' 43' ' ' LEU . 2.8 pp -122.73 125.62 45.9 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.056 0.455 . . . . 0.0 110.583 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -174.19 -45.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.539 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 48' ' ' PHE . . . . . 0.527 ' O ' ' NH1' ' D' ' 53' ' ' ARG . 77.8 t80 -172.92 67.96 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.293 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 67.2 mttm 55.94 39.48 30.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.278 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 50' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 6.6 t -64.15 -52.78 57.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.921 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 62.1 mt -49.0 -34.34 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.856 0.36 . . . . 0.0 110.264 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -72.53 -29.85 63.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.01 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 53' ' ' ARG . . . . . 0.527 ' NH1' ' O ' ' D' ' 48' ' ' PHE . 95.3 mtm-85 -72.09 -48.2 45.74 Favored 'General case' 0 CA--C 1.522 -0.122 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.616 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 54' ' ' PHE . . . . . 0.472 ' CB ' ' NH2' ' A' ' 45' ' ' ARG . 87.4 m-85 -68.04 -42.09 81.08 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.792 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -65.64 -40.94 93.06 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.279 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -77.18 -21.87 53.33 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.61 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -74.28 -48.71 26.82 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.318 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.41 -31.47 78.98 Favored Glycine 0 N--CA 1.46 0.265 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 59' ' ' LEU . . . . . 0.402 ' C ' ' CD1' ' D' ' 59' ' ' LEU . 0.2 OUTLIER -65.1 -62.69 1.4 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.831 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 97.3 mttt . . . . . 0 C--N 1.333 -0.131 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.573 179.675 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo . . . . . 0 N--CA 1.487 1.104 0 N-CA-C 110.905 -0.46 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.411 HD13 ' HB3' ' B' ' 31' ' ' SER . 2.1 pp -70.53 -30.21 66.9 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.704 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -56.09 -40.41 73.59 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 120.586 -0.446 . . . . 0.0 109.815 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.7 t -58.54 -45.84 90.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.423 ' O ' HG22 ' A' ' 33' ' ' ILE . . . -60.45 -32.26 71.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.755 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -65.24 -47.31 77.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.553 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.5 p -65.28 -35.05 79.82 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.409 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.5 mm -66.07 -50.51 68.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.607 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.423 HG22 ' O ' ' A' ' 29' ' ' ALA . 15.4 tt -68.87 -28.61 40.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.795 -179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.99 -48.86 30.69 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.497 -0.858 . . . . 0.0 111.121 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.0 mm -64.51 -44.49 96.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.808 0.337 . . . . 0.0 110.162 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.2 tp -63.63 -39.21 93.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.034 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -63.32 -46.1 88.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.268 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 16.6 tp -65.66 -47.55 75.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.843 0.354 . . . . 0.0 111.535 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 29.2 mm -61.66 -50.1 81.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.408 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -65.77 -33.02 74.9 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.23 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 21.0 t-105 -64.3 -52.62 57.64 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.811 0.339 . . . . 0.0 111.406 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.3 mt -67.75 -50.38 60.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.82 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.469 HD11 ' CD1' ' A' ' 47' ' ' PHE . 22.7 tp -61.94 -44.89 95.83 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.03 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.439 ' O ' ' CB ' ' A' ' 50' ' ' SER . 28.4 t70 -58.99 -44.58 91.63 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.811 -0.355 . . . . 0.0 110.119 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 61.8 ttt85 -60.39 -45.04 95.0 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.612 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.5 pp -135.74 129.9 33.32 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.919 0.39 . . . . 0.0 110.996 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.469 ' CD1' HD11 ' A' ' 43' ' ' LEU . 60.2 t80 -173.83 -33.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.366 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.471 ' O ' ' CD2' ' A' ' 48' ' ' PHE . 52.9 t80 -172.52 45.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.164 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt 73.28 40.69 0.52 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.235 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.462 ' O ' ' N ' ' A' ' 53' ' ' ARG . 9.8 t -62.12 -46.24 89.89 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.004 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 91.2 mt -44.13 -38.97 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.025 0.44 . . . . 0.0 110.26 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -74.99 -28.26 60.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.217 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.53 ' O ' ' CD2' ' A' ' 57' ' ' HIS . 87.1 mtt180 -68.76 -49.48 58.33 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 121.007 0.432 . . . . 0.0 110.344 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -71.35 -39.97 70.96 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.876 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -64.76 -40.35 95.15 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.795 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -76.86 -41.17 45.0 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.971 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.53 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 9.2 m-70 -59.73 -48.43 81.73 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.665 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.807 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.99 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.672 0.272 . . . . 0.0 110.683 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -49.95 -36.75 44.93 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.447 2.098 . . . . 0.0 111.242 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.442 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 18.2 tp -57.5 -50.72 72.16 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.939 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.21 -51.24 70.4 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 93.1 t -54.6 -38.82 43.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -57.86 -40.25 79.71 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.72 -40.14 94.83 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.232 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' SER . . . . . 0.411 ' HB3' HD13 ' A' ' 26' ' ' LEU . 31.9 p -67.22 -55.76 12.7 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.587 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.446 HG23 ' N ' ' B' ' 33' ' ' ILE . 18.5 tt -59.7 -41.13 84.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.904 -178.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.446 ' N ' HG23 ' B' ' 32' ' ' ILE . 16.3 tt -70.05 -29.76 41.28 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.213 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.76 -51.05 37.76 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.0 mp -61.03 -43.66 96.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 12.3 tp -60.91 -38.24 85.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.684 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -66.94 -52.72 39.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.706 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 42.0 tp -62.45 -50.54 71.06 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.602 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.453 HD13 ' HA ' ' B' ' 39' ' ' ILE . 14.7 mm -61.36 -42.19 92.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.423 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 6.4 tt -61.91 -38.82 89.82 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.075 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 49.9 t-105 -63.65 -55.49 23.12 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 60.2 mt -63.65 -53.47 44.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.767 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.503 ' O ' HD23 ' B' ' 43' ' ' LEU . 0.8 OUTLIER -57.88 -47.34 83.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.128 -178.755 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -59.72 -45.98 90.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.928 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -58.71 -52.33 66.17 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.058 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.11 129.82 56.77 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 120.996 0.427 . . . . 0.0 110.277 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -175.04 -55.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.296 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -169.31 71.74 0.08 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.306 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 49.5 mttp 60.14 30.19 19.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.469 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 11.0 t -56.31 -50.84 70.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.857 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 59.2 mt -51.9 -44.37 37.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.889 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.494 ' CE2' ' OE1' ' B' ' 56' ' ' GLU . 78.2 t80 -71.99 -32.2 66.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.474 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.529 ' O ' ' CG ' ' B' ' 57' ' ' HIS . 78.7 mtp180 -67.67 -45.99 73.66 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.724 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -71.89 -38.94 69.91 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.792 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -64.18 -41.22 97.19 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.49 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 56' ' ' GLU . . . . . 0.494 ' OE1' ' CE2' ' B' ' 52' ' ' TYR . 21.1 pt-20 -76.78 -39.02 52.96 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.692 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 57' ' ' HIS . . . . . 0.529 ' CG ' ' O ' ' B' ' 53' ' ' ARG . 6.4 m-70 -58.63 -48.21 81.76 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.657 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.31 -28.5 73.64 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 11.0 mp -104.64 66.68 0.79 Allowed 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 97.6 mttt . . . . . 0 N--CA 1.466 0.336 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.362 -179.791 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 49.14 68.66 3.3 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.674 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -51.65 -31.57 41.28 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.496 2.131 . . . . 0.0 111.186 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 26' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' C' ' 29' ' ' ALA . 3.0 pp -60.69 -28.24 68.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.781 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -46.94 -38.9 11.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.259 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 68.2 t -59.78 -40.96 84.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 29' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' C' ' 26' ' ' LEU . . . -62.33 -34.42 76.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.392 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.18 -49.5 69.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.927 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 4.4 p -64.6 -50.79 65.81 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 3.2 tp -60.17 -37.94 75.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.559 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 51.1 mt -67.73 -38.0 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.654 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.5 -51.81 34.46 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.804 -0.713 . . . . 0.0 111.967 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 9.6 pt -64.45 -37.9 81.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.467 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 13.0 tp -65.7 -40.73 92.59 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -63.86 -52.61 59.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.587 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 50.9 tp -63.63 -47.8 79.87 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.652 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 84.4 mt -59.92 -45.35 95.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.143 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.5 -38.82 92.34 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.906 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 25.7 t-105 -59.46 -57.21 13.99 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.334 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 54.1 mt -63.75 -54.53 30.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -177.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.501 ' O ' HD23 ' C' ' 43' ' ' LEU . 0.8 OUTLIER -58.45 -48.98 78.96 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.75 0.309 . . . . 0.0 111.191 -178.443 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 44' ' ' ASP . . . . . 0.502 ' O ' ' CB ' ' C' ' 50' ' ' SER . 38.7 t70 -57.49 -48.67 78.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.986 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 45' ' ' ARG . . . . . 0.488 ' NH1' HD11 ' C' ' 51' ' ' ILE . 34.2 ttt-85 -56.79 -52.8 63.65 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.229 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 46' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' C' ' 43' ' ' LEU . 2.6 pp -113.68 129.94 56.49 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.132 0.491 . . . . 0.0 110.977 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -173.81 -39.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.329 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -169.51 -67.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.368 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -150.44 25.63 0.78 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.096 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 50' ' ' SER . . . . . 0.502 ' CB ' ' O ' ' C' ' 44' ' ' ASP . 6.6 t -50.23 -53.65 26.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.559 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 51' ' ' ILE . . . . . 0.488 HD11 ' NH1' ' C' ' 45' ' ' ARG . 66.3 mt -50.68 -49.41 25.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.212 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -73.6 -31.11 63.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.687 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -70.42 -49.4 49.24 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.428 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -67.36 -41.47 85.05 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.351 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -62.61 -38.68 91.13 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 120.484 -0.487 . . . . 0.0 110.809 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 . . . . . 0 CA--C 1.536 0.433 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.916 179.657 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 25' ' ' PRO . . . . . 0.425 ' O ' ' N ' ' D' ' 29' ' ' ALA . 76.0 Cg_exo . . . . . 0 N--CA 1.489 1.211 0 N-CA-C 110.819 -0.493 . . . . 0.0 110.819 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 26' ' ' LEU . . . . . 0.443 ' O ' ' HB3' ' D' ' 29' ' ' ALA . 25.9 tp -56.48 -48.47 77.07 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.2 -51.2 71.0 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.21 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 89.3 t -60.28 -29.16 43.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.57 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' D' ' 26' ' ' LEU . . . -66.88 -37.05 83.68 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.32 -38.41 74.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.561 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 1.4 m -68.98 -47.57 65.25 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.7 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 32' ' ' ILE . . . . . 0.435 HG23 ' N ' ' D' ' 33' ' ' ILE . 10.0 tp -69.11 -41.22 81.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.632 -178.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 33' ' ' ILE . . . . . 0.435 ' N ' HG23 ' D' ' 32' ' ' ILE . 9.9 tt -67.06 -39.95 84.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.498 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.65 -51.03 32.73 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.879 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 35' ' ' ILE . . . . . 0.426 HD13 ' O ' ' D' ' 35' ' ' ILE . 0.2 OUTLIER -59.93 -43.59 92.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.409 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.405 ' N ' ' CG2' ' D' ' 35' ' ' ILE . 49.7 tp -60.41 -39.6 87.96 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.89 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -61.35 -48.4 81.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.29 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 57.4 tp -55.47 -52.79 62.46 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.837 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 39' ' ' ILE . . . . . 0.408 HD13 ' CD1' ' D' ' 35' ' ' ILE . 1.4 mp -61.88 -33.23 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.443 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 6.1 tp -65.49 -42.97 91.56 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.717 0.294 . . . . 0.0 110.576 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 21.9 t-105 -66.13 -58.75 4.74 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 120.883 0.373 . . . . 0.0 111.54 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 42' ' ' ILE . . . . . 0.519 ' CG2' ' N ' ' D' ' 43' ' ' LEU . 9.1 tt -60.47 -47.39 92.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.466 -177.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.519 ' N ' ' CG2' ' D' ' 42' ' ' ILE . 23.0 tp -63.43 -44.86 93.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.564 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 44' ' ' ASP . . . . . 0.516 ' OD1' ' CE1' ' D' ' 54' ' ' PHE . 40.8 t0 -56.44 -37.69 70.59 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 45' ' ' ARG . . . . . 0.512 ' HB3' HD23 ' D' ' 46' ' ' LEU . 12.4 ttm180 -69.42 -53.53 18.86 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.895 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 46' ' ' LEU . . . . . 0.512 HD23 ' HB3' ' D' ' 45' ' ' ARG . 0.2 OUTLIER -117.08 113.5 22.39 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.987 0.422 . . . . 0.0 110.149 179.367 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -174.8 83.9 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.074 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 54.97 71.61 0.53 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.525 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 98.5 mttt 51.2 48.89 22.18 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.289 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 2.6 t -68.79 -52.85 25.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.127 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 9.4 mt -47.74 -37.54 5.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.087 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -73.87 -31.27 63.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.133 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -71.08 -47.2 59.67 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.877 0.37 . . . . 0.0 110.772 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 54' ' ' PHE . . . . . 0.516 ' CE1' ' OD1' ' D' ' 44' ' ' ASP . 64.9 m-85 -71.74 -37.35 70.59 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.763 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -67.84 -41.16 83.41 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.615 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -76.71 -36.96 56.86 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.72 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 62.7 t-80 -63.49 -48.31 78.15 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.299 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.04 -27.91 73.55 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 5.9 tp -92.96 39.07 1.03 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.871 0.367 . . . . 0.0 110.326 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 3.1 tmtm? . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.386 -179.666 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo . . . . . 0 N--CA 1.493 1.445 0 CA-C-O 120.931 0.305 . . . . 0.0 111.661 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 pp -62.64 -29.8 70.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.06 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.457 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -50.48 -34.48 25.14 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.152 0.501 . . . . 0.0 109.982 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.2 t -59.13 -48.81 85.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 CA-C-O 121.539 0.685 . . . . 0.0 109.274 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.22 -30.69 71.27 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.567 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -63.68 -47.36 81.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.213 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.9 t -62.22 -48.07 81.6 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.866 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.2 mp -62.12 -33.51 58.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.293 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 38.4 mt -70.49 -38.92 75.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 121.123 -0.231 . . . . 0.0 110.759 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.15 -53.48 18.08 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.393 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.464 HG23 ' N ' ' A' ' 36' ' ' LEU . 19.2 tt -60.24 -41.1 85.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.728 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.464 ' N ' HG23 ' A' ' 35' ' ' ILE . 40.5 tp -66.42 -30.87 71.33 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.35 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -68.55 -48.97 62.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.472 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.5 mp -63.86 -50.36 69.15 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.978 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 86.1 mt -62.13 -48.1 90.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.378 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.7 tp -61.08 -42.1 97.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.701 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.7 t-105 -62.46 -56.26 19.85 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 120.865 0.364 . . . . 0.0 111.518 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.03 -55.24 24.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.871 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.2 tp -61.24 -48.15 82.78 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.289 -0.564 . . . . 0.0 111.36 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -53.58 -39.15 64.6 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 42.1 ttt-85 -63.49 -51.17 66.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.442 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 48' ' ' PHE . 7.1 mt -83.18 -77.05 0.26 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.023 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.416 ' CD2' ' N ' ' A' ' 48' ' ' PHE . 88.4 t80 46.69 -88.25 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.415 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.534 ' N ' ' O ' ' A' ' 46' ' ' LEU . 62.5 t80 -164.39 87.33 0.48 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.099 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm 59.14 27.47 16.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.13 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.8 t -59.78 -44.47 93.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.657 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.439 ' H ' HD12 ' A' ' 51' ' ' ILE . 3.3 mp -52.19 -36.38 20.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.01 0.433 . . . . 0.0 110.068 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.495 ' CD2' ' OE2' ' A' ' 56' ' ' GLU . 81.4 t80 -74.01 -27.78 61.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.221 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 48' ' ' PHE . 68.2 mtt85 -69.97 -49.33 52.76 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.96 0.409 . . . . 0.0 110.559 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -72.03 -39.17 69.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.945 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -66.79 -39.69 87.86 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.711 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.495 ' OE2' ' CD2' ' A' ' 52' ' ' TYR . 10.1 pt-20 -76.17 -40.36 52.66 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.658 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.529 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 6.4 m-70 -60.68 -47.43 86.29 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.54 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.948 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.935 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 120.635 0.255 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -50.4 -29.33 23.56 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.511 2.141 . . . . 0.0 111.606 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 14.3 tp -61.64 -52.29 64.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.189 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' B' ' 30' ' ' ALA . . . -58.98 -46.34 88.36 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.609 0.719 . . . . 0.0 109.384 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 72.5 t -56.69 -47.11 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.1 -44.38 52.07 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' B' ' 27' ' ' ALA . . . -56.69 -50.35 72.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.796 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 60.7 p -57.45 -48.81 78.19 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 120.309 -0.557 . . . . 0.0 111.447 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 34.1 mm -59.67 -35.64 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.114 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 86.3 mt -70.24 -34.43 58.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.572 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.85 -52.94 21.86 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.497 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 7.9 pt -64.7 -39.97 87.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.1 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 37.3 tp -62.23 -40.03 94.8 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.47 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -66.85 -53.68 30.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.732 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 34.8 tp -61.99 -53.21 58.74 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.737 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 56.7 mt -60.48 -44.22 95.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.794 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 32.5 tp -56.72 -43.26 80.42 Favored 'General case' 0 C--O 1.222 -0.364 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 21.7 t-105 -60.44 -54.19 48.58 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.161 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 5.2 mm -54.02 -58.34 3.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-O 121.237 0.541 . . . . 0.0 111.921 -177.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.665 ' C ' HD12 ' B' ' 43' ' ' LEU . 0.3 OUTLIER -62.4 -35.8 80.33 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.78 -178.488 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 44' ' ' ASP . . . . . 0.429 ' O ' ' OG ' ' B' ' 50' ' ' SER . 22.8 t70 -58.1 -44.84 87.87 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -65.77 -45.01 84.09 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.444 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.509 ' C ' ' H ' ' B' ' 48' ' ' PHE . 0.3 OUTLIER -113.74 -120.49 0.3 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.098 179.485 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.482 ' H ' HD12 ' B' ' 46' ' ' LEU . 37.3 t80 68.06 -35.29 0.27 Allowed 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.15 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 48' ' ' PHE . . . . . 0.509 ' H ' ' C ' ' B' ' 46' ' ' LEU . 31.0 t80 -169.06 42.97 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.678 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt 45.05 40.38 4.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.57 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 50' ' ' SER . . . . . 0.461 ' O ' ' N ' ' B' ' 53' ' ' ARG . 1.4 p -61.8 -24.02 66.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.857 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 9.4 mt -41.55 -41.05 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.878 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -74.25 -29.69 61.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.379 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.461 ' N ' ' O ' ' B' ' 50' ' ' SER . 99.2 mtt180 -71.53 -47.61 54.11 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.935 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 54' ' ' PHE . . . . . 0.596 ' CE1' ' NH2' ' C' ' 45' ' ' ARG . 66.6 m-85 -72.81 -39.7 66.43 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.939 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -67.87 -39.26 83.76 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.644 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -76.93 -38.83 52.62 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.614 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -62.02 -47.29 85.42 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.259 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.12 -27.48 72.95 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 35.2 tp -79.85 -73.76 0.33 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.711 0.291 . . . . 0.0 110.541 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 68.5 mttm . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.601 -179.995 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 17.9 m . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 24' ' ' ASP . . . . . 0.459 ' HB2' ' HB3' ' C' ' 27' ' ' ALA . 0.7 OUTLIER -177.54 56.53 0.11 Allowed Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.493 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.77 -30.42 68.91 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.104 1.869 . . . . 0.0 110.698 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 26' ' ' LEU . . . . . 0.431 ' O ' ' HB3' ' C' ' 29' ' ' ALA . 19.2 tp -68.8 -48.26 64.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.068 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 27' ' ' ALA . . . . . 0.459 ' HB3' ' HB2' ' C' ' 24' ' ' ASP . . . -59.61 -46.91 87.58 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.234 0.54 . . . . 0.0 109.615 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 82.1 t -59.39 -34.34 54.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.247 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 29' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' C' ' 26' ' ' LEU . . . -63.91 -34.85 78.88 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.47 -42.71 78.35 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.231 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 6.6 t -68.45 -48.48 64.45 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.189 -0.604 . . . . 0.0 111.802 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 32' ' ' ILE . . . . . 0.406 HG23 ' N ' ' C' ' 33' ' ' ILE . 14.6 tt -66.03 -40.84 88.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.64 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 33' ' ' ILE . . . . . 0.406 ' N ' HG23 ' C' ' 32' ' ' ILE . 14.7 tt -69.22 -36.4 72.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.703 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.09 -51.45 38.97 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 120.497 -0.858 . . . . 0.0 110.973 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 34.7 mm -60.6 -41.21 87.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 13.4 tp -60.45 -45.02 95.18 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.361 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 37' ' ' HIS . . . . . 0.476 ' C ' ' ND1' ' C' ' 37' ' ' HIS . 9.1 t-80 -60.82 -52.29 65.71 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.84 0.352 . . . . 0.0 111.379 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 55.4 tp -56.6 -48.62 77.04 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.05 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 56.1 mt -63.79 -34.47 68.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.006 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 40' ' ' LEU . . . . . 0.516 ' O ' HD13 ' C' ' 40' ' ' LEU . 0.2 OUTLIER -64.52 -48.64 74.37 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.633 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 15.3 t-105 -62.81 -56.96 12.74 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 73.6 mt -59.48 -51.91 67.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.872 -177.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.622 ' C ' HD13 ' C' ' 43' ' ' LEU . 2.8 tm? -58.87 -50.77 72.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.504 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -56.88 -35.16 68.62 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.025 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 45' ' ' ARG . . . . . 0.596 ' NH2' ' CE1' ' B' ' 54' ' ' PHE . 50.8 ttp180 -69.95 -57.68 4.74 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.831 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 46' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' C' ' 43' ' ' LEU . 1.1 pp -108.17 -164.34 0.95 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.66 0.267 . . . . 0.0 111.058 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 12.2 t80 74.42 -11.12 1.05 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.919 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 48' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' C' ' 49' ' ' LYS . 32.2 t80 -164.09 158.0 18.84 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.468 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 49' ' ' LYS . . . . . 0.541 ' N ' ' CD1' ' C' ' 48' ' ' PHE . 36.5 tttm -72.52 42.38 0.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.285 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 50' ' ' SER . . . . . 0.456 ' H ' ' C ' ' C' ' 48' ' ' PHE . 6.7 t -66.47 -47.5 72.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.0 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 71.5 mt -43.95 -42.17 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.941 -0.303 . . . . 0.0 111.306 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -72.47 -29.82 64.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.302 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -71.3 -49.66 40.51 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.535 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 54' ' ' PHE . . . . . 0.404 ' CB ' ' NH2' ' D' ' 45' ' ' ARG . 45.7 m-85 -65.68 -44.24 86.83 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.38 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -63.06 -36.47 83.69 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.527 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 . . . . . 0 CA--C 1.536 0.406 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.63 179.655 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo . . . . . 0 N--CA 1.495 1.567 0 CA-C-O 121.095 0.373 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 16.9 tp -61.53 -51.72 67.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.652 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.63 -44.99 93.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.44 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 88.9 t -59.48 -38.44 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.88 -35.32 76.33 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.93 -51.12 59.15 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.08 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 6.1 p -61.18 -50.52 72.82 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.786 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 3.3 tp -62.11 -37.65 78.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.596 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 29.4 mt -62.72 -41.31 91.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 120.399 -0.521 . . . . 0.0 109.673 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.97 -46.15 83.31 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.06 -0.59 . . . . 0.0 111.957 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.61 -47.48 93.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.918 0.389 . . . . 0.0 110.523 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 21.6 tp -64.18 -32.17 73.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.055 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -64.87 -49.94 68.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.005 0.431 . . . . 0.0 110.523 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 46.9 tp -63.12 -46.55 86.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.1 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.42 -47.62 91.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.122 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -62.54 -37.88 87.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.241 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 40.4 t-105 -62.27 -57.29 11.94 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.524 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 62.0 mt -61.45 -53.57 46.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.954 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 55.9 tp -58.76 -47.22 85.43 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.946 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -54.33 -45.26 72.62 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 45' ' ' ARG . . . . . 0.424 ' HB3' HD23 ' D' ' 46' ' ' LEU . 77.0 ttt180 -59.18 -53.13 61.84 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.402 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 46' ' ' LEU . . . . . 0.424 HD23 ' HB3' ' D' ' 45' ' ' ARG . 0.1 OUTLIER -109.91 113.3 25.92 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 120.904 0.383 . . . . 0.0 110.185 179.055 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -173.67 91.89 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.42 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 54.29 59.19 4.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.416 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? 53.69 54.61 9.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.49 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 5.6 t -68.11 -52.01 39.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.134 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 58.0 mt -48.5 -35.13 5.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.627 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -70.81 -29.93 66.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.085 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -69.63 -42.62 74.08 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.963 0.411 . . . . 0.0 110.464 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -72.09 -39.37 69.0 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.802 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -66.09 -40.74 91.04 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.511 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 56' ' ' GLU . . . . . 0.44 ' CD ' ' N ' ' D' ' 57' ' ' HIS . 2.9 pp20? -76.39 -37.13 57.6 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.501 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 57' ' ' HIS . . . . . 0.44 ' N ' ' CD ' ' D' ' 56' ' ' GLU . 86.3 t60 -60.69 -51.69 68.28 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.275 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.07 -26.66 73.42 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 14.7 tp -152.86 88.0 1.31 Allowed 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 64.5 mttp . . . . . 0 N--CA 1.458 -0.042 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.497 -179.617 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo . . . . . 0 N--CA 1.492 1.397 0 N-CA-C 111.226 -0.336 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.439 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 16.2 tp -63.65 -53.22 54.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.032 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.2 -41.93 85.06 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 95.8 t -63.41 -32.35 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.241 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 26' ' ' LEU . . . -65.48 -36.21 83.2 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.43 -50.12 55.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.955 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.8 p -61.15 -50.09 74.57 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.683 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.0 tp -63.98 -34.19 66.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.072 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.1 mt -68.44 -43.04 84.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.553 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.28 -51.45 37.96 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.013 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 35' ' ' ILE . 9.7 tt -62.27 -40.09 86.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.017 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.402 ' N ' ' CG2' ' A' ' 35' ' ' ILE . 48.5 tp -64.57 -36.02 82.88 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.304 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -67.33 -50.9 58.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.803 0.335 . . . . 0.0 110.964 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 26.9 tp -61.74 -52.65 63.4 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.713 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 60.9 mt -62.73 -48.4 88.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.097 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 43.3 tp -54.78 -43.29 72.68 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 17.8 t-105 -60.67 -54.37 46.12 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.304 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.436 ' CG2' ' N ' ' A' ' 43' ' ' LEU . 1.0 OUTLIER -54.27 -48.9 66.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.002 -177.601 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.436 ' N ' ' CG2' ' A' ' 42' ' ' ILE . 20.6 tp -64.4 -41.9 96.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.386 -178.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -59.45 -36.24 75.57 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -71.18 -51.45 24.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.823 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.6 pp -123.67 125.34 44.61 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.109 0.48 . . . . 0.0 110.707 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -173.95 -43.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.251 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -172.48 67.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.263 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 68.2 mttm 55.43 38.55 30.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.411 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 34.8 t -63.35 -48.07 79.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.806 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 80.0 mt -48.69 -39.1 10.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.926 0.393 . . . . 0.0 109.989 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.517 ' CE2' ' OE2' ' A' ' 56' ' ' GLU . 93.3 t80 -70.98 -29.56 65.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.314 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.515 ' O ' ' CD2' ' A' ' 57' ' ' HIS . 90.2 mtt-85 -69.12 -44.17 72.93 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.125 0.488 . . . . 0.0 110.388 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.524 ' CB ' HH21 ' B' ' 45' ' ' ARG . 58.2 m-85 -70.94 -40.68 71.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.804 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -65.75 -39.27 90.91 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.744 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.517 ' OE2' ' CE2' ' A' ' 52' ' ' TYR . 12.5 pt-20 -76.47 -40.43 50.42 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.902 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.515 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 6.9 m-70 -60.98 -52.26 65.75 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.487 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.606 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.543 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 . . . . . 0 CA--C 1.528 0.102 0 CA-C-O 120.475 0.179 . . . . 0.0 110.682 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -50.7 -33.04 38.47 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.407 2.072 . . . . 0.0 111.309 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.454 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 17.7 tp -61.13 -51.2 70.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.064 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.75 -42.42 97.38 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 91.6 t -61.67 -34.91 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -61.37 -40.41 94.2 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.94 -50.98 68.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.07 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 4.3 p -60.17 -53.11 61.64 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 8.8 tp -60.16 -38.48 77.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.993 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 69.2 mt -64.41 -40.3 88.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.029 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.8 -52.31 49.31 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 48.4 mm -56.36 -43.38 77.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.971 0.415 . . . . 0.0 110.034 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 11.4 tp -62.12 -36.1 80.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.654 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' HIS . . . . . 0.607 ' NE2' ' NE2' ' C' ' 37' ' ' HIS . 18.8 t60 -67.96 -54.43 18.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.942 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 40.2 tp -62.68 -49.94 73.11 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.63 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' B' ' 39' ' ' ILE . 15.8 mm -62.29 -44.03 98.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.513 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 43.8 tp -59.17 -39.9 83.95 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.534 -0.466 . . . . 0.0 109.877 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 21.8 t-105 -63.47 -56.28 17.38 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.413 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 94.6 mt -55.41 -51.57 55.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.141 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 mt -60.21 -44.82 94.83 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.216 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -58.71 -37.82 76.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.805 0.336 . . . . 0.0 110.657 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.524 HH21 ' CB ' ' A' ' 54' ' ' PHE . 61.8 ttt85 -68.93 -48.34 63.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.067 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.416 HD23 ' HB3' ' B' ' 45' ' ' ARG . 0.1 OUTLIER -118.46 111.8 19.12 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 120.974 0.416 . . . . 0.0 110.371 179.503 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -175.46 87.79 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.185 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 48.8 t80 58.43 60.41 2.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.462 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp 54.76 47.88 21.43 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.522 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 6.5 t -62.93 -49.82 73.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.859 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 10.9 mt -48.55 -40.82 11.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.704 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -71.34 -28.69 64.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.53 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -69.38 -43.51 73.37 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.606 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -73.47 -44.58 57.7 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.938 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -62.93 -40.08 96.53 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.513 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -77.49 -37.32 51.42 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.549 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -58.63 -48.19 81.87 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.348 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.32 -33.07 84.99 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -81.89 -72.36 0.44 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 63.4 tttm . . . . . 0 C--N 1.331 -0.209 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.379 -179.896 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 29.6 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -159.96 71.3 3.14 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.856 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -51.26 -30.96 35.19 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.446 2.097 . . . . 0.0 111.273 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 12.0 tp -61.02 -52.04 66.68 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.906 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 27' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' C' ' 30' ' ' ALA . . . -60.27 -46.59 89.31 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.019 178.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 76.5 t -57.15 -47.27 84.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.79 -42.2 57.85 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 30' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' C' ' 27' ' ' ALA . . . -59.13 -49.58 77.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.919 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 1.1 p -57.8 -50.94 71.59 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.283 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 22.1 mm -61.79 -29.57 46.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.65 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 2.3 mm -68.18 -41.35 83.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.35 -52.64 25.61 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.574 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 48.1 mm -60.88 -43.98 96.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.887 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 12.5 tp -63.93 -40.67 96.98 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 37' ' ' HIS . . . . . 0.607 ' NE2' ' NE2' ' B' ' 37' ' ' HIS . 57.1 t60 -60.95 -48.66 80.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.88 0.371 . . . . 0.0 111.173 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 38' ' ' LEU . . . . . 0.439 HD11 HD11 ' C' ' 42' ' ' ILE . 29.6 tp -65.05 -50.8 64.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.106 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 4.3 mm -60.21 -47.52 91.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.389 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 40' ' ' LEU . . . . . 0.407 ' O ' ' CB ' ' C' ' 44' ' ' ASP . 3.1 mm? -64.58 -36.95 85.9 Favored 'General case' 0 C--O 1.22 -0.476 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.036 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 41' ' ' TRP . . . . . 0.458 ' CZ3' ' CZ2' ' D' ' 41' ' ' TRP . 14.2 t-105 -60.47 -53.95 51.41 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.141 0.495 . . . . 0.0 111.257 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 42' ' ' ILE . . . . . 0.439 HD11 HD11 ' C' ' 38' ' ' LEU . 90.4 mt -66.85 -56.41 14.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.052 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.491 ' O ' HD23 ' C' ' 43' ' ' LEU . 0.6 OUTLIER -56.43 -48.19 77.52 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.642 -178.62 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 44' ' ' ASP . . . . . 0.407 ' CB ' ' O ' ' C' ' 40' ' ' LEU . 28.9 t70 -53.8 -45.7 70.84 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 60.3 ttt85 -58.22 -52.19 66.61 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.069 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 9.8 mt -72.28 -76.87 0.1 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.511 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 47' ' ' PHE . . . . . 0.492 ' CG ' ' N ' ' C' ' 48' ' ' PHE . 37.4 t80 52.4 -177.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.176 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 48' ' ' PHE . . . . . 0.492 ' N ' ' CG ' ' C' ' 47' ' ' PHE . 39.0 m-85 -56.24 -41.36 75.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.954 0.407 . . . . 0.0 110.34 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -171.91 48.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.102 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 5.1 t -69.95 -45.88 66.5 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.65 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 64.5 mt -44.48 -55.68 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -74.96 -34.91 62.1 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -71.24 -49.99 37.59 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.819 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -66.04 -43.85 86.32 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.232 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -63.22 -36.64 84.33 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.702 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 . . . . . 0 CA--C 1.536 0.438 0 C-N-CA 120.384 -0.527 . . . . 0.0 110.879 179.401 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo . . . . . 0 N--CA 1.49 1.308 0 N-CA-C 110.8 -0.5 . . . . 0.0 110.8 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 26' ' ' LEU . . . . . 0.453 ' O ' ' HB3' ' D' ' 29' ' ' ALA . 14.1 tp -60.29 -51.96 67.3 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.509 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.46 -47.9 82.5 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 94.4 t -58.47 -33.73 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.197 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' D' ' 26' ' ' LEU . . . -64.43 -35.77 81.99 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.41 -39.09 81.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.392 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.96 -53.44 26.14 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.28 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 32' ' ' ILE . . . . . 0.415 HG23 ' N ' ' D' ' 33' ' ' ILE . 16.8 tt -62.65 -40.12 87.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.67 -178.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 33' ' ' ILE . . . . . 0.418 HG21 HD13 ' D' ' 33' ' ' ILE . 9.2 tt -70.05 -30.7 44.94 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 C-N-CA 120.179 -0.608 . . . . 0.0 110.282 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.68 -53.3 16.67 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 2.1 mp -60.87 -43.92 96.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 11.9 tp -62.31 -34.55 76.82 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.447 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -66.09 -49.99 65.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.655 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 50.2 tp -60.33 -50.94 71.64 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.045 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 4.9 mm -60.26 -43.44 93.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 33.6 mt -61.56 -40.88 96.31 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.272 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 41' ' ' TRP . . . . . 0.458 ' CZ2' ' CZ3' ' C' ' 41' ' ' TRP . 40.4 t-105 -62.52 -53.96 47.0 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.64 0.257 . . . . 0.0 111.451 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 66.1 mt -63.49 -54.25 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -177.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' D' ' 46' ' ' LEU . 54.5 tp -61.57 -45.39 94.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.406 -178.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 44' ' ' ASP . . . . . 0.439 ' O ' ' CB ' ' D' ' 50' ' ' SER . 11.6 t70 -64.04 -32.39 73.93 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.466 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 56.2 ttt-85 -69.07 -56.31 8.12 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.262 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 46' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' D' ' 43' ' ' LEU . 0.1 OUTLIER -105.76 -167.39 1.31 Allowed 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.588 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 9.9 t80 72.86 124.96 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.78 0.324 . . . . 0.0 110.291 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 48' ' ' PHE . . . . . 0.436 ' CD2' ' O ' ' D' ' 48' ' ' PHE . 40.7 t80 59.74 20.01 8.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.424 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt 47.53 66.92 0.9 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.401 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 50' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 45.4 t -67.75 -46.57 71.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.005 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 51' ' ' ILE . . . . . 0.4 ' H ' HG13 ' D' ' 51' ' ' ILE . 55.8 mt -45.88 -40.27 3.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.84 0.352 . . . . 0.0 110.401 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -72.42 -32.91 66.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.051 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -72.01 -50.18 30.79 Favored 'General case' 0 C--N 1.335 -0.038 0 CA-C-O 120.911 0.386 . . . . 0.0 110.74 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -64.49 -42.4 95.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.25 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -63.69 -40.38 96.65 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.08 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -75.86 -20.8 57.82 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.452 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -74.13 -50.32 19.95 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.525 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.14 -27.72 73.55 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 6.4 tp -80.69 43.0 0.65 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.818 0.342 . . . . 0.0 110.421 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.579 -179.979 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 31.4 Cg_endo . . . . . 0 N--CA 1.491 1.335 0 N-CA-C 110.636 -0.563 . . . . 0.0 110.636 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.5 tp -69.39 -44.55 71.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.982 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.2 -55.91 18.36 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.314 0.578 . . . . 0.0 110.015 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.2 t -55.09 -43.61 70.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.109 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 25' ' ' PRO . . . -53.61 -45.44 70.07 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.45 -48.11 77.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.873 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.79 -43.57 69.4 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 120.438 -0.505 . . . . 0.0 109.891 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.6 mt -62.5 -39.72 85.52 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.052 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 93.6 mt -66.58 -41.97 89.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.466 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.89 -51.57 33.93 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.047 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.52 HG23 ' N ' ' A' ' 36' ' ' LEU . 14.9 tt -62.65 -43.56 98.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.34 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.52 ' N ' HG23 ' A' ' 35' ' ' ILE . 9.9 tp -63.96 -33.57 76.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.301 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -66.73 -53.54 32.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.829 0.347 . . . . 0.0 111.217 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.2 tp -59.85 -48.43 81.73 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.975 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.4 mm -61.47 -41.83 91.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.795 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.2 mt -59.98 -45.28 93.24 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.288 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 15.4 t-105 -61.52 -57.7 11.07 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.608 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 94.6 mt -56.88 -56.31 15.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -177.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 47' ' ' PHE . 24.1 tp -61.45 -51.29 69.33 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.208 -178.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -47.36 -40.54 17.62 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.445 ' NH2' ' CB ' ' D' ' 54' ' ' PHE . 61.4 ttt180 -64.37 -52.43 58.32 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.143 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.48 33.62 1.98 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.884 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.457 ' N ' ' O ' ' A' ' 43' ' ' LEU . 66.1 t80 -85.26 84.92 7.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.772 0.32 . . . . 0.0 110.571 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.5 t80 56.55 60.86 2.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.45 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 51.29 27.35 3.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.491 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.9 t -49.68 -30.42 9.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.565 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.1 mt -50.01 -41.26 17.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.954 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -73.55 -28.36 61.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.142 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.499 ' N ' ' CD ' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -69.98 -48.77 56.91 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.309 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.467 ' CB ' ' NH2' ' B' ' 45' ' ' ARG . 53.6 m-85 -71.23 -37.24 72.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.95 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -68.31 -39.13 82.1 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.734 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -77.38 -40.94 42.06 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.102 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -64.07 -47.37 80.39 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.751 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.854 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.916 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.682 0.277 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.04 -31.34 53.4 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.437 2.092 . . . . 0.0 111.278 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.411 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 16.5 tp -60.2 -51.2 70.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.903 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.27 -45.45 93.27 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 89.1 t -60.04 -36.55 68.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.094 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -61.5 -35.75 78.57 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.91 -45.15 75.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.325 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 8.0 p -66.01 -52.64 47.5 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.524 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.479 HG23 ' N ' ' B' ' 33' ' ' ILE . 20.4 tt -61.45 -42.32 93.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -178.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.479 ' N ' HG23 ' B' ' 32' ' ' ILE . 13.9 tt -69.38 -29.64 42.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 C-N-CA 119.794 -0.763 . . . . 0.0 110.232 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.98 -51.68 38.02 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.539 HG22 HD12 ' B' ' 39' ' ' ILE . 46.6 mm -61.26 -38.12 79.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 120.603 -0.439 . . . . 0.0 109.888 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 10.2 tp -62.55 -41.77 99.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.694 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -66.84 -51.71 52.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.888 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 39.9 tp -60.99 -49.44 77.45 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.284 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.539 HD12 HG22 ' B' ' 35' ' ' ILE . 26.7 mt -61.86 -42.08 93.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.465 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 56.3 tp -60.92 -41.25 95.79 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.271 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 41.3 t-105 -63.82 -57.77 8.85 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.785 0.326 . . . . 0.0 111.789 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 68.7 mt -59.19 -53.44 47.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.364 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.663 HD13 ' C ' ' B' ' 43' ' ' LEU . 3.1 tm? -55.94 -50.87 69.58 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.746 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -53.15 -45.43 68.43 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.945 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.467 ' NH2' ' CB ' ' A' ' 54' ' ' PHE . 65.8 ttt180 -61.43 -56.68 17.57 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.349 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.439 HD23 ' HB3' ' B' ' 45' ' ' ARG . 0.1 OUTLIER -108.61 130.99 55.31 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.05 0.452 . . . . 0.0 110.315 179.62 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.525 ' O ' ' CD2' ' B' ' 48' ' ' PHE . 63.7 t80 -174.04 -64.51 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.124 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 48' ' ' PHE . . . . . 0.525 ' CD2' ' O ' ' B' ' 47' ' ' PHE . 8.4 m-85 -161.25 83.65 0.64 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.813 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 64.8 mttp 53.86 27.89 7.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.535 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 8.0 t -57.67 -51.99 67.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.726 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 89.0 mt -52.92 -41.81 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.765 0.317 . . . . 0.0 110.685 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.506 ' CD2' ' OE2' ' B' ' 56' ' ' GLU . 81.7 t80 -72.46 -30.97 65.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.634 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -72.0 -46.14 58.3 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.971 0.415 . . . . 0.0 110.817 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -71.45 -38.05 71.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.99 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -70.77 -38.08 73.4 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.717 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 56' ' ' GLU . . . . . 0.506 ' OE2' ' CD2' ' B' ' 52' ' ' TYR . 10.4 pt-20 -76.16 -38.46 56.63 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.691 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -66.76 -45.64 77.89 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.279 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.32 -27.6 69.57 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 5.4 tp -70.14 -67.87 0.46 Allowed 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.786 0.327 . . . . 0.0 110.481 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.552 -179.939 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 54.9 68.62 2.47 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.739 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.22 -35.68 53.57 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.486 2.124 . . . . 0.0 111.466 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 26' ' ' LEU . . . . . 0.518 ' O ' ' HB3' ' C' ' 29' ' ' ALA . 14.2 tp -60.12 -51.11 71.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.859 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.53 -43.63 75.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.747 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 90.2 t -60.99 -32.03 51.42 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 29' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' C' ' 26' ' ' LEU . . . -64.45 -38.3 90.54 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.96 -51.89 59.3 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.058 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 5.3 t -60.57 -51.45 69.37 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.52 -0.472 . . . . 0.0 112.146 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 9.9 tp -61.84 -30.93 49.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.39 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 12.1 mt -67.0 -41.53 87.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 120.627 -0.429 . . . . 0.0 109.997 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.48 -51.22 32.72 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.933 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 35' ' ' ILE . . . . . 0.525 ' O ' HD13 ' C' ' 35' ' ' ILE . 0.2 OUTLIER -59.92 -45.61 94.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-O 121.378 0.608 . . . . 0.0 109.663 -179.678 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.454 ' N ' ' CG2' ' C' ' 35' ' ' ILE . 53.6 tp -60.34 -40.47 90.8 Favored 'General case' 0 C--O 1.215 -0.746 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.129 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -59.27 -52.41 65.79 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.158 0.504 . . . . 0.0 111.017 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 16.7 tp -56.38 -50.14 72.41 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.407 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 1.2 mp -65.49 -31.65 54.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.853 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 40' ' ' LEU . . . . . 0.489 ' O ' HD13 ' C' ' 40' ' ' LEU . 0.2 OUTLIER -64.38 -47.96 77.28 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.719 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 15.9 t-105 -63.84 -56.41 15.6 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 120.804 -0.359 . . . . 0.0 111.511 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 96.2 mt -56.84 -55.41 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.416 -0.514 . . . . 0.0 112.003 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.654 ' C ' HD13 ' C' ' 43' ' ' LEU . 3.0 tm? -61.73 -50.9 70.57 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.939 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 44' ' ' ASP . . . . . 0.513 ' OD2' ' NH1' ' D' ' 45' ' ' ARG . 25.3 t70 -47.14 -43.32 20.69 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.047 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 60.9 ttt-85 -64.15 -52.26 59.91 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.576 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.15 114.94 26.69 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.595 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -174.22 102.36 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.416 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 48' ' ' PHE . . . . . 0.402 ' O ' ' CD2' ' C' ' 48' ' ' PHE . 51.6 t80 44.37 49.87 8.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.581 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? 57.16 40.27 28.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.306 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 50' ' ' SER . . . . . 0.42 ' HA ' ' HE ' ' C' ' 53' ' ' ARG . 4.6 t -62.39 -34.55 76.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.318 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 51' ' ' ILE . . . . . 0.401 HG13 ' H ' ' C' ' 51' ' ' ILE . 60.6 mt -47.34 -41.01 6.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.21 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 52' ' ' TYR . . . . . 0.478 ' CZ ' ' OE1' ' C' ' 56' ' ' GLU . 89.2 t80 -72.37 -29.41 63.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.519 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 53' ' ' ARG . . . . . 0.42 ' HE ' ' HA ' ' C' ' 50' ' ' SER . 73.1 mtm180 -71.38 -48.0 52.76 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.648 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -68.4 -41.84 79.91 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.397 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -64.44 -36.92 85.72 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.824 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 56' ' ' GLU . . . . . 0.478 ' OE1' ' CZ ' ' C' ' 52' ' ' TYR . 64.8 tt0 . . . . . 0 CA--C 1.536 0.405 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.784 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo . . . . . 0 N--CA 1.493 1.462 0 N-CA-C 110.725 -0.529 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 26' ' ' LEU . . . . . 0.4 ' O ' ' HB3' ' D' ' 29' ' ' ALA . 16.6 tp -63.3 -50.39 70.25 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.0 -47.3 85.71 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 71.7 t -60.11 -32.41 50.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.324 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' D' ' 26' ' ' LEU . . . -66.96 -32.9 74.45 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.05 -44.45 69.14 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.726 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 31' ' ' SER . . . . . 0.446 ' OG ' ' CD1' ' C' ' 26' ' ' LEU . 2.3 m -68.17 -45.01 74.64 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.733 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 32' ' ' ILE . . . . . 0.402 HD13 HG21 ' D' ' 32' ' ' ILE . 11.5 tt -68.16 -41.47 84.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.553 -178.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 13.0 tt -70.02 -34.67 60.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.485 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.07 -51.64 22.36 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.674 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 3.5 tp -64.02 -37.48 79.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.76 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 50.3 tp -64.07 -38.33 90.67 Favored 'General case' 0 CA--C 1.521 -0.136 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -65.95 -43.39 88.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.075 0.464 . . . . 0.0 109.86 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 mt -59.87 -51.36 70.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.778 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 74.3 mt -63.26 -40.48 89.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.209 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 7.6 tt -63.16 -45.22 92.85 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.981 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 31.8 t-105 -65.71 -52.0 54.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.89 0.376 . . . . 0.0 111.928 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 74.6 mt -63.29 -53.46 45.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.874 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 26.6 tp -61.87 -45.78 92.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.817 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 44' ' ' ASP . . . . . 0.464 ' O ' ' CB ' ' D' ' 50' ' ' SER . 27.5 t70 -55.66 -43.19 76.06 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.611 -0.436 . . . . 0.0 109.925 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 45' ' ' ARG . . . . . 0.513 ' NH1' ' OD2' ' C' ' 44' ' ' ASP . 67.5 ttt180 -61.97 -51.38 68.31 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.596 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 46' ' ' LEU . . . . . 0.412 HD23 ' HB3' ' D' ' 45' ' ' ARG . 0.1 OUTLIER -124.1 124.69 43.07 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 120.95 0.405 . . . . 0.0 110.207 179.177 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -174.61 -43.8 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.513 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 48' ' ' PHE . . . . . 0.428 ' CD2' ' O ' ' D' ' 48' ' ' PHE . 72.4 t80 -165.81 63.93 0.11 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.307 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? 54.52 40.19 31.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.182 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 50' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 7.4 t -62.15 -51.06 69.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.086 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 78.0 mt -48.51 -35.71 6.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.183 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 52' ' ' TYR . . . . . 0.501 ' CE2' ' OE2' ' D' ' 56' ' ' GLU . 90.6 t80 -71.44 -30.13 65.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.101 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -70.35 -43.18 70.75 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.974 0.416 . . . . 0.0 110.452 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 54' ' ' PHE . . . . . 0.445 ' CB ' ' NH2' ' A' ' 45' ' ' ARG . 72.9 m-85 -71.6 -39.89 70.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.727 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -66.11 -40.95 91.11 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.477 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 56' ' ' GLU . . . . . 0.501 ' OE2' ' CE2' ' D' ' 52' ' ' TYR . 12.7 pt-20 -74.41 -38.33 63.12 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.454 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 -61.1 -46.15 91.81 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.119 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.46 -26.95 71.12 Favored Glycine 0 N--CA 1.462 0.406 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.16 75.18 1.28 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 53.2 tttp . . . . . 0 C--N 1.332 -0.158 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.48 -179.709 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo . . . . . 0 N--CA 1.494 1.548 0 N-CA-C 111.306 -0.305 . . . . 0.0 111.306 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.468 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 20.2 tp -62.88 -48.28 79.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.97 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.55 -45.34 92.09 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 97.4 t -63.01 -28.32 44.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.379 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 26' ' ' LEU . . . -68.6 -36.43 78.68 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.35 -45.51 65.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.281 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.8 p -68.63 -44.58 73.89 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.243 -0.583 . . . . 0.0 111.754 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.421 HG23 ' N ' ' A' ' 33' ' ' ILE . 10.3 tp -68.48 -40.44 82.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.6 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.421 ' N ' HG23 ' A' ' 32' ' ' ILE . 14.1 tt -71.27 -33.56 51.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.607 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.45 -51.64 20.5 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.35 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.417 HG23 ' N ' ' A' ' 36' ' ' LEU . 10.4 tp -63.31 -38.32 81.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.553 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.417 ' N ' HG23 ' A' ' 35' ' ' ILE . 56.1 tp -65.9 -32.79 74.5 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.888 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -67.81 -52.07 41.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.833 0.349 . . . . 0.0 110.602 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 30.4 tp -61.14 -52.17 65.97 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.426 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 74.1 mt -61.72 -42.25 93.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.979 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 34.8 tp -60.91 -41.93 97.06 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.343 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.4 t-105 -63.9 -59.53 4.4 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 120.973 0.416 . . . . 0.0 111.553 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 96.3 mt -56.59 -54.41 29.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.606 -177.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.519 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.7 OUTLIER -60.24 -45.47 93.11 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.691 -179.037 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -51.02 -41.38 59.77 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -65.04 -50.48 66.05 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.134 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.475 ' O ' ' O ' ' A' ' 43' ' ' LEU . 0.7 OUTLIER -92.63 131.29 37.85 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.074 -179.434 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.436 ' CD2' ' N ' ' A' ' 48' ' ' PHE . 73.6 t80 -163.55 -94.97 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.858 0.361 . . . . 0.0 110.564 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.436 ' N ' ' CD2' ' A' ' 47' ' ' PHE . 57.6 t80 -132.6 57.8 1.78 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.821 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.2 tttt 71.14 25.67 3.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.721 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.9 t -59.21 -43.19 92.29 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.571 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 56.9 mt -45.04 -41.65 2.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.604 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -74.11 -27.94 61.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.023 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.532 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 90.9 mtt-85 -71.2 -48.57 50.77 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.598 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -71.5 -41.18 69.59 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.052 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -67.53 -38.69 84.59 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.731 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.542 ' OE2' ' CD2' ' A' ' 57' ' ' HIS . 1.8 pp20? -76.65 -42.31 42.44 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.067 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.542 ' CD2' ' OE2' ' A' ' 56' ' ' GLU . 24.9 m80 -61.11 -45.66 93.77 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.552 -0.459 . . . . 0.0 109.907 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.982 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 -179.915 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.731 0.301 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -50.74 -36.68 52.25 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.618 2.212 . . . . 0.0 111.537 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.42 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 15.0 tp -60.6 -52.38 65.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.798 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.53 -42.99 93.53 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 93.8 t -62.51 -33.89 61.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -63.74 -34.49 78.0 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.28 -47.01 63.16 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.397 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 6.3 p -65.21 -48.13 74.44 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.234 -0.586 . . . . 0.0 111.524 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.51 HG23 ' N ' ' B' ' 33' ' ' ILE . 10.4 tp -65.55 -44.32 93.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -178.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.51 ' N ' HG23 ' B' ' 32' ' ' ILE . 15.1 tt -66.67 -33.49 63.79 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.066 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.248 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.48 -45.3 86.52 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 91.2 mt -61.57 -44.54 98.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 14.1 tp -61.06 -36.1 78.7 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.312 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' HIS . . . . . 0.585 ' NE2' ' CE1' ' C' ' 37' ' ' HIS . 7.5 t-80 -67.34 -50.33 60.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.782 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 22.7 tp -63.66 -52.43 60.78 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.778 -178.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.431 ' N ' ' CD1' ' B' ' 39' ' ' ILE . 1.4 mp -61.15 -43.03 95.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.071 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 43.0 tp -61.21 -37.5 83.25 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.311 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 32.5 t-105 -63.3 -56.69 14.34 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.662 0.268 . . . . 0.0 111.291 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 68.2 mt -60.92 -53.46 48.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 C-N-CA 120.231 -0.588 . . . . 0.0 111.714 -178.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.539 ' O ' HD23 ' B' ' 43' ' ' LEU . 0.9 OUTLIER -57.33 -45.02 84.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.94 -179.021 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -58.97 -45.5 90.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.833 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 57.8 ttt85 -59.74 -52.75 64.14 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 120.181 -0.607 . . . . 0.0 111.059 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.23 112.13 24.11 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.953 0.406 . . . . 0.0 110.166 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -165.78 79.23 0.28 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.252 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 34.0 t80 62.11 55.28 2.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.745 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 74.7 tttt 60.24 50.15 6.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.818 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 5.8 t -70.71 -44.42 66.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.602 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 64.5 mt -44.38 -35.87 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.656 0.265 . . . . 0.0 111.228 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -70.34 -28.19 64.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.482 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 78.3 mtt85 -68.64 -42.39 78.07 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.378 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -72.73 -42.23 64.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.783 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -63.93 -39.88 95.18 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.632 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -76.72 -38.36 54.44 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.697 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -59.56 -44.82 93.17 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.656 -0.418 . . . . 0.0 109.926 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.98 -24.03 53.22 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 59' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' B' ' 60' ' ' LYS . 1.6 tt -131.0 52.01 2.09 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 -178.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 60' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' B' ' 59' ' ' LEU . 16.2 ptpt . . . . . 0 N--CA 1.474 0.751 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.524 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 37.3 t . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 46.15 75.3 0.67 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.709 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -51.55 -33.48 48.15 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.483 2.122 . . . . 0.0 111.432 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.15 -47.88 82.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.739 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.44 -39.18 60.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.726 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 80.7 t -59.78 -44.29 93.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.01 -33.51 72.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.405 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.14 -44.01 80.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.209 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 8.0 p -67.51 -47.54 69.67 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 18.6 tt -66.52 -38.19 81.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.979 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 70.0 mt -68.13 -42.22 84.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.005 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.7 -50.04 45.24 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 121.062 -0.59 . . . . 0.0 111.677 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.71 -43.53 98.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.89 0.376 . . . . 0.0 110.257 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 56.8 tp -63.55 -37.98 89.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.248 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 37' ' ' HIS . . . . . 0.585 ' CE1' ' NE2' ' B' ' 37' ' ' HIS . 12.3 t-80 -66.09 -48.4 71.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.808 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 41.3 tp -67.07 -55.23 15.2 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.84 0.352 . . . . 0.0 111.697 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 39' ' ' ILE . . . . . 0.427 ' CD1' ' N ' ' C' ' 39' ' ' ILE . 1.3 mp -59.35 -45.46 93.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.487 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 44.7 tp -62.03 -41.89 98.59 Favored 'General case' 0 C--O 1.218 -0.564 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.983 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 16.0 t-105 -57.16 -59.53 4.96 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 120.812 0.339 . . . . 0.0 111.488 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 34.8 mt -62.88 -57.1 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.344 -0.542 . . . . 0.0 112.315 -177.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.48 ' O ' HD23 ' C' ' 43' ' ' LEU . 0.6 OUTLIER -57.17 -51.84 67.72 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.519 -177.986 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -53.29 -41.89 66.05 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 18.5 tpt85 -58.39 -52.35 65.97 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.729 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 46' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' C' ' 48' ' ' PHE . 1.9 mt -82.25 -72.7 0.43 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.0 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 82.2 t80 57.76 -77.91 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.314 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 48' ' ' PHE . . . . . 0.537 ' N ' ' O ' ' C' ' 46' ' ' LEU . 84.7 t80 -158.84 -40.19 0.06 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.065 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -173.59 31.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.089 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 50' ' ' SER . . . . . 0.429 ' OG ' ' CD1' ' C' ' 54' ' ' PHE . 35.8 t -63.73 -39.78 95.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.139 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 40.3 mt -46.6 -50.86 5.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.613 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -73.6 -32.18 63.97 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -72.03 -49.76 34.12 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.644 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 54' ' ' PHE . . . . . 0.429 ' CD1' ' OG ' ' C' ' 50' ' ' SER . 10.8 m-85 -66.44 -42.17 88.06 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.29 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -64.56 -37.67 88.35 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.903 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 . . . . . 0 CA--C 1.536 0.434 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.465 179.399 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 25' ' ' PRO . . . . . 0.404 ' O ' ' HB2' ' D' ' 29' ' ' ALA . 64.0 Cg_exo . . . . . 0 N--CA 1.488 1.173 0 N-CA-C 110.405 -0.652 . . . . 0.0 110.405 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 16.8 tp -65.18 -45.28 85.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.321 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.75 -61.09 2.65 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 87.0 t -50.44 -43.36 22.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.734 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' D' ' 25' ' ' PRO . . . -53.57 -45.3 69.89 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.015 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.83 -40.87 98.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.984 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 2.5 t -61.44 -52.04 66.22 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.613 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 14.8 tt -64.93 -30.93 51.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.623 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 39.3 mt -66.35 -44.24 90.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.927 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.49 -50.53 43.02 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.982 -0.628 . . . . 0.0 111.975 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 35' ' ' ILE . . . . . 0.402 ' CG2' ' N ' ' D' ' 36' ' ' LEU . 4.5 tt -58.22 -43.15 85.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.001 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.402 ' N ' ' CG2' ' D' ' 35' ' ' ILE . 7.4 tp -69.22 -27.64 65.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.503 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -67.78 -56.04 10.73 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.187 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 3.5 pp -68.87 -34.69 75.87 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.854 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 52.9 mt -62.77 -45.12 99.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 120.311 -0.556 . . . . 0.0 109.778 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 36.8 mt -64.01 -41.55 97.42 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.471 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 9.2 t-105 -59.96 -58.0 10.43 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.332 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 79.0 mt -59.92 -53.5 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.406 -177.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 28.8 tp -59.96 -44.14 94.61 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.82 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 44' ' ' ASP . . . . . 0.436 ' O ' ' CB ' ' D' ' 50' ' ' SER . 26.6 t70 -55.95 -46.15 78.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.126 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 56.3 ttt85 -60.49 -50.67 72.65 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.868 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 pp -125.4 127.93 47.34 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.145 0.498 . . . . 0.0 110.796 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -174.77 -42.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.092 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -171.66 63.46 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.234 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 55.7 mttm 58.23 37.81 26.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.226 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 50' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 10.8 t -59.29 -50.29 74.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.835 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 68.1 mt -50.56 -41.44 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.607 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -72.2 -31.38 65.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.084 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -70.96 -47.04 61.21 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.001 0.429 . . . . 0.0 110.601 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -69.71 -36.32 75.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.676 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -68.92 -40.74 78.89 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.5 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -75.78 -33.44 60.18 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.481 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -66.43 -47.34 73.5 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.694 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.23 -36.37 93.32 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 110.641 -0.983 . . . . 0.0 110.641 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 mp -74.9 -67.43 0.64 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt . . . . . 0 N--CA 1.462 0.14 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.397 179.753 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo . . . . . 0 N--CA 1.492 1.424 0 N-CA-C 111.025 -0.413 . . . . 0.0 111.025 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.5 tp -64.23 -48.72 74.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.041 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -65.32 -50.23 66.44 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.296 0.57 . . . . 0.0 109.739 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 82.3 t -57.95 -44.67 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.94 -36.52 67.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.514 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -63.04 -51.29 67.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.536 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.3 p -56.53 -50.07 72.92 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.912 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.6 mm -61.18 -32.16 52.12 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.99 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.2 mm -69.75 -40.13 78.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.223 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.43 -53.13 26.65 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.311 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 40.9 mm -62.12 -44.03 98.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 C-N-CA 120.461 -0.495 . . . . 0.0 110.306 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 47.4 tp -57.84 -47.92 81.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.568 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.474 ' C ' ' ND1' ' A' ' 37' ' ' HIS . 5.0 t-80 -60.16 -47.91 83.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.085 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 42.7 tp -55.66 -51.91 65.63 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.182 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.5 tt -64.17 -32.85 59.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.456 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.501 HD13 ' O ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -63.14 -47.96 80.53 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.419 -179.254 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 14.2 t-105 -63.44 -55.27 25.55 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 120.614 0.245 . . . . 0.0 111.551 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 88.8 mt -58.91 -52.74 56.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.34 -0.544 . . . . 0.0 112.124 -177.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.423 HD11 ' CD1' ' A' ' 47' ' ' PHE . 22.6 tp -62.43 -44.08 97.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.391 -178.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -57.01 -43.37 81.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.764 0.316 . . . . 0.0 110.171 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.516 ' NH1' HD11 ' A' ' 51' ' ' ILE . 57.0 ttt-85 -63.95 -48.67 75.58 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.471 -0.491 . . . . 0.0 110.725 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.6 pp -127.71 127.33 43.5 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.031 0.443 . . . . 0.0 110.8 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.423 ' CD1' HD11 ' A' ' 43' ' ' LEU . 61.4 t80 -174.03 -39.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.233 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.523 ' O ' ' NH1' ' A' ' 53' ' ' ARG . 63.8 t80 -172.08 61.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.213 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm 60.13 37.66 20.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.162 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.0 t -61.7 -47.7 84.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.752 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.516 HD11 ' NH1' ' A' ' 45' ' ' ARG . 16.2 mt -49.44 -37.2 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.493 ' CE2' ' OE2' ' A' ' 56' ' ' GLU . 92.5 t80 -72.69 -30.16 63.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.241 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.523 ' NH1' ' O ' ' A' ' 48' ' ' PHE . 93.9 mtm-85 -71.77 -46.78 57.25 Favored 'General case' 0 N--CA 1.461 0.102 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.54 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -70.47 -37.8 74.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.863 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -69.76 -38.85 76.92 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.696 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.493 ' OE2' ' CE2' ' A' ' 52' ' ' TYR . 12.2 pt-20 -76.57 -38.85 54.29 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.91 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.523 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 6.8 m-70 -66.45 -42.63 87.33 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.738 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.909 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -179.924 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 . . . . . 0 CA--C 1.537 0.466 0 CA-C-O 119.905 -0.093 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -48.56 -36.7 32.39 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.873 1.715 . . . . 0.0 111.723 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.546 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 17.6 tp -61.14 -51.22 70.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.222 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.37 -45.52 84.35 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 84.4 t -59.48 -32.82 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.557 -0.747 . . . . 0.0 108.999 178.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -62.39 -37.43 85.73 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.05 -49.99 65.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.831 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 4.8 t -60.07 -50.56 73.24 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 20.4 tt -63.65 -35.04 71.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.36 -178.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 45.7 mt -69.05 -37.85 77.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.392 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.77 -56.2 8.62 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.506 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.479 HD12 ' N ' ' B' ' 36' ' ' LEU . 2.3 pp -56.44 -40.07 65.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.387 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.479 ' N ' HD12 ' B' ' 35' ' ' ILE . 54.7 tp -65.34 -34.41 78.26 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.388 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -66.45 -53.54 34.28 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.449 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 29.7 tp -66.32 -50.16 64.58 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.649 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 74.2 mt -59.74 -44.88 94.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.663 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 49.7 tp -64.04 -37.61 88.06 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.032 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' TRP . . . . . 0.45 ' CZ3' ' CZ2' ' C' ' 41' ' ' TRP . 23.1 t-105 -59.66 -52.32 66.01 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.543 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.6 mt -71.9 -56.83 8.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 120.079 -0.649 . . . . 0.0 111.674 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.498 ' O ' HD23 ' B' ' 43' ' ' LEU . 0.8 OUTLIER -50.67 -46.61 58.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.865 -179.066 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -67.94 -40.92 83.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.761 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 53.5 ttt85 -51.75 -51.83 53.24 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.813 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.72 -82.8 0.25 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.494 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.449 ' O ' ' CD1' ' B' ' 48' ' ' PHE . 60.5 t80 57.51 -87.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.501 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' PHE . . . . . 0.449 ' CD1' ' O ' ' B' ' 47' ' ' PHE . 34.1 m-85 -153.44 86.38 1.21 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.037 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 65.9 mttm 51.76 34.51 13.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.362 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 7.9 t -58.98 -47.07 86.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.405 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 53.4 mt -49.83 -50.8 17.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.909 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -71.41 -32.66 68.67 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.693 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -71.52 -43.74 65.92 Favored 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.017 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -71.41 -39.49 71.09 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.756 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 55' ' ' PHE . . . . . 0.413 ' CD1' ' C ' ' B' ' 55' ' ' PHE . 24.3 t80 -70.2 -39.11 75.38 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.816 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -76.66 -35.91 57.68 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 120.424 -0.511 . . . . 0.0 110.729 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -67.3 -49.19 65.17 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.511 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.94 -28.6 68.9 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 7.8 tp -72.51 -68.92 0.44 Allowed 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.742 0.306 . . . . 0.0 110.527 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 55.4 tttp . . . . . 0 N--CA 1.467 0.375 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.405 179.814 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 13.7 m . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -158.43 72.75 3.86 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.83 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -50.91 -30.52 30.61 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.538 2.158 . . . . 0.0 111.269 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 26' ' ' LEU . . . . . 0.489 ' O ' ' HB3' ' C' ' 29' ' ' ALA . 16.6 tp -55.48 -51.68 66.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.045 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.69 -47.62 85.44 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 99.3 t -59.58 -29.98 43.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 29' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' C' ' 26' ' ' LEU . . . -66.82 -35.61 80.45 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.15 -42.38 76.03 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.337 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 3.9 p -69.9 -46.22 65.91 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.72 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 32' ' ' ILE . . . . . 0.419 HG23 ' N ' ' C' ' 33' ' ' ILE . 10.1 tt -67.66 -40.18 83.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.524 -178.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 33' ' ' ILE . . . . . 0.419 ' N ' HG23 ' C' ' 32' ' ' ILE . 8.0 tt -69.33 -35.17 66.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.502 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.77 -53.24 20.76 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.272 -0.966 . . . . 0.0 110.953 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 96.8 mt -57.86 -42.87 83.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.306 -0.558 . . . . 0.0 109.977 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 15.0 tp -61.83 -39.45 91.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.101 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -61.52 -50.66 71.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.887 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 10.4 mp -60.52 -48.6 81.08 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.403 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 71.8 mt -59.95 -44.72 95.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.133 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.5 mt -62.44 -39.39 93.17 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.336 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 41' ' ' TRP . . . . . 0.45 ' CZ2' ' CZ3' ' B' ' 41' ' ' TRP . 24.3 t-105 -60.52 -57.67 11.76 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 120.89 0.376 . . . . 0.0 111.248 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 72.0 mt -60.64 -56.36 18.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.129 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.469 ' O ' HD23 ' C' ' 43' ' ' LEU . 0.7 OUTLIER -57.42 -50.99 71.24 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.773 -178.451 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -51.23 -42.59 61.09 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -59.07 -53.31 59.83 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.511 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 46' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' C' ' 48' ' ' PHE . 3.4 mt -79.71 -72.45 0.4 Allowed 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.949 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 75.3 t80 50.0 -88.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.272 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 48' ' ' PHE . . . . . 0.503 ' N ' ' O ' ' C' ' 46' ' ' LEU . 55.5 t80 -161.13 89.96 0.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.3 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 74.1 tttt 54.92 22.33 4.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.065 0.459 . . . . 0.0 110.027 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 11.3 t -61.1 -38.68 87.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.078 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 51' ' ' ILE . . . . . 0.404 ' H ' HG13 ' C' ' 51' ' ' ILE . 67.4 mt -48.68 -53.91 5.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.755 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -75.09 -33.6 61.65 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 20.0 mmt85 -69.93 -48.83 56.92 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.837 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -69.93 -39.95 75.81 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.302 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -62.13 -41.33 98.16 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.818 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 . . . . . 0 CA--C 1.535 0.388 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.892 179.506 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo . . . . . 0 N--CA 1.49 1.303 0 N-CA-C 110.693 -0.541 . . . . 0.0 110.693 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 26' ' ' LEU . . . . . 0.402 ' O ' ' HB3' ' D' ' 29' ' ' ALA . 16.4 tp -62.89 -50.55 70.45 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.78 -46.16 88.15 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 92.0 t -59.77 -37.25 70.55 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.343 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' D' ' 26' ' ' LEU . . . -61.37 -37.07 82.03 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.45 -50.11 66.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.773 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 4.0 t -60.78 -51.47 69.19 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 7.3 tp -62.26 -35.71 70.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.582 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 26.5 mt -63.23 -44.58 99.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.736 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.49 -45.5 94.67 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.755 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 88.3 mt -62.39 -43.5 98.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.784 0.326 . . . . 0.0 110.525 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 18.1 tp -65.18 -33.2 75.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.326 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -68.13 -50.65 53.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.897 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 55.9 tp -61.28 -47.93 83.74 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.802 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 95.8 mt -61.91 -43.82 98.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.856 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 40' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' D' ' 40' ' ' LEU . 20.0 mt -59.62 -49.4 77.9 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.452 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 11.9 t-105 -58.41 -58.86 6.66 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.929 0.395 . . . . 0.0 111.705 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 73.1 mt -57.89 -60.4 2.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 27.6 tp -57.18 -46.56 82.7 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.447 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -50.98 -45.98 61.16 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.633 -0.427 . . . . 0.0 109.926 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 45' ' ' ARG . . . . . 0.413 ' O ' ' CG1' ' D' ' 51' ' ' ILE . 70.0 ttt180 -64.56 -56.85 11.35 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 119.914 -0.715 . . . . 0.0 111.394 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 46' ' ' LEU . . . . . 0.429 HD23 ' N ' ' D' ' 46' ' ' LEU . 0.1 OUTLIER -91.36 114.82 27.45 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.021 -179.872 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 47' ' ' PHE . . . . . 0.569 ' O ' ' N ' ' D' ' 49' ' ' LYS . 77.0 t80 -172.92 90.22 0.09 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.073 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 57.94 -73.49 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.45 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 49' ' ' LYS . . . . . 0.569 ' N ' ' O ' ' D' ' 47' ' ' PHE . 10.7 ttpp -165.58 37.46 0.06 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.884 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 50' ' ' SER . . . . . 0.532 ' O ' ' N ' ' D' ' 53' ' ' ARG . 13.0 t -62.77 -45.06 94.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.082 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 51' ' ' ILE . . . . . 0.413 ' CG1' ' O ' ' D' ' 45' ' ' ARG . 23.6 mt -41.25 -30.35 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.869 0.366 . . . . 0.0 110.487 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 52' ' ' TYR . . . . . 0.518 ' CE2' ' OE1' ' D' ' 56' ' ' GLU . 85.7 t80 -74.12 -33.84 63.72 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.34 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 53' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' D' ' 50' ' ' SER . 6.9 ptm180 -69.64 -40.14 76.68 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.351 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -72.71 -41.92 64.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.884 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -65.74 -40.18 91.86 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.459 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 56' ' ' GLU . . . . . 0.518 ' OE1' ' CE2' ' D' ' 52' ' ' TYR . 10.8 pt-20 -75.85 -38.81 57.61 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.796 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -61.51 -43.99 97.87 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 120.876 -0.329 . . . . 0.0 110.34 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.84 -27.82 71.75 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 7.9 tp -84.09 -75.75 0.33 Allowed 'General case' 0 C--O 1.231 0.087 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.615 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt . . . . . 0 N--CA 1.467 0.422 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.539 179.799 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo . . . . . 0 N--CA 1.492 1.43 0 N-CA-C 111.217 -0.34 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 22.0 tp -61.54 -50.49 72.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.969 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.74 -46.75 88.26 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.271 0.558 . . . . 0.0 109.551 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 92.4 t -59.03 -41.44 83.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.51 -31.36 71.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.757 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.95 -43.52 71.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.649 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.7 t -66.18 -43.32 87.22 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.914 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 38.4 mm -67.24 -42.42 87.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.684 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.2 tt -71.15 -33.38 50.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.721 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.13 -52.0 15.65 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.315 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.418 HG23 ' N ' ' A' ' 36' ' ' LEU . 20.2 tt -63.16 -39.57 85.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.695 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.418 ' N ' HG23 ' A' ' 35' ' ' ILE . 47.1 tp -66.63 -32.39 73.69 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.086 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -68.34 -49.6 59.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.675 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.6 tp -63.31 -51.93 64.02 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.222 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 81.1 mt -61.79 -42.92 96.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.947 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.5 tt -63.56 -37.75 88.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.624 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 41.6 t-105 -65.11 -54.66 26.47 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.034 0.445 . . . . 0.0 111.305 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.553 ' CG2' ' N ' ' A' ' 43' ' ' LEU . 5.9 tt -63.74 -51.26 72.2 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.646 -177.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.553 ' N ' ' CG2' ' A' ' 42' ' ' ILE . 29.6 tp -63.21 -48.85 76.55 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.008 -177.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' A' ' 44' ' ' ASP . 60.2 t0 -51.59 -38.9 56.63 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.417 ' NH2' ' CB ' ' D' ' 54' ' ' PHE . 64.3 ttt180 -64.76 -52.24 58.02 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.522 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 48' ' ' PHE . 5.3 mt -86.31 -76.67 0.34 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 119.934 -0.706 . . . . 0.0 110.817 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 69.5 t80 51.4 -86.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.892 0.377 . . . . 0.0 110.373 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.515 ' N ' ' O ' ' A' ' 46' ' ' LEU . 38.5 t80 -158.31 90.58 1.04 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.142 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm 52.11 17.01 0.62 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.116 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.9 t -51.7 -41.87 61.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.612 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 35.7 mt -48.18 -41.63 10.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.055 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -71.41 -30.14 65.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.295 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.51 ' O ' ' CG ' ' A' ' 57' ' ' HIS . 1.8 mpt_? -66.8 -45.03 79.67 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.074 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -70.96 -38.62 72.81 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.479 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -63.55 -40.48 97.11 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.646 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -77.0 -40.19 47.55 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.789 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.51 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 56.0 m170 -57.4 -50.47 72.89 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.202 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.632 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 179.478 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 5.9 t0 . . . . . 0 CA--C 1.532 0.252 0 CA-C-O 121.035 0.445 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -48.13 -27.89 9.97 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.031 1.82 . . . . 0.0 111.092 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.412 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 1.7 pp -72.79 -31.2 64.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.894 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.9 -39.71 66.02 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.972 0.415 . . . . 0.0 109.999 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 94.2 t -60.23 -43.64 93.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -56.97 -35.57 69.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.391 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.13 -49.81 66.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.878 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 22.2 p -59.16 -51.19 71.07 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 19.1 tt -65.39 -33.75 65.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.295 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 28.9 mt -67.34 -37.36 78.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.766 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.85 -51.38 24.73 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 83.3 mt -58.14 -49.29 82.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.412 0.625 . . . . 0.0 109.734 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 12.1 tp -58.53 -39.89 81.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.318 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -61.41 -48.35 81.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.58 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 10.1 mp -63.57 -51.05 67.04 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.832 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 mp -61.38 -46.05 97.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.076 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -63.16 -37.12 85.95 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.058 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 15.4 t-105 -60.85 -57.5 12.39 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.154 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 68.8 mt -61.88 -55.38 24.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.8 -177.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.491 ' O ' HD23 ' B' ' 43' ' ' LEU . 0.7 OUTLIER -56.4 -50.61 71.12 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.044 -178.554 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -55.74 -39.64 71.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.245 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -59.73 -53.46 57.77 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.678 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' B' ' 48' ' ' PHE . 0.9 OUTLIER -80.93 -72.81 0.4 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.52 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.432 ' CD2' ' N ' ' B' ' 48' ' ' PHE . 84.7 t80 47.24 -88.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.569 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 48' ' ' PHE . . . . . 0.517 ' N ' ' O ' ' B' ' 46' ' ' LEU . 80.7 t80 -154.36 84.5 1.12 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.325 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 62.4 mttp 48.73 27.36 1.51 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.439 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 16.0 p -63.49 -34.76 78.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.689 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' ILE . . . . . 0.423 ' H ' HG13 ' B' ' 51' ' ' ILE . 21.2 mt -49.88 -46.6 22.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.662 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.515 ' CD2' ' OE1' ' B' ' 56' ' ' GLU . 64.5 t80 -72.45 -27.88 62.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.553 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -70.8 -45.27 64.94 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.631 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -72.89 -41.57 64.5 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.561 -0.455 . . . . 0.0 110.75 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -66.01 -39.69 90.47 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.545 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 56' ' ' GLU . . . . . 0.515 ' OE1' ' CD2' ' B' ' 52' ' ' TYR . 9.6 pt-20 -75.6 -39.28 58.19 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.571 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -61.22 -41.79 97.47 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.621 -0.431 . . . . 0.0 110.092 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.31 -32.4 76.81 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 25.0 tp -63.25 -52.56 61.61 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.074 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt . . . . . 0 C--N 1.332 -0.157 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.569 179.982 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 36.8 p . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 46.22 74.75 0.75 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.73 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.62 -29.27 32.09 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.605 2.204 . . . . 0.0 111.378 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 26' ' ' LEU . . . . . 0.583 HD13 ' HB2' ' D' ' 31' ' ' SER . 3.7 pp -65.18 -35.46 81.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.786 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.22 -49.44 33.08 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.123 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 61.3 t -55.53 -36.45 41.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 29' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' C' ' 26' ' ' LEU . . . -63.3 -33.94 76.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.546 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.76 -40.1 79.91 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.853 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 3.3 t -69.14 -54.0 17.2 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.488 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 32' ' ' ILE . . . . . 0.443 HG23 ' N ' ' C' ' 33' ' ' ILE . 17.5 tt -60.98 -40.87 86.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.53 -178.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 33' ' ' ILE . . . . . 0.443 ' N ' HG23 ' C' ' 32' ' ' ILE . 13.6 tt -70.98 -31.21 44.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.609 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.08 -51.95 30.76 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.242 -0.98 . . . . 0.0 111.084 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.59 -34.71 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 C-N-CA 120.173 -0.611 . . . . 0.0 109.943 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 46.0 tp -64.89 -39.68 93.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.359 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -68.29 -49.67 58.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.513 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 34.9 tp -61.01 -51.87 67.41 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.226 0.536 . . . . 0.0 111.253 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 1.2 mp -60.58 -43.29 94.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.262 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 40' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' C' ' 40' ' ' LEU . 18.6 mt -61.04 -40.5 93.85 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.935 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 18.0 t-105 -59.43 -58.11 10.03 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.366 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 56.1 mt -62.33 -54.94 27.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.497 ' O ' HD23 ' C' ' 43' ' ' LEU . 0.7 OUTLIER -59.94 -49.28 78.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.472 -178.183 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 44' ' ' ASP . . . . . 0.484 ' O ' ' CB ' ' C' ' 50' ' ' SER . 61.2 t0 -57.81 -42.4 84.18 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.655 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 45' ' ' ARG . . . . . 0.507 ' NH1' ' CD1' ' C' ' 51' ' ' ILE . 3.2 tpt85 -61.04 -52.74 63.69 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.204 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 46' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' C' ' 43' ' ' LEU . 0.1 OUTLIER -118.31 137.37 53.12 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.039 0.447 . . . . 0.0 110.661 179.538 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -172.59 -38.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.107 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -172.67 -46.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.312 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 45.0 tttt -173.89 39.67 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.846 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 50' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' C' ' 44' ' ' ASP . 47.9 t -65.31 -51.61 59.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.807 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 51' ' ' ILE . . . . . 0.507 ' CD1' ' NH1' ' C' ' 45' ' ' ARG . 96.0 mt -43.39 -40.89 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.677 0.275 . . . . 0.0 111.215 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -73.62 -28.52 61.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.6 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 56.8 ttm-85 -69.71 -49.35 54.18 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.052 0.453 . . . . 0.0 110.246 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -69.08 -42.6 75.97 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.702 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -63.22 -37.02 85.61 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.792 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 . . . . . 0 CA--C 1.536 0.423 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.739 179.418 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo . . . . . 0 N--CA 1.492 1.413 0 N-CA-C 110.647 -0.559 . . . . 0.0 110.647 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 26' ' ' LEU . . . . . 0.403 ' O ' ' HB3' ' D' ' 29' ' ' ALA . 17.8 tp -59.11 -49.83 76.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.231 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 27' ' ' ALA . . . . . 0.443 ' HB1' HD11 ' C' ' 26' ' ' LEU . . . -58.03 -53.81 54.04 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 83.5 t -52.43 -43.88 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.463 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' D' ' 26' ' ' LEU . . . -53.8 -42.55 68.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.227 0.537 . . . . 0.0 109.924 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.61 -42.54 98.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.792 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 31' ' ' SER . . . . . 0.583 ' HB2' HD13 ' C' ' 26' ' ' LEU . 6.3 t -61.68 -52.64 63.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.841 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 13.6 tt -64.01 -31.08 51.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.574 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 33.2 mt -67.21 -40.88 85.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.488 -0.485 . . . . 0.0 109.725 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.39 -52.05 33.49 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 120.991 -0.623 . . . . 0.0 111.64 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 4.3 mm -60.23 -43.85 94.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.109 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 47.0 tp -62.23 -38.61 89.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.346 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -63.96 -51.23 65.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.849 0.356 . . . . 0.0 110.908 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 50.5 tp -58.12 -45.56 87.07 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.513 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 97.4 mt -62.36 -40.16 86.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.628 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 40' ' ' LEU . . . . . 0.517 HD13 ' O ' ' D' ' 40' ' ' LEU . 0.2 OUTLIER -61.84 -44.03 97.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.18 -179.401 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 28.2 t-105 -63.83 -56.36 16.0 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.736 0.303 . . . . 0.0 111.782 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 74.3 mt -58.71 -53.43 47.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.244 -0.435 . . . . 0.0 112.017 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 36.9 tp -61.55 -46.73 88.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.733 0.301 . . . . 0.0 111.089 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -52.99 -46.8 68.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.295 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -63.19 -50.69 69.34 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.89 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.17 123.99 46.86 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.974 0.416 . . . . 0.0 110.33 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -172.27 -47.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.246 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -172.08 71.12 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.275 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt 54.29 33.37 18.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.289 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 9.7 t -57.77 -50.09 74.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.745 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 55.5 mt -52.56 -44.23 44.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.598 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -71.91 -30.59 65.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.27 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -71.22 -44.15 65.94 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.892 0.377 . . . . 0.0 110.747 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 54' ' ' PHE . . . . . 0.417 ' CB ' ' NH2' ' A' ' 45' ' ' ARG . 50.9 m-85 -71.92 -38.29 69.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.88 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -69.18 -40.1 78.3 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.652 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -76.62 -36.6 57.37 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.616 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -65.47 -47.51 75.83 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.667 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.54 -28.99 72.23 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 10.6 mp -103.85 65.48 0.82 Allowed 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 86.6 tttt . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.652 -179.817 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo . . . . . 0 N--CA 1.493 1.457 0 N-CA-C 111.163 -0.36 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.3 tp -63.71 -50.56 68.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.218 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -63.18 -44.71 94.64 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.329 0.585 . . . . 0.0 109.917 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.9 t -58.79 -45.89 91.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.259 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.98 -31.38 69.84 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.606 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -66.09 -50.43 64.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.446 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.3 t -58.02 -42.43 85.28 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.402 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.1 mp -65.95 -37.98 81.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.184 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.416 HG21 HD13 ' A' ' 33' ' ' ILE . 2.4 tt -69.03 -36.44 73.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.637 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.43 -52.34 17.27 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.159 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.83 -43.44 91.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.145 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 57.2 tp -64.7 -34.69 78.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.359 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -65.39 -50.33 65.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.844 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.5 mp -62.84 -47.25 84.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.976 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.9 mt -61.62 -44.84 99.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.1 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 35.0 tp -62.86 -43.33 99.09 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.7 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.9 t-105 -62.32 -58.46 7.62 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 120.82 0.343 . . . . 0.0 111.847 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 73.7 mt -59.54 -54.31 36.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.743 -177.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.5 tp -58.34 -50.8 72.34 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.801 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -52.11 -38.85 58.73 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.07 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.435 HH21 ' CB ' ' D' ' 54' ' ' PHE . 54.0 ttt85 -64.65 -54.35 33.23 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.596 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 48' ' ' PHE . 0.1 OUTLIER -91.91 -84.83 0.26 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.862 -179.525 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.421 ' CD2' ' N ' ' A' ' 48' ' ' PHE . 82.2 t80 56.54 -80.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.539 ' N ' ' O ' ' A' ' 46' ' ' LEU . 65.2 t80 -165.64 98.04 0.67 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.375 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt 47.93 33.32 3.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.485 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 53' ' ' ARG . 5.4 t -63.9 -44.15 93.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.89 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.42 HG12 ' H ' ' A' ' 51' ' ' ILE . 6.3 mm -41.93 -43.52 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.488 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.507 ' CE2' ' OE1' ' A' ' 56' ' ' GLU . 90.8 t80 -73.23 -31.22 64.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.352 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.531 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 23.4 mmt180 -70.79 -48.44 54.21 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-O 120.975 0.417 . . . . 0.0 110.541 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -70.05 -35.99 74.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.621 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -68.13 -41.02 82.31 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 120.886 -0.325 . . . . 0.0 111.613 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.507 ' OE1' ' CE2' ' A' ' 52' ' ' TYR . 21.4 pt-20 -76.4 -41.92 46.11 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.119 -0.633 . . . . 0.0 111.02 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.531 ' ND1' ' O ' ' A' ' 53' ' ' ARG . 15.8 m80 -61.95 -51.83 66.5 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.324 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.667 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 179.695 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.61 0.243 . . . . 0.0 110.804 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -50.56 -35.02 44.89 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.502 2.135 . . . . 0.0 111.495 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.501 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 17.8 tp -59.15 -51.49 69.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.975 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.49 -44.52 93.05 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 88.5 t -61.03 -32.64 53.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -64.15 -34.14 77.39 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.03 -46.53 64.86 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.318 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 3.9 m -66.04 -47.3 74.84 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 119.981 -0.688 . . . . 0.0 111.561 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.542 HG23 ' N ' ' B' ' 33' ' ' ILE . 21.1 tt -64.48 -45.19 96.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.738 -178.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.542 ' N ' HG23 ' B' ' 32' ' ' ILE . 16.4 tt -64.86 -34.78 72.62 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.087 0 C-N-CA 119.409 -0.916 . . . . 0.0 109.937 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.49 -46.06 93.36 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 94.3 mt -59.52 -43.3 90.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 37.4 tp -60.01 -40.17 88.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.578 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -66.08 -51.56 56.91 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 31.8 tp -61.95 -51.86 66.39 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 120.865 0.365 . . . . 0.0 111.717 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.413 ' N ' ' CD1' ' B' ' 39' ' ' ILE . 1.3 mp -61.45 -40.52 86.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.021 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 62.9 tp -62.56 -37.32 85.69 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.501 -0.48 . . . . 0.0 109.983 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 39.3 t-105 -64.32 -56.04 17.2 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.637 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 54.6 mt -63.23 -50.84 77.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.424 -0.511 . . . . 0.0 111.769 -177.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.499 ' O ' HD23 ' B' ' 43' ' ' LEU . 0.9 OUTLIER -61.15 -49.3 77.78 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.442 -178.734 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -61.5 -37.44 83.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.693 0.282 . . . . 0.0 110.952 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 50.0 ttt-85 -65.84 -51.02 62.44 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.703 -0.399 . . . . 0.0 112.066 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' B' ' 43' ' ' LEU . 0.6 OUTLIER -123.31 -159.39 0.84 Allowed 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 120.882 0.372 . . . . 0.0 111.58 -179.086 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.464 ' O ' ' CD2' ' B' ' 47' ' ' PHE . 31.1 t80 50.06 19.43 0.48 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.203 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -168.77 -1.67 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.38 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt 44.61 40.24 3.91 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.606 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 2.3 p -62.96 -33.28 75.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.753 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 78.0 mt -47.33 -46.09 9.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.82 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -72.16 -30.0 64.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.439 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.529 ' O ' ' ND1' ' B' ' 57' ' ' HIS . 95.5 mtt-85 -71.54 -45.6 61.89 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.727 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -71.54 -38.34 71.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.911 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -70.03 -39.35 75.81 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.608 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 56' ' ' GLU . . . . . 0.528 ' OE2' ' CD2' ' B' ' 57' ' ' HIS . 1.2 pp20? -75.75 -39.76 56.62 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.748 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 57' ' ' HIS . . . . . 0.529 ' ND1' ' O ' ' B' ' 53' ' ' ARG . 26.6 m80 -65.16 -45.38 85.17 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.29 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.72 -27.79 73.01 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 9.4 tp -86.17 58.25 4.95 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.897 0.38 . . . . 0.0 110.349 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? . . . . . 0 N--CA 1.466 0.352 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.417 -179.886 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 25.9 t . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 53.46 70.61 1.7 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.676 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -51.74 -38.75 67.36 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.573 2.182 . . . . 0.0 111.565 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 26' ' ' LEU . . . . . 0.415 ' O ' ' HB3' ' C' ' 29' ' ' ALA . 26.0 tp -57.16 -48.61 78.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.018 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.44 -48.98 77.26 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.389 0.614 . . . . 0.0 109.497 178.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 85.4 t -58.95 -31.67 45.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 29' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' C' ' 26' ' ' LEU . . . -66.34 -33.87 76.69 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.15 -43.71 73.78 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.305 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 4.4 p -69.58 -45.92 67.55 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 119.972 -0.691 . . . . 0.0 111.616 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 13.5 tt -67.87 -39.72 82.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.563 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 33' ' ' ILE . . . . . 0.402 HG21 HD13 ' C' ' 33' ' ' ILE . 7.6 tt -70.01 -35.91 66.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.784 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.67 -51.42 25.42 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 120.413 -0.898 . . . . 0.0 111.202 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 94.0 mt -61.21 -46.3 96.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.551 -0.46 . . . . 0.0 109.846 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 15.4 tp -58.14 -42.87 86.8 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.894 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -59.72 -51.78 68.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.757 0.313 . . . . 0.0 111.484 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 35.9 tp -57.47 -52.6 64.71 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.751 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 39' ' ' ILE . . . . . 0.401 ' N ' ' CD1' ' C' ' 39' ' ' ILE . 1.3 mp -61.02 -41.04 87.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.836 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 40' ' ' LEU . . . . . 0.535 ' O ' HD13 ' C' ' 40' ' ' LEU . 0.2 OUTLIER -59.66 -43.06 94.1 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.746 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 12.9 t-105 -61.45 -58.5 7.91 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.466 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 96.2 mt -55.76 -56.91 9.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.92 -177.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.513 ' O ' HD23 ' C' ' 43' ' ' LEU . 0.6 OUTLIER -59.7 -45.55 91.77 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.881 -178.871 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -48.55 -46.38 38.8 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 54.9 ttt-85 -64.54 -48.16 76.11 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.94 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 46' ' ' LEU . . . . . 0.496 ' O ' ' N ' ' C' ' 48' ' ' PHE . 8.2 mt -82.68 4.4 25.11 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.126 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 47' ' ' PHE . . . . . 0.518 ' O ' ' N ' ' C' ' 49' ' ' LYS . 48.3 t80 -45.34 91.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.86 0.362 . . . . 0.0 110.78 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 48' ' ' PHE . . . . . 0.496 ' N ' ' O ' ' C' ' 46' ' ' LEU . 88.1 t80 55.47 -81.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.615 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 49' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' C' ' 47' ' ' PHE . 76.6 tttt -161.01 39.05 0.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.101 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 50' ' ' SER . . . . . 0.432 ' OG ' ' CE2' ' C' ' 54' ' ' PHE . 4.8 t -70.83 -26.14 63.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.465 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 53.0 mt -42.05 -48.02 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.211 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -73.25 -28.73 62.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.398 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 20.0 mmt85 -71.78 -49.3 40.08 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.662 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 54' ' ' PHE . . . . . 0.432 ' CE2' ' OG ' ' C' ' 50' ' ' SER . 38.0 m-85 -69.46 -39.2 77.87 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.44 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -66.8 -38.04 85.72 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 120.561 -0.455 . . . . 0.0 111.026 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 . . . . . 0 CA--C 1.534 0.336 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.852 179.63 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo . . . . . 0 N--CA 1.491 1.378 0 N-CA-C 110.815 -0.494 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 17.7 tp -63.21 -50.95 68.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.612 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 27' ' ' ALA . . . . . 0.43 ' O ' ' HB3' ' D' ' 30' ' ' ALA . . . -64.75 -47.28 78.77 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.811 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 96.5 t -56.76 -41.74 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.38 -38.94 85.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.471 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 30' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' D' ' 27' ' ' ALA . . . -58.69 -50.55 73.45 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.739 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 6.2 t -62.97 -39.76 95.66 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.365 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 5.2 mm -62.42 -48.24 89.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.444 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 18.5 tt -66.84 -31.1 51.97 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.282 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.92 -48.96 57.88 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.222 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 97.2 mt -63.79 -44.49 98.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.065 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 33.9 tp -63.45 -30.68 71.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.012 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -68.68 -51.28 43.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.754 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 43.3 tp -59.5 -48.07 83.06 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.51 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 96.8 mt -61.06 -43.86 97.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.786 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 22.1 mt -61.34 -41.04 96.39 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.351 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 46.7 t-105 -61.61 -54.66 39.96 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.767 0.318 . . . . 0.0 111.556 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 64.1 mt -62.9 -55.78 21.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 120.293 -0.563 . . . . 0.0 112.182 -177.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 43.1 tp -59.06 -50.25 74.79 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.173 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 44' ' ' ASP . . . . . 0.459 ' O ' ' CB ' ' D' ' 50' ' ' SER . 31.6 t70 -52.72 -44.83 66.64 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.106 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -58.35 -54.84 42.5 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.395 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.13 106.91 15.65 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 120.956 0.408 . . . . 0.0 110.121 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -174.6 94.47 0.08 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.306 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 35.7 t80 59.3 49.53 8.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.536 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? 54.72 52.56 11.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.596 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 50' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 11.5 t -62.82 -49.48 74.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.994 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 53.0 mt -45.18 -43.91 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.926 0.393 . . . . 0.0 110.584 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -71.48 -28.09 63.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.65 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 53' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' D' ' 50' ' ' SER . 12.0 ttm180 -70.09 -49.67 48.61 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.035 0.445 . . . . 0.0 110.175 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 54' ' ' PHE . . . . . 0.435 ' CB ' HH21 ' A' ' 45' ' ' ARG . 55.1 m-85 -65.42 -43.02 91.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.303 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -63.23 -38.36 90.88 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.919 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -76.06 -22.51 55.58 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.615 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -75.07 -54.34 7.32 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.167 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -73.9 -26.12 69.9 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 12.6 tp -146.41 86.91 1.7 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 63.7 mttp . . . . . 0 C--N 1.334 -0.096 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.592 -179.725 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo . . . . . 0 N--CA 1.492 1.428 0 CA-C-O 120.975 0.323 . . . . 0.0 111.297 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.2 tp -62.55 -49.61 74.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.944 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.75 -46.25 88.91 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.0 t -60.05 -40.41 83.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.15 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.73 -30.89 71.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.716 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.61 -51.06 46.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.53 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.1 p -61.76 -36.68 81.72 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.574 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.7 mm -68.4 -41.75 83.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.594 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 33' ' ' ILE . 4.4 tt -70.64 -34.19 56.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.371 -0.531 . . . . 0.0 110.744 -178.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.64 -52.15 13.47 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.697 -0.764 . . . . 0.0 111.389 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.489 HG23 ' N ' ' A' ' 36' ' ' LEU . 15.3 tt -63.17 -44.52 99.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.784 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.489 ' N ' HG23 ' A' ' 35' ' ' ILE . 48.9 tp -59.93 -41.88 92.73 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.811 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -60.07 -49.92 75.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.745 0.307 . . . . 0.0 111.093 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 37.2 tp -59.3 -51.81 68.33 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.925 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.3 mp -61.6 -46.06 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.049 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.575 HD13 ' O ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -59.7 -39.93 86.23 Favored 'General case' 0 C--O 1.218 -0.59 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.297 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 13.5 t-105 -62.64 -57.11 12.22 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.483 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 97.2 mt -56.43 -54.59 26.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.703 -177.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 47' ' ' PHE . 34.5 tp -61.64 -42.5 98.98 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.359 -0.537 . . . . 0.0 110.978 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -51.59 -44.93 62.98 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -63.2 -54.8 31.9 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.246 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 48' ' ' PHE . 5.5 mt -77.15 -77.19 0.15 Allowed 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.777 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.416 ' CD2' ' N ' ' A' ' 48' ' ' PHE . 93.3 t80 53.88 -83.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.788 0.328 . . . . 0.0 110.434 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.533 ' N ' ' O ' ' A' ' 46' ' ' LEU . 81.2 t80 -167.65 86.72 0.24 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.259 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm 59.8 30.44 20.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.339 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.5 t -68.46 -29.18 67.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.621 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.9 mm -44.21 -43.18 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-O 120.989 0.423 . . . . 0.0 110.283 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -74.6 -28.44 60.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.349 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.507 ' O ' ' CG ' ' A' ' 57' ' ' HIS . 98.9 mtt180 -68.28 -49.82 57.89 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.015 0.436 . . . . 0.0 110.46 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -72.39 -40.35 67.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.93 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -63.73 -40.75 97.5 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.617 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -77.16 -41.79 40.32 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.973 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.507 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 6.2 m-70 -56.9 -50.42 72.59 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.277 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.587 0 N-CA-C 110.756 -0.937 . . . . 0.0 110.756 179.426 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.748 0.309 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.412 ' O ' ' N ' ' B' ' 29' ' ' ALA . 53.9 Cg_exo -51.0 -33.66 43.37 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.668 2.245 . . . . 0.0 111.52 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.461 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 19.2 tp -59.7 -50.93 71.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.269 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.52 -42.9 99.5 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.423 ' O ' HG22 ' B' ' 32' ' ' ILE . 82.3 t -63.47 -31.08 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -64.83 -34.9 79.46 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.15 -47.45 61.58 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.385 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 4.8 t -64.83 -48.35 74.67 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.534 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.52 HG23 ' N ' ' B' ' 33' ' ' ILE . 10.7 tp -65.41 -44.48 94.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.966 -178.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.52 ' N ' HG23 ' B' ' 32' ' ' ILE . 15.6 tt -66.18 -32.85 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.975 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.64 -45.84 81.21 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 5.2 mm -60.08 -42.79 91.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 12.0 tp -61.71 -37.4 84.03 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.373 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' HIS . . . . . 0.458 ' NE2' ' NE2' ' C' ' 37' ' ' HIS . 1.5 t60 -65.66 -53.03 46.83 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 28.6 tp -64.79 -52.38 57.18 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.452 ' N ' ' CD1' ' B' ' 39' ' ' ILE . 1.3 mp -62.05 -47.97 90.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.883 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 41.6 tp -61.2 -35.94 78.53 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.253 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 41.2 t-105 -63.44 -57.16 11.16 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.384 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 73.2 mt -60.93 -53.01 55.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.768 -177.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' B' ' 43' ' ' LEU . 11.1 mt -60.12 -53.31 59.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.421 -178.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' ASP . . . . . 0.411 ' O ' ' CB ' ' B' ' 50' ' ' SER . 66.2 t0 -57.41 -31.74 66.15 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.158 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -66.36 -50.67 62.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.282 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' B' ' 48' ' ' PHE . 0.1 OUTLIER -110.2 -88.98 0.49 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.821 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 33.9 t80 57.04 -79.37 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.888 0.375 . . . . 0.0 110.414 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 48' ' ' PHE . . . . . 0.533 ' N ' ' O ' ' B' ' 46' ' ' LEU . 47.7 t80 -138.75 58.53 1.65 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.536 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm 57.15 54.61 6.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.424 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 50' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' B' ' 44' ' ' ASP . 39.0 t -65.69 -45.74 81.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.133 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 59.2 mt -46.72 -28.6 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.044 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.49 ' CZ ' ' OE1' ' B' ' 56' ' ' GLU . 60.4 t80 -71.85 -36.94 70.31 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.72 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -70.77 -45.28 65.03 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.881 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 54' ' ' PHE . . . . . 0.438 ' CD1' ' NH1' ' C' ' 45' ' ' ARG . 61.4 m-85 -70.18 -35.9 74.29 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.923 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -71.17 -39.76 71.68 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.72 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 56' ' ' GLU . . . . . 0.49 ' OE1' ' CZ ' ' B' ' 52' ' ' TYR . 18.3 pt-20 -76.11 -39.25 55.61 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.871 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -67.48 -43.4 81.06 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.414 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.05 -28.57 72.31 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 10.8 mp -102.69 65.4 0.91 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.537 -179.816 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 15.7 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -158.48 72.66 3.83 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.812 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.2 -32.42 40.37 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.529 2.153 . . . . 0.0 111.461 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 14.2 tp -62.01 -52.04 65.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.1 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 27' ' ' ALA . . . . . 0.43 ' O ' ' HB3' ' C' ' 30' ' ' ALA . . . -61.41 -47.77 84.24 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.03 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 92.4 t -54.6 -50.26 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.54 -44.02 56.25 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.565 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 30' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' C' ' 27' ' ' ALA . . . -55.81 -50.35 70.76 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 3.0 t -57.6 -52.27 66.09 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.401 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 21.5 mm -58.88 -30.71 43.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.715 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 50.3 mt -69.03 -40.2 80.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.395 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.81 -52.12 26.26 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 120.657 -0.783 . . . . 0.0 111.81 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 35' ' ' ILE . . . . . 0.482 ' H ' HD12 ' C' ' 35' ' ' ILE . 3.4 mp -62.52 -44.47 99.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.776 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 54.7 tp -60.48 -39.15 86.63 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.707 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 37' ' ' HIS . . . . . 0.458 ' NE2' ' NE2' ' B' ' 37' ' ' HIS . 1.1 t60 -61.33 -51.07 70.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.922 0.391 . . . . 0.0 110.794 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.25 -51.93 66.32 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.837 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 26.3 mm -60.52 -41.52 88.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.179 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 40' ' ' LEU . . . . . 0.526 ' O ' HD13 ' C' ' 40' ' ' LEU . 0.2 OUTLIER -61.56 -41.88 98.01 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.426 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 16.5 t-105 -63.11 -57.55 10.21 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 120.889 0.376 . . . . 0.0 111.414 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 82.3 mt -57.91 -55.6 20.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.877 -177.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.494 ' O ' HD23 ' C' ' 43' ' ' LEU . 0.7 OUTLIER -59.3 -48.78 80.33 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.63 -178.938 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -49.08 -45.37 43.02 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 45' ' ' ARG . . . . . 0.455 ' CZ ' HD21 ' C' ' 46' ' ' LEU . 62.4 ttp85 -61.47 -50.89 70.93 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.086 -0.646 . . . . 0.0 110.708 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 46' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' C' ' 48' ' ' PHE . 12.4 mt -76.44 -76.89 0.15 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.052 -0.659 . . . . 0.0 111.253 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 69.2 t80 58.32 -78.0 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.428 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 48' ' ' PHE . . . . . 0.528 ' N ' ' O ' ' C' ' 46' ' ' LEU . 38.7 t80 -169.57 -29.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.336 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 49' ' ' LYS . . . . . 0.415 ' NZ ' ' CD2' ' C' ' 52' ' ' TYR . 49.8 tttm -173.07 18.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.91 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.08 -32.34 69.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.697 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 35.1 mt -56.38 -54.17 31.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.438 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 52' ' ' TYR . . . . . 0.415 ' CD2' ' NZ ' ' C' ' 49' ' ' LYS . 70.5 t80 -76.87 -33.11 57.87 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 63.6 mmt-85 -66.76 -49.45 65.88 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.635 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -73.67 -39.75 64.21 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.901 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -61.03 -40.72 94.69 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.463 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? . . . . . 0 N--CA 1.463 0.201 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.319 179.417 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo . . . . . 0 N--CA 1.49 1.266 0 N-CA-C 110.394 -0.656 . . . . 0.0 110.394 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 16.2 tp -62.84 -50.33 71.35 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.04 178.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 27' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' D' ' 30' ' ' ALA . . . -60.46 -47.78 84.61 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.78 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 87.1 t -58.2 -50.57 77.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.581 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.33 -42.82 53.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.645 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 30' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' D' ' 27' ' ' ALA . . . -57.69 -49.86 75.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.568 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.28 -47.63 80.95 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.534 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 27.2 mm -62.21 -35.09 67.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.861 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 74.5 mt -67.23 -41.75 87.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.696 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.63 -51.34 31.26 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.008 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 14.1 tt -62.63 -39.96 86.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.091 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 52.8 tp -66.35 -34.47 78.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.852 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -65.88 -48.15 72.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.444 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 59.9 tp -63.14 -50.98 68.31 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.162 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 91.8 mt -59.46 -45.93 93.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.995 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 7.7 tp -62.7 -38.02 88.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.339 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 38.9 t-105 -62.23 -52.59 63.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.764 0.316 . . . . 0.0 111.551 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 64.8 mt -66.32 -53.49 35.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -177.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 54.2 tp -60.95 -46.12 91.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.697 0.284 . . . . 0.0 111.308 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 44' ' ' ASP . . . . . 0.489 ' O ' ' CB ' ' D' ' 50' ' ' SER . 28.1 t70 -59.8 -47.2 86.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.769 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -58.53 -50.19 74.66 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.101 -0.64 . . . . 0.0 111.071 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 2.5 pp -124.49 134.9 52.88 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.898 0.38 . . . . 0.0 110.655 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -168.43 -39.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.346 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -171.17 -36.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.401 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 177.28 26.81 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.899 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 50' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 10.3 t -50.22 -54.55 20.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.02 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 87.4 mt -48.93 -40.68 12.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.268 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -73.79 -30.8 62.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.307 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 53' ' ' ARG . . . . . 0.405 ' HE ' ' HA ' ' D' ' 50' ' ' SER . 43.4 mtm180 -67.31 -47.23 71.16 Favored 'General case' 0 CA--C 1.522 -0.097 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.318 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -71.97 -41.51 67.63 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.809 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -59.7 -43.74 93.96 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.368 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -78.21 -31.62 49.49 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.455 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -58.32 -52.16 66.77 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.874 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.82 -35.12 72.6 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.55 23.83 0.61 Allowed 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.181 -179.755 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.426 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 27.2 Cg_endo . . . . . 0 N--CA 1.493 1.496 0 CA-C-O 121.075 0.365 . . . . 0.0 111.26 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.417 ' O ' HD13 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -63.87 -54.52 33.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.875 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.56 ' O ' HD11 ' D' ' 26' ' ' LEU . . . -63.97 -50.41 68.68 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.895 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 87.5 t -55.47 -47.13 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 25' ' ' PRO . . . -54.14 -41.0 67.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.968 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.32 -48.7 80.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.665 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.415 ' HB2' HD13 ' D' ' 26' ' ' LEU . 6.4 t -59.43 -46.23 89.31 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.193 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 43.7 mm -60.63 -38.19 77.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.792 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.7 mm -69.74 -36.09 68.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.692 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.95 -52.03 26.03 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.611 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.1 pt -66.76 -37.74 80.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.626 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -67.83 -36.68 80.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.269 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.462 ' CE1' ' NE2' ' D' ' 37' ' ' HIS . 0.3 OUTLIER -68.09 -50.37 55.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.194 -179.463 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 38.2 tp -65.68 -51.53 58.66 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.332 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 89.5 mt -60.84 -51.65 70.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.333 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 41.2 tp -59.71 -40.29 87.46 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.478 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 27.1 t-105 -61.08 -55.55 31.32 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.706 0.288 . . . . 0.0 111.484 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 96.8 mt -57.93 -55.81 19.53 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 CA-C-O 121.242 0.544 . . . . 0.0 111.536 -178.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.67 HD12 ' C ' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -59.43 -37.71 78.8 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.567 -179.165 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -59.65 -41.47 90.6 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -63.01 -46.65 86.64 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.15 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.421 ' O ' ' O ' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -106.59 -112.65 0.28 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.991 179.654 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.421 ' O ' ' O ' ' A' ' 46' ' ' LEU . 32.6 t80 47.76 97.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.861 0.362 . . . . 0.0 110.248 -179.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.522 ' O ' ' CD2' ' A' ' 48' ' ' PHE . 49.0 t80 60.37 27.94 17.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.552 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.6 mttm 53.01 65.56 1.48 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.589 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.422 ' O ' ' N ' ' A' ' 53' ' ' ARG . 4.7 t -69.51 -28.83 66.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.02 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.0 mt -44.34 -43.23 2.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.916 0.389 . . . . 0.0 110.221 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -71.65 -28.03 63.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.038 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.501 ' HG3' ' CE1' ' A' ' 57' ' ' HIS . 43.9 ttm180 -71.1 -49.24 46.49 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 120.948 0.404 . . . . 0.0 110.315 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -65.4 -44.78 86.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.604 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -65.7 -35.0 79.49 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.265 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -76.89 -24.81 52.52 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.865 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.501 ' CE1' ' HG3' ' A' ' 53' ' ' ARG . 2.0 m-70 -76.7 -47.14 22.87 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.389 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.444 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -179.842 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 . . . . . 0 C--O 1.232 0.171 0 CA-C-O 120.707 0.289 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.444 ' O ' ' HB2' ' B' ' 29' ' ' ALA . 50.4 Cg_exo -51.96 -32.67 48.86 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.563 2.176 . . . . 0.0 111.206 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 20.6 tp -60.32 -47.13 87.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.737 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.94 -57.37 7.05 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.433 ' O ' HG22 ' B' ' 32' ' ' ILE . 82.4 t -52.67 -34.81 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' B' ' 25' ' ' PRO . . . -64.27 -34.74 78.8 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.005 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.56 -48.66 59.55 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.511 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 42.2 t -63.69 -48.85 75.45 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.574 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.474 HG23 ' N ' ' B' ' 33' ' ' ILE . 19.5 tt -65.66 -43.0 93.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.122 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.474 ' N ' HG23 ' B' ' 32' ' ' ILE . 8.2 tt -67.17 -30.33 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.854 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.69 -51.21 37.19 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 179.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 96.8 mt -58.12 -46.09 88.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.255 0.55 . . . . 0.0 109.98 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 11.2 tp -60.76 -38.15 84.25 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.894 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 37' ' ' HIS . . . . . 0.454 ' ND1' ' C ' ' B' ' 37' ' ' HIS . 0.4 OUTLIER -65.86 -53.95 33.1 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.811 0.338 . . . . 0.0 111.718 -178.984 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 27.4 tp -60.59 -54.74 41.72 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.691 -178.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.432 HD13 ' HA ' ' B' ' 39' ' ' ILE . 11.5 mm -60.61 -43.7 95.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.523 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 31.0 tp -54.87 -44.53 74.11 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -60.75 -54.64 42.78 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.218 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 47.9 mm -51.18 -53.66 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.325 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.581 ' O ' HD23 ' B' ' 43' ' ' LEU . 1.0 OUTLIER -61.9 -38.97 90.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.136 -178.747 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -58.65 -47.58 83.96 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.219 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 53.4 ttt85 -69.92 -53.59 17.21 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.689 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' B' ' 43' ' ' LEU . 1.9 pp -108.49 147.32 31.87 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.027 0.441 . . . . 0.0 111.198 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -172.45 -48.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.074 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -172.2 -38.34 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.304 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.524 ' NZ ' ' CG ' ' B' ' 52' ' ' TYR . 42.9 tttm -172.88 21.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.259 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 13.2 t -59.01 -46.56 87.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.194 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 71.4 mt -45.53 -32.3 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.906 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.524 ' CG ' ' NZ ' ' B' ' 49' ' ' LYS . 26.3 t80 -72.17 -31.23 65.74 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.461 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.481 ' CD ' ' N ' ' B' ' 53' ' ' ARG . 0.9 OUTLIER -71.57 -45.1 63.19 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.622 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -71.14 -38.15 72.24 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.045 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -70.91 -39.47 72.72 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.655 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -75.27 -39.08 60.1 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.916 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -67.57 -44.94 77.0 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.437 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.8 -28.02 67.6 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 7.9 tp -84.01 49.84 1.72 Allowed 'General case' 0 C--O 1.231 0.102 0 CA-C-O 120.823 0.344 . . . . 0.0 110.375 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 34.9 tptt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.516 -179.869 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 7.8 m . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 53.78 77.01 0.47 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.795 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -50.42 -35.12 43.95 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.544 2.163 . . . . 0.0 111.533 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 18.6 tp -60.97 -49.11 78.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.736 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.39 -45.59 92.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.113 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 91.5 t -58.46 -43.94 87.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.42 -38.48 71.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.338 0.59 . . . . 0.0 109.494 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.6 -46.83 84.01 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.172 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 2.2 p -63.08 -52.39 62.89 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.912 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 14.7 tt -59.95 -35.74 62.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.538 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 49.8 mt -68.13 -37.53 78.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.64 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.24 -52.95 20.09 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.869 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 35' ' ' ILE . . . . . 0.409 ' CG1' ' N ' ' C' ' 36' ' ' LEU . 6.5 pt -62.14 -41.51 91.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.396 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.409 ' N ' ' CG1' ' C' ' 35' ' ' ILE . 10.5 tp -65.11 -40.79 95.0 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.341 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -62.15 -50.76 70.59 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 50.9 tp -67.7 -48.63 66.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.915 0.388 . . . . 0.0 111.624 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 92.3 mt -58.38 -50.53 78.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.311 -178.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -65.82 -37.16 85.48 Favored 'General case' 0 C--O 1.221 -0.441 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.027 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 21.9 t-105 -56.8 -53.52 56.92 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.276 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 60.3 mt -70.82 -56.54 10.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.524 -0.47 . . . . 0.0 112.251 -177.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.493 ' O ' HD23 ' C' ' 43' ' ' LEU . 0.7 OUTLIER -54.44 -50.85 66.68 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.825 -178.554 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 44' ' ' ASP . . . . . 0.484 ' O ' ' CB ' ' C' ' 50' ' ' SER . 36.4 t70 -58.05 -42.56 85.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.355 -0.384 . . . . 0.0 109.997 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -53.62 -51.96 61.4 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 119.889 -0.724 . . . . 0.0 110.573 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 46' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' C' ' 47' ' ' PHE . 5.7 mt -74.89 -74.21 0.21 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 120.016 -0.674 . . . . 0.0 111.035 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 47' ' ' PHE . . . . . 0.467 ' CG ' ' N ' ' C' ' 48' ' ' PHE . 21.4 t80 45.78 -171.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.283 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 48' ' ' PHE . . . . . 0.467 ' N ' ' CG ' ' C' ' 47' ' ' PHE . 26.2 m-85 -56.3 -54.63 43.13 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.243 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -153.21 36.82 0.48 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.248 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 50' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' C' ' 44' ' ' ASP . 1.4 t -50.21 -52.41 35.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.18 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 62.0 mt -50.46 -51.57 18.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.264 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -74.45 -31.56 62.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.876 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -69.93 -48.64 57.71 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.474 -0.491 . . . . 0.0 110.672 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -69.57 -42.11 74.94 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.54 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -63.06 -36.66 84.31 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.501 -0.479 . . . . 0.0 110.864 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 . . . . . 0 CA--C 1.536 0.428 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.801 179.466 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo . . . . . 0 N--CA 1.493 1.466 0 N-CA-C 111.108 -0.382 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 26' ' ' LEU . . . . . 0.56 HD11 ' O ' ' A' ' 27' ' ' ALA . 2.5 pp -59.6 -28.51 67.25 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.069 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 27' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' D' ' 30' ' ' ALA . . . -50.57 -34.18 24.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.702 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 84.6 t -59.41 -47.81 89.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.83 -35.43 74.72 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.474 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 30' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' D' ' 27' ' ' ALA . . . -60.56 -52.26 65.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.83 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 36.7 m -60.16 -44.7 94.8 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.042 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 5.6 mm -61.82 -34.64 63.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.768 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 51.9 mt -69.36 -37.45 75.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.5 -52.41 26.15 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.858 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 35' ' ' ILE . . . . . 0.471 HG23 ' N ' ' D' ' 36' ' ' LEU . 19.1 tt -63.25 -42.5 96.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.111 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.471 ' N ' HG23 ' D' ' 35' ' ' ILE . 59.5 tp -61.91 -39.15 90.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.79 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 37' ' ' HIS . . . . . 0.462 ' NE2' ' CE1' ' A' ' 37' ' ' HIS . 2.6 t60 -62.08 -49.23 76.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.387 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 39.1 tp -57.02 -47.32 81.17 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.439 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 95.3 mt -59.79 -43.15 91.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.614 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 57.9 mt -62.07 -39.88 93.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.303 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 17.8 t-105 -61.78 -55.15 33.15 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 120.642 0.258 . . . . 0.0 111.231 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 61.7 mt -61.65 -54.7 31.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.401 -0.519 . . . . 0.0 112.154 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 53.2 tp -59.85 -50.13 74.98 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.199 -178.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 44' ' ' ASP . . . . . 0.439 ' O ' ' CB ' ' D' ' 50' ' ' SER . 8.8 t0 -53.49 -44.3 68.91 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.186 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 30.2 ttm-85 -59.67 -52.41 65.63 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 120.061 -0.655 . . . . 0.0 110.376 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.39 106.22 15.49 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.01 0.433 . . . . 0.0 110.272 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -173.47 101.54 0.12 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.322 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 47.35 50.38 14.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.662 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? 56.01 53.8 8.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.546 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 50' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 7.5 t -63.94 -51.21 65.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.296 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 20.0 mt -47.4 -33.13 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.324 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -73.87 -28.14 61.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.961 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 53' ' ' ARG . . . . . 0.414 ' N ' ' O ' ' D' ' 50' ' ' SER . 74.6 mtm180 -72.7 -47.34 48.02 Favored 'General case' 0 N--CA 1.461 0.093 0 CA-C-O 120.923 0.392 . . . . 0.0 110.748 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -72.06 -39.74 68.82 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.896 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -68.77 -40.03 79.93 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.663 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -75.34 -37.83 60.5 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.386 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -62.61 -48.75 78.05 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.22 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.02 -27.47 73.86 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 6.4 tp -92.65 60.16 3.43 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.772 0.32 . . . . 0.0 110.594 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 65.3 tttp . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.402 179.815 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.449 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 61.4 Cg_exo . . . . . 0 N--CA 1.492 1.389 0 CA-C-O 121.062 0.359 . . . . 0.0 111.335 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.3 tp -62.02 -50.39 72.23 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.784 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.17 -53.37 50.37 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.08 0.467 . . . . 0.0 110.068 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.9 t -56.86 -40.42 71.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 25' ' ' PRO . . . -57.78 -42.26 83.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.623 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.64 -42.7 93.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.735 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.0 t -60.34 -41.66 94.05 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.011 -0.675 . . . . 0.0 110.138 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.7 mt -63.02 -43.78 99.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.733 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.6 tt -70.23 -29.91 41.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.016 -178.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.09 -50.55 22.23 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.002 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.552 ' O ' HD13 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -65.1 -41.28 91.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.409 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.6 tp -62.47 -36.68 83.23 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.95 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -67.4 -41.99 84.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.944 0.402 . . . . 0.0 110.317 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.84 -57.95 8.29 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.211 0.529 . . . . 0.0 111.441 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.45 HD13 ' HA ' ' A' ' 39' ' ' ILE . 9.2 mm -61.75 -45.78 97.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.828 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.407 ' O ' ' CB ' ' A' ' 44' ' ' ASP . 57.9 tp -60.26 -38.75 84.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.269 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 31.2 t-105 -63.89 -54.05 40.93 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 120.922 0.392 . . . . 0.0 111.486 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 97.1 mt -62.51 -55.32 24.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.141 -0.623 . . . . 0.0 111.813 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.0 tp -60.29 -46.76 88.73 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.072 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.407 ' CB ' ' O ' ' A' ' 40' ' ' LEU . 18.6 t70 -50.5 -47.25 57.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -59.98 -53.03 62.69 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.535 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 47' ' ' PHE . 15.5 mt -73.4 -78.54 0.09 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.034 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.484 ' O ' ' N ' ' A' ' 49' ' ' LYS . 13.3 t80 41.32 -164.5 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.405 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.408 ' N ' ' CG ' ' A' ' 47' ' ' PHE . 20.7 m-85 -64.53 68.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.358 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 47' ' ' PHE . 29.7 mtmm 46.29 47.0 13.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.619 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.428 ' O ' ' N ' ' A' ' 53' ' ' ARG . 90.3 p -69.06 -30.9 69.32 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.631 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.1 mt -44.14 -42.1 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.963 0.411 . . . . 0.0 110.052 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.407 ' CZ ' ' OE1' ' A' ' 56' ' ' GLU . 52.8 t80 -74.85 -28.92 60.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.136 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.522 ' O ' ' CD2' ' A' ' 57' ' ' HIS . 67.9 mtm180 -70.98 -48.25 54.32 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.468 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.434 ' CE1' HD22 ' B' ' 46' ' ' LEU . 54.9 m-85 -71.2 -40.55 71.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.768 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -66.21 -39.57 89.73 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.755 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.407 ' OE1' ' CZ ' ' A' ' 52' ' ' TYR . 15.7 pt-20 -76.35 -41.1 49.4 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.828 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.522 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 10.2 m-70 -60.14 -47.93 83.84 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.53 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.822 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.871 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.744 0.307 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -51.18 -35.66 53.0 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.465 2.11 . . . . 0.0 111.354 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.45 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 15.8 tp -59.38 -51.35 70.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.839 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.93 -43.48 86.31 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 92.0 t -61.93 -33.29 57.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.235 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -64.41 -35.38 80.71 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.26 -45.86 68.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.258 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 3.9 t -66.19 -52.07 51.66 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.331 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.473 HG23 ' N ' ' B' ' 33' ' ' ILE . 10.9 tp -60.77 -43.04 94.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -178.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.473 ' N ' HG23 ' B' ' 32' ' ' ILE . 7.8 tt -69.89 -28.57 37.24 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.08 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.329 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.64 -50.61 41.59 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 mp -62.86 -42.14 95.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 11.0 tp -58.25 -46.96 85.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.889 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -63.9 -52.03 61.8 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 40.9 tp -58.23 -47.09 84.63 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 120.549 -0.461 . . . . 0.0 111.136 -178.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 3.2 mm -63.79 -41.06 91.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.982 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 0.528 HD13 ' O ' ' B' ' 40' ' ' LEU . 0.2 OUTLIER -60.51 -42.6 96.73 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.904 -179.55 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 46.0 t-105 -64.81 -57.22 9.47 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 75.5 mt -58.48 -53.75 42.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.597 -177.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 41.9 tp -59.73 -46.44 89.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.164 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -55.07 -47.28 75.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.648 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -62.75 -48.56 78.64 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.491 -0.483 . . . . 0.0 111.351 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.434 HD22 ' CE1' ' A' ' 54' ' ' PHE . 0.2 OUTLIER -121.54 124.19 43.81 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.125 0.488 . . . . 0.0 110.43 179.381 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -172.98 -47.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.367 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -171.1 65.81 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.389 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm 55.25 35.44 24.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.566 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 11.2 t -60.0 -49.22 78.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.919 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 48.0 mt -47.36 -31.26 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.759 0.314 . . . . 0.0 110.882 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.527 ' CD2' ' OE1' ' B' ' 56' ' ' GLU . 76.2 t80 -70.84 -29.8 66.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.465 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -71.14 -44.01 66.44 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.41 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -71.21 -38.73 72.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.011 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -69.76 -39.28 76.81 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.737 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 56' ' ' GLU . . . . . 0.527 ' OE1' ' CD2' ' B' ' 52' ' ' TYR . 10.6 pt-20 -75.58 -38.51 59.09 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 120.254 -0.579 . . . . 0.0 110.644 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -65.03 -47.23 78.16 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.322 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.0 -28.64 73.78 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 32.9 tp -73.39 -68.72 0.48 Allowed 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.402 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.54 179.946 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -156.74 68.83 4.56 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.899 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -51.23 -30.34 32.63 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.514 2.142 . . . . 0.0 111.141 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 16.8 tp -59.09 -51.52 69.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.757 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.5 -46.97 87.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.033 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 61.3 t -58.82 -42.72 86.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.0 -37.9 72.33 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.47 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.38 -49.77 70.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.103 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 31' ' ' SER . . . . . 0.436 ' OG ' ' CD1' ' B' ' 26' ' ' LEU . 2.9 m -60.23 -50.79 72.26 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.96 -179.047 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 17.5 tt -63.71 -33.68 63.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.983 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 32.3 mt -67.24 -42.21 87.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.441 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.07 -49.51 46.69 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 121.019 -0.61 . . . . 0.0 111.666 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 5.1 mm -61.67 -45.37 98.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.128 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 11.6 tp -61.22 -41.65 97.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.169 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -61.51 -48.67 80.01 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.61 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 31.2 tp -63.19 -52.93 60.34 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -178.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 1.3 mp -60.46 -46.19 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.017 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -62.06 -40.62 96.39 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.821 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 6.7 t-105 -57.71 -58.41 8.46 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.245 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 68.8 mt -62.13 -56.27 18.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -177.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.647 ' C ' HD13 ' C' ' 43' ' ' LEU . 3.0 tm? -57.99 -52.82 63.92 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.177 -178.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -53.35 -41.24 65.59 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -57.61 -56.23 24.63 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.455 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 46' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' C' ' 48' ' ' PHE . 2.2 mt -80.73 -71.12 0.48 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.855 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 47' ' ' PHE . . . . . 0.46 ' CD2' ' N ' ' C' ' 48' ' ' PHE . 85.2 t80 49.26 -89.56 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.181 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 48' ' ' PHE . . . . . 0.51 ' N ' ' O ' ' C' ' 46' ' ' LEU . 68.7 t80 -153.49 85.52 1.19 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.236 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 56.9 mttp 52.09 29.26 6.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.935 0.398 . . . . 0.0 110.187 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 11.3 t -62.47 -39.54 93.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.121 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 54.6 mt -47.08 -48.91 8.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.306 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -71.69 -32.25 67.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.58 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -70.75 -48.07 56.34 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.481 -0.487 . . . . 0.0 110.619 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -66.03 -42.28 89.81 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.226 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -63.09 -39.29 94.26 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.459 -0.497 . . . . 0.0 110.854 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 . . . . . 0 CA--C 1.535 0.39 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.759 179.82 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo . . . . . 0 N--CA 1.485 0.983 0 N-CA-C 110.227 -0.721 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 pp -68.13 -35.4 78.05 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.088 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 27' ' ' ALA . . . . . 0.415 ' O ' ' HB3' ' D' ' 30' ' ' ALA . . . -51.07 -37.95 48.7 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.102 0.477 . . . . 0.0 109.879 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 71.4 t -59.24 -47.42 90.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 CA-C-O 121.428 0.632 . . . . 0.0 109.487 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.33 -39.49 76.0 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.286 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 30' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' D' ' 27' ' ' ALA . . . -58.47 -47.3 84.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.174 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 11.2 t -57.36 -50.21 73.7 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.871 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 61.0 mt -61.35 -31.71 51.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.55 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 55.2 mt -68.19 -40.46 82.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.348 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.99 -52.14 25.28 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.883 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 35' ' ' ILE . . . . . 0.429 HG23 ' N ' ' D' ' 36' ' ' LEU . 15.6 tt -61.95 -42.29 94.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.806 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.429 ' N ' HG23 ' D' ' 35' ' ' ILE . 43.6 tp -63.71 -34.9 78.9 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.985 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -63.67 -50.93 67.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.964 0.411 . . . . 0.0 110.247 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 36.3 tp -58.35 -47.5 83.57 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.85 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 5.0 mm -61.69 -44.37 98.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.319 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 40' ' ' LEU . . . . . 0.561 ' O ' HD23 ' D' ' 40' ' ' LEU . 0.8 OUTLIER -61.82 -39.26 91.17 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 -179.366 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 23.7 t-105 -64.07 -56.6 13.83 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 120.875 0.369 . . . . 0.0 111.434 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 82.1 mt -58.55 -53.2 50.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.777 -177.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 29.9 tp -61.1 -47.4 86.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.881 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -51.91 -44.16 63.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.265 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 45' ' ' ARG . . . . . 0.502 ' HE ' ' CD2' ' D' ' 46' ' ' LEU . 60.1 ttp180 -64.12 -53.45 49.29 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.77 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 46' ' ' LEU . . . . . 0.502 ' CD2' ' HE ' ' D' ' 45' ' ' ARG . 0.2 OUTLIER -113.53 110.31 20.05 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.046 0.451 . . . . 0.0 110.3 179.143 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -174.77 92.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.146 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 53.96 58.16 5.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.539 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? 53.73 52.93 12.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.95 0.405 . . . . 0.0 110.372 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 50' ' ' SER . . . . . 0.524 ' OG ' ' NH2' ' D' ' 53' ' ' ARG . 8.1 t -68.22 -51.76 41.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.227 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 4.7 mt -48.15 -35.01 5.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -72.37 -28.97 63.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.05 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 53' ' ' ARG . . . . . 0.524 ' NH2' ' OG ' ' D' ' 50' ' ' SER . 36.7 mtm105 -71.86 -46.49 57.76 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.96 0.41 . . . . 0.0 110.525 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -70.94 -36.85 72.79 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.788 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -70.06 -39.7 75.49 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.659 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -75.43 -37.73 60.23 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.614 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -65.94 -44.37 85.27 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.27 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.18 -26.74 70.67 Favored Glycine 0 N--CA 1.462 0.374 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.8 70.24 0.77 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.271 0.558 . . . . 0.0 109.728 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 16.3 ttpp . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.512 -179.721 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo . . . . . 0 N--CA 1.491 1.367 0 N-CA-C 110.957 -0.44 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.4 tp -65.21 -50.27 66.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.18 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.452 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -65.43 -50.67 64.54 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.34 0.59 . . . . 0.0 109.568 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.2 t -54.59 -46.68 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.44 -42.36 70.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.691 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -55.72 -47.63 76.54 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.17 0.51 . . . . 0.0 110.567 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 80.8 p -62.39 -39.96 94.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.803 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 35.6 mm -61.97 -47.58 92.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.608 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.9 tt -68.96 -29.64 44.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.7 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.13 -50.21 47.61 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.171 -1.014 . . . . 0.0 110.578 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 28.1 mm -62.91 -44.24 99.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 51.4 tp -63.21 -31.13 72.2 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.433 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -69.5 -52.22 28.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.985 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 32.1 tp -61.76 -51.28 68.99 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.207 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.9 mm -61.86 -43.69 97.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.908 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 35.5 tp -61.2 -38.95 88.39 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.381 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 44.3 t-105 -63.78 -55.17 25.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.824 0.345 . . . . 0.0 111.647 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.7 mt -61.44 -51.65 70.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 120.454 -0.498 . . . . 0.0 111.78 -177.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.407 HD11 ' CD1' ' A' ' 47' ' ' PHE . 23.9 tp -60.96 -42.35 98.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.983 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -57.78 -45.29 86.19 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -60.03 -48.66 80.78 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.484 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.4 pp -130.91 132.87 45.39 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.026 0.441 . . . . 0.0 111.088 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.407 ' CD1' HD11 ' A' ' 43' ' ' LEU . 49.2 t80 -175.41 -38.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.161 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -167.24 60.03 0.08 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.251 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp 60.85 42.47 13.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.38 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.5 t -62.34 -49.91 73.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.696 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 94.1 mt -49.67 -41.96 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.205 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -72.26 -28.5 63.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.216 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.525 ' O ' ' CD2' ' A' ' 57' ' ' HIS . 12.1 mmm180 -69.71 -46.57 65.68 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.317 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -71.41 -40.23 70.61 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.075 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -67.37 -38.18 84.34 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.746 -179.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.52 ' OE2' ' CE1' ' A' ' 57' ' ' HIS . 0.7 OUTLIER -77.5 -38.03 49.91 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.876 -179.974 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.525 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 26.4 m-70 -63.87 -50.54 68.41 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.469 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.468 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 -179.825 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.665 0.269 . . . . 0.0 110.76 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -51.55 -31.4 39.61 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.57 2.18 . . . . 0.0 111.427 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.417 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 19.0 tp -58.76 -51.28 70.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.912 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.62 -46.12 91.46 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 91.8 t -59.74 -35.84 62.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -62.34 -35.63 79.71 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.6 -45.54 71.71 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.387 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 8.4 p -65.5 -51.86 56.94 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.423 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.511 HG23 ' N ' ' B' ' 33' ' ' ILE . 20.0 tt -61.86 -43.05 96.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -178.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.511 ' N ' HG23 ' B' ' 32' ' ' ILE . 8.3 tt -69.16 -30.3 45.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 C-N-CA 119.731 -0.788 . . . . 0.0 110.304 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.52 -50.55 42.7 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 mp -61.58 -41.59 90.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 19.8 tp -60.39 -40.97 92.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.747 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -67.71 -51.76 45.71 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 35.1 tp -61.68 -52.4 64.47 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.614 -178.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.6 mm -62.0 -41.76 92.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.392 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 46.0 tp -59.59 -41.66 90.78 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.249 -0.58 . . . . 0.0 109.944 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 9.9 t-105 -62.5 -59.37 5.05 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.724 0.297 . . . . 0.0 111.724 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 72.0 mt -58.53 -56.52 15.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.635 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.467 ' O ' HD23 ' B' ' 43' ' ' LEU . 0.6 OUTLIER -55.0 -49.78 70.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.641 -178.988 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -52.24 -44.19 64.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.326 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -59.2 -53.01 63.1 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.641 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 2.8 mt -77.45 -141.03 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 119.871 -0.732 . . . . 0.0 110.594 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.424 ' O ' ' O ' ' B' ' 48' ' ' PHE . 47.8 t80 59.78 110.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.615 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 48' ' ' PHE . . . . . 0.545 ' CG ' ' N ' ' B' ' 49' ' ' LYS . 57.5 t80 48.35 -178.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.404 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.545 ' N ' ' CG ' ' B' ' 48' ' ' PHE . 0.1 OUTLIER -72.19 45.42 0.13 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.377 -179.878 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 50' ' ' SER . . . . . 0.401 ' H ' ' C ' ' B' ' 48' ' ' PHE . 11.1 t -62.56 -47.57 83.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.853 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 51.2 mt -48.22 -41.88 10.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.592 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.515 ' CE2' ' OE2' ' B' ' 56' ' ' GLU . 78.9 t80 -71.39 -29.72 65.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.446 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 69.6 mtm180 -68.14 -44.04 76.93 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.412 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -72.26 -39.47 68.37 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.762 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -64.45 -40.84 96.5 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.488 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 56' ' ' GLU . . . . . 0.515 ' OE2' ' CE2' ' B' ' 52' ' ' TYR . 13.2 pt-20 -76.48 -38.79 54.79 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.63 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -59.08 -47.06 86.63 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.174 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.35 -28.37 73.65 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 8.0 tp -88.87 49.06 1.72 Allowed 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.708 0.289 . . . . 0.0 110.468 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm . . . . . 0 N--CA 1.469 0.481 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.627 -179.986 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 25.1 t . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -159.18 70.78 3.46 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.871 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.0 -29.51 36.26 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.621 2.214 . . . . 0.0 111.281 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.59 -56.32 23.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.89 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.2 -46.79 82.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.57 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 74.6 t -58.21 -43.44 85.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.64 -39.93 78.08 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.528 178.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.77 -49.37 76.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.164 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 2.2 t -62.17 -53.79 50.26 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 16.5 tt -58.44 -35.8 55.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.663 -179.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 51.0 mt -67.46 -37.48 78.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.399 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.33 -51.22 28.11 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.93 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -62.82 -43.54 98.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 11.4 tp -63.22 -41.61 99.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.838 0.351 . . . . 0.0 110.237 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -61.61 -48.06 82.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.522 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 51.3 tp -65.0 -51.01 64.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.789 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 50.9 mt -59.3 -48.49 86.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.19 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -63.25 -37.65 88.08 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.671 -0.412 . . . . 0.0 109.981 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 25.5 t-105 -59.35 -59.37 5.56 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.346 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 48.4 mt -62.63 -54.97 26.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.514 -0.474 . . . . 0.0 112.047 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.673 ' C ' HD13 ' C' ' 43' ' ' LEU . 3.2 tm? -57.9 -52.36 65.83 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.196 -178.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 44' ' ' ASP . . . . . 0.454 ' O ' ' CB ' ' C' ' 50' ' ' SER . 67.9 t0 -53.11 -41.94 65.49 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.02 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -58.49 -53.24 60.61 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.791 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 46' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' C' ' 48' ' ' PHE . 3.6 mt -84.53 -71.41 0.52 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.176 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 91.7 t80 56.75 -80.42 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.246 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 48' ' ' PHE . . . . . 0.527 ' N ' ' O ' ' C' ' 46' ' ' LEU . 86.4 t80 -172.91 -22.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.334 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 49' ' ' LYS . . . . . 0.464 ' NZ ' ' CD1' ' C' ' 52' ' ' TYR . 49.8 tttm -170.75 21.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.91 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 50' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' C' ' 44' ' ' ASP . 10.8 t -62.08 -48.47 80.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.282 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 51' ' ' ILE . . . . . 0.426 ' H ' HG13 ' C' ' 51' ' ' ILE . 12.8 mt -50.21 -53.99 9.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.3 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 52' ' ' TYR . . . . . 0.464 ' CD1' ' NZ ' ' C' ' 49' ' ' LYS . 27.7 t80 -70.57 -32.83 70.38 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.668 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 19.9 mmt85 -70.01 -43.41 71.4 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.586 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -66.29 -47.23 74.3 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.176 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -62.2 -36.55 82.27 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.925 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 56' ' ' GLU . . . . . 0.411 ' O ' ' OE1' ' C' ' 56' ' ' GLU . 3.0 tm-20 . . . . . 0 CA--C 1.536 0.428 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.535 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 N--CA 1.494 1.548 0 N-CA-C 111.091 -0.388 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' D' D ' 26' ' ' LEU . . . . . 0.553 ' O ' ' HB3' ' D' ' 29' ' ' ALA . 2.4 pp -65.95 -30.88 71.52 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.678 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.32 -49.7 42.83 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 95.4 t -50.81 -38.09 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 178.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' D' ' 26' ' ' LEU . . . -62.6 -40.06 95.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.639 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.94 -50.48 68.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.268 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 45.9 t -60.51 -51.89 67.53 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.904 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 20.1 tt -63.27 -31.41 52.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.629 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 19.4 mt -67.47 -41.8 86.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.017 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.01 -51.74 32.32 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.121 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 10.7 tp -64.49 -39.18 84.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.402 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 56.8 tp -64.58 -38.64 91.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.109 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 32.4 t60 -65.11 -48.66 72.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.368 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 50.3 tp -59.08 -47.01 86.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.562 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.36 -42.76 94.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.851 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 40.2 mt -61.58 -42.45 98.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.208 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 18.4 t-105 -62.07 -55.58 27.63 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.696 0.284 . . . . 0.0 111.508 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 72.5 mt -60.54 -54.93 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -177.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 40.0 tp -60.92 -44.43 97.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.61 0.243 . . . . 0.0 111.343 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 44' ' ' ASP . . . . . 0.435 ' O ' ' CB ' ' D' ' 50' ' ' SER . 22.6 t70 -58.08 -42.77 86.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.594 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 45' ' ' ARG . . . . . 0.433 ' HG3' HD11 ' D' ' 51' ' ' ILE . 9.8 tpt180 -66.11 -56.61 10.6 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.066 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 46' ' ' LEU . . . . . 0.414 HD23 ' HB3' ' D' ' 45' ' ' ARG . 0.2 OUTLIER -106.67 130.8 54.34 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.376 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -171.76 -43.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.454 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -172.71 -48.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.426 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -172.46 28.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.339 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 50' ' ' SER . . . . . 0.435 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 7.8 t -57.92 -50.93 71.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.181 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 51' ' ' ILE . . . . . 0.433 HD11 ' HG3' ' D' ' 45' ' ' ARG . 7.3 mt -49.39 -39.35 13.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.32 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 52' ' ' TYR . . . . . 0.465 ' CE2' ' OE2' ' D' ' 56' ' ' GLU . 82.5 t80 -73.98 -29.56 62.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.242 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 -68.15 -48.32 65.67 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.916 0.388 . . . . 0.0 110.482 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -72.34 -39.49 68.12 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.752 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -62.1 -41.96 98.74 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.348 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 56' ' ' GLU . . . . . 0.465 ' OE2' ' CE2' ' D' ' 52' ' ' TYR . 14.8 pt-20 -77.49 -37.11 51.88 Favored 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 120.219 -0.592 . . . . 0.0 110.434 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -56.18 -48.89 75.48 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.217 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.82 -27.08 74.16 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.439 -1.065 . . . . 0.0 110.439 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 59' ' ' LEU . . . . . 0.411 ' N ' ' CD2' ' D' ' 59' ' ' LEU . 3.0 mm? -99.29 52.69 0.95 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.025 0.441 . . . . 0.0 109.983 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 63.7 tttp . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.586 179.923 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo . . . . . 0 N--CA 1.491 1.347 0 N-CA-C 111.03 -0.412 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.9 tp -63.3 -49.01 75.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.936 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.497 ' HB1' HD11 ' D' ' 26' ' ' LEU . . . -60.84 -55.08 37.25 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.7 t -51.87 -47.66 40.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.811 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.93 -48.84 64.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.899 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.76 -48.63 66.65 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.787 ' OG ' HD13 ' D' ' 26' ' ' LEU . 0.9 OUTLIER -53.18 -53.01 56.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.482 179.755 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 44.7 mm -53.62 -38.25 33.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.223 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 70.6 mt -69.47 -32.8 54.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.291 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.1 -53.04 15.66 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.855 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -33.97 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.108 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.6 tp -69.41 -35.97 76.27 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.338 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.561 ' CE1' ' CD2' ' B' ' 37' ' ' HIS . 47.9 t60 -70.01 -51.3 33.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.654 0.264 . . . . 0.0 111.054 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.6 tp -62.73 -50.38 71.32 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.934 0.397 . . . . 0.0 111.222 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 29.5 mm -63.32 -44.59 99.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.279 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 50.2 tp -60.66 -43.23 97.91 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.234 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 16.6 t-105 -61.91 -57.24 12.52 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.744 0.307 . . . . 0.0 111.74 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 76.5 mt -59.56 -55.46 23.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.531 -0.467 . . . . 0.0 112.22 -177.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.7 tp -59.73 -46.97 87.51 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.167 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -53.71 -41.78 67.34 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.402 HH22 ' HB3' ' D' ' 54' ' ' PHE . 45.2 ttt-85 -60.59 -51.53 69.04 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.252 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.81 107.42 18.61 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 120.776 -0.369 . . . . 0.0 110.203 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -174.11 100.32 0.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.217 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.508 ' O ' ' CD2' ' A' ' 48' ' ' PHE . 69.3 t80 45.45 52.07 9.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.39 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.0 mttp 55.32 52.94 10.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.618 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.5 t -62.65 -42.78 99.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.96 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.551 ' H ' HD12 ' A' ' 51' ' ' ILE . 3.5 mp -47.74 -31.48 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.504 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -72.95 -28.51 62.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.097 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.542 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 77.9 mtp180 -68.42 -48.04 65.68 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.378 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -71.46 -39.28 71.04 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.795 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -64.36 -39.97 94.94 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.7 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.534 ' OE2' ' CD2' ' A' ' 57' ' ' HIS . 1.6 pp20? -77.01 -41.29 43.32 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.851 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.542 ' ND1' ' O ' ' A' ' 53' ' ' ARG . 23.9 m80 -57.87 -50.49 73.14 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 120.314 -0.554 . . . . 0.0 109.782 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.672 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 179.556 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.785 0.326 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -50.84 -30.6 30.42 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.646 2.231 . . . . 0.0 111.244 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.466 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 19.7 tp -60.85 -50.12 74.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.078 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.43 -43.1 79.08 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 83.7 t -61.37 -34.3 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -64.29 -34.63 78.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.305 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.13 -51.68 43.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.087 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 6.1 p -61.71 -50.42 72.53 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.783 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.425 HG23 ' N ' ' B' ' 33' ' ' ILE . 3.8 tp -62.33 -40.93 89.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.989 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.425 ' N ' HG23 ' B' ' 32' ' ' ILE . 34.1 mt -62.19 -44.3 98.91 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.922 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.04 -53.78 43.56 Favored Glycine 0 N--CA 1.462 0.376 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 96.8 mt -50.55 -39.13 17.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.94 -45.89 90.32 Favored 'General case' 0 C--O 1.219 -0.5 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.28 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 37' ' ' HIS . . . . . 0.561 ' CD2' ' CE1' ' A' ' 37' ' ' HIS . 1.4 t60 -60.35 -48.58 81.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.592 -178.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.423 HD12 ' N ' ' B' ' 38' ' ' LEU . 9.6 mp -64.07 -47.86 78.45 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.741 -178.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 18.1 mm -62.52 -47.93 90.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.295 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 7.1 mp -63.66 -34.01 76.9 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 28.6 t-105 -64.66 -57.26 9.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 120.89 0.376 . . . . 0.0 111.262 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 77.7 mt -60.0 -51.73 69.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.773 -178.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 8.6 mt -63.4 -50.94 67.85 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.502 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 44' ' ' ASP . . . . . 0.478 ' O ' ' CB ' ' B' ' 50' ' ' SER . 36.3 t70 -53.4 -41.94 66.46 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.325 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -65.3 -45.45 84.32 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.946 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 2.5 pp -139.5 124.08 18.32 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.266 0.555 . . . . 0.0 111.507 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -173.79 -31.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.879 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 48' ' ' PHE . . . . . 0.415 ' O ' ' CD2' ' B' ' 48' ' ' PHE . 63.4 t80 -167.4 58.93 0.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.051 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 97.5 mttt 55.14 53.95 9.47 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.504 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 50' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' B' ' 44' ' ' ASP . 3.0 p -68.39 -52.28 34.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.995 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 51' ' ' ILE . . . . . 0.407 ' N ' ' OG ' ' B' ' 50' ' ' SER . 80.6 mt -50.3 -46.73 25.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.974 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.518 ' CE2' ' OE2' ' B' ' 56' ' ' GLU . 86.5 t80 -71.25 -29.82 65.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.317 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 33.1 mmm-85 -70.76 -44.7 66.2 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.831 0.348 . . . . 0.0 110.541 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 54' ' ' PHE . . . . . 0.401 ' HB3' HH22 ' C' ' 45' ' ' ARG . 55.0 m-85 -71.64 -39.23 70.53 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.881 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -68.18 -38.97 82.6 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.684 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 56' ' ' GLU . . . . . 0.518 ' OE2' ' CE2' ' B' ' 52' ' ' TYR . 11.5 pt-20 -76.16 -38.54 56.55 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.569 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -62.88 -47.67 82.33 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.235 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.79 -27.58 72.24 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 9.9 tp -89.38 59.46 4.83 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-O 120.837 0.351 . . . . 0.0 110.275 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp . . . . . 0 N--CA 1.466 0.372 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.287 -179.984 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -35.83 100.54 0.2 Allowed Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.45 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.85 -34.79 37.75 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.044 1.83 . . . . 0.0 111.559 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 26' ' ' LEU . . . . . 0.401 ' C ' ' CD1' ' C' ' 26' ' ' LEU . 0.2 OUTLIER -58.48 -55.69 31.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.489 0.662 . . . . 0.0 109.477 179.428 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.49 -45.63 88.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.427 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 88.0 t -56.9 -40.19 70.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.9 -37.65 85.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.761 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.41 -51.24 64.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.542 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 10.4 p -63.44 -51.45 65.66 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 120.689 -0.404 . . . . 0.0 112.04 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 20.7 tt -59.85 -36.51 66.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.764 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 41.3 mt -68.5 -39.56 80.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.64 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.78 -52.81 31.19 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.734 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 6.8 pt -61.91 -42.59 95.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.295 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 8.7 tp -63.82 -34.34 77.69 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.313 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -66.75 -52.67 41.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.241 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 33.1 tp -61.9 -49.44 76.19 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.045 0.45 . . . . 0.0 111.121 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 30.3 mm -59.79 -43.89 92.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.73 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 25.7 mt -62.34 -40.28 95.84 Favored 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.919 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 25.0 t-105 -59.58 -52.31 66.1 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.308 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 65.9 mt -66.68 -56.59 13.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.266 -0.574 . . . . 0.0 112.411 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.65 ' C ' HD13 ' C' ' 43' ' ' LEU . 2.9 tm? -58.28 -52.09 67.05 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.886 -178.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -52.93 -43.38 66.24 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.22 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 45' ' ' ARG . . . . . 0.401 HH22 ' HB3' ' B' ' 54' ' ' PHE . 52.9 ttt-85 -58.84 -52.09 67.21 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.853 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 46' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' C' ' 48' ' ' PHE . 8.5 mt -79.59 -73.95 0.32 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 120.274 -0.571 . . . . 0.0 111.263 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 49.3 t80 62.03 -71.32 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.407 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 48' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' C' ' 46' ' ' LEU . 66.2 t80 -172.75 -32.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.261 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 46.6 tttp -172.96 26.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.917 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 39.6 t -63.73 -42.23 97.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.298 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 58.3 mt -48.98 -52.78 9.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.389 -179.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -74.86 -32.64 61.96 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -71.73 -49.58 37.94 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.673 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -67.66 -43.32 80.53 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.428 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -64.88 -35.87 82.54 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.829 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 . . . . . 0 CA--C 1.534 0.336 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.561 179.262 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo . . . . . 0 N--CA 1.488 1.176 0 N-CA-C 110.878 -0.47 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 26' ' ' LEU . . . . . 0.787 HD13 ' OG ' ' A' ' 31' ' ' SER . 3.9 pp -66.18 -42.71 88.52 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.832 179.282 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 27' ' ' ALA . . . . . 0.574 ' N ' HD12 ' D' ' 26' ' ' LEU . . . -49.31 -53.47 21.81 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.558 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 87.7 t -48.1 -36.98 6.49 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.06 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' D' ' 26' ' ' LEU . . . -65.58 -37.04 85.52 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.275 0.56 . . . . 0.0 109.818 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.94 -51.22 60.43 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.883 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 58.4 m -62.43 -50.44 71.48 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 3.3 tp -62.29 -35.84 71.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.73 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 37.7 mt -68.03 -38.21 79.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.07 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.38 -50.76 42.02 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.15 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 35' ' ' ILE . . . . . 0.477 HG23 ' N ' ' D' ' 36' ' ' LEU . 18.4 tt -66.05 -42.75 92.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.347 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.477 ' N ' HG23 ' D' ' 35' ' ' ILE . 7.2 tp -60.62 -38.5 84.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.864 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -66.92 -45.43 77.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.604 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 31.6 tp -57.67 -54.3 48.46 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.195 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 13.6 pt -64.08 -37.31 79.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.816 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 17.9 mt -58.82 -42.55 89.48 Favored 'General case' 0 C--O 1.224 -0.263 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 33.5 t-105 -64.58 -51.44 62.72 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.101 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 mm -56.48 -56.72 12.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.531 -0.467 . . . . 0.0 111.771 -177.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 36.6 tp -62.03 -45.23 94.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.789 0.328 . . . . 0.0 110.8 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -50.76 -44.44 58.61 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.004 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -66.48 -54.57 22.52 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.564 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.72 105.62 15.74 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.279 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -172.99 95.79 0.12 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.313 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 52.2 51.69 15.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.742 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 18.0 mtpp 54.44 49.75 17.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.594 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 10.9 t -61.85 -46.36 89.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.992 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 38.2 mt -49.44 -39.11 13.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.656 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -72.72 -28.86 62.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.112 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 35.7 mtm105 -71.5 -47.49 55.08 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.984 0.421 . . . . 0.0 110.56 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 54' ' ' PHE . . . . . 0.402 ' HB3' HH22 ' A' ' 45' ' ' ARG . 73.6 m-85 -71.16 -35.16 71.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.739 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -70.64 -37.91 73.81 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.604 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -77.51 -37.89 50.11 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.644 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -66.16 -48.63 70.11 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.504 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.86 -27.34 72.0 Favored Glycine 0 N--CA 1.461 0.311 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.13 77.15 1.77 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 57.3 tttm . . . . . 0 C--N 1.333 -0.111 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.539 -179.695 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.443 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 52.9 Cg_exo . . . . . 0 N--CA 1.491 1.345 0 N-CA-C 111.115 -0.379 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.3 tp -65.56 -50.73 64.09 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.059 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.437 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -63.43 -50.23 70.61 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.392 0.615 . . . . 0.0 109.567 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.3 t -57.94 -45.27 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 25' ' ' PRO . . . -55.6 -35.36 65.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.779 179.21 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -64.55 -50.05 68.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.413 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.423 ' OG ' HD13 ' D' ' 26' ' ' LEU . 9.6 m -58.52 -41.09 84.65 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.477 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 35.5 mm -64.52 -41.74 93.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.505 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 33' ' ' ILE . 2.6 tt -68.43 -35.61 71.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.627 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.26 -51.47 32.53 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 89.3 mt -60.7 -43.87 95.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.96 0.409 . . . . 0.0 110.067 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.2 tp -65.01 -31.07 72.13 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.364 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.462 ' HD1' ' C ' ' A' ' 37' ' ' HIS . 0.3 OUTLIER -68.55 -51.97 37.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.805 0.336 . . . . 0.0 110.903 -179.517 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 51.2 tp -62.58 -51.44 67.31 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.265 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 83.5 mt -61.98 -44.58 99.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.076 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 35.0 tp -60.32 -41.72 94.09 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.322 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.1 t-105 -62.59 -57.78 9.88 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 120.95 0.405 . . . . 0.0 111.516 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 95.3 mt -56.64 -54.72 25.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.925 -177.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 47' ' ' PHE . 29.0 tp -61.97 -44.01 97.64 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.025 -178.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -50.43 -45.95 56.13 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 57.7 ttt85 -61.71 -52.72 63.12 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.14 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 48' ' ' PHE . 5.6 mt -81.93 -77.38 0.22 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.806 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.464 ' N ' ' O ' ' A' ' 43' ' ' LEU . 92.6 t80 52.9 -83.69 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.8 0.333 . . . . 0.0 110.415 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.525 ' N ' ' O ' ' A' ' 46' ' ' LEU . 49.9 t80 -157.39 81.43 0.9 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.119 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.6 mttm 51.28 25.35 2.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.244 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 53' ' ' ARG . 3.9 t -61.76 -29.66 70.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.587 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.9 mt -45.34 -37.0 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.988 0.423 . . . . 0.0 110.06 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -74.37 -27.58 60.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.001 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.537 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 95.7 mtt-85 -71.61 -48.63 46.84 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.542 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -71.33 -38.93 71.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.006 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -69.87 -38.87 76.55 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 120.829 -0.349 . . . . 0.0 111.724 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.523 ' OE2' ' CD2' ' A' ' 57' ' ' HIS . 0.8 OUTLIER -75.84 -38.42 58.05 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.785 -179.871 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.537 ' ND1' ' O ' ' A' ' 53' ' ' ARG . 27.8 m170 -66.39 -44.95 81.64 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.449 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.38 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 179.889 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.655 0.264 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.42 ' O ' ' HB2' ' B' ' 29' ' ' ALA . 64.4 Cg_exo -49.68 -28.96 18.36 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.365 2.043 . . . . 0.0 111.241 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 19.4 tp -60.85 -51.19 70.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.86 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 27' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' B' ' 30' ' ' ALA . . . -65.64 -51.68 57.7 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.362 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 14.7 t -56.97 -42.33 78.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' B' ' 25' ' ' PRO . . . -55.82 -43.91 77.41 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 30' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' B' ' 27' ' ' ALA . . . -56.43 -44.85 80.81 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.384 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -61.35 -48.99 78.77 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.299 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 74.7 mt -57.39 -48.73 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.743 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 15.5 tt -67.96 -27.16 36.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.695 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.7 -49.18 57.2 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.2 mp -67.78 -41.13 84.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 12.4 tp -55.87 -52.05 65.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.925 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -67.36 -40.65 85.82 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.308 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 48.1 tp -63.29 -57.86 9.02 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 120.652 -0.419 . . . . 0.0 112.097 -178.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 4.6 tt -66.56 -36.87 78.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.812 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 52.5 tp -63.98 -36.74 84.98 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.539 -0.465 . . . . 0.0 109.966 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -67.73 -56.67 8.37 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.805 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.538 ' CG2' ' N ' ' B' ' 43' ' ' LEU . 8.3 tt -62.38 -47.63 92.13 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.476 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.071 -177.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.538 ' N ' ' CG2' ' B' ' 42' ' ' ILE . 17.8 tp -63.92 -47.0 82.29 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.338 -177.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 44' ' ' ASP . . . . . 0.422 ' O ' ' OG ' ' B' ' 50' ' ' SER . 41.7 t0 -57.96 -38.28 75.72 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 70.2 ttt-85 -69.67 -45.79 67.56 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.082 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 2.7 pp -133.62 125.61 29.11 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.098 0.475 . . . . 0.0 110.904 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.508 ' CD1' HD11 ' B' ' 43' ' ' LEU . 66.2 t80 -173.74 -37.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.551 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -172.21 56.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.297 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp 60.62 43.23 12.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.43 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 50' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' B' ' 44' ' ' ASP . 13.4 t -63.73 -51.02 66.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.817 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 73.1 mt -46.53 -40.46 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.856 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.522 ' CE2' ' OE2' ' B' ' 56' ' ' GLU . 92.0 t80 -71.65 -30.2 65.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.55 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.523 ' O ' ' CD2' ' B' ' 57' ' ' HIS . 93.5 mtt180 -70.63 -45.12 65.81 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.011 0.434 . . . . 0.0 110.655 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -71.66 -38.06 70.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.824 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -68.48 -39.1 81.49 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.529 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 56' ' ' GLU . . . . . 0.522 ' OE2' ' CE2' ' B' ' 52' ' ' TYR . 12.4 pt-20 -75.92 -39.4 56.31 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 120.296 -0.561 . . . . 0.0 110.683 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 57' ' ' HIS . . . . . 0.523 ' CD2' ' O ' ' B' ' 53' ' ' ARG . 9.9 m-70 -63.5 -45.5 90.41 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.552 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.45 -28.49 73.19 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 5.1 tp -89.66 33.2 0.84 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.872 0.367 . . . . 0.0 110.336 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 60' ' ' LYS . . . . . 0.586 ' HZ3' ' HE3' ' C' ' 49' ' ' LYS . 25.3 pttm . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.597 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 24' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' C' ' 24' ' ' ASP . 6.8 p30 -170.65 72.55 0.57 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.787 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -51.54 -33.59 48.52 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 C-N-CA 122.152 1.901 . . . . 0.0 111.047 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 18.5 tp -64.81 -50.43 66.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.97 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 27' ' ' ALA . . . . . 0.408 ' O ' ' HB3' ' C' ' 30' ' ' ALA . . . -60.52 -48.06 83.41 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.507 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 28' ' ' VAL . . . . . 0.401 ' O ' ' OG ' ' C' ' 31' ' ' SER . 48.2 t -57.28 -42.58 80.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.12 -42.23 80.5 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 30' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' C' ' 27' ' ' ALA . . . -57.58 -49.86 75.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.553 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 31' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' C' ' 28' ' ' VAL . 2.5 p -56.85 -46.74 81.55 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.93 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 52.4 mt -61.36 -33.91 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.518 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 3.4 mm -67.37 -42.78 87.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.072 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.1 -51.63 32.47 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.942 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 35' ' ' ILE . . . . . 0.463 HG23 ' N ' ' C' ' 36' ' ' LEU . 14.8 tt -63.26 -41.62 93.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.762 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.463 ' N ' HG23 ' C' ' 35' ' ' ILE . 56.0 tp -64.96 -38.43 90.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.273 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.3 t60 -63.96 -50.68 67.64 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 28.5 tp -61.57 -48.29 81.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.494 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 66.9 mt -61.41 -43.16 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.291 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 40' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' C' ' 40' ' ' LEU . 36.6 mt -64.23 -40.29 95.73 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.398 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 10.3 t-105 -61.98 -60.72 3.21 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.114 0.483 . . . . 0.0 111.431 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 42' ' ' ILE . . . . . 0.554 ' CG2' ' N ' ' C' ' 43' ' ' LEU . 9.0 tt -58.6 -50.82 77.69 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.579 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.691 -177.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.627 ' C ' HD13 ' C' ' 43' ' ' LEU . 2.7 tm? -61.26 -53.6 54.71 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.792 -177.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 44' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' C' ' 44' ' ' ASP . 68.2 t0 -52.01 -34.43 42.78 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 45' ' ' ARG . . . . . 0.46 ' O ' ' CD1' ' C' ' 51' ' ' ILE . 39.0 ttt-85 -69.03 -51.07 42.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.012 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 20.2 mt -79.96 -126.29 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.935 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 5.4 t80 72.75 -155.26 0.08 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.084 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -71.57 65.4 0.47 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.549 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 49' ' ' LYS . . . . . 0.586 ' HE3' ' HZ3' ' B' ' 60' ' ' LYS . 49.7 mttp 54.87 52.57 11.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.938 0.399 . . . . 0.0 110.092 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 38.7 t -62.14 -40.97 97.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.221 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 51' ' ' ILE . . . . . 0.472 ' H ' HD12 ' C' ' 51' ' ' ILE . 3.7 mp -46.87 -47.5 8.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.356 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -72.36 -29.79 64.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.549 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -69.99 -47.24 62.98 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.685 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -69.58 -41.18 76.17 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.346 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -62.52 -39.69 94.37 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.837 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 CA--C 1.537 0.457 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.199 179.602 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo . . . . . 0 N--CA 1.491 1.342 0 N-CA-C 110.83 -0.488 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' D' D ' 26' ' ' LEU . . . . . 0.423 HD13 ' OG ' ' A' ' 31' ' ' SER . 2.9 pp -57.13 -29.25 63.41 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.019 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 27' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' D' ' 30' ' ' ALA . . . -50.03 -41.6 47.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.776 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 79.0 t -57.31 -44.48 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.42 -29.88 70.21 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.681 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 30' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' D' ' 27' ' ' ALA . . . -69.88 -42.31 73.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.778 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 16.0 p -69.61 -46.42 66.32 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.675 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 9.5 tt -67.99 -40.16 82.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.554 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 13.0 tt -71.28 -32.38 46.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.43 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.82 -52.49 14.71 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 35' ' ' ILE . . . . . 0.435 HG23 ' N ' ' D' ' 36' ' ' LEU . 19.0 tt -63.12 -39.89 86.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.912 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.435 ' N ' HG23 ' D' ' 35' ' ' ILE . 43.8 tp -63.9 -37.52 87.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.911 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 37' ' ' HIS . . . . . 0.502 ' HD1' ' C ' ' D' ' 37' ' ' HIS . 0.3 OUTLIER -64.05 -50.06 69.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.431 -179.918 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 32.0 tp -57.98 -47.64 82.38 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.698 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 97.7 mt -60.78 -43.82 96.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.16 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 40' ' ' LEU . . . . . 0.547 HD13 ' O ' ' D' ' 40' ' ' LEU . 0.2 OUTLIER -61.89 -40.86 96.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.181 -179.45 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 41' ' ' TRP . . . . . 0.505 ' HE1' HH21 ' D' ' 45' ' ' ARG . 30.8 t-105 -62.09 -55.02 33.22 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.739 0.304 . . . . 0.0 111.287 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 79.2 mt -60.03 -55.98 20.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.913 -178.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 52.7 tp -58.34 -41.5 84.79 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.841 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 44' ' ' ASP . . . . . 0.426 ' O ' ' CB ' ' D' ' 50' ' ' SER . 4.2 t70 -58.54 -40.84 84.1 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 45' ' ' ARG . . . . . 0.505 HH21 ' HE1' ' D' ' 41' ' ' TRP . 14.8 ttm180 -62.78 -50.91 69.17 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.546 -0.461 . . . . 0.0 110.445 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.39 109.45 21.44 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.001 0.429 . . . . 0.0 109.908 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -173.18 86.53 0.06 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.374 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 53.71 55.64 8.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.419 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt 60.35 52.19 4.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.223 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 50' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 0.3 OUTLIER -58.79 -42.23 88.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.73 -179.59 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 51' ' ' ILE . . . . . 0.731 HD13 ' H ' ' D' ' 51' ' ' ILE . 0.0 OUTLIER -55.37 -43.52 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -70.59 -28.24 64.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.122 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -68.7 -44.61 73.59 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.42 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -72.16 -40.99 67.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.775 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -63.19 -41.04 99.12 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.449 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -76.94 -36.89 56.24 Favored 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.562 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -58.44 -49.81 75.98 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.406 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.47 -27.35 73.07 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -93.86 57.55 2.49 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 86.8 tttt . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.53 -179.96 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 90.3 p . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 4.3 p30 -163.18 74.39 1.93 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.805 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.42 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 56.5 Cg_exo -50.51 -35.36 45.57 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.137 1.891 . . . . 0.0 110.904 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 18.6 tp -64.81 -51.52 61.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.972 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.23 -51.57 65.69 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.142 0.496 . . . . 0.0 109.928 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 49.2 t -56.91 -42.86 79.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.651 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 25' ' ' PRO . . . -55.93 -45.49 78.73 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.73 -46.04 81.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.113 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.3 t -56.05 -50.66 70.34 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.332 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 55.3 mt -56.59 -37.82 54.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.611 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 87.5 mt -65.37 -41.88 92.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.055 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.13 -52.32 37.59 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.643 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.5 -44.6 93.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 52.4 tp -63.9 -32.06 73.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.485 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -68.62 -51.66 39.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.817 0.341 . . . . 0.0 111.043 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 28.8 tp -63.04 -51.22 67.59 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.29 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.8 mm -61.58 -44.33 98.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.983 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 47.5 tp -61.54 -38.91 89.15 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.302 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 39.9 t-105 -63.5 -55.72 21.79 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.87 0.367 . . . . 0.0 111.405 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 74.8 mt -59.47 -54.18 38.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.802 -177.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 44.9 tp -61.25 -44.66 96.89 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.961 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -51.98 -44.87 64.23 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.472 ' NH2' ' CB ' ' D' ' 54' ' ' PHE . 65.8 ttt180 -61.2 -50.89 71.29 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.255 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.5 mt -81.73 -131.3 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.78 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 39.5 t80 62.47 101.31 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.592 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 41.73 38.83 1.03 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.605 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 66.9 mttm 53.39 49.42 19.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.158 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.9 t -49.49 -27.37 4.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.632 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.452 ' CD1' ' O ' ' A' ' 45' ' ' ARG . 3.6 mp -47.5 -45.33 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.9 0.381 . . . . 0.0 110.093 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.519 ' CE2' ' OE1' ' A' ' 56' ' ' GLU . 86.8 t80 -71.15 -29.04 64.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.175 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.527 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 79.5 mtp180 -69.02 -45.53 70.27 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.027 0.441 . . . . 0.0 110.33 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -70.69 -37.11 73.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.651 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -67.91 -39.91 83.49 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 120.629 -0.429 . . . . 0.0 111.661 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.519 ' OE1' ' CE2' ' A' ' 52' ' ' TYR . 21.9 pt-20 -76.41 -40.1 51.72 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.145 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.527 ' ND1' ' O ' ' A' ' 53' ' ' ARG . 32.6 m170 -64.77 -45.84 84.65 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.757 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.9 -27.89 73.18 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.774 -0.931 . . . . 0.0 110.774 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.9 tp -85.86 50.28 1.94 Allowed 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.807 0.337 . . . . 0.0 110.425 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.558 -179.868 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -159.86 70.16 3.12 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.72 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -51.63 -32.87 46.43 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.492 2.128 . . . . 0.0 111.27 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.462 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 19.2 tp -61.5 -47.31 86.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.904 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.93 -46.15 91.82 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 91.9 t -60.56 -33.39 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -63.39 -35.65 81.12 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.77 -44.07 74.43 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.386 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 4.8 t -67.02 -51.32 56.34 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 120.081 -0.648 . . . . 0.0 111.563 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.464 HG23 ' N ' ' B' ' 33' ' ' ILE . 19.9 tt -62.72 -40.96 90.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.738 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.464 ' N ' HG23 ' B' ' 32' ' ' ILE . 17.4 tt -71.68 -28.44 31.01 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.14 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.247 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.15 -52.22 28.85 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 6.4 pt -64.27 -42.94 96.99 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.217 0 C-N-CA 120.234 -0.587 . . . . 0.0 109.902 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 11.5 tp -59.75 -39.44 84.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.67 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' HIS . . . . . 0.545 ' NE2' ' NE2' ' C' ' 37' ' ' HIS . 28.9 t60 -68.0 -54.46 18.27 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -178.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 38.5 tp -62.12 -51.54 67.48 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 120.999 0.428 . . . . 0.0 111.761 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.478 ' N ' ' CD1' ' B' ' 39' ' ' ILE . 1.2 mp -62.18 -43.36 97.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.229 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 37.0 tp -59.46 -38.49 80.9 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.98 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 6.8 t-105 -63.85 -63.23 1.22 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.998 0.428 . . . . 0.0 111.611 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.548 ' CG2' ' N ' ' B' ' 43' ' ' LEU . 8.6 tt -53.25 -50.89 44.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 119.944 -0.703 . . . . 0.0 110.74 -177.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.548 ' N ' ' CG2' ' B' ' 42' ' ' ILE . 0.5 OUTLIER -57.65 -50.23 73.86 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.46 -178.128 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -50.27 -37.27 35.17 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 63.9 ttt-85 -68.95 -50.99 44.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.084 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.438 ' O ' ' O ' ' B' ' 43' ' ' LEU . 0.3 OUTLIER -96.79 128.47 43.77 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.614 -179.398 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -162.53 -54.29 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.422 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -170.92 -60.31 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.303 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -147.87 18.46 1.13 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.316 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 47.3 t -54.34 -49.84 68.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.729 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 49.9 mt -53.84 -50.05 54.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.986 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.479 ' CE2' ' OE2' ' B' ' 56' ' ' GLU . 79.2 t80 -74.18 -30.6 62.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.748 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 20.1 mmt85 -69.15 -47.75 64.15 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.705 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' PHE . . . . . 0.409 ' HB3' HH22 ' C' ' 45' ' ' ARG . 47.9 m-85 -72.6 -39.77 67.04 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.872 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -64.08 -41.39 97.34 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 120.751 -0.379 . . . . 0.0 111.462 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' GLU . . . . . 0.479 ' OE2' ' CE2' ' B' ' 52' ' ' TYR . 10.9 pt-20 -76.92 -38.07 54.13 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 120.404 -0.519 . . . . 0.0 110.738 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -59.58 -49.27 78.4 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.35 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.21 -29.48 74.43 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 9.6 tp -87.29 58.12 4.83 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.802 0.334 . . . . 0.0 110.296 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 62.8 mttp . . . . . 0 N--CA 1.466 0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.399 -179.904 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -157.71 72.29 4.24 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.778 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -51.04 -35.69 51.62 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.485 2.123 . . . . 0.0 111.221 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 26' ' ' LEU . . . . . 0.414 ' O ' ' HB3' ' C' ' 29' ' ' ALA . 15.3 tp -58.16 -53.07 62.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.958 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.25 -46.09 91.0 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.044 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 89.9 t -60.25 -33.46 53.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 29' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' C' ' 26' ' ' LEU . . . -64.07 -38.39 90.9 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.95 -51.32 62.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.106 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 2.8 p -62.01 -52.27 64.67 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.595 -0.442 . . . . 0.0 112.022 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 10.1 tp -59.37 -37.71 70.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.489 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 29.6 mt -63.14 -40.86 90.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.73 -52.1 45.71 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.65 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 50.2 mm -56.7 -48.24 81.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.551 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 7.4 tp -62.73 -34.3 76.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.834 0.35 . . . . 0.0 110.816 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 37' ' ' HIS . . . . . 0.545 ' NE2' ' NE2' ' B' ' 37' ' ' HIS . 1.5 t60 -65.12 -50.16 67.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.431 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 11.0 mp -66.56 -44.86 81.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.411 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 30.6 mm -63.34 -47.14 93.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.268 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 34.8 mt -65.9 -40.46 91.55 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.666 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 32.7 t-105 -61.27 -54.47 43.69 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.021 0.439 . . . . 0.0 111.607 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 82.8 mt -65.43 -55.0 22.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.113 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.651 ' C ' HD13 ' C' ' 43' ' ' LEU . 2.9 tm? -59.83 -52.37 65.76 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.141 -178.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 44' ' ' ASP . . . . . 0.499 ' OD1' ' CE1' ' C' ' 54' ' ' PHE . 66.4 t0 -52.86 -41.77 64.6 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.107 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 45' ' ' ARG . . . . . 0.409 HH22 ' HB3' ' B' ' 54' ' ' PHE . 55.1 ttt-85 -59.94 -53.55 56.58 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.224 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 46' ' ' LEU . . . . . 0.403 ' O ' ' CB ' ' C' ' 47' ' ' PHE . 4.1 mt -84.08 -140.42 0.07 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.091 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 47' ' ' PHE . . . . . 0.529 ' O ' ' N ' ' C' ' 49' ' ' LYS . 7.2 t80 78.63 -164.22 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.168 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 48' ' ' PHE . . . . . 0.406 ' O ' ' C ' ' C' ' 49' ' ' LYS . 85.9 t80 -57.03 81.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.406 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 49' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' C' ' 47' ' ' PHE . 15.9 ptpt 33.27 53.34 0.41 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.122 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 42.9 t -57.88 -46.32 85.06 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.302 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 51' ' ' ILE . . . . . 0.553 ' H ' HD12 ' C' ' 51' ' ' ILE . 3.5 mp -43.46 -42.48 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.944 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -71.11 -31.2 67.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.455 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 53' ' ' ARG . . . . . 0.515 ' O ' ' CG ' ' C' ' 57' ' ' HIS . 76.0 mtp180 -70.13 -46.73 64.16 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.512 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 54' ' ' PHE . . . . . 0.499 ' CE1' ' OD1' ' C' ' 44' ' ' ASP . 32.2 m-85 -66.14 -43.49 86.93 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.29 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -61.67 -39.9 93.03 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.693 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -76.62 -22.82 53.64 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.894 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 57' ' ' HIS . . . . . 0.515 ' CG ' ' O ' ' C' ' 53' ' ' ARG . 5.8 m-70 -72.28 -46.14 57.11 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.909 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.2 -28.79 73.19 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 5.7 tp -93.21 31.26 1.5 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.78 0.324 . . . . 0.0 110.373 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt . . . . . 0 N--CA 1.469 0.479 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.496 -179.93 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 9.2 p . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 24' ' ' ASP . . . . . 0.461 ' O ' ' N ' ' D' ' 27' ' ' ALA . 19.2 p30 -166.06 63.11 0.82 Allowed Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.498 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -45.41 -27.3 3.18 Favored 'Trans proline' 0 C--N 1.3 -2.005 0 C-N-CA 121.518 1.478 . . . . 0.0 110.496 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 pp -67.86 -37.53 81.94 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.7 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 27' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' D' ' 24' ' ' ASP . . . -51.4 -40.38 59.16 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.741 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 90.4 t -57.58 -45.21 86.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.67 -32.79 70.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.265 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 30' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' D' ' 27' ' ' ALA . . . -67.61 -35.41 78.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.992 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 5.1 t -68.38 -50.84 50.2 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.519 -0.473 . . . . 0.0 111.081 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 63.9 mt -64.72 -40.33 88.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.407 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 33' ' ' ILE . . . . . 0.401 HG21 HD13 ' D' ' 33' ' ' ILE . 6.8 tt -68.95 -35.68 70.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.893 -178.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.72 -52.64 14.48 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.673 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 35' ' ' ILE . . . . . 0.47 HG23 ' N ' ' D' ' 36' ' ' LEU . 10.3 tp -63.15 -40.83 90.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.934 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.47 ' N ' HG23 ' D' ' 35' ' ' ILE . 52.4 tp -63.4 -37.46 87.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.755 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -63.07 -50.74 69.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.465 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 37.3 tp -57.04 -48.3 78.87 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.554 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.05 -41.26 85.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.67 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 37.9 mt -62.32 -39.41 92.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.186 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 31.5 t-105 -63.33 -54.4 37.62 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.798 0.332 . . . . 0.0 111.23 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 61.5 mt -61.77 -53.19 51.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 120.65 -0.42 . . . . 0.0 112.11 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' D' ' 46' ' ' LEU . 37.0 tp -61.51 -48.38 81.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.12 -178.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 44' ' ' ASP . . . . . 0.443 ' O ' ' CB ' ' D' ' 50' ' ' SER . 32.3 t70 -54.36 -45.69 72.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.209 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -60.1 -50.23 74.54 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.513 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 46' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' D' ' 43' ' ' LEU . 2.8 pp -122.73 125.62 45.9 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.056 0.455 . . . . 0.0 110.583 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -174.19 -45.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.539 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 48' ' ' PHE . . . . . 0.527 ' O ' ' NH1' ' D' ' 53' ' ' ARG . 77.8 t80 -172.92 67.96 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.293 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 67.2 mttm 55.94 39.48 30.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.278 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 50' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 6.6 t -64.15 -52.78 57.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.921 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 62.1 mt -49.0 -34.34 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.856 0.36 . . . . 0.0 110.264 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -72.53 -29.85 63.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.01 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 53' ' ' ARG . . . . . 0.527 ' NH1' ' O ' ' D' ' 48' ' ' PHE . 95.3 mtm-85 -72.09 -48.2 45.74 Favored 'General case' 0 CA--C 1.522 -0.122 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.616 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 54' ' ' PHE . . . . . 0.472 ' CB ' ' NH2' ' A' ' 45' ' ' ARG . 87.4 m-85 -68.04 -42.09 81.08 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.792 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -65.64 -40.94 93.06 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.279 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -77.18 -21.87 53.33 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.61 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -74.28 -48.71 26.82 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.318 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.41 -31.47 78.98 Favored Glycine 0 N--CA 1.46 0.265 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 59' ' ' LEU . . . . . 0.402 ' C ' ' CD1' ' D' ' 59' ' ' LEU . 0.2 OUTLIER -65.1 -62.69 1.4 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.831 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 97.3 mttt . . . . . 0 C--N 1.333 -0.131 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.573 179.675 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -167.77 70.14 0.89 Allowed Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.605 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -49.62 -29.13 18.43 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 C-N-CA 121.783 1.655 . . . . 0.0 110.905 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.411 HD13 ' HB3' ' B' ' 31' ' ' SER . 2.1 pp -70.53 -30.21 66.9 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.704 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -56.09 -40.41 73.59 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 120.586 -0.446 . . . . 0.0 109.815 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.7 t -58.54 -45.84 90.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.423 ' O ' HG22 ' A' ' 33' ' ' ILE . . . -60.45 -32.26 71.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.755 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -65.24 -47.31 77.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.553 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.5 p -65.28 -35.05 79.82 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.409 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.5 mm -66.07 -50.51 68.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.607 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.423 HG22 ' O ' ' A' ' 29' ' ' ALA . 15.4 tt -68.87 -28.61 40.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.795 -179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.99 -48.86 30.69 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.497 -0.858 . . . . 0.0 111.121 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.0 mm -64.51 -44.49 96.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.808 0.337 . . . . 0.0 110.162 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.2 tp -63.63 -39.21 93.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.034 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -63.32 -46.1 88.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.268 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 16.6 tp -65.66 -47.55 75.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.843 0.354 . . . . 0.0 111.535 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 29.2 mm -61.66 -50.1 81.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.408 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -65.77 -33.02 74.9 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.23 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 21.0 t-105 -64.3 -52.62 57.64 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.811 0.339 . . . . 0.0 111.406 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.3 mt -67.75 -50.38 60.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.82 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.469 HD11 ' CD1' ' A' ' 47' ' ' PHE . 22.7 tp -61.94 -44.89 95.83 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.03 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.439 ' O ' ' CB ' ' A' ' 50' ' ' SER . 28.4 t70 -58.99 -44.58 91.63 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.811 -0.355 . . . . 0.0 110.119 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 61.8 ttt85 -60.39 -45.04 95.0 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.612 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.5 pp -135.74 129.9 33.32 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.919 0.39 . . . . 0.0 110.996 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.469 ' CD1' HD11 ' A' ' 43' ' ' LEU . 60.2 t80 -173.83 -33.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.366 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.471 ' O ' ' CD2' ' A' ' 48' ' ' PHE . 52.9 t80 -172.52 45.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.164 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt 73.28 40.69 0.52 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.235 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.462 ' O ' ' N ' ' A' ' 53' ' ' ARG . 9.8 t -62.12 -46.24 89.89 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.004 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 91.2 mt -44.13 -38.97 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.025 0.44 . . . . 0.0 110.26 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -74.99 -28.26 60.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.217 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.53 ' O ' ' CD2' ' A' ' 57' ' ' HIS . 87.1 mtt180 -68.76 -49.48 58.33 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 121.007 0.432 . . . . 0.0 110.344 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -71.35 -39.97 70.96 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.876 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -64.76 -40.35 95.15 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.795 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -76.86 -41.17 45.0 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.971 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.53 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 9.2 m-70 -59.73 -48.43 81.73 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.665 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.01 -28.32 73.75 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.6 tp -88.43 50.45 1.97 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.762 0.315 . . . . 0.0 110.335 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.599 -179.948 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 12.3 m . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 51.29 69.02 2.78 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.683 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -49.95 -36.75 44.93 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.447 2.098 . . . . 0.0 111.242 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.442 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 18.2 tp -57.5 -50.72 72.16 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.939 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.21 -51.24 70.4 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 93.1 t -54.6 -38.82 43.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -57.86 -40.25 79.71 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.72 -40.14 94.83 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.232 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' SER . . . . . 0.411 ' HB3' HD13 ' A' ' 26' ' ' LEU . 31.9 p -67.22 -55.76 12.7 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.587 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.446 HG23 ' N ' ' B' ' 33' ' ' ILE . 18.5 tt -59.7 -41.13 84.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.904 -178.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.446 ' N ' HG23 ' B' ' 32' ' ' ILE . 16.3 tt -70.05 -29.76 41.28 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.213 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.76 -51.05 37.76 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.0 mp -61.03 -43.66 96.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 12.3 tp -60.91 -38.24 85.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.684 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -66.94 -52.72 39.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.706 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 42.0 tp -62.45 -50.54 71.06 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.602 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.453 HD13 ' HA ' ' B' ' 39' ' ' ILE . 14.7 mm -61.36 -42.19 92.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.423 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 6.4 tt -61.91 -38.82 89.82 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.075 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 49.9 t-105 -63.65 -55.49 23.12 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 60.2 mt -63.65 -53.47 44.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.767 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.503 ' O ' HD23 ' B' ' 43' ' ' LEU . 0.8 OUTLIER -57.88 -47.34 83.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.128 -178.755 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -59.72 -45.98 90.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.928 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -58.71 -52.33 66.17 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.058 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.11 129.82 56.77 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 120.996 0.427 . . . . 0.0 110.277 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -175.04 -55.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.296 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -169.31 71.74 0.08 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.306 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 49.5 mttp 60.14 30.19 19.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.469 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 11.0 t -56.31 -50.84 70.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.857 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 59.2 mt -51.9 -44.37 37.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.889 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.494 ' CE2' ' OE1' ' B' ' 56' ' ' GLU . 78.2 t80 -71.99 -32.2 66.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.474 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.529 ' O ' ' CG ' ' B' ' 57' ' ' HIS . 78.7 mtp180 -67.67 -45.99 73.66 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.724 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -71.89 -38.94 69.91 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.792 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -64.18 -41.22 97.19 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.49 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 56' ' ' GLU . . . . . 0.494 ' OE1' ' CE2' ' B' ' 52' ' ' TYR . 21.1 pt-20 -76.78 -39.02 52.96 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.692 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 57' ' ' HIS . . . . . 0.529 ' CG ' ' O ' ' B' ' 53' ' ' ARG . 6.4 m-70 -58.63 -48.21 81.76 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.657 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.31 -28.5 73.64 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 11.0 mp -104.64 66.68 0.79 Allowed 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 97.6 mttt . . . . . 0 N--CA 1.466 0.336 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.362 -179.791 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 49.14 68.66 3.3 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.674 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -51.65 -31.57 41.28 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.496 2.131 . . . . 0.0 111.186 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 26' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' C' ' 29' ' ' ALA . 3.0 pp -60.69 -28.24 68.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.781 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -46.94 -38.9 11.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.259 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 68.2 t -59.78 -40.96 84.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 29' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' C' ' 26' ' ' LEU . . . -62.33 -34.42 76.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.392 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.18 -49.5 69.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.927 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 4.4 p -64.6 -50.79 65.81 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 3.2 tp -60.17 -37.94 75.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.559 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 51.1 mt -67.73 -38.0 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.654 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.5 -51.81 34.46 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.804 -0.713 . . . . 0.0 111.967 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 9.6 pt -64.45 -37.9 81.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.467 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 13.0 tp -65.7 -40.73 92.59 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -63.86 -52.61 59.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.587 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 50.9 tp -63.63 -47.8 79.87 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.652 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 84.4 mt -59.92 -45.35 95.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.143 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.5 -38.82 92.34 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.906 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 25.7 t-105 -59.46 -57.21 13.99 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.334 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 54.1 mt -63.75 -54.53 30.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -177.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.501 ' O ' HD23 ' C' ' 43' ' ' LEU . 0.8 OUTLIER -58.45 -48.98 78.96 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.75 0.309 . . . . 0.0 111.191 -178.443 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 44' ' ' ASP . . . . . 0.502 ' O ' ' CB ' ' C' ' 50' ' ' SER . 38.7 t70 -57.49 -48.67 78.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.986 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 45' ' ' ARG . . . . . 0.488 ' NH1' HD11 ' C' ' 51' ' ' ILE . 34.2 ttt-85 -56.79 -52.8 63.65 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.229 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 46' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' C' ' 43' ' ' LEU . 2.6 pp -113.68 129.94 56.49 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.132 0.491 . . . . 0.0 110.977 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -173.81 -39.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.329 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -169.51 -67.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.368 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -150.44 25.63 0.78 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.096 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 50' ' ' SER . . . . . 0.502 ' CB ' ' O ' ' C' ' 44' ' ' ASP . 6.6 t -50.23 -53.65 26.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.559 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 51' ' ' ILE . . . . . 0.488 HD11 ' NH1' ' C' ' 45' ' ' ARG . 66.3 mt -50.68 -49.41 25.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.212 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -73.6 -31.11 63.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.687 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 53' ' ' ARG . . . . . 0.471 ' O ' ' CG ' ' C' ' 57' ' ' HIS . 84.3 mtt-85 -70.42 -49.4 49.24 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.428 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -67.36 -41.47 85.05 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.351 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -62.61 -38.68 91.13 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 120.484 -0.487 . . . . 0.0 110.809 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -78.67 -22.48 46.71 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.916 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 57' ' ' HIS . . . . . 0.471 ' CG ' ' O ' ' C' ' 53' ' ' ARG . 2.8 m-70 -73.26 -48.24 36.42 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.355 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.91 -27.69 70.66 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 10.9 mp -105.42 66.87 0.75 Allowed 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.453 -179.89 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 26.5 p . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -162.23 83.7 1.64 Allowed Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.083 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 25' ' ' PRO . . . . . 0.425 ' O ' ' N ' ' D' ' 29' ' ' ALA . 76.0 Cg_exo -49.41 -37.86 42.11 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 121.863 1.709 . . . . 0.0 110.819 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 26' ' ' LEU . . . . . 0.443 ' O ' ' HB3' ' D' ' 29' ' ' ALA . 25.9 tp -56.48 -48.47 77.07 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.2 -51.2 71.0 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.21 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 89.3 t -60.28 -29.16 43.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.57 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' D' ' 26' ' ' LEU . . . -66.88 -37.05 83.68 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.32 -38.41 74.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.561 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 1.4 m -68.98 -47.57 65.25 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.7 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 32' ' ' ILE . . . . . 0.435 HG23 ' N ' ' D' ' 33' ' ' ILE . 10.0 tp -69.11 -41.22 81.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.632 -178.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 33' ' ' ILE . . . . . 0.435 ' N ' HG23 ' D' ' 32' ' ' ILE . 9.9 tt -67.06 -39.95 84.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.498 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.65 -51.03 32.73 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.879 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 35' ' ' ILE . . . . . 0.426 HD13 ' O ' ' D' ' 35' ' ' ILE . 0.2 OUTLIER -59.93 -43.59 92.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.409 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.405 ' N ' ' CG2' ' D' ' 35' ' ' ILE . 49.7 tp -60.41 -39.6 87.96 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.89 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -61.35 -48.4 81.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.29 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 57.4 tp -55.47 -52.79 62.46 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.837 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 39' ' ' ILE . . . . . 0.408 HD13 ' CD1' ' D' ' 35' ' ' ILE . 1.4 mp -61.88 -33.23 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.443 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 6.1 tp -65.49 -42.97 91.56 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.717 0.294 . . . . 0.0 110.576 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 21.9 t-105 -66.13 -58.75 4.74 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 120.883 0.373 . . . . 0.0 111.54 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 42' ' ' ILE . . . . . 0.519 ' CG2' ' N ' ' D' ' 43' ' ' LEU . 9.1 tt -60.47 -47.39 92.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.466 -177.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.519 ' N ' ' CG2' ' D' ' 42' ' ' ILE . 23.0 tp -63.43 -44.86 93.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.564 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 44' ' ' ASP . . . . . 0.516 ' OD1' ' CE1' ' D' ' 54' ' ' PHE . 40.8 t0 -56.44 -37.69 70.59 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 45' ' ' ARG . . . . . 0.512 ' HB3' HD23 ' D' ' 46' ' ' LEU . 12.4 ttm180 -69.42 -53.53 18.86 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.895 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 46' ' ' LEU . . . . . 0.512 HD23 ' HB3' ' D' ' 45' ' ' ARG . 0.2 OUTLIER -117.08 113.5 22.39 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.987 0.422 . . . . 0.0 110.149 179.367 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -174.8 83.9 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.074 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 54.97 71.61 0.53 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.525 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 98.5 mttt 51.2 48.89 22.18 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.289 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 2.6 t -68.79 -52.85 25.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.127 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 9.4 mt -47.74 -37.54 5.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.087 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -73.87 -31.27 63.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.133 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -71.08 -47.2 59.67 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.877 0.37 . . . . 0.0 110.772 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 54' ' ' PHE . . . . . 0.516 ' CE1' ' OD1' ' D' ' 44' ' ' ASP . 64.9 m-85 -71.74 -37.35 70.59 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.763 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -67.84 -41.16 83.41 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.615 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -76.71 -36.96 56.86 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.72 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 62.7 t-80 -63.49 -48.31 78.15 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.299 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.04 -27.91 73.55 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 5.9 tp -92.96 39.07 1.03 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.871 0.367 . . . . 0.0 110.326 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 3.1 tmtm? . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.386 -179.666 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.1 t . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 51.31 70.86 1.73 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.854 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.35 -34.05 48.52 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.603 2.202 . . . . 0.0 111.661 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 pp -62.64 -29.8 70.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.06 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.457 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -50.48 -34.48 25.14 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.152 0.501 . . . . 0.0 109.982 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.2 t -59.13 -48.81 85.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 CA-C-O 121.539 0.685 . . . . 0.0 109.274 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.22 -30.69 71.27 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.567 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -63.68 -47.36 81.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.213 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.9 t -62.22 -48.07 81.6 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.866 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.2 mp -62.12 -33.51 58.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.293 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 38.4 mt -70.49 -38.92 75.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 121.123 -0.231 . . . . 0.0 110.759 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.15 -53.48 18.08 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.393 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.464 HG23 ' N ' ' A' ' 36' ' ' LEU . 19.2 tt -60.24 -41.1 85.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.728 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.464 ' N ' HG23 ' A' ' 35' ' ' ILE . 40.5 tp -66.42 -30.87 71.33 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.35 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -68.55 -48.97 62.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.472 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.5 mp -63.86 -50.36 69.15 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.978 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 86.1 mt -62.13 -48.1 90.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.378 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.7 tp -61.08 -42.1 97.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.701 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.7 t-105 -62.46 -56.26 19.85 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 120.865 0.364 . . . . 0.0 111.518 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.03 -55.24 24.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.871 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.2 tp -61.24 -48.15 82.78 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.289 -0.564 . . . . 0.0 111.36 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -53.58 -39.15 64.6 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 42.1 ttt-85 -63.49 -51.17 66.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.442 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 48' ' ' PHE . 7.1 mt -83.18 -77.05 0.26 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.023 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.416 ' CD2' ' N ' ' A' ' 48' ' ' PHE . 88.4 t80 46.69 -88.25 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.415 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.534 ' N ' ' O ' ' A' ' 46' ' ' LEU . 62.5 t80 -164.39 87.33 0.48 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.099 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm 59.14 27.47 16.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.13 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.8 t -59.78 -44.47 93.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.657 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.439 ' H ' HD12 ' A' ' 51' ' ' ILE . 3.3 mp -52.19 -36.38 20.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.01 0.433 . . . . 0.0 110.068 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.495 ' CD2' ' OE2' ' A' ' 56' ' ' GLU . 81.4 t80 -74.01 -27.78 61.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.221 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 48' ' ' PHE . 68.2 mtt85 -69.97 -49.33 52.76 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.96 0.409 . . . . 0.0 110.559 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -72.03 -39.17 69.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.945 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -66.79 -39.69 87.86 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.711 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.495 ' OE2' ' CD2' ' A' ' 52' ' ' TYR . 10.1 pt-20 -76.17 -40.36 52.66 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.658 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.529 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 6.4 m-70 -60.68 -47.43 86.29 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.54 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.68 -30.11 75.8 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.6 tp -87.8 27.63 1.13 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.95 0.375 . . . . 0.0 110.316 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.013 -179.771 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 94.8 p . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -160.83 79.4 2.31 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.709 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -50.4 -29.33 23.56 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.511 2.141 . . . . 0.0 111.606 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 14.3 tp -61.64 -52.29 64.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.189 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' B' ' 30' ' ' ALA . . . -58.98 -46.34 88.36 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.609 0.719 . . . . 0.0 109.384 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 72.5 t -56.69 -47.11 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.1 -44.38 52.07 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' B' ' 27' ' ' ALA . . . -56.69 -50.35 72.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.796 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 60.7 p -57.45 -48.81 78.19 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 120.309 -0.557 . . . . 0.0 111.447 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 34.1 mm -59.67 -35.64 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.114 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 86.3 mt -70.24 -34.43 58.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.572 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.85 -52.94 21.86 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.497 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 7.9 pt -64.7 -39.97 87.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.1 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 37.3 tp -62.23 -40.03 94.8 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.47 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -66.85 -53.68 30.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.732 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 34.8 tp -61.99 -53.21 58.74 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.737 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 56.7 mt -60.48 -44.22 95.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.794 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 32.5 tp -56.72 -43.26 80.42 Favored 'General case' 0 C--O 1.222 -0.364 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 21.7 t-105 -60.44 -54.19 48.58 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.161 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 5.2 mm -54.02 -58.34 3.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-O 121.237 0.541 . . . . 0.0 111.921 -177.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.665 ' C ' HD12 ' B' ' 43' ' ' LEU . 0.3 OUTLIER -62.4 -35.8 80.33 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.78 -178.488 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 44' ' ' ASP . . . . . 0.429 ' O ' ' OG ' ' B' ' 50' ' ' SER . 22.8 t70 -58.1 -44.84 87.87 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -65.77 -45.01 84.09 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.444 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.509 ' C ' ' H ' ' B' ' 48' ' ' PHE . 0.3 OUTLIER -113.74 -120.49 0.3 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.098 179.485 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.482 ' H ' HD12 ' B' ' 46' ' ' LEU . 37.3 t80 68.06 -35.29 0.27 Allowed 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.15 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' PHE . . . . . 0.509 ' H ' ' C ' ' B' ' 46' ' ' LEU . 31.0 t80 -169.06 42.97 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.678 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt 45.05 40.38 4.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.57 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' SER . . . . . 0.461 ' O ' ' N ' ' B' ' 53' ' ' ARG . 1.4 p -61.8 -24.02 66.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.857 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 9.4 mt -41.55 -41.05 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.878 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -74.25 -29.69 61.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.379 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.461 ' N ' ' O ' ' B' ' 50' ' ' SER . 99.2 mtt180 -71.53 -47.61 54.11 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.935 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 54' ' ' PHE . . . . . 0.596 ' CE1' ' NH2' ' C' ' 45' ' ' ARG . 66.6 m-85 -72.81 -39.7 66.43 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.939 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -67.87 -39.26 83.76 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.644 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -76.93 -38.83 52.62 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.614 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -62.02 -47.29 85.42 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.259 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.12 -27.48 72.95 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 35.2 tp -79.85 -73.76 0.33 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.711 0.291 . . . . 0.0 110.541 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 68.5 mttm . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.601 -179.995 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 17.9 m . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 24' ' ' ASP . . . . . 0.459 ' HB2' ' HB3' ' C' ' 27' ' ' ALA . 0.7 OUTLIER -177.54 56.53 0.11 Allowed Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.493 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.77 -30.42 68.91 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.104 1.869 . . . . 0.0 110.698 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 26' ' ' LEU . . . . . 0.431 ' O ' ' HB3' ' C' ' 29' ' ' ALA . 19.2 tp -68.8 -48.26 64.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.068 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 27' ' ' ALA . . . . . 0.459 ' HB3' ' HB2' ' C' ' 24' ' ' ASP . . . -59.61 -46.91 87.58 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.234 0.54 . . . . 0.0 109.615 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 82.1 t -59.39 -34.34 54.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.247 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 29' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' C' ' 26' ' ' LEU . . . -63.91 -34.85 78.88 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.47 -42.71 78.35 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.231 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 6.6 t -68.45 -48.48 64.45 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.189 -0.604 . . . . 0.0 111.802 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 32' ' ' ILE . . . . . 0.406 HG23 ' N ' ' C' ' 33' ' ' ILE . 14.6 tt -66.03 -40.84 88.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.64 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 33' ' ' ILE . . . . . 0.406 ' N ' HG23 ' C' ' 32' ' ' ILE . 14.7 tt -69.22 -36.4 72.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.703 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.09 -51.45 38.97 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 120.497 -0.858 . . . . 0.0 110.973 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 34.7 mm -60.6 -41.21 87.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 13.4 tp -60.45 -45.02 95.18 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.361 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 37' ' ' HIS . . . . . 0.476 ' C ' ' ND1' ' C' ' 37' ' ' HIS . 9.1 t-80 -60.82 -52.29 65.71 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.84 0.352 . . . . 0.0 111.379 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 55.4 tp -56.6 -48.62 77.04 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.05 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 56.1 mt -63.79 -34.47 68.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.006 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 40' ' ' LEU . . . . . 0.516 ' O ' HD13 ' C' ' 40' ' ' LEU . 0.2 OUTLIER -64.52 -48.64 74.37 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.633 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 15.3 t-105 -62.81 -56.96 12.74 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 73.6 mt -59.48 -51.91 67.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.872 -177.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.622 ' C ' HD13 ' C' ' 43' ' ' LEU . 2.8 tm? -58.87 -50.77 72.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.504 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -56.88 -35.16 68.62 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.025 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 45' ' ' ARG . . . . . 0.596 ' NH2' ' CE1' ' B' ' 54' ' ' PHE . 50.8 ttp180 -69.95 -57.68 4.74 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.831 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 46' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' C' ' 43' ' ' LEU . 1.1 pp -108.17 -164.34 0.95 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.66 0.267 . . . . 0.0 111.058 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 12.2 t80 74.42 -11.12 1.05 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.919 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 48' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' C' ' 49' ' ' LYS . 32.2 t80 -164.09 158.0 18.84 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.468 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 49' ' ' LYS . . . . . 0.541 ' N ' ' CD1' ' C' ' 48' ' ' PHE . 36.5 tttm -72.52 42.38 0.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.285 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 50' ' ' SER . . . . . 0.456 ' H ' ' C ' ' C' ' 48' ' ' PHE . 6.7 t -66.47 -47.5 72.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.0 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 71.5 mt -43.95 -42.17 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.941 -0.303 . . . . 0.0 111.306 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -72.47 -29.82 64.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.302 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -71.3 -49.66 40.51 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.535 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 54' ' ' PHE . . . . . 0.404 ' CB ' ' NH2' ' D' ' 45' ' ' ARG . 45.7 m-85 -65.68 -44.24 86.83 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.38 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -63.06 -36.47 83.69 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.527 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -75.53 -24.77 56.79 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.63 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -73.34 -46.14 51.06 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 120.241 -0.584 . . . . 0.0 109.836 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.51 -27.2 73.94 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 8.8 tp -90.67 57.21 3.52 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-O 120.801 0.334 . . . . 0.0 110.49 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 86.9 tttt . . . . . 0 N--CA 1.467 0.393 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.447 -179.929 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 46.8 t . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 48.43 90.06 0.08 OUTLIER Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.62 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -47.61 -30.12 11.8 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.945 1.763 . . . . 0.0 111.263 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 16.9 tp -61.53 -51.72 67.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.652 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.63 -44.99 93.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.44 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 88.9 t -59.48 -38.44 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.88 -35.32 76.33 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.93 -51.12 59.15 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.08 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 6.1 p -61.18 -50.52 72.82 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.786 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 3.3 tp -62.11 -37.65 78.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.596 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 29.4 mt -62.72 -41.31 91.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 120.399 -0.521 . . . . 0.0 109.673 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.97 -46.15 83.31 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.06 -0.59 . . . . 0.0 111.957 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.61 -47.48 93.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.918 0.389 . . . . 0.0 110.523 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 21.6 tp -64.18 -32.17 73.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.055 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -64.87 -49.94 68.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.005 0.431 . . . . 0.0 110.523 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 46.9 tp -63.12 -46.55 86.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.1 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.42 -47.62 91.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.122 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -62.54 -37.88 87.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.241 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 40.4 t-105 -62.27 -57.29 11.94 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.524 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 62.0 mt -61.45 -53.57 46.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.954 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 55.9 tp -58.76 -47.22 85.43 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.946 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -54.33 -45.26 72.62 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 45' ' ' ARG . . . . . 0.424 ' HB3' HD23 ' D' ' 46' ' ' LEU . 77.0 ttt180 -59.18 -53.13 61.84 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.402 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 46' ' ' LEU . . . . . 0.424 HD23 ' HB3' ' D' ' 45' ' ' ARG . 0.1 OUTLIER -109.91 113.3 25.92 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 120.904 0.383 . . . . 0.0 110.185 179.055 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -173.67 91.89 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.42 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 54.29 59.19 4.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.416 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 49' ' ' LYS . . . . . 0.462 ' HB3' ' HZ2' ' D' ' 49' ' ' LYS . 5.2 mtpm? 53.69 54.61 9.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.49 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 5.6 t -68.11 -52.01 39.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.134 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 58.0 mt -48.5 -35.13 5.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.627 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -70.81 -29.93 66.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.085 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -69.63 -42.62 74.08 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.963 0.411 . . . . 0.0 110.464 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -72.09 -39.37 69.0 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.802 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -66.09 -40.74 91.04 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.511 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 56' ' ' GLU . . . . . 0.44 ' CD ' ' N ' ' D' ' 57' ' ' HIS . 2.9 pp20? -76.39 -37.13 57.6 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.501 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 57' ' ' HIS . . . . . 0.44 ' N ' ' CD ' ' D' ' 56' ' ' GLU . 86.3 t60 -60.69 -51.69 68.28 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.275 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.07 -26.66 73.42 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 14.7 tp -152.86 88.0 1.31 Allowed 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 64.5 mttp . . . . . 0 N--CA 1.458 -0.042 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.497 -179.617 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.3 p . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 46.01 73.38 1.0 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.734 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.78 -34.68 55.62 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.474 2.116 . . . . 0.0 111.226 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.439 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 16.2 tp -63.65 -53.22 54.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.032 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.2 -41.93 85.06 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 95.8 t -63.41 -32.35 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.241 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 26' ' ' LEU . . . -65.48 -36.21 83.2 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.43 -50.12 55.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.955 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.8 p -61.15 -50.09 74.57 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.683 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.0 tp -63.98 -34.19 66.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.072 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.1 mt -68.44 -43.04 84.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.553 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.28 -51.45 37.96 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.013 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 35' ' ' ILE . 9.7 tt -62.27 -40.09 86.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.017 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.402 ' N ' ' CG2' ' A' ' 35' ' ' ILE . 48.5 tp -64.57 -36.02 82.88 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.304 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -67.33 -50.9 58.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.803 0.335 . . . . 0.0 110.964 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 26.9 tp -61.74 -52.65 63.4 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.713 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 60.9 mt -62.73 -48.4 88.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.097 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 43.3 tp -54.78 -43.29 72.68 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 17.8 t-105 -60.67 -54.37 46.12 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.304 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.436 ' CG2' ' N ' ' A' ' 43' ' ' LEU . 1.0 OUTLIER -54.27 -48.9 66.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.002 -177.601 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.436 ' N ' ' CG2' ' A' ' 42' ' ' ILE . 20.6 tp -64.4 -41.9 96.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.386 -178.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -59.45 -36.24 75.57 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -71.18 -51.45 24.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.823 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.6 pp -123.67 125.34 44.61 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.109 0.48 . . . . 0.0 110.707 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -173.95 -43.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.251 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -172.48 67.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.263 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 68.2 mttm 55.43 38.55 30.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.411 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 34.8 t -63.35 -48.07 79.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.806 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 80.0 mt -48.69 -39.1 10.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.926 0.393 . . . . 0.0 109.989 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.517 ' CE2' ' OE2' ' A' ' 56' ' ' GLU . 93.3 t80 -70.98 -29.56 65.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.314 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.515 ' O ' ' CD2' ' A' ' 57' ' ' HIS . 90.2 mtt-85 -69.12 -44.17 72.93 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.125 0.488 . . . . 0.0 110.388 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.524 ' CB ' HH21 ' B' ' 45' ' ' ARG . 58.2 m-85 -70.94 -40.68 71.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.804 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -65.75 -39.27 90.91 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.744 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.517 ' OE2' ' CE2' ' A' ' 52' ' ' TYR . 12.5 pt-20 -76.47 -40.43 50.42 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.902 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.515 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 6.9 m-70 -60.98 -52.26 65.75 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.487 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.27 -25.76 73.7 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.5 tp -148.1 87.78 1.62 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm . . . . . 0 C--N 1.333 -0.136 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.644 -179.739 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 70.7 m . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -160.04 80.87 2.41 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.682 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -50.7 -33.04 38.47 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.407 2.072 . . . . 0.0 111.309 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.454 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 17.7 tp -61.13 -51.2 70.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.064 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.75 -42.42 97.38 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 91.6 t -61.67 -34.91 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -61.37 -40.41 94.2 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.94 -50.98 68.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.07 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 4.3 p -60.17 -53.11 61.64 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 8.8 tp -60.16 -38.48 77.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.993 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 69.2 mt -64.41 -40.3 88.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.029 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.8 -52.31 49.31 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 48.4 mm -56.36 -43.38 77.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.971 0.415 . . . . 0.0 110.034 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 11.4 tp -62.12 -36.1 80.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.654 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' HIS . . . . . 0.607 ' NE2' ' NE2' ' C' ' 37' ' ' HIS . 18.8 t60 -67.96 -54.43 18.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.942 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 40.2 tp -62.68 -49.94 73.11 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.63 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' B' ' 39' ' ' ILE . 15.8 mm -62.29 -44.03 98.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.513 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 43.8 tp -59.17 -39.9 83.95 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.534 -0.466 . . . . 0.0 109.877 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 21.8 t-105 -63.47 -56.28 17.38 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.413 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 94.6 mt -55.41 -51.57 55.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.141 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 mt -60.21 -44.82 94.83 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.216 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -58.71 -37.82 76.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.805 0.336 . . . . 0.0 110.657 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.524 HH21 ' CB ' ' A' ' 54' ' ' PHE . 61.8 ttt85 -68.93 -48.34 63.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.067 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.416 HD23 ' HB3' ' B' ' 45' ' ' ARG . 0.1 OUTLIER -118.46 111.8 19.12 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 120.974 0.416 . . . . 0.0 110.371 179.503 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -175.46 87.79 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.185 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 48.8 t80 58.43 60.41 2.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.462 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp 54.76 47.88 21.43 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.522 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 6.5 t -62.93 -49.82 73.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.859 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 10.9 mt -48.55 -40.82 11.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.704 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -71.34 -28.69 64.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.53 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -69.38 -43.51 73.37 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.606 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -73.47 -44.58 57.7 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.938 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -62.93 -40.08 96.53 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.513 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -77.49 -37.32 51.42 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.549 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -58.63 -48.19 81.87 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.348 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.32 -33.07 84.99 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -81.89 -72.36 0.44 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 63.4 tttm . . . . . 0 C--N 1.331 -0.209 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.379 -179.896 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 29.6 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -159.96 71.3 3.14 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.856 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -51.26 -30.96 35.19 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.446 2.097 . . . . 0.0 111.273 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 12.0 tp -61.02 -52.04 66.68 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.906 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 27' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' C' ' 30' ' ' ALA . . . -60.27 -46.59 89.31 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.019 178.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 76.5 t -57.15 -47.27 84.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.79 -42.2 57.85 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 30' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' C' ' 27' ' ' ALA . . . -59.13 -49.58 77.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.919 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 1.1 p -57.8 -50.94 71.59 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.283 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 22.1 mm -61.79 -29.57 46.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.65 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 2.3 mm -68.18 -41.35 83.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.35 -52.64 25.61 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.574 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 48.1 mm -60.88 -43.98 96.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.887 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 12.5 tp -63.93 -40.67 96.98 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 37' ' ' HIS . . . . . 0.607 ' NE2' ' NE2' ' B' ' 37' ' ' HIS . 57.1 t60 -60.95 -48.66 80.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.88 0.371 . . . . 0.0 111.173 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 38' ' ' LEU . . . . . 0.439 HD11 HD11 ' C' ' 42' ' ' ILE . 29.6 tp -65.05 -50.8 64.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.106 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 4.3 mm -60.21 -47.52 91.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.389 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 40' ' ' LEU . . . . . 0.407 ' O ' ' CB ' ' C' ' 44' ' ' ASP . 3.1 mm? -64.58 -36.95 85.9 Favored 'General case' 0 C--O 1.22 -0.476 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.036 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 41' ' ' TRP . . . . . 0.458 ' CZ3' ' CZ2' ' D' ' 41' ' ' TRP . 14.2 t-105 -60.47 -53.95 51.41 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.141 0.495 . . . . 0.0 111.257 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 42' ' ' ILE . . . . . 0.439 HD11 HD11 ' C' ' 38' ' ' LEU . 90.4 mt -66.85 -56.41 14.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.052 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.491 ' O ' HD23 ' C' ' 43' ' ' LEU . 0.6 OUTLIER -56.43 -48.19 77.52 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.642 -178.62 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 44' ' ' ASP . . . . . 0.407 ' CB ' ' O ' ' C' ' 40' ' ' LEU . 28.9 t70 -53.8 -45.7 70.84 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 60.3 ttt85 -58.22 -52.19 66.61 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.069 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 9.8 mt -72.28 -76.87 0.1 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.511 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 47' ' ' PHE . . . . . 0.492 ' CG ' ' N ' ' C' ' 48' ' ' PHE . 37.4 t80 52.4 -177.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.176 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 48' ' ' PHE . . . . . 0.492 ' N ' ' CG ' ' C' ' 47' ' ' PHE . 39.0 m-85 -56.24 -41.36 75.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.954 0.407 . . . . 0.0 110.34 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -171.91 48.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.102 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 5.1 t -69.95 -45.88 66.5 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.65 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 64.5 mt -44.48 -55.68 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -74.96 -34.91 62.1 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 53' ' ' ARG . . . . . 0.46 ' O ' ' CG ' ' C' ' 57' ' ' HIS . 96.9 mtt180 -71.24 -49.99 37.59 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.819 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -66.04 -43.85 86.32 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.232 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -63.22 -36.64 84.33 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.702 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -77.58 -23.61 49.92 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 120.384 -0.527 . . . . 0.0 110.879 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 57' ' ' HIS . . . . . 0.46 ' CG ' ' O ' ' C' ' 53' ' ' ARG . 38.4 m170 -73.5 -48.69 31.29 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.038 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.38 -31.21 79.66 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 18.0 tp -65.16 -58.54 5.75 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.758 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 65.9 tttm . . . . . 0 C--N 1.331 -0.196 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.518 179.906 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 89.0 p . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -157.19 58.54 1.56 Allowed Pre-proline 0 N--CA 1.465 0.288 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.634 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.56 -29.61 36.61 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.022 1.815 . . . . 0.0 110.8 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 26' ' ' LEU . . . . . 0.453 ' O ' ' HB3' ' D' ' 29' ' ' ALA . 14.1 tp -60.29 -51.96 67.3 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.509 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.46 -47.9 82.5 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 94.4 t -58.47 -33.73 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.197 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' D' ' 26' ' ' LEU . . . -64.43 -35.77 81.99 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.41 -39.09 81.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.392 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.96 -53.44 26.14 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.28 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 32' ' ' ILE . . . . . 0.415 HG23 ' N ' ' D' ' 33' ' ' ILE . 16.8 tt -62.65 -40.12 87.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.67 -178.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 33' ' ' ILE . . . . . 0.418 HG21 HD13 ' D' ' 33' ' ' ILE . 9.2 tt -70.05 -30.7 44.94 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 C-N-CA 120.179 -0.608 . . . . 0.0 110.282 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.68 -53.3 16.67 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 2.1 mp -60.87 -43.92 96.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 11.9 tp -62.31 -34.55 76.82 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.447 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -66.09 -49.99 65.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.655 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 50.2 tp -60.33 -50.94 71.64 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.045 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 4.9 mm -60.26 -43.44 93.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 33.6 mt -61.56 -40.88 96.31 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.272 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 41' ' ' TRP . . . . . 0.458 ' CZ2' ' CZ3' ' C' ' 41' ' ' TRP . 40.4 t-105 -62.52 -53.96 47.0 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.64 0.257 . . . . 0.0 111.451 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 66.1 mt -63.49 -54.25 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -177.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' D' ' 46' ' ' LEU . 54.5 tp -61.57 -45.39 94.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.406 -178.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 44' ' ' ASP . . . . . 0.439 ' O ' ' CB ' ' D' ' 50' ' ' SER . 11.6 t70 -64.04 -32.39 73.93 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.466 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 56.2 ttt-85 -69.07 -56.31 8.12 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.262 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 46' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' D' ' 43' ' ' LEU . 0.1 OUTLIER -105.76 -167.39 1.31 Allowed 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.588 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 9.9 t80 72.86 124.96 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.78 0.324 . . . . 0.0 110.291 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 48' ' ' PHE . . . . . 0.436 ' CD2' ' O ' ' D' ' 48' ' ' PHE . 40.7 t80 59.74 20.01 8.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.424 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt 47.53 66.92 0.9 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.401 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 50' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 45.4 t -67.75 -46.57 71.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.005 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 51' ' ' ILE . . . . . 0.4 ' H ' HG13 ' D' ' 51' ' ' ILE . 55.8 mt -45.88 -40.27 3.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.84 0.352 . . . . 0.0 110.401 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -72.42 -32.91 66.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.051 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -72.01 -50.18 30.79 Favored 'General case' 0 C--N 1.335 -0.038 0 CA-C-O 120.911 0.386 . . . . 0.0 110.74 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -64.49 -42.4 95.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.25 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -63.69 -40.38 96.65 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.08 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -75.86 -20.8 57.82 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.452 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -74.13 -50.32 19.95 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.525 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.14 -27.72 73.55 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 6.4 tp -80.69 43.0 0.65 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.818 0.342 . . . . 0.0 110.421 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.579 -179.979 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.4 t . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.489 ' HB2' ' HB3' ' A' ' 27' ' ' ALA . 0.4 OUTLIER 177.01 55.44 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.614 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 31.4 Cg_endo -63.25 -30.34 73.98 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.041 1.827 . . . . 0.0 110.636 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.5 tp -69.39 -44.55 71.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.982 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.489 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . . . -64.2 -55.91 18.36 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.314 0.578 . . . . 0.0 110.015 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.2 t -55.09 -43.61 70.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.109 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 25' ' ' PRO . . . -53.61 -45.44 70.07 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.45 -48.11 77.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.873 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.79 -43.57 69.4 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 120.438 -0.505 . . . . 0.0 109.891 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.6 mt -62.5 -39.72 85.52 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.052 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 93.6 mt -66.58 -41.97 89.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.466 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.89 -51.57 33.93 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.047 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.52 HG23 ' N ' ' A' ' 36' ' ' LEU . 14.9 tt -62.65 -43.56 98.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.34 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.52 ' N ' HG23 ' A' ' 35' ' ' ILE . 9.9 tp -63.96 -33.57 76.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.301 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -66.73 -53.54 32.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.829 0.347 . . . . 0.0 111.217 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.2 tp -59.85 -48.43 81.73 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.975 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.4 mm -61.47 -41.83 91.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.795 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.2 mt -59.98 -45.28 93.24 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.288 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 15.4 t-105 -61.52 -57.7 11.07 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.608 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 94.6 mt -56.88 -56.31 15.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -177.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 47' ' ' PHE . 24.1 tp -61.45 -51.29 69.33 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.208 -178.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -47.36 -40.54 17.62 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.445 ' NH2' ' CB ' ' D' ' 54' ' ' PHE . 61.4 ttt180 -64.37 -52.43 58.32 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.143 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.48 33.62 1.98 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.884 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.457 ' N ' ' O ' ' A' ' 43' ' ' LEU . 66.1 t80 -85.26 84.92 7.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.772 0.32 . . . . 0.0 110.571 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.5 t80 56.55 60.86 2.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.45 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 51.29 27.35 3.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.491 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.9 t -49.68 -30.42 9.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.565 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.1 mt -50.01 -41.26 17.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.954 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -73.55 -28.36 61.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.142 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.499 ' N ' ' CD ' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -69.98 -48.77 56.91 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.309 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.467 ' CB ' ' NH2' ' B' ' 45' ' ' ARG . 53.6 m-85 -71.23 -37.24 72.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.95 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -68.31 -39.13 82.1 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.734 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -77.38 -40.94 42.06 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.102 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -64.07 -47.37 80.39 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.751 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.92 -27.67 70.67 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.9 tp -88.18 49.55 1.82 Allowed 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.804 0.335 . . . . 0.0 110.395 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.4 ttpp . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.565 -179.927 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 27.5 m . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -160.82 76.12 2.59 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.738 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.04 -31.34 53.4 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.437 2.092 . . . . 0.0 111.278 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.411 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 16.5 tp -60.2 -51.2 70.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.903 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.27 -45.45 93.27 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 89.1 t -60.04 -36.55 68.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.094 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -61.5 -35.75 78.57 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.91 -45.15 75.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.325 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 8.0 p -66.01 -52.64 47.5 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.524 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.479 HG23 ' N ' ' B' ' 33' ' ' ILE . 20.4 tt -61.45 -42.32 93.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -178.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.479 ' N ' HG23 ' B' ' 32' ' ' ILE . 13.9 tt -69.38 -29.64 42.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 C-N-CA 119.794 -0.763 . . . . 0.0 110.232 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.98 -51.68 38.02 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.539 HG22 HD12 ' B' ' 39' ' ' ILE . 46.6 mm -61.26 -38.12 79.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 120.603 -0.439 . . . . 0.0 109.888 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 10.2 tp -62.55 -41.77 99.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.694 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -66.84 -51.71 52.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.888 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 39.9 tp -60.99 -49.44 77.45 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.284 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.539 HD12 HG22 ' B' ' 35' ' ' ILE . 26.7 mt -61.86 -42.08 93.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.465 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 56.3 tp -60.92 -41.25 95.79 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.271 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 41.3 t-105 -63.82 -57.77 8.85 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.785 0.326 . . . . 0.0 111.789 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 68.7 mt -59.19 -53.44 47.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.364 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.663 HD13 ' C ' ' B' ' 43' ' ' LEU . 3.1 tm? -55.94 -50.87 69.58 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.746 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -53.15 -45.43 68.43 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.945 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.467 ' NH2' ' CB ' ' A' ' 54' ' ' PHE . 65.8 ttt180 -61.43 -56.68 17.57 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.349 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.439 HD23 ' HB3' ' B' ' 45' ' ' ARG . 0.1 OUTLIER -108.61 130.99 55.31 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.05 0.452 . . . . 0.0 110.315 179.62 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.525 ' O ' ' CD2' ' B' ' 48' ' ' PHE . 63.7 t80 -174.04 -64.51 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.124 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 48' ' ' PHE . . . . . 0.525 ' CD2' ' O ' ' B' ' 47' ' ' PHE . 8.4 m-85 -161.25 83.65 0.64 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.813 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 64.8 mttp 53.86 27.89 7.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.535 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 8.0 t -57.67 -51.99 67.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.726 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 89.0 mt -52.92 -41.81 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.765 0.317 . . . . 0.0 110.685 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.506 ' CD2' ' OE2' ' B' ' 56' ' ' GLU . 81.7 t80 -72.46 -30.97 65.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.634 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -72.0 -46.14 58.3 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.971 0.415 . . . . 0.0 110.817 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -71.45 -38.05 71.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.99 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -70.77 -38.08 73.4 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.717 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 56' ' ' GLU . . . . . 0.506 ' OE2' ' CD2' ' B' ' 52' ' ' TYR . 10.4 pt-20 -76.16 -38.46 56.63 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.691 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -66.76 -45.64 77.89 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.279 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.32 -27.6 69.57 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 5.4 tp -70.14 -67.87 0.46 Allowed 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.786 0.327 . . . . 0.0 110.481 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.552 -179.939 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 54.9 68.62 2.47 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.739 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.22 -35.68 53.57 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.486 2.124 . . . . 0.0 111.466 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 26' ' ' LEU . . . . . 0.518 ' O ' ' HB3' ' C' ' 29' ' ' ALA . 14.2 tp -60.12 -51.11 71.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.859 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.53 -43.63 75.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.747 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 90.2 t -60.99 -32.03 51.42 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 29' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' C' ' 26' ' ' LEU . . . -64.45 -38.3 90.54 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.96 -51.89 59.3 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.058 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 5.3 t -60.57 -51.45 69.37 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.52 -0.472 . . . . 0.0 112.146 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 9.9 tp -61.84 -30.93 49.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.39 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 12.1 mt -67.0 -41.53 87.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 120.627 -0.429 . . . . 0.0 109.997 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.48 -51.22 32.72 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.933 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 35' ' ' ILE . . . . . 0.525 ' O ' HD13 ' C' ' 35' ' ' ILE . 0.2 OUTLIER -59.92 -45.61 94.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-O 121.378 0.608 . . . . 0.0 109.663 -179.678 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.454 ' N ' ' CG2' ' C' ' 35' ' ' ILE . 53.6 tp -60.34 -40.47 90.8 Favored 'General case' 0 C--O 1.215 -0.746 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.129 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -59.27 -52.41 65.79 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.158 0.504 . . . . 0.0 111.017 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 16.7 tp -56.38 -50.14 72.41 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.407 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 1.2 mp -65.49 -31.65 54.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.853 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 40' ' ' LEU . . . . . 0.489 ' O ' HD13 ' C' ' 40' ' ' LEU . 0.2 OUTLIER -64.38 -47.96 77.28 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.719 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 15.9 t-105 -63.84 -56.41 15.6 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 120.804 -0.359 . . . . 0.0 111.511 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 96.2 mt -56.84 -55.41 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.416 -0.514 . . . . 0.0 112.003 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.654 ' C ' HD13 ' C' ' 43' ' ' LEU . 3.0 tm? -61.73 -50.9 70.57 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.939 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 44' ' ' ASP . . . . . 0.513 ' OD2' ' NH1' ' D' ' 45' ' ' ARG . 25.3 t70 -47.14 -43.32 20.69 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.047 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 60.9 ttt-85 -64.15 -52.26 59.91 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.576 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.15 114.94 26.69 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.595 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -174.22 102.36 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.416 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 48' ' ' PHE . . . . . 0.402 ' O ' ' CD2' ' C' ' 48' ' ' PHE . 51.6 t80 44.37 49.87 8.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.581 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? 57.16 40.27 28.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.306 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 50' ' ' SER . . . . . 0.42 ' HA ' ' HE ' ' C' ' 53' ' ' ARG . 4.6 t -62.39 -34.55 76.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.318 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 51' ' ' ILE . . . . . 0.401 HG13 ' H ' ' C' ' 51' ' ' ILE . 60.6 mt -47.34 -41.01 6.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.21 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 52' ' ' TYR . . . . . 0.478 ' CZ ' ' OE1' ' C' ' 56' ' ' GLU . 89.2 t80 -72.37 -29.41 63.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.519 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 53' ' ' ARG . . . . . 0.524 ' O ' ' CG ' ' C' ' 57' ' ' HIS . 73.1 mtm180 -71.38 -48.0 52.76 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.648 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -68.4 -41.84 79.91 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.397 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -64.44 -36.92 85.72 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.824 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 56' ' ' GLU . . . . . 0.478 ' OE1' ' CZ ' ' C' ' 52' ' ' TYR . 64.8 tt0 -77.94 -24.02 48.36 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.784 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 57' ' ' HIS . . . . . 0.524 ' CG ' ' O ' ' C' ' 53' ' ' ARG . 3.5 m-70 -73.18 -46.83 48.44 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 120.489 -0.485 . . . . 0.0 109.911 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.71 -28.13 72.47 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 9.6 tp -89.73 58.68 4.37 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.761 0.315 . . . . 0.0 110.376 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 61.3 mttp . . . . . 0 N--CA 1.468 0.456 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.413 -179.972 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 74.9 p . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 24' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' D' ' 24' ' ' ASP . 7.3 p30 -160.55 75.6 2.73 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.153 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.61 -30.48 85.84 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 121.164 1.243 . . . . 0.0 110.725 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 26' ' ' LEU . . . . . 0.4 ' O ' ' HB3' ' D' ' 29' ' ' ALA . 16.6 tp -63.3 -50.39 70.25 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.0 -47.3 85.71 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 71.7 t -60.11 -32.41 50.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.324 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' D' ' 26' ' ' LEU . . . -66.96 -32.9 74.45 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.05 -44.45 69.14 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.726 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 31' ' ' SER . . . . . 0.446 ' OG ' ' CD1' ' C' ' 26' ' ' LEU . 2.3 m -68.17 -45.01 74.64 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.733 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 32' ' ' ILE . . . . . 0.402 HD13 HG21 ' D' ' 32' ' ' ILE . 11.5 tt -68.16 -41.47 84.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.553 -178.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 13.0 tt -70.02 -34.67 60.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.485 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.07 -51.64 22.36 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.674 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 3.5 tp -64.02 -37.48 79.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.76 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 50.3 tp -64.07 -38.33 90.67 Favored 'General case' 0 CA--C 1.521 -0.136 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -65.95 -43.39 88.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.075 0.464 . . . . 0.0 109.86 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 mt -59.87 -51.36 70.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.778 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 74.3 mt -63.26 -40.48 89.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.209 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 7.6 tt -63.16 -45.22 92.85 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.981 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 31.8 t-105 -65.71 -52.0 54.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.89 0.376 . . . . 0.0 111.928 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 74.6 mt -63.29 -53.46 45.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.874 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 26.6 tp -61.87 -45.78 92.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.817 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 44' ' ' ASP . . . . . 0.464 ' O ' ' CB ' ' D' ' 50' ' ' SER . 27.5 t70 -55.66 -43.19 76.06 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.611 -0.436 . . . . 0.0 109.925 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 45' ' ' ARG . . . . . 0.513 ' NH1' ' OD2' ' C' ' 44' ' ' ASP . 67.5 ttt180 -61.97 -51.38 68.31 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.596 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 46' ' ' LEU . . . . . 0.412 HD23 ' HB3' ' D' ' 45' ' ' ARG . 0.1 OUTLIER -124.1 124.69 43.07 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 120.95 0.405 . . . . 0.0 110.207 179.177 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -174.61 -43.8 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.513 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 48' ' ' PHE . . . . . 0.428 ' CD2' ' O ' ' D' ' 48' ' ' PHE . 72.4 t80 -165.81 63.93 0.11 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.307 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? 54.52 40.19 31.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.182 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 50' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 7.4 t -62.15 -51.06 69.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.086 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 78.0 mt -48.51 -35.71 6.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.183 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 52' ' ' TYR . . . . . 0.501 ' CE2' ' OE2' ' D' ' 56' ' ' GLU . 90.6 t80 -71.44 -30.13 65.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.101 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -70.35 -43.18 70.75 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.974 0.416 . . . . 0.0 110.452 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 54' ' ' PHE . . . . . 0.445 ' CB ' ' NH2' ' A' ' 45' ' ' ARG . 72.9 m-85 -71.6 -39.89 70.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.727 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -66.11 -40.95 91.11 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.477 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 56' ' ' GLU . . . . . 0.501 ' OE2' ' CE2' ' D' ' 52' ' ' TYR . 12.7 pt-20 -74.41 -38.33 63.12 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.454 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 -61.1 -46.15 91.81 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.119 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.46 -26.95 71.12 Favored Glycine 0 N--CA 1.462 0.406 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.16 75.18 1.28 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 53.2 tttp . . . . . 0 C--N 1.332 -0.158 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.48 -179.709 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.3 p . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 0.5 OUTLIER 49.68 55.66 17.22 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.73 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 37.2 Cg_endo -65.37 -29.59 54.04 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.311 2.007 . . . . 0.0 111.306 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.468 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 20.2 tp -62.88 -48.28 79.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.97 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.55 -45.34 92.09 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 97.4 t -63.01 -28.32 44.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.379 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 26' ' ' LEU . . . -68.6 -36.43 78.68 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.35 -45.51 65.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.281 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.8 p -68.63 -44.58 73.89 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.243 -0.583 . . . . 0.0 111.754 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.421 HG23 ' N ' ' A' ' 33' ' ' ILE . 10.3 tp -68.48 -40.44 82.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.6 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.421 ' N ' HG23 ' A' ' 32' ' ' ILE . 14.1 tt -71.27 -33.56 51.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.607 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.45 -51.64 20.5 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.35 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.417 HG23 ' N ' ' A' ' 36' ' ' LEU . 10.4 tp -63.31 -38.32 81.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.553 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.417 ' N ' HG23 ' A' ' 35' ' ' ILE . 56.1 tp -65.9 -32.79 74.5 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.888 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -67.81 -52.07 41.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.833 0.349 . . . . 0.0 110.602 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 30.4 tp -61.14 -52.17 65.97 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.426 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 74.1 mt -61.72 -42.25 93.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.979 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 34.8 tp -60.91 -41.93 97.06 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.343 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.4 t-105 -63.9 -59.53 4.4 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 120.973 0.416 . . . . 0.0 111.553 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 96.3 mt -56.59 -54.41 29.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.606 -177.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.519 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.7 OUTLIER -60.24 -45.47 93.11 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.691 -179.037 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -51.02 -41.38 59.77 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -65.04 -50.48 66.05 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.134 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.475 ' O ' ' O ' ' A' ' 43' ' ' LEU . 0.7 OUTLIER -92.63 131.29 37.85 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.074 -179.434 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.436 ' CD2' ' N ' ' A' ' 48' ' ' PHE . 73.6 t80 -163.55 -94.97 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.858 0.361 . . . . 0.0 110.564 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.436 ' N ' ' CD2' ' A' ' 47' ' ' PHE . 57.6 t80 -132.6 57.8 1.78 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.821 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.2 tttt 71.14 25.67 3.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.721 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.9 t -59.21 -43.19 92.29 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.571 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 56.9 mt -45.04 -41.65 2.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.604 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -74.11 -27.94 61.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.023 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.532 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 90.9 mtt-85 -71.2 -48.57 50.77 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.598 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -71.5 -41.18 69.59 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.052 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -67.53 -38.69 84.59 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.731 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.542 ' OE2' ' CD2' ' A' ' 57' ' ' HIS . 1.8 pp20? -76.65 -42.31 42.44 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.067 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.542 ' CD2' ' OE2' ' A' ' 56' ' ' GLU . 24.9 m80 -61.11 -45.66 93.77 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.552 -0.459 . . . . 0.0 109.907 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.69 -27.71 73.39 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.5 tp -92.24 56.3 2.77 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.871 0.335 . . . . 0.0 110.677 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt . . . . . 0 C--N 1.329 -0.3 0 C-N-CA 120.859 -0.337 . . . . 0.0 110.474 179.886 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 96.2 p . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -160.01 73.34 3.1 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.772 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -50.74 -36.68 52.25 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.618 2.212 . . . . 0.0 111.537 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.42 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 15.0 tp -60.6 -52.38 65.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.798 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.53 -42.99 93.53 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 93.8 t -62.51 -33.89 61.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -63.74 -34.49 78.0 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.28 -47.01 63.16 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.397 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 6.3 p -65.21 -48.13 74.44 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.234 -0.586 . . . . 0.0 111.524 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.51 HG23 ' N ' ' B' ' 33' ' ' ILE . 10.4 tp -65.55 -44.32 93.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -178.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.51 ' N ' HG23 ' B' ' 32' ' ' ILE . 15.1 tt -66.67 -33.49 63.79 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.066 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.248 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.48 -45.3 86.52 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 91.2 mt -61.57 -44.54 98.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 14.1 tp -61.06 -36.1 78.7 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.312 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' HIS . . . . . 0.585 ' NE2' ' CE1' ' C' ' 37' ' ' HIS . 7.5 t-80 -67.34 -50.33 60.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.782 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 22.7 tp -63.66 -52.43 60.78 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.778 -178.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.431 ' N ' ' CD1' ' B' ' 39' ' ' ILE . 1.4 mp -61.15 -43.03 95.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.071 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 43.0 tp -61.21 -37.5 83.25 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.311 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 32.5 t-105 -63.3 -56.69 14.34 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.662 0.268 . . . . 0.0 111.291 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 68.2 mt -60.92 -53.46 48.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 C-N-CA 120.231 -0.588 . . . . 0.0 111.714 -178.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.539 ' O ' HD23 ' B' ' 43' ' ' LEU . 0.9 OUTLIER -57.33 -45.02 84.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.94 -179.021 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -58.97 -45.5 90.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.833 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 57.8 ttt85 -59.74 -52.75 64.14 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 120.181 -0.607 . . . . 0.0 111.059 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.23 112.13 24.11 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.953 0.406 . . . . 0.0 110.166 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -165.78 79.23 0.28 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.252 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 34.0 t80 62.11 55.28 2.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.745 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 74.7 tttt 60.24 50.15 6.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.818 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 5.8 t -70.71 -44.42 66.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.602 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 64.5 mt -44.38 -35.87 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.656 0.265 . . . . 0.0 111.228 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -70.34 -28.19 64.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.482 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 78.3 mtt85 -68.64 -42.39 78.07 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.378 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -72.73 -42.23 64.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.783 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -63.93 -39.88 95.18 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.632 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -76.72 -38.36 54.44 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.697 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -59.56 -44.82 93.17 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.656 -0.418 . . . . 0.0 109.926 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.98 -24.03 53.22 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' B' ' 60' ' ' LYS . 1.6 tt -131.0 52.01 2.09 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 -178.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 60' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' B' ' 59' ' ' LEU . 16.2 ptpt . . . . . 0 N--CA 1.474 0.751 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.524 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 37.3 t . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 46.15 75.3 0.67 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.709 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -51.55 -33.48 48.15 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.483 2.122 . . . . 0.0 111.432 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.15 -47.88 82.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.739 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.44 -39.18 60.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.726 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 80.7 t -59.78 -44.29 93.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.01 -33.51 72.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.405 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.14 -44.01 80.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.209 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 8.0 p -67.51 -47.54 69.67 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 18.6 tt -66.52 -38.19 81.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.979 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 70.0 mt -68.13 -42.22 84.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.005 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.7 -50.04 45.24 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 121.062 -0.59 . . . . 0.0 111.677 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.71 -43.53 98.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.89 0.376 . . . . 0.0 110.257 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 56.8 tp -63.55 -37.98 89.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.248 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 37' ' ' HIS . . . . . 0.585 ' CE1' ' NE2' ' B' ' 37' ' ' HIS . 12.3 t-80 -66.09 -48.4 71.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.808 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 41.3 tp -67.07 -55.23 15.2 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.84 0.352 . . . . 0.0 111.697 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 39' ' ' ILE . . . . . 0.427 ' CD1' ' N ' ' C' ' 39' ' ' ILE . 1.3 mp -59.35 -45.46 93.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.487 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 44.7 tp -62.03 -41.89 98.59 Favored 'General case' 0 C--O 1.218 -0.564 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.983 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 16.0 t-105 -57.16 -59.53 4.96 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 120.812 0.339 . . . . 0.0 111.488 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 34.8 mt -62.88 -57.1 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.344 -0.542 . . . . 0.0 112.315 -177.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.48 ' O ' HD23 ' C' ' 43' ' ' LEU . 0.6 OUTLIER -57.17 -51.84 67.72 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.519 -177.986 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -53.29 -41.89 66.05 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 18.5 tpt85 -58.39 -52.35 65.97 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.729 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 46' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' C' ' 48' ' ' PHE . 1.9 mt -82.25 -72.7 0.43 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.0 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 82.2 t80 57.76 -77.91 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.314 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 48' ' ' PHE . . . . . 0.537 ' N ' ' O ' ' C' ' 46' ' ' LEU . 84.7 t80 -158.84 -40.19 0.06 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.065 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -173.59 31.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.089 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 50' ' ' SER . . . . . 0.429 ' OG ' ' CD1' ' C' ' 54' ' ' PHE . 35.8 t -63.73 -39.78 95.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.139 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 40.3 mt -46.6 -50.86 5.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.613 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -73.6 -32.18 63.97 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 53' ' ' ARG . . . . . 0.53 ' O ' ' CG ' ' C' ' 57' ' ' HIS . 99.5 mtt180 -72.03 -49.76 34.12 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.644 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 54' ' ' PHE . . . . . 0.429 ' CD1' ' OG ' ' C' ' 50' ' ' SER . 10.8 m-85 -66.44 -42.17 88.06 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.29 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -64.56 -37.67 88.35 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.903 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -77.29 -22.18 52.43 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.465 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 57' ' ' HIS . . . . . 0.53 ' CG ' ' O ' ' C' ' 53' ' ' ARG . 3.7 m-70 -74.0 -47.25 38.45 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.059 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.43 -27.23 71.44 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 9.2 tp -92.18 60.23 3.68 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-O 120.811 0.339 . . . . 0.0 110.419 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm . . . . . 0 N--CA 1.467 0.396 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.366 -179.96 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 49.0 m . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 24' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' D' ' 24' ' ' ASP . 4.3 p30 -172.26 68.25 0.41 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.818 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 25' ' ' PRO . . . . . 0.404 ' O ' ' HB2' ' D' ' 29' ' ' ALA . 64.0 Cg_exo -49.54 -30.41 21.38 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 C-N-CA 121.935 1.757 . . . . 0.0 110.405 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 16.8 tp -65.18 -45.28 85.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.321 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.75 -61.09 2.65 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 87.0 t -50.44 -43.36 22.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.734 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' D' ' 25' ' ' PRO . . . -53.57 -45.3 69.89 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.015 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.83 -40.87 98.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.984 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 2.5 t -61.44 -52.04 66.22 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.613 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 14.8 tt -64.93 -30.93 51.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.623 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 39.3 mt -66.35 -44.24 90.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.927 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.49 -50.53 43.02 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.982 -0.628 . . . . 0.0 111.975 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 35' ' ' ILE . . . . . 0.402 ' CG2' ' N ' ' D' ' 36' ' ' LEU . 4.5 tt -58.22 -43.15 85.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.001 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.402 ' N ' ' CG2' ' D' ' 35' ' ' ILE . 7.4 tp -69.22 -27.64 65.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.503 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -67.78 -56.04 10.73 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.187 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 3.5 pp -68.87 -34.69 75.87 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.854 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 52.9 mt -62.77 -45.12 99.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 120.311 -0.556 . . . . 0.0 109.778 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 36.8 mt -64.01 -41.55 97.42 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.471 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 9.2 t-105 -59.96 -58.0 10.43 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.332 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 79.0 mt -59.92 -53.5 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.406 -177.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 28.8 tp -59.96 -44.14 94.61 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.82 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 44' ' ' ASP . . . . . 0.436 ' O ' ' CB ' ' D' ' 50' ' ' SER . 26.6 t70 -55.95 -46.15 78.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.126 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 56.3 ttt85 -60.49 -50.67 72.65 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.868 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 pp -125.4 127.93 47.34 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.145 0.498 . . . . 0.0 110.796 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -174.77 -42.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.092 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -171.66 63.46 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.234 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 55.7 mttm 58.23 37.81 26.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.226 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 50' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 10.8 t -59.29 -50.29 74.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.835 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 68.1 mt -50.56 -41.44 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.607 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -72.2 -31.38 65.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.084 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -70.96 -47.04 61.21 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.001 0.429 . . . . 0.0 110.601 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -69.71 -36.32 75.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.676 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -68.92 -40.74 78.89 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.5 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -75.78 -33.44 60.18 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.481 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -66.43 -47.34 73.5 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.694 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.23 -36.37 93.32 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 110.641 -0.983 . . . . 0.0 110.641 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 mp -74.9 -67.43 0.64 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt . . . . . 0 N--CA 1.462 0.14 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.397 179.753 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.1 p . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 0.7 OUTLIER 46.71 54.0 14.32 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.724 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 34.7 Cg_endo -63.87 -28.04 67.3 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.466 2.11 . . . . 0.0 111.025 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.5 tp -64.23 -48.72 74.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.041 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -65.32 -50.23 66.44 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.296 0.57 . . . . 0.0 109.739 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 82.3 t -57.95 -44.67 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.94 -36.52 67.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.514 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -63.04 -51.29 67.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.536 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.3 p -56.53 -50.07 72.92 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.912 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.6 mm -61.18 -32.16 52.12 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.99 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.2 mm -69.75 -40.13 78.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.223 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.43 -53.13 26.65 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.311 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 40.9 mm -62.12 -44.03 98.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 C-N-CA 120.461 -0.495 . . . . 0.0 110.306 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 47.4 tp -57.84 -47.92 81.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.568 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.474 ' C ' ' ND1' ' A' ' 37' ' ' HIS . 5.0 t-80 -60.16 -47.91 83.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.085 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 42.7 tp -55.66 -51.91 65.63 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.182 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.5 tt -64.17 -32.85 59.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.456 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.501 HD13 ' O ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -63.14 -47.96 80.53 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.419 -179.254 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 14.2 t-105 -63.44 -55.27 25.55 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 120.614 0.245 . . . . 0.0 111.551 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 88.8 mt -58.91 -52.74 56.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.34 -0.544 . . . . 0.0 112.124 -177.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.423 HD11 ' CD1' ' A' ' 47' ' ' PHE . 22.6 tp -62.43 -44.08 97.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.391 -178.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -57.01 -43.37 81.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.764 0.316 . . . . 0.0 110.171 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.516 ' NH1' HD11 ' A' ' 51' ' ' ILE . 57.0 ttt-85 -63.95 -48.67 75.58 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.471 -0.491 . . . . 0.0 110.725 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.6 pp -127.71 127.33 43.5 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.031 0.443 . . . . 0.0 110.8 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.423 ' CD1' HD11 ' A' ' 43' ' ' LEU . 61.4 t80 -174.03 -39.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.233 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.523 ' O ' ' NH1' ' A' ' 53' ' ' ARG . 63.8 t80 -172.08 61.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.213 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm 60.13 37.66 20.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.162 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.0 t -61.7 -47.7 84.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.752 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.516 HD11 ' NH1' ' A' ' 45' ' ' ARG . 16.2 mt -49.44 -37.2 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.493 ' CE2' ' OE2' ' A' ' 56' ' ' GLU . 92.5 t80 -72.69 -30.16 63.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.241 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.523 ' NH1' ' O ' ' A' ' 48' ' ' PHE . 93.9 mtm-85 -71.77 -46.78 57.25 Favored 'General case' 0 N--CA 1.461 0.102 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.54 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -70.47 -37.8 74.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.863 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -69.76 -38.85 76.92 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.696 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 60' ' ' LYS . 12.2 pt-20 -76.57 -38.85 54.29 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.91 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.523 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 6.8 m-70 -66.45 -42.63 87.33 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.738 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.67 -27.34 61.31 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 59' ' ' LEU . 0.6 OUTLIER -157.87 63.72 0.46 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.966 0.412 . . . . 0.0 110.554 -179.865 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 56' ' ' GLU . 4.2 tmtt? . . . . . 0 N--CA 1.469 0.476 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.183 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 31.5 t . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -37.32 101.85 0.23 Allowed Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.967 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -48.56 -36.7 32.39 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.873 1.715 . . . . 0.0 111.723 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.546 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 17.6 tp -61.14 -51.22 70.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.222 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.37 -45.52 84.35 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 84.4 t -59.48 -32.82 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.557 -0.747 . . . . 0.0 108.999 178.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -62.39 -37.43 85.73 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.05 -49.99 65.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.831 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 4.8 t -60.07 -50.56 73.24 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 20.4 tt -63.65 -35.04 71.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.36 -178.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 45.7 mt -69.05 -37.85 77.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.392 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.77 -56.2 8.62 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.506 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.479 HD12 ' N ' ' B' ' 36' ' ' LEU . 2.3 pp -56.44 -40.07 65.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.387 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.479 ' N ' HD12 ' B' ' 35' ' ' ILE . 54.7 tp -65.34 -34.41 78.26 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.388 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -66.45 -53.54 34.28 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.449 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 29.7 tp -66.32 -50.16 64.58 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.649 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 74.2 mt -59.74 -44.88 94.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.663 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 49.7 tp -64.04 -37.61 88.06 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.032 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' TRP . . . . . 0.45 ' CZ3' ' CZ2' ' C' ' 41' ' ' TRP . 23.1 t-105 -59.66 -52.32 66.01 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.543 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.6 mt -71.9 -56.83 8.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 120.079 -0.649 . . . . 0.0 111.674 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.498 ' O ' HD23 ' B' ' 43' ' ' LEU . 0.8 OUTLIER -50.67 -46.61 58.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.865 -179.066 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -67.94 -40.92 83.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.761 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 53.5 ttt85 -51.75 -51.83 53.24 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.813 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.72 -82.8 0.25 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.494 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.449 ' O ' ' CD1' ' B' ' 48' ' ' PHE . 60.5 t80 57.51 -87.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.501 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' PHE . . . . . 0.449 ' CD1' ' O ' ' B' ' 47' ' ' PHE . 34.1 m-85 -153.44 86.38 1.21 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.037 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 65.9 mttm 51.76 34.51 13.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.362 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 7.9 t -58.98 -47.07 86.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.405 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 53.4 mt -49.83 -50.8 17.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.909 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -71.41 -32.66 68.67 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.693 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -71.52 -43.74 65.92 Favored 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.017 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -71.41 -39.49 71.09 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.756 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 55' ' ' PHE . . . . . 0.413 ' CD1' ' C ' ' B' ' 55' ' ' PHE . 24.3 t80 -70.2 -39.11 75.38 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.816 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -76.66 -35.91 57.68 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 120.424 -0.511 . . . . 0.0 110.729 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -67.3 -49.19 65.17 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.511 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.94 -28.6 68.9 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 7.8 tp -72.51 -68.92 0.44 Allowed 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.742 0.306 . . . . 0.0 110.527 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 55.4 tttp . . . . . 0 N--CA 1.467 0.375 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.405 179.814 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 13.7 m . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -158.43 72.75 3.86 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.83 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -50.91 -30.52 30.61 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.538 2.158 . . . . 0.0 111.269 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 26' ' ' LEU . . . . . 0.489 ' O ' ' HB3' ' C' ' 29' ' ' ALA . 16.6 tp -55.48 -51.68 66.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.045 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.69 -47.62 85.44 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 99.3 t -59.58 -29.98 43.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 29' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' C' ' 26' ' ' LEU . . . -66.82 -35.61 80.45 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.15 -42.38 76.03 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.337 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 3.9 p -69.9 -46.22 65.91 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.72 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 32' ' ' ILE . . . . . 0.419 HG23 ' N ' ' C' ' 33' ' ' ILE . 10.1 tt -67.66 -40.18 83.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.524 -178.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 33' ' ' ILE . . . . . 0.419 ' N ' HG23 ' C' ' 32' ' ' ILE . 8.0 tt -69.33 -35.17 66.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.502 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.77 -53.24 20.76 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.272 -0.966 . . . . 0.0 110.953 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 96.8 mt -57.86 -42.87 83.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.306 -0.558 . . . . 0.0 109.977 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 15.0 tp -61.83 -39.45 91.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.101 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -61.52 -50.66 71.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.887 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 10.4 mp -60.52 -48.6 81.08 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.403 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 71.8 mt -59.95 -44.72 95.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.133 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.5 mt -62.44 -39.39 93.17 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.336 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 41' ' ' TRP . . . . . 0.45 ' CZ2' ' CZ3' ' B' ' 41' ' ' TRP . 24.3 t-105 -60.52 -57.67 11.76 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 120.89 0.376 . . . . 0.0 111.248 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 72.0 mt -60.64 -56.36 18.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.129 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.469 ' O ' HD23 ' C' ' 43' ' ' LEU . 0.7 OUTLIER -57.42 -50.99 71.24 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.773 -178.451 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -51.23 -42.59 61.09 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -59.07 -53.31 59.83 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.511 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 46' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' C' ' 48' ' ' PHE . 3.4 mt -79.71 -72.45 0.4 Allowed 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.949 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 75.3 t80 50.0 -88.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.272 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 48' ' ' PHE . . . . . 0.503 ' N ' ' O ' ' C' ' 46' ' ' LEU . 55.5 t80 -161.13 89.96 0.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.3 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 74.1 tttt 54.92 22.33 4.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.065 0.459 . . . . 0.0 110.027 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 11.3 t -61.1 -38.68 87.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.078 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 51' ' ' ILE . . . . . 0.404 ' H ' HG13 ' C' ' 51' ' ' ILE . 67.4 mt -48.68 -53.91 5.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.755 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -75.09 -33.6 61.65 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 20.0 mmt85 -69.93 -48.83 56.92 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.837 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -69.93 -39.95 75.81 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.302 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -62.13 -41.33 98.16 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.818 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -80.05 -21.8 43.05 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.892 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -70.25 -47.69 60.2 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 120.438 -0.505 . . . . 0.0 109.64 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.86 -26.97 73.73 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 59' ' ' LEU . . . . . 0.44 ' N ' ' CD2' ' C' ' 59' ' ' LEU . 3.8 mm? -100.54 64.78 1.15 Allowed 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 60' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' C' ' 59' ' ' LEU . 50.0 pttt . . . . . 0 N--CA 1.474 0.768 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.665 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 177.45 75.11 0.11 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.073 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -49.14 -33.03 26.16 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.089 1.859 . . . . 0.0 110.693 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 26' ' ' LEU . . . . . 0.402 ' O ' ' HB3' ' D' ' 29' ' ' ALA . 16.4 tp -62.89 -50.55 70.45 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.78 -46.16 88.15 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 92.0 t -59.77 -37.25 70.55 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.343 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' D' ' 26' ' ' LEU . . . -61.37 -37.07 82.03 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.45 -50.11 66.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.773 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 4.0 t -60.78 -51.47 69.19 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 7.3 tp -62.26 -35.71 70.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.582 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 26.5 mt -63.23 -44.58 99.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.736 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.49 -45.5 94.67 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.755 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 88.3 mt -62.39 -43.5 98.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.784 0.326 . . . . 0.0 110.525 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 18.1 tp -65.18 -33.2 75.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.326 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -68.13 -50.65 53.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.897 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 55.9 tp -61.28 -47.93 83.74 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.802 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 95.8 mt -61.91 -43.82 98.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.856 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 40' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' D' ' 40' ' ' LEU . 20.0 mt -59.62 -49.4 77.9 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.452 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 11.9 t-105 -58.41 -58.86 6.66 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.929 0.395 . . . . 0.0 111.705 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 73.1 mt -57.89 -60.4 2.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 27.6 tp -57.18 -46.56 82.7 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.447 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -50.98 -45.98 61.16 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.633 -0.427 . . . . 0.0 109.926 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 45' ' ' ARG . . . . . 0.413 ' O ' ' CG1' ' D' ' 51' ' ' ILE . 70.0 ttt180 -64.56 -56.85 11.35 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 119.914 -0.715 . . . . 0.0 111.394 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 46' ' ' LEU . . . . . 0.429 HD23 ' N ' ' D' ' 46' ' ' LEU . 0.1 OUTLIER -91.36 114.82 27.45 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.021 -179.872 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 47' ' ' PHE . . . . . 0.569 ' O ' ' N ' ' D' ' 49' ' ' LYS . 77.0 t80 -172.92 90.22 0.09 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.073 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 57.94 -73.49 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.45 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 49' ' ' LYS . . . . . 0.569 ' N ' ' O ' ' D' ' 47' ' ' PHE . 10.7 ttpp -165.58 37.46 0.06 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.884 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 50' ' ' SER . . . . . 0.532 ' O ' ' N ' ' D' ' 53' ' ' ARG . 13.0 t -62.77 -45.06 94.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.082 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 51' ' ' ILE . . . . . 0.413 ' CG1' ' O ' ' D' ' 45' ' ' ARG . 23.6 mt -41.25 -30.35 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.869 0.366 . . . . 0.0 110.487 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 52' ' ' TYR . . . . . 0.518 ' CE2' ' OE1' ' D' ' 56' ' ' GLU . 85.7 t80 -74.12 -33.84 63.72 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.34 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 53' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' D' ' 50' ' ' SER . 6.9 ptm180 -69.64 -40.14 76.68 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.351 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -72.71 -41.92 64.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.884 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 55' ' ' PHE . . . . . 0.418 ' CD1' HD11 ' C' ' 59' ' ' LEU . 33.9 t80 -65.74 -40.18 91.86 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.459 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 56' ' ' GLU . . . . . 0.518 ' OE1' ' CE2' ' D' ' 52' ' ' TYR . 10.8 pt-20 -75.85 -38.81 57.61 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.796 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -61.51 -43.99 97.87 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 120.876 -0.329 . . . . 0.0 110.34 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.84 -27.82 71.75 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 7.9 tp -84.09 -75.75 0.33 Allowed 'General case' 0 C--O 1.231 0.087 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.615 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt . . . . . 0 N--CA 1.467 0.422 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.539 179.799 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.4 m . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 51.54 72.28 1.26 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.755 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.33 -32.57 42.31 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.483 2.122 . . . . 0.0 111.217 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 22.0 tp -61.54 -50.49 72.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.969 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.74 -46.75 88.26 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.271 0.558 . . . . 0.0 109.551 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 92.4 t -59.03 -41.44 83.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.51 -31.36 71.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.757 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.95 -43.52 71.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.649 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.7 t -66.18 -43.32 87.22 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.914 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 38.4 mm -67.24 -42.42 87.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.684 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.2 tt -71.15 -33.38 50.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.721 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.13 -52.0 15.65 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.315 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.418 HG23 ' N ' ' A' ' 36' ' ' LEU . 20.2 tt -63.16 -39.57 85.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.695 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.418 ' N ' HG23 ' A' ' 35' ' ' ILE . 47.1 tp -66.63 -32.39 73.69 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.086 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -68.34 -49.6 59.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.675 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.6 tp -63.31 -51.93 64.02 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.222 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 81.1 mt -61.79 -42.92 96.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.947 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.5 tt -63.56 -37.75 88.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.624 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 41.6 t-105 -65.11 -54.66 26.47 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.034 0.445 . . . . 0.0 111.305 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.553 ' CG2' ' N ' ' A' ' 43' ' ' LEU . 5.9 tt -63.74 -51.26 72.2 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.646 -177.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.553 ' N ' ' CG2' ' A' ' 42' ' ' ILE . 29.6 tp -63.21 -48.85 76.55 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.008 -177.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' A' ' 44' ' ' ASP . 60.2 t0 -51.59 -38.9 56.63 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.417 ' NH2' ' CB ' ' D' ' 54' ' ' PHE . 64.3 ttt180 -64.76 -52.24 58.02 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.522 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 48' ' ' PHE . 5.3 mt -86.31 -76.67 0.34 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 119.934 -0.706 . . . . 0.0 110.817 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 69.5 t80 51.4 -86.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.892 0.377 . . . . 0.0 110.373 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.515 ' N ' ' O ' ' A' ' 46' ' ' LEU . 38.5 t80 -158.31 90.58 1.04 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.142 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm 52.11 17.01 0.62 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.116 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.9 t -51.7 -41.87 61.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.612 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 35.7 mt -48.18 -41.63 10.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.055 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -71.41 -30.14 65.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.295 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.51 ' O ' ' CG ' ' A' ' 57' ' ' HIS . 1.8 mpt_? -66.8 -45.03 79.67 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.074 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -70.96 -38.62 72.81 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.479 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -63.55 -40.48 97.11 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.646 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.403 ' O ' ' N ' ' A' ' 60' ' ' LYS . 22.5 pt-20 -77.0 -40.19 47.55 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.789 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.51 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 56.0 m170 -57.4 -50.47 72.89 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.202 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.1 -26.77 73.85 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.4 tp -156.12 89.18 1.13 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.328 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 56' ' ' GLU . 68.7 mttm . . . . . 0 CA--C 1.526 0.034 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.551 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -165.61 69.38 1.25 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.035 0.445 . . . . 0.0 110.663 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -48.13 -27.89 9.97 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.031 1.82 . . . . 0.0 111.092 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.412 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 1.7 pp -72.79 -31.2 64.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.894 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.9 -39.71 66.02 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.972 0.415 . . . . 0.0 109.999 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 94.2 t -60.23 -43.64 93.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -56.97 -35.57 69.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.391 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.13 -49.81 66.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.878 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 22.2 p -59.16 -51.19 71.07 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 19.1 tt -65.39 -33.75 65.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.295 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 28.9 mt -67.34 -37.36 78.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.766 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.85 -51.38 24.73 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 83.3 mt -58.14 -49.29 82.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.412 0.625 . . . . 0.0 109.734 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 12.1 tp -58.53 -39.89 81.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.318 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -61.41 -48.35 81.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.58 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 10.1 mp -63.57 -51.05 67.04 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.832 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 mp -61.38 -46.05 97.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.076 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -63.16 -37.12 85.95 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.058 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 15.4 t-105 -60.85 -57.5 12.39 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.154 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 68.8 mt -61.88 -55.38 24.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.8 -177.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.491 ' O ' HD23 ' B' ' 43' ' ' LEU . 0.7 OUTLIER -56.4 -50.61 71.12 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.044 -178.554 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -55.74 -39.64 71.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.245 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -59.73 -53.46 57.77 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.678 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' B' ' 48' ' ' PHE . 0.9 OUTLIER -80.93 -72.81 0.4 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.52 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.432 ' CD2' ' N ' ' B' ' 48' ' ' PHE . 84.7 t80 47.24 -88.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.569 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' PHE . . . . . 0.517 ' N ' ' O ' ' B' ' 46' ' ' LEU . 80.7 t80 -154.36 84.5 1.12 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.325 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 62.4 mttp 48.73 27.36 1.51 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.439 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 16.0 p -63.49 -34.76 78.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.689 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' ILE . . . . . 0.423 ' H ' HG13 ' B' ' 51' ' ' ILE . 21.2 mt -49.88 -46.6 22.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.662 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.515 ' CD2' ' OE1' ' B' ' 56' ' ' GLU . 64.5 t80 -72.45 -27.88 62.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.553 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -70.8 -45.27 64.94 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.631 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -72.89 -41.57 64.5 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.561 -0.455 . . . . 0.0 110.75 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -66.01 -39.69 90.47 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.545 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 56' ' ' GLU . . . . . 0.515 ' OE1' ' CD2' ' B' ' 52' ' ' TYR . 9.6 pt-20 -75.6 -39.28 58.19 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.571 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -61.22 -41.79 97.47 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.621 -0.431 . . . . 0.0 110.092 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.31 -32.4 76.81 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 25.0 tp -63.25 -52.56 61.61 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.074 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt . . . . . 0 C--N 1.332 -0.157 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.569 179.982 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 36.8 p . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 46.22 74.75 0.75 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.73 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.62 -29.27 32.09 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.605 2.204 . . . . 0.0 111.378 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 26' ' ' LEU . . . . . 0.583 HD13 ' HB2' ' D' ' 31' ' ' SER . 3.7 pp -65.18 -35.46 81.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.786 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.22 -49.44 33.08 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.123 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 61.3 t -55.53 -36.45 41.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 29' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' C' ' 26' ' ' LEU . . . -63.3 -33.94 76.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.546 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.76 -40.1 79.91 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.853 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 3.3 t -69.14 -54.0 17.2 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.488 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 32' ' ' ILE . . . . . 0.443 HG23 ' N ' ' C' ' 33' ' ' ILE . 17.5 tt -60.98 -40.87 86.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.53 -178.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 33' ' ' ILE . . . . . 0.443 ' N ' HG23 ' C' ' 32' ' ' ILE . 13.6 tt -70.98 -31.21 44.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.609 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.08 -51.95 30.76 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.242 -0.98 . . . . 0.0 111.084 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.59 -34.71 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 C-N-CA 120.173 -0.611 . . . . 0.0 109.943 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 46.0 tp -64.89 -39.68 93.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.359 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -68.29 -49.67 58.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.513 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 34.9 tp -61.01 -51.87 67.41 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.226 0.536 . . . . 0.0 111.253 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 1.2 mp -60.58 -43.29 94.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.262 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 40' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' C' ' 40' ' ' LEU . 18.6 mt -61.04 -40.5 93.85 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.935 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 18.0 t-105 -59.43 -58.11 10.03 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.366 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 56.1 mt -62.33 -54.94 27.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.497 ' O ' HD23 ' C' ' 43' ' ' LEU . 0.7 OUTLIER -59.94 -49.28 78.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.472 -178.183 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 44' ' ' ASP . . . . . 0.484 ' O ' ' CB ' ' C' ' 50' ' ' SER . 61.2 t0 -57.81 -42.4 84.18 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.655 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 45' ' ' ARG . . . . . 0.507 ' NH1' ' CD1' ' C' ' 51' ' ' ILE . 3.2 tpt85 -61.04 -52.74 63.69 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.204 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 46' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' C' ' 43' ' ' LEU . 0.1 OUTLIER -118.31 137.37 53.12 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.039 0.447 . . . . 0.0 110.661 179.538 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -172.59 -38.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.107 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -172.67 -46.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.312 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 45.0 tttt -173.89 39.67 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.846 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 50' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' C' ' 44' ' ' ASP . 47.9 t -65.31 -51.61 59.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.807 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 51' ' ' ILE . . . . . 0.507 ' CD1' ' NH1' ' C' ' 45' ' ' ARG . 96.0 mt -43.39 -40.89 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.677 0.275 . . . . 0.0 111.215 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -73.62 -28.52 61.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.6 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 53' ' ' ARG . . . . . 0.52 ' HG3' ' CE1' ' C' ' 57' ' ' HIS . 56.8 ttm-85 -69.71 -49.35 54.18 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.052 0.453 . . . . 0.0 110.246 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -69.08 -42.6 75.97 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.702 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -63.22 -37.02 85.61 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.792 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -78.66 -24.16 45.32 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.739 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 57' ' ' HIS . . . . . 0.52 ' CE1' ' HG3' ' C' ' 53' ' ' ARG . 1.9 m-70 -71.79 -49.29 40.08 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.848 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.41 -27.45 72.67 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 8.7 tp -94.44 53.24 1.66 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.706 0.288 . . . . 0.0 110.442 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 22.6 pttp . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.627 179.987 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 32.5 p . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -156.36 62.33 2.92 Favored Pre-proline 0 C--N 1.331 -0.227 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.517 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -50.02 -34.53 38.35 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 122.148 1.899 . . . . 0.0 110.647 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 26' ' ' LEU . . . . . 0.403 ' O ' ' HB3' ' D' ' 29' ' ' ALA . 17.8 tp -59.11 -49.83 76.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.231 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 27' ' ' ALA . . . . . 0.443 ' HB1' HD11 ' C' ' 26' ' ' LEU . . . -58.03 -53.81 54.04 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 83.5 t -52.43 -43.88 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.463 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' D' ' 26' ' ' LEU . . . -53.8 -42.55 68.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.227 0.537 . . . . 0.0 109.924 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.61 -42.54 98.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.792 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 31' ' ' SER . . . . . 0.583 ' HB2' HD13 ' C' ' 26' ' ' LEU . 6.3 t -61.68 -52.64 63.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.841 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 13.6 tt -64.01 -31.08 51.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.574 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 33.2 mt -67.21 -40.88 85.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.488 -0.485 . . . . 0.0 109.725 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.39 -52.05 33.49 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 120.991 -0.623 . . . . 0.0 111.64 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 4.3 mm -60.23 -43.85 94.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.109 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 47.0 tp -62.23 -38.61 89.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.346 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -63.96 -51.23 65.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.849 0.356 . . . . 0.0 110.908 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 50.5 tp -58.12 -45.56 87.07 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.513 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 97.4 mt -62.36 -40.16 86.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.628 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 40' ' ' LEU . . . . . 0.517 HD13 ' O ' ' D' ' 40' ' ' LEU . 0.2 OUTLIER -61.84 -44.03 97.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.18 -179.401 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 28.2 t-105 -63.83 -56.36 16.0 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.736 0.303 . . . . 0.0 111.782 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 74.3 mt -58.71 -53.43 47.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.244 -0.435 . . . . 0.0 112.017 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 36.9 tp -61.55 -46.73 88.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.733 0.301 . . . . 0.0 111.089 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -52.99 -46.8 68.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.295 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -63.19 -50.69 69.34 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.89 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.17 123.99 46.86 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.974 0.416 . . . . 0.0 110.33 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -172.27 -47.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.246 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -172.08 71.12 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.275 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt 54.29 33.37 18.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.289 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 9.7 t -57.77 -50.09 74.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.745 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 55.5 mt -52.56 -44.23 44.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.598 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -71.91 -30.59 65.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.27 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -71.22 -44.15 65.94 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.892 0.377 . . . . 0.0 110.747 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 54' ' ' PHE . . . . . 0.417 ' CB ' ' NH2' ' A' ' 45' ' ' ARG . 50.9 m-85 -71.92 -38.29 69.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.88 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -69.18 -40.1 78.3 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.652 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -76.62 -36.6 57.37 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.616 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -65.47 -47.51 75.83 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.667 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.54 -28.99 72.23 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 10.6 mp -103.85 65.48 0.82 Allowed 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 86.6 tttt . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.652 -179.817 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 52.6 p . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.445 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 2.8 m-20 49.58 53.11 13.87 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.643 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 28.0 Cg_endo -62.14 -29.09 80.44 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.437 2.092 . . . . 0.0 111.163 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.3 tp -63.71 -50.56 68.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.218 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -63.18 -44.71 94.64 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.329 0.585 . . . . 0.0 109.917 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.9 t -58.79 -45.89 91.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.259 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.98 -31.38 69.84 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.606 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -66.09 -50.43 64.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.446 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.3 t -58.02 -42.43 85.28 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.402 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.1 mp -65.95 -37.98 81.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.184 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.416 HG21 HD13 ' A' ' 33' ' ' ILE . 2.4 tt -69.03 -36.44 73.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.637 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.43 -52.34 17.27 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.159 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.83 -43.44 91.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.145 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 57.2 tp -64.7 -34.69 78.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.359 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -65.39 -50.33 65.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.844 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.5 mp -62.84 -47.25 84.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.976 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.9 mt -61.62 -44.84 99.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.1 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 35.0 tp -62.86 -43.33 99.09 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.7 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.9 t-105 -62.32 -58.46 7.62 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 120.82 0.343 . . . . 0.0 111.847 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 73.7 mt -59.54 -54.31 36.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.743 -177.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.5 tp -58.34 -50.8 72.34 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.801 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -52.11 -38.85 58.73 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.07 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.435 HH21 ' CB ' ' D' ' 54' ' ' PHE . 54.0 ttt85 -64.65 -54.35 33.23 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.596 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 48' ' ' PHE . 0.1 OUTLIER -91.91 -84.83 0.26 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.862 -179.525 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.421 ' CD2' ' N ' ' A' ' 48' ' ' PHE . 82.2 t80 56.54 -80.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.539 ' N ' ' O ' ' A' ' 46' ' ' LEU . 65.2 t80 -165.64 98.04 0.67 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.375 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt 47.93 33.32 3.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.485 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 53' ' ' ARG . 5.4 t -63.9 -44.15 93.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.89 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.42 HG12 ' H ' ' A' ' 51' ' ' ILE . 6.3 mm -41.93 -43.52 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.488 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.507 ' CE2' ' OE1' ' A' ' 56' ' ' GLU . 90.8 t80 -73.23 -31.22 64.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.352 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.531 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 23.4 mmt180 -70.79 -48.44 54.21 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-O 120.975 0.417 . . . . 0.0 110.541 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -70.05 -35.99 74.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.621 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -68.13 -41.02 82.31 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 120.886 -0.325 . . . . 0.0 111.613 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.507 ' OE1' ' CE2' ' A' ' 52' ' ' TYR . 21.4 pt-20 -76.4 -41.92 46.11 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.119 -0.633 . . . . 0.0 111.02 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.531 ' ND1' ' O ' ' A' ' 53' ' ' ARG . 15.8 m80 -61.95 -51.83 66.5 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.324 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.14 -25.69 74.0 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.6 tp -150.23 88.67 1.53 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.082 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.286 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 45.6 t . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -160.89 79.47 2.28 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.804 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -50.56 -35.02 44.89 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.502 2.135 . . . . 0.0 111.495 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.501 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 17.8 tp -59.15 -51.49 69.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.975 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.49 -44.52 93.05 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 88.5 t -61.03 -32.64 53.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -64.15 -34.14 77.39 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.03 -46.53 64.86 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.318 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 3.9 m -66.04 -47.3 74.84 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 119.981 -0.688 . . . . 0.0 111.561 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.542 HG23 ' N ' ' B' ' 33' ' ' ILE . 21.1 tt -64.48 -45.19 96.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.738 -178.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.542 ' N ' HG23 ' B' ' 32' ' ' ILE . 16.4 tt -64.86 -34.78 72.62 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.087 0 C-N-CA 119.409 -0.916 . . . . 0.0 109.937 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.49 -46.06 93.36 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 94.3 mt -59.52 -43.3 90.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 37.4 tp -60.01 -40.17 88.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.578 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -66.08 -51.56 56.91 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 31.8 tp -61.95 -51.86 66.39 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 120.865 0.365 . . . . 0.0 111.717 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.413 ' N ' ' CD1' ' B' ' 39' ' ' ILE . 1.3 mp -61.45 -40.52 86.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.021 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 62.9 tp -62.56 -37.32 85.69 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.501 -0.48 . . . . 0.0 109.983 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 39.3 t-105 -64.32 -56.04 17.2 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.637 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 54.6 mt -63.23 -50.84 77.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.424 -0.511 . . . . 0.0 111.769 -177.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.499 ' O ' HD23 ' B' ' 43' ' ' LEU . 0.9 OUTLIER -61.15 -49.3 77.78 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.442 -178.734 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -61.5 -37.44 83.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.693 0.282 . . . . 0.0 110.952 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 50.0 ttt-85 -65.84 -51.02 62.44 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.703 -0.399 . . . . 0.0 112.066 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' B' ' 43' ' ' LEU . 0.6 OUTLIER -123.31 -159.39 0.84 Allowed 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 120.882 0.372 . . . . 0.0 111.58 -179.086 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.464 ' O ' ' CD2' ' B' ' 47' ' ' PHE . 31.1 t80 50.06 19.43 0.48 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.203 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -168.77 -1.67 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.38 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt 44.61 40.24 3.91 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.606 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 2.3 p -62.96 -33.28 75.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.753 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 78.0 mt -47.33 -46.09 9.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.82 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -72.16 -30.0 64.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.439 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.529 ' O ' ' ND1' ' B' ' 57' ' ' HIS . 95.5 mtt-85 -71.54 -45.6 61.89 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.727 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -71.54 -38.34 71.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.911 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -70.03 -39.35 75.81 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.608 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 56' ' ' GLU . . . . . 0.528 ' OE2' ' CD2' ' B' ' 57' ' ' HIS . 1.2 pp20? -75.75 -39.76 56.62 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.748 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 57' ' ' HIS . . . . . 0.529 ' ND1' ' O ' ' B' ' 53' ' ' ARG . 26.6 m80 -65.16 -45.38 85.17 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.29 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.72 -27.79 73.01 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 9.4 tp -86.17 58.25 4.95 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.897 0.38 . . . . 0.0 110.349 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? . . . . . 0 N--CA 1.466 0.352 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.417 -179.886 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 25.9 t . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 53.46 70.61 1.7 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.676 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -51.74 -38.75 67.36 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.573 2.182 . . . . 0.0 111.565 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 26' ' ' LEU . . . . . 0.415 ' O ' ' HB3' ' C' ' 29' ' ' ALA . 26.0 tp -57.16 -48.61 78.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.018 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.44 -48.98 77.26 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.389 0.614 . . . . 0.0 109.497 178.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 85.4 t -58.95 -31.67 45.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 29' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' C' ' 26' ' ' LEU . . . -66.34 -33.87 76.69 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.15 -43.71 73.78 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.305 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 4.4 p -69.58 -45.92 67.55 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 119.972 -0.691 . . . . 0.0 111.616 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 13.5 tt -67.87 -39.72 82.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.563 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 33' ' ' ILE . . . . . 0.402 HG21 HD13 ' C' ' 33' ' ' ILE . 7.6 tt -70.01 -35.91 66.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.784 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.67 -51.42 25.42 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 120.413 -0.898 . . . . 0.0 111.202 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 94.0 mt -61.21 -46.3 96.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.551 -0.46 . . . . 0.0 109.846 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 15.4 tp -58.14 -42.87 86.8 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.894 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -59.72 -51.78 68.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.757 0.313 . . . . 0.0 111.484 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 35.9 tp -57.47 -52.6 64.71 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.751 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 39' ' ' ILE . . . . . 0.401 ' N ' ' CD1' ' C' ' 39' ' ' ILE . 1.3 mp -61.02 -41.04 87.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.836 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 40' ' ' LEU . . . . . 0.535 ' O ' HD13 ' C' ' 40' ' ' LEU . 0.2 OUTLIER -59.66 -43.06 94.1 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.746 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 12.9 t-105 -61.45 -58.5 7.91 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.466 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 96.2 mt -55.76 -56.91 9.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.92 -177.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.513 ' O ' HD23 ' C' ' 43' ' ' LEU . 0.6 OUTLIER -59.7 -45.55 91.77 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.881 -178.871 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -48.55 -46.38 38.8 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 54.9 ttt-85 -64.54 -48.16 76.11 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.94 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 46' ' ' LEU . . . . . 0.496 ' O ' ' N ' ' C' ' 48' ' ' PHE . 8.2 mt -82.68 4.4 25.11 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.126 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 47' ' ' PHE . . . . . 0.518 ' O ' ' N ' ' C' ' 49' ' ' LYS . 48.3 t80 -45.34 91.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.86 0.362 . . . . 0.0 110.78 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 48' ' ' PHE . . . . . 0.496 ' N ' ' O ' ' C' ' 46' ' ' LEU . 88.1 t80 55.47 -81.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.615 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 49' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' C' ' 47' ' ' PHE . 76.6 tttt -161.01 39.05 0.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.101 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 50' ' ' SER . . . . . 0.432 ' OG ' ' CE2' ' C' ' 54' ' ' PHE . 4.8 t -70.83 -26.14 63.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.465 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 53.0 mt -42.05 -48.02 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.211 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -73.25 -28.73 62.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.398 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 53' ' ' ARG . . . . . 0.527 ' O ' ' CG ' ' C' ' 57' ' ' HIS . 20.0 mmt85 -71.78 -49.3 40.08 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.662 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 54' ' ' PHE . . . . . 0.432 ' CE2' ' OG ' ' C' ' 50' ' ' SER . 38.0 m-85 -69.46 -39.2 77.87 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.44 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 55' ' ' PHE . . . . . 0.418 ' CZ ' HD22 ' C' ' 59' ' ' LEU . 84.0 t80 -66.8 -38.04 85.72 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 120.561 -0.455 . . . . 0.0 111.026 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -79.43 -22.93 43.57 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.852 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 57' ' ' HIS . . . . . 0.527 ' CG ' ' O ' ' C' ' 53' ' ' ARG . 2.2 m-70 -75.91 -45.49 35.02 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.229 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.48 -28.1 72.68 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 59' ' ' LEU . . . . . 0.418 HD22 ' CZ ' ' C' ' 55' ' ' PHE . 11.1 mp -100.41 64.92 1.18 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt . . . . . 0 N--CA 1.466 0.368 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.423 179.899 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 55.3 p . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -157.94 64.38 2.98 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.191 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -48.72 -31.8 20.17 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.058 1.839 . . . . 0.0 110.815 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 17.7 tp -63.21 -50.95 68.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.612 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 27' ' ' ALA . . . . . 0.43 ' O ' ' HB3' ' D' ' 30' ' ' ALA . . . -64.75 -47.28 78.77 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.811 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 96.5 t -56.76 -41.74 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.38 -38.94 85.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.471 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 30' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' D' ' 27' ' ' ALA . . . -58.69 -50.55 73.45 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.739 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 6.2 t -62.97 -39.76 95.66 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.365 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 5.2 mm -62.42 -48.24 89.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.444 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 18.5 tt -66.84 -31.1 51.97 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.282 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.92 -48.96 57.88 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.222 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 97.2 mt -63.79 -44.49 98.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.065 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 33.9 tp -63.45 -30.68 71.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.012 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -68.68 -51.28 43.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.754 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 43.3 tp -59.5 -48.07 83.06 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.51 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 96.8 mt -61.06 -43.86 97.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.786 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 22.1 mt -61.34 -41.04 96.39 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.351 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 46.7 t-105 -61.61 -54.66 39.96 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.767 0.318 . . . . 0.0 111.556 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 64.1 mt -62.9 -55.78 21.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 120.293 -0.563 . . . . 0.0 112.182 -177.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 43.1 tp -59.06 -50.25 74.79 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.173 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 44' ' ' ASP . . . . . 0.459 ' O ' ' CB ' ' D' ' 50' ' ' SER . 31.6 t70 -52.72 -44.83 66.64 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.106 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -58.35 -54.84 42.5 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.395 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.13 106.91 15.65 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 120.956 0.408 . . . . 0.0 110.121 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -174.6 94.47 0.08 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.306 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 35.7 t80 59.3 49.53 8.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.536 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? 54.72 52.56 11.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.596 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 50' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 11.5 t -62.82 -49.48 74.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.994 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 53.0 mt -45.18 -43.91 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.926 0.393 . . . . 0.0 110.584 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -71.48 -28.09 63.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.65 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 53' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' D' ' 50' ' ' SER . 12.0 ttm180 -70.09 -49.67 48.61 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.035 0.445 . . . . 0.0 110.175 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 54' ' ' PHE . . . . . 0.435 ' CB ' HH21 ' A' ' 45' ' ' ARG . 55.1 m-85 -65.42 -43.02 91.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.303 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -63.23 -38.36 90.88 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.919 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -76.06 -22.51 55.58 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.615 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -75.07 -54.34 7.32 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.167 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -73.9 -26.12 69.9 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 12.6 tp -146.41 86.91 1.7 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 63.7 mttp . . . . . 0 C--N 1.334 -0.096 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.592 -179.725 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -159.44 71.11 3.37 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.708 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -50.05 -33.44 34.81 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.432 2.088 . . . . 0.0 111.297 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.2 tp -62.55 -49.61 74.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.944 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.75 -46.25 88.91 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.0 t -60.05 -40.41 83.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.15 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.73 -30.89 71.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.716 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.61 -51.06 46.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.53 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.1 p -61.76 -36.68 81.72 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.574 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.7 mm -68.4 -41.75 83.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.594 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 33' ' ' ILE . 4.4 tt -70.64 -34.19 56.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.371 -0.531 . . . . 0.0 110.744 -178.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.64 -52.15 13.47 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.697 -0.764 . . . . 0.0 111.389 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.489 HG23 ' N ' ' A' ' 36' ' ' LEU . 15.3 tt -63.17 -44.52 99.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.784 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.489 ' N ' HG23 ' A' ' 35' ' ' ILE . 48.9 tp -59.93 -41.88 92.73 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.811 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -60.07 -49.92 75.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.745 0.307 . . . . 0.0 111.093 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 37.2 tp -59.3 -51.81 68.33 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.925 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.3 mp -61.6 -46.06 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.049 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.575 HD13 ' O ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -59.7 -39.93 86.23 Favored 'General case' 0 C--O 1.218 -0.59 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.297 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 13.5 t-105 -62.64 -57.11 12.22 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.483 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 97.2 mt -56.43 -54.59 26.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.703 -177.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 47' ' ' PHE . 34.5 tp -61.64 -42.5 98.98 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.359 -0.537 . . . . 0.0 110.978 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -51.59 -44.93 62.98 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -63.2 -54.8 31.9 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.246 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 48' ' ' PHE . 5.5 mt -77.15 -77.19 0.15 Allowed 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.777 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.416 ' CD2' ' N ' ' A' ' 48' ' ' PHE . 93.3 t80 53.88 -83.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.788 0.328 . . . . 0.0 110.434 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.533 ' N ' ' O ' ' A' ' 46' ' ' LEU . 81.2 t80 -167.65 86.72 0.24 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.259 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm 59.8 30.44 20.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.339 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.5 t -68.46 -29.18 67.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.621 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.9 mm -44.21 -43.18 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-O 120.989 0.423 . . . . 0.0 110.283 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -74.6 -28.44 60.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.349 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.507 ' O ' ' CG ' ' A' ' 57' ' ' HIS . 98.9 mtt180 -68.28 -49.82 57.89 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.015 0.436 . . . . 0.0 110.46 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -72.39 -40.35 67.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.93 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -63.73 -40.75 97.5 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.617 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -77.16 -41.79 40.32 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.973 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.507 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 6.2 m-70 -56.9 -50.42 72.59 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.277 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.92 -27.01 71.33 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.756 -0.937 . . . . 0.0 110.756 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.8 tp -158.56 90.74 1.03 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.493 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.6 mttt . . . . . 0 C--N 1.338 0.089 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.477 -179.949 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 55.23 74.78 0.68 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.732 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.412 ' O ' ' N ' ' B' ' 29' ' ' ALA . 53.9 Cg_exo -51.0 -33.66 43.37 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.668 2.245 . . . . 0.0 111.52 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.461 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 19.2 tp -59.7 -50.93 71.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.269 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.52 -42.9 99.5 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.423 ' O ' HG22 ' B' ' 32' ' ' ILE . 82.3 t -63.47 -31.08 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -64.83 -34.9 79.46 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.15 -47.45 61.58 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.385 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 4.8 t -64.83 -48.35 74.67 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.534 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.52 HG23 ' N ' ' B' ' 33' ' ' ILE . 10.7 tp -65.41 -44.48 94.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.966 -178.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.52 ' N ' HG23 ' B' ' 32' ' ' ILE . 15.6 tt -66.18 -32.85 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.975 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.64 -45.84 81.21 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 5.2 mm -60.08 -42.79 91.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 12.0 tp -61.71 -37.4 84.03 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.373 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' HIS . . . . . 0.458 ' NE2' ' NE2' ' C' ' 37' ' ' HIS . 1.5 t60 -65.66 -53.03 46.83 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 28.6 tp -64.79 -52.38 57.18 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.452 ' N ' ' CD1' ' B' ' 39' ' ' ILE . 1.3 mp -62.05 -47.97 90.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.883 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 41.6 tp -61.2 -35.94 78.53 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.253 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 41.2 t-105 -63.44 -57.16 11.16 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.384 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 73.2 mt -60.93 -53.01 55.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.768 -177.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' B' ' 43' ' ' LEU . 11.1 mt -60.12 -53.31 59.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.421 -178.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' ASP . . . . . 0.411 ' O ' ' CB ' ' B' ' 50' ' ' SER . 66.2 t0 -57.41 -31.74 66.15 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.158 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -66.36 -50.67 62.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.282 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' B' ' 48' ' ' PHE . 0.1 OUTLIER -110.2 -88.98 0.49 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.821 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 33.9 t80 57.04 -79.37 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.888 0.375 . . . . 0.0 110.414 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' PHE . . . . . 0.533 ' N ' ' O ' ' B' ' 46' ' ' LEU . 47.7 t80 -138.75 58.53 1.65 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.536 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm 57.15 54.61 6.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.424 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' B' ' 44' ' ' ASP . 39.0 t -65.69 -45.74 81.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.133 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 59.2 mt -46.72 -28.6 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.044 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.49 ' CZ ' ' OE1' ' B' ' 56' ' ' GLU . 60.4 t80 -71.85 -36.94 70.31 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.72 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -70.77 -45.28 65.03 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.881 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 54' ' ' PHE . . . . . 0.438 ' CD1' ' NH1' ' C' ' 45' ' ' ARG . 61.4 m-85 -70.18 -35.9 74.29 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.923 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -71.17 -39.76 71.68 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.72 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 56' ' ' GLU . . . . . 0.49 ' OE1' ' CZ ' ' B' ' 52' ' ' TYR . 18.3 pt-20 -76.11 -39.25 55.61 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.871 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -67.48 -43.4 81.06 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.414 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.05 -28.57 72.31 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 10.8 mp -102.69 65.4 0.91 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.537 -179.816 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 15.7 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -158.48 72.66 3.83 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.812 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.2 -32.42 40.37 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.529 2.153 . . . . 0.0 111.461 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 14.2 tp -62.01 -52.04 65.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.1 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 27' ' ' ALA . . . . . 0.43 ' O ' ' HB3' ' C' ' 30' ' ' ALA . . . -61.41 -47.77 84.24 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.03 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 92.4 t -54.6 -50.26 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.54 -44.02 56.25 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.565 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 30' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' C' ' 27' ' ' ALA . . . -55.81 -50.35 70.76 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 3.0 t -57.6 -52.27 66.09 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.401 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 21.5 mm -58.88 -30.71 43.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.715 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 50.3 mt -69.03 -40.2 80.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.395 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.81 -52.12 26.26 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 120.657 -0.783 . . . . 0.0 111.81 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 35' ' ' ILE . . . . . 0.482 ' H ' HD12 ' C' ' 35' ' ' ILE . 3.4 mp -62.52 -44.47 99.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.776 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 54.7 tp -60.48 -39.15 86.63 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.707 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 37' ' ' HIS . . . . . 0.458 ' NE2' ' NE2' ' B' ' 37' ' ' HIS . 1.1 t60 -61.33 -51.07 70.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.922 0.391 . . . . 0.0 110.794 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.25 -51.93 66.32 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.837 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 26.3 mm -60.52 -41.52 88.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.179 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 40' ' ' LEU . . . . . 0.526 ' O ' HD13 ' C' ' 40' ' ' LEU . 0.2 OUTLIER -61.56 -41.88 98.01 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.426 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 16.5 t-105 -63.11 -57.55 10.21 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 120.889 0.376 . . . . 0.0 111.414 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 82.3 mt -57.91 -55.6 20.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.877 -177.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.494 ' O ' HD23 ' C' ' 43' ' ' LEU . 0.7 OUTLIER -59.3 -48.78 80.33 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.63 -178.938 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -49.08 -45.37 43.02 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 45' ' ' ARG . . . . . 0.455 ' CZ ' HD21 ' C' ' 46' ' ' LEU . 62.4 ttp85 -61.47 -50.89 70.93 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.086 -0.646 . . . . 0.0 110.708 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 46' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' C' ' 48' ' ' PHE . 12.4 mt -76.44 -76.89 0.15 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.052 -0.659 . . . . 0.0 111.253 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 69.2 t80 58.32 -78.0 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.428 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 48' ' ' PHE . . . . . 0.528 ' N ' ' O ' ' C' ' 46' ' ' LEU . 38.7 t80 -169.57 -29.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.336 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 49' ' ' LYS . . . . . 0.415 ' NZ ' ' CD2' ' C' ' 52' ' ' TYR . 49.8 tttm -173.07 18.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.91 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.08 -32.34 69.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.697 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 35.1 mt -56.38 -54.17 31.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.438 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 52' ' ' TYR . . . . . 0.415 ' CD2' ' NZ ' ' C' ' 49' ' ' LYS . 70.5 t80 -76.87 -33.11 57.87 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 53' ' ' ARG . . . . . 0.535 ' O ' ' CD2' ' C' ' 57' ' ' HIS . 63.6 mmt-85 -66.76 -49.45 65.88 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.635 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -73.67 -39.75 64.21 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.901 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -61.03 -40.72 94.69 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.463 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 56' ' ' GLU . . . . . 0.518 ' OE2' ' ND1' ' C' ' 57' ' ' HIS . 1.2 pp20? -78.65 -39.83 35.85 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.319 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 57' ' ' HIS . . . . . 0.535 ' CD2' ' O ' ' C' ' 53' ' ' ARG . 7.2 m-70 -52.05 -49.49 63.35 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 58' ' ' GLY . . . . . 0.435 ' C ' HD22 ' C' ' 59' ' ' LEU . . . -68.12 -27.4 73.72 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 59' ' ' LEU . . . . . 0.435 HD22 ' C ' ' C' ' 58' ' ' GLY . 3.7 mm? -103.96 64.15 0.78 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 62.7 tttm . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.519 -179.963 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 24' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' D' ' 24' ' ' ASP . 9.2 p30 -162.58 65.13 1.64 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.125 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -48.98 -31.1 19.47 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 121.916 1.744 . . . . 0.0 110.394 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 16.2 tp -62.84 -50.33 71.35 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.04 178.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 27' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' D' ' 30' ' ' ALA . . . -60.46 -47.78 84.61 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.78 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 87.1 t -58.2 -50.57 77.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.581 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.33 -42.82 53.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.645 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 30' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' D' ' 27' ' ' ALA . . . -57.69 -49.86 75.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.568 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.28 -47.63 80.95 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.534 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 27.2 mm -62.21 -35.09 67.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.861 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 74.5 mt -67.23 -41.75 87.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.696 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.63 -51.34 31.26 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.008 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 14.1 tt -62.63 -39.96 86.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.091 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 52.8 tp -66.35 -34.47 78.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.852 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -65.88 -48.15 72.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.444 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 59.9 tp -63.14 -50.98 68.31 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.162 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 91.8 mt -59.46 -45.93 93.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.995 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 7.7 tp -62.7 -38.02 88.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.339 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 38.9 t-105 -62.23 -52.59 63.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.764 0.316 . . . . 0.0 111.551 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 64.8 mt -66.32 -53.49 35.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -177.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 54.2 tp -60.95 -46.12 91.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.697 0.284 . . . . 0.0 111.308 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 44' ' ' ASP . . . . . 0.489 ' O ' ' CB ' ' D' ' 50' ' ' SER . 28.1 t70 -59.8 -47.2 86.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.769 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -58.53 -50.19 74.66 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.101 -0.64 . . . . 0.0 111.071 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 2.5 pp -124.49 134.9 52.88 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.898 0.38 . . . . 0.0 110.655 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -168.43 -39.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.346 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -171.17 -36.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.401 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 177.28 26.81 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.899 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 50' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 10.3 t -50.22 -54.55 20.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.02 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 87.4 mt -48.93 -40.68 12.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.268 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -73.79 -30.8 62.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.307 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 53' ' ' ARG . . . . . 0.405 ' HE ' ' HA ' ' D' ' 50' ' ' SER . 43.4 mtm180 -67.31 -47.23 71.16 Favored 'General case' 0 CA--C 1.522 -0.097 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.318 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -71.97 -41.51 67.63 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.809 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -59.7 -43.74 93.96 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.368 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -78.21 -31.62 49.49 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.455 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -58.32 -52.16 66.77 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.874 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.82 -35.12 72.6 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.55 23.83 0.61 Allowed 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.181 -179.755 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 82.0 p . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.416 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 1.7 m-20 53.76 54.06 11.56 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.605 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.426 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 27.2 Cg_endo -62.06 -28.96 80.72 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.4 2.067 . . . . 0.0 111.26 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.417 ' O ' HD13 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -63.87 -54.52 33.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.875 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.56 ' O ' HD11 ' D' ' 26' ' ' LEU . . . -63.97 -50.41 68.68 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.895 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 87.5 t -55.47 -47.13 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 25' ' ' PRO . . . -54.14 -41.0 67.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.968 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.32 -48.7 80.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.665 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.415 ' HB2' HD13 ' D' ' 26' ' ' LEU . 6.4 t -59.43 -46.23 89.31 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.193 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 43.7 mm -60.63 -38.19 77.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.792 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.7 mm -69.74 -36.09 68.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.692 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.95 -52.03 26.03 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.611 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.1 pt -66.76 -37.74 80.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.626 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -67.83 -36.68 80.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.269 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.462 ' CE1' ' NE2' ' D' ' 37' ' ' HIS . 0.3 OUTLIER -68.09 -50.37 55.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.194 -179.463 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 38.2 tp -65.68 -51.53 58.66 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.332 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 89.5 mt -60.84 -51.65 70.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.333 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 41.2 tp -59.71 -40.29 87.46 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.478 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 27.1 t-105 -61.08 -55.55 31.32 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.706 0.288 . . . . 0.0 111.484 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 96.8 mt -57.93 -55.81 19.53 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 CA-C-O 121.242 0.544 . . . . 0.0 111.536 -178.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.67 HD12 ' C ' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -59.43 -37.71 78.8 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.567 -179.165 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -59.65 -41.47 90.6 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -63.01 -46.65 86.64 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.15 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.421 ' O ' ' O ' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -106.59 -112.65 0.28 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.991 179.654 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.421 ' O ' ' O ' ' A' ' 46' ' ' LEU . 32.6 t80 47.76 97.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.861 0.362 . . . . 0.0 110.248 -179.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.522 ' O ' ' CD2' ' A' ' 48' ' ' PHE . 49.0 t80 60.37 27.94 17.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.552 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.6 mttm 53.01 65.56 1.48 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.589 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.422 ' O ' ' N ' ' A' ' 53' ' ' ARG . 4.7 t -69.51 -28.83 66.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.02 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.0 mt -44.34 -43.23 2.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.916 0.389 . . . . 0.0 110.221 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -71.65 -28.03 63.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.038 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.501 ' HG3' ' CE1' ' A' ' 57' ' ' HIS . 43.9 ttm180 -71.1 -49.24 46.49 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 120.948 0.404 . . . . 0.0 110.315 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -65.4 -44.78 86.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.604 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -65.7 -35.0 79.49 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.265 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -76.89 -24.81 52.52 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.865 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.501 ' CE1' ' HG3' ' A' ' 53' ' ' ARG . 2.0 m-70 -76.7 -47.14 22.87 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.389 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.43 -27.08 73.93 Favored Glycine 0 N--CA 1.463 0.444 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.07 82.18 1.38 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.241 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.8 mttp . . . . . 0 C--N 1.334 -0.078 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.639 -179.829 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 20.9 p . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -158.19 76.1 3.65 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.789 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.444 ' O ' ' HB2' ' B' ' 29' ' ' ALA . 50.4 Cg_exo -51.96 -32.67 48.86 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.563 2.176 . . . . 0.0 111.206 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 20.6 tp -60.32 -47.13 87.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.737 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.94 -57.37 7.05 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.433 ' O ' HG22 ' B' ' 32' ' ' ILE . 82.4 t -52.67 -34.81 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' B' ' 25' ' ' PRO . . . -64.27 -34.74 78.8 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.005 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.56 -48.66 59.55 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.511 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 42.2 t -63.69 -48.85 75.45 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.574 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.474 HG23 ' N ' ' B' ' 33' ' ' ILE . 19.5 tt -65.66 -43.0 93.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.122 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.474 ' N ' HG23 ' B' ' 32' ' ' ILE . 8.2 tt -67.17 -30.33 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.854 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.69 -51.21 37.19 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 179.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 96.8 mt -58.12 -46.09 88.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.255 0.55 . . . . 0.0 109.98 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 11.2 tp -60.76 -38.15 84.25 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.894 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 37' ' ' HIS . . . . . 0.454 ' ND1' ' C ' ' B' ' 37' ' ' HIS . 0.4 OUTLIER -65.86 -53.95 33.1 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.811 0.338 . . . . 0.0 111.718 -178.984 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 27.4 tp -60.59 -54.74 41.72 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.691 -178.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.432 HD13 ' HA ' ' B' ' 39' ' ' ILE . 11.5 mm -60.61 -43.7 95.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.523 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 31.0 tp -54.87 -44.53 74.11 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -60.75 -54.64 42.78 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.218 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 47.9 mm -51.18 -53.66 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.325 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.581 ' O ' HD23 ' B' ' 43' ' ' LEU . 1.0 OUTLIER -61.9 -38.97 90.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.136 -178.747 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -58.65 -47.58 83.96 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.219 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 53.4 ttt85 -69.92 -53.59 17.21 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.689 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' B' ' 43' ' ' LEU . 1.9 pp -108.49 147.32 31.87 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.027 0.441 . . . . 0.0 111.198 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -172.45 -48.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.074 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -172.2 -38.34 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.304 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.524 ' NZ ' ' CG ' ' B' ' 52' ' ' TYR . 42.9 tttm -172.88 21.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.259 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 13.2 t -59.01 -46.56 87.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.194 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 71.4 mt -45.53 -32.3 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.906 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.524 ' CG ' ' NZ ' ' B' ' 49' ' ' LYS . 26.3 t80 -72.17 -31.23 65.74 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.461 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.481 ' CD ' ' N ' ' B' ' 53' ' ' ARG . 0.9 OUTLIER -71.57 -45.1 63.19 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.622 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -71.14 -38.15 72.24 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.045 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -70.91 -39.47 72.72 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.655 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -75.27 -39.08 60.1 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.916 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -67.57 -44.94 77.0 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.437 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.8 -28.02 67.6 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 7.9 tp -84.01 49.84 1.72 Allowed 'General case' 0 C--O 1.231 0.102 0 CA-C-O 120.823 0.344 . . . . 0.0 110.375 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 34.9 tptt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.516 -179.869 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 7.8 m . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 53.78 77.01 0.47 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.795 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -50.42 -35.12 43.95 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.544 2.163 . . . . 0.0 111.533 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 18.6 tp -60.97 -49.11 78.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.736 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.39 -45.59 92.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.113 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 91.5 t -58.46 -43.94 87.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.42 -38.48 71.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.338 0.59 . . . . 0.0 109.494 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.6 -46.83 84.01 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.172 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 2.2 p -63.08 -52.39 62.89 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.912 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 14.7 tt -59.95 -35.74 62.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.538 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 49.8 mt -68.13 -37.53 78.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.64 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.24 -52.95 20.09 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.869 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 35' ' ' ILE . . . . . 0.409 ' CG1' ' N ' ' C' ' 36' ' ' LEU . 6.5 pt -62.14 -41.51 91.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.396 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.409 ' N ' ' CG1' ' C' ' 35' ' ' ILE . 10.5 tp -65.11 -40.79 95.0 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.341 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -62.15 -50.76 70.59 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 50.9 tp -67.7 -48.63 66.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.915 0.388 . . . . 0.0 111.624 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 92.3 mt -58.38 -50.53 78.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.311 -178.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -65.82 -37.16 85.48 Favored 'General case' 0 C--O 1.221 -0.441 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.027 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 21.9 t-105 -56.8 -53.52 56.92 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.276 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 60.3 mt -70.82 -56.54 10.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.524 -0.47 . . . . 0.0 112.251 -177.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.493 ' O ' HD23 ' C' ' 43' ' ' LEU . 0.7 OUTLIER -54.44 -50.85 66.68 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.825 -178.554 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 44' ' ' ASP . . . . . 0.484 ' O ' ' CB ' ' C' ' 50' ' ' SER . 36.4 t70 -58.05 -42.56 85.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.355 -0.384 . . . . 0.0 109.997 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -53.62 -51.96 61.4 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 119.889 -0.724 . . . . 0.0 110.573 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 46' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' C' ' 47' ' ' PHE . 5.7 mt -74.89 -74.21 0.21 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 120.016 -0.674 . . . . 0.0 111.035 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 47' ' ' PHE . . . . . 0.467 ' CG ' ' N ' ' C' ' 48' ' ' PHE . 21.4 t80 45.78 -171.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.283 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 48' ' ' PHE . . . . . 0.467 ' N ' ' CG ' ' C' ' 47' ' ' PHE . 26.2 m-85 -56.3 -54.63 43.13 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.243 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -153.21 36.82 0.48 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.248 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 50' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' C' ' 44' ' ' ASP . 1.4 t -50.21 -52.41 35.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.18 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 62.0 mt -50.46 -51.57 18.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.264 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -74.45 -31.56 62.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.876 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 53' ' ' ARG . . . . . 0.518 ' O ' ' CG ' ' C' ' 57' ' ' HIS . 85.3 mtt180 -69.93 -48.64 57.71 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.474 -0.491 . . . . 0.0 110.672 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -69.57 -42.11 74.94 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.54 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -63.06 -36.66 84.31 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.501 -0.479 . . . . 0.0 110.864 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -80.05 -24.07 40.97 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.801 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 57' ' ' HIS . . . . . 0.518 ' CG ' ' O ' ' C' ' 53' ' ' ARG . 2.8 m-70 -72.41 -45.23 60.61 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.122 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.69 -28.36 73.54 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 10.9 mp -103.08 66.14 0.9 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 65.3 tttm . . . . . 0 N--CA 1.466 0.344 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.45 -179.928 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' D' D ' 24' ' ' ASP . . . . . 0.461 ' N ' ' HD3' ' D' ' 25' ' ' PRO . 1.0 OUTLIER -163.2 58.45 0.74 Allowed Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.648 179.517 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 25' ' ' PRO . . . . . 0.461 ' HD3' ' N ' ' D' ' 24' ' ' ASP . 4.6 Cg_exo -73.54 -50.95 0.17 Allowed 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.94 1.76 . . . . 0.0 111.108 179.272 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 26' ' ' LEU . . . . . 0.56 HD11 ' O ' ' A' ' 27' ' ' ALA . 2.5 pp -59.6 -28.51 67.25 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.069 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 27' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' D' ' 30' ' ' ALA . . . -50.57 -34.18 24.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.702 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 84.6 t -59.41 -47.81 89.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.83 -35.43 74.72 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.474 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 30' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' D' ' 27' ' ' ALA . . . -60.56 -52.26 65.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.83 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 36.7 m -60.16 -44.7 94.8 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.042 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 5.6 mm -61.82 -34.64 63.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.768 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 51.9 mt -69.36 -37.45 75.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.5 -52.41 26.15 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.858 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 35' ' ' ILE . . . . . 0.471 HG23 ' N ' ' D' ' 36' ' ' LEU . 19.1 tt -63.25 -42.5 96.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.111 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.471 ' N ' HG23 ' D' ' 35' ' ' ILE . 59.5 tp -61.91 -39.15 90.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.79 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 37' ' ' HIS . . . . . 0.462 ' NE2' ' CE1' ' A' ' 37' ' ' HIS . 2.6 t60 -62.08 -49.23 76.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.387 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 39.1 tp -57.02 -47.32 81.17 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.439 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 95.3 mt -59.79 -43.15 91.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.614 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 57.9 mt -62.07 -39.88 93.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.303 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 17.8 t-105 -61.78 -55.15 33.15 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 120.642 0.258 . . . . 0.0 111.231 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 61.7 mt -61.65 -54.7 31.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.401 -0.519 . . . . 0.0 112.154 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 53.2 tp -59.85 -50.13 74.98 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.199 -178.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 44' ' ' ASP . . . . . 0.439 ' O ' ' CB ' ' D' ' 50' ' ' SER . 8.8 t0 -53.49 -44.3 68.91 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.186 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 30.2 ttm-85 -59.67 -52.41 65.63 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 120.061 -0.655 . . . . 0.0 110.376 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.39 106.22 15.49 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.01 0.433 . . . . 0.0 110.272 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -173.47 101.54 0.12 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.322 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 47.35 50.38 14.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.662 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? 56.01 53.8 8.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.546 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 50' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 7.5 t -63.94 -51.21 65.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.296 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 20.0 mt -47.4 -33.13 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.324 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -73.87 -28.14 61.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.961 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 53' ' ' ARG . . . . . 0.414 ' N ' ' O ' ' D' ' 50' ' ' SER . 74.6 mtm180 -72.7 -47.34 48.02 Favored 'General case' 0 N--CA 1.461 0.093 0 CA-C-O 120.923 0.392 . . . . 0.0 110.748 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -72.06 -39.74 68.82 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.896 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -68.77 -40.03 79.93 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.663 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -75.34 -37.83 60.5 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.386 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -62.61 -48.75 78.05 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.22 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.02 -27.47 73.86 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 6.4 tp -92.65 60.16 3.43 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.772 0.32 . . . . 0.0 110.594 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 65.3 tttp . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.402 179.815 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.3 p . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 55.3 76.17 0.53 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.842 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.449 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 61.4 Cg_exo -49.66 -29.33 19.24 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.475 2.117 . . . . 0.0 111.335 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.3 tp -62.02 -50.39 72.23 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.784 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.17 -53.37 50.37 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.08 0.467 . . . . 0.0 110.068 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.9 t -56.86 -40.42 71.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 25' ' ' PRO . . . -57.78 -42.26 83.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.623 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.64 -42.7 93.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.735 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.0 t -60.34 -41.66 94.05 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.011 -0.675 . . . . 0.0 110.138 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.7 mt -63.02 -43.78 99.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.733 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.6 tt -70.23 -29.91 41.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.016 -178.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.09 -50.55 22.23 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.002 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.552 ' O ' HD13 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -65.1 -41.28 91.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.409 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.6 tp -62.47 -36.68 83.23 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.95 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -67.4 -41.99 84.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.944 0.402 . . . . 0.0 110.317 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.84 -57.95 8.29 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.211 0.529 . . . . 0.0 111.441 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.45 HD13 ' HA ' ' A' ' 39' ' ' ILE . 9.2 mm -61.75 -45.78 97.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.828 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.407 ' O ' ' CB ' ' A' ' 44' ' ' ASP . 57.9 tp -60.26 -38.75 84.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.269 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 31.2 t-105 -63.89 -54.05 40.93 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 120.922 0.392 . . . . 0.0 111.486 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 97.1 mt -62.51 -55.32 24.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.141 -0.623 . . . . 0.0 111.813 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.0 tp -60.29 -46.76 88.73 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.072 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.407 ' CB ' ' O ' ' A' ' 40' ' ' LEU . 18.6 t70 -50.5 -47.25 57.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -59.98 -53.03 62.69 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.535 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 47' ' ' PHE . 15.5 mt -73.4 -78.54 0.09 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.034 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.484 ' O ' ' N ' ' A' ' 49' ' ' LYS . 13.3 t80 41.32 -164.5 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.405 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.408 ' N ' ' CG ' ' A' ' 47' ' ' PHE . 20.7 m-85 -64.53 68.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.358 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 47' ' ' PHE . 29.7 mtmm 46.29 47.0 13.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.619 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.428 ' O ' ' N ' ' A' ' 53' ' ' ARG . 90.3 p -69.06 -30.9 69.32 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.631 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.1 mt -44.14 -42.1 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.963 0.411 . . . . 0.0 110.052 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.407 ' CZ ' ' OE1' ' A' ' 56' ' ' GLU . 52.8 t80 -74.85 -28.92 60.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.136 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.522 ' O ' ' CD2' ' A' ' 57' ' ' HIS . 67.9 mtm180 -70.98 -48.25 54.32 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.468 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.434 ' CE1' HD22 ' B' ' 46' ' ' LEU . 54.9 m-85 -71.2 -40.55 71.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.768 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -66.21 -39.57 89.73 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.755 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.407 ' OE1' ' CZ ' ' A' ' 52' ' ' TYR . 15.7 pt-20 -76.35 -41.1 49.4 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.828 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.522 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 10.2 m-70 -60.14 -47.93 83.84 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.53 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.76 -27.82 73.57 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.9 tp -91.69 60.18 3.92 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.727 0.299 . . . . 0.0 110.637 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.011 -179.932 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 71.3 m . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -160.88 68.72 2.59 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.772 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -51.18 -35.66 53.0 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.465 2.11 . . . . 0.0 111.354 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.45 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 15.8 tp -59.38 -51.35 70.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.839 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.93 -43.48 86.31 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 92.0 t -61.93 -33.29 57.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.235 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -64.41 -35.38 80.71 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.26 -45.86 68.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.258 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 3.9 t -66.19 -52.07 51.66 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.331 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.473 HG23 ' N ' ' B' ' 33' ' ' ILE . 10.9 tp -60.77 -43.04 94.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -178.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.473 ' N ' HG23 ' B' ' 32' ' ' ILE . 7.8 tt -69.89 -28.57 37.24 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.08 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.329 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.64 -50.61 41.59 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 mp -62.86 -42.14 95.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 11.0 tp -58.25 -46.96 85.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.889 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -63.9 -52.03 61.8 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 40.9 tp -58.23 -47.09 84.63 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 120.549 -0.461 . . . . 0.0 111.136 -178.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 3.2 mm -63.79 -41.06 91.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.982 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.528 HD13 ' O ' ' B' ' 40' ' ' LEU . 0.2 OUTLIER -60.51 -42.6 96.73 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.904 -179.55 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 46.0 t-105 -64.81 -57.22 9.47 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 75.5 mt -58.48 -53.75 42.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.597 -177.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 41.9 tp -59.73 -46.44 89.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.164 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -55.07 -47.28 75.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.648 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -62.75 -48.56 78.64 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.491 -0.483 . . . . 0.0 111.351 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.434 HD22 ' CE1' ' A' ' 54' ' ' PHE . 0.2 OUTLIER -121.54 124.19 43.81 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.125 0.488 . . . . 0.0 110.43 179.381 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -172.98 -47.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.367 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -171.1 65.81 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.389 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm 55.25 35.44 24.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.566 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 11.2 t -60.0 -49.22 78.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.919 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 48.0 mt -47.36 -31.26 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.759 0.314 . . . . 0.0 110.882 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.527 ' CD2' ' OE1' ' B' ' 56' ' ' GLU . 76.2 t80 -70.84 -29.8 66.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.465 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -71.14 -44.01 66.44 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.41 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -71.21 -38.73 72.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.011 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -69.76 -39.28 76.81 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.737 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 56' ' ' GLU . . . . . 0.527 ' OE1' ' CD2' ' B' ' 52' ' ' TYR . 10.6 pt-20 -75.58 -38.51 59.09 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 120.254 -0.579 . . . . 0.0 110.644 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -65.03 -47.23 78.16 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.322 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.0 -28.64 73.78 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 32.9 tp -73.39 -68.72 0.48 Allowed 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.402 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.54 179.946 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -156.74 68.83 4.56 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.899 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -51.23 -30.34 32.63 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.514 2.142 . . . . 0.0 111.141 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 16.8 tp -59.09 -51.52 69.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.757 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.5 -46.97 87.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.033 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 61.3 t -58.82 -42.72 86.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.0 -37.9 72.33 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.47 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.38 -49.77 70.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.103 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 31' ' ' SER . . . . . 0.436 ' OG ' ' CD1' ' B' ' 26' ' ' LEU . 2.9 m -60.23 -50.79 72.26 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.96 -179.047 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 17.5 tt -63.71 -33.68 63.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.983 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 32.3 mt -67.24 -42.21 87.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.441 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.07 -49.51 46.69 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 121.019 -0.61 . . . . 0.0 111.666 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 5.1 mm -61.67 -45.37 98.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.128 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 11.6 tp -61.22 -41.65 97.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.169 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -61.51 -48.67 80.01 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.61 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 31.2 tp -63.19 -52.93 60.34 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -178.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 1.3 mp -60.46 -46.19 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.017 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -62.06 -40.62 96.39 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.821 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 6.7 t-105 -57.71 -58.41 8.46 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.245 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 68.8 mt -62.13 -56.27 18.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -177.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.647 ' C ' HD13 ' C' ' 43' ' ' LEU . 3.0 tm? -57.99 -52.82 63.92 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.177 -178.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -53.35 -41.24 65.59 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -57.61 -56.23 24.63 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.455 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 46' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' C' ' 48' ' ' PHE . 2.2 mt -80.73 -71.12 0.48 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.855 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 47' ' ' PHE . . . . . 0.46 ' CD2' ' N ' ' C' ' 48' ' ' PHE . 85.2 t80 49.26 -89.56 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.181 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 48' ' ' PHE . . . . . 0.51 ' N ' ' O ' ' C' ' 46' ' ' LEU . 68.7 t80 -153.49 85.52 1.19 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.236 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 56.9 mttp 52.09 29.26 6.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.935 0.398 . . . . 0.0 110.187 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 11.3 t -62.47 -39.54 93.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.121 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 54.6 mt -47.08 -48.91 8.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.306 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -71.69 -32.25 67.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.58 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 53' ' ' ARG . . . . . 0.524 ' O ' ' CD2' ' C' ' 57' ' ' HIS . 77.3 mtp180 -70.75 -48.07 56.34 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.481 -0.487 . . . . 0.0 110.619 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -66.03 -42.28 89.81 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.226 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -63.09 -39.29 94.26 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.459 -0.497 . . . . 0.0 110.854 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -76.99 -22.03 53.78 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.759 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 57' ' ' HIS . . . . . 0.524 ' CD2' ' O ' ' C' ' 53' ' ' ARG . 11.9 m-70 -73.75 -49.24 26.51 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.091 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.85 -27.45 72.76 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 8.3 tp -91.86 48.66 1.46 Allowed 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.809 0.337 . . . . 0.0 110.375 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.531 -179.874 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 24.3 m . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' D' D ' 24' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' D' ' 27' ' ' ALA . 29.5 p30 -175.46 61.8 0.22 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.373 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -45.85 -27.36 3.95 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 C-N-CA 121.389 1.393 . . . . 0.0 110.227 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 pp -68.13 -35.4 78.05 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.088 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 27' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' D' ' 24' ' ' ASP . . . -51.07 -37.95 48.7 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.102 0.477 . . . . 0.0 109.879 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 71.4 t -59.24 -47.42 90.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 CA-C-O 121.428 0.632 . . . . 0.0 109.487 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.33 -39.49 76.0 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.286 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 30' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' D' ' 27' ' ' ALA . . . -58.47 -47.3 84.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.174 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 11.2 t -57.36 -50.21 73.7 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.871 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 61.0 mt -61.35 -31.71 51.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.55 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 55.2 mt -68.19 -40.46 82.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.348 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.99 -52.14 25.28 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.883 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 35' ' ' ILE . . . . . 0.429 HG23 ' N ' ' D' ' 36' ' ' LEU . 15.6 tt -61.95 -42.29 94.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.806 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.429 ' N ' HG23 ' D' ' 35' ' ' ILE . 43.6 tp -63.71 -34.9 78.9 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.985 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -63.67 -50.93 67.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.964 0.411 . . . . 0.0 110.247 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 36.3 tp -58.35 -47.5 83.57 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.85 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 5.0 mm -61.69 -44.37 98.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.319 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 40' ' ' LEU . . . . . 0.561 ' O ' HD23 ' D' ' 40' ' ' LEU . 0.8 OUTLIER -61.82 -39.26 91.17 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 -179.366 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 23.7 t-105 -64.07 -56.6 13.83 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 120.875 0.369 . . . . 0.0 111.434 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 82.1 mt -58.55 -53.2 50.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.777 -177.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 29.9 tp -61.1 -47.4 86.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.881 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -51.91 -44.16 63.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.265 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 45' ' ' ARG . . . . . 0.502 ' HE ' ' CD2' ' D' ' 46' ' ' LEU . 60.1 ttp180 -64.12 -53.45 49.29 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.77 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 46' ' ' LEU . . . . . 0.502 ' CD2' ' HE ' ' D' ' 45' ' ' ARG . 0.2 OUTLIER -113.53 110.31 20.05 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.046 0.451 . . . . 0.0 110.3 179.143 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -174.77 92.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.146 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 53.96 58.16 5.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.539 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? 53.73 52.93 12.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.95 0.405 . . . . 0.0 110.372 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 50' ' ' SER . . . . . 0.524 ' OG ' ' NH2' ' D' ' 53' ' ' ARG . 8.1 t -68.22 -51.76 41.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.227 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 4.7 mt -48.15 -35.01 5.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -72.37 -28.97 63.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.05 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 53' ' ' ARG . . . . . 0.524 ' NH2' ' OG ' ' D' ' 50' ' ' SER . 36.7 mtm105 -71.86 -46.49 57.76 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.96 0.41 . . . . 0.0 110.525 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -70.94 -36.85 72.79 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.788 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -70.06 -39.7 75.49 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.659 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -75.43 -37.73 60.23 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.614 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -65.94 -44.37 85.27 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.27 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.18 -26.74 70.67 Favored Glycine 0 N--CA 1.462 0.374 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.8 70.24 0.77 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.271 0.558 . . . . 0.0 109.728 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 16.3 ttpp . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.512 -179.721 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 56.7 m . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.515 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 6.1 p30 -174.83 75.55 0.32 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.798 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -52.16 -35.45 62.79 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.15 1.9 . . . . 0.0 110.957 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.4 tp -65.21 -50.27 66.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.18 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.452 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -65.43 -50.67 64.54 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.34 0.59 . . . . 0.0 109.568 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.2 t -54.59 -46.68 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.44 -42.36 70.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.691 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -55.72 -47.63 76.54 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.17 0.51 . . . . 0.0 110.567 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 80.8 p -62.39 -39.96 94.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.803 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 35.6 mm -61.97 -47.58 92.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.608 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.9 tt -68.96 -29.64 44.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.7 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.13 -50.21 47.61 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.171 -1.014 . . . . 0.0 110.578 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 28.1 mm -62.91 -44.24 99.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 51.4 tp -63.21 -31.13 72.2 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.433 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -69.5 -52.22 28.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.985 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 32.1 tp -61.76 -51.28 68.99 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.207 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.9 mm -61.86 -43.69 97.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.908 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 35.5 tp -61.2 -38.95 88.39 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.381 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 44.3 t-105 -63.78 -55.17 25.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.824 0.345 . . . . 0.0 111.647 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.7 mt -61.44 -51.65 70.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 120.454 -0.498 . . . . 0.0 111.78 -177.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.407 HD11 ' CD1' ' A' ' 47' ' ' PHE . 23.9 tp -60.96 -42.35 98.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.983 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -57.78 -45.29 86.19 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -60.03 -48.66 80.78 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.484 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.4 pp -130.91 132.87 45.39 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.026 0.441 . . . . 0.0 111.088 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.407 ' CD1' HD11 ' A' ' 43' ' ' LEU . 49.2 t80 -175.41 -38.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.161 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -167.24 60.03 0.08 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.251 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp 60.85 42.47 13.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.38 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.5 t -62.34 -49.91 73.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.696 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 94.1 mt -49.67 -41.96 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.205 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -72.26 -28.5 63.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.216 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.525 ' O ' ' CD2' ' A' ' 57' ' ' HIS . 12.1 mmm180 -69.71 -46.57 65.68 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.317 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -71.41 -40.23 70.61 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.075 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -67.37 -38.18 84.34 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.746 -179.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.52 ' OE2' ' CE1' ' A' ' 57' ' ' HIS . 0.7 OUTLIER -77.5 -38.03 49.91 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.876 -179.974 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.525 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 26.4 m-70 -63.87 -50.54 68.41 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.469 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.75 -27.41 72.42 Favored Glycine 0 N--CA 1.463 0.468 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.81 71.82 0.77 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.122 0.487 . . . . 0.0 109.919 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 N--CA 1.466 0.346 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.594 179.992 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 44.8 t . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 56.94 70.02 1.52 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.76 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -51.55 -31.4 39.61 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.57 2.18 . . . . 0.0 111.427 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.417 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 19.0 tp -58.76 -51.28 70.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.912 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.62 -46.12 91.46 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 91.8 t -59.74 -35.84 62.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -62.34 -35.63 79.71 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.6 -45.54 71.71 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.387 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 8.4 p -65.5 -51.86 56.94 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.423 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.511 HG23 ' N ' ' B' ' 33' ' ' ILE . 20.0 tt -61.86 -43.05 96.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -178.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.511 ' N ' HG23 ' B' ' 32' ' ' ILE . 8.3 tt -69.16 -30.3 45.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 C-N-CA 119.731 -0.788 . . . . 0.0 110.304 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.52 -50.55 42.7 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 mp -61.58 -41.59 90.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 19.8 tp -60.39 -40.97 92.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.747 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -67.71 -51.76 45.71 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 35.1 tp -61.68 -52.4 64.47 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.614 -178.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.6 mm -62.0 -41.76 92.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.392 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 46.0 tp -59.59 -41.66 90.78 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.249 -0.58 . . . . 0.0 109.944 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 9.9 t-105 -62.5 -59.37 5.05 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.724 0.297 . . . . 0.0 111.724 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 72.0 mt -58.53 -56.52 15.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.635 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.467 ' O ' HD23 ' B' ' 43' ' ' LEU . 0.6 OUTLIER -55.0 -49.78 70.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.641 -178.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -52.24 -44.19 64.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.326 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -59.2 -53.01 63.1 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.641 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 2.8 mt -77.45 -141.03 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 119.871 -0.732 . . . . 0.0 110.594 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.424 ' O ' ' O ' ' B' ' 48' ' ' PHE . 47.8 t80 59.78 110.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.615 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 48' ' ' PHE . . . . . 0.545 ' CG ' ' N ' ' B' ' 49' ' ' LYS . 57.5 t80 48.35 -178.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.404 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.545 ' N ' ' CG ' ' B' ' 48' ' ' PHE . 0.1 OUTLIER -72.19 45.42 0.13 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.377 -179.878 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 50' ' ' SER . . . . . 0.401 ' H ' ' C ' ' B' ' 48' ' ' PHE . 11.1 t -62.56 -47.57 83.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.853 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 51.2 mt -48.22 -41.88 10.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.592 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.515 ' CE2' ' OE2' ' B' ' 56' ' ' GLU . 78.9 t80 -71.39 -29.72 65.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.446 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 69.6 mtm180 -68.14 -44.04 76.93 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.412 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -72.26 -39.47 68.37 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.762 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -64.45 -40.84 96.5 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.488 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 56' ' ' GLU . . . . . 0.515 ' OE2' ' CE2' ' B' ' 52' ' ' TYR . 13.2 pt-20 -76.48 -38.79 54.79 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.63 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -59.08 -47.06 86.63 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.174 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.35 -28.37 73.65 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 8.0 tp -88.87 49.06 1.72 Allowed 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.708 0.289 . . . . 0.0 110.468 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm . . . . . 0 N--CA 1.469 0.481 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.627 -179.986 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 25.1 t . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -159.18 70.78 3.46 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.871 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.0 -29.51 36.26 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.621 2.214 . . . . 0.0 111.281 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.59 -56.32 23.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.89 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.2 -46.79 82.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.57 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 74.6 t -58.21 -43.44 85.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.64 -39.93 78.08 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.528 178.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.77 -49.37 76.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.164 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 2.2 t -62.17 -53.79 50.26 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 16.5 tt -58.44 -35.8 55.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.663 -179.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 51.0 mt -67.46 -37.48 78.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.399 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.33 -51.22 28.11 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.93 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -62.82 -43.54 98.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 11.4 tp -63.22 -41.61 99.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.838 0.351 . . . . 0.0 110.237 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -61.61 -48.06 82.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.522 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 51.3 tp -65.0 -51.01 64.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.789 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 50.9 mt -59.3 -48.49 86.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.19 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -63.25 -37.65 88.08 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.671 -0.412 . . . . 0.0 109.981 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 25.5 t-105 -59.35 -59.37 5.56 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.346 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 48.4 mt -62.63 -54.97 26.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.514 -0.474 . . . . 0.0 112.047 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.673 ' C ' HD13 ' C' ' 43' ' ' LEU . 3.2 tm? -57.9 -52.36 65.83 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.196 -178.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 44' ' ' ASP . . . . . 0.454 ' O ' ' CB ' ' C' ' 50' ' ' SER . 67.9 t0 -53.11 -41.94 65.49 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.02 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -58.49 -53.24 60.61 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.791 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 46' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' C' ' 48' ' ' PHE . 3.6 mt -84.53 -71.41 0.52 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.176 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 91.7 t80 56.75 -80.42 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.246 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 48' ' ' PHE . . . . . 0.527 ' N ' ' O ' ' C' ' 46' ' ' LEU . 86.4 t80 -172.91 -22.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.334 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 49' ' ' LYS . . . . . 0.464 ' NZ ' ' CD1' ' C' ' 52' ' ' TYR . 49.8 tttm -170.75 21.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.91 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 50' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' C' ' 44' ' ' ASP . 10.8 t -62.08 -48.47 80.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.282 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 51' ' ' ILE . . . . . 0.426 ' H ' HG13 ' C' ' 51' ' ' ILE . 12.8 mt -50.21 -53.99 9.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.3 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 52' ' ' TYR . . . . . 0.464 ' CD1' ' NZ ' ' C' ' 49' ' ' LYS . 27.7 t80 -70.57 -32.83 70.38 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.668 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 19.9 mmt85 -70.01 -43.41 71.4 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.586 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -66.29 -47.23 74.3 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.176 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -62.2 -36.55 82.27 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.925 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 56' ' ' GLU . . . . . 0.411 ' O ' ' OE1' ' C' ' 56' ' ' GLU . 3.0 tm-20 -77.97 -21.9 50.25 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.535 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -73.42 -48.9 30.11 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 120.341 -0.544 . . . . 0.0 109.974 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.69 -27.11 73.09 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 8.6 tp -83.9 57.39 4.12 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.824 0.345 . . . . 0.0 110.311 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 18.7 tptm . . . . . 0 N--CA 1.466 0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.281 -179.867 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 18.4 p . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' D' D ' 24' ' ' ASP . . . . . 0.494 ' N ' ' HD3' ' D' ' 25' ' ' PRO . 0.7 OUTLIER -166.45 55.66 0.36 Allowed Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.811 179.606 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 25' ' ' PRO . . . . . 0.494 ' HD3' ' N ' ' D' ' 24' ' ' ASP . 6.1 Cg_exo -73.52 -41.19 1.24 Allowed 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 121.663 1.575 . . . . 0.0 111.091 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 26' ' ' LEU . . . . . 0.553 ' O ' ' HB3' ' D' ' 29' ' ' ALA . 2.4 pp -65.95 -30.88 71.52 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.678 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.32 -49.7 42.83 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 95.4 t -50.81 -38.09 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 178.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' D' ' 26' ' ' LEU . . . -62.6 -40.06 95.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.639 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.94 -50.48 68.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.268 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 45.9 t -60.51 -51.89 67.53 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.904 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 20.1 tt -63.27 -31.41 52.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.629 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 19.4 mt -67.47 -41.8 86.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.017 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.01 -51.74 32.32 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.121 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 10.7 tp -64.49 -39.18 84.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.402 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 56.8 tp -64.58 -38.64 91.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.109 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 32.4 t60 -65.11 -48.66 72.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.368 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 50.3 tp -59.08 -47.01 86.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.562 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.36 -42.76 94.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.851 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 40.2 mt -61.58 -42.45 98.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.208 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 18.4 t-105 -62.07 -55.58 27.63 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.696 0.284 . . . . 0.0 111.508 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 72.5 mt -60.54 -54.93 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -177.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 40.0 tp -60.92 -44.43 97.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.61 0.243 . . . . 0.0 111.343 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 44' ' ' ASP . . . . . 0.435 ' O ' ' CB ' ' D' ' 50' ' ' SER . 22.6 t70 -58.08 -42.77 86.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.594 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 45' ' ' ARG . . . . . 0.433 ' HG3' HD11 ' D' ' 51' ' ' ILE . 9.8 tpt180 -66.11 -56.61 10.6 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.066 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 46' ' ' LEU . . . . . 0.414 HD23 ' HB3' ' D' ' 45' ' ' ARG . 0.2 OUTLIER -106.67 130.8 54.34 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.376 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -171.76 -43.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.454 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -172.71 -48.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.426 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -172.46 28.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.339 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 50' ' ' SER . . . . . 0.435 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 7.8 t -57.92 -50.93 71.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.181 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 51' ' ' ILE . . . . . 0.433 HD11 ' HG3' ' D' ' 45' ' ' ARG . 7.3 mt -49.39 -39.35 13.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.32 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 52' ' ' TYR . . . . . 0.465 ' CE2' ' OE2' ' D' ' 56' ' ' GLU . 82.5 t80 -73.98 -29.56 62.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.242 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 -68.15 -48.32 65.67 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.916 0.388 . . . . 0.0 110.482 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -72.34 -39.49 68.12 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.752 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -62.1 -41.96 98.74 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.348 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 56' ' ' GLU . . . . . 0.465 ' OE2' ' CE2' ' D' ' 52' ' ' TYR . 14.8 pt-20 -77.49 -37.11 51.88 Favored 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 120.219 -0.592 . . . . 0.0 110.434 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -56.18 -48.89 75.48 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.217 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.82 -27.08 74.16 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.439 -1.065 . . . . 0.0 110.439 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 59' ' ' LEU . . . . . 0.411 ' N ' ' CD2' ' D' ' 59' ' ' LEU . 3.0 mm? -99.29 52.69 0.95 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.025 0.441 . . . . 0.0 109.983 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 63.7 tttp . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.586 179.923 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.2 m . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -163.29 74.85 1.9 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.782 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -51.29 -37.33 59.75 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.222 1.948 . . . . 0.0 111.03 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.9 tp -63.3 -49.01 75.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.936 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.497 ' HB1' HD11 ' D' ' 26' ' ' LEU . . . -60.84 -55.08 37.25 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.7 t -51.87 -47.66 40.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.811 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.93 -48.84 64.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.899 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.76 -48.63 66.65 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.787 ' OG ' HD13 ' D' ' 26' ' ' LEU . 0.9 OUTLIER -53.18 -53.01 56.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.482 179.755 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 44.7 mm -53.62 -38.25 33.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.223 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 70.6 mt -69.47 -32.8 54.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.291 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.1 -53.04 15.66 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.855 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -33.97 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.108 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.6 tp -69.41 -35.97 76.27 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.338 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.561 ' CE1' ' CD2' ' B' ' 37' ' ' HIS . 47.9 t60 -70.01 -51.3 33.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.654 0.264 . . . . 0.0 111.054 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.6 tp -62.73 -50.38 71.32 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.934 0.397 . . . . 0.0 111.222 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 29.5 mm -63.32 -44.59 99.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.279 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 50.2 tp -60.66 -43.23 97.91 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.234 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 16.6 t-105 -61.91 -57.24 12.52 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.744 0.307 . . . . 0.0 111.74 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 76.5 mt -59.56 -55.46 23.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.531 -0.467 . . . . 0.0 112.22 -177.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.7 tp -59.73 -46.97 87.51 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.167 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -53.71 -41.78 67.34 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.402 HH22 ' HB3' ' D' ' 54' ' ' PHE . 45.2 ttt-85 -60.59 -51.53 69.04 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.252 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.81 107.42 18.61 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 120.776 -0.369 . . . . 0.0 110.203 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -174.11 100.32 0.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.217 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.508 ' O ' ' CD2' ' A' ' 48' ' ' PHE . 69.3 t80 45.45 52.07 9.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.39 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.0 mttp 55.32 52.94 10.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.618 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.5 t -62.65 -42.78 99.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.96 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.551 ' H ' HD12 ' A' ' 51' ' ' ILE . 3.5 mp -47.74 -31.48 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.504 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -72.95 -28.51 62.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.097 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.542 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 77.9 mtp180 -68.42 -48.04 65.68 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.378 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -71.46 -39.28 71.04 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.795 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -64.36 -39.97 94.94 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.7 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.534 ' OE2' ' CD2' ' A' ' 57' ' ' HIS . 1.6 pp20? -77.01 -41.29 43.32 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.851 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.542 ' ND1' ' O ' ' A' ' 53' ' ' ARG . 23.9 m80 -57.87 -50.49 73.14 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 120.314 -0.554 . . . . 0.0 109.782 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.16 -26.83 72.96 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.0 tp -156.27 90.07 1.17 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.433 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.0 pttm . . . . . 0 N--CA 1.458 -0.055 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.657 -179.719 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 72.3 m . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -159.83 70.76 3.18 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.867 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -50.84 -30.6 30.42 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.646 2.231 . . . . 0.0 111.244 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.466 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 19.7 tp -60.85 -50.12 74.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.078 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.43 -43.1 79.08 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 83.7 t -61.37 -34.3 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -64.29 -34.63 78.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.305 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.13 -51.68 43.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.087 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 6.1 p -61.71 -50.42 72.53 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.783 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.425 HG23 ' N ' ' B' ' 33' ' ' ILE . 3.8 tp -62.33 -40.93 89.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.989 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.425 ' N ' HG23 ' B' ' 32' ' ' ILE . 34.1 mt -62.19 -44.3 98.91 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.922 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.04 -53.78 43.56 Favored Glycine 0 N--CA 1.462 0.376 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 96.8 mt -50.55 -39.13 17.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.94 -45.89 90.32 Favored 'General case' 0 C--O 1.219 -0.5 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.28 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 37' ' ' HIS . . . . . 0.561 ' CD2' ' CE1' ' A' ' 37' ' ' HIS . 1.4 t60 -60.35 -48.58 81.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.592 -178.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.423 HD12 ' N ' ' B' ' 38' ' ' LEU . 9.6 mp -64.07 -47.86 78.45 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.741 -178.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 18.1 mm -62.52 -47.93 90.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.295 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 7.1 mp -63.66 -34.01 76.9 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 28.6 t-105 -64.66 -57.26 9.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 120.89 0.376 . . . . 0.0 111.262 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 77.7 mt -60.0 -51.73 69.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.773 -178.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 8.6 mt -63.4 -50.94 67.85 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.502 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 44' ' ' ASP . . . . . 0.478 ' O ' ' CB ' ' B' ' 50' ' ' SER . 36.3 t70 -53.4 -41.94 66.46 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.325 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -65.3 -45.45 84.32 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.946 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 2.5 pp -139.5 124.08 18.32 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.266 0.555 . . . . 0.0 111.507 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -173.79 -31.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.879 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 48' ' ' PHE . . . . . 0.415 ' O ' ' CD2' ' B' ' 48' ' ' PHE . 63.4 t80 -167.4 58.93 0.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.051 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 97.5 mttt 55.14 53.95 9.47 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.504 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 50' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' B' ' 44' ' ' ASP . 3.0 p -68.39 -52.28 34.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.995 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 51' ' ' ILE . . . . . 0.407 ' N ' ' OG ' ' B' ' 50' ' ' SER . 80.6 mt -50.3 -46.73 25.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.974 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.518 ' CE2' ' OE2' ' B' ' 56' ' ' GLU . 86.5 t80 -71.25 -29.82 65.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.317 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 33.1 mmm-85 -70.76 -44.7 66.2 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.831 0.348 . . . . 0.0 110.541 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 54' ' ' PHE . . . . . 0.401 ' HB3' HH22 ' C' ' 45' ' ' ARG . 55.0 m-85 -71.64 -39.23 70.53 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.881 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -68.18 -38.97 82.6 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.684 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 56' ' ' GLU . . . . . 0.518 ' OE2' ' CE2' ' B' ' 52' ' ' TYR . 11.5 pt-20 -76.16 -38.54 56.55 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.569 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -62.88 -47.67 82.33 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.235 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.79 -27.58 72.24 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 9.9 tp -89.38 59.46 4.83 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-O 120.837 0.351 . . . . 0.0 110.275 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp . . . . . 0 N--CA 1.466 0.372 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.287 -179.984 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -35.83 100.54 0.2 Allowed Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.45 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.85 -34.79 37.75 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.044 1.83 . . . . 0.0 111.559 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 26' ' ' LEU . . . . . 0.401 ' C ' ' CD1' ' C' ' 26' ' ' LEU . 0.2 OUTLIER -58.48 -55.69 31.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.489 0.662 . . . . 0.0 109.477 179.428 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.49 -45.63 88.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.427 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 88.0 t -56.9 -40.19 70.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.9 -37.65 85.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.761 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.41 -51.24 64.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.542 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 10.4 p -63.44 -51.45 65.66 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 120.689 -0.404 . . . . 0.0 112.04 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 20.7 tt -59.85 -36.51 66.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.764 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 41.3 mt -68.5 -39.56 80.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.64 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.78 -52.81 31.19 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.734 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 6.8 pt -61.91 -42.59 95.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.295 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 8.7 tp -63.82 -34.34 77.69 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.313 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -66.75 -52.67 41.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.241 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 33.1 tp -61.9 -49.44 76.19 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.045 0.45 . . . . 0.0 111.121 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 30.3 mm -59.79 -43.89 92.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.73 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 25.7 mt -62.34 -40.28 95.84 Favored 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.919 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 25.0 t-105 -59.58 -52.31 66.1 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.308 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 65.9 mt -66.68 -56.59 13.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.266 -0.574 . . . . 0.0 112.411 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.65 ' C ' HD13 ' C' ' 43' ' ' LEU . 2.9 tm? -58.28 -52.09 67.05 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.886 -178.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -52.93 -43.38 66.24 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.22 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 45' ' ' ARG . . . . . 0.401 HH22 ' HB3' ' B' ' 54' ' ' PHE . 52.9 ttt-85 -58.84 -52.09 67.21 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.853 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 46' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' C' ' 48' ' ' PHE . 8.5 mt -79.59 -73.95 0.32 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 120.274 -0.571 . . . . 0.0 111.263 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 49.3 t80 62.03 -71.32 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.407 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 48' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' C' ' 46' ' ' LEU . 66.2 t80 -172.75 -32.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.261 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 46.6 tttp -172.96 26.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.917 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 39.6 t -63.73 -42.23 97.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.298 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 58.3 mt -48.98 -52.78 9.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.389 -179.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -74.86 -32.64 61.96 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 53' ' ' ARG . . . . . 0.514 ' O ' ' CG ' ' C' ' 57' ' ' HIS . 96.1 mtt180 -71.73 -49.58 37.94 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.673 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -67.66 -43.32 80.53 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.428 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -64.88 -35.87 82.54 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.829 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -77.56 -24.28 49.84 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.561 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 57' ' ' HIS . . . . . 0.514 ' CG ' ' O ' ' C' ' 53' ' ' ARG . 3.2 m-70 -73.16 -45.51 56.16 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 120.541 -0.464 . . . . 0.0 109.77 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.1 -27.16 72.69 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 7.7 tp -84.12 57.73 4.36 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.837 0.351 . . . . 0.0 110.466 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 62.0 tttm . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.4 -179.952 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 15.2 p30 -162.34 76.39 2.09 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.021 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -51.45 -30.47 35.14 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.06 1.84 . . . . 0.0 110.878 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 26' ' ' LEU . . . . . 0.787 HD13 ' OG ' ' A' ' 31' ' ' SER . 3.9 pp -66.18 -42.71 88.52 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.832 179.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 27' ' ' ALA . . . . . 0.574 ' N ' HD12 ' D' ' 26' ' ' LEU . . . -49.31 -53.47 21.81 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.558 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 87.7 t -48.1 -36.98 6.49 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.06 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' D' ' 26' ' ' LEU . . . -65.58 -37.04 85.52 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.275 0.56 . . . . 0.0 109.818 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.94 -51.22 60.43 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.883 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 58.4 m -62.43 -50.44 71.48 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 3.3 tp -62.29 -35.84 71.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.73 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 37.7 mt -68.03 -38.21 79.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.07 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.38 -50.76 42.02 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.15 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 35' ' ' ILE . . . . . 0.477 HG23 ' N ' ' D' ' 36' ' ' LEU . 18.4 tt -66.05 -42.75 92.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.347 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.477 ' N ' HG23 ' D' ' 35' ' ' ILE . 7.2 tp -60.62 -38.5 84.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.864 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -66.92 -45.43 77.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.604 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 31.6 tp -57.67 -54.3 48.46 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.195 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 13.6 pt -64.08 -37.31 79.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.816 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 17.9 mt -58.82 -42.55 89.48 Favored 'General case' 0 C--O 1.224 -0.263 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 33.5 t-105 -64.58 -51.44 62.72 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.101 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 mm -56.48 -56.72 12.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.531 -0.467 . . . . 0.0 111.771 -177.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 36.6 tp -62.03 -45.23 94.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.789 0.328 . . . . 0.0 110.8 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -50.76 -44.44 58.61 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.004 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -66.48 -54.57 22.52 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.564 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.72 105.62 15.74 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.279 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -172.99 95.79 0.12 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.313 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 52.2 51.69 15.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.742 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 18.0 mtpp 54.44 49.75 17.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.594 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 10.9 t -61.85 -46.36 89.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.992 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 38.2 mt -49.44 -39.11 13.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.656 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -72.72 -28.86 62.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.112 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 35.7 mtm105 -71.5 -47.49 55.08 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.984 0.421 . . . . 0.0 110.56 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 54' ' ' PHE . . . . . 0.402 ' HB3' HH22 ' A' ' 45' ' ' ARG . 73.6 m-85 -71.16 -35.16 71.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.739 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -70.64 -37.91 73.81 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.604 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -77.51 -37.89 50.11 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.644 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -66.16 -48.63 70.11 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.504 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.86 -27.34 72.0 Favored Glycine 0 N--CA 1.461 0.311 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.13 77.15 1.77 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 57.3 tttm . . . . . 0 C--N 1.333 -0.111 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.539 -179.695 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 38.23 69.48 1.49 Allowed Pre-proline 0 N--CA 1.463 0.203 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.964 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.443 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 52.9 Cg_exo -51.04 -33.35 42.53 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.275 1.983 . . . . 0.0 111.115 179.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.3 tp -65.56 -50.73 64.09 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.059 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.437 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -63.43 -50.23 70.61 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.392 0.615 . . . . 0.0 109.567 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.3 t -57.94 -45.27 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 25' ' ' PRO . . . -55.6 -35.36 65.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.779 179.21 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -64.55 -50.05 68.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.413 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.423 ' OG ' HD13 ' D' ' 26' ' ' LEU . 9.6 m -58.52 -41.09 84.65 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.477 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 35.5 mm -64.52 -41.74 93.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.505 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 33' ' ' ILE . 2.6 tt -68.43 -35.61 71.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.627 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.26 -51.47 32.53 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 89.3 mt -60.7 -43.87 95.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.96 0.409 . . . . 0.0 110.067 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.2 tp -65.01 -31.07 72.13 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.364 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.462 ' HD1' ' C ' ' A' ' 37' ' ' HIS . 0.3 OUTLIER -68.55 -51.97 37.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.805 0.336 . . . . 0.0 110.903 -179.517 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 51.2 tp -62.58 -51.44 67.31 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.265 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 83.5 mt -61.98 -44.58 99.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.076 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 35.0 tp -60.32 -41.72 94.09 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.322 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.1 t-105 -62.59 -57.78 9.88 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 120.95 0.405 . . . . 0.0 111.516 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 95.3 mt -56.64 -54.72 25.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.925 -177.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 47' ' ' PHE . 29.0 tp -61.97 -44.01 97.64 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.025 -178.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -50.43 -45.95 56.13 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 57.7 ttt85 -61.71 -52.72 63.12 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.14 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 48' ' ' PHE . 5.6 mt -81.93 -77.38 0.22 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.806 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.464 ' N ' ' O ' ' A' ' 43' ' ' LEU . 92.6 t80 52.9 -83.69 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.8 0.333 . . . . 0.0 110.415 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.525 ' N ' ' O ' ' A' ' 46' ' ' LEU . 49.9 t80 -157.39 81.43 0.9 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.119 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.6 mttm 51.28 25.35 2.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.244 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 53' ' ' ARG . 3.9 t -61.76 -29.66 70.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.587 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.9 mt -45.34 -37.0 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.988 0.423 . . . . 0.0 110.06 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -74.37 -27.58 60.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.001 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.537 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 95.7 mtt-85 -71.61 -48.63 46.84 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.542 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -71.33 -38.93 71.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.006 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -69.87 -38.87 76.55 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 120.829 -0.349 . . . . 0.0 111.724 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.523 ' OE2' ' CD2' ' A' ' 57' ' ' HIS . 0.8 OUTLIER -75.84 -38.42 58.05 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.785 -179.871 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.537 ' ND1' ' O ' ' A' ' 53' ' ' ARG . 27.8 m170 -66.39 -44.95 81.64 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.449 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.68 -27.38 73.38 Favored Glycine 0 N--CA 1.462 0.38 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.49 78.91 1.8 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.933 0.397 . . . . 0.0 110.001 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? . . . . . 0 C--N 1.333 -0.127 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.654 -179.819 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 29.3 t . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 48.76 65.83 6.56 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.42 ' O ' ' HB2' ' B' ' 29' ' ' ALA . 64.4 Cg_exo -49.68 -28.96 18.36 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.365 2.043 . . . . 0.0 111.241 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 19.4 tp -60.85 -51.19 70.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.86 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 27' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' B' ' 30' ' ' ALA . . . -65.64 -51.68 57.7 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.362 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 14.7 t -56.97 -42.33 78.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' B' ' 25' ' ' PRO . . . -55.82 -43.91 77.41 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 30' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' B' ' 27' ' ' ALA . . . -56.43 -44.85 80.81 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.384 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -61.35 -48.99 78.77 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.299 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 74.7 mt -57.39 -48.73 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.743 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 15.5 tt -67.96 -27.16 36.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.695 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.7 -49.18 57.2 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.2 mp -67.78 -41.13 84.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 12.4 tp -55.87 -52.05 65.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.925 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -67.36 -40.65 85.82 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.308 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 48.1 tp -63.29 -57.86 9.02 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 120.652 -0.419 . . . . 0.0 112.097 -178.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 4.6 tt -66.56 -36.87 78.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.812 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 52.5 tp -63.98 -36.74 84.98 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.539 -0.465 . . . . 0.0 109.966 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -67.73 -56.67 8.37 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.805 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.538 ' CG2' ' N ' ' B' ' 43' ' ' LEU . 8.3 tt -62.38 -47.63 92.13 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.476 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.071 -177.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.538 ' N ' ' CG2' ' B' ' 42' ' ' ILE . 17.8 tp -63.92 -47.0 82.29 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.338 -177.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 44' ' ' ASP . . . . . 0.422 ' O ' ' OG ' ' B' ' 50' ' ' SER . 41.7 t0 -57.96 -38.28 75.72 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 70.2 ttt-85 -69.67 -45.79 67.56 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.082 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 2.7 pp -133.62 125.61 29.11 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.098 0.475 . . . . 0.0 110.904 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.508 ' CD1' HD11 ' B' ' 43' ' ' LEU . 66.2 t80 -173.74 -37.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.551 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -172.21 56.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.297 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp 60.62 43.23 12.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.43 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 50' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' B' ' 44' ' ' ASP . 13.4 t -63.73 -51.02 66.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.817 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 73.1 mt -46.53 -40.46 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.856 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.522 ' CE2' ' OE2' ' B' ' 56' ' ' GLU . 92.0 t80 -71.65 -30.2 65.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.55 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.523 ' O ' ' CD2' ' B' ' 57' ' ' HIS . 93.5 mtt180 -70.63 -45.12 65.81 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.011 0.434 . . . . 0.0 110.655 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -71.66 -38.06 70.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.824 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -68.48 -39.1 81.49 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.529 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 56' ' ' GLU . . . . . 0.522 ' OE2' ' CE2' ' B' ' 52' ' ' TYR . 12.4 pt-20 -75.92 -39.4 56.31 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 120.296 -0.561 . . . . 0.0 110.683 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 57' ' ' HIS . . . . . 0.523 ' CD2' ' O ' ' B' ' 53' ' ' ARG . 9.9 m-70 -63.5 -45.5 90.41 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.552 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.45 -28.49 73.19 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 5.1 tp -89.66 33.2 0.84 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.872 0.367 . . . . 0.0 110.336 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 60' ' ' LYS . . . . . 0.586 ' HZ3' ' HE3' ' C' ' 49' ' ' LYS . 25.3 pttm . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.597 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 24' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' C' ' 24' ' ' ASP . 6.8 p30 -170.65 72.55 0.57 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.787 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -51.54 -33.59 48.52 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 C-N-CA 122.152 1.901 . . . . 0.0 111.047 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 18.5 tp -64.81 -50.43 66.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.97 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 27' ' ' ALA . . . . . 0.408 ' O ' ' HB3' ' C' ' 30' ' ' ALA . . . -60.52 -48.06 83.41 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.507 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 28' ' ' VAL . . . . . 0.401 ' O ' ' OG ' ' C' ' 31' ' ' SER . 48.2 t -57.28 -42.58 80.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.12 -42.23 80.5 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 30' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' C' ' 27' ' ' ALA . . . -57.58 -49.86 75.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.553 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 31' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' C' ' 28' ' ' VAL . 2.5 p -56.85 -46.74 81.55 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.93 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 52.4 mt -61.36 -33.91 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.518 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 3.4 mm -67.37 -42.78 87.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.072 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.1 -51.63 32.47 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.942 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 35' ' ' ILE . . . . . 0.463 HG23 ' N ' ' C' ' 36' ' ' LEU . 14.8 tt -63.26 -41.62 93.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.762 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.463 ' N ' HG23 ' C' ' 35' ' ' ILE . 56.0 tp -64.96 -38.43 90.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.273 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.3 t60 -63.96 -50.68 67.64 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 28.5 tp -61.57 -48.29 81.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.494 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 66.9 mt -61.41 -43.16 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.291 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 40' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' C' ' 40' ' ' LEU . 36.6 mt -64.23 -40.29 95.73 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.398 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 10.3 t-105 -61.98 -60.72 3.21 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.114 0.483 . . . . 0.0 111.431 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 42' ' ' ILE . . . . . 0.554 ' CG2' ' N ' ' C' ' 43' ' ' LEU . 9.0 tt -58.6 -50.82 77.69 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.579 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.691 -177.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.627 ' C ' HD13 ' C' ' 43' ' ' LEU . 2.7 tm? -61.26 -53.6 54.71 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.792 -177.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 44' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' C' ' 44' ' ' ASP . 68.2 t0 -52.01 -34.43 42.78 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 45' ' ' ARG . . . . . 0.46 ' O ' ' CD1' ' C' ' 51' ' ' ILE . 39.0 ttt-85 -69.03 -51.07 42.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.012 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 20.2 mt -79.96 -126.29 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.935 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 5.4 t80 72.75 -155.26 0.08 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.084 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -71.57 65.4 0.47 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.549 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 49' ' ' LYS . . . . . 0.586 ' HE3' ' HZ3' ' B' ' 60' ' ' LYS . 49.7 mttp 54.87 52.57 11.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.938 0.399 . . . . 0.0 110.092 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 38.7 t -62.14 -40.97 97.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.221 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 51' ' ' ILE . . . . . 0.472 ' H ' HD12 ' C' ' 51' ' ' ILE . 3.7 mp -46.87 -47.5 8.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.356 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -72.36 -29.79 64.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.549 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 53' ' ' ARG . . . . . 0.527 ' O ' ' CG ' ' C' ' 57' ' ' HIS . 91.8 mtt180 -69.99 -47.24 62.98 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.685 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -69.58 -41.18 76.17 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.346 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -62.52 -39.69 94.37 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.837 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -79.24 -23.11 43.93 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.199 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 57' ' ' HIS . . . . . 0.527 ' CG ' ' O ' ' C' ' 53' ' ' ARG . 2.4 m-70 -72.67 -51.58 18.85 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.256 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.33 -27.65 73.41 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 7.8 tp -92.05 53.68 2.22 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.793 0.33 . . . . 0.0 110.305 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 64.8 tttm . . . . . 0 N--CA 1.466 0.351 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.354 -179.939 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 10.7 p . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' D' D ' 24' ' ' ASP . . . . . 0.406 ' N ' ' HD3' ' D' ' 25' ' ' PRO . 31.1 m-20 -158.13 58.44 1.39 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.53 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 25' ' ' PRO . . . . . 0.406 ' HD3' ' N ' ' D' ' 24' ' ' ASP . 54.4 Cg_exo -51.09 -30.38 31.54 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 121.671 1.58 . . . . 0.0 110.83 178.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 26' ' ' LEU . . . . . 0.423 HD13 ' OG ' ' A' ' 31' ' ' SER . 2.9 pp -57.13 -29.25 63.41 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.019 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 27' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' D' ' 30' ' ' ALA . . . -50.03 -41.6 47.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.776 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 79.0 t -57.31 -44.48 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.42 -29.88 70.21 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.681 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 30' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' D' ' 27' ' ' ALA . . . -69.88 -42.31 73.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.778 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 16.0 p -69.61 -46.42 66.32 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.675 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 9.5 tt -67.99 -40.16 82.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.554 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 13.0 tt -71.28 -32.38 46.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.43 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.82 -52.49 14.71 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 35' ' ' ILE . . . . . 0.435 HG23 ' N ' ' D' ' 36' ' ' LEU . 19.0 tt -63.12 -39.89 86.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.912 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.435 ' N ' HG23 ' D' ' 35' ' ' ILE . 43.8 tp -63.9 -37.52 87.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.911 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 37' ' ' HIS . . . . . 0.502 ' HD1' ' C ' ' D' ' 37' ' ' HIS . 0.3 OUTLIER -64.05 -50.06 69.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.431 -179.918 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 32.0 tp -57.98 -47.64 82.38 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.698 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 97.7 mt -60.78 -43.82 96.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.16 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 40' ' ' LEU . . . . . 0.547 HD13 ' O ' ' D' ' 40' ' ' LEU . 0.2 OUTLIER -61.89 -40.86 96.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.181 -179.45 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 41' ' ' TRP . . . . . 0.505 ' HE1' HH21 ' D' ' 45' ' ' ARG . 30.8 t-105 -62.09 -55.02 33.22 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.739 0.304 . . . . 0.0 111.287 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 79.2 mt -60.03 -55.98 20.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.913 -178.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 52.7 tp -58.34 -41.5 84.79 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.841 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 44' ' ' ASP . . . . . 0.426 ' O ' ' CB ' ' D' ' 50' ' ' SER . 4.2 t70 -58.54 -40.84 84.1 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 45' ' ' ARG . . . . . 0.505 HH21 ' HE1' ' D' ' 41' ' ' TRP . 14.8 ttm180 -62.78 -50.91 69.17 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.546 -0.461 . . . . 0.0 110.445 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.39 109.45 21.44 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.001 0.429 . . . . 0.0 109.908 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -173.18 86.53 0.06 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.374 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 53.71 55.64 8.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.419 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt 60.35 52.19 4.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.223 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 50' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 0.3 OUTLIER -58.79 -42.23 88.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.73 -179.59 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 51' ' ' ILE . . . . . 0.731 HD13 ' H ' ' D' ' 51' ' ' ILE . 0.0 OUTLIER -55.37 -43.52 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -70.59 -28.24 64.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.122 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -68.7 -44.61 73.59 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.42 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -72.16 -40.99 67.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.775 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -63.19 -41.04 99.12 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.449 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -76.94 -36.89 56.24 Favored 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.562 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -58.44 -49.81 75.98 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.406 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.47 -27.35 73.07 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -93.86 57.55 2.49 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 86.8 tttt . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.53 -179.96 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.42 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 56.5 Cg_exo . . . . . 0 N--CA 1.489 1.259 0 N-CA-C 110.904 -0.46 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 18.6 tp -64.81 -51.52 61.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.972 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.23 -51.57 65.69 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.142 0.496 . . . . 0.0 109.928 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 49.2 t -56.91 -42.86 79.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.651 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 25' ' ' PRO . . . -55.93 -45.49 78.73 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.73 -46.04 81.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.113 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.3 t -56.05 -50.66 70.34 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.332 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 55.3 mt -56.59 -37.82 54.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.611 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 87.5 mt -65.37 -41.88 92.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.055 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.13 -52.32 37.59 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.643 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.5 -44.6 93.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 52.4 tp -63.9 -32.06 73.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.485 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -68.62 -51.66 39.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.817 0.341 . . . . 0.0 111.043 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 28.8 tp -63.04 -51.22 67.59 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.29 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.8 mm -61.58 -44.33 98.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.983 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 47.5 tp -61.54 -38.91 89.15 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.302 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 39.9 t-105 -63.5 -55.72 21.79 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.87 0.367 . . . . 0.0 111.405 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 74.8 mt -59.47 -54.18 38.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.802 -177.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 44.9 tp -61.25 -44.66 96.89 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.961 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -51.98 -44.87 64.23 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.472 ' NH2' ' CB ' ' D' ' 54' ' ' PHE . 65.8 ttt180 -61.2 -50.89 71.29 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.255 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.5 mt -81.73 -131.3 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.78 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 39.5 t80 62.47 101.31 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.592 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 41.73 38.83 1.03 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.605 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 66.9 mttm 53.39 49.42 19.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.158 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.9 t -49.49 -27.37 4.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.632 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.452 ' CD1' ' O ' ' A' ' 45' ' ' ARG . 3.6 mp -47.5 -45.33 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.9 0.381 . . . . 0.0 110.093 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.519 ' CE2' ' OE1' ' A' ' 56' ' ' GLU . 86.8 t80 -71.15 -29.04 64.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.175 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.527 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 79.5 mtp180 -69.02 -45.53 70.27 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.027 0.441 . . . . 0.0 110.33 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -70.69 -37.11 73.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.651 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -67.91 -39.91 83.49 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 120.629 -0.429 . . . . 0.0 111.661 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.519 ' OE1' ' CE2' ' A' ' 52' ' ' TYR . 21.9 pt-20 -76.41 -40.1 51.72 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.145 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.527 ' ND1' ' O ' ' A' ' 53' ' ' ARG . 32.6 m170 -64.77 -45.84 84.65 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.757 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.815 0 N-CA-C 110.774 -0.931 . . . . 0.0 110.774 179.917 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.718 0.294 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -51.63 -32.87 46.43 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.492 2.128 . . . . 0.0 111.27 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.462 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 19.2 tp -61.5 -47.31 86.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.904 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.93 -46.15 91.82 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 91.9 t -60.56 -33.39 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -63.39 -35.65 81.12 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.77 -44.07 74.43 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.386 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 4.8 t -67.02 -51.32 56.34 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 120.081 -0.648 . . . . 0.0 111.563 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.464 HG23 ' N ' ' B' ' 33' ' ' ILE . 19.9 tt -62.72 -40.96 90.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.738 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.464 ' N ' HG23 ' B' ' 32' ' ' ILE . 17.4 tt -71.68 -28.44 31.01 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.14 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.247 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.15 -52.22 28.85 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 6.4 pt -64.27 -42.94 96.99 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.217 0 C-N-CA 120.234 -0.587 . . . . 0.0 109.902 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 11.5 tp -59.75 -39.44 84.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.67 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . 0.545 ' NE2' ' NE2' ' C' ' 37' ' ' HIS . 28.9 t60 -68.0 -54.46 18.27 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -178.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 38.5 tp -62.12 -51.54 67.48 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 120.999 0.428 . . . . 0.0 111.761 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.478 ' CD1' ' N ' ' B' ' 39' ' ' ILE . 1.2 mp -62.18 -43.36 97.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.229 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 37.0 tp -59.46 -38.49 80.9 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.98 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 6.8 t-105 -63.85 -63.23 1.22 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.998 0.428 . . . . 0.0 111.611 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.548 ' CG2' ' N ' ' B' ' 43' ' ' LEU . 8.6 tt -53.25 -50.89 44.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 119.944 -0.703 . . . . 0.0 110.74 -177.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.548 ' N ' ' CG2' ' B' ' 42' ' ' ILE . 0.5 OUTLIER -57.65 -50.23 73.86 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.46 -178.128 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -50.27 -37.27 35.17 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 63.9 ttt-85 -68.95 -50.99 44.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.084 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.438 ' O ' ' O ' ' B' ' 43' ' ' LEU . 0.3 OUTLIER -96.79 128.47 43.77 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.614 -179.398 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -162.53 -54.29 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.422 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -170.92 -60.31 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.303 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -147.87 18.46 1.13 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.316 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 47.3 t -54.34 -49.84 68.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.729 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 49.9 mt -53.84 -50.05 54.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.986 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.479 ' CE2' ' OE2' ' B' ' 56' ' ' GLU . 79.2 t80 -74.18 -30.6 62.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.748 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 20.1 mmt85 -69.15 -47.75 64.15 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.705 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . 0.409 ' HB3' HH22 ' C' ' 45' ' ' ARG . 47.9 m-85 -72.6 -39.77 67.04 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.872 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -64.08 -41.39 97.34 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 120.751 -0.379 . . . . 0.0 111.462 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . 0.479 ' OE2' ' CE2' ' B' ' 52' ' ' TYR . 10.9 pt-20 -76.92 -38.07 54.13 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 120.404 -0.519 . . . . 0.0 110.738 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -59.58 -49.27 78.4 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.35 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.21 -29.48 74.43 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 9.6 tp -87.29 58.12 4.83 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.802 0.334 . . . . 0.0 110.296 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 62.8 mttp . . . . . 0 N--CA 1.466 0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.399 -179.904 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -157.71 72.29 4.24 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.778 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -51.04 -35.69 51.62 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.485 2.123 . . . . 0.0 111.221 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . 0.414 ' O ' ' HB3' ' C' ' 29' ' ' ALA . 15.3 tp -58.16 -53.07 62.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.958 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.25 -46.09 91.0 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.044 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 89.9 t -60.25 -33.46 53.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' C' ' 26' ' ' LEU . . . -64.07 -38.39 90.9 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.95 -51.32 62.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.106 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 2.8 p -62.01 -52.27 64.67 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.595 -0.442 . . . . 0.0 112.022 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 10.1 tp -59.37 -37.71 70.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.489 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 29.6 mt -63.14 -40.86 90.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.73 -52.1 45.71 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.65 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 50.2 mm -56.7 -48.24 81.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.551 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 7.4 tp -62.73 -34.3 76.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.834 0.35 . . . . 0.0 110.816 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . 0.545 ' NE2' ' NE2' ' B' ' 37' ' ' HIS . 1.5 t60 -65.12 -50.16 67.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.431 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 11.0 mp -66.56 -44.86 81.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.411 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 30.6 mm -63.34 -47.14 93.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.268 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 34.8 mt -65.9 -40.46 91.55 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.666 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 32.7 t-105 -61.27 -54.47 43.69 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.021 0.439 . . . . 0.0 111.607 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 82.8 mt -65.43 -55.0 22.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.113 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.651 ' C ' HD13 ' C' ' 43' ' ' LEU . 2.9 tm? -59.83 -52.37 65.76 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.141 -178.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . 0.499 ' OD1' ' CE1' ' C' ' 54' ' ' PHE . 66.4 t0 -52.86 -41.77 64.6 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.107 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . 0.409 HH22 ' HB3' ' B' ' 54' ' ' PHE . 55.1 ttt-85 -59.94 -53.55 56.58 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.224 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . 0.403 ' O ' ' CB ' ' C' ' 47' ' ' PHE . 4.1 mt -84.08 -140.42 0.07 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.091 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . 0.529 ' O ' ' N ' ' C' ' 49' ' ' LYS . 7.2 t80 78.63 -164.22 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.168 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . 0.406 ' O ' ' C ' ' C' ' 49' ' ' LYS . 85.9 t80 -57.03 81.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.406 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' C' ' 47' ' ' PHE . 15.9 ptpt 33.27 53.34 0.41 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.122 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 42.9 t -57.88 -46.32 85.06 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.302 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 51' ' ' ILE . . . . . 0.553 ' H ' HD12 ' C' ' 51' ' ' ILE . 3.5 mp -43.46 -42.48 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.944 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -71.11 -31.2 67.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.455 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -70.13 -46.73 64.16 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.512 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . 0.499 ' CE1' ' OD1' ' C' ' 44' ' ' ASP . 32.2 m-85 -66.14 -43.49 86.93 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.29 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -61.67 -39.9 93.03 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.693 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 . . . . . 0 CA--C 1.535 0.373 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.894 179.724 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo . . . . . 0 N--CA 1.483 0.907 0 N-CA-C 110.496 -0.617 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 pp -67.86 -37.53 81.94 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.7 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 27' ' ' ALA . . . . . 0.451 ' O ' ' HB3' ' D' ' 30' ' ' ALA . . . -51.4 -40.38 59.16 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.741 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 90.4 t -57.58 -45.21 86.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.67 -32.79 70.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.265 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' D' ' 27' ' ' ALA . . . -67.61 -35.41 78.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.992 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 5.1 t -68.38 -50.84 50.2 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.519 -0.473 . . . . 0.0 111.081 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 63.9 mt -64.72 -40.33 88.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.407 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . 0.401 HG21 HD13 ' D' ' 33' ' ' ILE . 6.8 tt -68.95 -35.68 70.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.893 -178.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.72 -52.64 14.48 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.673 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . 0.47 HG23 ' N ' ' D' ' 36' ' ' LEU . 10.3 tp -63.15 -40.83 90.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.934 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.47 ' N ' HG23 ' D' ' 35' ' ' ILE . 52.4 tp -63.4 -37.46 87.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.755 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -63.07 -50.74 69.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.465 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 37.3 tp -57.04 -48.3 78.87 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.554 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.05 -41.26 85.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.67 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 37.9 mt -62.32 -39.41 92.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.186 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 31.5 t-105 -63.33 -54.4 37.62 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.798 0.332 . . . . 0.0 111.23 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 61.5 mt -61.77 -53.19 51.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 120.65 -0.42 . . . . 0.0 112.11 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' D' ' 46' ' ' LEU . 37.0 tp -61.51 -48.38 81.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.12 -178.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . 0.443 ' O ' ' CB ' ' D' ' 50' ' ' SER . 32.3 t70 -54.36 -45.69 72.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.209 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -60.1 -50.23 74.54 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.513 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' D' ' 43' ' ' LEU . 2.8 pp -122.73 125.62 45.9 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.056 0.455 . . . . 0.0 110.583 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -174.19 -45.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.539 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . 0.527 ' O ' ' NH1' ' D' ' 53' ' ' ARG . 77.8 t80 -172.92 67.96 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.293 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 67.2 mttm 55.94 39.48 30.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.278 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 6.6 t -64.15 -52.78 57.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.921 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 62.1 mt -49.0 -34.34 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.856 0.36 . . . . 0.0 110.264 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -72.53 -29.85 63.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.01 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 53' ' ' ARG . . . . . 0.527 ' NH1' ' O ' ' D' ' 48' ' ' PHE . 95.3 mtm-85 -72.09 -48.2 45.74 Favored 'General case' 0 CA--C 1.522 -0.122 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.616 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . 0.472 ' CB ' ' NH2' ' A' ' 45' ' ' ARG . 87.4 m-85 -68.04 -42.09 81.08 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.792 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -65.64 -40.94 93.06 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.279 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -77.18 -21.87 53.33 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.61 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -74.28 -48.71 26.82 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.318 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.41 -31.47 78.98 Favored Glycine 0 N--CA 1.46 0.265 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 59' ' ' LEU . . . . . 0.402 ' C ' ' CD1' ' D' ' 59' ' ' LEU . 0.2 OUTLIER -65.1 -62.69 1.4 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.831 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 97.3 mttt . . . . . 0 C--N 1.333 -0.131 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.573 179.675 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo . . . . . 0 N--CA 1.487 1.104 0 N-CA-C 110.905 -0.46 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.411 HD13 ' HB3' ' B' ' 31' ' ' SER . 2.1 pp -70.53 -30.21 66.9 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.704 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -56.09 -40.41 73.59 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 120.586 -0.446 . . . . 0.0 109.815 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.7 t -58.54 -45.84 90.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.423 ' O ' HG22 ' A' ' 33' ' ' ILE . . . -60.45 -32.26 71.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.755 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -65.24 -47.31 77.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.553 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.5 p -65.28 -35.05 79.82 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.409 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.5 mm -66.07 -50.51 68.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.607 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.423 HG22 ' O ' ' A' ' 29' ' ' ALA . 15.4 tt -68.87 -28.61 40.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.795 -179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.99 -48.86 30.69 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.497 -0.858 . . . . 0.0 111.121 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.0 mm -64.51 -44.49 96.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.808 0.337 . . . . 0.0 110.162 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.2 tp -63.63 -39.21 93.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.034 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -63.32 -46.1 88.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.268 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 16.6 tp -65.66 -47.55 75.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.843 0.354 . . . . 0.0 111.535 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 29.2 mm -61.66 -50.1 81.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.408 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -65.77 -33.02 74.9 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.23 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 21.0 t-105 -64.3 -52.62 57.64 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.811 0.339 . . . . 0.0 111.406 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.3 mt -67.75 -50.38 60.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.82 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.469 HD11 ' CD1' ' A' ' 47' ' ' PHE . 22.7 tp -61.94 -44.89 95.83 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.03 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.439 ' O ' ' CB ' ' A' ' 50' ' ' SER . 28.4 t70 -58.99 -44.58 91.63 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.811 -0.355 . . . . 0.0 110.119 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 61.8 ttt85 -60.39 -45.04 95.0 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.612 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.5 pp -135.74 129.9 33.32 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.919 0.39 . . . . 0.0 110.996 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.469 ' CD1' HD11 ' A' ' 43' ' ' LEU . 60.2 t80 -173.83 -33.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.366 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.471 ' CD2' ' O ' ' A' ' 48' ' ' PHE . 52.9 t80 -172.52 45.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.164 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt 73.28 40.69 0.52 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.235 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.462 ' O ' ' N ' ' A' ' 53' ' ' ARG . 9.8 t -62.12 -46.24 89.89 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.004 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 91.2 mt -44.13 -38.97 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.025 0.44 . . . . 0.0 110.26 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -74.99 -28.26 60.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.217 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.53 ' O ' ' CD2' ' A' ' 57' ' ' HIS . 87.1 mtt180 -68.76 -49.48 58.33 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 121.007 0.432 . . . . 0.0 110.344 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -71.35 -39.97 70.96 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.876 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -64.76 -40.35 95.15 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.795 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -76.86 -41.17 45.0 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.971 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.53 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 9.2 m-70 -59.73 -48.43 81.73 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.665 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.807 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.99 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.672 0.272 . . . . 0.0 110.683 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -49.95 -36.75 44.93 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.447 2.098 . . . . 0.0 111.242 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.442 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 18.2 tp -57.5 -50.72 72.16 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.939 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.21 -51.24 70.4 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 93.1 t -54.6 -38.82 43.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -57.86 -40.25 79.71 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.72 -40.14 94.83 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.232 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . 0.411 ' HB3' HD13 ' A' ' 26' ' ' LEU . 31.9 p -67.22 -55.76 12.7 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.587 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.446 HG23 ' N ' ' B' ' 33' ' ' ILE . 18.5 tt -59.7 -41.13 84.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.904 -178.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.446 ' N ' HG23 ' B' ' 32' ' ' ILE . 16.3 tt -70.05 -29.76 41.28 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.213 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.76 -51.05 37.76 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.0 mp -61.03 -43.66 96.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 12.3 tp -60.91 -38.24 85.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.684 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -66.94 -52.72 39.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.706 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 42.0 tp -62.45 -50.54 71.06 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.602 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.453 HD13 ' HA ' ' B' ' 39' ' ' ILE . 14.7 mm -61.36 -42.19 92.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.423 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 6.4 tt -61.91 -38.82 89.82 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.075 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 49.9 t-105 -63.65 -55.49 23.12 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 60.2 mt -63.65 -53.47 44.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.767 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.503 HD23 ' O ' ' B' ' 43' ' ' LEU . 0.8 OUTLIER -57.88 -47.34 83.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.128 -178.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -59.72 -45.98 90.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.928 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -58.71 -52.33 66.17 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.058 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.11 129.82 56.77 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 120.996 0.427 . . . . 0.0 110.277 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -175.04 -55.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.296 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -169.31 71.74 0.08 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.306 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 49.5 mttp 60.14 30.19 19.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.469 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 11.0 t -56.31 -50.84 70.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.857 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 59.2 mt -51.9 -44.37 37.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.889 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.494 ' CE2' ' OE1' ' B' ' 56' ' ' GLU . 78.2 t80 -71.99 -32.2 66.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.474 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.529 ' O ' ' CG ' ' B' ' 57' ' ' HIS . 78.7 mtp180 -67.67 -45.99 73.66 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.724 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -71.89 -38.94 69.91 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.792 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -64.18 -41.22 97.19 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.49 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . 0.494 ' OE1' ' CE2' ' B' ' 52' ' ' TYR . 21.1 pt-20 -76.78 -39.02 52.96 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.692 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' HIS . . . . . 0.529 ' CG ' ' O ' ' B' ' 53' ' ' ARG . 6.4 m-70 -58.63 -48.21 81.76 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.657 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.31 -28.5 73.64 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 11.0 mp -104.64 66.68 0.79 Allowed 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 97.6 mttt . . . . . 0 N--CA 1.466 0.336 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.362 -179.791 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 49.14 68.66 3.3 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.674 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -51.65 -31.57 41.28 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.496 2.131 . . . . 0.0 111.186 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' C' ' 29' ' ' ALA . 3.0 pp -60.69 -28.24 68.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.781 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -46.94 -38.9 11.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.259 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 68.2 t -59.78 -40.96 84.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' C' ' 26' ' ' LEU . . . -62.33 -34.42 76.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.392 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.18 -49.5 69.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.927 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 4.4 p -64.6 -50.79 65.81 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 3.2 tp -60.17 -37.94 75.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.559 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 51.1 mt -67.73 -38.0 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.654 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.5 -51.81 34.46 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.804 -0.713 . . . . 0.0 111.967 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 9.6 pt -64.45 -37.9 81.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.467 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 13.0 tp -65.7 -40.73 92.59 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -63.86 -52.61 59.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.587 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 50.9 tp -63.63 -47.8 79.87 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.652 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 84.4 mt -59.92 -45.35 95.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.143 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.5 -38.82 92.34 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.906 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 25.7 t-105 -59.46 -57.21 13.99 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.334 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 54.1 mt -63.75 -54.53 30.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -177.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.501 HD23 ' O ' ' C' ' 43' ' ' LEU . 0.8 OUTLIER -58.45 -48.98 78.96 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.75 0.309 . . . . 0.0 111.191 -178.443 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . 0.502 ' O ' ' CB ' ' C' ' 50' ' ' SER . 38.7 t70 -57.49 -48.67 78.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.986 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . 0.488 ' NH1' HD11 ' C' ' 51' ' ' ILE . 34.2 ttt-85 -56.79 -52.8 63.65 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.229 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' C' ' 43' ' ' LEU . 2.6 pp -113.68 129.94 56.49 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.132 0.491 . . . . 0.0 110.977 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -173.81 -39.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.329 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -169.51 -67.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.368 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -150.44 25.63 0.78 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.096 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . 0.502 ' CB ' ' O ' ' C' ' 44' ' ' ASP . 6.6 t -50.23 -53.65 26.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.559 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 51' ' ' ILE . . . . . 0.488 HD11 ' NH1' ' C' ' 45' ' ' ARG . 66.3 mt -50.68 -49.41 25.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.212 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -73.6 -31.11 63.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.687 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -70.42 -49.4 49.24 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.428 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -67.36 -41.47 85.05 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.351 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -62.61 -38.68 91.13 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 120.484 -0.487 . . . . 0.0 110.809 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 . . . . . 0 CA--C 1.536 0.433 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.916 179.657 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . 0.425 ' O ' ' N ' ' D' ' 29' ' ' ALA . 76.0 Cg_exo . . . . . 0 N--CA 1.489 1.211 0 N-CA-C 110.819 -0.493 . . . . 0.0 110.819 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . 0.443 ' O ' ' HB3' ' D' ' 29' ' ' ALA . 25.9 tp -56.48 -48.47 77.07 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.2 -51.2 71.0 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.21 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 89.3 t -60.28 -29.16 43.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.57 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' D' ' 26' ' ' LEU . . . -66.88 -37.05 83.68 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.32 -38.41 74.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.561 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 1.4 m -68.98 -47.57 65.25 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.7 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . 0.435 HG23 ' N ' ' D' ' 33' ' ' ILE . 10.0 tp -69.11 -41.22 81.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.632 -178.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . 0.435 ' N ' HG23 ' D' ' 32' ' ' ILE . 9.9 tt -67.06 -39.95 84.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.498 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.65 -51.03 32.73 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.879 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . 0.426 ' O ' HD13 ' D' ' 35' ' ' ILE . 0.2 OUTLIER -59.93 -43.59 92.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.409 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.405 ' N ' ' CG2' ' D' ' 35' ' ' ILE . 49.7 tp -60.41 -39.6 87.96 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.89 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -61.35 -48.4 81.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.29 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 57.4 tp -55.47 -52.79 62.46 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.837 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . 0.408 HD13 ' CD1' ' D' ' 35' ' ' ILE . 1.4 mp -61.88 -33.23 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.443 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 6.1 tp -65.49 -42.97 91.56 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.717 0.294 . . . . 0.0 110.576 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 21.9 t-105 -66.13 -58.75 4.74 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 120.883 0.373 . . . . 0.0 111.54 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . 0.519 ' CG2' ' N ' ' D' ' 43' ' ' LEU . 9.1 tt -60.47 -47.39 92.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.466 -177.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.519 ' N ' ' CG2' ' D' ' 42' ' ' ILE . 23.0 tp -63.43 -44.86 93.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.564 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . 0.516 ' OD1' ' CE1' ' D' ' 54' ' ' PHE . 40.8 t0 -56.44 -37.69 70.59 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . 0.512 ' HB3' HD23 ' D' ' 46' ' ' LEU . 12.4 ttm180 -69.42 -53.53 18.86 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.895 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . 0.512 HD23 ' HB3' ' D' ' 45' ' ' ARG . 0.2 OUTLIER -117.08 113.5 22.39 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.987 0.422 . . . . 0.0 110.149 179.367 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -174.8 83.9 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.074 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 54.97 71.61 0.53 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.525 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 98.5 mttt 51.2 48.89 22.18 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.289 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 2.6 t -68.79 -52.85 25.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.127 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 9.4 mt -47.74 -37.54 5.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.087 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -73.87 -31.27 63.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.133 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -71.08 -47.2 59.67 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.877 0.37 . . . . 0.0 110.772 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . 0.516 ' CE1' ' OD1' ' D' ' 44' ' ' ASP . 64.9 m-85 -71.74 -37.35 70.59 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.763 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -67.84 -41.16 83.41 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.615 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -76.71 -36.96 56.86 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.72 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 62.7 t-80 -63.49 -48.31 78.15 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.299 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.04 -27.91 73.55 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 5.9 tp -92.96 39.07 1.03 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.871 0.367 . . . . 0.0 110.326 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 3.1 tmtm? . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.386 -179.666 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo . . . . . 0 N--CA 1.493 1.445 0 CA-C-O 120.931 0.305 . . . . 0.0 111.661 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 pp -62.64 -29.8 70.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.06 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.457 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -50.48 -34.48 25.14 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.152 0.501 . . . . 0.0 109.982 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.2 t -59.13 -48.81 85.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 CA-C-O 121.539 0.685 . . . . 0.0 109.274 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.22 -30.69 71.27 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.567 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -63.68 -47.36 81.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.213 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.9 t -62.22 -48.07 81.6 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.866 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.2 mp -62.12 -33.51 58.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.293 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 38.4 mt -70.49 -38.92 75.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 121.123 -0.231 . . . . 0.0 110.759 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.15 -53.48 18.08 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.393 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.464 HG23 ' N ' ' A' ' 36' ' ' LEU . 19.2 tt -60.24 -41.1 85.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.728 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.464 ' N ' HG23 ' A' ' 35' ' ' ILE . 40.5 tp -66.42 -30.87 71.33 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.35 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -68.55 -48.97 62.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.472 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.5 mp -63.86 -50.36 69.15 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.978 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 86.1 mt -62.13 -48.1 90.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.378 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.7 tp -61.08 -42.1 97.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.701 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.7 t-105 -62.46 -56.26 19.85 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 120.865 0.364 . . . . 0.0 111.518 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.03 -55.24 24.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.871 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.2 tp -61.24 -48.15 82.78 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.289 -0.564 . . . . 0.0 111.36 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -53.58 -39.15 64.6 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 42.1 ttt-85 -63.49 -51.17 66.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.442 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 48' ' ' PHE . 7.1 mt -83.18 -77.05 0.26 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.023 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.416 ' CD2' ' N ' ' A' ' 48' ' ' PHE . 88.4 t80 46.69 -88.25 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.415 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.534 ' N ' ' O ' ' A' ' 46' ' ' LEU . 62.5 t80 -164.39 87.33 0.48 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.099 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm 59.14 27.47 16.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.13 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.8 t -59.78 -44.47 93.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.657 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.439 ' H ' HD12 ' A' ' 51' ' ' ILE . 3.3 mp -52.19 -36.38 20.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.01 0.433 . . . . 0.0 110.068 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.495 ' CD2' ' OE2' ' A' ' 56' ' ' GLU . 81.4 t80 -74.01 -27.78 61.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.221 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 48' ' ' PHE . 68.2 mtt85 -69.97 -49.33 52.76 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.96 0.409 . . . . 0.0 110.559 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -72.03 -39.17 69.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.945 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -66.79 -39.69 87.86 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.711 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.495 ' OE2' ' CD2' ' A' ' 52' ' ' TYR . 10.1 pt-20 -76.17 -40.36 52.66 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.658 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.529 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 6.4 m-70 -60.68 -47.43 86.29 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.54 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.948 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.935 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 120.635 0.255 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -50.4 -29.33 23.56 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.511 2.141 . . . . 0.0 111.606 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 14.3 tp -61.64 -52.29 64.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.189 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' B' ' 30' ' ' ALA . . . -58.98 -46.34 88.36 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.609 0.719 . . . . 0.0 109.384 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 72.5 t -56.69 -47.11 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.1 -44.38 52.07 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' B' ' 27' ' ' ALA . . . -56.69 -50.35 72.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.796 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 60.7 p -57.45 -48.81 78.19 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 120.309 -0.557 . . . . 0.0 111.447 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 34.1 mm -59.67 -35.64 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.114 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 86.3 mt -70.24 -34.43 58.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.572 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.85 -52.94 21.86 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.497 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 7.9 pt -64.7 -39.97 87.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.1 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 37.3 tp -62.23 -40.03 94.8 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.47 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 22.3 t-160 -66.85 -53.68 30.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.732 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 34.8 tp -61.99 -53.21 58.74 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.737 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 56.7 mt -60.48 -44.22 95.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.794 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 32.5 tp -56.72 -43.26 80.42 Favored 'General case' 0 C--O 1.222 -0.364 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 21.7 t-105 -60.44 -54.19 48.58 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.161 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 5.2 mm -54.02 -58.34 3.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-O 121.237 0.541 . . . . 0.0 111.921 -177.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.665 ' C ' HD12 ' B' ' 43' ' ' LEU . 0.3 OUTLIER -62.4 -35.8 80.33 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.78 -178.488 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . 0.429 ' O ' ' OG ' ' B' ' 50' ' ' SER . 22.8 t70 -58.1 -44.84 87.87 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -65.77 -45.01 84.09 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.444 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.509 ' C ' ' H ' ' B' ' 48' ' ' PHE . 0.3 OUTLIER -113.74 -120.49 0.3 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.098 179.485 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.482 ' H ' HD12 ' B' ' 46' ' ' LEU . 37.3 t80 68.06 -35.29 0.27 Allowed 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.15 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . 0.509 ' H ' ' C ' ' B' ' 46' ' ' LEU . 31.0 t80 -169.06 42.97 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.678 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt 45.05 40.38 4.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.57 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . 0.461 ' O ' ' N ' ' B' ' 53' ' ' ARG . 1.4 p -61.8 -24.02 66.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.857 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 9.4 mt -41.55 -41.05 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.878 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -74.25 -29.69 61.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.379 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.461 ' N ' ' O ' ' B' ' 50' ' ' SER . 99.2 mtt180 -71.53 -47.61 54.11 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.935 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . 0.596 ' CE1' ' NH2' ' C' ' 45' ' ' ARG . 66.6 m-85 -72.81 -39.7 66.43 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.939 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -67.87 -39.26 83.76 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.644 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -76.93 -38.83 52.62 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.614 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -62.02 -47.29 85.42 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.259 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.12 -27.48 72.95 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 35.2 tp -79.85 -73.76 0.33 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.711 0.291 . . . . 0.0 110.541 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 68.5 mttm . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.601 -179.995 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 17.9 m . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . 0.459 ' HB2' ' HB3' ' C' ' 27' ' ' ALA . 0.7 OUTLIER -177.54 56.53 0.11 Allowed Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.493 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.77 -30.42 68.91 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.104 1.869 . . . . 0.0 110.698 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . 0.431 ' O ' ' HB3' ' C' ' 29' ' ' ALA . 19.2 tp -68.8 -48.26 64.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.068 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 27' ' ' ALA . . . . . 0.459 ' HB3' ' HB2' ' C' ' 24' ' ' ASP . . . -59.61 -46.91 87.58 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.234 0.54 . . . . 0.0 109.615 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 82.1 t -59.39 -34.34 54.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.247 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' C' ' 26' ' ' LEU . . . -63.91 -34.85 78.88 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.47 -42.71 78.35 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.231 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 6.6 t -68.45 -48.48 64.45 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.189 -0.604 . . . . 0.0 111.802 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . 0.406 HG23 ' N ' ' C' ' 33' ' ' ILE . 14.6 tt -66.03 -40.84 88.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.64 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . 0.406 ' N ' HG23 ' C' ' 32' ' ' ILE . 14.7 tt -69.22 -36.4 72.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.703 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.09 -51.45 38.97 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 120.497 -0.858 . . . . 0.0 110.973 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 34.7 mm -60.6 -41.21 87.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 13.4 tp -60.45 -45.02 95.18 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.361 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . 0.476 ' C ' ' ND1' ' C' ' 37' ' ' HIS . 9.1 t-80 -60.82 -52.29 65.71 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.84 0.352 . . . . 0.0 111.379 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 55.4 tp -56.6 -48.62 77.04 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.05 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 56.1 mt -63.79 -34.47 68.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.006 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . 0.516 HD13 ' O ' ' C' ' 40' ' ' LEU . 0.2 OUTLIER -64.52 -48.64 74.37 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.633 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 15.3 t-105 -62.81 -56.96 12.74 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 73.6 mt -59.48 -51.91 67.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.872 -177.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.622 ' C ' HD13 ' C' ' 43' ' ' LEU . 2.8 tm? -58.87 -50.77 72.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.504 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -56.88 -35.16 68.62 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.025 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . 0.596 ' NH2' ' CE1' ' B' ' 54' ' ' PHE . 50.8 ttp180 -69.95 -57.68 4.74 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.831 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' C' ' 43' ' ' LEU . 1.1 pp -108.17 -164.34 0.95 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.66 0.267 . . . . 0.0 111.058 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 12.2 t80 74.42 -11.12 1.05 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.919 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' C' ' 49' ' ' LYS . 32.2 t80 -164.09 158.0 18.84 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.468 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . 0.541 ' N ' ' CD1' ' C' ' 48' ' ' PHE . 36.5 tttm -72.52 42.38 0.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.285 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . 0.456 ' H ' ' C ' ' C' ' 48' ' ' PHE . 6.7 t -66.47 -47.5 72.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.0 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 71.5 mt -43.95 -42.17 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.941 -0.303 . . . . 0.0 111.306 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -72.47 -29.82 64.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.302 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -71.3 -49.66 40.51 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.535 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . 0.404 ' CB ' ' NH2' ' D' ' 45' ' ' ARG . 45.7 m-85 -65.68 -44.24 86.83 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.38 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -63.06 -36.47 83.69 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.527 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 . . . . . 0 CA--C 1.536 0.406 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.63 179.655 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo . . . . . 0 N--CA 1.495 1.567 0 CA-C-O 121.095 0.373 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 16.9 tp -61.53 -51.72 67.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.652 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.63 -44.99 93.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.44 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 88.9 t -59.48 -38.44 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.88 -35.32 76.33 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.93 -51.12 59.15 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.08 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 6.1 p -61.18 -50.52 72.82 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.786 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 3.3 tp -62.11 -37.65 78.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.596 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 29.4 mt -62.72 -41.31 91.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 120.399 -0.521 . . . . 0.0 109.673 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.97 -46.15 83.31 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.06 -0.59 . . . . 0.0 111.957 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.61 -47.48 93.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.918 0.389 . . . . 0.0 110.523 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 21.6 tp -64.18 -32.17 73.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.055 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -64.87 -49.94 68.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.005 0.431 . . . . 0.0 110.523 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 46.9 tp -63.12 -46.55 86.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.1 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.42 -47.62 91.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.122 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -62.54 -37.88 87.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.241 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 40.4 t-105 -62.27 -57.29 11.94 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.524 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 62.0 mt -61.45 -53.57 46.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.954 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 55.9 tp -58.76 -47.22 85.43 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.946 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -54.33 -45.26 72.62 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . 0.424 ' HB3' HD23 ' D' ' 46' ' ' LEU . 77.0 ttt180 -59.18 -53.13 61.84 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.402 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . 0.424 HD23 ' HB3' ' D' ' 45' ' ' ARG . 0.1 OUTLIER -109.91 113.3 25.92 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 120.904 0.383 . . . . 0.0 110.185 179.055 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -173.67 91.89 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.42 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 54.29 59.19 4.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.416 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? 53.69 54.61 9.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.49 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 5.6 t -68.11 -52.01 39.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.134 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 58.0 mt -48.5 -35.13 5.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.627 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -70.81 -29.93 66.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.085 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -69.63 -42.62 74.08 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.963 0.411 . . . . 0.0 110.464 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -72.09 -39.37 69.0 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.802 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -66.09 -40.74 91.04 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.511 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 56' ' ' GLU . . . . . 0.44 ' CD ' ' N ' ' D' ' 57' ' ' HIS . 2.9 pp20? -76.39 -37.13 57.6 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.501 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 57' ' ' HIS . . . . . 0.44 ' N ' ' CD ' ' D' ' 56' ' ' GLU . 86.3 t60 -60.69 -51.69 68.28 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.275 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.07 -26.66 73.42 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 14.7 tp -152.86 88.0 1.31 Allowed 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 64.5 mttp . . . . . 0 N--CA 1.458 -0.042 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.497 -179.617 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo . . . . . 0 N--CA 1.492 1.397 0 N-CA-C 111.226 -0.336 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.439 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 16.2 tp -63.65 -53.22 54.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.032 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.2 -41.93 85.06 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 95.8 t -63.41 -32.35 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.241 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 26' ' ' LEU . . . -65.48 -36.21 83.2 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.43 -50.12 55.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.955 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.8 p -61.15 -50.09 74.57 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.683 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.0 tp -63.98 -34.19 66.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.072 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.1 mt -68.44 -43.04 84.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.553 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.28 -51.45 37.96 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.013 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 35' ' ' ILE . 9.7 tt -62.27 -40.09 86.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.017 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.402 ' N ' ' CG2' ' A' ' 35' ' ' ILE . 48.5 tp -64.57 -36.02 82.88 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.304 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -67.33 -50.9 58.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.803 0.335 . . . . 0.0 110.964 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 26.9 tp -61.74 -52.65 63.4 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.713 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 60.9 mt -62.73 -48.4 88.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.097 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 43.3 tp -54.78 -43.29 72.68 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 17.8 t-105 -60.67 -54.37 46.12 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.304 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.436 ' CG2' ' N ' ' A' ' 43' ' ' LEU . 1.0 OUTLIER -54.27 -48.9 66.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.002 -177.601 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.436 ' N ' ' CG2' ' A' ' 42' ' ' ILE . 20.6 tp -64.4 -41.9 96.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.386 -178.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -59.45 -36.24 75.57 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -71.18 -51.45 24.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.823 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.6 pp -123.67 125.34 44.61 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.109 0.48 . . . . 0.0 110.707 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -173.95 -43.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.251 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -172.48 67.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.263 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 68.2 mttm 55.43 38.55 30.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.411 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 34.8 t -63.35 -48.07 79.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.806 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 80.0 mt -48.69 -39.1 10.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.926 0.393 . . . . 0.0 109.989 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.517 ' CE2' ' OE2' ' A' ' 56' ' ' GLU . 93.3 t80 -70.98 -29.56 65.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.314 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.515 ' O ' ' CD2' ' A' ' 57' ' ' HIS . 90.2 mtt-85 -69.12 -44.17 72.93 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.125 0.488 . . . . 0.0 110.388 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.524 ' CB ' HH21 ' B' ' 45' ' ' ARG . 58.2 m-85 -70.94 -40.68 71.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.804 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -65.75 -39.27 90.91 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.744 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.517 ' OE2' ' CE2' ' A' ' 52' ' ' TYR . 12.5 pt-20 -76.47 -40.43 50.42 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.902 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.515 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 6.9 m-70 -60.98 -52.26 65.75 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.487 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.606 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.543 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 . . . . . 0 CA--C 1.528 0.102 0 CA-C-O 120.475 0.179 . . . . 0.0 110.682 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -50.7 -33.04 38.47 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.407 2.072 . . . . 0.0 111.309 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.454 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 17.7 tp -61.13 -51.2 70.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.064 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.75 -42.42 97.38 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 91.6 t -61.67 -34.91 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -61.37 -40.41 94.2 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.94 -50.98 68.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.07 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 4.3 p -60.17 -53.11 61.64 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 8.8 tp -60.16 -38.48 77.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.993 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 69.2 mt -64.41 -40.3 88.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.029 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.8 -52.31 49.31 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 48.4 mm -56.36 -43.38 77.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.971 0.415 . . . . 0.0 110.034 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 11.4 tp -62.12 -36.1 80.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.654 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . 0.607 ' NE2' ' NE2' ' C' ' 37' ' ' HIS . 18.8 t60 -67.96 -54.43 18.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.942 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 40.2 tp -62.68 -49.94 73.11 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.63 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' B' ' 39' ' ' ILE . 15.8 mm -62.29 -44.03 98.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.513 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 43.8 tp -59.17 -39.9 83.95 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.534 -0.466 . . . . 0.0 109.877 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 21.8 t-105 -63.47 -56.28 17.38 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.413 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 94.6 mt -55.41 -51.57 55.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.141 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 mt -60.21 -44.82 94.83 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.216 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -58.71 -37.82 76.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.805 0.336 . . . . 0.0 110.657 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.524 HH21 ' CB ' ' A' ' 54' ' ' PHE . 61.8 ttt85 -68.93 -48.34 63.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.067 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.416 HD23 ' HB3' ' B' ' 45' ' ' ARG . 0.1 OUTLIER -118.46 111.8 19.12 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 120.974 0.416 . . . . 0.0 110.371 179.503 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -175.46 87.79 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.185 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 48.8 t80 58.43 60.41 2.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.462 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp 54.76 47.88 21.43 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.522 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 6.5 t -62.93 -49.82 73.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.859 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 10.9 mt -48.55 -40.82 11.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.704 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -71.34 -28.69 64.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.53 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -69.38 -43.51 73.37 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.606 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -73.47 -44.58 57.7 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.938 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -62.93 -40.08 96.53 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.513 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -77.49 -37.32 51.42 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.549 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -58.63 -48.19 81.87 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.348 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.32 -33.07 84.99 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -81.89 -72.36 0.44 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 63.4 tttm . . . . . 0 C--N 1.331 -0.209 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.379 -179.896 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 29.6 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -159.96 71.3 3.14 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.856 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -51.26 -30.96 35.19 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.446 2.097 . . . . 0.0 111.273 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 12.0 tp -61.02 -52.04 66.68 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.906 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 27' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' C' ' 30' ' ' ALA . . . -60.27 -46.59 89.31 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.019 178.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 76.5 t -57.15 -47.27 84.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.79 -42.2 57.85 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' C' ' 27' ' ' ALA . . . -59.13 -49.58 77.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.919 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 1.1 p -57.8 -50.94 71.59 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.283 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 22.1 mm -61.79 -29.57 46.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.65 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 2.3 mm -68.18 -41.35 83.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.35 -52.64 25.61 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.574 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 48.1 mm -60.88 -43.98 96.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.887 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 12.5 tp -63.93 -40.67 96.98 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . 0.607 ' NE2' ' NE2' ' B' ' 37' ' ' HIS . 57.1 t60 -60.95 -48.66 80.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.88 0.371 . . . . 0.0 111.173 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . 0.439 HD11 HD11 ' C' ' 42' ' ' ILE . 29.6 tp -65.05 -50.8 64.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.106 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 4.3 mm -60.21 -47.52 91.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.389 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . 0.407 ' O ' ' CB ' ' C' ' 44' ' ' ASP . 3.1 mm? -64.58 -36.95 85.9 Favored 'General case' 0 C--O 1.22 -0.476 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.036 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . 0.458 ' CZ3' ' CZ2' ' D' ' 41' ' ' TRP . 14.2 t-105 -60.47 -53.95 51.41 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.141 0.495 . . . . 0.0 111.257 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . 0.439 HD11 HD11 ' C' ' 38' ' ' LEU . 90.4 mt -66.85 -56.41 14.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.052 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.491 HD23 ' O ' ' C' ' 43' ' ' LEU . 0.6 OUTLIER -56.43 -48.19 77.52 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.642 -178.62 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . 0.407 ' CB ' ' O ' ' C' ' 40' ' ' LEU . 28.9 t70 -53.8 -45.7 70.84 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 60.3 ttt85 -58.22 -52.19 66.61 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.069 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 9.8 mt -72.28 -76.87 0.1 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.511 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . 0.492 ' CG ' ' N ' ' C' ' 48' ' ' PHE . 37.4 t80 52.4 -177.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.176 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . 0.492 ' N ' ' CG ' ' C' ' 47' ' ' PHE . 39.0 m-85 -56.24 -41.36 75.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.954 0.407 . . . . 0.0 110.34 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -171.91 48.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.102 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 5.1 t -69.95 -45.88 66.5 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.65 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 64.5 mt -44.48 -55.68 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -74.96 -34.91 62.1 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -71.24 -49.99 37.59 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.819 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -66.04 -43.85 86.32 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.232 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -63.22 -36.64 84.33 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.702 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 . . . . . 0 CA--C 1.536 0.438 0 C-N-CA 120.384 -0.527 . . . . 0.0 110.879 179.401 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo . . . . . 0 N--CA 1.49 1.308 0 N-CA-C 110.8 -0.5 . . . . 0.0 110.8 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . 0.453 ' O ' ' HB3' ' D' ' 29' ' ' ALA . 14.1 tp -60.29 -51.96 67.3 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.509 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.46 -47.9 82.5 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 94.4 t -58.47 -33.73 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.197 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' D' ' 26' ' ' LEU . . . -64.43 -35.77 81.99 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.41 -39.09 81.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.392 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.96 -53.44 26.14 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.28 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . 0.415 HG23 ' N ' ' D' ' 33' ' ' ILE . 16.8 tt -62.65 -40.12 87.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.67 -178.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . 0.418 HG21 HD13 ' D' ' 33' ' ' ILE . 9.2 tt -70.05 -30.7 44.94 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 C-N-CA 120.179 -0.608 . . . . 0.0 110.282 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.68 -53.3 16.67 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 2.1 mp -60.87 -43.92 96.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 11.9 tp -62.31 -34.55 76.82 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.447 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 21.5 t-160 -66.09 -49.99 65.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.655 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 50.2 tp -60.33 -50.94 71.64 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.045 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 4.9 mm -60.26 -43.44 93.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 33.6 mt -61.56 -40.88 96.31 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.272 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . 0.458 ' CZ2' ' CZ3' ' C' ' 41' ' ' TRP . 40.4 t-105 -62.52 -53.96 47.0 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.64 0.257 . . . . 0.0 111.451 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 66.1 mt -63.49 -54.25 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -177.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' D' ' 46' ' ' LEU . 54.5 tp -61.57 -45.39 94.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.406 -178.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . 0.439 ' O ' ' CB ' ' D' ' 50' ' ' SER . 11.6 t70 -64.04 -32.39 73.93 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.466 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 56.2 ttt-85 -69.07 -56.31 8.12 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.262 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' D' ' 43' ' ' LEU . 0.1 OUTLIER -105.76 -167.39 1.31 Allowed 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.588 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 9.9 t80 72.86 124.96 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.78 0.324 . . . . 0.0 110.291 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . 0.436 ' CD2' ' O ' ' D' ' 48' ' ' PHE . 40.7 t80 59.74 20.01 8.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.424 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt 47.53 66.92 0.9 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.401 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 45.4 t -67.75 -46.57 71.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.005 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 51' ' ' ILE . . . . . 0.4 ' H ' HG13 ' D' ' 51' ' ' ILE . 55.8 mt -45.88 -40.27 3.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.84 0.352 . . . . 0.0 110.401 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -72.42 -32.91 66.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.051 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -72.01 -50.18 30.79 Favored 'General case' 0 C--N 1.335 -0.038 0 CA-C-O 120.911 0.386 . . . . 0.0 110.74 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -64.49 -42.4 95.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.25 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -63.69 -40.38 96.65 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.08 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -75.86 -20.8 57.82 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.452 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -74.13 -50.32 19.95 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.525 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.14 -27.72 73.55 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 6.4 tp -80.69 43.0 0.65 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.818 0.342 . . . . 0.0 110.421 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.579 -179.979 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 31.4 Cg_endo . . . . . 0 N--CA 1.491 1.335 0 N-CA-C 110.636 -0.563 . . . . 0.0 110.636 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.5 tp -69.39 -44.55 71.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.982 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.2 -55.91 18.36 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.314 0.578 . . . . 0.0 110.015 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.2 t -55.09 -43.61 70.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.109 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 25' ' ' PRO . . . -53.61 -45.44 70.07 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.45 -48.11 77.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.873 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.79 -43.57 69.4 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 120.438 -0.505 . . . . 0.0 109.891 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.6 mt -62.5 -39.72 85.52 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.052 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 93.6 mt -66.58 -41.97 89.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.466 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.89 -51.57 33.93 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.047 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.52 HG23 ' N ' ' A' ' 36' ' ' LEU . 14.9 tt -62.65 -43.56 98.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.34 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.52 ' N ' HG23 ' A' ' 35' ' ' ILE . 9.9 tp -63.96 -33.57 76.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.301 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -66.73 -53.54 32.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.829 0.347 . . . . 0.0 111.217 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.2 tp -59.85 -48.43 81.73 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.975 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.4 mm -61.47 -41.83 91.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.795 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.2 mt -59.98 -45.28 93.24 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.288 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 15.4 t-105 -61.52 -57.7 11.07 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.608 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 94.6 mt -56.88 -56.31 15.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -177.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 47' ' ' PHE . 24.1 tp -61.45 -51.29 69.33 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.208 -178.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -47.36 -40.54 17.62 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.445 ' NH2' ' CB ' ' D' ' 54' ' ' PHE . 61.4 ttt180 -64.37 -52.43 58.32 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.143 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.48 33.62 1.98 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.884 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.457 ' N ' ' O ' ' A' ' 43' ' ' LEU . 66.1 t80 -85.26 84.92 7.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.772 0.32 . . . . 0.0 110.571 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.5 t80 56.55 60.86 2.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.45 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 51.29 27.35 3.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.491 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.9 t -49.68 -30.42 9.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.565 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.1 mt -50.01 -41.26 17.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.954 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -73.55 -28.36 61.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.142 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.521 ' O ' ' CD2' ' A' ' 57' ' ' HIS . 0.8 OUTLIER -69.98 -48.77 56.91 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.309 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.467 ' CB ' ' NH2' ' B' ' 45' ' ' ARG . 53.6 m-85 -71.23 -37.24 72.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.95 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -68.31 -39.13 82.1 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.734 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -77.38 -40.94 42.06 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.102 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.521 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 21.5 m-70 -64.07 -47.37 80.39 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.751 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.854 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.916 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.682 0.277 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.04 -31.34 53.4 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.437 2.092 . . . . 0.0 111.278 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.411 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 16.5 tp -60.2 -51.2 70.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.903 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.27 -45.45 93.27 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 89.1 t -60.04 -36.55 68.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.094 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -61.5 -35.75 78.57 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.91 -45.15 75.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.325 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 8.0 p -66.01 -52.64 47.5 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.524 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.479 HG23 ' N ' ' B' ' 33' ' ' ILE . 20.4 tt -61.45 -42.32 93.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -178.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.479 ' N ' HG23 ' B' ' 32' ' ' ILE . 13.9 tt -69.38 -29.64 42.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 C-N-CA 119.794 -0.763 . . . . 0.0 110.232 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.98 -51.68 38.02 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.539 HG22 HD12 ' B' ' 39' ' ' ILE . 46.6 mm -61.26 -38.12 79.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 120.603 -0.439 . . . . 0.0 109.888 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 10.2 tp -62.55 -41.77 99.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.694 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -66.84 -51.71 52.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.888 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 39.9 tp -60.99 -49.44 77.45 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.284 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.539 HD12 HG22 ' B' ' 35' ' ' ILE . 26.7 mt -61.86 -42.08 93.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.465 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 56.3 tp -60.92 -41.25 95.79 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.271 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 41.3 t-105 -63.82 -57.77 8.85 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.785 0.326 . . . . 0.0 111.789 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 68.7 mt -59.19 -53.44 47.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.364 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.663 HD13 ' C ' ' B' ' 43' ' ' LEU . 3.1 tm? -55.94 -50.87 69.58 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.746 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -53.15 -45.43 68.43 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.945 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.467 ' NH2' ' CB ' ' A' ' 54' ' ' PHE . 65.8 ttt180 -61.43 -56.68 17.57 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.349 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.439 HD23 ' HB3' ' B' ' 45' ' ' ARG . 0.1 OUTLIER -108.61 130.99 55.31 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.05 0.452 . . . . 0.0 110.315 179.62 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.525 ' O ' ' CD2' ' B' ' 48' ' ' PHE . 63.7 t80 -174.04 -64.51 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.124 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . 0.525 ' CD2' ' O ' ' B' ' 47' ' ' PHE . 8.4 m-85 -161.25 83.65 0.64 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.813 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 64.8 mttp 53.86 27.89 7.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.535 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 8.0 t -57.67 -51.99 67.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.726 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 89.0 mt -52.92 -41.81 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.765 0.317 . . . . 0.0 110.685 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.506 ' CD2' ' OE2' ' B' ' 56' ' ' GLU . 81.7 t80 -72.46 -30.97 65.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.634 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -72.0 -46.14 58.3 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.971 0.415 . . . . 0.0 110.817 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -71.45 -38.05 71.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.99 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -70.77 -38.08 73.4 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.717 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . 0.506 ' OE2' ' CD2' ' B' ' 52' ' ' TYR . 10.4 pt-20 -76.16 -38.46 56.63 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.691 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -66.76 -45.64 77.89 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.279 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.32 -27.6 69.57 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 5.4 tp -70.14 -67.87 0.46 Allowed 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.786 0.327 . . . . 0.0 110.481 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.552 -179.939 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 54.9 68.62 2.47 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.739 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.22 -35.68 53.57 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.486 2.124 . . . . 0.0 111.466 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . 0.518 ' O ' ' HB3' ' C' ' 29' ' ' ALA . 14.2 tp -60.12 -51.11 71.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.859 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.53 -43.63 75.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.747 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 90.2 t -60.99 -32.03 51.42 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' C' ' 26' ' ' LEU . . . -64.45 -38.3 90.54 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.96 -51.89 59.3 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.058 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 5.3 t -60.57 -51.45 69.37 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.52 -0.472 . . . . 0.0 112.146 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 9.9 tp -61.84 -30.93 49.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.39 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 12.1 mt -67.0 -41.53 87.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 120.627 -0.429 . . . . 0.0 109.997 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.48 -51.22 32.72 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.933 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . 0.525 HD13 ' O ' ' C' ' 35' ' ' ILE . 0.2 OUTLIER -59.92 -45.61 94.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-O 121.378 0.608 . . . . 0.0 109.663 -179.678 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.454 ' N ' ' CG2' ' C' ' 35' ' ' ILE . 53.6 tp -60.34 -40.47 90.8 Favored 'General case' 0 C--O 1.215 -0.746 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.129 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -59.27 -52.41 65.79 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.158 0.504 . . . . 0.0 111.017 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 16.7 tp -56.38 -50.14 72.41 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.407 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 1.2 mp -65.49 -31.65 54.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.853 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . 0.489 HD13 ' O ' ' C' ' 40' ' ' LEU . 0.2 OUTLIER -64.38 -47.96 77.28 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.719 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 15.9 t-105 -63.84 -56.41 15.6 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 120.804 -0.359 . . . . 0.0 111.511 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 96.2 mt -56.84 -55.41 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.416 -0.514 . . . . 0.0 112.003 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.654 ' C ' HD13 ' C' ' 43' ' ' LEU . 3.0 tm? -61.73 -50.9 70.57 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.939 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . 0.513 ' OD2' ' NH1' ' D' ' 45' ' ' ARG . 25.3 t70 -47.14 -43.32 20.69 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.047 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 60.9 ttt-85 -64.15 -52.26 59.91 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.576 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.15 114.94 26.69 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.595 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -174.22 102.36 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.416 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . 0.402 ' O ' ' CD2' ' C' ' 48' ' ' PHE . 51.6 t80 44.37 49.87 8.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.581 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? 57.16 40.27 28.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.306 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . 0.42 ' HA ' ' HE ' ' C' ' 53' ' ' ARG . 4.6 t -62.39 -34.55 76.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.318 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 51' ' ' ILE . . . . . 0.401 HG13 ' H ' ' C' ' 51' ' ' ILE . 60.6 mt -47.34 -41.01 6.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.21 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 52' ' ' TYR . . . . . 0.478 ' CZ ' ' OE1' ' C' ' 56' ' ' GLU . 89.2 t80 -72.37 -29.41 63.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.519 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 53' ' ' ARG . . . . . 0.42 ' HE ' ' HA ' ' C' ' 50' ' ' SER . 73.1 mtm180 -71.38 -48.0 52.76 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.648 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -68.4 -41.84 79.91 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.397 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -64.44 -36.92 85.72 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.824 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . 0.478 ' OE1' ' CZ ' ' C' ' 52' ' ' TYR . 64.8 tt0 . . . . . 0 CA--C 1.536 0.405 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.784 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo . . . . . 0 N--CA 1.493 1.462 0 N-CA-C 110.725 -0.529 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . 0.4 ' O ' ' HB3' ' D' ' 29' ' ' ALA . 16.6 tp -63.3 -50.39 70.25 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.0 -47.3 85.71 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 71.7 t -60.11 -32.41 50.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.324 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' D' ' 26' ' ' LEU . . . -66.96 -32.9 74.45 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.05 -44.45 69.14 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.726 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . 0.446 ' OG ' ' CD1' ' C' ' 26' ' ' LEU . 2.3 m -68.17 -45.01 74.64 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.733 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . 0.402 HD13 HG21 ' D' ' 32' ' ' ILE . 11.5 tt -68.16 -41.47 84.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.553 -178.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 13.0 tt -70.02 -34.67 60.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.485 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.07 -51.64 22.36 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.674 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 3.5 tp -64.02 -37.48 79.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.76 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 50.3 tp -64.07 -38.33 90.67 Favored 'General case' 0 CA--C 1.521 -0.136 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -65.95 -43.39 88.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.075 0.464 . . . . 0.0 109.86 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 mt -59.87 -51.36 70.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.778 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 74.3 mt -63.26 -40.48 89.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.209 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 7.6 tt -63.16 -45.22 92.85 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.981 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 31.8 t-105 -65.71 -52.0 54.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.89 0.376 . . . . 0.0 111.928 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 74.6 mt -63.29 -53.46 45.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.874 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 26.6 tp -61.87 -45.78 92.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.817 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . 0.464 ' O ' ' CB ' ' D' ' 50' ' ' SER . 27.5 t70 -55.66 -43.19 76.06 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.611 -0.436 . . . . 0.0 109.925 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . 0.513 ' NH1' ' OD2' ' C' ' 44' ' ' ASP . 67.5 ttt180 -61.97 -51.38 68.31 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.596 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . 0.412 HD23 ' HB3' ' D' ' 45' ' ' ARG . 0.1 OUTLIER -124.1 124.69 43.07 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 120.95 0.405 . . . . 0.0 110.207 179.177 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -174.61 -43.8 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.513 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . 0.428 ' CD2' ' O ' ' D' ' 48' ' ' PHE . 72.4 t80 -165.81 63.93 0.11 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.307 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? 54.52 40.19 31.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.182 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 7.4 t -62.15 -51.06 69.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.086 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 78.0 mt -48.51 -35.71 6.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.183 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 52' ' ' TYR . . . . . 0.501 ' CE2' ' OE2' ' D' ' 56' ' ' GLU . 90.6 t80 -71.44 -30.13 65.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.101 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -70.35 -43.18 70.75 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.974 0.416 . . . . 0.0 110.452 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . 0.445 ' CB ' ' NH2' ' A' ' 45' ' ' ARG . 72.9 m-85 -71.6 -39.89 70.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.727 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -66.11 -40.95 91.11 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.477 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 56' ' ' GLU . . . . . 0.501 ' OE2' ' CE2' ' D' ' 52' ' ' TYR . 12.7 pt-20 -74.41 -38.33 63.12 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.454 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 -61.1 -46.15 91.81 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.119 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.46 -26.95 71.12 Favored Glycine 0 N--CA 1.462 0.406 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.16 75.18 1.28 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 53.2 tttp . . . . . 0 C--N 1.332 -0.158 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.48 -179.709 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo . . . . . 0 N--CA 1.494 1.548 0 N-CA-C 111.306 -0.305 . . . . 0.0 111.306 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.468 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 20.2 tp -62.88 -48.28 79.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.97 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.55 -45.34 92.09 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 97.4 t -63.01 -28.32 44.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.379 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 26' ' ' LEU . . . -68.6 -36.43 78.68 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.35 -45.51 65.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.281 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.8 p -68.63 -44.58 73.89 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.243 -0.583 . . . . 0.0 111.754 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.421 HG23 ' N ' ' A' ' 33' ' ' ILE . 10.3 tp -68.48 -40.44 82.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.6 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.421 ' N ' HG23 ' A' ' 32' ' ' ILE . 14.1 tt -71.27 -33.56 51.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.607 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.45 -51.64 20.5 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.35 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.417 HG23 ' N ' ' A' ' 36' ' ' LEU . 10.4 tp -63.31 -38.32 81.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.553 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.417 ' N ' HG23 ' A' ' 35' ' ' ILE . 56.1 tp -65.9 -32.79 74.5 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.888 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 -67.81 -52.07 41.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.833 0.349 . . . . 0.0 110.602 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 30.4 tp -61.14 -52.17 65.97 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.426 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 74.1 mt -61.72 -42.25 93.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.979 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 34.8 tp -60.91 -41.93 97.06 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.343 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.4 t-105 -63.9 -59.53 4.4 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 120.973 0.416 . . . . 0.0 111.553 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 96.3 mt -56.59 -54.41 29.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.606 -177.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.519 HD23 ' O ' ' A' ' 43' ' ' LEU . 0.7 OUTLIER -60.24 -45.47 93.11 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.691 -179.037 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -51.02 -41.38 59.77 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -65.04 -50.48 66.05 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.134 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.475 ' O ' ' O ' ' A' ' 43' ' ' LEU . 0.7 OUTLIER -92.63 131.29 37.85 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.074 -179.434 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.436 ' CD2' ' N ' ' A' ' 48' ' ' PHE . 73.6 t80 -163.55 -94.97 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.858 0.361 . . . . 0.0 110.564 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.436 ' N ' ' CD2' ' A' ' 47' ' ' PHE . 57.6 t80 -132.6 57.8 1.78 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.821 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.2 tttt 71.14 25.67 3.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.721 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.9 t -59.21 -43.19 92.29 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.571 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 56.9 mt -45.04 -41.65 2.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.604 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -74.11 -27.94 61.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.023 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.532 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 90.9 mtt-85 -71.2 -48.57 50.77 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.598 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -71.5 -41.18 69.59 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.052 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -67.53 -38.69 84.59 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.731 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.542 ' OE2' ' CD2' ' A' ' 57' ' ' HIS . 1.8 pp20? -76.65 -42.31 42.44 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.067 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.542 ' CD2' ' OE2' ' A' ' 56' ' ' GLU . 24.9 m80 -61.11 -45.66 93.77 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.552 -0.459 . . . . 0.0 109.907 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.982 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 -179.915 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.731 0.301 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -50.74 -36.68 52.25 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.618 2.212 . . . . 0.0 111.537 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.42 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 15.0 tp -60.6 -52.38 65.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.798 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.53 -42.99 93.53 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 93.8 t -62.51 -33.89 61.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -63.74 -34.49 78.0 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.28 -47.01 63.16 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.397 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 6.3 p -65.21 -48.13 74.44 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.234 -0.586 . . . . 0.0 111.524 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.51 HG23 ' N ' ' B' ' 33' ' ' ILE . 10.4 tp -65.55 -44.32 93.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -178.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.51 ' N ' HG23 ' B' ' 32' ' ' ILE . 15.1 tt -66.67 -33.49 63.79 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.066 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.248 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.48 -45.3 86.52 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 91.2 mt -61.57 -44.54 98.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 14.1 tp -61.06 -36.1 78.7 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.312 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . 0.585 ' NE2' ' CE1' ' C' ' 37' ' ' HIS . 7.5 t-80 -67.34 -50.33 60.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.782 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 22.7 tp -63.66 -52.43 60.78 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.778 -178.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.431 ' CD1' ' N ' ' B' ' 39' ' ' ILE . 1.4 mp -61.15 -43.03 95.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.071 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 43.0 tp -61.21 -37.5 83.25 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.311 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 32.5 t-105 -63.3 -56.69 14.34 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.662 0.268 . . . . 0.0 111.291 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 68.2 mt -60.92 -53.46 48.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 C-N-CA 120.231 -0.588 . . . . 0.0 111.714 -178.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.539 HD23 ' O ' ' B' ' 43' ' ' LEU . 0.9 OUTLIER -57.33 -45.02 84.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.94 -179.021 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -58.97 -45.5 90.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.833 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 57.8 ttt85 -59.74 -52.75 64.14 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 120.181 -0.607 . . . . 0.0 111.059 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.23 112.13 24.11 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.953 0.406 . . . . 0.0 110.166 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -165.78 79.23 0.28 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.252 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 34.0 t80 62.11 55.28 2.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.745 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 74.7 tttt 60.24 50.15 6.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.818 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 5.8 t -70.71 -44.42 66.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.602 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 64.5 mt -44.38 -35.87 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.656 0.265 . . . . 0.0 111.228 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -70.34 -28.19 64.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.482 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 78.3 mtt85 -68.64 -42.39 78.07 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.378 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -72.73 -42.23 64.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.783 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -63.93 -39.88 95.18 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.632 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -76.72 -38.36 54.44 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.697 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -59.56 -44.82 93.17 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.656 -0.418 . . . . 0.0 109.926 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.98 -24.03 53.22 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' B' ' 60' ' ' LYS . 1.6 tt -131.0 52.01 2.09 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 -178.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' B' ' 59' ' ' LEU . 16.2 ptpt . . . . . 0 N--CA 1.474 0.751 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.524 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 37.3 t . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 46.15 75.3 0.67 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.709 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -51.55 -33.48 48.15 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.483 2.122 . . . . 0.0 111.432 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.15 -47.88 82.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.739 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.44 -39.18 60.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.726 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 80.7 t -59.78 -44.29 93.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.01 -33.51 72.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.405 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.14 -44.01 80.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.209 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 8.0 p -67.51 -47.54 69.67 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 18.6 tt -66.52 -38.19 81.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.979 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 70.0 mt -68.13 -42.22 84.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.005 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.7 -50.04 45.24 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 121.062 -0.59 . . . . 0.0 111.677 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.71 -43.53 98.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.89 0.376 . . . . 0.0 110.257 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 56.8 tp -63.55 -37.98 89.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.248 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . 0.585 ' CE1' ' NE2' ' B' ' 37' ' ' HIS . 12.3 t-80 -66.09 -48.4 71.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.808 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 41.3 tp -67.07 -55.23 15.2 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.84 0.352 . . . . 0.0 111.697 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . 0.427 ' N ' ' CD1' ' C' ' 39' ' ' ILE . 1.3 mp -59.35 -45.46 93.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.487 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 44.7 tp -62.03 -41.89 98.59 Favored 'General case' 0 C--O 1.218 -0.564 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.983 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 16.0 t-105 -57.16 -59.53 4.96 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 120.812 0.339 . . . . 0.0 111.488 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 34.8 mt -62.88 -57.1 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.344 -0.542 . . . . 0.0 112.315 -177.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.48 HD23 ' O ' ' C' ' 43' ' ' LEU . 0.6 OUTLIER -57.17 -51.84 67.72 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.519 -177.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -53.29 -41.89 66.05 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 18.5 tpt85 -58.39 -52.35 65.97 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.729 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' C' ' 48' ' ' PHE . 1.9 mt -82.25 -72.7 0.43 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.0 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 82.2 t80 57.76 -77.91 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.314 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . 0.537 ' N ' ' O ' ' C' ' 46' ' ' LEU . 84.7 t80 -158.84 -40.19 0.06 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.065 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -173.59 31.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.089 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . 0.429 ' OG ' ' CD1' ' C' ' 54' ' ' PHE . 35.8 t -63.73 -39.78 95.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.139 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 40.3 mt -46.6 -50.86 5.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.613 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -73.6 -32.18 63.97 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -72.03 -49.76 34.12 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.644 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . 0.429 ' CD1' ' OG ' ' C' ' 50' ' ' SER . 10.8 m-85 -66.44 -42.17 88.06 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.29 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -64.56 -37.67 88.35 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.903 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 . . . . . 0 CA--C 1.536 0.434 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.465 179.399 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . 0.404 ' O ' ' HB2' ' D' ' 29' ' ' ALA . 64.0 Cg_exo . . . . . 0 N--CA 1.488 1.173 0 N-CA-C 110.405 -0.652 . . . . 0.0 110.405 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 16.8 tp -65.18 -45.28 85.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.321 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.75 -61.09 2.65 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 87.0 t -50.44 -43.36 22.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.734 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' D' ' 25' ' ' PRO . . . -53.57 -45.3 69.89 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.015 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.83 -40.87 98.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.984 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 2.5 t -61.44 -52.04 66.22 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.613 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 14.8 tt -64.93 -30.93 51.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.623 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 39.3 mt -66.35 -44.24 90.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.927 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.49 -50.53 43.02 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.982 -0.628 . . . . 0.0 111.975 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . 0.402 ' CG2' ' N ' ' D' ' 36' ' ' LEU . 4.5 tt -58.22 -43.15 85.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.001 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.402 ' N ' ' CG2' ' D' ' 35' ' ' ILE . 7.4 tp -69.22 -27.64 65.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.503 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -67.78 -56.04 10.73 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.187 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 3.5 pp -68.87 -34.69 75.87 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.854 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 52.9 mt -62.77 -45.12 99.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 120.311 -0.556 . . . . 0.0 109.778 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 36.8 mt -64.01 -41.55 97.42 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.471 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 9.2 t-105 -59.96 -58.0 10.43 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.332 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 79.0 mt -59.92 -53.5 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.406 -177.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 28.8 tp -59.96 -44.14 94.61 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.82 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . 0.436 ' O ' ' CB ' ' D' ' 50' ' ' SER . 26.6 t70 -55.95 -46.15 78.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.126 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 56.3 ttt85 -60.49 -50.67 72.65 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.868 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 pp -125.4 127.93 47.34 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.145 0.498 . . . . 0.0 110.796 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -174.77 -42.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.092 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -171.66 63.46 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.234 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 55.7 mttm 58.23 37.81 26.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.226 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 10.8 t -59.29 -50.29 74.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.835 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 68.1 mt -50.56 -41.44 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.607 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -72.2 -31.38 65.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.084 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -70.96 -47.04 61.21 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.001 0.429 . . . . 0.0 110.601 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -69.71 -36.32 75.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.676 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -68.92 -40.74 78.89 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.5 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -75.78 -33.44 60.18 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.481 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -66.43 -47.34 73.5 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.694 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.23 -36.37 93.32 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 110.641 -0.983 . . . . 0.0 110.641 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 mp -74.9 -67.43 0.64 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt . . . . . 0 N--CA 1.462 0.14 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.397 179.753 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo . . . . . 0 N--CA 1.492 1.424 0 N-CA-C 111.025 -0.413 . . . . 0.0 111.025 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.5 tp -64.23 -48.72 74.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.041 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -65.32 -50.23 66.44 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.296 0.57 . . . . 0.0 109.739 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 82.3 t -57.95 -44.67 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.94 -36.52 67.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.514 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -63.04 -51.29 67.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.536 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.3 p -56.53 -50.07 72.92 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.912 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.6 mm -61.18 -32.16 52.12 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.99 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.2 mm -69.75 -40.13 78.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.223 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.43 -53.13 26.65 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.311 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 40.9 mm -62.12 -44.03 98.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 C-N-CA 120.461 -0.495 . . . . 0.0 110.306 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 47.4 tp -57.84 -47.92 81.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.568 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.474 ' C ' ' ND1' ' A' ' 37' ' ' HIS . 5.0 t-80 -60.16 -47.91 83.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.085 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 42.7 tp -55.66 -51.91 65.63 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.182 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.5 tt -64.17 -32.85 59.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.456 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.501 HD13 ' O ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -63.14 -47.96 80.53 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.419 -179.254 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 14.2 t-105 -63.44 -55.27 25.55 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 120.614 0.245 . . . . 0.0 111.551 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 88.8 mt -58.91 -52.74 56.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.34 -0.544 . . . . 0.0 112.124 -177.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.423 HD11 ' CD1' ' A' ' 47' ' ' PHE . 22.6 tp -62.43 -44.08 97.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.391 -178.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -57.01 -43.37 81.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.764 0.316 . . . . 0.0 110.171 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.516 ' NH1' HD11 ' A' ' 51' ' ' ILE . 57.0 ttt-85 -63.95 -48.67 75.58 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.471 -0.491 . . . . 0.0 110.725 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.6 pp -127.71 127.33 43.5 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.031 0.443 . . . . 0.0 110.8 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.423 ' CD1' HD11 ' A' ' 43' ' ' LEU . 61.4 t80 -174.03 -39.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.233 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.523 ' O ' ' NH1' ' A' ' 53' ' ' ARG . 63.8 t80 -172.08 61.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.213 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm 60.13 37.66 20.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.162 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.0 t -61.7 -47.7 84.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.752 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.516 HD11 ' NH1' ' A' ' 45' ' ' ARG . 16.2 mt -49.44 -37.2 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.493 ' CE2' ' OE2' ' A' ' 56' ' ' GLU . 92.5 t80 -72.69 -30.16 63.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.241 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.523 ' NH1' ' O ' ' A' ' 48' ' ' PHE . 93.9 mtm-85 -71.77 -46.78 57.25 Favored 'General case' 0 N--CA 1.461 0.102 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.54 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -70.47 -37.8 74.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.863 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -69.76 -38.85 76.92 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.696 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.493 ' OE2' ' CE2' ' A' ' 52' ' ' TYR . 12.2 pt-20 -76.57 -38.85 54.29 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.91 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.523 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 6.8 m-70 -66.45 -42.63 87.33 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.738 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.909 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -179.924 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 . . . . . 0 CA--C 1.537 0.466 0 CA-C-O 119.905 -0.093 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -48.56 -36.7 32.39 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.873 1.715 . . . . 0.0 111.723 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.546 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 17.6 tp -61.14 -51.22 70.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.222 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.37 -45.52 84.35 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 84.4 t -59.48 -32.82 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.557 -0.747 . . . . 0.0 108.999 178.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -62.39 -37.43 85.73 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.05 -49.99 65.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.831 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 4.8 t -60.07 -50.56 73.24 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 20.4 tt -63.65 -35.04 71.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.36 -178.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 45.7 mt -69.05 -37.85 77.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.392 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.77 -56.2 8.62 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.506 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.479 HD12 ' N ' ' B' ' 36' ' ' LEU . 2.3 pp -56.44 -40.07 65.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.387 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.479 ' N ' HD12 ' B' ' 35' ' ' ILE . 54.7 tp -65.34 -34.41 78.26 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.388 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -66.45 -53.54 34.28 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.449 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 29.7 tp -66.32 -50.16 64.58 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.649 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 74.2 mt -59.74 -44.88 94.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.663 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 49.7 tp -64.04 -37.61 88.06 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.032 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . 0.45 ' CZ3' ' CZ2' ' C' ' 41' ' ' TRP . 23.1 t-105 -59.66 -52.32 66.01 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.543 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.6 mt -71.9 -56.83 8.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 120.079 -0.649 . . . . 0.0 111.674 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.498 HD23 ' O ' ' B' ' 43' ' ' LEU . 0.8 OUTLIER -50.67 -46.61 58.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.865 -179.066 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -67.94 -40.92 83.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.761 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 53.5 ttt85 -51.75 -51.83 53.24 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.813 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.72 -82.8 0.25 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.494 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.449 ' O ' ' CD1' ' B' ' 48' ' ' PHE . 60.5 t80 57.51 -87.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.501 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . 0.449 ' CD1' ' O ' ' B' ' 47' ' ' PHE . 34.1 m-85 -153.44 86.38 1.21 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.037 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 65.9 mttm 51.76 34.51 13.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.362 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 7.9 t -58.98 -47.07 86.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.405 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 53.4 mt -49.83 -50.8 17.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.909 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -71.41 -32.66 68.67 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.693 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -71.52 -43.74 65.92 Favored 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.017 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -71.41 -39.49 71.09 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.756 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . 0.413 ' CD1' ' C ' ' B' ' 55' ' ' PHE . 24.3 t80 -70.2 -39.11 75.38 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.816 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -76.66 -35.91 57.68 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 120.424 -0.511 . . . . 0.0 110.729 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -67.3 -49.19 65.17 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.511 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.94 -28.6 68.9 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 7.8 tp -72.51 -68.92 0.44 Allowed 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.742 0.306 . . . . 0.0 110.527 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 55.4 tttp . . . . . 0 N--CA 1.467 0.375 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.405 179.814 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 13.7 m . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -158.43 72.75 3.86 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.83 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -50.91 -30.52 30.61 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.538 2.158 . . . . 0.0 111.269 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . 0.489 ' O ' ' HB3' ' C' ' 29' ' ' ALA . 16.6 tp -55.48 -51.68 66.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.045 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.69 -47.62 85.44 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 99.3 t -59.58 -29.98 43.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' C' ' 26' ' ' LEU . . . -66.82 -35.61 80.45 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.15 -42.38 76.03 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.337 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 3.9 p -69.9 -46.22 65.91 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.72 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . 0.419 HG23 ' N ' ' C' ' 33' ' ' ILE . 10.1 tt -67.66 -40.18 83.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.524 -178.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . 0.419 ' N ' HG23 ' C' ' 32' ' ' ILE . 8.0 tt -69.33 -35.17 66.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.502 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.77 -53.24 20.76 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.272 -0.966 . . . . 0.0 110.953 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 96.8 mt -57.86 -42.87 83.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.306 -0.558 . . . . 0.0 109.977 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 15.0 tp -61.83 -39.45 91.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.101 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -61.52 -50.66 71.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.887 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 10.4 mp -60.52 -48.6 81.08 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.403 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 71.8 mt -59.95 -44.72 95.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.133 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.5 mt -62.44 -39.39 93.17 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.336 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . 0.45 ' CZ2' ' CZ3' ' B' ' 41' ' ' TRP . 24.3 t-105 -60.52 -57.67 11.76 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 120.89 0.376 . . . . 0.0 111.248 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 72.0 mt -60.64 -56.36 18.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.129 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.469 HD23 ' O ' ' C' ' 43' ' ' LEU . 0.7 OUTLIER -57.42 -50.99 71.24 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.773 -178.451 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -51.23 -42.59 61.09 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -59.07 -53.31 59.83 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.511 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' C' ' 48' ' ' PHE . 3.4 mt -79.71 -72.45 0.4 Allowed 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.949 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 75.3 t80 50.0 -88.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.272 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . 0.503 ' N ' ' O ' ' C' ' 46' ' ' LEU . 55.5 t80 -161.13 89.96 0.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.3 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 74.1 tttt 54.92 22.33 4.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.065 0.459 . . . . 0.0 110.027 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 11.3 t -61.1 -38.68 87.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.078 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 51' ' ' ILE . . . . . 0.404 ' H ' HG13 ' C' ' 51' ' ' ILE . 67.4 mt -48.68 -53.91 5.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.755 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -75.09 -33.6 61.65 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 20.0 mmt85 -69.93 -48.83 56.92 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.837 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -69.93 -39.95 75.81 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.302 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -62.13 -41.33 98.16 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.818 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 . . . . . 0 CA--C 1.535 0.388 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.892 179.506 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo . . . . . 0 N--CA 1.49 1.303 0 N-CA-C 110.693 -0.541 . . . . 0.0 110.693 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . 0.402 ' O ' ' HB3' ' D' ' 29' ' ' ALA . 16.4 tp -62.89 -50.55 70.45 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.78 -46.16 88.15 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 92.0 t -59.77 -37.25 70.55 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.343 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' D' ' 26' ' ' LEU . . . -61.37 -37.07 82.03 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.45 -50.11 66.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.773 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 4.0 t -60.78 -51.47 69.19 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 7.3 tp -62.26 -35.71 70.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.582 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 26.5 mt -63.23 -44.58 99.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.736 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.49 -45.5 94.67 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.755 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 88.3 mt -62.39 -43.5 98.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.784 0.326 . . . . 0.0 110.525 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 18.1 tp -65.18 -33.2 75.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.326 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -68.13 -50.65 53.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.897 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 55.9 tp -61.28 -47.93 83.74 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.802 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 95.8 mt -61.91 -43.82 98.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.856 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' D' ' 40' ' ' LEU . 20.0 mt -59.62 -49.4 77.9 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.452 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 11.9 t-105 -58.41 -58.86 6.66 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.929 0.395 . . . . 0.0 111.705 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 73.1 mt -57.89 -60.4 2.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 27.6 tp -57.18 -46.56 82.7 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.447 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -50.98 -45.98 61.16 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.633 -0.427 . . . . 0.0 109.926 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . 0.413 ' O ' ' CG1' ' D' ' 51' ' ' ILE . 70.0 ttt180 -64.56 -56.85 11.35 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 119.914 -0.715 . . . . 0.0 111.394 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . 0.429 HD23 ' N ' ' D' ' 46' ' ' LEU . 0.1 OUTLIER -91.36 114.82 27.45 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.021 -179.872 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 47' ' ' PHE . . . . . 0.569 ' O ' ' N ' ' D' ' 49' ' ' LYS . 77.0 t80 -172.92 90.22 0.09 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.073 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 57.94 -73.49 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.45 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . 0.569 ' N ' ' O ' ' D' ' 47' ' ' PHE . 10.7 ttpp -165.58 37.46 0.06 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.884 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . 0.532 ' O ' ' N ' ' D' ' 53' ' ' ARG . 13.0 t -62.77 -45.06 94.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.082 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 51' ' ' ILE . . . . . 0.413 ' CG1' ' O ' ' D' ' 45' ' ' ARG . 23.6 mt -41.25 -30.35 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.869 0.366 . . . . 0.0 110.487 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 52' ' ' TYR . . . . . 0.518 ' CE2' ' OE1' ' D' ' 56' ' ' GLU . 85.7 t80 -74.12 -33.84 63.72 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.34 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 53' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' D' ' 50' ' ' SER . 6.9 ptm180 -69.64 -40.14 76.68 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.351 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -72.71 -41.92 64.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.884 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -65.74 -40.18 91.86 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.459 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 56' ' ' GLU . . . . . 0.518 ' OE1' ' CE2' ' D' ' 52' ' ' TYR . 10.8 pt-20 -75.85 -38.81 57.61 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.796 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -61.51 -43.99 97.87 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 120.876 -0.329 . . . . 0.0 110.34 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.84 -27.82 71.75 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 7.9 tp -84.09 -75.75 0.33 Allowed 'General case' 0 C--O 1.231 0.087 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.615 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt . . . . . 0 N--CA 1.467 0.422 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.539 179.799 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo . . . . . 0 N--CA 1.492 1.43 0 N-CA-C 111.217 -0.34 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 22.0 tp -61.54 -50.49 72.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.969 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.74 -46.75 88.26 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.271 0.558 . . . . 0.0 109.551 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 92.4 t -59.03 -41.44 83.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.51 -31.36 71.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.757 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.95 -43.52 71.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.649 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.7 t -66.18 -43.32 87.22 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.914 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 38.4 mm -67.24 -42.42 87.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.684 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.2 tt -71.15 -33.38 50.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.721 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.13 -52.0 15.65 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.315 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.418 HG23 ' N ' ' A' ' 36' ' ' LEU . 20.2 tt -63.16 -39.57 85.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.695 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.418 ' N ' HG23 ' A' ' 35' ' ' ILE . 47.1 tp -66.63 -32.39 73.69 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.086 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -68.34 -49.6 59.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.675 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.6 tp -63.31 -51.93 64.02 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.222 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 81.1 mt -61.79 -42.92 96.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.947 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.5 tt -63.56 -37.75 88.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.624 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 41.6 t-105 -65.11 -54.66 26.47 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.034 0.445 . . . . 0.0 111.305 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.553 ' CG2' ' N ' ' A' ' 43' ' ' LEU . 5.9 tt -63.74 -51.26 72.2 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.646 -177.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.553 ' N ' ' CG2' ' A' ' 42' ' ' ILE . 29.6 tp -63.21 -48.85 76.55 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.008 -177.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' A' ' 44' ' ' ASP . 60.2 t0 -51.59 -38.9 56.63 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.417 ' NH2' ' CB ' ' D' ' 54' ' ' PHE . 64.3 ttt180 -64.76 -52.24 58.02 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.522 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 48' ' ' PHE . 5.3 mt -86.31 -76.67 0.34 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 119.934 -0.706 . . . . 0.0 110.817 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 69.5 t80 51.4 -86.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.892 0.377 . . . . 0.0 110.373 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.515 ' N ' ' O ' ' A' ' 46' ' ' LEU . 38.5 t80 -158.31 90.58 1.04 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.142 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm 52.11 17.01 0.62 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.116 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.9 t -51.7 -41.87 61.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.612 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 35.7 mt -48.18 -41.63 10.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.055 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -71.41 -30.14 65.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.295 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.51 ' O ' ' CG ' ' A' ' 57' ' ' HIS . 1.8 mpt_? -66.8 -45.03 79.67 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.074 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -70.96 -38.62 72.81 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.479 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -63.55 -40.48 97.11 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.646 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -77.0 -40.19 47.55 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.789 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.51 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 56.0 m170 -57.4 -50.47 72.89 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.202 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.632 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 179.478 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 5.9 t0 . . . . . 0 CA--C 1.532 0.252 0 CA-C-O 121.035 0.445 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -48.13 -27.89 9.97 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.031 1.82 . . . . 0.0 111.092 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.412 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 1.7 pp -72.79 -31.2 64.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.894 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.9 -39.71 66.02 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.972 0.415 . . . . 0.0 109.999 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 94.2 t -60.23 -43.64 93.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -56.97 -35.57 69.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.391 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.13 -49.81 66.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.878 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 22.2 p -59.16 -51.19 71.07 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 19.1 tt -65.39 -33.75 65.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.295 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 28.9 mt -67.34 -37.36 78.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.766 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.85 -51.38 24.73 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 83.3 mt -58.14 -49.29 82.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.412 0.625 . . . . 0.0 109.734 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 12.1 tp -58.53 -39.89 81.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.318 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -61.41 -48.35 81.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.58 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 10.1 mp -63.57 -51.05 67.04 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.832 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 mp -61.38 -46.05 97.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.076 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -63.16 -37.12 85.95 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.058 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 15.4 t-105 -60.85 -57.5 12.39 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.154 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 68.8 mt -61.88 -55.38 24.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.8 -177.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.491 HD23 ' O ' ' B' ' 43' ' ' LEU . 0.7 OUTLIER -56.4 -50.61 71.12 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.044 -178.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -55.74 -39.64 71.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.245 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -59.73 -53.46 57.77 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.678 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' B' ' 48' ' ' PHE . 0.9 OUTLIER -80.93 -72.81 0.4 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.52 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.432 ' CD2' ' N ' ' B' ' 48' ' ' PHE . 84.7 t80 47.24 -88.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.569 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . 0.517 ' N ' ' O ' ' B' ' 46' ' ' LEU . 80.7 t80 -154.36 84.5 1.12 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.325 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 62.4 mttp 48.73 27.36 1.51 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.439 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 16.0 p -63.49 -34.76 78.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.689 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . 0.423 ' H ' HG13 ' B' ' 51' ' ' ILE . 21.2 mt -49.88 -46.6 22.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.662 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.515 ' CD2' ' OE1' ' B' ' 56' ' ' GLU . 64.5 t80 -72.45 -27.88 62.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.553 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -70.8 -45.27 64.94 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.631 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -72.89 -41.57 64.5 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.561 -0.455 . . . . 0.0 110.75 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -66.01 -39.69 90.47 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.545 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . 0.515 ' OE1' ' CD2' ' B' ' 52' ' ' TYR . 9.6 pt-20 -75.6 -39.28 58.19 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.571 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -61.22 -41.79 97.47 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.621 -0.431 . . . . 0.0 110.092 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.31 -32.4 76.81 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 25.0 tp -63.25 -52.56 61.61 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.074 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt . . . . . 0 C--N 1.332 -0.157 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.569 179.982 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 36.8 p . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 46.22 74.75 0.75 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.73 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.62 -29.27 32.09 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.605 2.204 . . . . 0.0 111.378 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . 0.583 HD13 ' HB2' ' D' ' 31' ' ' SER . 3.7 pp -65.18 -35.46 81.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.786 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.22 -49.44 33.08 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.123 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 61.3 t -55.53 -36.45 41.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' C' ' 26' ' ' LEU . . . -63.3 -33.94 76.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.546 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.76 -40.1 79.91 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.853 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 3.3 t -69.14 -54.0 17.2 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.488 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . 0.443 HG23 ' N ' ' C' ' 33' ' ' ILE . 17.5 tt -60.98 -40.87 86.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.53 -178.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . 0.443 ' N ' HG23 ' C' ' 32' ' ' ILE . 13.6 tt -70.98 -31.21 44.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.609 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.08 -51.95 30.76 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.242 -0.98 . . . . 0.0 111.084 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.59 -34.71 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 C-N-CA 120.173 -0.611 . . . . 0.0 109.943 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 46.0 tp -64.89 -39.68 93.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.359 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -68.29 -49.67 58.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.513 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 34.9 tp -61.01 -51.87 67.41 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.226 0.536 . . . . 0.0 111.253 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 1.2 mp -60.58 -43.29 94.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.262 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' C' ' 40' ' ' LEU . 18.6 mt -61.04 -40.5 93.85 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.935 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 18.0 t-105 -59.43 -58.11 10.03 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.366 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 56.1 mt -62.33 -54.94 27.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.497 HD23 ' O ' ' C' ' 43' ' ' LEU . 0.7 OUTLIER -59.94 -49.28 78.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.472 -178.183 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . 0.484 ' O ' ' CB ' ' C' ' 50' ' ' SER . 61.2 t0 -57.81 -42.4 84.18 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.655 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . 0.507 ' NH1' ' CD1' ' C' ' 51' ' ' ILE . 3.2 tpt85 -61.04 -52.74 63.69 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.204 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' C' ' 43' ' ' LEU . 0.1 OUTLIER -118.31 137.37 53.12 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.039 0.447 . . . . 0.0 110.661 179.538 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -172.59 -38.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.107 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -172.67 -46.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.312 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 45.0 tttt -173.89 39.67 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.846 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' C' ' 44' ' ' ASP . 47.9 t -65.31 -51.61 59.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.807 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 51' ' ' ILE . . . . . 0.507 ' CD1' ' NH1' ' C' ' 45' ' ' ARG . 96.0 mt -43.39 -40.89 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.677 0.275 . . . . 0.0 111.215 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -73.62 -28.52 61.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.6 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 56.8 ttm-85 -69.71 -49.35 54.18 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.052 0.453 . . . . 0.0 110.246 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -69.08 -42.6 75.97 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.702 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -63.22 -37.02 85.61 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.792 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 . . . . . 0 CA--C 1.536 0.423 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.739 179.418 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo . . . . . 0 N--CA 1.492 1.413 0 N-CA-C 110.647 -0.559 . . . . 0.0 110.647 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . 0.403 ' O ' ' HB3' ' D' ' 29' ' ' ALA . 17.8 tp -59.11 -49.83 76.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.231 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 27' ' ' ALA . . . . . 0.443 ' HB1' HD11 ' C' ' 26' ' ' LEU . . . -58.03 -53.81 54.04 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 83.5 t -52.43 -43.88 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.463 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' D' ' 26' ' ' LEU . . . -53.8 -42.55 68.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.227 0.537 . . . . 0.0 109.924 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.61 -42.54 98.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.792 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . 0.583 ' HB2' HD13 ' C' ' 26' ' ' LEU . 6.3 t -61.68 -52.64 63.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.841 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 13.6 tt -64.01 -31.08 51.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.574 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 33.2 mt -67.21 -40.88 85.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.488 -0.485 . . . . 0.0 109.725 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.39 -52.05 33.49 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 120.991 -0.623 . . . . 0.0 111.64 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 4.3 mm -60.23 -43.85 94.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.109 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 47.0 tp -62.23 -38.61 89.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.346 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -63.96 -51.23 65.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.849 0.356 . . . . 0.0 110.908 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 50.5 tp -58.12 -45.56 87.07 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.513 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 97.4 mt -62.36 -40.16 86.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.628 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . 0.517 ' O ' HD13 ' D' ' 40' ' ' LEU . 0.2 OUTLIER -61.84 -44.03 97.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.18 -179.401 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 28.2 t-105 -63.83 -56.36 16.0 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.736 0.303 . . . . 0.0 111.782 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 74.3 mt -58.71 -53.43 47.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.244 -0.435 . . . . 0.0 112.017 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 36.9 tp -61.55 -46.73 88.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.733 0.301 . . . . 0.0 111.089 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -52.99 -46.8 68.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.295 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -63.19 -50.69 69.34 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.89 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.17 123.99 46.86 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.974 0.416 . . . . 0.0 110.33 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -172.27 -47.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.246 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -172.08 71.12 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.275 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt 54.29 33.37 18.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.289 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 9.7 t -57.77 -50.09 74.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.745 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 55.5 mt -52.56 -44.23 44.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.598 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -71.91 -30.59 65.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.27 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -71.22 -44.15 65.94 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.892 0.377 . . . . 0.0 110.747 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . 0.417 ' CB ' ' NH2' ' A' ' 45' ' ' ARG . 50.9 m-85 -71.92 -38.29 69.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.88 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -69.18 -40.1 78.3 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.652 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -76.62 -36.6 57.37 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.616 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -65.47 -47.51 75.83 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.667 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.54 -28.99 72.23 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 10.6 mp -103.85 65.48 0.82 Allowed 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 86.6 tttt . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.652 -179.817 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo . . . . . 0 N--CA 1.493 1.457 0 N-CA-C 111.163 -0.36 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.3 tp -63.71 -50.56 68.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.218 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -63.18 -44.71 94.64 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.329 0.585 . . . . 0.0 109.917 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.9 t -58.79 -45.89 91.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.259 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.98 -31.38 69.84 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.606 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -66.09 -50.43 64.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.446 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.3 t -58.02 -42.43 85.28 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.402 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.1 mp -65.95 -37.98 81.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.184 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.416 HG21 HD13 ' A' ' 33' ' ' ILE . 2.4 tt -69.03 -36.44 73.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.637 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.43 -52.34 17.27 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.159 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.83 -43.44 91.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.145 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 57.2 tp -64.7 -34.69 78.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.359 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -65.39 -50.33 65.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.844 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.5 mp -62.84 -47.25 84.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.976 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.9 mt -61.62 -44.84 99.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.1 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 35.0 tp -62.86 -43.33 99.09 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.7 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.9 t-105 -62.32 -58.46 7.62 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 120.82 0.343 . . . . 0.0 111.847 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 73.7 mt -59.54 -54.31 36.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.743 -177.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.5 tp -58.34 -50.8 72.34 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.801 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -52.11 -38.85 58.73 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.07 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.435 HH21 ' CB ' ' D' ' 54' ' ' PHE . 54.0 ttt85 -64.65 -54.35 33.23 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.596 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 48' ' ' PHE . 0.1 OUTLIER -91.91 -84.83 0.26 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.862 -179.525 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.421 ' CD2' ' N ' ' A' ' 48' ' ' PHE . 82.2 t80 56.54 -80.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.539 ' N ' ' O ' ' A' ' 46' ' ' LEU . 65.2 t80 -165.64 98.04 0.67 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.375 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt 47.93 33.32 3.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.485 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 53' ' ' ARG . 5.4 t -63.9 -44.15 93.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.89 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.42 HG12 ' H ' ' A' ' 51' ' ' ILE . 6.3 mm -41.93 -43.52 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.488 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.507 ' CE2' ' OE1' ' A' ' 56' ' ' GLU . 90.8 t80 -73.23 -31.22 64.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.352 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.531 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 23.4 mmt180 -70.79 -48.44 54.21 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-O 120.975 0.417 . . . . 0.0 110.541 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -70.05 -35.99 74.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.621 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -68.13 -41.02 82.31 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 120.886 -0.325 . . . . 0.0 111.613 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.507 ' OE1' ' CE2' ' A' ' 52' ' ' TYR . 21.4 pt-20 -76.4 -41.92 46.11 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.119 -0.633 . . . . 0.0 111.02 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.531 ' ND1' ' O ' ' A' ' 53' ' ' ARG . 15.8 m80 -61.95 -51.83 66.5 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.324 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.667 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 179.695 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.61 0.243 . . . . 0.0 110.804 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -50.56 -35.02 44.89 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.502 2.135 . . . . 0.0 111.495 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.501 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 17.8 tp -59.15 -51.49 69.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.975 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.49 -44.52 93.05 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 88.5 t -61.03 -32.64 53.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -64.15 -34.14 77.39 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.03 -46.53 64.86 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.318 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 3.9 m -66.04 -47.3 74.84 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 119.981 -0.688 . . . . 0.0 111.561 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.542 HG23 ' N ' ' B' ' 33' ' ' ILE . 21.1 tt -64.48 -45.19 96.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.738 -178.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.542 ' N ' HG23 ' B' ' 32' ' ' ILE . 16.4 tt -64.86 -34.78 72.62 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.087 0 C-N-CA 119.409 -0.916 . . . . 0.0 109.937 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.49 -46.06 93.36 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 94.3 mt -59.52 -43.3 90.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 37.4 tp -60.01 -40.17 88.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.578 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -66.08 -51.56 56.91 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 31.8 tp -61.95 -51.86 66.39 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 120.865 0.365 . . . . 0.0 111.717 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.413 ' N ' ' CD1' ' B' ' 39' ' ' ILE . 1.3 mp -61.45 -40.52 86.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.021 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 62.9 tp -62.56 -37.32 85.69 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.501 -0.48 . . . . 0.0 109.983 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 39.3 t-105 -64.32 -56.04 17.2 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.637 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 54.6 mt -63.23 -50.84 77.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.424 -0.511 . . . . 0.0 111.769 -177.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.499 HD23 ' O ' ' B' ' 43' ' ' LEU . 0.9 OUTLIER -61.15 -49.3 77.78 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.442 -178.734 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -61.5 -37.44 83.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.693 0.282 . . . . 0.0 110.952 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 50.0 ttt-85 -65.84 -51.02 62.44 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.703 -0.399 . . . . 0.0 112.066 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' B' ' 43' ' ' LEU . 0.6 OUTLIER -123.31 -159.39 0.84 Allowed 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 120.882 0.372 . . . . 0.0 111.58 -179.086 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.464 ' O ' ' CD2' ' B' ' 47' ' ' PHE . 31.1 t80 50.06 19.43 0.48 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.203 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -168.77 -1.67 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.38 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt 44.61 40.24 3.91 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.606 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 2.3 p -62.96 -33.28 75.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.753 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 78.0 mt -47.33 -46.09 9.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.82 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -72.16 -30.0 64.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.439 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.529 ' O ' ' ND1' ' B' ' 57' ' ' HIS . 95.5 mtt-85 -71.54 -45.6 61.89 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.727 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -71.54 -38.34 71.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.911 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -70.03 -39.35 75.81 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.608 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . 0.528 ' OE2' ' CD2' ' B' ' 57' ' ' HIS . 1.2 pp20? -75.75 -39.76 56.62 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.748 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' HIS . . . . . 0.529 ' ND1' ' O ' ' B' ' 53' ' ' ARG . 26.6 m80 -65.16 -45.38 85.17 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.29 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.72 -27.79 73.01 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 9.4 tp -86.17 58.25 4.95 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.897 0.38 . . . . 0.0 110.349 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? . . . . . 0 N--CA 1.466 0.352 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.417 -179.886 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 25.9 t . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 53.46 70.61 1.7 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.676 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -51.74 -38.75 67.36 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.573 2.182 . . . . 0.0 111.565 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . 0.415 ' O ' ' HB3' ' C' ' 29' ' ' ALA . 26.0 tp -57.16 -48.61 78.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.018 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.44 -48.98 77.26 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.389 0.614 . . . . 0.0 109.497 178.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 85.4 t -58.95 -31.67 45.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' C' ' 26' ' ' LEU . . . -66.34 -33.87 76.69 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.15 -43.71 73.78 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.305 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 4.4 p -69.58 -45.92 67.55 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 119.972 -0.691 . . . . 0.0 111.616 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 13.5 tt -67.87 -39.72 82.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.563 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . 0.402 HG21 HD13 ' C' ' 33' ' ' ILE . 7.6 tt -70.01 -35.91 66.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.784 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.67 -51.42 25.42 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 120.413 -0.898 . . . . 0.0 111.202 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 94.0 mt -61.21 -46.3 96.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.551 -0.46 . . . . 0.0 109.846 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 15.4 tp -58.14 -42.87 86.8 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.894 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -59.72 -51.78 68.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.757 0.313 . . . . 0.0 111.484 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 35.9 tp -57.47 -52.6 64.71 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.751 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . 0.401 ' N ' ' CD1' ' C' ' 39' ' ' ILE . 1.3 mp -61.02 -41.04 87.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.836 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . 0.535 HD13 ' O ' ' C' ' 40' ' ' LEU . 0.2 OUTLIER -59.66 -43.06 94.1 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.746 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 12.9 t-105 -61.45 -58.5 7.91 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.466 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 96.2 mt -55.76 -56.91 9.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.92 -177.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.513 HD23 ' O ' ' C' ' 43' ' ' LEU . 0.6 OUTLIER -59.7 -45.55 91.77 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.881 -178.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -48.55 -46.38 38.8 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 54.9 ttt-85 -64.54 -48.16 76.11 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.94 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . 0.496 ' O ' ' N ' ' C' ' 48' ' ' PHE . 8.2 mt -82.68 4.4 25.11 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.126 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . 0.518 ' O ' ' N ' ' C' ' 49' ' ' LYS . 48.3 t80 -45.34 91.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.86 0.362 . . . . 0.0 110.78 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . 0.496 ' N ' ' O ' ' C' ' 46' ' ' LEU . 88.1 t80 55.47 -81.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.615 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' C' ' 47' ' ' PHE . 76.6 tttt -161.01 39.05 0.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.101 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . 0.432 ' OG ' ' CE2' ' C' ' 54' ' ' PHE . 4.8 t -70.83 -26.14 63.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.465 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 53.0 mt -42.05 -48.02 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.211 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -73.25 -28.73 62.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.398 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 20.0 mmt85 -71.78 -49.3 40.08 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.662 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . 0.432 ' CE2' ' OG ' ' C' ' 50' ' ' SER . 38.0 m-85 -69.46 -39.2 77.87 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.44 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -66.8 -38.04 85.72 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 120.561 -0.455 . . . . 0.0 111.026 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 . . . . . 0 CA--C 1.534 0.336 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.852 179.63 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo . . . . . 0 N--CA 1.491 1.378 0 N-CA-C 110.815 -0.494 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 17.7 tp -63.21 -50.95 68.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.612 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 27' ' ' ALA . . . . . 0.43 ' O ' ' HB3' ' D' ' 30' ' ' ALA . . . -64.75 -47.28 78.77 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.811 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 96.5 t -56.76 -41.74 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.38 -38.94 85.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.471 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' D' ' 27' ' ' ALA . . . -58.69 -50.55 73.45 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.739 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 6.2 t -62.97 -39.76 95.66 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.365 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 5.2 mm -62.42 -48.24 89.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.444 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 18.5 tt -66.84 -31.1 51.97 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.282 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.92 -48.96 57.88 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.222 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 97.2 mt -63.79 -44.49 98.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.065 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 33.9 tp -63.45 -30.68 71.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.012 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -68.68 -51.28 43.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.754 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 43.3 tp -59.5 -48.07 83.06 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.51 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 96.8 mt -61.06 -43.86 97.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.786 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 22.1 mt -61.34 -41.04 96.39 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.351 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 46.7 t-105 -61.61 -54.66 39.96 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.767 0.318 . . . . 0.0 111.556 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 64.1 mt -62.9 -55.78 21.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 120.293 -0.563 . . . . 0.0 112.182 -177.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 43.1 tp -59.06 -50.25 74.79 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.173 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . 0.459 ' O ' ' CB ' ' D' ' 50' ' ' SER . 31.6 t70 -52.72 -44.83 66.64 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.106 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -58.35 -54.84 42.5 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.395 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.13 106.91 15.65 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 120.956 0.408 . . . . 0.0 110.121 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -174.6 94.47 0.08 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.306 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 35.7 t80 59.3 49.53 8.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.536 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? 54.72 52.56 11.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.596 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 11.5 t -62.82 -49.48 74.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.994 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 53.0 mt -45.18 -43.91 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.926 0.393 . . . . 0.0 110.584 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -71.48 -28.09 63.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.65 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 53' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' D' ' 50' ' ' SER . 12.0 ttm180 -70.09 -49.67 48.61 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.035 0.445 . . . . 0.0 110.175 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . 0.435 ' CB ' HH21 ' A' ' 45' ' ' ARG . 55.1 m-85 -65.42 -43.02 91.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.303 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -63.23 -38.36 90.88 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.919 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -76.06 -22.51 55.58 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.615 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -75.07 -54.34 7.32 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.167 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -73.9 -26.12 69.9 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 12.6 tp -146.41 86.91 1.7 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 63.7 mttp . . . . . 0 C--N 1.334 -0.096 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.592 -179.725 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo . . . . . 0 N--CA 1.492 1.428 0 CA-C-O 120.975 0.323 . . . . 0.0 111.297 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.2 tp -62.55 -49.61 74.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.944 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.75 -46.25 88.91 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.0 t -60.05 -40.41 83.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.15 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.73 -30.89 71.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.716 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.61 -51.06 46.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.53 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.1 p -61.76 -36.68 81.72 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.574 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.7 mm -68.4 -41.75 83.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.594 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 33' ' ' ILE . 4.4 tt -70.64 -34.19 56.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.371 -0.531 . . . . 0.0 110.744 -178.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.64 -52.15 13.47 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.697 -0.764 . . . . 0.0 111.389 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.489 HG23 ' N ' ' A' ' 36' ' ' LEU . 15.3 tt -63.17 -44.52 99.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.784 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.489 ' N ' HG23 ' A' ' 35' ' ' ILE . 48.9 tp -59.93 -41.88 92.73 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.811 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 20.9 t-160 -60.07 -49.92 75.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.745 0.307 . . . . 0.0 111.093 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 37.2 tp -59.3 -51.81 68.33 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.925 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.3 mp -61.6 -46.06 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.049 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.575 HD13 ' O ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -59.7 -39.93 86.23 Favored 'General case' 0 C--O 1.218 -0.59 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.297 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 13.5 t-105 -62.64 -57.11 12.22 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.483 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 97.2 mt -56.43 -54.59 26.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.703 -177.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 47' ' ' PHE . 34.5 tp -61.64 -42.5 98.98 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.359 -0.537 . . . . 0.0 110.978 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -51.59 -44.93 62.98 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -63.2 -54.8 31.9 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.246 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 48' ' ' PHE . 5.5 mt -77.15 -77.19 0.15 Allowed 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.777 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.416 ' CD2' ' N ' ' A' ' 48' ' ' PHE . 93.3 t80 53.88 -83.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.788 0.328 . . . . 0.0 110.434 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.533 ' N ' ' O ' ' A' ' 46' ' ' LEU . 81.2 t80 -167.65 86.72 0.24 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.259 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm 59.8 30.44 20.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.339 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.5 t -68.46 -29.18 67.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.621 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.9 mm -44.21 -43.18 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-O 120.989 0.423 . . . . 0.0 110.283 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -74.6 -28.44 60.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.349 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.507 ' O ' ' CG ' ' A' ' 57' ' ' HIS . 98.9 mtt180 -68.28 -49.82 57.89 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.015 0.436 . . . . 0.0 110.46 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -72.39 -40.35 67.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.93 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -63.73 -40.75 97.5 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.617 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -77.16 -41.79 40.32 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.973 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.507 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 6.2 m-70 -56.9 -50.42 72.59 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.277 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.587 0 N-CA-C 110.756 -0.937 . . . . 0.0 110.756 179.426 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.748 0.309 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.412 ' O ' ' N ' ' B' ' 29' ' ' ALA . 53.9 Cg_exo -51.0 -33.66 43.37 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.668 2.245 . . . . 0.0 111.52 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.461 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 19.2 tp -59.7 -50.93 71.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.269 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.52 -42.9 99.5 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.423 ' O ' HG22 ' B' ' 32' ' ' ILE . 82.3 t -63.47 -31.08 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -64.83 -34.9 79.46 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.15 -47.45 61.58 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.385 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 4.8 t -64.83 -48.35 74.67 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.534 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.52 HG23 ' N ' ' B' ' 33' ' ' ILE . 10.7 tp -65.41 -44.48 94.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.966 -178.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.52 ' N ' HG23 ' B' ' 32' ' ' ILE . 15.6 tt -66.18 -32.85 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.975 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.64 -45.84 81.21 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 5.2 mm -60.08 -42.79 91.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 12.0 tp -61.71 -37.4 84.03 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.373 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . 0.458 ' NE2' ' NE2' ' C' ' 37' ' ' HIS . 1.5 t60 -65.66 -53.03 46.83 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 28.6 tp -64.79 -52.38 57.18 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.452 ' CD1' ' N ' ' B' ' 39' ' ' ILE . 1.3 mp -62.05 -47.97 90.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.883 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 41.6 tp -61.2 -35.94 78.53 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.253 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 41.2 t-105 -63.44 -57.16 11.16 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.384 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 73.2 mt -60.93 -53.01 55.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.768 -177.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' B' ' 43' ' ' LEU . 11.1 mt -60.12 -53.31 59.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.421 -178.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . 0.411 ' O ' ' CB ' ' B' ' 50' ' ' SER . 66.2 t0 -57.41 -31.74 66.15 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.158 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -66.36 -50.67 62.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.282 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' B' ' 48' ' ' PHE . 0.1 OUTLIER -110.2 -88.98 0.49 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.821 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 33.9 t80 57.04 -79.37 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.888 0.375 . . . . 0.0 110.414 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . 0.533 ' N ' ' O ' ' B' ' 46' ' ' LEU . 47.7 t80 -138.75 58.53 1.65 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.536 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm 57.15 54.61 6.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.424 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' B' ' 44' ' ' ASP . 39.0 t -65.69 -45.74 81.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.133 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 59.2 mt -46.72 -28.6 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.044 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.49 ' CZ ' ' OE1' ' B' ' 56' ' ' GLU . 60.4 t80 -71.85 -36.94 70.31 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.72 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -70.77 -45.28 65.03 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.881 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . 0.438 ' CD1' ' NH1' ' C' ' 45' ' ' ARG . 61.4 m-85 -70.18 -35.9 74.29 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.923 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -71.17 -39.76 71.68 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.72 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . 0.49 ' OE1' ' CZ ' ' B' ' 52' ' ' TYR . 18.3 pt-20 -76.11 -39.25 55.61 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.871 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -67.48 -43.4 81.06 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.414 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.05 -28.57 72.31 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 10.8 mp -102.69 65.4 0.91 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.537 -179.816 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 15.7 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -158.48 72.66 3.83 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.812 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.2 -32.42 40.37 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.529 2.153 . . . . 0.0 111.461 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 14.2 tp -62.01 -52.04 65.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.1 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 27' ' ' ALA . . . . . 0.43 ' O ' ' HB3' ' C' ' 30' ' ' ALA . . . -61.41 -47.77 84.24 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.03 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 92.4 t -54.6 -50.26 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.54 -44.02 56.25 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.565 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' C' ' 27' ' ' ALA . . . -55.81 -50.35 70.76 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 3.0 t -57.6 -52.27 66.09 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.401 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 21.5 mm -58.88 -30.71 43.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.715 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 50.3 mt -69.03 -40.2 80.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.395 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.81 -52.12 26.26 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 120.657 -0.783 . . . . 0.0 111.81 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . 0.482 ' H ' HD12 ' C' ' 35' ' ' ILE . 3.4 mp -62.52 -44.47 99.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.776 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 54.7 tp -60.48 -39.15 86.63 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.707 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . 0.458 ' NE2' ' NE2' ' B' ' 37' ' ' HIS . 1.1 t60 -61.33 -51.07 70.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.922 0.391 . . . . 0.0 110.794 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.25 -51.93 66.32 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.837 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 26.3 mm -60.52 -41.52 88.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.179 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . 0.526 HD13 ' O ' ' C' ' 40' ' ' LEU . 0.2 OUTLIER -61.56 -41.88 98.01 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.426 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 16.5 t-105 -63.11 -57.55 10.21 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 120.889 0.376 . . . . 0.0 111.414 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 82.3 mt -57.91 -55.6 20.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.877 -177.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.494 HD23 ' O ' ' C' ' 43' ' ' LEU . 0.7 OUTLIER -59.3 -48.78 80.33 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.63 -178.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -49.08 -45.37 43.02 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . 0.455 ' CZ ' HD21 ' C' ' 46' ' ' LEU . 62.4 ttp85 -61.47 -50.89 70.93 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.086 -0.646 . . . . 0.0 110.708 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' C' ' 48' ' ' PHE . 12.4 mt -76.44 -76.89 0.15 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.052 -0.659 . . . . 0.0 111.253 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 69.2 t80 58.32 -78.0 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.428 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . 0.528 ' N ' ' O ' ' C' ' 46' ' ' LEU . 38.7 t80 -169.57 -29.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.336 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . 0.415 ' NZ ' ' CD2' ' C' ' 52' ' ' TYR . 49.8 tttm -173.07 18.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.91 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.08 -32.34 69.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.697 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 35.1 mt -56.38 -54.17 31.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.438 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 52' ' ' TYR . . . . . 0.415 ' CD2' ' NZ ' ' C' ' 49' ' ' LYS . 70.5 t80 -76.87 -33.11 57.87 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 63.6 mmt-85 -66.76 -49.45 65.88 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.635 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -73.67 -39.75 64.21 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.901 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -61.03 -40.72 94.69 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.463 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? . . . . . 0 N--CA 1.463 0.201 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.319 179.417 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo . . . . . 0 N--CA 1.49 1.266 0 N-CA-C 110.394 -0.656 . . . . 0.0 110.394 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 16.2 tp -62.84 -50.33 71.35 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.04 178.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 27' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' D' ' 30' ' ' ALA . . . -60.46 -47.78 84.61 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.78 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 87.1 t -58.2 -50.57 77.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.581 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.33 -42.82 53.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.645 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' D' ' 27' ' ' ALA . . . -57.69 -49.86 75.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.568 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.28 -47.63 80.95 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.534 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 27.2 mm -62.21 -35.09 67.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.861 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 74.5 mt -67.23 -41.75 87.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.696 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.63 -51.34 31.26 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.008 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 14.1 tt -62.63 -39.96 86.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.091 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 52.8 tp -66.35 -34.47 78.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.852 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -65.88 -48.15 72.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.444 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 59.9 tp -63.14 -50.98 68.31 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.162 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 91.8 mt -59.46 -45.93 93.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.995 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 7.7 tp -62.7 -38.02 88.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.339 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 38.9 t-105 -62.23 -52.59 63.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.764 0.316 . . . . 0.0 111.551 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 64.8 mt -66.32 -53.49 35.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -177.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 54.2 tp -60.95 -46.12 91.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.697 0.284 . . . . 0.0 111.308 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . 0.489 ' O ' ' CB ' ' D' ' 50' ' ' SER . 28.1 t70 -59.8 -47.2 86.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.769 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -58.53 -50.19 74.66 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.101 -0.64 . . . . 0.0 111.071 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 2.5 pp -124.49 134.9 52.88 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.898 0.38 . . . . 0.0 110.655 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -168.43 -39.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.346 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -171.17 -36.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.401 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 177.28 26.81 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.899 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 10.3 t -50.22 -54.55 20.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.02 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 87.4 mt -48.93 -40.68 12.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.268 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -73.79 -30.8 62.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.307 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 53' ' ' ARG . . . . . 0.405 ' HE ' ' HA ' ' D' ' 50' ' ' SER . 43.4 mtm180 -67.31 -47.23 71.16 Favored 'General case' 0 CA--C 1.522 -0.097 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.318 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -71.97 -41.51 67.63 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.809 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -59.7 -43.74 93.96 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.368 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -78.21 -31.62 49.49 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.455 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -58.32 -52.16 66.77 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.874 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.82 -35.12 72.6 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.55 23.83 0.61 Allowed 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.181 -179.755 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.426 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 27.2 Cg_endo . . . . . 0 N--CA 1.493 1.496 0 CA-C-O 121.075 0.365 . . . . 0.0 111.26 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.417 ' O ' HD13 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -63.87 -54.52 33.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.875 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.56 ' O ' HD11 ' D' ' 26' ' ' LEU . . . -63.97 -50.41 68.68 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.895 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 87.5 t -55.47 -47.13 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 25' ' ' PRO . . . -54.14 -41.0 67.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.968 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.32 -48.7 80.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.665 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.415 ' HB2' HD13 ' D' ' 26' ' ' LEU . 6.4 t -59.43 -46.23 89.31 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.193 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 43.7 mm -60.63 -38.19 77.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.792 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.7 mm -69.74 -36.09 68.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.692 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.95 -52.03 26.03 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.611 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.1 pt -66.76 -37.74 80.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.626 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -67.83 -36.68 80.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.269 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.462 ' CE1' ' NE2' ' D' ' 37' ' ' HIS . 0.3 OUTLIER -68.09 -50.37 55.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.194 -179.463 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 38.2 tp -65.68 -51.53 58.66 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.332 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 89.5 mt -60.84 -51.65 70.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.333 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 41.2 tp -59.71 -40.29 87.46 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.478 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 27.1 t-105 -61.08 -55.55 31.32 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.706 0.288 . . . . 0.0 111.484 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 96.8 mt -57.93 -55.81 19.53 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 CA-C-O 121.242 0.544 . . . . 0.0 111.536 -178.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.67 ' C ' HD12 ' A' ' 43' ' ' LEU . 0.5 OUTLIER -59.43 -37.71 78.8 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.567 -179.165 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -59.65 -41.47 90.6 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -63.01 -46.65 86.64 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.15 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.421 ' O ' ' O ' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -106.59 -112.65 0.28 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.991 179.654 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.421 ' O ' ' O ' ' A' ' 46' ' ' LEU . 32.6 t80 47.76 97.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.861 0.362 . . . . 0.0 110.248 -179.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.522 ' CD2' ' O ' ' A' ' 48' ' ' PHE . 49.0 t80 60.37 27.94 17.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.552 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.6 mttm 53.01 65.56 1.48 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.589 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.422 ' O ' ' N ' ' A' ' 53' ' ' ARG . 4.7 t -69.51 -28.83 66.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.02 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.0 mt -44.34 -43.23 2.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.916 0.389 . . . . 0.0 110.221 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -71.65 -28.03 63.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.038 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.427 ' CG ' ' CE1' ' A' ' 57' ' ' HIS . 43.9 ttm180 -71.1 -49.24 46.49 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 120.948 0.404 . . . . 0.0 110.315 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -65.4 -44.78 86.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.604 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -65.7 -35.0 79.49 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.265 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -76.89 -24.81 52.52 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.865 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.427 ' CE1' ' CG ' ' A' ' 53' ' ' ARG . 41.5 m170 -76.7 -47.14 22.87 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.389 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.444 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -179.842 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 . . . . . 0 C--O 1.232 0.171 0 CA-C-O 120.707 0.289 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.444 ' O ' ' HB2' ' B' ' 29' ' ' ALA . 50.4 Cg_exo -51.96 -32.67 48.86 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.563 2.176 . . . . 0.0 111.206 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 20.6 tp -60.32 -47.13 87.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.737 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.94 -57.37 7.05 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.433 ' O ' HG22 ' B' ' 32' ' ' ILE . 82.4 t -52.67 -34.81 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' B' ' 25' ' ' PRO . . . -64.27 -34.74 78.8 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.56 -48.66 59.55 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.511 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 42.2 t -63.69 -48.85 75.45 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.574 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.474 HG23 ' N ' ' B' ' 33' ' ' ILE . 19.5 tt -65.66 -43.0 93.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.122 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.474 ' N ' HG23 ' B' ' 32' ' ' ILE . 8.2 tt -67.17 -30.33 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.854 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.69 -51.21 37.19 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 179.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 96.8 mt -58.12 -46.09 88.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.255 0.55 . . . . 0.0 109.98 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 11.2 tp -60.76 -38.15 84.25 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.894 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . 0.454 ' ND1' ' C ' ' B' ' 37' ' ' HIS . 0.4 OUTLIER -65.86 -53.95 33.1 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.811 0.338 . . . . 0.0 111.718 -178.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 27.4 tp -60.59 -54.74 41.72 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.691 -178.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.432 HD13 ' HA ' ' B' ' 39' ' ' ILE . 11.5 mm -60.61 -43.7 95.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.523 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 31.0 tp -54.87 -44.53 74.11 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -60.75 -54.64 42.78 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.218 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 47.9 mm -51.18 -53.66 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.325 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.581 HD23 ' O ' ' B' ' 43' ' ' LEU . 1.0 OUTLIER -61.9 -38.97 90.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.136 -178.747 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -58.65 -47.58 83.96 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.219 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 53.4 ttt85 -69.92 -53.59 17.21 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.689 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' B' ' 43' ' ' LEU . 1.9 pp -108.49 147.32 31.87 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.027 0.441 . . . . 0.0 111.198 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -172.45 -48.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.074 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -172.2 -38.34 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.304 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.524 ' NZ ' ' CG ' ' B' ' 52' ' ' TYR . 42.9 tttm -172.88 21.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.259 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 13.2 t -59.01 -46.56 87.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.194 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 71.4 mt -45.53 -32.3 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.906 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.524 ' CG ' ' NZ ' ' B' ' 49' ' ' LYS . 26.3 t80 -72.17 -31.23 65.74 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.461 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.481 ' N ' ' CD ' ' B' ' 53' ' ' ARG . 0.9 OUTLIER -71.57 -45.1 63.19 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.622 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -71.14 -38.15 72.24 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.045 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -70.91 -39.47 72.72 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.655 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -75.27 -39.08 60.1 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.916 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -67.57 -44.94 77.0 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.437 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.8 -28.02 67.6 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 7.9 tp -84.01 49.84 1.72 Allowed 'General case' 0 C--O 1.231 0.102 0 CA-C-O 120.823 0.344 . . . . 0.0 110.375 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 34.9 tptt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.516 -179.869 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 7.8 m . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 53.78 77.01 0.47 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.795 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -50.42 -35.12 43.95 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.544 2.163 . . . . 0.0 111.533 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 18.6 tp -60.97 -49.11 78.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.736 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.39 -45.59 92.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.113 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 91.5 t -58.46 -43.94 87.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.42 -38.48 71.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.338 0.59 . . . . 0.0 109.494 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.6 -46.83 84.01 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.172 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 2.2 p -63.08 -52.39 62.89 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.912 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 14.7 tt -59.95 -35.74 62.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.538 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 49.8 mt -68.13 -37.53 78.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.64 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.24 -52.95 20.09 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.869 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . 0.409 ' CG1' ' N ' ' C' ' 36' ' ' LEU . 6.5 pt -62.14 -41.51 91.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.396 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.409 ' N ' ' CG1' ' C' ' 35' ' ' ILE . 10.5 tp -65.11 -40.79 95.0 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.341 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -62.15 -50.76 70.59 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 50.9 tp -67.7 -48.63 66.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.915 0.388 . . . . 0.0 111.624 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 92.3 mt -58.38 -50.53 78.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.311 -178.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -65.82 -37.16 85.48 Favored 'General case' 0 C--O 1.221 -0.441 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.027 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 21.9 t-105 -56.8 -53.52 56.92 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.276 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 60.3 mt -70.82 -56.54 10.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.524 -0.47 . . . . 0.0 112.251 -177.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.493 HD23 ' O ' ' C' ' 43' ' ' LEU . 0.7 OUTLIER -54.44 -50.85 66.68 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.825 -178.554 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . 0.484 ' O ' ' CB ' ' C' ' 50' ' ' SER . 36.4 t70 -58.05 -42.56 85.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.355 -0.384 . . . . 0.0 109.997 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -53.62 -51.96 61.4 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 119.889 -0.724 . . . . 0.0 110.573 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' C' ' 47' ' ' PHE . 5.7 mt -74.89 -74.21 0.21 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 120.016 -0.674 . . . . 0.0 111.035 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . 0.467 ' CG ' ' N ' ' C' ' 48' ' ' PHE . 21.4 t80 45.78 -171.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.283 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . 0.467 ' N ' ' CG ' ' C' ' 47' ' ' PHE . 26.2 m-85 -56.3 -54.63 43.13 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.243 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -153.21 36.82 0.48 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.248 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' C' ' 44' ' ' ASP . 1.4 t -50.21 -52.41 35.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.18 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 62.0 mt -50.46 -51.57 18.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.264 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -74.45 -31.56 62.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.876 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -69.93 -48.64 57.71 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.474 -0.491 . . . . 0.0 110.672 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -69.57 -42.11 74.94 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.54 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -63.06 -36.66 84.31 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.501 -0.479 . . . . 0.0 110.864 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 . . . . . 0 CA--C 1.536 0.428 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.801 179.466 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo . . . . . 0 N--CA 1.493 1.466 0 N-CA-C 111.108 -0.382 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . 0.56 HD11 ' O ' ' A' ' 27' ' ' ALA . 2.5 pp -59.6 -28.51 67.25 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.069 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 27' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' D' ' 30' ' ' ALA . . . -50.57 -34.18 24.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.702 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 84.6 t -59.41 -47.81 89.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.83 -35.43 74.72 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.474 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' D' ' 27' ' ' ALA . . . -60.56 -52.26 65.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.83 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 36.7 m -60.16 -44.7 94.8 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.042 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 5.6 mm -61.82 -34.64 63.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.768 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 51.9 mt -69.36 -37.45 75.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.5 -52.41 26.15 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.858 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . 0.471 HG23 ' N ' ' D' ' 36' ' ' LEU . 19.1 tt -63.25 -42.5 96.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.111 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.471 ' N ' HG23 ' D' ' 35' ' ' ILE . 59.5 tp -61.91 -39.15 90.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.79 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . 0.462 ' NE2' ' CE1' ' A' ' 37' ' ' HIS . 2.6 t60 -62.08 -49.23 76.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.387 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 39.1 tp -57.02 -47.32 81.17 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.439 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 95.3 mt -59.79 -43.15 91.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.614 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 57.9 mt -62.07 -39.88 93.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.303 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 17.8 t-105 -61.78 -55.15 33.15 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 120.642 0.258 . . . . 0.0 111.231 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 61.7 mt -61.65 -54.7 31.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.401 -0.519 . . . . 0.0 112.154 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 53.2 tp -59.85 -50.13 74.98 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.199 -178.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . 0.439 ' O ' ' CB ' ' D' ' 50' ' ' SER . 8.8 t0 -53.49 -44.3 68.91 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.186 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 30.2 ttm-85 -59.67 -52.41 65.63 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 120.061 -0.655 . . . . 0.0 110.376 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.39 106.22 15.49 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.01 0.433 . . . . 0.0 110.272 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -173.47 101.54 0.12 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.322 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 47.35 50.38 14.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.662 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? 56.01 53.8 8.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.546 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 7.5 t -63.94 -51.21 65.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.296 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 20.0 mt -47.4 -33.13 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.324 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -73.87 -28.14 61.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.961 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 53' ' ' ARG . . . . . 0.414 ' N ' ' O ' ' D' ' 50' ' ' SER . 74.6 mtm180 -72.7 -47.34 48.02 Favored 'General case' 0 N--CA 1.461 0.093 0 CA-C-O 120.923 0.392 . . . . 0.0 110.748 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -72.06 -39.74 68.82 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.896 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -68.77 -40.03 79.93 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.663 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -75.34 -37.83 60.5 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.386 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -62.61 -48.75 78.05 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.22 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.02 -27.47 73.86 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 6.4 tp -92.65 60.16 3.43 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.772 0.32 . . . . 0.0 110.594 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 65.3 tttp . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.402 179.815 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.449 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 61.4 Cg_exo . . . . . 0 N--CA 1.492 1.389 0 CA-C-O 121.062 0.359 . . . . 0.0 111.335 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.3 tp -62.02 -50.39 72.23 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.784 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.17 -53.37 50.37 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.08 0.467 . . . . 0.0 110.068 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.9 t -56.86 -40.42 71.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 25' ' ' PRO . . . -57.78 -42.26 83.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.623 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.64 -42.7 93.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.735 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.0 t -60.34 -41.66 94.05 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.011 -0.675 . . . . 0.0 110.138 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.7 mt -63.02 -43.78 99.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.733 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.6 tt -70.23 -29.91 41.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.016 -178.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.09 -50.55 22.23 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.002 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.552 HD13 ' O ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -65.1 -41.28 91.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.409 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.6 tp -62.47 -36.68 83.23 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.95 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -67.4 -41.99 84.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.944 0.402 . . . . 0.0 110.317 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.84 -57.95 8.29 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.211 0.529 . . . . 0.0 111.441 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.45 HD13 ' HA ' ' A' ' 39' ' ' ILE . 9.2 mm -61.75 -45.78 97.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.828 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.407 ' O ' ' CB ' ' A' ' 44' ' ' ASP . 57.9 tp -60.26 -38.75 84.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.269 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 31.2 t-105 -63.89 -54.05 40.93 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 120.922 0.392 . . . . 0.0 111.486 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 97.1 mt -62.51 -55.32 24.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.141 -0.623 . . . . 0.0 111.813 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.0 tp -60.29 -46.76 88.73 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.072 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.407 ' CB ' ' O ' ' A' ' 40' ' ' LEU . 18.6 t70 -50.5 -47.25 57.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -59.98 -53.03 62.69 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.535 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 47' ' ' PHE . 15.5 mt -73.4 -78.54 0.09 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.034 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.484 ' O ' ' N ' ' A' ' 49' ' ' LYS . 13.3 t80 41.32 -164.5 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.405 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.408 ' N ' ' CG ' ' A' ' 47' ' ' PHE . 20.7 m-85 -64.53 68.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.358 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 47' ' ' PHE . 29.7 mtmm 46.29 47.0 13.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.619 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.428 ' O ' ' N ' ' A' ' 53' ' ' ARG . 90.3 p -69.06 -30.9 69.32 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.631 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.1 mt -44.14 -42.1 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.963 0.411 . . . . 0.0 110.052 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.407 ' CZ ' ' OE1' ' A' ' 56' ' ' GLU . 52.8 t80 -74.85 -28.92 60.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.136 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.522 ' O ' ' CD2' ' A' ' 57' ' ' HIS . 67.9 mtm180 -70.98 -48.25 54.32 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.468 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.434 ' CE1' HD22 ' B' ' 46' ' ' LEU . 54.9 m-85 -71.2 -40.55 71.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.768 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -66.21 -39.57 89.73 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.755 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.407 ' OE1' ' CZ ' ' A' ' 52' ' ' TYR . 15.7 pt-20 -76.35 -41.1 49.4 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.828 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.522 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 10.2 m-70 -60.14 -47.93 83.84 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.53 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.822 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.871 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.744 0.307 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -51.18 -35.66 53.0 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.465 2.11 . . . . 0.0 111.354 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.45 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 15.8 tp -59.38 -51.35 70.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.839 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.93 -43.48 86.31 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 92.0 t -61.93 -33.29 57.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.235 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -64.41 -35.38 80.71 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.26 -45.86 68.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.258 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 3.9 t -66.19 -52.07 51.66 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.331 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.473 HG23 ' N ' ' B' ' 33' ' ' ILE . 10.9 tp -60.77 -43.04 94.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -178.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.473 ' N ' HG23 ' B' ' 32' ' ' ILE . 7.8 tt -69.89 -28.57 37.24 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.08 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.329 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.64 -50.61 41.59 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 mp -62.86 -42.14 95.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 11.0 tp -58.25 -46.96 85.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.889 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 15.2 t-160 -63.9 -52.03 61.8 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 40.9 tp -58.23 -47.09 84.63 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 120.549 -0.461 . . . . 0.0 111.136 -178.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 3.2 mm -63.79 -41.06 91.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.982 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 0.528 ' O ' HD13 ' B' ' 40' ' ' LEU . 0.2 OUTLIER -60.51 -42.6 96.73 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.904 -179.55 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 46.0 t-105 -64.81 -57.22 9.47 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 75.5 mt -58.48 -53.75 42.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.597 -177.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 41.9 tp -59.73 -46.44 89.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.164 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -55.07 -47.28 75.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.648 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -62.75 -48.56 78.64 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.491 -0.483 . . . . 0.0 111.351 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.434 HD22 ' CE1' ' A' ' 54' ' ' PHE . 0.2 OUTLIER -121.54 124.19 43.81 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.125 0.488 . . . . 0.0 110.43 179.381 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -172.98 -47.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.367 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -171.1 65.81 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.389 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm 55.25 35.44 24.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.566 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 11.2 t -60.0 -49.22 78.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.919 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 48.0 mt -47.36 -31.26 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.759 0.314 . . . . 0.0 110.882 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.527 ' CD2' ' OE1' ' B' ' 56' ' ' GLU . 76.2 t80 -70.84 -29.8 66.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.465 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -71.14 -44.01 66.44 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.41 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -71.21 -38.73 72.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.011 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -69.76 -39.28 76.81 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.737 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . 0.527 ' OE1' ' CD2' ' B' ' 52' ' ' TYR . 10.6 pt-20 -75.58 -38.51 59.09 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 120.254 -0.579 . . . . 0.0 110.644 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -65.03 -47.23 78.16 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.322 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.0 -28.64 73.78 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 32.9 tp -73.39 -68.72 0.48 Allowed 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.402 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.54 179.946 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -156.74 68.83 4.56 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.899 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -51.23 -30.34 32.63 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.514 2.142 . . . . 0.0 111.141 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 16.8 tp -59.09 -51.52 69.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.757 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.5 -46.97 87.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.033 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 61.3 t -58.82 -42.72 86.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.0 -37.9 72.33 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.47 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.38 -49.77 70.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.103 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . 0.436 ' OG ' ' CD1' ' B' ' 26' ' ' LEU . 2.9 m -60.23 -50.79 72.26 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.96 -179.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 17.5 tt -63.71 -33.68 63.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.983 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 32.3 mt -67.24 -42.21 87.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.441 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.07 -49.51 46.69 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 121.019 -0.61 . . . . 0.0 111.666 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 5.1 mm -61.67 -45.37 98.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.128 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 11.6 tp -61.22 -41.65 97.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.169 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 32.7 t60 -61.51 -48.67 80.01 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.61 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 31.2 tp -63.19 -52.93 60.34 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -178.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 1.3 mp -60.46 -46.19 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.017 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -62.06 -40.62 96.39 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.821 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 6.7 t-105 -57.71 -58.41 8.46 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.245 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 68.8 mt -62.13 -56.27 18.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -177.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.647 ' C ' HD13 ' C' ' 43' ' ' LEU . 3.0 tm? -57.99 -52.82 63.92 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.177 -178.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -53.35 -41.24 65.59 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -57.61 -56.23 24.63 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.455 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' C' ' 48' ' ' PHE . 2.2 mt -80.73 -71.12 0.48 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.855 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . 0.46 ' CD2' ' N ' ' C' ' 48' ' ' PHE . 85.2 t80 49.26 -89.56 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.181 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . 0.51 ' N ' ' O ' ' C' ' 46' ' ' LEU . 68.7 t80 -153.49 85.52 1.19 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.236 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 56.9 mttp 52.09 29.26 6.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.935 0.398 . . . . 0.0 110.187 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 11.3 t -62.47 -39.54 93.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.121 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 54.6 mt -47.08 -48.91 8.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.306 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -71.69 -32.25 67.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.58 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -70.75 -48.07 56.34 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.481 -0.487 . . . . 0.0 110.619 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -66.03 -42.28 89.81 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.226 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -63.09 -39.29 94.26 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.459 -0.497 . . . . 0.0 110.854 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 . . . . . 0 CA--C 1.535 0.39 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.759 179.82 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo . . . . . 0 N--CA 1.485 0.983 0 N-CA-C 110.227 -0.721 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 pp -68.13 -35.4 78.05 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.088 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 27' ' ' ALA . . . . . 0.415 ' O ' ' HB3' ' D' ' 30' ' ' ALA . . . -51.07 -37.95 48.7 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.102 0.477 . . . . 0.0 109.879 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 71.4 t -59.24 -47.42 90.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 CA-C-O 121.428 0.632 . . . . 0.0 109.487 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.33 -39.49 76.0 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.286 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' D' ' 27' ' ' ALA . . . -58.47 -47.3 84.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.174 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 11.2 t -57.36 -50.21 73.7 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.871 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 61.0 mt -61.35 -31.71 51.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.55 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 55.2 mt -68.19 -40.46 82.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.348 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.99 -52.14 25.28 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.883 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . 0.429 HG23 ' N ' ' D' ' 36' ' ' LEU . 15.6 tt -61.95 -42.29 94.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.806 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.429 ' N ' HG23 ' D' ' 35' ' ' ILE . 43.6 tp -63.71 -34.9 78.9 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.985 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -63.67 -50.93 67.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.964 0.411 . . . . 0.0 110.247 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 36.3 tp -58.35 -47.5 83.57 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.85 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 5.0 mm -61.69 -44.37 98.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.319 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . 0.561 HD23 ' O ' ' D' ' 40' ' ' LEU . 0.8 OUTLIER -61.82 -39.26 91.17 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 -179.366 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 23.7 t-105 -64.07 -56.6 13.83 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 120.875 0.369 . . . . 0.0 111.434 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 82.1 mt -58.55 -53.2 50.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.777 -177.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 29.9 tp -61.1 -47.4 86.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.881 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -51.91 -44.16 63.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.265 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . 0.502 ' HE ' ' CD2' ' D' ' 46' ' ' LEU . 60.1 ttp180 -64.12 -53.45 49.29 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.77 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . 0.502 ' CD2' ' HE ' ' D' ' 45' ' ' ARG . 0.2 OUTLIER -113.53 110.31 20.05 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.046 0.451 . . . . 0.0 110.3 179.143 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -174.77 92.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.146 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 53.96 58.16 5.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.539 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? 53.73 52.93 12.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.95 0.405 . . . . 0.0 110.372 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . 0.524 ' OG ' ' NH2' ' D' ' 53' ' ' ARG . 8.1 t -68.22 -51.76 41.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.227 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 4.7 mt -48.15 -35.01 5.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -72.37 -28.97 63.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.05 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 53' ' ' ARG . . . . . 0.524 ' NH2' ' OG ' ' D' ' 50' ' ' SER . 36.7 mtm105 -71.86 -46.49 57.76 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.96 0.41 . . . . 0.0 110.525 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -70.94 -36.85 72.79 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.788 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -70.06 -39.7 75.49 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.659 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -75.43 -37.73 60.23 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.614 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -65.94 -44.37 85.27 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.27 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.18 -26.74 70.67 Favored Glycine 0 N--CA 1.462 0.374 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.8 70.24 0.77 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.271 0.558 . . . . 0.0 109.728 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 16.3 ttpp . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.512 -179.721 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo . . . . . 0 N--CA 1.491 1.367 0 N-CA-C 110.957 -0.44 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.4 tp -65.21 -50.27 66.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.18 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.452 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -65.43 -50.67 64.54 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.34 0.59 . . . . 0.0 109.568 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.2 t -54.59 -46.68 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.44 -42.36 70.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.691 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -55.72 -47.63 76.54 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.17 0.51 . . . . 0.0 110.567 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 80.8 p -62.39 -39.96 94.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.803 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 35.6 mm -61.97 -47.58 92.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.608 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.9 tt -68.96 -29.64 44.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.7 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.13 -50.21 47.61 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.171 -1.014 . . . . 0.0 110.578 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 28.1 mm -62.91 -44.24 99.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 51.4 tp -63.21 -31.13 72.2 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.433 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -69.5 -52.22 28.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.985 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 32.1 tp -61.76 -51.28 68.99 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.207 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.9 mm -61.86 -43.69 97.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.908 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 35.5 tp -61.2 -38.95 88.39 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.381 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 44.3 t-105 -63.78 -55.17 25.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.824 0.345 . . . . 0.0 111.647 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.7 mt -61.44 -51.65 70.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 120.454 -0.498 . . . . 0.0 111.78 -177.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.407 HD11 ' CD1' ' A' ' 47' ' ' PHE . 23.9 tp -60.96 -42.35 98.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.983 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -57.78 -45.29 86.19 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -60.03 -48.66 80.78 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.484 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.4 pp -130.91 132.87 45.39 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.026 0.441 . . . . 0.0 111.088 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.407 ' CD1' HD11 ' A' ' 43' ' ' LEU . 49.2 t80 -175.41 -38.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.161 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -167.24 60.03 0.08 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.251 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp 60.85 42.47 13.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.38 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.5 t -62.34 -49.91 73.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.696 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 94.1 mt -49.67 -41.96 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.205 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -72.26 -28.5 63.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.216 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.525 ' O ' ' CD2' ' A' ' 57' ' ' HIS . 12.1 mmm180 -69.71 -46.57 65.68 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.317 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -71.41 -40.23 70.61 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.075 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -67.37 -38.18 84.34 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.746 -179.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.52 ' OE2' ' CE1' ' A' ' 57' ' ' HIS . 0.7 OUTLIER -77.5 -38.03 49.91 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.876 -179.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.525 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 26.4 m-70 -63.87 -50.54 68.41 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.469 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.468 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 -179.825 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.665 0.269 . . . . 0.0 110.76 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -51.55 -31.4 39.61 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.57 2.18 . . . . 0.0 111.427 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.417 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 19.0 tp -58.76 -51.28 70.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.912 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.62 -46.12 91.46 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 91.8 t -59.74 -35.84 62.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -62.34 -35.63 79.71 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.6 -45.54 71.71 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.387 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 8.4 p -65.5 -51.86 56.94 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.423 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.511 HG23 ' N ' ' B' ' 33' ' ' ILE . 20.0 tt -61.86 -43.05 96.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -178.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.511 ' N ' HG23 ' B' ' 32' ' ' ILE . 8.3 tt -69.16 -30.3 45.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 C-N-CA 119.731 -0.788 . . . . 0.0 110.304 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.52 -50.55 42.7 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 mp -61.58 -41.59 90.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 19.8 tp -60.39 -40.97 92.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.747 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -67.71 -51.76 45.71 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 35.1 tp -61.68 -52.4 64.47 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.614 -178.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.6 mm -62.0 -41.76 92.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.392 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 46.0 tp -59.59 -41.66 90.78 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.249 -0.58 . . . . 0.0 109.944 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 9.9 t-105 -62.5 -59.37 5.05 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.724 0.297 . . . . 0.0 111.724 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 72.0 mt -58.53 -56.52 15.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.635 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.467 HD23 ' O ' ' B' ' 43' ' ' LEU . 0.6 OUTLIER -55.0 -49.78 70.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.641 -178.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -52.24 -44.19 64.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.326 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -59.2 -53.01 63.1 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.641 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 2.8 mt -77.45 -141.03 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 119.871 -0.732 . . . . 0.0 110.594 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.424 ' O ' ' O ' ' B' ' 48' ' ' PHE . 47.8 t80 59.78 110.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.615 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . 0.545 ' CG ' ' N ' ' B' ' 49' ' ' LYS . 57.5 t80 48.35 -178.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.404 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.545 ' N ' ' CG ' ' B' ' 48' ' ' PHE . 0.1 OUTLIER -72.19 45.42 0.13 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.377 -179.878 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . 0.401 ' H ' ' C ' ' B' ' 48' ' ' PHE . 11.1 t -62.56 -47.57 83.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.853 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 51.2 mt -48.22 -41.88 10.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.592 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.515 ' CE2' ' OE2' ' B' ' 56' ' ' GLU . 78.9 t80 -71.39 -29.72 65.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.446 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 69.6 mtm180 -68.14 -44.04 76.93 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.412 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -72.26 -39.47 68.37 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.762 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -64.45 -40.84 96.5 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.488 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . 0.515 ' OE2' ' CE2' ' B' ' 52' ' ' TYR . 13.2 pt-20 -76.48 -38.79 54.79 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.63 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -59.08 -47.06 86.63 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.174 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.35 -28.37 73.65 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 8.0 tp -88.87 49.06 1.72 Allowed 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.708 0.289 . . . . 0.0 110.468 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm . . . . . 0 N--CA 1.469 0.481 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.627 -179.986 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 25.1 t . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -159.18 70.78 3.46 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.871 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.0 -29.51 36.26 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.621 2.214 . . . . 0.0 111.281 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.59 -56.32 23.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.89 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.2 -46.79 82.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.57 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 74.6 t -58.21 -43.44 85.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.64 -39.93 78.08 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.528 178.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.77 -49.37 76.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.164 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 2.2 t -62.17 -53.79 50.26 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 16.5 tt -58.44 -35.8 55.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.663 -179.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 51.0 mt -67.46 -37.48 78.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.399 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.33 -51.22 28.11 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.93 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -62.82 -43.54 98.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 11.4 tp -63.22 -41.61 99.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.838 0.351 . . . . 0.0 110.237 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -61.61 -48.06 82.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.522 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 51.3 tp -65.0 -51.01 64.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.789 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 50.9 mt -59.3 -48.49 86.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.19 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -63.25 -37.65 88.08 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.671 -0.412 . . . . 0.0 109.981 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 25.5 t-105 -59.35 -59.37 5.56 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.346 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 48.4 mt -62.63 -54.97 26.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.514 -0.474 . . . . 0.0 112.047 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.673 ' C ' HD13 ' C' ' 43' ' ' LEU . 3.2 tm? -57.9 -52.36 65.83 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.196 -178.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . 0.454 ' O ' ' CB ' ' C' ' 50' ' ' SER . 67.9 t0 -53.11 -41.94 65.49 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.02 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -58.49 -53.24 60.61 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.791 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' C' ' 48' ' ' PHE . 3.6 mt -84.53 -71.41 0.52 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.176 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 91.7 t80 56.75 -80.42 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.246 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . 0.527 ' N ' ' O ' ' C' ' 46' ' ' LEU . 86.4 t80 -172.91 -22.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.334 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . 0.464 ' NZ ' ' CD1' ' C' ' 52' ' ' TYR . 49.8 tttm -170.75 21.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.91 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' C' ' 44' ' ' ASP . 10.8 t -62.08 -48.47 80.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.282 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 51' ' ' ILE . . . . . 0.426 ' H ' HG13 ' C' ' 51' ' ' ILE . 12.8 mt -50.21 -53.99 9.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.3 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 52' ' ' TYR . . . . . 0.464 ' CD1' ' NZ ' ' C' ' 49' ' ' LYS . 27.7 t80 -70.57 -32.83 70.38 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.668 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 19.9 mmt85 -70.01 -43.41 71.4 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.586 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -66.29 -47.23 74.3 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.176 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -62.2 -36.55 82.27 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.925 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . 0.411 ' O ' ' OE1' ' C' ' 56' ' ' GLU . 3.0 tm-20 . . . . . 0 CA--C 1.536 0.428 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.535 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 N--CA 1.494 1.548 0 N-CA-C 111.091 -0.388 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . 0.553 ' O ' ' HB3' ' D' ' 29' ' ' ALA . 2.4 pp -65.95 -30.88 71.52 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.678 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.32 -49.7 42.83 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 95.4 t -50.81 -38.09 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 178.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' D' ' 26' ' ' LEU . . . -62.6 -40.06 95.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.639 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.94 -50.48 68.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.268 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 45.9 t -60.51 -51.89 67.53 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.904 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 20.1 tt -63.27 -31.41 52.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.629 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 19.4 mt -67.47 -41.8 86.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.017 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.01 -51.74 32.32 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.121 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 10.7 tp -64.49 -39.18 84.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.402 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 56.8 tp -64.58 -38.64 91.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.109 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 32.4 t60 -65.11 -48.66 72.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.368 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 50.3 tp -59.08 -47.01 86.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.562 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.36 -42.76 94.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.851 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 40.2 mt -61.58 -42.45 98.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.208 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 18.4 t-105 -62.07 -55.58 27.63 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.696 0.284 . . . . 0.0 111.508 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 72.5 mt -60.54 -54.93 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -177.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 40.0 tp -60.92 -44.43 97.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.61 0.243 . . . . 0.0 111.343 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . 0.435 ' O ' ' CB ' ' D' ' 50' ' ' SER . 22.6 t70 -58.08 -42.77 86.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.594 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . 0.433 ' HG3' HD11 ' D' ' 51' ' ' ILE . 9.8 tpt180 -66.11 -56.61 10.6 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.066 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . 0.414 HD23 ' HB3' ' D' ' 45' ' ' ARG . 0.2 OUTLIER -106.67 130.8 54.34 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.376 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -171.76 -43.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.454 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -172.71 -48.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.426 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -172.46 28.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.339 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . 0.435 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 7.8 t -57.92 -50.93 71.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.181 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 51' ' ' ILE . . . . . 0.433 HD11 ' HG3' ' D' ' 45' ' ' ARG . 7.3 mt -49.39 -39.35 13.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.32 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 52' ' ' TYR . . . . . 0.465 ' CE2' ' OE2' ' D' ' 56' ' ' GLU . 82.5 t80 -73.98 -29.56 62.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.242 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 -68.15 -48.32 65.67 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.916 0.388 . . . . 0.0 110.482 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -72.34 -39.49 68.12 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.752 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -62.1 -41.96 98.74 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.348 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 56' ' ' GLU . . . . . 0.465 ' OE2' ' CE2' ' D' ' 52' ' ' TYR . 14.8 pt-20 -77.49 -37.11 51.88 Favored 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 120.219 -0.592 . . . . 0.0 110.434 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -56.18 -48.89 75.48 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.217 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.82 -27.08 74.16 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.439 -1.065 . . . . 0.0 110.439 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 59' ' ' LEU . . . . . 0.411 ' N ' ' CD2' ' D' ' 59' ' ' LEU . 3.0 mm? -99.29 52.69 0.95 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.025 0.441 . . . . 0.0 109.983 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 63.7 tttp . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.586 179.923 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo . . . . . 0 N--CA 1.491 1.347 0 N-CA-C 111.03 -0.412 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.9 tp -63.3 -49.01 75.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.936 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.497 ' HB1' HD11 ' D' ' 26' ' ' LEU . . . -60.84 -55.08 37.25 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.7 t -51.87 -47.66 40.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.811 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.93 -48.84 64.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.899 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.76 -48.63 66.65 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.787 ' OG ' HD13 ' D' ' 26' ' ' LEU . 0.9 OUTLIER -53.18 -53.01 56.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.482 179.755 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 44.7 mm -53.62 -38.25 33.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.223 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 70.6 mt -69.47 -32.8 54.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.291 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.1 -53.04 15.66 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.855 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -33.97 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.108 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.6 tp -69.41 -35.97 76.27 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.338 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.561 ' CE1' ' CD2' ' B' ' 37' ' ' HIS . 47.9 t60 -70.01 -51.3 33.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.654 0.264 . . . . 0.0 111.054 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.6 tp -62.73 -50.38 71.32 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.934 0.397 . . . . 0.0 111.222 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 29.5 mm -63.32 -44.59 99.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.279 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 50.2 tp -60.66 -43.23 97.91 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.234 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 16.6 t-105 -61.91 -57.24 12.52 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.744 0.307 . . . . 0.0 111.74 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 76.5 mt -59.56 -55.46 23.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.531 -0.467 . . . . 0.0 112.22 -177.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.7 tp -59.73 -46.97 87.51 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.167 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -53.71 -41.78 67.34 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.402 HH22 ' HB3' ' D' ' 54' ' ' PHE . 45.2 ttt-85 -60.59 -51.53 69.04 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.252 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.81 107.42 18.61 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 120.776 -0.369 . . . . 0.0 110.203 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -174.11 100.32 0.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.217 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.508 ' CD2' ' O ' ' A' ' 48' ' ' PHE . 69.3 t80 45.45 52.07 9.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.39 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.0 mttp 55.32 52.94 10.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.618 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.5 t -62.65 -42.78 99.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.96 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.551 ' H ' HD12 ' A' ' 51' ' ' ILE . 3.5 mp -47.74 -31.48 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.504 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -72.95 -28.51 62.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.097 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.542 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 77.9 mtp180 -68.42 -48.04 65.68 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.378 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -71.46 -39.28 71.04 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.795 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -64.36 -39.97 94.94 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.7 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.534 ' OE2' ' CD2' ' A' ' 57' ' ' HIS . 1.6 pp20? -77.01 -41.29 43.32 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.851 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.542 ' ND1' ' O ' ' A' ' 53' ' ' ARG . 23.9 m80 -57.87 -50.49 73.14 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 120.314 -0.554 . . . . 0.0 109.782 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.672 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 179.556 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.785 0.326 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -50.84 -30.6 30.42 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.646 2.231 . . . . 0.0 111.244 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.466 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 19.7 tp -60.85 -50.12 74.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.078 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.43 -43.1 79.08 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 83.7 t -61.37 -34.3 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -64.29 -34.63 78.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.305 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.13 -51.68 43.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.087 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 6.1 p -61.71 -50.42 72.53 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.783 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.425 HG23 ' N ' ' B' ' 33' ' ' ILE . 3.8 tp -62.33 -40.93 89.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.989 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.425 ' N ' HG23 ' B' ' 32' ' ' ILE . 34.1 mt -62.19 -44.3 98.91 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.922 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.04 -53.78 43.56 Favored Glycine 0 N--CA 1.462 0.376 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 96.8 mt -50.55 -39.13 17.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.94 -45.89 90.32 Favored 'General case' 0 C--O 1.219 -0.5 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.28 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . 0.561 ' CD2' ' CE1' ' A' ' 37' ' ' HIS . 1.4 t60 -60.35 -48.58 81.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.592 -178.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.423 ' N ' HD12 ' B' ' 38' ' ' LEU . 9.6 mp -64.07 -47.86 78.45 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.741 -178.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 18.1 mm -62.52 -47.93 90.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.295 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 7.1 mp -63.66 -34.01 76.9 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 28.6 t-105 -64.66 -57.26 9.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 120.89 0.376 . . . . 0.0 111.262 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 77.7 mt -60.0 -51.73 69.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.773 -178.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 8.6 mt -63.4 -50.94 67.85 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.502 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . 0.478 ' O ' ' CB ' ' B' ' 50' ' ' SER . 36.3 t70 -53.4 -41.94 66.46 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.325 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -65.3 -45.45 84.32 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.946 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 2.5 pp -139.5 124.08 18.32 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.266 0.555 . . . . 0.0 111.507 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -173.79 -31.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.879 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . 0.415 ' O ' ' CD2' ' B' ' 48' ' ' PHE . 63.4 t80 -167.4 58.93 0.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.051 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 97.5 mttt 55.14 53.95 9.47 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.504 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' B' ' 44' ' ' ASP . 3.0 p -68.39 -52.28 34.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.995 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . 0.407 ' N ' ' OG ' ' B' ' 50' ' ' SER . 80.6 mt -50.3 -46.73 25.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.974 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.518 ' CE2' ' OE2' ' B' ' 56' ' ' GLU . 86.5 t80 -71.25 -29.82 65.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.317 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 33.1 mmm-85 -70.76 -44.7 66.2 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.831 0.348 . . . . 0.0 110.541 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . 0.401 ' HB3' HH22 ' C' ' 45' ' ' ARG . 55.0 m-85 -71.64 -39.23 70.53 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.881 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -68.18 -38.97 82.6 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.684 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . 0.518 ' OE2' ' CE2' ' B' ' 52' ' ' TYR . 11.5 pt-20 -76.16 -38.54 56.55 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.569 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -62.88 -47.67 82.33 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.235 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.79 -27.58 72.24 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 9.9 tp -89.38 59.46 4.83 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-O 120.837 0.351 . . . . 0.0 110.275 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp . . . . . 0 N--CA 1.466 0.372 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.287 -179.984 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -35.83 100.54 0.2 Allowed Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.45 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.85 -34.79 37.75 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.044 1.83 . . . . 0.0 111.559 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . 0.401 ' C ' ' CD1' ' C' ' 26' ' ' LEU . 0.2 OUTLIER -58.48 -55.69 31.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.489 0.662 . . . . 0.0 109.477 179.428 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.49 -45.63 88.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.427 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 88.0 t -56.9 -40.19 70.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.9 -37.65 85.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.761 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.41 -51.24 64.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.542 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 10.4 p -63.44 -51.45 65.66 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 120.689 -0.404 . . . . 0.0 112.04 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 20.7 tt -59.85 -36.51 66.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.764 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 41.3 mt -68.5 -39.56 80.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.64 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.78 -52.81 31.19 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.734 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 6.8 pt -61.91 -42.59 95.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.295 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 8.7 tp -63.82 -34.34 77.69 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.313 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -66.75 -52.67 41.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.241 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 33.1 tp -61.9 -49.44 76.19 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.045 0.45 . . . . 0.0 111.121 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 30.3 mm -59.79 -43.89 92.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.73 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 25.7 mt -62.34 -40.28 95.84 Favored 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.919 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 25.0 t-105 -59.58 -52.31 66.1 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.308 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 65.9 mt -66.68 -56.59 13.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.266 -0.574 . . . . 0.0 112.411 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.65 ' C ' HD13 ' C' ' 43' ' ' LEU . 2.9 tm? -58.28 -52.09 67.05 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.886 -178.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -52.93 -43.38 66.24 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.22 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . 0.401 HH22 ' HB3' ' B' ' 54' ' ' PHE . 52.9 ttt-85 -58.84 -52.09 67.21 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.853 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' C' ' 48' ' ' PHE . 8.5 mt -79.59 -73.95 0.32 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 120.274 -0.571 . . . . 0.0 111.263 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 49.3 t80 62.03 -71.32 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.407 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' C' ' 46' ' ' LEU . 66.2 t80 -172.75 -32.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.261 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 46.6 tttp -172.96 26.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.917 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 39.6 t -63.73 -42.23 97.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.298 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 58.3 mt -48.98 -52.78 9.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.389 -179.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -74.86 -32.64 61.96 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -71.73 -49.58 37.94 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.673 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -67.66 -43.32 80.53 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.428 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -64.88 -35.87 82.54 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.829 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 . . . . . 0 CA--C 1.534 0.336 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.561 179.262 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo . . . . . 0 N--CA 1.488 1.176 0 N-CA-C 110.878 -0.47 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . 0.787 HD13 ' OG ' ' A' ' 31' ' ' SER . 3.9 pp -66.18 -42.71 88.52 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.832 179.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 27' ' ' ALA . . . . . 0.574 ' N ' HD12 ' D' ' 26' ' ' LEU . . . -49.31 -53.47 21.81 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.558 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 87.7 t -48.1 -36.98 6.49 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.06 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' D' ' 26' ' ' LEU . . . -65.58 -37.04 85.52 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.275 0.56 . . . . 0.0 109.818 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.94 -51.22 60.43 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.883 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 58.4 m -62.43 -50.44 71.48 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 3.3 tp -62.29 -35.84 71.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.73 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 37.7 mt -68.03 -38.21 79.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.07 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.38 -50.76 42.02 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.15 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . 0.477 HG23 ' N ' ' D' ' 36' ' ' LEU . 18.4 tt -66.05 -42.75 92.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.347 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.477 ' N ' HG23 ' D' ' 35' ' ' ILE . 7.2 tp -60.62 -38.5 84.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.864 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -66.92 -45.43 77.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.604 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 31.6 tp -57.67 -54.3 48.46 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.195 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 13.6 pt -64.08 -37.31 79.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.816 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 17.9 mt -58.82 -42.55 89.48 Favored 'General case' 0 C--O 1.224 -0.263 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 33.5 t-105 -64.58 -51.44 62.72 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.101 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 mm -56.48 -56.72 12.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.531 -0.467 . . . . 0.0 111.771 -177.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 36.6 tp -62.03 -45.23 94.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.789 0.328 . . . . 0.0 110.8 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -50.76 -44.44 58.61 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.004 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -66.48 -54.57 22.52 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.564 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.72 105.62 15.74 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.279 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -172.99 95.79 0.12 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.313 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 52.2 51.69 15.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.742 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 18.0 mtpp 54.44 49.75 17.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.594 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 10.9 t -61.85 -46.36 89.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.992 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 38.2 mt -49.44 -39.11 13.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.656 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -72.72 -28.86 62.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.112 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 35.7 mtm105 -71.5 -47.49 55.08 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.984 0.421 . . . . 0.0 110.56 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . 0.402 ' HB3' HH22 ' A' ' 45' ' ' ARG . 73.6 m-85 -71.16 -35.16 71.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.739 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -70.64 -37.91 73.81 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.604 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -77.51 -37.89 50.11 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.644 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -66.16 -48.63 70.11 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.504 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.86 -27.34 72.0 Favored Glycine 0 N--CA 1.461 0.311 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.13 77.15 1.77 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 57.3 tttm . . . . . 0 C--N 1.333 -0.111 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.539 -179.695 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.443 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 52.9 Cg_exo . . . . . 0 N--CA 1.491 1.345 0 N-CA-C 111.115 -0.379 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.3 tp -65.56 -50.73 64.09 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.059 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.437 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -63.43 -50.23 70.61 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.392 0.615 . . . . 0.0 109.567 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.3 t -57.94 -45.27 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 25' ' ' PRO . . . -55.6 -35.36 65.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.779 179.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -64.55 -50.05 68.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.413 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.423 ' OG ' HD13 ' D' ' 26' ' ' LEU . 9.6 m -58.52 -41.09 84.65 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.477 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 35.5 mm -64.52 -41.74 93.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.505 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 33' ' ' ILE . 2.6 tt -68.43 -35.61 71.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.627 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.26 -51.47 32.53 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 89.3 mt -60.7 -43.87 95.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.96 0.409 . . . . 0.0 110.067 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.2 tp -65.01 -31.07 72.13 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.364 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.462 ' HD1' ' C ' ' A' ' 37' ' ' HIS . 0.3 OUTLIER -68.55 -51.97 37.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.805 0.336 . . . . 0.0 110.903 -179.517 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 51.2 tp -62.58 -51.44 67.31 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.265 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 83.5 mt -61.98 -44.58 99.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.076 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 35.0 tp -60.32 -41.72 94.09 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.322 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.1 t-105 -62.59 -57.78 9.88 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 120.95 0.405 . . . . 0.0 111.516 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 95.3 mt -56.64 -54.72 25.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.925 -177.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 47' ' ' PHE . 29.0 tp -61.97 -44.01 97.64 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.025 -178.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -50.43 -45.95 56.13 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 57.7 ttt85 -61.71 -52.72 63.12 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.14 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 48' ' ' PHE . 5.6 mt -81.93 -77.38 0.22 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.806 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.464 ' N ' ' O ' ' A' ' 43' ' ' LEU . 92.6 t80 52.9 -83.69 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.8 0.333 . . . . 0.0 110.415 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.525 ' N ' ' O ' ' A' ' 46' ' ' LEU . 49.9 t80 -157.39 81.43 0.9 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.119 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.6 mttm 51.28 25.35 2.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.244 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 53' ' ' ARG . 3.9 t -61.76 -29.66 70.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.587 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.9 mt -45.34 -37.0 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.988 0.423 . . . . 0.0 110.06 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -74.37 -27.58 60.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.001 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.537 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 95.7 mtt-85 -71.61 -48.63 46.84 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.542 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -71.33 -38.93 71.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.006 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -69.87 -38.87 76.55 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 120.829 -0.349 . . . . 0.0 111.724 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.523 ' OE2' ' CD2' ' A' ' 57' ' ' HIS . 0.8 OUTLIER -75.84 -38.42 58.05 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.785 -179.871 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.537 ' ND1' ' O ' ' A' ' 53' ' ' ARG . 27.8 m170 -66.39 -44.95 81.64 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.449 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.38 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 179.889 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.655 0.264 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.42 ' O ' ' HB2' ' B' ' 29' ' ' ALA . 64.4 Cg_exo -49.68 -28.96 18.36 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.365 2.043 . . . . 0.0 111.241 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 19.4 tp -60.85 -51.19 70.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.86 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' B' ' 30' ' ' ALA . . . -65.64 -51.68 57.7 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.362 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 14.7 t -56.97 -42.33 78.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' B' ' 25' ' ' PRO . . . -55.82 -43.91 77.41 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' B' ' 27' ' ' ALA . . . -56.43 -44.85 80.81 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.384 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -61.35 -48.99 78.77 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.299 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 74.7 mt -57.39 -48.73 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.743 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 15.5 tt -67.96 -27.16 36.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.695 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.7 -49.18 57.2 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.2 mp -67.78 -41.13 84.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 12.4 tp -55.87 -52.05 65.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.925 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -67.36 -40.65 85.82 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.308 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 48.1 tp -63.29 -57.86 9.02 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 120.652 -0.419 . . . . 0.0 112.097 -178.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 4.6 tt -66.56 -36.87 78.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.812 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 52.5 tp -63.98 -36.74 84.98 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.539 -0.465 . . . . 0.0 109.966 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -67.73 -56.67 8.37 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.805 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.538 ' CG2' ' N ' ' B' ' 43' ' ' LEU . 8.3 tt -62.38 -47.63 92.13 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.476 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.071 -177.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.538 ' N ' ' CG2' ' B' ' 42' ' ' ILE . 17.8 tp -63.92 -47.0 82.29 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.338 -177.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . 0.422 ' O ' ' OG ' ' B' ' 50' ' ' SER . 41.7 t0 -57.96 -38.28 75.72 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 70.2 ttt-85 -69.67 -45.79 67.56 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.082 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 2.7 pp -133.62 125.61 29.11 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.098 0.475 . . . . 0.0 110.904 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.508 ' CD1' HD11 ' B' ' 43' ' ' LEU . 66.2 t80 -173.74 -37.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.551 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -172.21 56.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.297 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp 60.62 43.23 12.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.43 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' B' ' 44' ' ' ASP . 13.4 t -63.73 -51.02 66.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.817 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 73.1 mt -46.53 -40.46 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.856 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.522 ' CE2' ' OE2' ' B' ' 56' ' ' GLU . 92.0 t80 -71.65 -30.2 65.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.55 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.523 ' O ' ' CD2' ' B' ' 57' ' ' HIS . 93.5 mtt180 -70.63 -45.12 65.81 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.011 0.434 . . . . 0.0 110.655 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -71.66 -38.06 70.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.824 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -68.48 -39.1 81.49 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.529 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . 0.522 ' OE2' ' CE2' ' B' ' 52' ' ' TYR . 12.4 pt-20 -75.92 -39.4 56.31 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 120.296 -0.561 . . . . 0.0 110.683 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' HIS . . . . . 0.523 ' CD2' ' O ' ' B' ' 53' ' ' ARG . 9.9 m-70 -63.5 -45.5 90.41 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.552 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.45 -28.49 73.19 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 5.1 tp -89.66 33.2 0.84 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.872 0.367 . . . . 0.0 110.336 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . 0.586 ' HZ3' ' HE3' ' C' ' 49' ' ' LYS . 25.3 pttm . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.597 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . 0.433 ' N ' ' OD1' ' C' ' 24' ' ' ASP . 6.8 p30 -170.65 72.55 0.57 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.787 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -51.54 -33.59 48.52 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 C-N-CA 122.152 1.901 . . . . 0.0 111.047 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 18.5 tp -64.81 -50.43 66.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.97 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 27' ' ' ALA . . . . . 0.408 ' O ' ' HB3' ' C' ' 30' ' ' ALA . . . -60.52 -48.06 83.41 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.507 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . 0.401 ' O ' ' OG ' ' C' ' 31' ' ' SER . 48.2 t -57.28 -42.58 80.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.12 -42.23 80.5 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' C' ' 27' ' ' ALA . . . -57.58 -49.86 75.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.553 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' C' ' 28' ' ' VAL . 2.5 p -56.85 -46.74 81.55 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.93 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 52.4 mt -61.36 -33.91 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.518 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 3.4 mm -67.37 -42.78 87.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.072 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.1 -51.63 32.47 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.942 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . 0.463 HG23 ' N ' ' C' ' 36' ' ' LEU . 14.8 tt -63.26 -41.62 93.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.762 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.463 ' N ' HG23 ' C' ' 35' ' ' ILE . 56.0 tp -64.96 -38.43 90.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.273 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.3 t60 -63.96 -50.68 67.64 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 28.5 tp -61.57 -48.29 81.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.494 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 66.9 mt -61.41 -43.16 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.291 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' C' ' 40' ' ' LEU . 36.6 mt -64.23 -40.29 95.73 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.398 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 10.3 t-105 -61.98 -60.72 3.21 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.114 0.483 . . . . 0.0 111.431 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . 0.554 ' CG2' ' N ' ' C' ' 43' ' ' LEU . 9.0 tt -58.6 -50.82 77.69 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.579 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.691 -177.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.627 ' C ' HD13 ' C' ' 43' ' ' LEU . 2.7 tm? -61.26 -53.6 54.71 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.792 -177.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . 0.407 ' O ' ' OD1' ' C' ' 44' ' ' ASP . 68.2 t0 -52.01 -34.43 42.78 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . 0.46 ' O ' ' CD1' ' C' ' 51' ' ' ILE . 39.0 ttt-85 -69.03 -51.07 42.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.012 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 20.2 mt -79.96 -126.29 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.935 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 5.4 t80 72.75 -155.26 0.08 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.084 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -71.57 65.4 0.47 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.549 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . 0.586 ' HE3' ' HZ3' ' B' ' 60' ' ' LYS . 49.7 mttp 54.87 52.57 11.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.938 0.399 . . . . 0.0 110.092 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 38.7 t -62.14 -40.97 97.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.221 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 51' ' ' ILE . . . . . 0.472 ' H ' HD12 ' C' ' 51' ' ' ILE . 3.7 mp -46.87 -47.5 8.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.356 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -72.36 -29.79 64.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.549 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -69.99 -47.24 62.98 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.685 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -69.58 -41.18 76.17 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.346 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -62.52 -39.69 94.37 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.837 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 CA--C 1.537 0.457 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.199 179.602 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo . . . . . 0 N--CA 1.491 1.342 0 N-CA-C 110.83 -0.488 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . 0.423 HD13 ' OG ' ' A' ' 31' ' ' SER . 2.9 pp -57.13 -29.25 63.41 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 27' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' D' ' 30' ' ' ALA . . . -50.03 -41.6 47.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.776 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 79.0 t -57.31 -44.48 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.42 -29.88 70.21 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.681 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' D' ' 27' ' ' ALA . . . -69.88 -42.31 73.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.778 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 16.0 p -69.61 -46.42 66.32 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.675 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 9.5 tt -67.99 -40.16 82.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.554 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 13.0 tt -71.28 -32.38 46.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.43 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.82 -52.49 14.71 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . 0.435 HG23 ' N ' ' D' ' 36' ' ' LEU . 19.0 tt -63.12 -39.89 86.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.912 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.435 ' N ' HG23 ' D' ' 35' ' ' ILE . 43.8 tp -63.9 -37.52 87.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.911 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . 0.502 ' HD1' ' C ' ' D' ' 37' ' ' HIS . 0.3 OUTLIER -64.05 -50.06 69.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.431 -179.918 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 32.0 tp -57.98 -47.64 82.38 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.698 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 97.7 mt -60.78 -43.82 96.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.16 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . 0.547 ' O ' HD13 ' D' ' 40' ' ' LEU . 0.2 OUTLIER -61.89 -40.86 96.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.181 -179.45 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . 0.505 ' HE1' HH21 ' D' ' 45' ' ' ARG . 30.8 t-105 -62.09 -55.02 33.22 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.739 0.304 . . . . 0.0 111.287 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 79.2 mt -60.03 -55.98 20.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.913 -178.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 52.7 tp -58.34 -41.5 84.79 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.841 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . 0.426 ' O ' ' CB ' ' D' ' 50' ' ' SER . 4.2 t70 -58.54 -40.84 84.1 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . 0.505 HH21 ' HE1' ' D' ' 41' ' ' TRP . 14.8 ttm180 -62.78 -50.91 69.17 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.546 -0.461 . . . . 0.0 110.445 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.39 109.45 21.44 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.001 0.429 . . . . 0.0 109.908 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -173.18 86.53 0.06 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.374 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 53.71 55.64 8.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.419 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt 60.35 52.19 4.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.223 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 0.3 OUTLIER -58.79 -42.23 88.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.73 -179.59 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 51' ' ' ILE . . . . . 0.731 HD13 ' H ' ' D' ' 51' ' ' ILE . 0.0 OUTLIER -55.37 -43.52 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -70.59 -28.24 64.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.122 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -68.7 -44.61 73.59 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.42 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -72.16 -40.99 67.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.775 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -63.19 -41.04 99.12 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.449 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -76.94 -36.89 56.24 Favored 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.562 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -58.44 -49.81 75.98 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.406 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.47 -27.35 73.07 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -93.86 57.55 2.49 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 86.8 tttt . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.53 -179.96 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 90.3 p . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 4.3 p30 -163.18 74.39 1.93 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.805 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.42 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 56.5 Cg_exo -50.51 -35.36 45.57 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.137 1.891 . . . . 0.0 110.904 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 18.6 tp -64.81 -51.52 61.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.972 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.23 -51.57 65.69 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.142 0.496 . . . . 0.0 109.928 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 49.2 t -56.91 -42.86 79.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.651 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 25' ' ' PRO . . . -55.93 -45.49 78.73 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.73 -46.04 81.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.113 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.3 t -56.05 -50.66 70.34 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.332 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 55.3 mt -56.59 -37.82 54.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.611 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 87.5 mt -65.37 -41.88 92.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.055 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.13 -52.32 37.59 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.643 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.5 -44.6 93.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 52.4 tp -63.9 -32.06 73.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.485 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -68.62 -51.66 39.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.817 0.341 . . . . 0.0 111.043 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 28.8 tp -63.04 -51.22 67.59 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.29 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.8 mm -61.58 -44.33 98.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.983 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 47.5 tp -61.54 -38.91 89.15 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.302 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 39.9 t-105 -63.5 -55.72 21.79 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.87 0.367 . . . . 0.0 111.405 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 74.8 mt -59.47 -54.18 38.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.802 -177.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 44.9 tp -61.25 -44.66 96.89 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.961 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -51.98 -44.87 64.23 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.472 ' NH2' ' CB ' ' D' ' 54' ' ' PHE . 65.8 ttt180 -61.2 -50.89 71.29 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.255 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.5 mt -81.73 -131.3 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.78 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 39.5 t80 62.47 101.31 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.592 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 41.73 38.83 1.03 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.605 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 66.9 mttm 53.39 49.42 19.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.158 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.9 t -49.49 -27.37 4.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.632 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.452 ' CD1' ' O ' ' A' ' 45' ' ' ARG . 3.6 mp -47.5 -45.33 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.9 0.381 . . . . 0.0 110.093 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.519 ' CE2' ' OE1' ' A' ' 56' ' ' GLU . 86.8 t80 -71.15 -29.04 64.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.175 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.527 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 79.5 mtp180 -69.02 -45.53 70.27 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.027 0.441 . . . . 0.0 110.33 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -70.69 -37.11 73.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.651 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -67.91 -39.91 83.49 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 120.629 -0.429 . . . . 0.0 111.661 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.519 ' OE1' ' CE2' ' A' ' 52' ' ' TYR . 21.9 pt-20 -76.41 -40.1 51.72 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.145 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.527 ' ND1' ' O ' ' A' ' 53' ' ' ARG . 32.6 m170 -64.77 -45.84 84.65 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.757 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.9 -27.89 73.18 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.774 -0.931 . . . . 0.0 110.774 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.9 tp -85.86 50.28 1.94 Allowed 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.807 0.337 . . . . 0.0 110.425 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.558 -179.868 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -159.86 70.16 3.12 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.72 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -51.63 -32.87 46.43 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.492 2.128 . . . . 0.0 111.27 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.462 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 19.2 tp -61.5 -47.31 86.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.904 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.93 -46.15 91.82 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 91.9 t -60.56 -33.39 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -63.39 -35.65 81.12 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.77 -44.07 74.43 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.386 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 4.8 t -67.02 -51.32 56.34 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 120.081 -0.648 . . . . 0.0 111.563 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.464 HG23 ' N ' ' B' ' 33' ' ' ILE . 19.9 tt -62.72 -40.96 90.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.738 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.464 ' N ' HG23 ' B' ' 32' ' ' ILE . 17.4 tt -71.68 -28.44 31.01 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.14 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.247 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.15 -52.22 28.85 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 6.4 pt -64.27 -42.94 96.99 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.217 0 C-N-CA 120.234 -0.587 . . . . 0.0 109.902 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 11.5 tp -59.75 -39.44 84.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.67 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . 0.545 ' NE2' ' NE2' ' C' ' 37' ' ' HIS . 28.9 t60 -68.0 -54.46 18.27 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -178.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 38.5 tp -62.12 -51.54 67.48 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 120.999 0.428 . . . . 0.0 111.761 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.478 ' CD1' ' N ' ' B' ' 39' ' ' ILE . 1.2 mp -62.18 -43.36 97.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.229 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 37.0 tp -59.46 -38.49 80.9 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.98 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 6.8 t-105 -63.85 -63.23 1.22 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.998 0.428 . . . . 0.0 111.611 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.548 ' CG2' ' N ' ' B' ' 43' ' ' LEU . 8.6 tt -53.25 -50.89 44.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 119.944 -0.703 . . . . 0.0 110.74 -177.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.548 ' N ' ' CG2' ' B' ' 42' ' ' ILE . 0.5 OUTLIER -57.65 -50.23 73.86 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.46 -178.128 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -50.27 -37.27 35.17 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 63.9 ttt-85 -68.95 -50.99 44.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.084 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.438 ' O ' ' O ' ' B' ' 43' ' ' LEU . 0.3 OUTLIER -96.79 128.47 43.77 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.614 -179.398 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -162.53 -54.29 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.422 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -170.92 -60.31 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.303 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -147.87 18.46 1.13 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.316 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 47.3 t -54.34 -49.84 68.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.729 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 49.9 mt -53.84 -50.05 54.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.986 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.479 ' CE2' ' OE2' ' B' ' 56' ' ' GLU . 79.2 t80 -74.18 -30.6 62.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.748 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 20.1 mmt85 -69.15 -47.75 64.15 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.705 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . 0.409 ' HB3' HH22 ' C' ' 45' ' ' ARG . 47.9 m-85 -72.6 -39.77 67.04 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.872 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -64.08 -41.39 97.34 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 120.751 -0.379 . . . . 0.0 111.462 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . 0.479 ' OE2' ' CE2' ' B' ' 52' ' ' TYR . 10.9 pt-20 -76.92 -38.07 54.13 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 120.404 -0.519 . . . . 0.0 110.738 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -59.58 -49.27 78.4 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.35 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.21 -29.48 74.43 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 9.6 tp -87.29 58.12 4.83 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.802 0.334 . . . . 0.0 110.296 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 62.8 mttp . . . . . 0 N--CA 1.466 0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.399 -179.904 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -157.71 72.29 4.24 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.778 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -51.04 -35.69 51.62 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.485 2.123 . . . . 0.0 111.221 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . 0.414 ' O ' ' HB3' ' C' ' 29' ' ' ALA . 15.3 tp -58.16 -53.07 62.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.958 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.25 -46.09 91.0 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.044 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 89.9 t -60.25 -33.46 53.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' C' ' 26' ' ' LEU . . . -64.07 -38.39 90.9 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.95 -51.32 62.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.106 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 2.8 p -62.01 -52.27 64.67 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.595 -0.442 . . . . 0.0 112.022 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 10.1 tp -59.37 -37.71 70.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.489 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 29.6 mt -63.14 -40.86 90.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.73 -52.1 45.71 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.65 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 50.2 mm -56.7 -48.24 81.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.551 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 7.4 tp -62.73 -34.3 76.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.834 0.35 . . . . 0.0 110.816 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . 0.545 ' NE2' ' NE2' ' B' ' 37' ' ' HIS . 1.5 t60 -65.12 -50.16 67.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.431 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 11.0 mp -66.56 -44.86 81.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.411 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 30.6 mm -63.34 -47.14 93.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.268 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 34.8 mt -65.9 -40.46 91.55 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.666 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 32.7 t-105 -61.27 -54.47 43.69 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.021 0.439 . . . . 0.0 111.607 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 82.8 mt -65.43 -55.0 22.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.113 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.651 ' C ' HD13 ' C' ' 43' ' ' LEU . 2.9 tm? -59.83 -52.37 65.76 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.141 -178.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . 0.499 ' OD1' ' CE1' ' C' ' 54' ' ' PHE . 66.4 t0 -52.86 -41.77 64.6 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.107 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . 0.409 HH22 ' HB3' ' B' ' 54' ' ' PHE . 55.1 ttt-85 -59.94 -53.55 56.58 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.224 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . 0.403 ' O ' ' CB ' ' C' ' 47' ' ' PHE . 4.1 mt -84.08 -140.42 0.07 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.091 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . 0.529 ' O ' ' N ' ' C' ' 49' ' ' LYS . 7.2 t80 78.63 -164.22 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.168 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . 0.406 ' O ' ' C ' ' C' ' 49' ' ' LYS . 85.9 t80 -57.03 81.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.406 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' C' ' 47' ' ' PHE . 15.9 ptpt 33.27 53.34 0.41 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.122 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 42.9 t -57.88 -46.32 85.06 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.302 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 51' ' ' ILE . . . . . 0.553 ' H ' HD12 ' C' ' 51' ' ' ILE . 3.5 mp -43.46 -42.48 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.944 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -71.11 -31.2 67.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.455 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 53' ' ' ARG . . . . . 0.515 ' O ' ' CG ' ' C' ' 57' ' ' HIS . 76.0 mtp180 -70.13 -46.73 64.16 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.512 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . 0.499 ' CE1' ' OD1' ' C' ' 44' ' ' ASP . 32.2 m-85 -66.14 -43.49 86.93 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.29 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -61.67 -39.9 93.03 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.693 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -76.62 -22.82 53.64 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.894 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 57' ' ' HIS . . . . . 0.515 ' CG ' ' O ' ' C' ' 53' ' ' ARG . 5.8 m-70 -72.28 -46.14 57.11 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.909 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.2 -28.79 73.19 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 5.7 tp -93.21 31.26 1.5 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.78 0.324 . . . . 0.0 110.373 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt . . . . . 0 N--CA 1.469 0.479 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.496 -179.93 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 9.2 p . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . 0.461 ' O ' ' N ' ' D' ' 27' ' ' ALA . 19.2 p30 -166.06 63.11 0.82 Allowed Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.498 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -45.41 -27.3 3.18 Favored 'Trans proline' 0 C--N 1.3 -2.005 0 C-N-CA 121.518 1.478 . . . . 0.0 110.496 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 pp -67.86 -37.53 81.94 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.7 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 27' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' D' ' 24' ' ' ASP . . . -51.4 -40.38 59.16 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.741 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 90.4 t -57.58 -45.21 86.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.67 -32.79 70.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.265 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' D' ' 27' ' ' ALA . . . -67.61 -35.41 78.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.992 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 5.1 t -68.38 -50.84 50.2 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.519 -0.473 . . . . 0.0 111.081 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 63.9 mt -64.72 -40.33 88.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.407 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . 0.401 HG21 HD13 ' D' ' 33' ' ' ILE . 6.8 tt -68.95 -35.68 70.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.893 -178.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.72 -52.64 14.48 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.673 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . 0.47 HG23 ' N ' ' D' ' 36' ' ' LEU . 10.3 tp -63.15 -40.83 90.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.934 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.47 ' N ' HG23 ' D' ' 35' ' ' ILE . 52.4 tp -63.4 -37.46 87.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.755 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -63.07 -50.74 69.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.465 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 37.3 tp -57.04 -48.3 78.87 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.554 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.05 -41.26 85.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.67 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 37.9 mt -62.32 -39.41 92.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.186 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 31.5 t-105 -63.33 -54.4 37.62 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.798 0.332 . . . . 0.0 111.23 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 61.5 mt -61.77 -53.19 51.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 120.65 -0.42 . . . . 0.0 112.11 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' D' ' 46' ' ' LEU . 37.0 tp -61.51 -48.38 81.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.12 -178.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . 0.443 ' O ' ' CB ' ' D' ' 50' ' ' SER . 32.3 t70 -54.36 -45.69 72.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.209 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -60.1 -50.23 74.54 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.513 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' D' ' 43' ' ' LEU . 2.8 pp -122.73 125.62 45.9 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.056 0.455 . . . . 0.0 110.583 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -174.19 -45.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.539 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . 0.527 ' O ' ' NH1' ' D' ' 53' ' ' ARG . 77.8 t80 -172.92 67.96 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.293 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 67.2 mttm 55.94 39.48 30.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.278 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 6.6 t -64.15 -52.78 57.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.921 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 62.1 mt -49.0 -34.34 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.856 0.36 . . . . 0.0 110.264 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -72.53 -29.85 63.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.01 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 53' ' ' ARG . . . . . 0.527 ' NH1' ' O ' ' D' ' 48' ' ' PHE . 95.3 mtm-85 -72.09 -48.2 45.74 Favored 'General case' 0 CA--C 1.522 -0.122 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.616 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . 0.472 ' CB ' ' NH2' ' A' ' 45' ' ' ARG . 87.4 m-85 -68.04 -42.09 81.08 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.792 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -65.64 -40.94 93.06 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.279 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -77.18 -21.87 53.33 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.61 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -74.28 -48.71 26.82 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.318 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.41 -31.47 78.98 Favored Glycine 0 N--CA 1.46 0.265 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 59' ' ' LEU . . . . . 0.402 ' C ' ' CD1' ' D' ' 59' ' ' LEU . 0.2 OUTLIER -65.1 -62.69 1.4 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.831 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 97.3 mttt . . . . . 0 C--N 1.333 -0.131 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.573 179.675 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -167.77 70.14 0.89 Allowed Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.605 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -49.62 -29.13 18.43 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 C-N-CA 121.783 1.655 . . . . 0.0 110.905 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.411 HD13 ' HB3' ' B' ' 31' ' ' SER . 2.1 pp -70.53 -30.21 66.9 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.704 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -56.09 -40.41 73.59 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 120.586 -0.446 . . . . 0.0 109.815 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.7 t -58.54 -45.84 90.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.423 ' O ' HG22 ' A' ' 33' ' ' ILE . . . -60.45 -32.26 71.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.755 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -65.24 -47.31 77.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.553 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.5 p -65.28 -35.05 79.82 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.409 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.5 mm -66.07 -50.51 68.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.607 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.423 HG22 ' O ' ' A' ' 29' ' ' ALA . 15.4 tt -68.87 -28.61 40.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.795 -179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.99 -48.86 30.69 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.497 -0.858 . . . . 0.0 111.121 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.0 mm -64.51 -44.49 96.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.808 0.337 . . . . 0.0 110.162 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.2 tp -63.63 -39.21 93.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.034 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -63.32 -46.1 88.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.268 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 16.6 tp -65.66 -47.55 75.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.843 0.354 . . . . 0.0 111.535 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 29.2 mm -61.66 -50.1 81.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.408 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -65.77 -33.02 74.9 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.23 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 21.0 t-105 -64.3 -52.62 57.64 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.811 0.339 . . . . 0.0 111.406 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.3 mt -67.75 -50.38 60.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.82 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.469 HD11 ' CD1' ' A' ' 47' ' ' PHE . 22.7 tp -61.94 -44.89 95.83 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.03 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.439 ' O ' ' CB ' ' A' ' 50' ' ' SER . 28.4 t70 -58.99 -44.58 91.63 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.811 -0.355 . . . . 0.0 110.119 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 61.8 ttt85 -60.39 -45.04 95.0 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.612 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.5 pp -135.74 129.9 33.32 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.919 0.39 . . . . 0.0 110.996 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.469 ' CD1' HD11 ' A' ' 43' ' ' LEU . 60.2 t80 -173.83 -33.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.366 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.471 ' CD2' ' O ' ' A' ' 48' ' ' PHE . 52.9 t80 -172.52 45.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.164 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt 73.28 40.69 0.52 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.235 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.462 ' O ' ' N ' ' A' ' 53' ' ' ARG . 9.8 t -62.12 -46.24 89.89 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.004 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 91.2 mt -44.13 -38.97 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.025 0.44 . . . . 0.0 110.26 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -74.99 -28.26 60.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.217 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.53 ' O ' ' CD2' ' A' ' 57' ' ' HIS . 87.1 mtt180 -68.76 -49.48 58.33 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 121.007 0.432 . . . . 0.0 110.344 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -71.35 -39.97 70.96 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.876 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -64.76 -40.35 95.15 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.795 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -76.86 -41.17 45.0 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.971 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.53 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 9.2 m-70 -59.73 -48.43 81.73 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.665 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.01 -28.32 73.75 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.6 tp -88.43 50.45 1.97 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.762 0.315 . . . . 0.0 110.335 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.599 -179.948 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 12.3 m . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 51.29 69.02 2.78 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.683 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -49.95 -36.75 44.93 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.447 2.098 . . . . 0.0 111.242 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.442 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 18.2 tp -57.5 -50.72 72.16 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.939 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.21 -51.24 70.4 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 93.1 t -54.6 -38.82 43.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -57.86 -40.25 79.71 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.72 -40.14 94.83 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.232 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . 0.411 ' HB3' HD13 ' A' ' 26' ' ' LEU . 31.9 p -67.22 -55.76 12.7 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.587 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.446 HG23 ' N ' ' B' ' 33' ' ' ILE . 18.5 tt -59.7 -41.13 84.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.904 -178.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.446 ' N ' HG23 ' B' ' 32' ' ' ILE . 16.3 tt -70.05 -29.76 41.28 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.213 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.76 -51.05 37.76 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.0 mp -61.03 -43.66 96.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 12.3 tp -60.91 -38.24 85.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.684 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -66.94 -52.72 39.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.706 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 42.0 tp -62.45 -50.54 71.06 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.602 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.453 HD13 ' HA ' ' B' ' 39' ' ' ILE . 14.7 mm -61.36 -42.19 92.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.423 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 6.4 tt -61.91 -38.82 89.82 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.075 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 49.9 t-105 -63.65 -55.49 23.12 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 60.2 mt -63.65 -53.47 44.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.767 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.503 HD23 ' O ' ' B' ' 43' ' ' LEU . 0.8 OUTLIER -57.88 -47.34 83.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.128 -178.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -59.72 -45.98 90.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.928 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -58.71 -52.33 66.17 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.058 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.11 129.82 56.77 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 120.996 0.427 . . . . 0.0 110.277 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -175.04 -55.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.296 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -169.31 71.74 0.08 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.306 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 49.5 mttp 60.14 30.19 19.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.469 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 11.0 t -56.31 -50.84 70.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.857 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 59.2 mt -51.9 -44.37 37.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.889 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.494 ' CE2' ' OE1' ' B' ' 56' ' ' GLU . 78.2 t80 -71.99 -32.2 66.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.474 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.529 ' O ' ' CG ' ' B' ' 57' ' ' HIS . 78.7 mtp180 -67.67 -45.99 73.66 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.724 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -71.89 -38.94 69.91 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.792 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -64.18 -41.22 97.19 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.49 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . 0.494 ' OE1' ' CE2' ' B' ' 52' ' ' TYR . 21.1 pt-20 -76.78 -39.02 52.96 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.692 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' HIS . . . . . 0.529 ' CG ' ' O ' ' B' ' 53' ' ' ARG . 6.4 m-70 -58.63 -48.21 81.76 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.657 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.31 -28.5 73.64 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 11.0 mp -104.64 66.68 0.79 Allowed 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 97.6 mttt . . . . . 0 N--CA 1.466 0.336 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.362 -179.791 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 49.14 68.66 3.3 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.674 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -51.65 -31.57 41.28 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.496 2.131 . . . . 0.0 111.186 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' C' ' 29' ' ' ALA . 3.0 pp -60.69 -28.24 68.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.781 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -46.94 -38.9 11.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.259 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 68.2 t -59.78 -40.96 84.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' C' ' 26' ' ' LEU . . . -62.33 -34.42 76.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.392 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.18 -49.5 69.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.927 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 4.4 p -64.6 -50.79 65.81 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 3.2 tp -60.17 -37.94 75.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.559 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 51.1 mt -67.73 -38.0 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.654 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.5 -51.81 34.46 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.804 -0.713 . . . . 0.0 111.967 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 9.6 pt -64.45 -37.9 81.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.467 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 13.0 tp -65.7 -40.73 92.59 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -63.86 -52.61 59.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.587 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 50.9 tp -63.63 -47.8 79.87 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.652 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 84.4 mt -59.92 -45.35 95.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.143 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.5 -38.82 92.34 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.906 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 25.7 t-105 -59.46 -57.21 13.99 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.334 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 54.1 mt -63.75 -54.53 30.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -177.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.501 HD23 ' O ' ' C' ' 43' ' ' LEU . 0.8 OUTLIER -58.45 -48.98 78.96 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.75 0.309 . . . . 0.0 111.191 -178.443 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . 0.502 ' O ' ' CB ' ' C' ' 50' ' ' SER . 38.7 t70 -57.49 -48.67 78.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.986 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . 0.488 ' NH1' HD11 ' C' ' 51' ' ' ILE . 34.2 ttt-85 -56.79 -52.8 63.65 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.229 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' C' ' 43' ' ' LEU . 2.6 pp -113.68 129.94 56.49 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.132 0.491 . . . . 0.0 110.977 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -173.81 -39.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.329 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -169.51 -67.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.368 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -150.44 25.63 0.78 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.096 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . 0.502 ' CB ' ' O ' ' C' ' 44' ' ' ASP . 6.6 t -50.23 -53.65 26.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.559 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 51' ' ' ILE . . . . . 0.488 HD11 ' NH1' ' C' ' 45' ' ' ARG . 66.3 mt -50.68 -49.41 25.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.212 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -73.6 -31.11 63.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.687 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 53' ' ' ARG . . . . . 0.528 ' O ' ' CD2' ' C' ' 57' ' ' HIS . 84.3 mtt-85 -70.42 -49.4 49.24 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.428 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -67.36 -41.47 85.05 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.351 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -62.61 -38.68 91.13 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 120.484 -0.487 . . . . 0.0 110.809 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -78.67 -22.48 46.71 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.916 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 57' ' ' HIS . . . . . 0.528 ' CD2' ' O ' ' C' ' 53' ' ' ARG . 55.2 m170 -73.26 -48.24 36.42 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.355 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.91 -27.69 70.66 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 10.9 mp -105.42 66.87 0.75 Allowed 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.453 -179.89 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 26.5 p . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -162.23 83.7 1.64 Allowed Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.083 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . 0.425 ' O ' ' N ' ' D' ' 29' ' ' ALA . 76.0 Cg_exo -49.41 -37.86 42.11 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 121.863 1.709 . . . . 0.0 110.819 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . 0.443 ' O ' ' HB3' ' D' ' 29' ' ' ALA . 25.9 tp -56.48 -48.47 77.07 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.2 -51.2 71.0 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.21 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 89.3 t -60.28 -29.16 43.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.57 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' D' ' 26' ' ' LEU . . . -66.88 -37.05 83.68 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.32 -38.41 74.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.561 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 1.4 m -68.98 -47.57 65.25 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.7 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . 0.435 HG23 ' N ' ' D' ' 33' ' ' ILE . 10.0 tp -69.11 -41.22 81.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.632 -178.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . 0.435 ' N ' HG23 ' D' ' 32' ' ' ILE . 9.9 tt -67.06 -39.95 84.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.498 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.65 -51.03 32.73 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.879 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . 0.426 ' O ' HD13 ' D' ' 35' ' ' ILE . 0.2 OUTLIER -59.93 -43.59 92.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.409 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.405 ' N ' ' CG2' ' D' ' 35' ' ' ILE . 49.7 tp -60.41 -39.6 87.96 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.89 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -61.35 -48.4 81.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.29 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 57.4 tp -55.47 -52.79 62.46 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.837 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . 0.408 HD13 ' CD1' ' D' ' 35' ' ' ILE . 1.4 mp -61.88 -33.23 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.443 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 6.1 tp -65.49 -42.97 91.56 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.717 0.294 . . . . 0.0 110.576 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 21.9 t-105 -66.13 -58.75 4.74 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 120.883 0.373 . . . . 0.0 111.54 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . 0.519 ' CG2' ' N ' ' D' ' 43' ' ' LEU . 9.1 tt -60.47 -47.39 92.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.466 -177.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.519 ' N ' ' CG2' ' D' ' 42' ' ' ILE . 23.0 tp -63.43 -44.86 93.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.564 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . 0.516 ' OD1' ' CE1' ' D' ' 54' ' ' PHE . 40.8 t0 -56.44 -37.69 70.59 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . 0.512 ' HB3' HD23 ' D' ' 46' ' ' LEU . 12.4 ttm180 -69.42 -53.53 18.86 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.895 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . 0.512 HD23 ' HB3' ' D' ' 45' ' ' ARG . 0.2 OUTLIER -117.08 113.5 22.39 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.987 0.422 . . . . 0.0 110.149 179.367 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -174.8 83.9 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.074 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 54.97 71.61 0.53 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.525 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 98.5 mttt 51.2 48.89 22.18 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.289 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 2.6 t -68.79 -52.85 25.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.127 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 9.4 mt -47.74 -37.54 5.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.087 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -73.87 -31.27 63.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.133 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -71.08 -47.2 59.67 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.877 0.37 . . . . 0.0 110.772 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . 0.516 ' CE1' ' OD1' ' D' ' 44' ' ' ASP . 64.9 m-85 -71.74 -37.35 70.59 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.763 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -67.84 -41.16 83.41 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.615 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -76.71 -36.96 56.86 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.72 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 62.7 t-80 -63.49 -48.31 78.15 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.299 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.04 -27.91 73.55 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 5.9 tp -92.96 39.07 1.03 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.871 0.367 . . . . 0.0 110.326 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 3.1 tmtm? . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.386 -179.666 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.1 t . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 51.31 70.86 1.73 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.854 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.35 -34.05 48.52 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.603 2.202 . . . . 0.0 111.661 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 pp -62.64 -29.8 70.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.06 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.457 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -50.48 -34.48 25.14 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.152 0.501 . . . . 0.0 109.982 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.2 t -59.13 -48.81 85.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 CA-C-O 121.539 0.685 . . . . 0.0 109.274 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.22 -30.69 71.27 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.567 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -63.68 -47.36 81.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.213 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.9 t -62.22 -48.07 81.6 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.866 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.2 mp -62.12 -33.51 58.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.293 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 38.4 mt -70.49 -38.92 75.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 121.123 -0.231 . . . . 0.0 110.759 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.15 -53.48 18.08 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.393 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.464 HG23 ' N ' ' A' ' 36' ' ' LEU . 19.2 tt -60.24 -41.1 85.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.728 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.464 ' N ' HG23 ' A' ' 35' ' ' ILE . 40.5 tp -66.42 -30.87 71.33 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.35 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -68.55 -48.97 62.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.472 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.5 mp -63.86 -50.36 69.15 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.978 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 86.1 mt -62.13 -48.1 90.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.378 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.7 tp -61.08 -42.1 97.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.701 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.7 t-105 -62.46 -56.26 19.85 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 120.865 0.364 . . . . 0.0 111.518 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.03 -55.24 24.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.871 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.2 tp -61.24 -48.15 82.78 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.289 -0.564 . . . . 0.0 111.36 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -53.58 -39.15 64.6 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 42.1 ttt-85 -63.49 -51.17 66.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.442 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 48' ' ' PHE . 7.1 mt -83.18 -77.05 0.26 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.023 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.416 ' CD2' ' N ' ' A' ' 48' ' ' PHE . 88.4 t80 46.69 -88.25 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.415 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.534 ' N ' ' O ' ' A' ' 46' ' ' LEU . 62.5 t80 -164.39 87.33 0.48 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.099 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm 59.14 27.47 16.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.13 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.8 t -59.78 -44.47 93.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.657 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.439 ' H ' HD12 ' A' ' 51' ' ' ILE . 3.3 mp -52.19 -36.38 20.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.01 0.433 . . . . 0.0 110.068 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.495 ' CD2' ' OE2' ' A' ' 56' ' ' GLU . 81.4 t80 -74.01 -27.78 61.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.221 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 48' ' ' PHE . 68.2 mtt85 -69.97 -49.33 52.76 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.96 0.409 . . . . 0.0 110.559 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -72.03 -39.17 69.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.945 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -66.79 -39.69 87.86 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.711 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.495 ' OE2' ' CD2' ' A' ' 52' ' ' TYR . 10.1 pt-20 -76.17 -40.36 52.66 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.658 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.529 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 6.4 m-70 -60.68 -47.43 86.29 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.54 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.68 -30.11 75.8 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.6 tp -87.8 27.63 1.13 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.95 0.375 . . . . 0.0 110.316 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.013 -179.771 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 94.8 p . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -160.83 79.4 2.31 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.709 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -50.4 -29.33 23.56 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.511 2.141 . . . . 0.0 111.606 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 14.3 tp -61.64 -52.29 64.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.189 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' B' ' 30' ' ' ALA . . . -58.98 -46.34 88.36 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.609 0.719 . . . . 0.0 109.384 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 72.5 t -56.69 -47.11 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.1 -44.38 52.07 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' B' ' 27' ' ' ALA . . . -56.69 -50.35 72.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.796 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 60.7 p -57.45 -48.81 78.19 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 120.309 -0.557 . . . . 0.0 111.447 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 34.1 mm -59.67 -35.64 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.114 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 86.3 mt -70.24 -34.43 58.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.572 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.85 -52.94 21.86 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.497 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 7.9 pt -64.7 -39.97 87.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.1 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 37.3 tp -62.23 -40.03 94.8 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.47 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 22.3 t-160 -66.85 -53.68 30.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.732 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 34.8 tp -61.99 -53.21 58.74 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.737 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 56.7 mt -60.48 -44.22 95.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.794 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 32.5 tp -56.72 -43.26 80.42 Favored 'General case' 0 C--O 1.222 -0.364 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 21.7 t-105 -60.44 -54.19 48.58 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.161 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 5.2 mm -54.02 -58.34 3.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-O 121.237 0.541 . . . . 0.0 111.921 -177.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.665 ' C ' HD12 ' B' ' 43' ' ' LEU . 0.3 OUTLIER -62.4 -35.8 80.33 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.78 -178.488 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . 0.429 ' O ' ' OG ' ' B' ' 50' ' ' SER . 22.8 t70 -58.1 -44.84 87.87 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -65.77 -45.01 84.09 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.444 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.509 ' C ' ' H ' ' B' ' 48' ' ' PHE . 0.3 OUTLIER -113.74 -120.49 0.3 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.098 179.485 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.482 ' H ' HD12 ' B' ' 46' ' ' LEU . 37.3 t80 68.06 -35.29 0.27 Allowed 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.15 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . 0.509 ' H ' ' C ' ' B' ' 46' ' ' LEU . 31.0 t80 -169.06 42.97 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.678 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt 45.05 40.38 4.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.57 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . 0.461 ' O ' ' N ' ' B' ' 53' ' ' ARG . 1.4 p -61.8 -24.02 66.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.857 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 9.4 mt -41.55 -41.05 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.878 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -74.25 -29.69 61.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.379 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.461 ' N ' ' O ' ' B' ' 50' ' ' SER . 99.2 mtt180 -71.53 -47.61 54.11 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.935 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . 0.596 ' CE1' ' NH2' ' C' ' 45' ' ' ARG . 66.6 m-85 -72.81 -39.7 66.43 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.939 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -67.87 -39.26 83.76 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.644 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -76.93 -38.83 52.62 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.614 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -62.02 -47.29 85.42 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.259 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.12 -27.48 72.95 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 35.2 tp -79.85 -73.76 0.33 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.711 0.291 . . . . 0.0 110.541 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 68.5 mttm . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.601 -179.995 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 17.9 m . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . 0.459 ' HB2' ' HB3' ' C' ' 27' ' ' ALA . 0.7 OUTLIER -177.54 56.53 0.11 Allowed Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.493 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.77 -30.42 68.91 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.104 1.869 . . . . 0.0 110.698 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . 0.431 ' O ' ' HB3' ' C' ' 29' ' ' ALA . 19.2 tp -68.8 -48.26 64.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.068 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 27' ' ' ALA . . . . . 0.459 ' HB3' ' HB2' ' C' ' 24' ' ' ASP . . . -59.61 -46.91 87.58 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.234 0.54 . . . . 0.0 109.615 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 82.1 t -59.39 -34.34 54.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.247 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' C' ' 26' ' ' LEU . . . -63.91 -34.85 78.88 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.47 -42.71 78.35 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.231 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 6.6 t -68.45 -48.48 64.45 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.189 -0.604 . . . . 0.0 111.802 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . 0.406 HG23 ' N ' ' C' ' 33' ' ' ILE . 14.6 tt -66.03 -40.84 88.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.64 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . 0.406 ' N ' HG23 ' C' ' 32' ' ' ILE . 14.7 tt -69.22 -36.4 72.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.703 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.09 -51.45 38.97 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 120.497 -0.858 . . . . 0.0 110.973 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 34.7 mm -60.6 -41.21 87.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 13.4 tp -60.45 -45.02 95.18 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.361 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . 0.476 ' C ' ' ND1' ' C' ' 37' ' ' HIS . 9.1 t-80 -60.82 -52.29 65.71 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.84 0.352 . . . . 0.0 111.379 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 55.4 tp -56.6 -48.62 77.04 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.05 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 56.1 mt -63.79 -34.47 68.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.006 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . 0.516 HD13 ' O ' ' C' ' 40' ' ' LEU . 0.2 OUTLIER -64.52 -48.64 74.37 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.633 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 15.3 t-105 -62.81 -56.96 12.74 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 73.6 mt -59.48 -51.91 67.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.872 -177.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.622 ' C ' HD13 ' C' ' 43' ' ' LEU . 2.8 tm? -58.87 -50.77 72.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.504 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -56.88 -35.16 68.62 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.025 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . 0.596 ' NH2' ' CE1' ' B' ' 54' ' ' PHE . 50.8 ttp180 -69.95 -57.68 4.74 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.831 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' C' ' 43' ' ' LEU . 1.1 pp -108.17 -164.34 0.95 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.66 0.267 . . . . 0.0 111.058 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 12.2 t80 74.42 -11.12 1.05 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.919 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' C' ' 49' ' ' LYS . 32.2 t80 -164.09 158.0 18.84 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.468 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . 0.541 ' N ' ' CD1' ' C' ' 48' ' ' PHE . 36.5 tttm -72.52 42.38 0.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.285 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . 0.456 ' H ' ' C ' ' C' ' 48' ' ' PHE . 6.7 t -66.47 -47.5 72.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.0 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 71.5 mt -43.95 -42.17 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.941 -0.303 . . . . 0.0 111.306 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -72.47 -29.82 64.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.302 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -71.3 -49.66 40.51 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.535 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . 0.404 ' CB ' ' NH2' ' D' ' 45' ' ' ARG . 45.7 m-85 -65.68 -44.24 86.83 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.38 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -63.06 -36.47 83.69 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.527 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -75.53 -24.77 56.79 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.63 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -73.34 -46.14 51.06 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 120.241 -0.584 . . . . 0.0 109.836 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.51 -27.2 73.94 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 8.8 tp -90.67 57.21 3.52 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-O 120.801 0.334 . . . . 0.0 110.49 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 86.9 tttt . . . . . 0 N--CA 1.467 0.393 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.447 -179.929 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 46.8 t . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 48.43 90.06 0.08 OUTLIER Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.62 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -47.61 -30.12 11.8 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.945 1.763 . . . . 0.0 111.263 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 16.9 tp -61.53 -51.72 67.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.652 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.63 -44.99 93.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.44 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 88.9 t -59.48 -38.44 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.88 -35.32 76.33 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.93 -51.12 59.15 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.08 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 6.1 p -61.18 -50.52 72.82 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.786 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 3.3 tp -62.11 -37.65 78.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.596 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 29.4 mt -62.72 -41.31 91.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 120.399 -0.521 . . . . 0.0 109.673 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.97 -46.15 83.31 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.06 -0.59 . . . . 0.0 111.957 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.61 -47.48 93.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.918 0.389 . . . . 0.0 110.523 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 21.6 tp -64.18 -32.17 73.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.055 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -64.87 -49.94 68.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.005 0.431 . . . . 0.0 110.523 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 46.9 tp -63.12 -46.55 86.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.1 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.42 -47.62 91.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.122 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -62.54 -37.88 87.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.241 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 40.4 t-105 -62.27 -57.29 11.94 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.524 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 62.0 mt -61.45 -53.57 46.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.954 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 55.9 tp -58.76 -47.22 85.43 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.946 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -54.33 -45.26 72.62 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . 0.424 ' HB3' HD23 ' D' ' 46' ' ' LEU . 77.0 ttt180 -59.18 -53.13 61.84 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.402 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . 0.424 HD23 ' HB3' ' D' ' 45' ' ' ARG . 0.1 OUTLIER -109.91 113.3 25.92 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 120.904 0.383 . . . . 0.0 110.185 179.055 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -173.67 91.89 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.42 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 54.29 59.19 4.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.416 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . 0.462 ' HZ2' ' HB3' ' D' ' 49' ' ' LYS . 5.2 mtpm? 53.69 54.61 9.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.49 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 5.6 t -68.11 -52.01 39.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.134 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 58.0 mt -48.5 -35.13 5.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.627 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -70.81 -29.93 66.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.085 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -69.63 -42.62 74.08 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.963 0.411 . . . . 0.0 110.464 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -72.09 -39.37 69.0 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.802 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -66.09 -40.74 91.04 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.511 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 56' ' ' GLU . . . . . 0.44 ' CD ' ' N ' ' D' ' 57' ' ' HIS . 2.9 pp20? -76.39 -37.13 57.6 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.501 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 57' ' ' HIS . . . . . 0.44 ' N ' ' CD ' ' D' ' 56' ' ' GLU . 86.3 t60 -60.69 -51.69 68.28 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.275 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.07 -26.66 73.42 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 14.7 tp -152.86 88.0 1.31 Allowed 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 64.5 mttp . . . . . 0 N--CA 1.458 -0.042 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.497 -179.617 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.3 p . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 46.01 73.38 1.0 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.734 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.78 -34.68 55.62 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.474 2.116 . . . . 0.0 111.226 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.439 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 16.2 tp -63.65 -53.22 54.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.032 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.2 -41.93 85.06 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 95.8 t -63.41 -32.35 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.241 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 26' ' ' LEU . . . -65.48 -36.21 83.2 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.43 -50.12 55.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.955 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.8 p -61.15 -50.09 74.57 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.683 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.0 tp -63.98 -34.19 66.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.072 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.1 mt -68.44 -43.04 84.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.553 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.28 -51.45 37.96 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.013 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 35' ' ' ILE . 9.7 tt -62.27 -40.09 86.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.017 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.402 ' N ' ' CG2' ' A' ' 35' ' ' ILE . 48.5 tp -64.57 -36.02 82.88 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.304 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -67.33 -50.9 58.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.803 0.335 . . . . 0.0 110.964 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 26.9 tp -61.74 -52.65 63.4 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.713 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 60.9 mt -62.73 -48.4 88.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.097 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 43.3 tp -54.78 -43.29 72.68 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 17.8 t-105 -60.67 -54.37 46.12 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.304 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.436 ' CG2' ' N ' ' A' ' 43' ' ' LEU . 1.0 OUTLIER -54.27 -48.9 66.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.002 -177.601 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.436 ' N ' ' CG2' ' A' ' 42' ' ' ILE . 20.6 tp -64.4 -41.9 96.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.386 -178.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -59.45 -36.24 75.57 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -71.18 -51.45 24.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.823 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.6 pp -123.67 125.34 44.61 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.109 0.48 . . . . 0.0 110.707 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -173.95 -43.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.251 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -172.48 67.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.263 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 68.2 mttm 55.43 38.55 30.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.411 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 34.8 t -63.35 -48.07 79.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.806 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 80.0 mt -48.69 -39.1 10.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.926 0.393 . . . . 0.0 109.989 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.517 ' CE2' ' OE2' ' A' ' 56' ' ' GLU . 93.3 t80 -70.98 -29.56 65.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.314 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.515 ' O ' ' CD2' ' A' ' 57' ' ' HIS . 90.2 mtt-85 -69.12 -44.17 72.93 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.125 0.488 . . . . 0.0 110.388 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.524 ' CB ' HH21 ' B' ' 45' ' ' ARG . 58.2 m-85 -70.94 -40.68 71.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.804 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -65.75 -39.27 90.91 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.744 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.517 ' OE2' ' CE2' ' A' ' 52' ' ' TYR . 12.5 pt-20 -76.47 -40.43 50.42 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.902 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.515 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 6.9 m-70 -60.98 -52.26 65.75 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.487 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.27 -25.76 73.7 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.5 tp -148.1 87.78 1.62 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm . . . . . 0 C--N 1.333 -0.136 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.644 -179.739 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 70.7 m . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -160.04 80.87 2.41 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.682 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -50.7 -33.04 38.47 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.407 2.072 . . . . 0.0 111.309 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.454 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 17.7 tp -61.13 -51.2 70.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.064 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.75 -42.42 97.38 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 91.6 t -61.67 -34.91 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -61.37 -40.41 94.2 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.94 -50.98 68.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.07 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 4.3 p -60.17 -53.11 61.64 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 8.8 tp -60.16 -38.48 77.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.993 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 69.2 mt -64.41 -40.3 88.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.029 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.8 -52.31 49.31 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 48.4 mm -56.36 -43.38 77.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.971 0.415 . . . . 0.0 110.034 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 11.4 tp -62.12 -36.1 80.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.654 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . 0.607 ' NE2' ' NE2' ' C' ' 37' ' ' HIS . 18.8 t60 -67.96 -54.43 18.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.942 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 40.2 tp -62.68 -49.94 73.11 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.63 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' B' ' 39' ' ' ILE . 15.8 mm -62.29 -44.03 98.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.513 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 43.8 tp -59.17 -39.9 83.95 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.534 -0.466 . . . . 0.0 109.877 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 21.8 t-105 -63.47 -56.28 17.38 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.413 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 94.6 mt -55.41 -51.57 55.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.141 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 mt -60.21 -44.82 94.83 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.216 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -58.71 -37.82 76.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.805 0.336 . . . . 0.0 110.657 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.524 HH21 ' CB ' ' A' ' 54' ' ' PHE . 61.8 ttt85 -68.93 -48.34 63.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.067 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.416 HD23 ' HB3' ' B' ' 45' ' ' ARG . 0.1 OUTLIER -118.46 111.8 19.12 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 120.974 0.416 . . . . 0.0 110.371 179.503 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -175.46 87.79 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.185 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 48.8 t80 58.43 60.41 2.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.462 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp 54.76 47.88 21.43 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.522 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 6.5 t -62.93 -49.82 73.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.859 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 10.9 mt -48.55 -40.82 11.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.704 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -71.34 -28.69 64.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.53 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -69.38 -43.51 73.37 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.606 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -73.47 -44.58 57.7 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.938 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -62.93 -40.08 96.53 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.513 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -77.49 -37.32 51.42 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.549 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -58.63 -48.19 81.87 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.348 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.32 -33.07 84.99 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -81.89 -72.36 0.44 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 63.4 tttm . . . . . 0 C--N 1.331 -0.209 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.379 -179.896 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 29.6 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -159.96 71.3 3.14 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.856 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -51.26 -30.96 35.19 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.446 2.097 . . . . 0.0 111.273 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 12.0 tp -61.02 -52.04 66.68 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.906 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 27' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' C' ' 30' ' ' ALA . . . -60.27 -46.59 89.31 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.019 178.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 76.5 t -57.15 -47.27 84.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.79 -42.2 57.85 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' C' ' 27' ' ' ALA . . . -59.13 -49.58 77.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.919 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 1.1 p -57.8 -50.94 71.59 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.283 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 22.1 mm -61.79 -29.57 46.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.65 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 2.3 mm -68.18 -41.35 83.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.35 -52.64 25.61 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.574 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 48.1 mm -60.88 -43.98 96.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.887 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 12.5 tp -63.93 -40.67 96.98 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . 0.607 ' NE2' ' NE2' ' B' ' 37' ' ' HIS . 57.1 t60 -60.95 -48.66 80.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.88 0.371 . . . . 0.0 111.173 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . 0.439 HD11 HD11 ' C' ' 42' ' ' ILE . 29.6 tp -65.05 -50.8 64.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.106 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 4.3 mm -60.21 -47.52 91.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.389 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . 0.407 ' O ' ' CB ' ' C' ' 44' ' ' ASP . 3.1 mm? -64.58 -36.95 85.9 Favored 'General case' 0 C--O 1.22 -0.476 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.036 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . 0.458 ' CZ3' ' CZ2' ' D' ' 41' ' ' TRP . 14.2 t-105 -60.47 -53.95 51.41 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.141 0.495 . . . . 0.0 111.257 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . 0.439 HD11 HD11 ' C' ' 38' ' ' LEU . 90.4 mt -66.85 -56.41 14.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.052 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.491 HD23 ' O ' ' C' ' 43' ' ' LEU . 0.6 OUTLIER -56.43 -48.19 77.52 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.642 -178.62 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . 0.407 ' CB ' ' O ' ' C' ' 40' ' ' LEU . 28.9 t70 -53.8 -45.7 70.84 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 60.3 ttt85 -58.22 -52.19 66.61 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.069 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 9.8 mt -72.28 -76.87 0.1 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.511 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . 0.492 ' CG ' ' N ' ' C' ' 48' ' ' PHE . 37.4 t80 52.4 -177.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.176 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . 0.492 ' N ' ' CG ' ' C' ' 47' ' ' PHE . 39.0 m-85 -56.24 -41.36 75.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.954 0.407 . . . . 0.0 110.34 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -171.91 48.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.102 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 5.1 t -69.95 -45.88 66.5 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.65 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 64.5 mt -44.48 -55.68 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -74.96 -34.91 62.1 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 53' ' ' ARG . . . . . 0.526 ' O ' ' CD2' ' C' ' 57' ' ' HIS . 96.9 mtt180 -71.24 -49.99 37.59 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.819 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -66.04 -43.85 86.32 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.232 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -63.22 -36.64 84.33 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.702 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -77.58 -23.61 49.92 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 120.384 -0.527 . . . . 0.0 110.879 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 57' ' ' HIS . . . . . 0.526 ' CD2' ' O ' ' C' ' 53' ' ' ARG . 15.6 m-70 -73.5 -48.69 31.29 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.038 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.38 -31.21 79.66 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 18.0 tp -65.16 -58.54 5.75 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.758 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 65.9 tttm . . . . . 0 C--N 1.331 -0.196 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.518 179.906 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 89.0 p . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -157.19 58.54 1.56 Allowed Pre-proline 0 N--CA 1.465 0.288 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.634 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.56 -29.61 36.61 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.022 1.815 . . . . 0.0 110.8 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . 0.453 ' O ' ' HB3' ' D' ' 29' ' ' ALA . 14.1 tp -60.29 -51.96 67.3 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.509 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.46 -47.9 82.5 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 94.4 t -58.47 -33.73 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.197 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' D' ' 26' ' ' LEU . . . -64.43 -35.77 81.99 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.41 -39.09 81.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.392 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.96 -53.44 26.14 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.28 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . 0.415 HG23 ' N ' ' D' ' 33' ' ' ILE . 16.8 tt -62.65 -40.12 87.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.67 -178.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . 0.418 HG21 HD13 ' D' ' 33' ' ' ILE . 9.2 tt -70.05 -30.7 44.94 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 C-N-CA 120.179 -0.608 . . . . 0.0 110.282 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.68 -53.3 16.67 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 2.1 mp -60.87 -43.92 96.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 11.9 tp -62.31 -34.55 76.82 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.447 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 21.5 t-160 -66.09 -49.99 65.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.655 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 50.2 tp -60.33 -50.94 71.64 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.045 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 4.9 mm -60.26 -43.44 93.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 33.6 mt -61.56 -40.88 96.31 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.272 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . 0.458 ' CZ2' ' CZ3' ' C' ' 41' ' ' TRP . 40.4 t-105 -62.52 -53.96 47.0 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.64 0.257 . . . . 0.0 111.451 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 66.1 mt -63.49 -54.25 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -177.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' D' ' 46' ' ' LEU . 54.5 tp -61.57 -45.39 94.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.406 -178.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . 0.439 ' O ' ' CB ' ' D' ' 50' ' ' SER . 11.6 t70 -64.04 -32.39 73.93 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.466 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 56.2 ttt-85 -69.07 -56.31 8.12 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.262 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' D' ' 43' ' ' LEU . 0.1 OUTLIER -105.76 -167.39 1.31 Allowed 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.588 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 9.9 t80 72.86 124.96 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.78 0.324 . . . . 0.0 110.291 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . 0.436 ' CD2' ' O ' ' D' ' 48' ' ' PHE . 40.7 t80 59.74 20.01 8.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.424 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt 47.53 66.92 0.9 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.401 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 45.4 t -67.75 -46.57 71.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.005 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 51' ' ' ILE . . . . . 0.4 ' H ' HG13 ' D' ' 51' ' ' ILE . 55.8 mt -45.88 -40.27 3.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.84 0.352 . . . . 0.0 110.401 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -72.42 -32.91 66.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.051 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -72.01 -50.18 30.79 Favored 'General case' 0 C--N 1.335 -0.038 0 CA-C-O 120.911 0.386 . . . . 0.0 110.74 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -64.49 -42.4 95.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.25 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -63.69 -40.38 96.65 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.08 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -75.86 -20.8 57.82 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.452 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -74.13 -50.32 19.95 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.525 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.14 -27.72 73.55 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 6.4 tp -80.69 43.0 0.65 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.818 0.342 . . . . 0.0 110.421 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.579 -179.979 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.4 t . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.489 ' HB2' ' HB3' ' A' ' 27' ' ' ALA . 0.4 OUTLIER 177.01 55.44 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.614 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 31.4 Cg_endo -63.25 -30.34 73.98 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.041 1.827 . . . . 0.0 110.636 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.5 tp -69.39 -44.55 71.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.982 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.489 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . . . -64.2 -55.91 18.36 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.314 0.578 . . . . 0.0 110.015 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.2 t -55.09 -43.61 70.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.109 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 25' ' ' PRO . . . -53.61 -45.44 70.07 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.45 -48.11 77.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.873 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.79 -43.57 69.4 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 120.438 -0.505 . . . . 0.0 109.891 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.6 mt -62.5 -39.72 85.52 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.052 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 93.6 mt -66.58 -41.97 89.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.466 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.89 -51.57 33.93 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.047 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.52 HG23 ' N ' ' A' ' 36' ' ' LEU . 14.9 tt -62.65 -43.56 98.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.34 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.52 ' N ' HG23 ' A' ' 35' ' ' ILE . 9.9 tp -63.96 -33.57 76.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.301 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -66.73 -53.54 32.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.829 0.347 . . . . 0.0 111.217 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.2 tp -59.85 -48.43 81.73 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.975 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.4 mm -61.47 -41.83 91.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.795 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.2 mt -59.98 -45.28 93.24 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.288 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 15.4 t-105 -61.52 -57.7 11.07 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.608 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 94.6 mt -56.88 -56.31 15.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -177.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 47' ' ' PHE . 24.1 tp -61.45 -51.29 69.33 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.208 -178.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -47.36 -40.54 17.62 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.445 ' NH2' ' CB ' ' D' ' 54' ' ' PHE . 61.4 ttt180 -64.37 -52.43 58.32 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.143 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.48 33.62 1.98 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.884 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.457 ' N ' ' O ' ' A' ' 43' ' ' LEU . 66.1 t80 -85.26 84.92 7.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.772 0.32 . . . . 0.0 110.571 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.5 t80 56.55 60.86 2.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.45 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 51.29 27.35 3.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.491 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.9 t -49.68 -30.42 9.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.565 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.1 mt -50.01 -41.26 17.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.954 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -73.55 -28.36 61.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.142 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.521 ' O ' ' CD2' ' A' ' 57' ' ' HIS . 0.8 OUTLIER -69.98 -48.77 56.91 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.309 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.467 ' CB ' ' NH2' ' B' ' 45' ' ' ARG . 53.6 m-85 -71.23 -37.24 72.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.95 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -68.31 -39.13 82.1 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.734 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -77.38 -40.94 42.06 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.102 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.521 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 21.5 m-70 -64.07 -47.37 80.39 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.751 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.92 -27.67 70.67 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.9 tp -88.18 49.55 1.82 Allowed 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.804 0.335 . . . . 0.0 110.395 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.4 ttpp . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.565 -179.927 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 27.5 m . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -160.82 76.12 2.59 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.738 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.04 -31.34 53.4 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.437 2.092 . . . . 0.0 111.278 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.411 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 16.5 tp -60.2 -51.2 70.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.903 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.27 -45.45 93.27 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 89.1 t -60.04 -36.55 68.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.094 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -61.5 -35.75 78.57 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.91 -45.15 75.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.325 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 8.0 p -66.01 -52.64 47.5 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.524 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.479 HG23 ' N ' ' B' ' 33' ' ' ILE . 20.4 tt -61.45 -42.32 93.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -178.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.479 ' N ' HG23 ' B' ' 32' ' ' ILE . 13.9 tt -69.38 -29.64 42.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 C-N-CA 119.794 -0.763 . . . . 0.0 110.232 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.98 -51.68 38.02 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.539 HG22 HD12 ' B' ' 39' ' ' ILE . 46.6 mm -61.26 -38.12 79.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 120.603 -0.439 . . . . 0.0 109.888 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 10.2 tp -62.55 -41.77 99.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.694 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -66.84 -51.71 52.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.888 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 39.9 tp -60.99 -49.44 77.45 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.284 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.539 HD12 HG22 ' B' ' 35' ' ' ILE . 26.7 mt -61.86 -42.08 93.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.465 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 56.3 tp -60.92 -41.25 95.79 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.271 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 41.3 t-105 -63.82 -57.77 8.85 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.785 0.326 . . . . 0.0 111.789 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 68.7 mt -59.19 -53.44 47.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.364 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.663 HD13 ' C ' ' B' ' 43' ' ' LEU . 3.1 tm? -55.94 -50.87 69.58 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.746 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -53.15 -45.43 68.43 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.945 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.467 ' NH2' ' CB ' ' A' ' 54' ' ' PHE . 65.8 ttt180 -61.43 -56.68 17.57 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.349 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.439 HD23 ' HB3' ' B' ' 45' ' ' ARG . 0.1 OUTLIER -108.61 130.99 55.31 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.05 0.452 . . . . 0.0 110.315 179.62 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.525 ' O ' ' CD2' ' B' ' 48' ' ' PHE . 63.7 t80 -174.04 -64.51 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.124 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . 0.525 ' CD2' ' O ' ' B' ' 47' ' ' PHE . 8.4 m-85 -161.25 83.65 0.64 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.813 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 64.8 mttp 53.86 27.89 7.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.535 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 8.0 t -57.67 -51.99 67.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.726 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 89.0 mt -52.92 -41.81 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.765 0.317 . . . . 0.0 110.685 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.506 ' CD2' ' OE2' ' B' ' 56' ' ' GLU . 81.7 t80 -72.46 -30.97 65.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.634 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -72.0 -46.14 58.3 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.971 0.415 . . . . 0.0 110.817 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -71.45 -38.05 71.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.99 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -70.77 -38.08 73.4 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.717 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . 0.506 ' OE2' ' CD2' ' B' ' 52' ' ' TYR . 10.4 pt-20 -76.16 -38.46 56.63 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.691 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -66.76 -45.64 77.89 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.279 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.32 -27.6 69.57 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 5.4 tp -70.14 -67.87 0.46 Allowed 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.786 0.327 . . . . 0.0 110.481 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.552 -179.939 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 54.9 68.62 2.47 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.739 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.22 -35.68 53.57 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.486 2.124 . . . . 0.0 111.466 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . 0.518 ' O ' ' HB3' ' C' ' 29' ' ' ALA . 14.2 tp -60.12 -51.11 71.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.859 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.53 -43.63 75.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.747 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 90.2 t -60.99 -32.03 51.42 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' C' ' 26' ' ' LEU . . . -64.45 -38.3 90.54 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.96 -51.89 59.3 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.058 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 5.3 t -60.57 -51.45 69.37 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.52 -0.472 . . . . 0.0 112.146 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 9.9 tp -61.84 -30.93 49.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.39 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 12.1 mt -67.0 -41.53 87.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 120.627 -0.429 . . . . 0.0 109.997 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.48 -51.22 32.72 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.933 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . 0.525 HD13 ' O ' ' C' ' 35' ' ' ILE . 0.2 OUTLIER -59.92 -45.61 94.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-O 121.378 0.608 . . . . 0.0 109.663 -179.678 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.454 ' N ' ' CG2' ' C' ' 35' ' ' ILE . 53.6 tp -60.34 -40.47 90.8 Favored 'General case' 0 C--O 1.215 -0.746 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.129 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -59.27 -52.41 65.79 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.158 0.504 . . . . 0.0 111.017 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 16.7 tp -56.38 -50.14 72.41 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.407 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 1.2 mp -65.49 -31.65 54.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.853 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . 0.489 HD13 ' O ' ' C' ' 40' ' ' LEU . 0.2 OUTLIER -64.38 -47.96 77.28 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.719 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 15.9 t-105 -63.84 -56.41 15.6 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 120.804 -0.359 . . . . 0.0 111.511 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 96.2 mt -56.84 -55.41 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.416 -0.514 . . . . 0.0 112.003 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.654 ' C ' HD13 ' C' ' 43' ' ' LEU . 3.0 tm? -61.73 -50.9 70.57 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.939 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . 0.513 ' OD2' ' NH1' ' D' ' 45' ' ' ARG . 25.3 t70 -47.14 -43.32 20.69 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.047 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 60.9 ttt-85 -64.15 -52.26 59.91 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.576 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.15 114.94 26.69 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.595 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -174.22 102.36 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.416 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . 0.402 ' O ' ' CD2' ' C' ' 48' ' ' PHE . 51.6 t80 44.37 49.87 8.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.581 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? 57.16 40.27 28.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.306 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . 0.42 ' HA ' ' HE ' ' C' ' 53' ' ' ARG . 4.6 t -62.39 -34.55 76.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.318 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 51' ' ' ILE . . . . . 0.401 HG13 ' H ' ' C' ' 51' ' ' ILE . 60.6 mt -47.34 -41.01 6.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.21 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 52' ' ' TYR . . . . . 0.478 ' CZ ' ' OE1' ' C' ' 56' ' ' GLU . 89.2 t80 -72.37 -29.41 63.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.519 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 53' ' ' ARG . . . . . 0.524 ' O ' ' CG ' ' C' ' 57' ' ' HIS . 73.1 mtm180 -71.38 -48.0 52.76 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.648 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -68.4 -41.84 79.91 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.397 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -64.44 -36.92 85.72 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.824 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . 0.478 ' OE1' ' CZ ' ' C' ' 52' ' ' TYR . 64.8 tt0 -77.94 -24.02 48.36 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.784 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 57' ' ' HIS . . . . . 0.524 ' CG ' ' O ' ' C' ' 53' ' ' ARG . 60.7 m170 -73.18 -46.83 48.44 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 120.489 -0.485 . . . . 0.0 109.911 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.71 -28.13 72.47 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 9.6 tp -89.73 58.68 4.37 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.761 0.315 . . . . 0.0 110.376 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 61.3 mttp . . . . . 0 N--CA 1.468 0.456 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.413 -179.972 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 74.9 p . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' D' ' 24' ' ' ASP . 7.3 p30 -160.55 75.6 2.73 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.153 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.61 -30.48 85.84 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 121.164 1.243 . . . . 0.0 110.725 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . 0.4 ' O ' ' HB3' ' D' ' 29' ' ' ALA . 16.6 tp -63.3 -50.39 70.25 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.0 -47.3 85.71 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 71.7 t -60.11 -32.41 50.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.324 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' D' ' 26' ' ' LEU . . . -66.96 -32.9 74.45 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.05 -44.45 69.14 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.726 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . 0.446 ' OG ' ' CD1' ' C' ' 26' ' ' LEU . 2.3 m -68.17 -45.01 74.64 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.733 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . 0.402 HD13 HG21 ' D' ' 32' ' ' ILE . 11.5 tt -68.16 -41.47 84.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.553 -178.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 13.0 tt -70.02 -34.67 60.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.485 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.07 -51.64 22.36 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.674 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 3.5 tp -64.02 -37.48 79.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.76 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 50.3 tp -64.07 -38.33 90.67 Favored 'General case' 0 CA--C 1.521 -0.136 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -65.95 -43.39 88.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.075 0.464 . . . . 0.0 109.86 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 mt -59.87 -51.36 70.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.778 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 74.3 mt -63.26 -40.48 89.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.209 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 7.6 tt -63.16 -45.22 92.85 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.981 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 31.8 t-105 -65.71 -52.0 54.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.89 0.376 . . . . 0.0 111.928 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 74.6 mt -63.29 -53.46 45.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.874 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 26.6 tp -61.87 -45.78 92.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.817 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . 0.464 ' O ' ' CB ' ' D' ' 50' ' ' SER . 27.5 t70 -55.66 -43.19 76.06 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.611 -0.436 . . . . 0.0 109.925 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . 0.513 ' NH1' ' OD2' ' C' ' 44' ' ' ASP . 67.5 ttt180 -61.97 -51.38 68.31 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.596 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . 0.412 HD23 ' HB3' ' D' ' 45' ' ' ARG . 0.1 OUTLIER -124.1 124.69 43.07 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 120.95 0.405 . . . . 0.0 110.207 179.177 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -174.61 -43.8 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.513 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . 0.428 ' CD2' ' O ' ' D' ' 48' ' ' PHE . 72.4 t80 -165.81 63.93 0.11 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.307 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? 54.52 40.19 31.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.182 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 7.4 t -62.15 -51.06 69.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.086 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 78.0 mt -48.51 -35.71 6.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.183 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 52' ' ' TYR . . . . . 0.501 ' CE2' ' OE2' ' D' ' 56' ' ' GLU . 90.6 t80 -71.44 -30.13 65.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.101 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -70.35 -43.18 70.75 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.974 0.416 . . . . 0.0 110.452 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . 0.445 ' CB ' ' NH2' ' A' ' 45' ' ' ARG . 72.9 m-85 -71.6 -39.89 70.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.727 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -66.11 -40.95 91.11 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.477 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 56' ' ' GLU . . . . . 0.501 ' OE2' ' CE2' ' D' ' 52' ' ' TYR . 12.7 pt-20 -74.41 -38.33 63.12 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.454 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 -61.1 -46.15 91.81 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.119 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.46 -26.95 71.12 Favored Glycine 0 N--CA 1.462 0.406 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.16 75.18 1.28 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 53.2 tttp . . . . . 0 C--N 1.332 -0.158 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.48 -179.709 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.3 p . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 0.5 OUTLIER 49.68 55.66 17.22 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.73 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 37.2 Cg_endo -65.37 -29.59 54.04 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.311 2.007 . . . . 0.0 111.306 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.468 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 20.2 tp -62.88 -48.28 79.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.97 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.55 -45.34 92.09 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 97.4 t -63.01 -28.32 44.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.379 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 26' ' ' LEU . . . -68.6 -36.43 78.68 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.35 -45.51 65.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.281 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.8 p -68.63 -44.58 73.89 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.243 -0.583 . . . . 0.0 111.754 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.421 HG23 ' N ' ' A' ' 33' ' ' ILE . 10.3 tp -68.48 -40.44 82.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.6 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.421 ' N ' HG23 ' A' ' 32' ' ' ILE . 14.1 tt -71.27 -33.56 51.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.607 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.45 -51.64 20.5 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.35 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.417 HG23 ' N ' ' A' ' 36' ' ' LEU . 10.4 tp -63.31 -38.32 81.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.553 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.417 ' N ' HG23 ' A' ' 35' ' ' ILE . 56.1 tp -65.9 -32.79 74.5 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.888 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 -67.81 -52.07 41.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.833 0.349 . . . . 0.0 110.602 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 30.4 tp -61.14 -52.17 65.97 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.426 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 74.1 mt -61.72 -42.25 93.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.979 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 34.8 tp -60.91 -41.93 97.06 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.343 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.4 t-105 -63.9 -59.53 4.4 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 120.973 0.416 . . . . 0.0 111.553 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 96.3 mt -56.59 -54.41 29.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.606 -177.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.519 HD23 ' O ' ' A' ' 43' ' ' LEU . 0.7 OUTLIER -60.24 -45.47 93.11 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.691 -179.037 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -51.02 -41.38 59.77 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -65.04 -50.48 66.05 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.134 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.475 ' O ' ' O ' ' A' ' 43' ' ' LEU . 0.7 OUTLIER -92.63 131.29 37.85 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.074 -179.434 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.436 ' CD2' ' N ' ' A' ' 48' ' ' PHE . 73.6 t80 -163.55 -94.97 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.858 0.361 . . . . 0.0 110.564 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.436 ' N ' ' CD2' ' A' ' 47' ' ' PHE . 57.6 t80 -132.6 57.8 1.78 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.821 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.2 tttt 71.14 25.67 3.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.721 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.9 t -59.21 -43.19 92.29 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.571 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 56.9 mt -45.04 -41.65 2.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.604 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -74.11 -27.94 61.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.023 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.532 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 90.9 mtt-85 -71.2 -48.57 50.77 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.598 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -71.5 -41.18 69.59 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.052 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -67.53 -38.69 84.59 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.731 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.542 ' OE2' ' CD2' ' A' ' 57' ' ' HIS . 1.8 pp20? -76.65 -42.31 42.44 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.067 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.542 ' CD2' ' OE2' ' A' ' 56' ' ' GLU . 24.9 m80 -61.11 -45.66 93.77 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.552 -0.459 . . . . 0.0 109.907 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.69 -27.71 73.39 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.5 tp -92.24 56.3 2.77 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.871 0.335 . . . . 0.0 110.677 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt . . . . . 0 C--N 1.329 -0.3 0 C-N-CA 120.859 -0.337 . . . . 0.0 110.474 179.886 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 96.2 p . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -160.01 73.34 3.1 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.772 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -50.74 -36.68 52.25 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.618 2.212 . . . . 0.0 111.537 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.42 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 15.0 tp -60.6 -52.38 65.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.798 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.53 -42.99 93.53 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 93.8 t -62.51 -33.89 61.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -63.74 -34.49 78.0 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.28 -47.01 63.16 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.397 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 6.3 p -65.21 -48.13 74.44 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.234 -0.586 . . . . 0.0 111.524 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.51 HG23 ' N ' ' B' ' 33' ' ' ILE . 10.4 tp -65.55 -44.32 93.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -178.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.51 ' N ' HG23 ' B' ' 32' ' ' ILE . 15.1 tt -66.67 -33.49 63.79 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.066 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.248 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.48 -45.3 86.52 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 91.2 mt -61.57 -44.54 98.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 14.1 tp -61.06 -36.1 78.7 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.312 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . 0.585 ' NE2' ' CE1' ' C' ' 37' ' ' HIS . 7.5 t-80 -67.34 -50.33 60.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.782 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 22.7 tp -63.66 -52.43 60.78 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.778 -178.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.431 ' CD1' ' N ' ' B' ' 39' ' ' ILE . 1.4 mp -61.15 -43.03 95.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.071 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 43.0 tp -61.21 -37.5 83.25 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.311 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 32.5 t-105 -63.3 -56.69 14.34 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.662 0.268 . . . . 0.0 111.291 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 68.2 mt -60.92 -53.46 48.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 C-N-CA 120.231 -0.588 . . . . 0.0 111.714 -178.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.539 HD23 ' O ' ' B' ' 43' ' ' LEU . 0.9 OUTLIER -57.33 -45.02 84.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.94 -179.021 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -58.97 -45.5 90.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.833 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 57.8 ttt85 -59.74 -52.75 64.14 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 120.181 -0.607 . . . . 0.0 111.059 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.23 112.13 24.11 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.953 0.406 . . . . 0.0 110.166 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -165.78 79.23 0.28 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.252 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 34.0 t80 62.11 55.28 2.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.745 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 74.7 tttt 60.24 50.15 6.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.818 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 5.8 t -70.71 -44.42 66.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.602 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 64.5 mt -44.38 -35.87 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.656 0.265 . . . . 0.0 111.228 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -70.34 -28.19 64.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.482 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 78.3 mtt85 -68.64 -42.39 78.07 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.378 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -72.73 -42.23 64.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.783 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -63.93 -39.88 95.18 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.632 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -76.72 -38.36 54.44 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.697 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -59.56 -44.82 93.17 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.656 -0.418 . . . . 0.0 109.926 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.98 -24.03 53.22 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' B' ' 60' ' ' LYS . 1.6 tt -131.0 52.01 2.09 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 -178.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' B' ' 59' ' ' LEU . 16.2 ptpt . . . . . 0 N--CA 1.474 0.751 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.524 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 37.3 t . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 46.15 75.3 0.67 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.709 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -51.55 -33.48 48.15 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.483 2.122 . . . . 0.0 111.432 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.15 -47.88 82.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.739 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.44 -39.18 60.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.726 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 80.7 t -59.78 -44.29 93.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.01 -33.51 72.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.405 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.14 -44.01 80.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.209 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 8.0 p -67.51 -47.54 69.67 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 18.6 tt -66.52 -38.19 81.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.979 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 70.0 mt -68.13 -42.22 84.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.005 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.7 -50.04 45.24 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 121.062 -0.59 . . . . 0.0 111.677 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.71 -43.53 98.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.89 0.376 . . . . 0.0 110.257 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 56.8 tp -63.55 -37.98 89.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.248 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . 0.585 ' CE1' ' NE2' ' B' ' 37' ' ' HIS . 12.3 t-80 -66.09 -48.4 71.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.808 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 41.3 tp -67.07 -55.23 15.2 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.84 0.352 . . . . 0.0 111.697 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . 0.427 ' N ' ' CD1' ' C' ' 39' ' ' ILE . 1.3 mp -59.35 -45.46 93.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.487 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 44.7 tp -62.03 -41.89 98.59 Favored 'General case' 0 C--O 1.218 -0.564 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.983 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 16.0 t-105 -57.16 -59.53 4.96 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 120.812 0.339 . . . . 0.0 111.488 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 34.8 mt -62.88 -57.1 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.344 -0.542 . . . . 0.0 112.315 -177.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.48 HD23 ' O ' ' C' ' 43' ' ' LEU . 0.6 OUTLIER -57.17 -51.84 67.72 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.519 -177.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -53.29 -41.89 66.05 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 18.5 tpt85 -58.39 -52.35 65.97 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.729 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' C' ' 48' ' ' PHE . 1.9 mt -82.25 -72.7 0.43 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.0 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 82.2 t80 57.76 -77.91 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.314 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . 0.537 ' N ' ' O ' ' C' ' 46' ' ' LEU . 84.7 t80 -158.84 -40.19 0.06 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.065 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -173.59 31.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.089 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . 0.429 ' OG ' ' CD1' ' C' ' 54' ' ' PHE . 35.8 t -63.73 -39.78 95.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.139 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 40.3 mt -46.6 -50.86 5.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.613 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -73.6 -32.18 63.97 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 53' ' ' ARG . . . . . 0.53 ' O ' ' CG ' ' C' ' 57' ' ' HIS . 99.5 mtt180 -72.03 -49.76 34.12 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.644 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . 0.429 ' CD1' ' OG ' ' C' ' 50' ' ' SER . 10.8 m-85 -66.44 -42.17 88.06 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.29 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -64.56 -37.67 88.35 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.903 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -77.29 -22.18 52.43 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.465 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 57' ' ' HIS . . . . . 0.53 ' CG ' ' O ' ' C' ' 53' ' ' ARG . 61.8 m170 -74.0 -47.25 38.45 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.059 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.43 -27.23 71.44 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 9.2 tp -92.18 60.23 3.68 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-O 120.811 0.339 . . . . 0.0 110.419 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm . . . . . 0 N--CA 1.467 0.396 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.366 -179.96 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 49.0 m . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' D' ' 24' ' ' ASP . 4.3 p30 -172.26 68.25 0.41 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.818 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . 0.404 ' O ' ' HB2' ' D' ' 29' ' ' ALA . 64.0 Cg_exo -49.54 -30.41 21.38 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 C-N-CA 121.935 1.757 . . . . 0.0 110.405 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 16.8 tp -65.18 -45.28 85.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.321 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.75 -61.09 2.65 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 87.0 t -50.44 -43.36 22.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.734 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' D' ' 25' ' ' PRO . . . -53.57 -45.3 69.89 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.015 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.83 -40.87 98.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.984 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 2.5 t -61.44 -52.04 66.22 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.613 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 14.8 tt -64.93 -30.93 51.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.623 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 39.3 mt -66.35 -44.24 90.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.927 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.49 -50.53 43.02 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.982 -0.628 . . . . 0.0 111.975 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . 0.402 ' CG2' ' N ' ' D' ' 36' ' ' LEU . 4.5 tt -58.22 -43.15 85.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.001 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.402 ' N ' ' CG2' ' D' ' 35' ' ' ILE . 7.4 tp -69.22 -27.64 65.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.503 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -67.78 -56.04 10.73 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.187 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 3.5 pp -68.87 -34.69 75.87 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.854 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 52.9 mt -62.77 -45.12 99.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 120.311 -0.556 . . . . 0.0 109.778 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 36.8 mt -64.01 -41.55 97.42 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.471 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 9.2 t-105 -59.96 -58.0 10.43 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.332 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 79.0 mt -59.92 -53.5 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.406 -177.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 28.8 tp -59.96 -44.14 94.61 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.82 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . 0.436 ' O ' ' CB ' ' D' ' 50' ' ' SER . 26.6 t70 -55.95 -46.15 78.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.126 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 56.3 ttt85 -60.49 -50.67 72.65 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.868 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 pp -125.4 127.93 47.34 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.145 0.498 . . . . 0.0 110.796 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -174.77 -42.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.092 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -171.66 63.46 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.234 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 55.7 mttm 58.23 37.81 26.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.226 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 10.8 t -59.29 -50.29 74.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.835 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 68.1 mt -50.56 -41.44 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.607 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -72.2 -31.38 65.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.084 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -70.96 -47.04 61.21 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.001 0.429 . . . . 0.0 110.601 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -69.71 -36.32 75.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.676 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -68.92 -40.74 78.89 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.5 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -75.78 -33.44 60.18 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.481 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -66.43 -47.34 73.5 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.694 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.23 -36.37 93.32 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 110.641 -0.983 . . . . 0.0 110.641 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 mp -74.9 -67.43 0.64 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt . . . . . 0 N--CA 1.462 0.14 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.397 179.753 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.1 p . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 0.7 OUTLIER 46.71 54.0 14.32 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.724 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 34.7 Cg_endo -63.87 -28.04 67.3 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.466 2.11 . . . . 0.0 111.025 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.5 tp -64.23 -48.72 74.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.041 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -65.32 -50.23 66.44 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.296 0.57 . . . . 0.0 109.739 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 82.3 t -57.95 -44.67 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.94 -36.52 67.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.514 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -63.04 -51.29 67.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.536 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.3 p -56.53 -50.07 72.92 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.912 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.6 mm -61.18 -32.16 52.12 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.99 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.2 mm -69.75 -40.13 78.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.223 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.43 -53.13 26.65 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.311 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 40.9 mm -62.12 -44.03 98.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 C-N-CA 120.461 -0.495 . . . . 0.0 110.306 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 47.4 tp -57.84 -47.92 81.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.568 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.474 ' C ' ' ND1' ' A' ' 37' ' ' HIS . 5.0 t-80 -60.16 -47.91 83.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.085 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 42.7 tp -55.66 -51.91 65.63 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.182 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.5 tt -64.17 -32.85 59.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.456 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.501 HD13 ' O ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -63.14 -47.96 80.53 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.419 -179.254 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 14.2 t-105 -63.44 -55.27 25.55 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 120.614 0.245 . . . . 0.0 111.551 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 88.8 mt -58.91 -52.74 56.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.34 -0.544 . . . . 0.0 112.124 -177.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.423 HD11 ' CD1' ' A' ' 47' ' ' PHE . 22.6 tp -62.43 -44.08 97.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.391 -178.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -57.01 -43.37 81.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.764 0.316 . . . . 0.0 110.171 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.516 ' NH1' HD11 ' A' ' 51' ' ' ILE . 57.0 ttt-85 -63.95 -48.67 75.58 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.471 -0.491 . . . . 0.0 110.725 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.6 pp -127.71 127.33 43.5 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.031 0.443 . . . . 0.0 110.8 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.423 ' CD1' HD11 ' A' ' 43' ' ' LEU . 61.4 t80 -174.03 -39.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.233 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.523 ' O ' ' NH1' ' A' ' 53' ' ' ARG . 63.8 t80 -172.08 61.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.213 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm 60.13 37.66 20.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.162 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.0 t -61.7 -47.7 84.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.752 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.516 HD11 ' NH1' ' A' ' 45' ' ' ARG . 16.2 mt -49.44 -37.2 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.493 ' CE2' ' OE2' ' A' ' 56' ' ' GLU . 92.5 t80 -72.69 -30.16 63.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.241 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.523 ' NH1' ' O ' ' A' ' 48' ' ' PHE . 93.9 mtm-85 -71.77 -46.78 57.25 Favored 'General case' 0 N--CA 1.461 0.102 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.54 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -70.47 -37.8 74.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.863 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -69.76 -38.85 76.92 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.696 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 60' ' ' LYS . 12.2 pt-20 -76.57 -38.85 54.29 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.91 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.523 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 6.8 m-70 -66.45 -42.63 87.33 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.738 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.67 -27.34 61.31 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 59' ' ' LEU . 0.6 OUTLIER -157.87 63.72 0.46 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.966 0.412 . . . . 0.0 110.554 -179.865 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 56' ' ' GLU . 4.2 tmtt? . . . . . 0 N--CA 1.469 0.476 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.183 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 31.5 t . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -37.32 101.85 0.23 Allowed Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.967 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -48.56 -36.7 32.39 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.873 1.715 . . . . 0.0 111.723 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.546 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 17.6 tp -61.14 -51.22 70.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.222 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.37 -45.52 84.35 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 84.4 t -59.48 -32.82 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.557 -0.747 . . . . 0.0 108.999 178.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -62.39 -37.43 85.73 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.05 -49.99 65.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.831 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 4.8 t -60.07 -50.56 73.24 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 20.4 tt -63.65 -35.04 71.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.36 -178.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 45.7 mt -69.05 -37.85 77.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.392 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.77 -56.2 8.62 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.506 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.479 HD12 ' N ' ' B' ' 36' ' ' LEU . 2.3 pp -56.44 -40.07 65.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.387 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.479 ' N ' HD12 ' B' ' 35' ' ' ILE . 54.7 tp -65.34 -34.41 78.26 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.388 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -66.45 -53.54 34.28 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.449 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 29.7 tp -66.32 -50.16 64.58 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.649 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 74.2 mt -59.74 -44.88 94.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.663 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 49.7 tp -64.04 -37.61 88.06 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.032 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . 0.45 ' CZ3' ' CZ2' ' C' ' 41' ' ' TRP . 23.1 t-105 -59.66 -52.32 66.01 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.543 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.6 mt -71.9 -56.83 8.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 120.079 -0.649 . . . . 0.0 111.674 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.498 HD23 ' O ' ' B' ' 43' ' ' LEU . 0.8 OUTLIER -50.67 -46.61 58.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.865 -179.066 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -67.94 -40.92 83.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.761 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 53.5 ttt85 -51.75 -51.83 53.24 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.813 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.72 -82.8 0.25 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.494 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.449 ' O ' ' CD1' ' B' ' 48' ' ' PHE . 60.5 t80 57.51 -87.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.501 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . 0.449 ' CD1' ' O ' ' B' ' 47' ' ' PHE . 34.1 m-85 -153.44 86.38 1.21 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.037 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 65.9 mttm 51.76 34.51 13.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.362 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 7.9 t -58.98 -47.07 86.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.405 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 53.4 mt -49.83 -50.8 17.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.909 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -71.41 -32.66 68.67 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.693 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -71.52 -43.74 65.92 Favored 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.017 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -71.41 -39.49 71.09 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.756 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . 0.413 ' CD1' ' C ' ' B' ' 55' ' ' PHE . 24.3 t80 -70.2 -39.11 75.38 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.816 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -76.66 -35.91 57.68 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 120.424 -0.511 . . . . 0.0 110.729 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -67.3 -49.19 65.17 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.511 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.94 -28.6 68.9 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 7.8 tp -72.51 -68.92 0.44 Allowed 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.742 0.306 . . . . 0.0 110.527 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 55.4 tttp . . . . . 0 N--CA 1.467 0.375 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.405 179.814 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 13.7 m . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -158.43 72.75 3.86 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.83 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -50.91 -30.52 30.61 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.538 2.158 . . . . 0.0 111.269 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . 0.489 ' O ' ' HB3' ' C' ' 29' ' ' ALA . 16.6 tp -55.48 -51.68 66.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.045 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.69 -47.62 85.44 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 99.3 t -59.58 -29.98 43.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' C' ' 26' ' ' LEU . . . -66.82 -35.61 80.45 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.15 -42.38 76.03 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.337 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 3.9 p -69.9 -46.22 65.91 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.72 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . 0.419 HG23 ' N ' ' C' ' 33' ' ' ILE . 10.1 tt -67.66 -40.18 83.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.524 -178.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . 0.419 ' N ' HG23 ' C' ' 32' ' ' ILE . 8.0 tt -69.33 -35.17 66.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.502 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.77 -53.24 20.76 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.272 -0.966 . . . . 0.0 110.953 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 96.8 mt -57.86 -42.87 83.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.306 -0.558 . . . . 0.0 109.977 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 15.0 tp -61.83 -39.45 91.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.101 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -61.52 -50.66 71.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.887 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 10.4 mp -60.52 -48.6 81.08 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.403 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 71.8 mt -59.95 -44.72 95.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.133 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.5 mt -62.44 -39.39 93.17 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.336 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . 0.45 ' CZ2' ' CZ3' ' B' ' 41' ' ' TRP . 24.3 t-105 -60.52 -57.67 11.76 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 120.89 0.376 . . . . 0.0 111.248 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 72.0 mt -60.64 -56.36 18.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.129 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.469 HD23 ' O ' ' C' ' 43' ' ' LEU . 0.7 OUTLIER -57.42 -50.99 71.24 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.773 -178.451 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -51.23 -42.59 61.09 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -59.07 -53.31 59.83 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.511 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' C' ' 48' ' ' PHE . 3.4 mt -79.71 -72.45 0.4 Allowed 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.949 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 75.3 t80 50.0 -88.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.272 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . 0.503 ' N ' ' O ' ' C' ' 46' ' ' LEU . 55.5 t80 -161.13 89.96 0.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.3 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 74.1 tttt 54.92 22.33 4.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.065 0.459 . . . . 0.0 110.027 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 11.3 t -61.1 -38.68 87.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.078 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 51' ' ' ILE . . . . . 0.404 ' H ' HG13 ' C' ' 51' ' ' ILE . 67.4 mt -48.68 -53.91 5.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.755 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -75.09 -33.6 61.65 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 20.0 mmt85 -69.93 -48.83 56.92 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.837 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -69.93 -39.95 75.81 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.302 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -62.13 -41.33 98.16 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.818 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -80.05 -21.8 43.05 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.892 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -70.25 -47.69 60.2 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 120.438 -0.505 . . . . 0.0 109.64 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.86 -26.97 73.73 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . 0.44 ' N ' ' CD2' ' C' ' 59' ' ' LEU . 3.8 mm? -100.54 64.78 1.15 Allowed 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' C' ' 59' ' ' LEU . 50.0 pttt . . . . . 0 N--CA 1.474 0.768 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.665 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 177.45 75.11 0.11 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.073 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -49.14 -33.03 26.16 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.089 1.859 . . . . 0.0 110.693 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . 0.402 ' O ' ' HB3' ' D' ' 29' ' ' ALA . 16.4 tp -62.89 -50.55 70.45 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.78 -46.16 88.15 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 92.0 t -59.77 -37.25 70.55 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.343 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' D' ' 26' ' ' LEU . . . -61.37 -37.07 82.03 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.45 -50.11 66.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.773 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 4.0 t -60.78 -51.47 69.19 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 7.3 tp -62.26 -35.71 70.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.582 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 26.5 mt -63.23 -44.58 99.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.736 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.49 -45.5 94.67 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.755 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 88.3 mt -62.39 -43.5 98.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.784 0.326 . . . . 0.0 110.525 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 18.1 tp -65.18 -33.2 75.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.326 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -68.13 -50.65 53.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.897 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 55.9 tp -61.28 -47.93 83.74 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.802 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 95.8 mt -61.91 -43.82 98.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.856 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' D' ' 40' ' ' LEU . 20.0 mt -59.62 -49.4 77.9 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.452 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 11.9 t-105 -58.41 -58.86 6.66 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.929 0.395 . . . . 0.0 111.705 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 73.1 mt -57.89 -60.4 2.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 27.6 tp -57.18 -46.56 82.7 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.447 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -50.98 -45.98 61.16 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.633 -0.427 . . . . 0.0 109.926 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . 0.413 ' O ' ' CG1' ' D' ' 51' ' ' ILE . 70.0 ttt180 -64.56 -56.85 11.35 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 119.914 -0.715 . . . . 0.0 111.394 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . 0.429 HD23 ' N ' ' D' ' 46' ' ' LEU . 0.1 OUTLIER -91.36 114.82 27.45 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.021 -179.872 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 47' ' ' PHE . . . . . 0.569 ' O ' ' N ' ' D' ' 49' ' ' LYS . 77.0 t80 -172.92 90.22 0.09 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.073 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 57.94 -73.49 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.45 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . 0.569 ' N ' ' O ' ' D' ' 47' ' ' PHE . 10.7 ttpp -165.58 37.46 0.06 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.884 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . 0.532 ' O ' ' N ' ' D' ' 53' ' ' ARG . 13.0 t -62.77 -45.06 94.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.082 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 51' ' ' ILE . . . . . 0.413 ' CG1' ' O ' ' D' ' 45' ' ' ARG . 23.6 mt -41.25 -30.35 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.869 0.366 . . . . 0.0 110.487 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 52' ' ' TYR . . . . . 0.518 ' CE2' ' OE1' ' D' ' 56' ' ' GLU . 85.7 t80 -74.12 -33.84 63.72 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.34 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 53' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' D' ' 50' ' ' SER . 6.9 ptm180 -69.64 -40.14 76.68 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.351 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -72.71 -41.92 64.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.884 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . 0.418 ' CD1' HD11 ' C' ' 59' ' ' LEU . 33.9 t80 -65.74 -40.18 91.86 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.459 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 56' ' ' GLU . . . . . 0.518 ' OE1' ' CE2' ' D' ' 52' ' ' TYR . 10.8 pt-20 -75.85 -38.81 57.61 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.796 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -61.51 -43.99 97.87 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 120.876 -0.329 . . . . 0.0 110.34 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.84 -27.82 71.75 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 7.9 tp -84.09 -75.75 0.33 Allowed 'General case' 0 C--O 1.231 0.087 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.615 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt . . . . . 0 N--CA 1.467 0.422 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.539 179.799 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.4 m . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 51.54 72.28 1.26 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.755 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.33 -32.57 42.31 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.483 2.122 . . . . 0.0 111.217 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 22.0 tp -61.54 -50.49 72.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.969 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.74 -46.75 88.26 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.271 0.558 . . . . 0.0 109.551 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 92.4 t -59.03 -41.44 83.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.51 -31.36 71.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.757 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.95 -43.52 71.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.649 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.7 t -66.18 -43.32 87.22 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.914 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 38.4 mm -67.24 -42.42 87.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.684 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.2 tt -71.15 -33.38 50.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.721 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.13 -52.0 15.65 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.315 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.418 HG23 ' N ' ' A' ' 36' ' ' LEU . 20.2 tt -63.16 -39.57 85.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.695 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.418 ' N ' HG23 ' A' ' 35' ' ' ILE . 47.1 tp -66.63 -32.39 73.69 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.086 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -68.34 -49.6 59.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.675 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.6 tp -63.31 -51.93 64.02 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.222 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 81.1 mt -61.79 -42.92 96.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.947 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.5 tt -63.56 -37.75 88.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.624 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 41.6 t-105 -65.11 -54.66 26.47 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.034 0.445 . . . . 0.0 111.305 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.553 ' CG2' ' N ' ' A' ' 43' ' ' LEU . 5.9 tt -63.74 -51.26 72.2 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.646 -177.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.553 ' N ' ' CG2' ' A' ' 42' ' ' ILE . 29.6 tp -63.21 -48.85 76.55 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.008 -177.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' A' ' 44' ' ' ASP . 60.2 t0 -51.59 -38.9 56.63 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.417 ' NH2' ' CB ' ' D' ' 54' ' ' PHE . 64.3 ttt180 -64.76 -52.24 58.02 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.522 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 48' ' ' PHE . 5.3 mt -86.31 -76.67 0.34 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 119.934 -0.706 . . . . 0.0 110.817 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 69.5 t80 51.4 -86.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.892 0.377 . . . . 0.0 110.373 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.515 ' N ' ' O ' ' A' ' 46' ' ' LEU . 38.5 t80 -158.31 90.58 1.04 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.142 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm 52.11 17.01 0.62 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.116 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.9 t -51.7 -41.87 61.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.612 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 35.7 mt -48.18 -41.63 10.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.055 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -71.41 -30.14 65.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.295 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.51 ' O ' ' CG ' ' A' ' 57' ' ' HIS . 1.8 mpt_? -66.8 -45.03 79.67 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.074 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -70.96 -38.62 72.81 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.479 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -63.55 -40.48 97.11 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.646 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.403 ' O ' ' N ' ' A' ' 60' ' ' LYS . 22.5 pt-20 -77.0 -40.19 47.55 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.789 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.51 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 56.0 m170 -57.4 -50.47 72.89 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.202 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.1 -26.77 73.85 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.4 tp -156.12 89.18 1.13 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.328 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 56' ' ' GLU . 68.7 mttm . . . . . 0 CA--C 1.526 0.034 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.551 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -165.61 69.38 1.25 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.035 0.445 . . . . 0.0 110.663 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -48.13 -27.89 9.97 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.031 1.82 . . . . 0.0 111.092 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.412 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 1.7 pp -72.79 -31.2 64.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.894 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.9 -39.71 66.02 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.972 0.415 . . . . 0.0 109.999 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 94.2 t -60.23 -43.64 93.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -56.97 -35.57 69.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.391 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.13 -49.81 66.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.878 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 22.2 p -59.16 -51.19 71.07 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 19.1 tt -65.39 -33.75 65.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.295 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 28.9 mt -67.34 -37.36 78.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.766 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.85 -51.38 24.73 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 83.3 mt -58.14 -49.29 82.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.412 0.625 . . . . 0.0 109.734 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 12.1 tp -58.53 -39.89 81.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.318 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -61.41 -48.35 81.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.58 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 10.1 mp -63.57 -51.05 67.04 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.832 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 mp -61.38 -46.05 97.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.076 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -63.16 -37.12 85.95 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.058 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 15.4 t-105 -60.85 -57.5 12.39 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.154 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 68.8 mt -61.88 -55.38 24.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.8 -177.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.491 HD23 ' O ' ' B' ' 43' ' ' LEU . 0.7 OUTLIER -56.4 -50.61 71.12 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.044 -178.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -55.74 -39.64 71.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.245 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -59.73 -53.46 57.77 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.678 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' B' ' 48' ' ' PHE . 0.9 OUTLIER -80.93 -72.81 0.4 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.52 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.432 ' CD2' ' N ' ' B' ' 48' ' ' PHE . 84.7 t80 47.24 -88.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.569 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . 0.517 ' N ' ' O ' ' B' ' 46' ' ' LEU . 80.7 t80 -154.36 84.5 1.12 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.325 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 62.4 mttp 48.73 27.36 1.51 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.439 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 16.0 p -63.49 -34.76 78.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.689 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . 0.423 ' H ' HG13 ' B' ' 51' ' ' ILE . 21.2 mt -49.88 -46.6 22.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.662 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.515 ' CD2' ' OE1' ' B' ' 56' ' ' GLU . 64.5 t80 -72.45 -27.88 62.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.553 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -70.8 -45.27 64.94 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.631 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -72.89 -41.57 64.5 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.561 -0.455 . . . . 0.0 110.75 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -66.01 -39.69 90.47 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.545 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . 0.515 ' OE1' ' CD2' ' B' ' 52' ' ' TYR . 9.6 pt-20 -75.6 -39.28 58.19 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.571 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -61.22 -41.79 97.47 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.621 -0.431 . . . . 0.0 110.092 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.31 -32.4 76.81 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 25.0 tp -63.25 -52.56 61.61 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.074 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt . . . . . 0 C--N 1.332 -0.157 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.569 179.982 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 36.8 p . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 46.22 74.75 0.75 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.73 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.62 -29.27 32.09 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.605 2.204 . . . . 0.0 111.378 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . 0.583 HD13 ' HB2' ' D' ' 31' ' ' SER . 3.7 pp -65.18 -35.46 81.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.786 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.22 -49.44 33.08 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.123 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 61.3 t -55.53 -36.45 41.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' C' ' 26' ' ' LEU . . . -63.3 -33.94 76.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.546 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.76 -40.1 79.91 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.853 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 3.3 t -69.14 -54.0 17.2 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.488 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . 0.443 HG23 ' N ' ' C' ' 33' ' ' ILE . 17.5 tt -60.98 -40.87 86.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.53 -178.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . 0.443 ' N ' HG23 ' C' ' 32' ' ' ILE . 13.6 tt -70.98 -31.21 44.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.609 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.08 -51.95 30.76 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.242 -0.98 . . . . 0.0 111.084 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.59 -34.71 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 C-N-CA 120.173 -0.611 . . . . 0.0 109.943 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 46.0 tp -64.89 -39.68 93.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.359 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -68.29 -49.67 58.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.513 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 34.9 tp -61.01 -51.87 67.41 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.226 0.536 . . . . 0.0 111.253 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 1.2 mp -60.58 -43.29 94.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.262 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' C' ' 40' ' ' LEU . 18.6 mt -61.04 -40.5 93.85 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.935 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 18.0 t-105 -59.43 -58.11 10.03 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.366 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 56.1 mt -62.33 -54.94 27.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.497 HD23 ' O ' ' C' ' 43' ' ' LEU . 0.7 OUTLIER -59.94 -49.28 78.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.472 -178.183 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . 0.484 ' O ' ' CB ' ' C' ' 50' ' ' SER . 61.2 t0 -57.81 -42.4 84.18 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.655 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . 0.507 ' NH1' ' CD1' ' C' ' 51' ' ' ILE . 3.2 tpt85 -61.04 -52.74 63.69 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.204 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' C' ' 43' ' ' LEU . 0.1 OUTLIER -118.31 137.37 53.12 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.039 0.447 . . . . 0.0 110.661 179.538 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -172.59 -38.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.107 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -172.67 -46.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.312 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 45.0 tttt -173.89 39.67 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.846 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' C' ' 44' ' ' ASP . 47.9 t -65.31 -51.61 59.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.807 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 51' ' ' ILE . . . . . 0.507 ' CD1' ' NH1' ' C' ' 45' ' ' ARG . 96.0 mt -43.39 -40.89 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.677 0.275 . . . . 0.0 111.215 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -73.62 -28.52 61.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.6 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 53' ' ' ARG . . . . . 0.463 ' O ' ' CD2' ' C' ' 57' ' ' HIS . 56.8 ttm-85 -69.71 -49.35 54.18 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.052 0.453 . . . . 0.0 110.246 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -69.08 -42.6 75.97 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.702 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -63.22 -37.02 85.61 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.792 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -78.66 -24.16 45.32 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.739 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 57' ' ' HIS . . . . . 0.463 ' CD2' ' O ' ' C' ' 53' ' ' ARG . 41.0 m170 -71.79 -49.29 40.08 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.848 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.41 -27.45 72.67 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 8.7 tp -94.44 53.24 1.66 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.706 0.288 . . . . 0.0 110.442 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 22.6 pttp . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.627 179.987 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 32.5 p . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -156.36 62.33 2.92 Favored Pre-proline 0 C--N 1.331 -0.227 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.517 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -50.02 -34.53 38.35 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 122.148 1.899 . . . . 0.0 110.647 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . 0.403 ' O ' ' HB3' ' D' ' 29' ' ' ALA . 17.8 tp -59.11 -49.83 76.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.231 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 27' ' ' ALA . . . . . 0.443 ' HB1' HD11 ' C' ' 26' ' ' LEU . . . -58.03 -53.81 54.04 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 83.5 t -52.43 -43.88 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.463 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' D' ' 26' ' ' LEU . . . -53.8 -42.55 68.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.227 0.537 . . . . 0.0 109.924 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.61 -42.54 98.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.792 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . 0.583 ' HB2' HD13 ' C' ' 26' ' ' LEU . 6.3 t -61.68 -52.64 63.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.841 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 13.6 tt -64.01 -31.08 51.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.574 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 33.2 mt -67.21 -40.88 85.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.488 -0.485 . . . . 0.0 109.725 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.39 -52.05 33.49 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 120.991 -0.623 . . . . 0.0 111.64 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 4.3 mm -60.23 -43.85 94.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.109 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 47.0 tp -62.23 -38.61 89.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.346 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -63.96 -51.23 65.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.849 0.356 . . . . 0.0 110.908 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 50.5 tp -58.12 -45.56 87.07 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.513 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 97.4 mt -62.36 -40.16 86.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.628 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . 0.517 ' O ' HD13 ' D' ' 40' ' ' LEU . 0.2 OUTLIER -61.84 -44.03 97.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.18 -179.401 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 28.2 t-105 -63.83 -56.36 16.0 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.736 0.303 . . . . 0.0 111.782 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 74.3 mt -58.71 -53.43 47.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.244 -0.435 . . . . 0.0 112.017 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 36.9 tp -61.55 -46.73 88.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.733 0.301 . . . . 0.0 111.089 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -52.99 -46.8 68.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.295 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -63.19 -50.69 69.34 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.89 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.17 123.99 46.86 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.974 0.416 . . . . 0.0 110.33 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -172.27 -47.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.246 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -172.08 71.12 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.275 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt 54.29 33.37 18.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.289 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 9.7 t -57.77 -50.09 74.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.745 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 55.5 mt -52.56 -44.23 44.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.598 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -71.91 -30.59 65.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.27 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -71.22 -44.15 65.94 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.892 0.377 . . . . 0.0 110.747 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . 0.417 ' CB ' ' NH2' ' A' ' 45' ' ' ARG . 50.9 m-85 -71.92 -38.29 69.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.88 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -69.18 -40.1 78.3 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.652 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -76.62 -36.6 57.37 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.616 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -65.47 -47.51 75.83 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.667 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.54 -28.99 72.23 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 10.6 mp -103.85 65.48 0.82 Allowed 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 86.6 tttt . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.652 -179.817 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 52.6 p . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.445 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 2.8 m-20 49.58 53.11 13.87 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.643 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 28.0 Cg_endo -62.14 -29.09 80.44 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.437 2.092 . . . . 0.0 111.163 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.3 tp -63.71 -50.56 68.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.218 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -63.18 -44.71 94.64 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.329 0.585 . . . . 0.0 109.917 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.9 t -58.79 -45.89 91.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.259 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.98 -31.38 69.84 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.606 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -66.09 -50.43 64.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.446 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.3 t -58.02 -42.43 85.28 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.402 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.1 mp -65.95 -37.98 81.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.184 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.416 HG21 HD13 ' A' ' 33' ' ' ILE . 2.4 tt -69.03 -36.44 73.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.637 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.43 -52.34 17.27 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.159 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.83 -43.44 91.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.145 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 57.2 tp -64.7 -34.69 78.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.359 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -65.39 -50.33 65.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.844 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.5 mp -62.84 -47.25 84.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.976 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.9 mt -61.62 -44.84 99.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.1 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 35.0 tp -62.86 -43.33 99.09 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.7 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.9 t-105 -62.32 -58.46 7.62 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 120.82 0.343 . . . . 0.0 111.847 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 73.7 mt -59.54 -54.31 36.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.743 -177.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.5 tp -58.34 -50.8 72.34 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.801 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -52.11 -38.85 58.73 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.07 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.435 HH21 ' CB ' ' D' ' 54' ' ' PHE . 54.0 ttt85 -64.65 -54.35 33.23 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.596 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 48' ' ' PHE . 0.1 OUTLIER -91.91 -84.83 0.26 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.862 -179.525 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.421 ' CD2' ' N ' ' A' ' 48' ' ' PHE . 82.2 t80 56.54 -80.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.539 ' N ' ' O ' ' A' ' 46' ' ' LEU . 65.2 t80 -165.64 98.04 0.67 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.375 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt 47.93 33.32 3.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.485 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 53' ' ' ARG . 5.4 t -63.9 -44.15 93.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.89 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.42 HG12 ' H ' ' A' ' 51' ' ' ILE . 6.3 mm -41.93 -43.52 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.488 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.507 ' CE2' ' OE1' ' A' ' 56' ' ' GLU . 90.8 t80 -73.23 -31.22 64.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.352 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.531 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 23.4 mmt180 -70.79 -48.44 54.21 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-O 120.975 0.417 . . . . 0.0 110.541 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -70.05 -35.99 74.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.621 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -68.13 -41.02 82.31 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 120.886 -0.325 . . . . 0.0 111.613 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.507 ' OE1' ' CE2' ' A' ' 52' ' ' TYR . 21.4 pt-20 -76.4 -41.92 46.11 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.119 -0.633 . . . . 0.0 111.02 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.531 ' ND1' ' O ' ' A' ' 53' ' ' ARG . 15.8 m80 -61.95 -51.83 66.5 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.324 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.14 -25.69 74.0 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.6 tp -150.23 88.67 1.53 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.082 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.286 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 45.6 t . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -160.89 79.47 2.28 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.804 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -50.56 -35.02 44.89 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.502 2.135 . . . . 0.0 111.495 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.501 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 17.8 tp -59.15 -51.49 69.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.975 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.49 -44.52 93.05 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 88.5 t -61.03 -32.64 53.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -64.15 -34.14 77.39 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.03 -46.53 64.86 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.318 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 3.9 m -66.04 -47.3 74.84 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 119.981 -0.688 . . . . 0.0 111.561 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.542 HG23 ' N ' ' B' ' 33' ' ' ILE . 21.1 tt -64.48 -45.19 96.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.738 -178.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.542 ' N ' HG23 ' B' ' 32' ' ' ILE . 16.4 tt -64.86 -34.78 72.62 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.087 0 C-N-CA 119.409 -0.916 . . . . 0.0 109.937 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.49 -46.06 93.36 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 94.3 mt -59.52 -43.3 90.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 37.4 tp -60.01 -40.17 88.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.578 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -66.08 -51.56 56.91 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 31.8 tp -61.95 -51.86 66.39 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 120.865 0.365 . . . . 0.0 111.717 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.413 ' N ' ' CD1' ' B' ' 39' ' ' ILE . 1.3 mp -61.45 -40.52 86.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.021 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 62.9 tp -62.56 -37.32 85.69 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.501 -0.48 . . . . 0.0 109.983 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 39.3 t-105 -64.32 -56.04 17.2 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.637 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 54.6 mt -63.23 -50.84 77.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.424 -0.511 . . . . 0.0 111.769 -177.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.499 HD23 ' O ' ' B' ' 43' ' ' LEU . 0.9 OUTLIER -61.15 -49.3 77.78 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.442 -178.734 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -61.5 -37.44 83.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.693 0.282 . . . . 0.0 110.952 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 50.0 ttt-85 -65.84 -51.02 62.44 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.703 -0.399 . . . . 0.0 112.066 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' B' ' 43' ' ' LEU . 0.6 OUTLIER -123.31 -159.39 0.84 Allowed 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 120.882 0.372 . . . . 0.0 111.58 -179.086 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.464 ' O ' ' CD2' ' B' ' 47' ' ' PHE . 31.1 t80 50.06 19.43 0.48 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.203 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -168.77 -1.67 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.38 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt 44.61 40.24 3.91 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.606 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 2.3 p -62.96 -33.28 75.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.753 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 78.0 mt -47.33 -46.09 9.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.82 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -72.16 -30.0 64.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.439 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.529 ' O ' ' ND1' ' B' ' 57' ' ' HIS . 95.5 mtt-85 -71.54 -45.6 61.89 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.727 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -71.54 -38.34 71.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.911 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -70.03 -39.35 75.81 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.608 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . 0.528 ' OE2' ' CD2' ' B' ' 57' ' ' HIS . 1.2 pp20? -75.75 -39.76 56.62 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.748 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' HIS . . . . . 0.529 ' ND1' ' O ' ' B' ' 53' ' ' ARG . 26.6 m80 -65.16 -45.38 85.17 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.29 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.72 -27.79 73.01 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 9.4 tp -86.17 58.25 4.95 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.897 0.38 . . . . 0.0 110.349 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? . . . . . 0 N--CA 1.466 0.352 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.417 -179.886 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 25.9 t . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 53.46 70.61 1.7 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.676 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -51.74 -38.75 67.36 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.573 2.182 . . . . 0.0 111.565 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . 0.415 ' O ' ' HB3' ' C' ' 29' ' ' ALA . 26.0 tp -57.16 -48.61 78.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.018 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.44 -48.98 77.26 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.389 0.614 . . . . 0.0 109.497 178.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 85.4 t -58.95 -31.67 45.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' C' ' 26' ' ' LEU . . . -66.34 -33.87 76.69 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.15 -43.71 73.78 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.305 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 4.4 p -69.58 -45.92 67.55 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 119.972 -0.691 . . . . 0.0 111.616 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 13.5 tt -67.87 -39.72 82.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.563 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . 0.402 HG21 HD13 ' C' ' 33' ' ' ILE . 7.6 tt -70.01 -35.91 66.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.784 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.67 -51.42 25.42 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 120.413 -0.898 . . . . 0.0 111.202 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 94.0 mt -61.21 -46.3 96.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.551 -0.46 . . . . 0.0 109.846 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 15.4 tp -58.14 -42.87 86.8 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.894 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -59.72 -51.78 68.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.757 0.313 . . . . 0.0 111.484 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 35.9 tp -57.47 -52.6 64.71 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.751 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . 0.401 ' N ' ' CD1' ' C' ' 39' ' ' ILE . 1.3 mp -61.02 -41.04 87.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.836 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . 0.535 HD13 ' O ' ' C' ' 40' ' ' LEU . 0.2 OUTLIER -59.66 -43.06 94.1 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.746 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 12.9 t-105 -61.45 -58.5 7.91 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.466 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 96.2 mt -55.76 -56.91 9.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.92 -177.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.513 HD23 ' O ' ' C' ' 43' ' ' LEU . 0.6 OUTLIER -59.7 -45.55 91.77 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.881 -178.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -48.55 -46.38 38.8 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 54.9 ttt-85 -64.54 -48.16 76.11 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.94 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . 0.496 ' O ' ' N ' ' C' ' 48' ' ' PHE . 8.2 mt -82.68 4.4 25.11 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.126 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . 0.518 ' O ' ' N ' ' C' ' 49' ' ' LYS . 48.3 t80 -45.34 91.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.86 0.362 . . . . 0.0 110.78 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . 0.496 ' N ' ' O ' ' C' ' 46' ' ' LEU . 88.1 t80 55.47 -81.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.615 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' C' ' 47' ' ' PHE . 76.6 tttt -161.01 39.05 0.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.101 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . 0.432 ' OG ' ' CE2' ' C' ' 54' ' ' PHE . 4.8 t -70.83 -26.14 63.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.465 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 53.0 mt -42.05 -48.02 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.211 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -73.25 -28.73 62.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.398 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 53' ' ' ARG . . . . . 0.527 ' O ' ' CG ' ' C' ' 57' ' ' HIS . 20.0 mmt85 -71.78 -49.3 40.08 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.662 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . 0.432 ' CE2' ' OG ' ' C' ' 50' ' ' SER . 38.0 m-85 -69.46 -39.2 77.87 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.44 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . 0.418 ' CZ ' HD22 ' C' ' 59' ' ' LEU . 84.0 t80 -66.8 -38.04 85.72 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 120.561 -0.455 . . . . 0.0 111.026 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -79.43 -22.93 43.57 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.852 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 57' ' ' HIS . . . . . 0.527 ' CG ' ' O ' ' C' ' 53' ' ' ARG . 44.5 m170 -75.91 -45.49 35.02 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.229 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.48 -28.1 72.68 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . 0.418 HD22 ' CZ ' ' C' ' 55' ' ' PHE . 11.1 mp -100.41 64.92 1.18 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt . . . . . 0 N--CA 1.466 0.368 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.423 179.899 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 55.3 p . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -157.94 64.38 2.98 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.191 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -48.72 -31.8 20.17 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.058 1.839 . . . . 0.0 110.815 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 17.7 tp -63.21 -50.95 68.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.612 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 27' ' ' ALA . . . . . 0.43 ' O ' ' HB3' ' D' ' 30' ' ' ALA . . . -64.75 -47.28 78.77 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.811 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 96.5 t -56.76 -41.74 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.38 -38.94 85.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.471 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' D' ' 27' ' ' ALA . . . -58.69 -50.55 73.45 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.739 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 6.2 t -62.97 -39.76 95.66 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.365 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 5.2 mm -62.42 -48.24 89.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.444 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 18.5 tt -66.84 -31.1 51.97 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.282 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.92 -48.96 57.88 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.222 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 97.2 mt -63.79 -44.49 98.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.065 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 33.9 tp -63.45 -30.68 71.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.012 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -68.68 -51.28 43.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.754 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 43.3 tp -59.5 -48.07 83.06 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.51 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 96.8 mt -61.06 -43.86 97.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.786 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 22.1 mt -61.34 -41.04 96.39 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.351 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 46.7 t-105 -61.61 -54.66 39.96 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.767 0.318 . . . . 0.0 111.556 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 64.1 mt -62.9 -55.78 21.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 120.293 -0.563 . . . . 0.0 112.182 -177.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 43.1 tp -59.06 -50.25 74.79 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.173 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . 0.459 ' O ' ' CB ' ' D' ' 50' ' ' SER . 31.6 t70 -52.72 -44.83 66.64 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.106 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -58.35 -54.84 42.5 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.395 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.13 106.91 15.65 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 120.956 0.408 . . . . 0.0 110.121 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -174.6 94.47 0.08 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.306 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 35.7 t80 59.3 49.53 8.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.536 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? 54.72 52.56 11.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.596 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 11.5 t -62.82 -49.48 74.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.994 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 53.0 mt -45.18 -43.91 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.926 0.393 . . . . 0.0 110.584 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -71.48 -28.09 63.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.65 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 53' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' D' ' 50' ' ' SER . 12.0 ttm180 -70.09 -49.67 48.61 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.035 0.445 . . . . 0.0 110.175 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . 0.435 ' CB ' HH21 ' A' ' 45' ' ' ARG . 55.1 m-85 -65.42 -43.02 91.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.303 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -63.23 -38.36 90.88 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.919 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -76.06 -22.51 55.58 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.615 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -75.07 -54.34 7.32 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.167 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -73.9 -26.12 69.9 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 12.6 tp -146.41 86.91 1.7 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 63.7 mttp . . . . . 0 C--N 1.334 -0.096 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.592 -179.725 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -159.44 71.11 3.37 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.708 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -50.05 -33.44 34.81 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.432 2.088 . . . . 0.0 111.297 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.2 tp -62.55 -49.61 74.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.944 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.75 -46.25 88.91 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.0 t -60.05 -40.41 83.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.15 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.73 -30.89 71.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.716 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.61 -51.06 46.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.53 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.1 p -61.76 -36.68 81.72 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.574 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.7 mm -68.4 -41.75 83.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.594 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 33' ' ' ILE . 4.4 tt -70.64 -34.19 56.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.371 -0.531 . . . . 0.0 110.744 -178.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.64 -52.15 13.47 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.697 -0.764 . . . . 0.0 111.389 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.489 HG23 ' N ' ' A' ' 36' ' ' LEU . 15.3 tt -63.17 -44.52 99.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.784 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.489 ' N ' HG23 ' A' ' 35' ' ' ILE . 48.9 tp -59.93 -41.88 92.73 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.811 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 20.9 t-160 -60.07 -49.92 75.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.745 0.307 . . . . 0.0 111.093 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 37.2 tp -59.3 -51.81 68.33 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.925 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.3 mp -61.6 -46.06 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.049 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.575 HD13 ' O ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -59.7 -39.93 86.23 Favored 'General case' 0 C--O 1.218 -0.59 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.297 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 13.5 t-105 -62.64 -57.11 12.22 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.483 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 97.2 mt -56.43 -54.59 26.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.703 -177.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 47' ' ' PHE . 34.5 tp -61.64 -42.5 98.98 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.359 -0.537 . . . . 0.0 110.978 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -51.59 -44.93 62.98 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -63.2 -54.8 31.9 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.246 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 48' ' ' PHE . 5.5 mt -77.15 -77.19 0.15 Allowed 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.777 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.416 ' CD2' ' N ' ' A' ' 48' ' ' PHE . 93.3 t80 53.88 -83.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.788 0.328 . . . . 0.0 110.434 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.533 ' N ' ' O ' ' A' ' 46' ' ' LEU . 81.2 t80 -167.65 86.72 0.24 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.259 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm 59.8 30.44 20.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.339 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.5 t -68.46 -29.18 67.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.621 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.9 mm -44.21 -43.18 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-O 120.989 0.423 . . . . 0.0 110.283 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -74.6 -28.44 60.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.349 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.507 ' O ' ' CG ' ' A' ' 57' ' ' HIS . 98.9 mtt180 -68.28 -49.82 57.89 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.015 0.436 . . . . 0.0 110.46 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -72.39 -40.35 67.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.93 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -63.73 -40.75 97.5 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.617 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -77.16 -41.79 40.32 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.973 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.507 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 6.2 m-70 -56.9 -50.42 72.59 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.277 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.92 -27.01 71.33 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.756 -0.937 . . . . 0.0 110.756 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.8 tp -158.56 90.74 1.03 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.493 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.6 mttt . . . . . 0 C--N 1.338 0.089 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.477 -179.949 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 55.23 74.78 0.68 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.732 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.412 ' O ' ' N ' ' B' ' 29' ' ' ALA . 53.9 Cg_exo -51.0 -33.66 43.37 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.668 2.245 . . . . 0.0 111.52 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.461 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 19.2 tp -59.7 -50.93 71.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.269 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.52 -42.9 99.5 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.423 ' O ' HG22 ' B' ' 32' ' ' ILE . 82.3 t -63.47 -31.08 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -64.83 -34.9 79.46 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.15 -47.45 61.58 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.385 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 4.8 t -64.83 -48.35 74.67 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.534 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.52 HG23 ' N ' ' B' ' 33' ' ' ILE . 10.7 tp -65.41 -44.48 94.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.966 -178.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.52 ' N ' HG23 ' B' ' 32' ' ' ILE . 15.6 tt -66.18 -32.85 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.975 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.64 -45.84 81.21 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 5.2 mm -60.08 -42.79 91.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 12.0 tp -61.71 -37.4 84.03 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.373 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . 0.458 ' NE2' ' NE2' ' C' ' 37' ' ' HIS . 1.5 t60 -65.66 -53.03 46.83 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 28.6 tp -64.79 -52.38 57.18 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.452 ' CD1' ' N ' ' B' ' 39' ' ' ILE . 1.3 mp -62.05 -47.97 90.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.883 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 41.6 tp -61.2 -35.94 78.53 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.253 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 41.2 t-105 -63.44 -57.16 11.16 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.384 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 73.2 mt -60.93 -53.01 55.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.768 -177.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' B' ' 43' ' ' LEU . 11.1 mt -60.12 -53.31 59.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.421 -178.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . 0.411 ' O ' ' CB ' ' B' ' 50' ' ' SER . 66.2 t0 -57.41 -31.74 66.15 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.158 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -66.36 -50.67 62.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.282 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' B' ' 48' ' ' PHE . 0.1 OUTLIER -110.2 -88.98 0.49 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.821 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 33.9 t80 57.04 -79.37 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.888 0.375 . . . . 0.0 110.414 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . 0.533 ' N ' ' O ' ' B' ' 46' ' ' LEU . 47.7 t80 -138.75 58.53 1.65 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.536 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm 57.15 54.61 6.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.424 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' B' ' 44' ' ' ASP . 39.0 t -65.69 -45.74 81.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.133 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 59.2 mt -46.72 -28.6 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.044 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.49 ' CZ ' ' OE1' ' B' ' 56' ' ' GLU . 60.4 t80 -71.85 -36.94 70.31 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.72 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -70.77 -45.28 65.03 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.881 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . 0.438 ' CD1' ' NH1' ' C' ' 45' ' ' ARG . 61.4 m-85 -70.18 -35.9 74.29 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.923 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -71.17 -39.76 71.68 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.72 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . 0.49 ' OE1' ' CZ ' ' B' ' 52' ' ' TYR . 18.3 pt-20 -76.11 -39.25 55.61 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.871 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -67.48 -43.4 81.06 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.414 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.05 -28.57 72.31 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 10.8 mp -102.69 65.4 0.91 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.537 -179.816 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 15.7 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -158.48 72.66 3.83 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.812 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.2 -32.42 40.37 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.529 2.153 . . . . 0.0 111.461 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 14.2 tp -62.01 -52.04 65.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.1 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 27' ' ' ALA . . . . . 0.43 ' O ' ' HB3' ' C' ' 30' ' ' ALA . . . -61.41 -47.77 84.24 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.03 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 92.4 t -54.6 -50.26 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.54 -44.02 56.25 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.565 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' C' ' 27' ' ' ALA . . . -55.81 -50.35 70.76 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 3.0 t -57.6 -52.27 66.09 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.401 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 21.5 mm -58.88 -30.71 43.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.715 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 50.3 mt -69.03 -40.2 80.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.395 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.81 -52.12 26.26 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 120.657 -0.783 . . . . 0.0 111.81 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . 0.482 ' H ' HD12 ' C' ' 35' ' ' ILE . 3.4 mp -62.52 -44.47 99.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.776 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 54.7 tp -60.48 -39.15 86.63 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.707 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . 0.458 ' NE2' ' NE2' ' B' ' 37' ' ' HIS . 1.1 t60 -61.33 -51.07 70.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.922 0.391 . . . . 0.0 110.794 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.25 -51.93 66.32 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.837 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 26.3 mm -60.52 -41.52 88.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.179 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . 0.526 HD13 ' O ' ' C' ' 40' ' ' LEU . 0.2 OUTLIER -61.56 -41.88 98.01 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.426 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 16.5 t-105 -63.11 -57.55 10.21 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 120.889 0.376 . . . . 0.0 111.414 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 82.3 mt -57.91 -55.6 20.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.877 -177.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.494 HD23 ' O ' ' C' ' 43' ' ' LEU . 0.7 OUTLIER -59.3 -48.78 80.33 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.63 -178.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -49.08 -45.37 43.02 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . 0.455 ' CZ ' HD21 ' C' ' 46' ' ' LEU . 62.4 ttp85 -61.47 -50.89 70.93 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.086 -0.646 . . . . 0.0 110.708 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' C' ' 48' ' ' PHE . 12.4 mt -76.44 -76.89 0.15 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.052 -0.659 . . . . 0.0 111.253 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 69.2 t80 58.32 -78.0 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.428 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . 0.528 ' N ' ' O ' ' C' ' 46' ' ' LEU . 38.7 t80 -169.57 -29.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.336 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . 0.415 ' NZ ' ' CD2' ' C' ' 52' ' ' TYR . 49.8 tttm -173.07 18.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.91 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.08 -32.34 69.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.697 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 35.1 mt -56.38 -54.17 31.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.438 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 52' ' ' TYR . . . . . 0.415 ' CD2' ' NZ ' ' C' ' 49' ' ' LYS . 70.5 t80 -76.87 -33.11 57.87 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 53' ' ' ARG . . . . . 0.535 ' O ' ' CD2' ' C' ' 57' ' ' HIS . 63.6 mmt-85 -66.76 -49.45 65.88 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.635 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -73.67 -39.75 64.21 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.901 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -61.03 -40.72 94.69 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.463 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . 0.518 ' OE2' ' ND1' ' C' ' 57' ' ' HIS . 1.2 pp20? -78.65 -39.83 35.85 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.319 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 57' ' ' HIS . . . . . 0.535 ' CD2' ' O ' ' C' ' 53' ' ' ARG . 7.2 m-70 -52.05 -49.49 63.35 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . 0.435 ' C ' HD22 ' C' ' 59' ' ' LEU . . . -68.12 -27.4 73.72 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . 0.435 HD22 ' C ' ' C' ' 58' ' ' GLY . 3.7 mm? -103.96 64.15 0.78 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 62.7 tttm . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.519 -179.963 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' D' ' 24' ' ' ASP . 9.2 p30 -162.58 65.13 1.64 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.125 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -48.98 -31.1 19.47 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 121.916 1.744 . . . . 0.0 110.394 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 16.2 tp -62.84 -50.33 71.35 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.04 178.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 27' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' D' ' 30' ' ' ALA . . . -60.46 -47.78 84.61 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.78 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 87.1 t -58.2 -50.57 77.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.581 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.33 -42.82 53.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.645 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' D' ' 27' ' ' ALA . . . -57.69 -49.86 75.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.568 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.28 -47.63 80.95 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.534 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 27.2 mm -62.21 -35.09 67.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.861 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 74.5 mt -67.23 -41.75 87.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.696 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.63 -51.34 31.26 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.008 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 14.1 tt -62.63 -39.96 86.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.091 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 52.8 tp -66.35 -34.47 78.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.852 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -65.88 -48.15 72.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.444 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 59.9 tp -63.14 -50.98 68.31 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.162 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 91.8 mt -59.46 -45.93 93.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.995 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 7.7 tp -62.7 -38.02 88.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.339 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 38.9 t-105 -62.23 -52.59 63.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.764 0.316 . . . . 0.0 111.551 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 64.8 mt -66.32 -53.49 35.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -177.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 54.2 tp -60.95 -46.12 91.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.697 0.284 . . . . 0.0 111.308 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . 0.489 ' O ' ' CB ' ' D' ' 50' ' ' SER . 28.1 t70 -59.8 -47.2 86.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.769 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -58.53 -50.19 74.66 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.101 -0.64 . . . . 0.0 111.071 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 2.5 pp -124.49 134.9 52.88 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.898 0.38 . . . . 0.0 110.655 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -168.43 -39.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.346 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -171.17 -36.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.401 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 177.28 26.81 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.899 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 10.3 t -50.22 -54.55 20.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.02 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 87.4 mt -48.93 -40.68 12.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.268 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -73.79 -30.8 62.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.307 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 53' ' ' ARG . . . . . 0.405 ' HE ' ' HA ' ' D' ' 50' ' ' SER . 43.4 mtm180 -67.31 -47.23 71.16 Favored 'General case' 0 CA--C 1.522 -0.097 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.318 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -71.97 -41.51 67.63 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.809 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -59.7 -43.74 93.96 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.368 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -78.21 -31.62 49.49 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.455 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -58.32 -52.16 66.77 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.874 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.82 -35.12 72.6 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.55 23.83 0.61 Allowed 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.181 -179.755 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 82.0 p . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.416 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 1.7 m-20 53.76 54.06 11.56 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.605 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.426 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 27.2 Cg_endo -62.06 -28.96 80.72 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.4 2.067 . . . . 0.0 111.26 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.417 ' O ' HD13 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -63.87 -54.52 33.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.875 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.56 ' O ' HD11 ' D' ' 26' ' ' LEU . . . -63.97 -50.41 68.68 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.895 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 87.5 t -55.47 -47.13 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 25' ' ' PRO . . . -54.14 -41.0 67.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.968 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.32 -48.7 80.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.665 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.415 ' HB2' HD13 ' D' ' 26' ' ' LEU . 6.4 t -59.43 -46.23 89.31 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.193 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 43.7 mm -60.63 -38.19 77.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.792 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.7 mm -69.74 -36.09 68.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.692 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.95 -52.03 26.03 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.611 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.1 pt -66.76 -37.74 80.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.626 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -67.83 -36.68 80.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.269 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.462 ' CE1' ' NE2' ' D' ' 37' ' ' HIS . 0.3 OUTLIER -68.09 -50.37 55.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.194 -179.463 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 38.2 tp -65.68 -51.53 58.66 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.332 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 89.5 mt -60.84 -51.65 70.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.333 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 41.2 tp -59.71 -40.29 87.46 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.478 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 27.1 t-105 -61.08 -55.55 31.32 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.706 0.288 . . . . 0.0 111.484 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 96.8 mt -57.93 -55.81 19.53 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 CA-C-O 121.242 0.544 . . . . 0.0 111.536 -178.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.67 ' C ' HD12 ' A' ' 43' ' ' LEU . 0.5 OUTLIER -59.43 -37.71 78.8 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.567 -179.165 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -59.65 -41.47 90.6 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -63.01 -46.65 86.64 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.15 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.421 ' O ' ' O ' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -106.59 -112.65 0.28 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.991 179.654 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.421 ' O ' ' O ' ' A' ' 46' ' ' LEU . 32.6 t80 47.76 97.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.861 0.362 . . . . 0.0 110.248 -179.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.522 ' CD2' ' O ' ' A' ' 48' ' ' PHE . 49.0 t80 60.37 27.94 17.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.552 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.6 mttm 53.01 65.56 1.48 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.589 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.422 ' O ' ' N ' ' A' ' 53' ' ' ARG . 4.7 t -69.51 -28.83 66.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.02 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.0 mt -44.34 -43.23 2.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.916 0.389 . . . . 0.0 110.221 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -71.65 -28.03 63.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.038 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.427 ' CG ' ' CE1' ' A' ' 57' ' ' HIS . 43.9 ttm180 -71.1 -49.24 46.49 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 120.948 0.404 . . . . 0.0 110.315 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -65.4 -44.78 86.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.604 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -65.7 -35.0 79.49 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.265 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -76.89 -24.81 52.52 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.865 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.427 ' CE1' ' CG ' ' A' ' 53' ' ' ARG . 41.5 m170 -76.7 -47.14 22.87 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.389 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.43 -27.08 73.93 Favored Glycine 0 N--CA 1.463 0.444 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.07 82.18 1.38 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.241 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.8 mttp . . . . . 0 C--N 1.334 -0.078 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.639 -179.829 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 20.9 p . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -158.19 76.1 3.65 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.789 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.444 ' O ' ' HB2' ' B' ' 29' ' ' ALA . 50.4 Cg_exo -51.96 -32.67 48.86 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.563 2.176 . . . . 0.0 111.206 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 20.6 tp -60.32 -47.13 87.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.737 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.94 -57.37 7.05 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.433 ' O ' HG22 ' B' ' 32' ' ' ILE . 82.4 t -52.67 -34.81 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' B' ' 25' ' ' PRO . . . -64.27 -34.74 78.8 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.56 -48.66 59.55 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.511 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 42.2 t -63.69 -48.85 75.45 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.574 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.474 HG23 ' N ' ' B' ' 33' ' ' ILE . 19.5 tt -65.66 -43.0 93.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.122 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.474 ' N ' HG23 ' B' ' 32' ' ' ILE . 8.2 tt -67.17 -30.33 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.854 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.69 -51.21 37.19 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 179.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 96.8 mt -58.12 -46.09 88.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.255 0.55 . . . . 0.0 109.98 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 11.2 tp -60.76 -38.15 84.25 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.894 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . 0.454 ' ND1' ' C ' ' B' ' 37' ' ' HIS . 0.4 OUTLIER -65.86 -53.95 33.1 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.811 0.338 . . . . 0.0 111.718 -178.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 27.4 tp -60.59 -54.74 41.72 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.691 -178.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.432 HD13 ' HA ' ' B' ' 39' ' ' ILE . 11.5 mm -60.61 -43.7 95.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.523 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 31.0 tp -54.87 -44.53 74.11 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -60.75 -54.64 42.78 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.218 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 47.9 mm -51.18 -53.66 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.325 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.581 HD23 ' O ' ' B' ' 43' ' ' LEU . 1.0 OUTLIER -61.9 -38.97 90.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.136 -178.747 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -58.65 -47.58 83.96 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.219 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 53.4 ttt85 -69.92 -53.59 17.21 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.689 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' B' ' 43' ' ' LEU . 1.9 pp -108.49 147.32 31.87 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.027 0.441 . . . . 0.0 111.198 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -172.45 -48.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.074 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -172.2 -38.34 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.304 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.524 ' NZ ' ' CG ' ' B' ' 52' ' ' TYR . 42.9 tttm -172.88 21.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.259 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 13.2 t -59.01 -46.56 87.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.194 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 71.4 mt -45.53 -32.3 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.906 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.524 ' CG ' ' NZ ' ' B' ' 49' ' ' LYS . 26.3 t80 -72.17 -31.23 65.74 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.461 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.481 ' N ' ' CD ' ' B' ' 53' ' ' ARG . 0.9 OUTLIER -71.57 -45.1 63.19 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.622 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -71.14 -38.15 72.24 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.045 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -70.91 -39.47 72.72 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.655 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -75.27 -39.08 60.1 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.916 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -67.57 -44.94 77.0 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.437 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.8 -28.02 67.6 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 7.9 tp -84.01 49.84 1.72 Allowed 'General case' 0 C--O 1.231 0.102 0 CA-C-O 120.823 0.344 . . . . 0.0 110.375 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 34.9 tptt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.516 -179.869 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 7.8 m . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 53.78 77.01 0.47 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.795 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -50.42 -35.12 43.95 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.544 2.163 . . . . 0.0 111.533 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 18.6 tp -60.97 -49.11 78.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.736 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.39 -45.59 92.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.113 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 91.5 t -58.46 -43.94 87.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.42 -38.48 71.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.338 0.59 . . . . 0.0 109.494 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.6 -46.83 84.01 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.172 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 2.2 p -63.08 -52.39 62.89 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.912 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 14.7 tt -59.95 -35.74 62.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.538 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 49.8 mt -68.13 -37.53 78.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.64 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.24 -52.95 20.09 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.869 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . 0.409 ' CG1' ' N ' ' C' ' 36' ' ' LEU . 6.5 pt -62.14 -41.51 91.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.396 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.409 ' N ' ' CG1' ' C' ' 35' ' ' ILE . 10.5 tp -65.11 -40.79 95.0 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.341 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -62.15 -50.76 70.59 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 50.9 tp -67.7 -48.63 66.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.915 0.388 . . . . 0.0 111.624 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 92.3 mt -58.38 -50.53 78.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.311 -178.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -65.82 -37.16 85.48 Favored 'General case' 0 C--O 1.221 -0.441 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.027 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 21.9 t-105 -56.8 -53.52 56.92 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.276 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 60.3 mt -70.82 -56.54 10.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.524 -0.47 . . . . 0.0 112.251 -177.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.493 HD23 ' O ' ' C' ' 43' ' ' LEU . 0.7 OUTLIER -54.44 -50.85 66.68 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.825 -178.554 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . 0.484 ' O ' ' CB ' ' C' ' 50' ' ' SER . 36.4 t70 -58.05 -42.56 85.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.355 -0.384 . . . . 0.0 109.997 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -53.62 -51.96 61.4 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 119.889 -0.724 . . . . 0.0 110.573 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' C' ' 47' ' ' PHE . 5.7 mt -74.89 -74.21 0.21 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 120.016 -0.674 . . . . 0.0 111.035 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . 0.467 ' CG ' ' N ' ' C' ' 48' ' ' PHE . 21.4 t80 45.78 -171.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.283 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . 0.467 ' N ' ' CG ' ' C' ' 47' ' ' PHE . 26.2 m-85 -56.3 -54.63 43.13 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.243 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -153.21 36.82 0.48 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.248 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' C' ' 44' ' ' ASP . 1.4 t -50.21 -52.41 35.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.18 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 62.0 mt -50.46 -51.57 18.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.264 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -74.45 -31.56 62.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.876 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 53' ' ' ARG . . . . . 0.531 ' O ' ' CD2' ' C' ' 57' ' ' HIS . 85.3 mtt180 -69.93 -48.64 57.71 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.474 -0.491 . . . . 0.0 110.672 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -69.57 -42.11 74.94 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.54 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -63.06 -36.66 84.31 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.501 -0.479 . . . . 0.0 110.864 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -80.05 -24.07 40.97 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.801 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 57' ' ' HIS . . . . . 0.531 ' CD2' ' O ' ' C' ' 53' ' ' ARG . 54.8 m170 -72.41 -45.23 60.61 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.122 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.69 -28.36 73.54 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 10.9 mp -103.08 66.14 0.9 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 65.3 tttm . . . . . 0 N--CA 1.466 0.344 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.45 -179.928 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . 0.461 ' N ' ' HD3' ' D' ' 25' ' ' PRO . 1.0 OUTLIER -163.2 58.45 0.74 Allowed Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.648 179.517 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . 0.461 ' HD3' ' N ' ' D' ' 24' ' ' ASP . 4.6 Cg_exo -73.54 -50.95 0.17 Allowed 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.94 1.76 . . . . 0.0 111.108 179.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . 0.56 HD11 ' O ' ' A' ' 27' ' ' ALA . 2.5 pp -59.6 -28.51 67.25 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.069 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 27' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' D' ' 30' ' ' ALA . . . -50.57 -34.18 24.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.702 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 84.6 t -59.41 -47.81 89.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.83 -35.43 74.72 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.474 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' D' ' 27' ' ' ALA . . . -60.56 -52.26 65.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.83 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 36.7 m -60.16 -44.7 94.8 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.042 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 5.6 mm -61.82 -34.64 63.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.768 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 51.9 mt -69.36 -37.45 75.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.5 -52.41 26.15 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.858 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . 0.471 HG23 ' N ' ' D' ' 36' ' ' LEU . 19.1 tt -63.25 -42.5 96.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.111 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.471 ' N ' HG23 ' D' ' 35' ' ' ILE . 59.5 tp -61.91 -39.15 90.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.79 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . 0.462 ' NE2' ' CE1' ' A' ' 37' ' ' HIS . 2.6 t60 -62.08 -49.23 76.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.387 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 39.1 tp -57.02 -47.32 81.17 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.439 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 95.3 mt -59.79 -43.15 91.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.614 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 57.9 mt -62.07 -39.88 93.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.303 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 17.8 t-105 -61.78 -55.15 33.15 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 120.642 0.258 . . . . 0.0 111.231 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 61.7 mt -61.65 -54.7 31.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.401 -0.519 . . . . 0.0 112.154 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 53.2 tp -59.85 -50.13 74.98 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.199 -178.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . 0.439 ' O ' ' CB ' ' D' ' 50' ' ' SER . 8.8 t0 -53.49 -44.3 68.91 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.186 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 30.2 ttm-85 -59.67 -52.41 65.63 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 120.061 -0.655 . . . . 0.0 110.376 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.39 106.22 15.49 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.01 0.433 . . . . 0.0 110.272 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -173.47 101.54 0.12 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.322 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 47.35 50.38 14.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.662 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? 56.01 53.8 8.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.546 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 7.5 t -63.94 -51.21 65.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.296 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 20.0 mt -47.4 -33.13 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.324 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -73.87 -28.14 61.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.961 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 53' ' ' ARG . . . . . 0.414 ' N ' ' O ' ' D' ' 50' ' ' SER . 74.6 mtm180 -72.7 -47.34 48.02 Favored 'General case' 0 N--CA 1.461 0.093 0 CA-C-O 120.923 0.392 . . . . 0.0 110.748 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -72.06 -39.74 68.82 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.896 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -68.77 -40.03 79.93 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.663 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -75.34 -37.83 60.5 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.386 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -62.61 -48.75 78.05 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.22 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.02 -27.47 73.86 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 6.4 tp -92.65 60.16 3.43 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.772 0.32 . . . . 0.0 110.594 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 65.3 tttp . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.402 179.815 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.3 p . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 55.3 76.17 0.53 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.842 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.449 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 61.4 Cg_exo -49.66 -29.33 19.24 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.475 2.117 . . . . 0.0 111.335 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.3 tp -62.02 -50.39 72.23 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.784 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.17 -53.37 50.37 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.08 0.467 . . . . 0.0 110.068 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.9 t -56.86 -40.42 71.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 25' ' ' PRO . . . -57.78 -42.26 83.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.623 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.64 -42.7 93.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.735 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.0 t -60.34 -41.66 94.05 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.011 -0.675 . . . . 0.0 110.138 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.7 mt -63.02 -43.78 99.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.733 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.6 tt -70.23 -29.91 41.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.016 -178.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.09 -50.55 22.23 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.002 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.552 HD13 ' O ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -65.1 -41.28 91.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.409 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.6 tp -62.47 -36.68 83.23 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.95 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -67.4 -41.99 84.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.944 0.402 . . . . 0.0 110.317 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.84 -57.95 8.29 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.211 0.529 . . . . 0.0 111.441 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.45 HD13 ' HA ' ' A' ' 39' ' ' ILE . 9.2 mm -61.75 -45.78 97.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.828 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.407 ' O ' ' CB ' ' A' ' 44' ' ' ASP . 57.9 tp -60.26 -38.75 84.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.269 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 31.2 t-105 -63.89 -54.05 40.93 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 120.922 0.392 . . . . 0.0 111.486 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 97.1 mt -62.51 -55.32 24.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.141 -0.623 . . . . 0.0 111.813 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.0 tp -60.29 -46.76 88.73 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.072 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.407 ' CB ' ' O ' ' A' ' 40' ' ' LEU . 18.6 t70 -50.5 -47.25 57.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -59.98 -53.03 62.69 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.535 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 47' ' ' PHE . 15.5 mt -73.4 -78.54 0.09 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.034 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.484 ' O ' ' N ' ' A' ' 49' ' ' LYS . 13.3 t80 41.32 -164.5 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.405 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.408 ' N ' ' CG ' ' A' ' 47' ' ' PHE . 20.7 m-85 -64.53 68.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.358 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 47' ' ' PHE . 29.7 mtmm 46.29 47.0 13.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.619 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.428 ' O ' ' N ' ' A' ' 53' ' ' ARG . 90.3 p -69.06 -30.9 69.32 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.631 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.1 mt -44.14 -42.1 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.963 0.411 . . . . 0.0 110.052 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.407 ' CZ ' ' OE1' ' A' ' 56' ' ' GLU . 52.8 t80 -74.85 -28.92 60.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.136 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.522 ' O ' ' CD2' ' A' ' 57' ' ' HIS . 67.9 mtm180 -70.98 -48.25 54.32 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.468 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.434 ' CE1' HD22 ' B' ' 46' ' ' LEU . 54.9 m-85 -71.2 -40.55 71.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.768 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -66.21 -39.57 89.73 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.755 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.407 ' OE1' ' CZ ' ' A' ' 52' ' ' TYR . 15.7 pt-20 -76.35 -41.1 49.4 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.828 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.522 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 10.2 m-70 -60.14 -47.93 83.84 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.53 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.76 -27.82 73.57 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.9 tp -91.69 60.18 3.92 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.727 0.299 . . . . 0.0 110.637 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.011 -179.932 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 71.3 m . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -160.88 68.72 2.59 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.772 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -51.18 -35.66 53.0 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.465 2.11 . . . . 0.0 111.354 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.45 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 15.8 tp -59.38 -51.35 70.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.839 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.93 -43.48 86.31 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 92.0 t -61.93 -33.29 57.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.235 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -64.41 -35.38 80.71 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.26 -45.86 68.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.258 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 3.9 t -66.19 -52.07 51.66 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.331 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.473 HG23 ' N ' ' B' ' 33' ' ' ILE . 10.9 tp -60.77 -43.04 94.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -178.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.473 ' N ' HG23 ' B' ' 32' ' ' ILE . 7.8 tt -69.89 -28.57 37.24 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.08 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.329 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.64 -50.61 41.59 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 mp -62.86 -42.14 95.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 11.0 tp -58.25 -46.96 85.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.889 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 15.2 t-160 -63.9 -52.03 61.8 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 40.9 tp -58.23 -47.09 84.63 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 120.549 -0.461 . . . . 0.0 111.136 -178.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 3.2 mm -63.79 -41.06 91.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.982 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.528 ' O ' HD13 ' B' ' 40' ' ' LEU . 0.2 OUTLIER -60.51 -42.6 96.73 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.904 -179.55 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 46.0 t-105 -64.81 -57.22 9.47 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 75.5 mt -58.48 -53.75 42.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.597 -177.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 41.9 tp -59.73 -46.44 89.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.164 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -55.07 -47.28 75.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.648 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -62.75 -48.56 78.64 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.491 -0.483 . . . . 0.0 111.351 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.434 HD22 ' CE1' ' A' ' 54' ' ' PHE . 0.2 OUTLIER -121.54 124.19 43.81 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.125 0.488 . . . . 0.0 110.43 179.381 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -172.98 -47.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.367 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -171.1 65.81 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.389 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm 55.25 35.44 24.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.566 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 11.2 t -60.0 -49.22 78.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.919 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 48.0 mt -47.36 -31.26 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.759 0.314 . . . . 0.0 110.882 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.527 ' CD2' ' OE1' ' B' ' 56' ' ' GLU . 76.2 t80 -70.84 -29.8 66.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.465 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -71.14 -44.01 66.44 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.41 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -71.21 -38.73 72.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.011 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -69.76 -39.28 76.81 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.737 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . 0.527 ' OE1' ' CD2' ' B' ' 52' ' ' TYR . 10.6 pt-20 -75.58 -38.51 59.09 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 120.254 -0.579 . . . . 0.0 110.644 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -65.03 -47.23 78.16 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.322 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.0 -28.64 73.78 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 32.9 tp -73.39 -68.72 0.48 Allowed 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.402 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.54 179.946 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -156.74 68.83 4.56 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.899 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -51.23 -30.34 32.63 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.514 2.142 . . . . 0.0 111.141 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 16.8 tp -59.09 -51.52 69.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.757 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.5 -46.97 87.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.033 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 61.3 t -58.82 -42.72 86.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.0 -37.9 72.33 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.47 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.38 -49.77 70.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.103 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . 0.436 ' OG ' ' CD1' ' B' ' 26' ' ' LEU . 2.9 m -60.23 -50.79 72.26 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.96 -179.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 17.5 tt -63.71 -33.68 63.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.983 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 32.3 mt -67.24 -42.21 87.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.441 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.07 -49.51 46.69 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 121.019 -0.61 . . . . 0.0 111.666 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 5.1 mm -61.67 -45.37 98.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.128 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 11.6 tp -61.22 -41.65 97.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.169 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 32.7 t60 -61.51 -48.67 80.01 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.61 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 31.2 tp -63.19 -52.93 60.34 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -178.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 1.3 mp -60.46 -46.19 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.017 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -62.06 -40.62 96.39 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.821 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 6.7 t-105 -57.71 -58.41 8.46 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.245 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 68.8 mt -62.13 -56.27 18.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -177.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.647 ' C ' HD13 ' C' ' 43' ' ' LEU . 3.0 tm? -57.99 -52.82 63.92 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.177 -178.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -53.35 -41.24 65.59 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -57.61 -56.23 24.63 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.455 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' C' ' 48' ' ' PHE . 2.2 mt -80.73 -71.12 0.48 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.855 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . 0.46 ' CD2' ' N ' ' C' ' 48' ' ' PHE . 85.2 t80 49.26 -89.56 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.181 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . 0.51 ' N ' ' O ' ' C' ' 46' ' ' LEU . 68.7 t80 -153.49 85.52 1.19 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.236 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 56.9 mttp 52.09 29.26 6.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.935 0.398 . . . . 0.0 110.187 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 11.3 t -62.47 -39.54 93.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.121 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 54.6 mt -47.08 -48.91 8.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.306 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -71.69 -32.25 67.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.58 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 53' ' ' ARG . . . . . 0.524 ' O ' ' CD2' ' C' ' 57' ' ' HIS . 77.3 mtp180 -70.75 -48.07 56.34 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.481 -0.487 . . . . 0.0 110.619 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -66.03 -42.28 89.81 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.226 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -63.09 -39.29 94.26 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.459 -0.497 . . . . 0.0 110.854 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -76.99 -22.03 53.78 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.759 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 57' ' ' HIS . . . . . 0.524 ' CD2' ' O ' ' C' ' 53' ' ' ARG . 11.9 m-70 -73.75 -49.24 26.51 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.091 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.85 -27.45 72.76 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 8.3 tp -91.86 48.66 1.46 Allowed 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.809 0.337 . . . . 0.0 110.375 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.531 -179.874 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 24.3 m . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' D' ' 27' ' ' ALA . 29.5 p30 -175.46 61.8 0.22 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.373 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -45.85 -27.36 3.95 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 C-N-CA 121.389 1.393 . . . . 0.0 110.227 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 pp -68.13 -35.4 78.05 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.088 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 27' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' D' ' 24' ' ' ASP . . . -51.07 -37.95 48.7 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.102 0.477 . . . . 0.0 109.879 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 71.4 t -59.24 -47.42 90.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 CA-C-O 121.428 0.632 . . . . 0.0 109.487 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.33 -39.49 76.0 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.286 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' D' ' 27' ' ' ALA . . . -58.47 -47.3 84.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.174 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 11.2 t -57.36 -50.21 73.7 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.871 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 61.0 mt -61.35 -31.71 51.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.55 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 55.2 mt -68.19 -40.46 82.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.348 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.99 -52.14 25.28 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.883 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . 0.429 HG23 ' N ' ' D' ' 36' ' ' LEU . 15.6 tt -61.95 -42.29 94.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.806 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.429 ' N ' HG23 ' D' ' 35' ' ' ILE . 43.6 tp -63.71 -34.9 78.9 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.985 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -63.67 -50.93 67.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.964 0.411 . . . . 0.0 110.247 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 36.3 tp -58.35 -47.5 83.57 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.85 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 5.0 mm -61.69 -44.37 98.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.319 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . 0.561 HD23 ' O ' ' D' ' 40' ' ' LEU . 0.8 OUTLIER -61.82 -39.26 91.17 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 -179.366 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 23.7 t-105 -64.07 -56.6 13.83 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 120.875 0.369 . . . . 0.0 111.434 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 82.1 mt -58.55 -53.2 50.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.777 -177.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 29.9 tp -61.1 -47.4 86.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.881 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -51.91 -44.16 63.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.265 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . 0.502 ' HE ' ' CD2' ' D' ' 46' ' ' LEU . 60.1 ttp180 -64.12 -53.45 49.29 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.77 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . 0.502 ' CD2' ' HE ' ' D' ' 45' ' ' ARG . 0.2 OUTLIER -113.53 110.31 20.05 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.046 0.451 . . . . 0.0 110.3 179.143 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -174.77 92.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.146 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 53.96 58.16 5.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.539 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? 53.73 52.93 12.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.95 0.405 . . . . 0.0 110.372 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . 0.524 ' OG ' ' NH2' ' D' ' 53' ' ' ARG . 8.1 t -68.22 -51.76 41.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.227 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 4.7 mt -48.15 -35.01 5.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -72.37 -28.97 63.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.05 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 53' ' ' ARG . . . . . 0.524 ' NH2' ' OG ' ' D' ' 50' ' ' SER . 36.7 mtm105 -71.86 -46.49 57.76 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.96 0.41 . . . . 0.0 110.525 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -70.94 -36.85 72.79 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.788 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -70.06 -39.7 75.49 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.659 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -75.43 -37.73 60.23 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.614 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -65.94 -44.37 85.27 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.27 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.18 -26.74 70.67 Favored Glycine 0 N--CA 1.462 0.374 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.8 70.24 0.77 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.271 0.558 . . . . 0.0 109.728 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 16.3 ttpp . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.512 -179.721 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 56.7 m . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.515 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 6.1 p30 -174.83 75.55 0.32 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.798 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -52.16 -35.45 62.79 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.15 1.9 . . . . 0.0 110.957 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.4 tp -65.21 -50.27 66.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.18 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.452 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -65.43 -50.67 64.54 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.34 0.59 . . . . 0.0 109.568 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.2 t -54.59 -46.68 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.44 -42.36 70.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.691 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -55.72 -47.63 76.54 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.17 0.51 . . . . 0.0 110.567 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 80.8 p -62.39 -39.96 94.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.803 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 35.6 mm -61.97 -47.58 92.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.608 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.9 tt -68.96 -29.64 44.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.7 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.13 -50.21 47.61 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.171 -1.014 . . . . 0.0 110.578 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 28.1 mm -62.91 -44.24 99.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 51.4 tp -63.21 -31.13 72.2 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.433 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -69.5 -52.22 28.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.985 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 32.1 tp -61.76 -51.28 68.99 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.207 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.9 mm -61.86 -43.69 97.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.908 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 35.5 tp -61.2 -38.95 88.39 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.381 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 44.3 t-105 -63.78 -55.17 25.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.824 0.345 . . . . 0.0 111.647 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.7 mt -61.44 -51.65 70.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 120.454 -0.498 . . . . 0.0 111.78 -177.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.407 HD11 ' CD1' ' A' ' 47' ' ' PHE . 23.9 tp -60.96 -42.35 98.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.983 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -57.78 -45.29 86.19 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -60.03 -48.66 80.78 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.484 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.4 pp -130.91 132.87 45.39 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.026 0.441 . . . . 0.0 111.088 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.407 ' CD1' HD11 ' A' ' 43' ' ' LEU . 49.2 t80 -175.41 -38.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.161 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -167.24 60.03 0.08 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.251 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp 60.85 42.47 13.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.38 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.5 t -62.34 -49.91 73.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.696 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 94.1 mt -49.67 -41.96 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.205 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -72.26 -28.5 63.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.216 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.525 ' O ' ' CD2' ' A' ' 57' ' ' HIS . 12.1 mmm180 -69.71 -46.57 65.68 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.317 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -71.41 -40.23 70.61 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.075 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -67.37 -38.18 84.34 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.746 -179.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.52 ' OE2' ' CE1' ' A' ' 57' ' ' HIS . 0.7 OUTLIER -77.5 -38.03 49.91 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.876 -179.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.525 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 26.4 m-70 -63.87 -50.54 68.41 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.469 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.75 -27.41 72.42 Favored Glycine 0 N--CA 1.463 0.468 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.81 71.82 0.77 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.122 0.487 . . . . 0.0 109.919 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 N--CA 1.466 0.346 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.594 179.992 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 44.8 t . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 56.94 70.02 1.52 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.76 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -51.55 -31.4 39.61 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.57 2.18 . . . . 0.0 111.427 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.417 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 19.0 tp -58.76 -51.28 70.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.912 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.62 -46.12 91.46 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 91.8 t -59.74 -35.84 62.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -62.34 -35.63 79.71 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.6 -45.54 71.71 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.387 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 8.4 p -65.5 -51.86 56.94 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.423 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.511 HG23 ' N ' ' B' ' 33' ' ' ILE . 20.0 tt -61.86 -43.05 96.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -178.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.511 ' N ' HG23 ' B' ' 32' ' ' ILE . 8.3 tt -69.16 -30.3 45.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 C-N-CA 119.731 -0.788 . . . . 0.0 110.304 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.52 -50.55 42.7 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 mp -61.58 -41.59 90.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 19.8 tp -60.39 -40.97 92.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.747 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -67.71 -51.76 45.71 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 35.1 tp -61.68 -52.4 64.47 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.614 -178.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.6 mm -62.0 -41.76 92.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.392 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 46.0 tp -59.59 -41.66 90.78 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.249 -0.58 . . . . 0.0 109.944 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 9.9 t-105 -62.5 -59.37 5.05 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.724 0.297 . . . . 0.0 111.724 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 72.0 mt -58.53 -56.52 15.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.635 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.467 HD23 ' O ' ' B' ' 43' ' ' LEU . 0.6 OUTLIER -55.0 -49.78 70.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.641 -178.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -52.24 -44.19 64.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.326 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -59.2 -53.01 63.1 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.641 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 2.8 mt -77.45 -141.03 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 119.871 -0.732 . . . . 0.0 110.594 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.424 ' O ' ' O ' ' B' ' 48' ' ' PHE . 47.8 t80 59.78 110.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.615 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . 0.545 ' CG ' ' N ' ' B' ' 49' ' ' LYS . 57.5 t80 48.35 -178.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.404 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.545 ' N ' ' CG ' ' B' ' 48' ' ' PHE . 0.1 OUTLIER -72.19 45.42 0.13 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.377 -179.878 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . 0.401 ' H ' ' C ' ' B' ' 48' ' ' PHE . 11.1 t -62.56 -47.57 83.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.853 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 51.2 mt -48.22 -41.88 10.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.592 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.515 ' CE2' ' OE2' ' B' ' 56' ' ' GLU . 78.9 t80 -71.39 -29.72 65.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.446 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 69.6 mtm180 -68.14 -44.04 76.93 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.412 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -72.26 -39.47 68.37 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.762 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -64.45 -40.84 96.5 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.488 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . 0.515 ' OE2' ' CE2' ' B' ' 52' ' ' TYR . 13.2 pt-20 -76.48 -38.79 54.79 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.63 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -59.08 -47.06 86.63 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.174 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.35 -28.37 73.65 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 8.0 tp -88.87 49.06 1.72 Allowed 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.708 0.289 . . . . 0.0 110.468 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm . . . . . 0 N--CA 1.469 0.481 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.627 -179.986 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 25.1 t . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -159.18 70.78 3.46 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.871 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.0 -29.51 36.26 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.621 2.214 . . . . 0.0 111.281 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.59 -56.32 23.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.89 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.2 -46.79 82.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.57 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 74.6 t -58.21 -43.44 85.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.64 -39.93 78.08 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.528 178.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.77 -49.37 76.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.164 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 2.2 t -62.17 -53.79 50.26 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 16.5 tt -58.44 -35.8 55.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.663 -179.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 51.0 mt -67.46 -37.48 78.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.399 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.33 -51.22 28.11 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.93 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -62.82 -43.54 98.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 11.4 tp -63.22 -41.61 99.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.838 0.351 . . . . 0.0 110.237 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -61.61 -48.06 82.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.522 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 51.3 tp -65.0 -51.01 64.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.789 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 50.9 mt -59.3 -48.49 86.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.19 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -63.25 -37.65 88.08 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.671 -0.412 . . . . 0.0 109.981 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 25.5 t-105 -59.35 -59.37 5.56 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.346 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 48.4 mt -62.63 -54.97 26.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.514 -0.474 . . . . 0.0 112.047 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.673 ' C ' HD13 ' C' ' 43' ' ' LEU . 3.2 tm? -57.9 -52.36 65.83 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.196 -178.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . 0.454 ' O ' ' CB ' ' C' ' 50' ' ' SER . 67.9 t0 -53.11 -41.94 65.49 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.02 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -58.49 -53.24 60.61 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.791 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' C' ' 48' ' ' PHE . 3.6 mt -84.53 -71.41 0.52 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.176 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 91.7 t80 56.75 -80.42 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.246 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . 0.527 ' N ' ' O ' ' C' ' 46' ' ' LEU . 86.4 t80 -172.91 -22.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.334 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . 0.464 ' NZ ' ' CD1' ' C' ' 52' ' ' TYR . 49.8 tttm -170.75 21.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.91 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' C' ' 44' ' ' ASP . 10.8 t -62.08 -48.47 80.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.282 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 51' ' ' ILE . . . . . 0.426 ' H ' HG13 ' C' ' 51' ' ' ILE . 12.8 mt -50.21 -53.99 9.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.3 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 52' ' ' TYR . . . . . 0.464 ' CD1' ' NZ ' ' C' ' 49' ' ' LYS . 27.7 t80 -70.57 -32.83 70.38 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.668 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 19.9 mmt85 -70.01 -43.41 71.4 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.586 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -66.29 -47.23 74.3 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.176 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -62.2 -36.55 82.27 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.925 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . 0.411 ' O ' ' OE1' ' C' ' 56' ' ' GLU . 3.0 tm-20 -77.97 -21.9 50.25 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.535 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -73.42 -48.9 30.11 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 120.341 -0.544 . . . . 0.0 109.974 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.69 -27.11 73.09 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 8.6 tp -83.9 57.39 4.12 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.824 0.345 . . . . 0.0 110.311 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 18.7 tptm . . . . . 0 N--CA 1.466 0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.281 -179.867 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 18.4 p . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . 0.494 ' N ' ' HD3' ' D' ' 25' ' ' PRO . 0.7 OUTLIER -166.45 55.66 0.36 Allowed Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.811 179.606 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . 0.494 ' HD3' ' N ' ' D' ' 24' ' ' ASP . 6.1 Cg_exo -73.52 -41.19 1.24 Allowed 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 121.663 1.575 . . . . 0.0 111.091 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . 0.553 ' O ' ' HB3' ' D' ' 29' ' ' ALA . 2.4 pp -65.95 -30.88 71.52 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.678 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.32 -49.7 42.83 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 95.4 t -50.81 -38.09 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 178.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' D' ' 26' ' ' LEU . . . -62.6 -40.06 95.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.639 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.94 -50.48 68.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.268 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 45.9 t -60.51 -51.89 67.53 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.904 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 20.1 tt -63.27 -31.41 52.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.629 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 19.4 mt -67.47 -41.8 86.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.017 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.01 -51.74 32.32 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.121 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 10.7 tp -64.49 -39.18 84.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.402 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 56.8 tp -64.58 -38.64 91.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.109 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 32.4 t60 -65.11 -48.66 72.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.368 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 50.3 tp -59.08 -47.01 86.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.562 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.36 -42.76 94.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.851 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 40.2 mt -61.58 -42.45 98.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.208 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 18.4 t-105 -62.07 -55.58 27.63 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.696 0.284 . . . . 0.0 111.508 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 72.5 mt -60.54 -54.93 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -177.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 40.0 tp -60.92 -44.43 97.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.61 0.243 . . . . 0.0 111.343 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . 0.435 ' O ' ' CB ' ' D' ' 50' ' ' SER . 22.6 t70 -58.08 -42.77 86.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.594 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . 0.433 ' HG3' HD11 ' D' ' 51' ' ' ILE . 9.8 tpt180 -66.11 -56.61 10.6 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.066 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . 0.414 HD23 ' HB3' ' D' ' 45' ' ' ARG . 0.2 OUTLIER -106.67 130.8 54.34 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.376 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -171.76 -43.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.454 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -172.71 -48.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.426 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -172.46 28.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.339 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . 0.435 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 7.8 t -57.92 -50.93 71.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.181 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 51' ' ' ILE . . . . . 0.433 HD11 ' HG3' ' D' ' 45' ' ' ARG . 7.3 mt -49.39 -39.35 13.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.32 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 52' ' ' TYR . . . . . 0.465 ' CE2' ' OE2' ' D' ' 56' ' ' GLU . 82.5 t80 -73.98 -29.56 62.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.242 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 -68.15 -48.32 65.67 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.916 0.388 . . . . 0.0 110.482 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -72.34 -39.49 68.12 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.752 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -62.1 -41.96 98.74 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.348 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 56' ' ' GLU . . . . . 0.465 ' OE2' ' CE2' ' D' ' 52' ' ' TYR . 14.8 pt-20 -77.49 -37.11 51.88 Favored 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 120.219 -0.592 . . . . 0.0 110.434 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -56.18 -48.89 75.48 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.217 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.82 -27.08 74.16 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.439 -1.065 . . . . 0.0 110.439 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 59' ' ' LEU . . . . . 0.411 ' N ' ' CD2' ' D' ' 59' ' ' LEU . 3.0 mm? -99.29 52.69 0.95 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.025 0.441 . . . . 0.0 109.983 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 63.7 tttp . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.586 179.923 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.2 m . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -163.29 74.85 1.9 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.782 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -51.29 -37.33 59.75 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.222 1.948 . . . . 0.0 111.03 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.9 tp -63.3 -49.01 75.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.936 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.497 ' HB1' HD11 ' D' ' 26' ' ' LEU . . . -60.84 -55.08 37.25 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.7 t -51.87 -47.66 40.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.811 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.93 -48.84 64.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.899 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.76 -48.63 66.65 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.787 ' OG ' HD13 ' D' ' 26' ' ' LEU . 0.9 OUTLIER -53.18 -53.01 56.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.482 179.755 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 44.7 mm -53.62 -38.25 33.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.223 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 70.6 mt -69.47 -32.8 54.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.291 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.1 -53.04 15.66 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.855 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -33.97 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.108 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.6 tp -69.41 -35.97 76.27 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.338 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.561 ' CE1' ' CD2' ' B' ' 37' ' ' HIS . 47.9 t60 -70.01 -51.3 33.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.654 0.264 . . . . 0.0 111.054 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.6 tp -62.73 -50.38 71.32 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.934 0.397 . . . . 0.0 111.222 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 29.5 mm -63.32 -44.59 99.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.279 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 50.2 tp -60.66 -43.23 97.91 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.234 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 16.6 t-105 -61.91 -57.24 12.52 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.744 0.307 . . . . 0.0 111.74 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 76.5 mt -59.56 -55.46 23.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.531 -0.467 . . . . 0.0 112.22 -177.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.7 tp -59.73 -46.97 87.51 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.167 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -53.71 -41.78 67.34 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.402 HH22 ' HB3' ' D' ' 54' ' ' PHE . 45.2 ttt-85 -60.59 -51.53 69.04 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.252 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.81 107.42 18.61 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 120.776 -0.369 . . . . 0.0 110.203 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -174.11 100.32 0.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.217 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.508 ' CD2' ' O ' ' A' ' 48' ' ' PHE . 69.3 t80 45.45 52.07 9.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.39 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.0 mttp 55.32 52.94 10.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.618 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.5 t -62.65 -42.78 99.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.96 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.551 ' H ' HD12 ' A' ' 51' ' ' ILE . 3.5 mp -47.74 -31.48 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.504 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -72.95 -28.51 62.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.097 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.542 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 77.9 mtp180 -68.42 -48.04 65.68 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.378 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -71.46 -39.28 71.04 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.795 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -64.36 -39.97 94.94 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.7 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.534 ' OE2' ' CD2' ' A' ' 57' ' ' HIS . 1.6 pp20? -77.01 -41.29 43.32 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.851 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.542 ' ND1' ' O ' ' A' ' 53' ' ' ARG . 23.9 m80 -57.87 -50.49 73.14 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 120.314 -0.554 . . . . 0.0 109.782 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.16 -26.83 72.96 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.0 tp -156.27 90.07 1.17 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.433 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.0 pttm . . . . . 0 N--CA 1.458 -0.055 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.657 -179.719 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 72.3 m . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -159.83 70.76 3.18 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.867 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -50.84 -30.6 30.42 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.646 2.231 . . . . 0.0 111.244 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.466 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 19.7 tp -60.85 -50.12 74.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.078 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.43 -43.1 79.08 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 83.7 t -61.37 -34.3 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' B' ' 26' ' ' LEU . . . -64.29 -34.63 78.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.305 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.13 -51.68 43.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.087 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 6.1 p -61.71 -50.42 72.53 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.783 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.425 HG23 ' N ' ' B' ' 33' ' ' ILE . 3.8 tp -62.33 -40.93 89.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.989 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.425 ' N ' HG23 ' B' ' 32' ' ' ILE . 34.1 mt -62.19 -44.3 98.91 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.922 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.04 -53.78 43.56 Favored Glycine 0 N--CA 1.462 0.376 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 96.8 mt -50.55 -39.13 17.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.94 -45.89 90.32 Favored 'General case' 0 C--O 1.219 -0.5 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.28 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . 0.561 ' CD2' ' CE1' ' A' ' 37' ' ' HIS . 1.4 t60 -60.35 -48.58 81.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.592 -178.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.423 ' N ' HD12 ' B' ' 38' ' ' LEU . 9.6 mp -64.07 -47.86 78.45 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.741 -178.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 18.1 mm -62.52 -47.93 90.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.295 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 7.1 mp -63.66 -34.01 76.9 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 28.6 t-105 -64.66 -57.26 9.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 120.89 0.376 . . . . 0.0 111.262 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 77.7 mt -60.0 -51.73 69.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.773 -178.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 8.6 mt -63.4 -50.94 67.85 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.502 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . 0.478 ' O ' ' CB ' ' B' ' 50' ' ' SER . 36.3 t70 -53.4 -41.94 66.46 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.325 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -65.3 -45.45 84.32 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.946 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 2.5 pp -139.5 124.08 18.32 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.266 0.555 . . . . 0.0 111.507 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -173.79 -31.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.879 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . 0.415 ' O ' ' CD2' ' B' ' 48' ' ' PHE . 63.4 t80 -167.4 58.93 0.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.051 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 97.5 mttt 55.14 53.95 9.47 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.504 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' B' ' 44' ' ' ASP . 3.0 p -68.39 -52.28 34.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.995 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . 0.407 ' N ' ' OG ' ' B' ' 50' ' ' SER . 80.6 mt -50.3 -46.73 25.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.974 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.518 ' CE2' ' OE2' ' B' ' 56' ' ' GLU . 86.5 t80 -71.25 -29.82 65.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.317 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 33.1 mmm-85 -70.76 -44.7 66.2 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.831 0.348 . . . . 0.0 110.541 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . 0.401 ' HB3' HH22 ' C' ' 45' ' ' ARG . 55.0 m-85 -71.64 -39.23 70.53 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.881 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -68.18 -38.97 82.6 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.684 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . 0.518 ' OE2' ' CE2' ' B' ' 52' ' ' TYR . 11.5 pt-20 -76.16 -38.54 56.55 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.569 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -62.88 -47.67 82.33 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.235 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.79 -27.58 72.24 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 9.9 tp -89.38 59.46 4.83 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-O 120.837 0.351 . . . . 0.0 110.275 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp . . . . . 0 N--CA 1.466 0.372 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.287 -179.984 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -35.83 100.54 0.2 Allowed Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.45 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.85 -34.79 37.75 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.044 1.83 . . . . 0.0 111.559 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . 0.401 ' C ' ' CD1' ' C' ' 26' ' ' LEU . 0.2 OUTLIER -58.48 -55.69 31.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.489 0.662 . . . . 0.0 109.477 179.428 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.49 -45.63 88.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.427 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 88.0 t -56.9 -40.19 70.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.9 -37.65 85.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.761 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.41 -51.24 64.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.542 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 10.4 p -63.44 -51.45 65.66 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 120.689 -0.404 . . . . 0.0 112.04 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 20.7 tt -59.85 -36.51 66.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.764 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 41.3 mt -68.5 -39.56 80.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.64 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.78 -52.81 31.19 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.734 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 6.8 pt -61.91 -42.59 95.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.295 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 8.7 tp -63.82 -34.34 77.69 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.313 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -66.75 -52.67 41.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.241 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 33.1 tp -61.9 -49.44 76.19 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.045 0.45 . . . . 0.0 111.121 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 30.3 mm -59.79 -43.89 92.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.73 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 25.7 mt -62.34 -40.28 95.84 Favored 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.919 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 25.0 t-105 -59.58 -52.31 66.1 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.308 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 65.9 mt -66.68 -56.59 13.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.266 -0.574 . . . . 0.0 112.411 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.65 ' C ' HD13 ' C' ' 43' ' ' LEU . 2.9 tm? -58.28 -52.09 67.05 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.886 -178.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -52.93 -43.38 66.24 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.22 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . 0.401 HH22 ' HB3' ' B' ' 54' ' ' PHE . 52.9 ttt-85 -58.84 -52.09 67.21 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.853 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' C' ' 48' ' ' PHE . 8.5 mt -79.59 -73.95 0.32 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 120.274 -0.571 . . . . 0.0 111.263 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 49.3 t80 62.03 -71.32 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.407 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' C' ' 46' ' ' LEU . 66.2 t80 -172.75 -32.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.261 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 46.6 tttp -172.96 26.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.917 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 39.6 t -63.73 -42.23 97.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.298 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 58.3 mt -48.98 -52.78 9.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.389 -179.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -74.86 -32.64 61.96 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 53' ' ' ARG . . . . . 0.527 ' O ' ' CD2' ' C' ' 57' ' ' HIS . 96.1 mtt180 -71.73 -49.58 37.94 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.673 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -67.66 -43.32 80.53 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.428 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -64.88 -35.87 82.54 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.829 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -77.56 -24.28 49.84 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.561 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 57' ' ' HIS . . . . . 0.527 ' CD2' ' O ' ' C' ' 53' ' ' ARG . 58.0 m170 -73.16 -45.51 56.16 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 120.541 -0.464 . . . . 0.0 109.77 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.1 -27.16 72.69 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 7.7 tp -84.12 57.73 4.36 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.837 0.351 . . . . 0.0 110.466 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 62.0 tttm . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.4 -179.952 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 15.2 p30 -162.34 76.39 2.09 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.021 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -51.45 -30.47 35.14 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.06 1.84 . . . . 0.0 110.878 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . 0.787 HD13 ' OG ' ' A' ' 31' ' ' SER . 3.9 pp -66.18 -42.71 88.52 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.832 179.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 27' ' ' ALA . . . . . 0.574 ' N ' HD12 ' D' ' 26' ' ' LEU . . . -49.31 -53.47 21.81 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.558 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 87.7 t -48.1 -36.98 6.49 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.06 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' D' ' 26' ' ' LEU . . . -65.58 -37.04 85.52 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.275 0.56 . . . . 0.0 109.818 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.94 -51.22 60.43 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.883 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 58.4 m -62.43 -50.44 71.48 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 3.3 tp -62.29 -35.84 71.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.73 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 37.7 mt -68.03 -38.21 79.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.07 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.38 -50.76 42.02 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.15 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . 0.477 HG23 ' N ' ' D' ' 36' ' ' LEU . 18.4 tt -66.05 -42.75 92.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.347 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.477 ' N ' HG23 ' D' ' 35' ' ' ILE . 7.2 tp -60.62 -38.5 84.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.864 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -66.92 -45.43 77.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.604 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 31.6 tp -57.67 -54.3 48.46 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.195 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 13.6 pt -64.08 -37.31 79.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.816 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 17.9 mt -58.82 -42.55 89.48 Favored 'General case' 0 C--O 1.224 -0.263 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 33.5 t-105 -64.58 -51.44 62.72 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.101 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 mm -56.48 -56.72 12.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.531 -0.467 . . . . 0.0 111.771 -177.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 36.6 tp -62.03 -45.23 94.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.789 0.328 . . . . 0.0 110.8 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -50.76 -44.44 58.61 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.004 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -66.48 -54.57 22.52 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.564 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.72 105.62 15.74 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.279 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -172.99 95.79 0.12 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.313 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 52.2 51.69 15.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.742 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 18.0 mtpp 54.44 49.75 17.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.594 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 10.9 t -61.85 -46.36 89.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.992 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 38.2 mt -49.44 -39.11 13.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.656 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -72.72 -28.86 62.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.112 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 35.7 mtm105 -71.5 -47.49 55.08 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.984 0.421 . . . . 0.0 110.56 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . 0.402 ' HB3' HH22 ' A' ' 45' ' ' ARG . 73.6 m-85 -71.16 -35.16 71.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.739 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -70.64 -37.91 73.81 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.604 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -77.51 -37.89 50.11 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.644 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -66.16 -48.63 70.11 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.504 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.86 -27.34 72.0 Favored Glycine 0 N--CA 1.461 0.311 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.13 77.15 1.77 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 57.3 tttm . . . . . 0 C--N 1.333 -0.111 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.539 -179.695 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 38.23 69.48 1.49 Allowed Pre-proline 0 N--CA 1.463 0.203 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.964 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.443 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 52.9 Cg_exo -51.04 -33.35 42.53 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.275 1.983 . . . . 0.0 111.115 179.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.3 tp -65.56 -50.73 64.09 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.059 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.437 ' O ' ' HB3' ' A' ' 30' ' ' ALA . . . -63.43 -50.23 70.61 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.392 0.615 . . . . 0.0 109.567 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.3 t -57.94 -45.27 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 25' ' ' PRO . . . -55.6 -35.36 65.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.779 179.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 27' ' ' ALA . . . -64.55 -50.05 68.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.413 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.423 ' OG ' HD13 ' D' ' 26' ' ' LEU . 9.6 m -58.52 -41.09 84.65 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.477 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 35.5 mm -64.52 -41.74 93.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.505 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 33' ' ' ILE . 2.6 tt -68.43 -35.61 71.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.627 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.26 -51.47 32.53 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 89.3 mt -60.7 -43.87 95.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.96 0.409 . . . . 0.0 110.067 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.2 tp -65.01 -31.07 72.13 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.364 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.462 ' HD1' ' C ' ' A' ' 37' ' ' HIS . 0.3 OUTLIER -68.55 -51.97 37.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.805 0.336 . . . . 0.0 110.903 -179.517 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 51.2 tp -62.58 -51.44 67.31 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.265 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 83.5 mt -61.98 -44.58 99.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.076 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 35.0 tp -60.32 -41.72 94.09 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.322 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.1 t-105 -62.59 -57.78 9.88 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 120.95 0.405 . . . . 0.0 111.516 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 95.3 mt -56.64 -54.72 25.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.925 -177.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 47' ' ' PHE . 29.0 tp -61.97 -44.01 97.64 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.025 -178.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -50.43 -45.95 56.13 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 57.7 ttt85 -61.71 -52.72 63.12 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.14 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 48' ' ' PHE . 5.6 mt -81.93 -77.38 0.22 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.806 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.464 ' N ' ' O ' ' A' ' 43' ' ' LEU . 92.6 t80 52.9 -83.69 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.8 0.333 . . . . 0.0 110.415 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.525 ' N ' ' O ' ' A' ' 46' ' ' LEU . 49.9 t80 -157.39 81.43 0.9 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.119 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.6 mttm 51.28 25.35 2.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.244 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 53' ' ' ARG . 3.9 t -61.76 -29.66 70.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.587 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.9 mt -45.34 -37.0 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.988 0.423 . . . . 0.0 110.06 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -74.37 -27.58 60.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.001 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.537 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 95.7 mtt-85 -71.61 -48.63 46.84 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.542 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -71.33 -38.93 71.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.006 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -69.87 -38.87 76.55 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 120.829 -0.349 . . . . 0.0 111.724 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.523 ' OE2' ' CD2' ' A' ' 57' ' ' HIS . 0.8 OUTLIER -75.84 -38.42 58.05 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.785 -179.871 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.537 ' ND1' ' O ' ' A' ' 53' ' ' ARG . 27.8 m170 -66.39 -44.95 81.64 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.449 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.68 -27.38 73.38 Favored Glycine 0 N--CA 1.462 0.38 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.49 78.91 1.8 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.933 0.397 . . . . 0.0 110.001 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? . . . . . 0 C--N 1.333 -0.127 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.654 -179.819 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 29.3 t . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 48.76 65.83 6.56 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.42 ' O ' ' HB2' ' B' ' 29' ' ' ALA . 64.4 Cg_exo -49.68 -28.96 18.36 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.365 2.043 . . . . 0.0 111.241 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 19.4 tp -60.85 -51.19 70.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.86 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' B' ' 30' ' ' ALA . . . -65.64 -51.68 57.7 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.362 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 14.7 t -56.97 -42.33 78.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' B' ' 25' ' ' PRO . . . -55.82 -43.91 77.41 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' B' ' 27' ' ' ALA . . . -56.43 -44.85 80.81 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.384 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 5.7 t -61.35 -48.99 78.77 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.299 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 74.7 mt -57.39 -48.73 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.743 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 15.5 tt -67.96 -27.16 36.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.695 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.7 -49.18 57.2 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 2.2 mp -67.78 -41.13 84.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 12.4 tp -55.87 -52.05 65.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.925 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -67.36 -40.65 85.82 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.308 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 48.1 tp -63.29 -57.86 9.02 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 120.652 -0.419 . . . . 0.0 112.097 -178.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 4.6 tt -66.56 -36.87 78.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.812 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 52.5 tp -63.98 -36.74 84.98 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.539 -0.465 . . . . 0.0 109.966 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -67.73 -56.67 8.37 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.805 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.538 ' CG2' ' N ' ' B' ' 43' ' ' LEU . 8.3 tt -62.38 -47.63 92.13 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.476 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.071 -177.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.538 ' N ' ' CG2' ' B' ' 42' ' ' ILE . 17.8 tp -63.92 -47.0 82.29 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.338 -177.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . 0.422 ' O ' ' OG ' ' B' ' 50' ' ' SER . 41.7 t0 -57.96 -38.28 75.72 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 70.2 ttt-85 -69.67 -45.79 67.56 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.082 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 2.7 pp -133.62 125.61 29.11 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.098 0.475 . . . . 0.0 110.904 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.508 ' CD1' HD11 ' B' ' 43' ' ' LEU . 66.2 t80 -173.74 -37.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.551 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -172.21 56.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.297 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp 60.62 43.23 12.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.43 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' B' ' 44' ' ' ASP . 13.4 t -63.73 -51.02 66.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.817 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 73.1 mt -46.53 -40.46 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.856 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.522 ' CE2' ' OE2' ' B' ' 56' ' ' GLU . 92.0 t80 -71.65 -30.2 65.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.55 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.523 ' O ' ' CD2' ' B' ' 57' ' ' HIS . 93.5 mtt180 -70.63 -45.12 65.81 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.011 0.434 . . . . 0.0 110.655 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -71.66 -38.06 70.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.824 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -68.48 -39.1 81.49 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.529 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . 0.522 ' OE2' ' CE2' ' B' ' 52' ' ' TYR . 12.4 pt-20 -75.92 -39.4 56.31 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 120.296 -0.561 . . . . 0.0 110.683 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' HIS . . . . . 0.523 ' CD2' ' O ' ' B' ' 53' ' ' ARG . 9.9 m-70 -63.5 -45.5 90.41 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.552 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.45 -28.49 73.19 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 5.1 tp -89.66 33.2 0.84 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.872 0.367 . . . . 0.0 110.336 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . 0.586 ' HZ3' ' HE3' ' C' ' 49' ' ' LYS . 25.3 pttm . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.597 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . 0.433 ' N ' ' OD1' ' C' ' 24' ' ' ASP . 6.8 p30 -170.65 72.55 0.57 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.787 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -51.54 -33.59 48.52 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 C-N-CA 122.152 1.901 . . . . 0.0 111.047 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 18.5 tp -64.81 -50.43 66.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.97 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 27' ' ' ALA . . . . . 0.408 ' O ' ' HB3' ' C' ' 30' ' ' ALA . . . -60.52 -48.06 83.41 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.507 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . 0.401 ' O ' ' OG ' ' C' ' 31' ' ' SER . 48.2 t -57.28 -42.58 80.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.12 -42.23 80.5 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' C' ' 27' ' ' ALA . . . -57.58 -49.86 75.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.553 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' C' ' 28' ' ' VAL . 2.5 p -56.85 -46.74 81.55 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.93 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 52.4 mt -61.36 -33.91 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.518 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 3.4 mm -67.37 -42.78 87.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.072 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.1 -51.63 32.47 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.942 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . 0.463 HG23 ' N ' ' C' ' 36' ' ' LEU . 14.8 tt -63.26 -41.62 93.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.762 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.463 ' N ' HG23 ' C' ' 35' ' ' ILE . 56.0 tp -64.96 -38.43 90.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.273 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.3 t60 -63.96 -50.68 67.64 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 28.5 tp -61.57 -48.29 81.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.494 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 66.9 mt -61.41 -43.16 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.291 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' C' ' 40' ' ' LEU . 36.6 mt -64.23 -40.29 95.73 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.398 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 10.3 t-105 -61.98 -60.72 3.21 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.114 0.483 . . . . 0.0 111.431 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . 0.554 ' CG2' ' N ' ' C' ' 43' ' ' LEU . 9.0 tt -58.6 -50.82 77.69 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.579 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.691 -177.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.627 ' C ' HD13 ' C' ' 43' ' ' LEU . 2.7 tm? -61.26 -53.6 54.71 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.792 -177.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . 0.407 ' O ' ' OD1' ' C' ' 44' ' ' ASP . 68.2 t0 -52.01 -34.43 42.78 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . 0.46 ' O ' ' CD1' ' C' ' 51' ' ' ILE . 39.0 ttt-85 -69.03 -51.07 42.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.012 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 20.2 mt -79.96 -126.29 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.935 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 5.4 t80 72.75 -155.26 0.08 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.084 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -71.57 65.4 0.47 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.549 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . 0.586 ' HE3' ' HZ3' ' B' ' 60' ' ' LYS . 49.7 mttp 54.87 52.57 11.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.938 0.399 . . . . 0.0 110.092 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 38.7 t -62.14 -40.97 97.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.221 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 51' ' ' ILE . . . . . 0.472 ' H ' HD12 ' C' ' 51' ' ' ILE . 3.7 mp -46.87 -47.5 8.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.356 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -72.36 -29.79 64.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.549 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 53' ' ' ARG . . . . . 0.527 ' O ' ' CG ' ' C' ' 57' ' ' HIS . 91.8 mtt180 -69.99 -47.24 62.98 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.685 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -69.58 -41.18 76.17 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.346 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -62.52 -39.69 94.37 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.837 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -79.24 -23.11 43.93 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.199 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 57' ' ' HIS . . . . . 0.527 ' CG ' ' O ' ' C' ' 53' ' ' ARG . 49.6 m170 -72.67 -51.58 18.85 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.256 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.33 -27.65 73.41 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 7.8 tp -92.05 53.68 2.22 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.793 0.33 . . . . 0.0 110.305 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 64.8 tttm . . . . . 0 N--CA 1.466 0.351 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.354 -179.939 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 10.7 p . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . 0.406 ' N ' ' HD3' ' D' ' 25' ' ' PRO . 31.1 m-20 -158.13 58.44 1.39 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.53 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . 0.406 ' HD3' ' N ' ' D' ' 24' ' ' ASP . 54.4 Cg_exo -51.09 -30.38 31.54 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 121.671 1.58 . . . . 0.0 110.83 178.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . 0.423 HD13 ' OG ' ' A' ' 31' ' ' SER . 2.9 pp -57.13 -29.25 63.41 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 27' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' D' ' 30' ' ' ALA . . . -50.03 -41.6 47.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.776 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 79.0 t -57.31 -44.48 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.42 -29.88 70.21 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.681 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' D' ' 27' ' ' ALA . . . -69.88 -42.31 73.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.778 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 16.0 p -69.61 -46.42 66.32 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.675 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 9.5 tt -67.99 -40.16 82.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.554 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 13.0 tt -71.28 -32.38 46.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.43 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.82 -52.49 14.71 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . 0.435 HG23 ' N ' ' D' ' 36' ' ' LEU . 19.0 tt -63.12 -39.89 86.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.912 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.435 ' N ' HG23 ' D' ' 35' ' ' ILE . 43.8 tp -63.9 -37.52 87.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.911 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . 0.502 ' HD1' ' C ' ' D' ' 37' ' ' HIS . 0.3 OUTLIER -64.05 -50.06 69.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.431 -179.918 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 32.0 tp -57.98 -47.64 82.38 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.698 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 97.7 mt -60.78 -43.82 96.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.16 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . 0.547 ' O ' HD13 ' D' ' 40' ' ' LEU . 0.2 OUTLIER -61.89 -40.86 96.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.181 -179.45 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . 0.505 ' HE1' HH21 ' D' ' 45' ' ' ARG . 30.8 t-105 -62.09 -55.02 33.22 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.739 0.304 . . . . 0.0 111.287 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 79.2 mt -60.03 -55.98 20.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.913 -178.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 52.7 tp -58.34 -41.5 84.79 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.841 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . 0.426 ' O ' ' CB ' ' D' ' 50' ' ' SER . 4.2 t70 -58.54 -40.84 84.1 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . 0.505 HH21 ' HE1' ' D' ' 41' ' ' TRP . 14.8 ttm180 -62.78 -50.91 69.17 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.546 -0.461 . . . . 0.0 110.445 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.39 109.45 21.44 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.001 0.429 . . . . 0.0 109.908 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -173.18 86.53 0.06 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.374 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 53.71 55.64 8.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.419 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt 60.35 52.19 4.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.223 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' D' ' 44' ' ' ASP . 0.3 OUTLIER -58.79 -42.23 88.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.73 -179.59 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 51' ' ' ILE . . . . . 0.731 HD13 ' H ' ' D' ' 51' ' ' ILE . 0.0 OUTLIER -55.37 -43.52 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -70.59 -28.24 64.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.122 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -68.7 -44.61 73.59 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.42 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -72.16 -40.99 67.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.775 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -63.19 -41.04 99.12 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.449 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -76.94 -36.89 56.24 Favored 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.562 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -58.44 -49.81 75.98 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.406 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.47 -27.35 73.07 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -93.86 57.55 2.49 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 86.8 tttt . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.53 -179.96 . . . . . . . . 0 0 . 1 stop_ save_